[
  {
    "conceptId": [35806345],
    "regimenName": ["VMCP/VBAP"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Carmustine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1350066],
      "conceptName": ["Carmustine"]
    },
    "Melphalan": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1301267],
      "conceptName": ["Melphalan"]
    },
    "Prednisone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    }
  },
  {
    "conceptId": [35806353],
    "regimenName": ["Interferon alfa and Thalidomide"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Thalidomide": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [19137042],
      "conceptName": ["Thalidomide"]
    },
    "Interferon Alfa-2b": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1380068],
      "conceptName": ["Interferon Alfa-2b"]
    },
    "Interferon Alfa-2a": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1379969],
      "conceptName": ["Interferon Alfa-2a"]
    }
  },
  {
    "conceptId": [35804139],
    "regimenName": ["Pirarubicin monotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Pirarubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [19093366],
      "conceptName": ["Pirarubicin"]
    }
  },
  {
    "conceptId": [35806127],
    "regimenName": ["Dacarbazine monotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Dacarbazine": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1311409],
      "conceptName": ["Dacarbazine"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Aldesleukin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1309770],
      "conceptName": ["Aldesleukin"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "gemcitabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314924],
      "conceptName": ["gemcitabine"]
    },
    "Bleomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1329241],
      "conceptName": ["Bleomycin"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Carmustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350066],
      "conceptName": ["Carmustine"]
    },
    "Procarbazine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1351779],
      "conceptName": ["Procarbazine"]
    },
    "hydroxyurea": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1377141],
      "conceptName": ["hydroxyurea"]
    },
    "Paclitaxel": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1378382],
      "conceptName": ["Paclitaxel"]
    },
    "Interferon Alfa-2b": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1380068],
      "conceptName": ["Interferon Alfa-2b"]
    },
    "Lomustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1391846],
      "conceptName": ["Lomustine"]
    },
    "Mechlorethamine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1394337],
      "conceptName": ["Mechlorethamine"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "Tamoxifen": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1436678],
      "conceptName": ["Tamoxifen"]
    },
    "Methylprednisolone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1506270],
      "conceptName": ["Methylprednisolone"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Vinblastine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008264],
      "conceptName": ["Vinblastine"]
    },
    "Vindesine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008336],
      "conceptName": ["Vindesine"]
    },
    "Ifosfamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    },
    "BCG, Live, Tice Strain": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19086176],
      "conceptName": ["BCG, Live, Tice Strain"]
    },
    "ipilimumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [40238188],
      "conceptName": ["ipilimumab"]
    },
    "brentuximab vedotin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [40241969],
      "conceptName": ["brentuximab vedotin"]
    }
  },
  {
    "conceptId": [35804365],
    "regimenName": ["VAC (Adriamycin)"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Fluorouracil": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "Melphalan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1301267],
      "conceptName": ["Melphalan"]
    },
    "imatinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1304107],
      "conceptName": ["imatinib"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Dacarbazine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311409],
      "conceptName": ["Dacarbazine"]
    },
    "Dactinomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311443],
      "conceptName": ["Dactinomycin"]
    },
    "alemtuzumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1312706],
      "conceptName": ["alemtuzumab"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "pegaspargase": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1326481],
      "conceptName": ["pegaspargase"]
    },
    "Bleomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1329241],
      "conceptName": ["Bleomycin"]
    },
    "bortezomib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1336825],
      "conceptName": ["bortezomib"]
    },
    "Carboplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344905],
      "conceptName": ["Carboplatin"]
    },
    "Carmustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350066],
      "conceptName": ["Carmustine"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Procarbazine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1351779],
      "conceptName": ["Procarbazine"]
    },
    "dasatinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1358436],
      "conceptName": ["dasatinib"]
    },
    "irinotecan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1367268],
      "conceptName": ["irinotecan"]
    },
    "Topotecan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1378509],
      "conceptName": ["Topotecan"]
    },
    "Mechlorethamine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1394337],
      "conceptName": ["Mechlorethamine"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "mercaptopurine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1436650],
      "conceptName": ["mercaptopurine"]
    },
    "Thioguanine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1437379],
      "conceptName": ["Thioguanine"]
    },
    "Methylprednisolone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1506270],
      "conceptName": ["Methylprednisolone"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "prednisolone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1550557],
      "conceptName": ["prednisolone"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Hyaluronidase / rituximab Injection [Rituxan Hycela]": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1593155],
      "conceptName": ["Hyaluronidase / rituximab Injection [Rituxan Hycela]"]
    },
    "Vinblastine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008264],
      "conceptName": ["Vinblastine"]
    },
    "Vindesine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008336],
      "conceptName": ["Vindesine"]
    },
    "everolimus": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19011440],
      "conceptName": ["everolimus"]
    },
    "ASPARAGINASE": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19012585],
      "conceptName": ["ASPARAGINASE"]
    },
    "lenalidomide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19026972],
      "conceptName": ["lenalidomide"]
    },
    "denileukin diftitox": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19051642],
      "conceptName": ["denileukin diftitox"]
    },
    "iodine-131-tositumomab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19054997],
      "conceptName": ["iodine-131-tositumomab"]
    },
    "Ifosfamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    },
    "BCG, Live, Tice Strain": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19086176],
      "conceptName": ["BCG, Live, Tice Strain"]
    },
    "Teniposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19136750],
      "conceptName": ["Teniposide"]
    },
    "ranimustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [35197850],
      "conceptName": ["ranimustine"]
    },
    "ofatumumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [40167582],
      "conceptName": ["ofatumumab"]
    },
    "ponatinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [43013182],
      "conceptName": ["ponatinib"]
    },
    "obinutuzumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [44507676],
      "conceptName": ["obinutuzumab"]
    }
  },
  {
    "conceptId": [35804013],
    "regimenName": ["R-TBI/Cy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "rituximab": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Mitoxantrone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1309188],
      "conceptName": ["Mitoxantrone"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Daunorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311799],
      "conceptName": ["Daunorubicin"]
    },
    "alemtuzumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1312706],
      "conceptName": ["alemtuzumab"]
    },
    "gemcitabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314924],
      "conceptName": ["gemcitabine"]
    },
    "Bleomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1329241],
      "conceptName": ["Bleomycin"]
    },
    "bortezomib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1336825],
      "conceptName": ["bortezomib"]
    },
    "Vorinostat": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1337651],
      "conceptName": ["Vorinostat"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Epirubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344354],
      "conceptName": ["Epirubicin"]
    },
    "Carmustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350066],
      "conceptName": ["Carmustine"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Procarbazine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1351779],
      "conceptName": ["Procarbazine"]
    },
    "fludarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1395557],
      "conceptName": ["fludarabine"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "Methylprednisolone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1506270],
      "conceptName": ["Methylprednisolone"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "prednisolone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1550557],
      "conceptName": ["prednisolone"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Hyaluronidase / rituximab Injection [Rituxan Hycela]": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1593155],
      "conceptName": ["Hyaluronidase / rituximab Injection [Rituxan Hycela]"]
    },
    "Vinblastine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008264],
      "conceptName": ["Vinblastine"]
    },
    "Vindesine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008336],
      "conceptName": ["Vindesine"]
    },
    "ASPARAGINASE": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19012585],
      "conceptName": ["ASPARAGINASE"]
    },
    "lenalidomide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19026972],
      "conceptName": ["lenalidomide"]
    },
    "Pentostatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19031224],
      "conceptName": ["Pentostatin"]
    },
    "doxorubicin liposome": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19051649],
      "conceptName": ["doxorubicin liposome"]
    },
    "Cladribine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19054825],
      "conceptName": ["Cladribine"]
    },
    "ibritumomab tiuxetan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19068830],
      "conceptName": ["ibritumomab tiuxetan"]
    },
    "Ifosfamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    },
    "Teniposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19136750],
      "conceptName": ["Teniposide"]
    },
    "Thalidomide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19137042],
      "conceptName": ["Thalidomide"]
    },
    "Cytarabine liposome": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [40175460],
      "conceptName": ["Cytarabine liposome"]
    },
    "vincristine liposome": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [42874135],
      "conceptName": ["vincristine liposome"]
    }
  },
  {
    "conceptId": [35101471],
    "regimenName": ["Methotrexate and Pegaspargase"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Methotrexate": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "pegaspargase": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1326481],
      "conceptName": ["pegaspargase"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    }
  },
  {
    "conceptId": [35807089],
    "regimenName": ["ABV (Vinblastine)"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Bleomycin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1329241],
      "conceptName": ["Bleomycin"]
    },
    "Vinblastine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [19008264],
      "conceptName": ["Vinblastine"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Dacarbazine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311409],
      "conceptName": ["Dacarbazine"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Procarbazine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1351779],
      "conceptName": ["Procarbazine"]
    },
    "Chlorambucil": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1390051],
      "conceptName": ["Chlorambucil"]
    },
    "Lomustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1391846],
      "conceptName": ["Lomustine"]
    },
    "Mechlorethamine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1394337],
      "conceptName": ["Mechlorethamine"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "Methylprednisolone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1506270],
      "conceptName": ["Methylprednisolone"]
    },
    "prednisolone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1550557],
      "conceptName": ["prednisolone"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Streptozocin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19136210],
      "conceptName": ["Streptozocin"]
    }
  },
  {
    "conceptId": [35806091],
    "regimenName": ["VAD plus C"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Chlorambucil": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1390051],
      "conceptName": ["Chlorambucil"]
    },
    "Dexamethasone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    }
  },
  {
    "conceptId": [35804536],
    "regimenName": ["Carboplatin and Ifosfamide"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Carboplatin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1344905],
      "conceptName": ["Carboplatin"]
    },
    "Ifosfamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Mesna": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1354698],
      "conceptName": ["Mesna"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "prednisolone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1550557],
      "conceptName": ["prednisolone"]
    },
    "lenalidomide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19026972],
      "conceptName": ["lenalidomide"]
    },
    "ofatumumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [40167582],
      "conceptName": ["ofatumumab"]
    }
  },
  {
    "conceptId": [35805885],
    "regimenName": ["Cladribine and Cytarabine"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Cytarabine": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Cladribine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [19054825],
      "conceptName": ["Cladribine"]
    },
    "Filgrastim": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1304850],
      "conceptName": ["Filgrastim"]
    },
    "Mitoxantrone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1309188],
      "conceptName": ["Mitoxantrone"]
    },
    "Daunorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311799],
      "conceptName": ["Daunorubicin"]
    }
  },
  {
    "conceptId": [35804577],
    "regimenName": ["FCM"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Cyclophosphamide": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "fludarabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1395557],
      "conceptName": ["fludarabine"]
    },
    "Mitoxantrone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1309188],
      "conceptName": ["Mitoxantrone"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    }
  },
  {
    "conceptId": [35806299],
    "regimenName": ["VMP, then Rd"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "lenalidomide": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [19026972],
      "conceptName": ["lenalidomide"]
    },
    "Melphalan": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1301267],
      "conceptName": ["Melphalan"]
    },
    "bortezomib": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1336825],
      "conceptName": ["bortezomib"]
    },
    "Prednisone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Dexamethasone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    }
  },
  {
    "conceptId": [35806590],
    "regimenName": ["Erlotinib and Gemcitabine"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "erlotinib": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1325363],
      "conceptName": ["erlotinib"]
    },
    "gemcitabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1314924],
      "conceptName": ["gemcitabine"]
    },
    "Carboplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344905],
      "conceptName": ["Carboplatin"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    }
  },
  {
    "conceptId": [35805103],
    "regimenName": ["m-BACOD"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Bleomycin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1329241],
      "conceptName": ["Bleomycin"]
    },
    "Methotrexate": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Dexamethasone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    }
  },
  {
    "conceptId": [35805342],
    "regimenName": ["PCF"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Paclitaxel": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1378382],
      "conceptName": ["Paclitaxel"]
    },
    "Cisplatin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "Fluorouracil": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    }
  },
  {
    "conceptId": [35806361],
    "regimenName": ["Epoetin and Lenalidomide"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "lenalidomide": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [19026972],
      "conceptName": ["lenalidomide"]
    },
    "Melphalan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1301267],
      "conceptName": ["Melphalan"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Azacitidine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314865],
      "conceptName": ["Azacitidine"]
    },
    "bortezomib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1336825],
      "conceptName": ["bortezomib"]
    },
    "Vorinostat": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1337651],
      "conceptName": ["Vorinostat"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Carboplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344905],
      "conceptName": ["Carboplatin"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Mesna": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1354698],
      "conceptName": ["Mesna"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Clarithromycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1750500],
      "conceptName": ["Clarithromycin"]
    },
    "bendamustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19015523],
      "conceptName": ["bendamustine"]
    },
    "Ifosfamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    },
    "elotuzumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [35604032],
      "conceptName": ["elotuzumab"]
    },
    "daratumumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [35605744],
      "conceptName": ["daratumumab"]
    },
    "ixazomib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [35606214],
      "conceptName": ["ixazomib"]
    },
    "ofatumumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [40167582],
      "conceptName": ["ofatumumab"]
    },
    "carfilzomib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [42873638],
      "conceptName": ["carfilzomib"]
    },
    "panobinostat": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [46221435],
      "conceptName": ["panobinostat"]
    }
  },
  {
    "conceptId": [35807525],
    "regimenName": ["Cisplatin, Dacarbazine, IL-2, IFN alfa-2b plus /- Carmustine"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Carmustine": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1350066],
      "conceptName": ["Carmustine"]
    },
    "Cisplatin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "Dacarbazine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1311409],
      "conceptName": ["Dacarbazine"]
    },
    "Aldesleukin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1309770],
      "conceptName": ["Aldesleukin"]
    },
    "Interferon Alfa-2b": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1380068],
      "conceptName": ["Interferon Alfa-2b"]
    }
  },
  {
    "conceptId": [35804155],
    "regimenName": ["Cisplatin and Methotrexate"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Methotrexate": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Cisplatin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Dactinomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311443],
      "conceptName": ["Dactinomycin"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Bleomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1329241],
      "conceptName": ["Bleomycin"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Mesna": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1354698],
      "conceptName": ["Mesna"]
    },
    "Paclitaxel": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1378382],
      "conceptName": ["Paclitaxel"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "Vinblastine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008264],
      "conceptName": ["Vinblastine"]
    },
    "Ifosfamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    }
  },
  {
    "conceptId": [35806665],
    "regimenName": ["R-CP"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Methylprednisolone": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1506270],
      "conceptName": ["Methylprednisolone"]
    },
    "rituximab": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Prednisone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    }
  },
  {
    "conceptId": [35806061],
    "regimenName": ["VDC"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "bortezomib": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1336825],
      "conceptName": ["bortezomib"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Dexamethasone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "Melphalan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1301267],
      "conceptName": ["Melphalan"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "lenalidomide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19026972],
      "conceptName": ["lenalidomide"]
    },
    "doxorubicin liposome": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19051649],
      "conceptName": ["doxorubicin liposome"]
    },
    "Thalidomide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19137042],
      "conceptName": ["Thalidomide"]
    }
  },
  {
    "conceptId": [35805041],
    "regimenName": ["R-GCVP"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "rituximab": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "gemcitabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1314924],
      "conceptName": ["gemcitabine"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "prednisolone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1550557],
      "conceptName": ["prednisolone"]
    }
  },
  {
    "conceptId": [35805249],
    "regimenName": ["Medroxyprogesterone and Tamoxifen"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Tamoxifen": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1436678],
      "conceptName": ["Tamoxifen"]
    },
    "Medroxyprogesterone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1500211],
      "conceptName": ["Medroxyprogesterone"]
    }
  },
  {
    "conceptId": [35804259],
    "regimenName": ["Capecitabine and Ixabepilone"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "capecitabine": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1337620],
      "conceptName": ["capecitabine"]
    },
    "ixabepilone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [19025348],
      "conceptName": ["ixabepilone"]
    }
  },
  {
    "conceptId": [35804065],
    "regimenName": ["Mitoxantrone, Pegaspargase, Vincristine, Dexamethasone"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "pegaspargase": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1326481],
      "conceptName": ["pegaspargase"]
    },
    "Dexamethasone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "Mitoxantrone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1309188],
      "conceptName": ["Mitoxantrone"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    }
  },
  {
    "conceptId": [35806054],
    "regimenName": ["CTD"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Thalidomide": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [19137042],
      "conceptName": ["Thalidomide"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Dexamethasone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "Melphalan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1301267],
      "conceptName": ["Melphalan"]
    },
    "bortezomib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1336825],
      "conceptName": ["bortezomib"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "carfilzomib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [42873638],
      "conceptName": ["carfilzomib"]
    }
  },
  {
    "conceptId": [35806592],
    "regimenName": ["GTX"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "docetaxel": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1315942],
      "conceptName": ["docetaxel"]
    },
    "gemcitabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1314924],
      "conceptName": ["gemcitabine"]
    },
    "capecitabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1337620],
      "conceptName": ["capecitabine"]
    }
  },
  {
    "conceptId": [35805820],
    "regimenName": ["OPPA"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Prednisone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Procarbazine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1351779],
      "conceptName": ["Procarbazine"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Dacarbazine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311409],
      "conceptName": ["Dacarbazine"]
    },
    "Bleomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1329241],
      "conceptName": ["Bleomycin"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Chlorambucil": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1390051],
      "conceptName": ["Chlorambucil"]
    },
    "Mechlorethamine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1394337],
      "conceptName": ["Mechlorethamine"]
    },
    "Vinblastine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008264],
      "conceptName": ["Vinblastine"]
    }
  },
  {
    "conceptId": [35101520],
    "regimenName": ["Bendamustine and Brentuximab vedotin"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "bendamustine": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [19015523],
      "conceptName": ["bendamustine"]
    },
    "brentuximab vedotin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [40241969],
      "conceptName": ["brentuximab vedotin"]
    }
  },
  {
    "conceptId": [35806271],
    "regimenName": ["Thalidomide monotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Thalidomide": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [19137042],
      "conceptName": ["Thalidomide"]
    },
    "Melphalan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1301267],
      "conceptName": ["Melphalan"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "gemcitabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314924],
      "conceptName": ["gemcitabine"]
    },
    "bortezomib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1336825],
      "conceptName": ["bortezomib"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "temozolomide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1341149],
      "conceptName": ["temozolomide"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Procarbazine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1351779],
      "conceptName": ["Procarbazine"]
    },
    "Interferon Alfa-2a": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1379969],
      "conceptName": ["Interferon Alfa-2a"]
    },
    "Interferon Alfa-2b": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1380068],
      "conceptName": ["Interferon Alfa-2b"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "prednisolone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1550557],
      "conceptName": ["prednisolone"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "bendamustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19015523],
      "conceptName": ["bendamustine"]
    },
    "doxorubicin liposome": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19051649],
      "conceptName": ["doxorubicin liposome"]
    },
    "daratumumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [35605744],
      "conceptName": ["daratumumab"]
    },
    "carfilzomib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [42873638],
      "conceptName": ["carfilzomib"]
    },
    "panobinostat": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [46221435],
      "conceptName": ["panobinostat"]
    }
  },
  {
    "conceptId": [35804169],
    "regimenName": ["Vinflunine monotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Vinflunine": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [36878852],
      "conceptName": ["Vinflunine"]
    }
  },
  {
    "conceptId": [35806847],
    "regimenName": ["Nilutamide and Orchiectomy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "nilutamide": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1315286],
      "conceptName": ["nilutamide"]
    }
  },
  {
    "conceptId": [35806893],
    "regimenName": ["CapeOx, Cetuximab, RT"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "oxaliplatin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1318011],
      "conceptName": ["oxaliplatin"]
    },
    "cetuximab": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1315411],
      "conceptName": ["cetuximab"]
    },
    "capecitabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1337620],
      "conceptName": ["capecitabine"]
    }
  },
  {
    "conceptId": [35806868],
    "regimenName": ["Doxorubicin and Strontium-89"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Strontium-89": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [19132890],
      "conceptName": ["Strontium-89"]
    }
  },
  {
    "conceptId": [35804168],
    "regimenName": ["Pemetrexed monotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "pemetrexed": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1304919],
      "conceptName": ["pemetrexed"]
    },
    "gefitinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1319193],
      "conceptName": ["gefitinib"]
    },
    "Carboplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344905],
      "conceptName": ["Carboplatin"]
    },
    "bevacizumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397141],
      "conceptName": ["bevacizumab"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "pembrolizumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [45775965],
      "conceptName": ["pembrolizumab"]
    }
  },
  {
    "conceptId": [35806411],
    "regimenName": ["Cisplatin, Gemcitabine, Bevacizumab"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "bevacizumab": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1397141],
      "conceptName": ["bevacizumab"]
    },
    "Cisplatin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "gemcitabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1314924],
      "conceptName": ["gemcitabine"]
    }
  },
  {
    "conceptId": [35804203],
    "regimenName": ["THL (Taxol)"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Paclitaxel": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1378382],
      "conceptName": ["Paclitaxel"]
    },
    "trastuzumab": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1387104],
      "conceptName": ["trastuzumab"]
    },
    "lapatinib": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1359548],
      "conceptName": ["lapatinib"]
    }
  },
  {
    "conceptId": [35805680],
    "regimenName": ["Cisplatin and S-1"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Cisplatin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "Hyaluronidase / trastuzumab Injection [Herceptin Hylecta]": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1366689],
      "conceptName": ["Hyaluronidase / trastuzumab Injection [Herceptin Hylecta]"]
    },
    "gemcitabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314924],
      "conceptName": ["gemcitabine"]
    }
  },
  {
    "conceptId": [35806333],
    "regimenName": ["V-HyperCAD"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "bortezomib": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1336825],
      "conceptName": ["bortezomib"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Dexamethasone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "Melphalan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1301267],
      "conceptName": ["Melphalan"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "Thalidomide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19137042],
      "conceptName": ["Thalidomide"]
    }
  },
  {
    "conceptId": [35805453],
    "regimenName": ["Cyclophosphamide and Topotecan"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Topotecan": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1378509],
      "conceptName": ["Topotecan"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Ifosfamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    }
  },
  {
    "conceptId": [35804012],
    "regimenName": ["R-BEAM"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Carmustine": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1350066],
      "conceptName": ["Carmustine"]
    },
    "Melphalan": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1301267],
      "conceptName": ["Melphalan"]
    },
    "rituximab": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Cytarabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Etoposide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "ibritumomab tiuxetan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19068830],
      "conceptName": ["ibritumomab tiuxetan"]
    }
  },
  {
    "conceptId": [35804321],
    "regimenName": ["nab-Paclitaxel and Atezolizumab"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Paclitaxel": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1378382],
      "conceptName": ["Paclitaxel"]
    },
    "atezolizumab": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [42629079],
      "conceptName": ["atezolizumab"]
    },
    "Carboplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344905],
      "conceptName": ["Carboplatin"]
    },
    "bevacizumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397141],
      "conceptName": ["bevacizumab"]
    }
  },
  {
    "conceptId": [35804260],
    "regimenName": ["Cisplatin and Vinorelbine"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Cisplatin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "vinorelbine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1343346],
      "conceptName": ["vinorelbine"]
    },
    "cetuximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1315411],
      "conceptName": ["cetuximab"]
    }
  },
  {
    "conceptId": [35803559],
    "regimenName": ["Cytarabine and Idarubicin, then Etoposide and Mitoxantrone, then Cytarabine, Idarubicin, Thioguanine"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Thioguanine": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1437379],
      "conceptName": ["Thioguanine"]
    },
    "Idarubicin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [19078097],
      "conceptName": ["Idarubicin"]
    },
    "Cytarabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Mitoxantrone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1309188],
      "conceptName": ["Mitoxantrone"]
    },
    "Etoposide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Tretinoin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [903643],
      "conceptName": ["Tretinoin"]
    }
  },
  {
    "conceptId": [35805369],
    "regimenName": ["Irinotecan and Mitomycin"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Mitomycin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1389036],
      "conceptName": ["Mitomycin"]
    },
    "irinotecan": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1367268],
      "conceptName": ["irinotecan"]
    }
  },
  {
    "conceptId": [35803528],
    "regimenName": ["Cytarabine, Daunorubicin, Mercaptopurine, Prednisolone"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Cytarabine": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "mercaptopurine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1436650],
      "conceptName": ["mercaptopurine"]
    },
    "Daunorubicin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1311799],
      "conceptName": ["Daunorubicin"]
    },
    "prednisolone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1550557],
      "conceptName": ["prednisolone"]
    }
  },
  {
    "conceptId": [35805321],
    "regimenName": ["Cobimetinib monotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Cobimetinib": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [35605804],
      "conceptName": ["Cobimetinib"]
    },
    "Vemurafenib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [40241937],
      "conceptName": ["Vemurafenib"]
    }
  },
  {
    "conceptId": [35803621],
    "regimenName": ["FCR"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "rituximab": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "fludarabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1395557],
      "conceptName": ["fludarabine"]
    },
    "Mitoxantrone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1309188],
      "conceptName": ["Mitoxantrone"]
    },
    "alemtuzumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1312706],
      "conceptName": ["alemtuzumab"]
    },
    "ibritumomab tiuxetan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19068830],
      "conceptName": ["ibritumomab tiuxetan"]
    }
  },
  {
    "conceptId": [35806385],
    "regimenName": ["Octreotide LAR monotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Octreotide": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1522957],
      "conceptName": ["Octreotide"]
    },
    "Interferon Alfa-2b": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1380068],
      "conceptName": ["Interferon Alfa-2b"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "everolimus": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19011440],
      "conceptName": ["everolimus"]
    },
    "Lutetium": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [44816340],
      "conceptName": ["Lutetium"]
    }
  },
  {
    "conceptId": [35805040],
    "regimenName": ["R-CHMP"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "doxorubicin liposome": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [19051649],
      "conceptName": ["doxorubicin liposome"]
    },
    "rituximab": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Prednisone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "vincristine liposome": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [42874135],
      "conceptName": ["vincristine liposome"]
    }
  },
  {
    "conceptId": [35804795],
    "regimenName": ["Cetuximab monotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "cetuximab": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1315411],
      "conceptName": ["cetuximab"]
    },
    "Fluorouracil": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "gemcitabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314924],
      "conceptName": ["gemcitabine"]
    },
    "docetaxel": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1315942],
      "conceptName": ["docetaxel"]
    },
    "oxaliplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1318011],
      "conceptName": ["oxaliplatin"]
    },
    "capecitabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1337620],
      "conceptName": ["capecitabine"]
    },
    "vinorelbine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1343346],
      "conceptName": ["vinorelbine"]
    },
    "Carboplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344905],
      "conceptName": ["Carboplatin"]
    },
    "irinotecan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1367268],
      "conceptName": ["irinotecan"]
    },
    "Leucovorin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1388796],
      "conceptName": ["Leucovorin"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "levoleucovorin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [40168303],
      "conceptName": ["levoleucovorin"]
    }
  },
  {
    "conceptId": [35805044],
    "regimenName": ["R-miniCHOP"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "rituximab": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Prednisone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "bortezomib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1336825],
      "conceptName": ["bortezomib"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "Hyaluronidase / rituximab Injection [Rituxan Hycela]": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1593155],
      "conceptName": ["Hyaluronidase / rituximab Injection [Rituxan Hycela]"]
    },
    "Vindesine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008336],
      "conceptName": ["Vindesine"]
    },
    "lenalidomide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19026972],
      "conceptName": ["lenalidomide"]
    },
    "Ifosfamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    },
    "Teniposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19136750],
      "conceptName": ["Teniposide"]
    }
  },
  {
    "conceptId": [35803617],
    "regimenName": ["BFR"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "bendamustine": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [19015523],
      "conceptName": ["bendamustine"]
    },
    "rituximab": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "fludarabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1395557],
      "conceptName": ["fludarabine"]
    }
  },
  {
    "conceptId": [35807048],
    "regimenName": ["Radioiodine ablation"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "iodine I-131": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [45775540],
      "conceptName": ["iodine I-131"]
    }
  },
  {
    "conceptId": [35101150],
    "regimenName": ["Dara-VTD"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "daratumumab": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [35605744],
      "conceptName": ["daratumumab"]
    },
    "Thalidomide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [19137042],
      "conceptName": ["Thalidomide"]
    },
    "bortezomib": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1336825],
      "conceptName": ["bortezomib"]
    },
    "Dexamethasone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    }
  },
  {
    "conceptId": [35804307],
    "regimenName": ["TCH (Taxotere, Carboplatin)"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Carboplatin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1344905],
      "conceptName": ["Carboplatin"]
    },
    "trastuzumab": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1387104],
      "conceptName": ["trastuzumab"]
    },
    "docetaxel": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1315942],
      "conceptName": ["docetaxel"]
    },
    "pertuzumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [42801287],
      "conceptName": ["pertuzumab"]
    }
  },
  {
    "conceptId": [35101643],
    "regimenName": ["mFOLFOX6 and Bevacizumab (L-Leucovorin)"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "oxaliplatin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1318011],
      "conceptName": ["oxaliplatin"]
    },
    "bevacizumab": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1397141],
      "conceptName": ["bevacizumab"]
    },
    "levoleucovorin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [40168303],
      "conceptName": ["levoleucovorin"]
    },
    "Fluorouracil": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "irinotecan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1367268],
      "conceptName": ["irinotecan"]
    }
  },
  {
    "conceptId": [35804230],
    "regimenName": ["ddTH (Taxotere)"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "trastuzumab": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1387104],
      "conceptName": ["trastuzumab"]
    },
    "docetaxel": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1315942],
      "conceptName": ["docetaxel"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Carboplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344905],
      "conceptName": ["Carboplatin"]
    },
    "pertuzumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [42801287],
      "conceptName": ["pertuzumab"]
    }
  },
  {
    "conceptId": [35805351],
    "regimenName": ["Cisplatin, Vinorelbine, RT"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Cisplatin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "vinorelbine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1343346],
      "conceptName": ["vinorelbine"]
    },
    "cetuximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1315411],
      "conceptName": ["cetuximab"]
    }
  },
  {
    "conceptId": [35803623],
    "regimenName": ["Fludarabine, Busulfan, ATG"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Busulfan": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1333357],
      "conceptName": ["Busulfan"]
    },
    "fludarabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1395557],
      "conceptName": ["fludarabine"]
    },
    "Melphalan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1301267],
      "conceptName": ["Melphalan"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "ibritumomab tiuxetan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19068830],
      "conceptName": ["ibritumomab tiuxetan"]
    }
  },
  {
    "conceptId": [35804227],
    "regimenName": ["Capecitabine monotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "capecitabine": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1337620],
      "conceptName": ["capecitabine"]
    },
    "neratinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [793846],
      "conceptName": ["neratinib"]
    },
    "Fluorouracil": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "fulvestrant": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1304044],
      "conceptName": ["fulvestrant"]
    },
    "gemcitabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314924],
      "conceptName": ["gemcitabine"]
    },
    "cetuximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1315411],
      "conceptName": ["cetuximab"]
    },
    "docetaxel": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1315942],
      "conceptName": ["docetaxel"]
    },
    "oxaliplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1318011],
      "conceptName": ["oxaliplatin"]
    },
    "erlotinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1325363],
      "conceptName": ["erlotinib"]
    },
    "temozolomide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1341149],
      "conceptName": ["temozolomide"]
    },
    "Epirubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344354],
      "conceptName": ["Epirubicin"]
    },
    "Carboplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344905],
      "conceptName": ["Carboplatin"]
    },
    "lapatinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1359548],
      "conceptName": ["lapatinib"]
    },
    "sorafenib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1363387],
      "conceptName": ["sorafenib"]
    },
    "irinotecan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1367268],
      "conceptName": ["irinotecan"]
    },
    "Paclitaxel": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1378382],
      "conceptName": ["Paclitaxel"]
    },
    "trastuzumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1387104],
      "conceptName": ["trastuzumab"]
    },
    "Mitomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1389036],
      "conceptName": ["Mitomycin"]
    },
    "bevacizumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397141],
      "conceptName": ["bevacizumab"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "ixabepilone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19025348],
      "conceptName": ["ixabepilone"]
    },
    "panitumumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19100985],
      "conceptName": ["panitumumab"]
    },
    "pertuzumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [42801287],
      "conceptName": ["pertuzumab"]
    }
  },
  {
    "conceptId": [35804004],
    "regimenName": ["CBV-Mx"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Carmustine": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1350066],
      "conceptName": ["Carmustine"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Mitoxantrone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1309188],
      "conceptName": ["Mitoxantrone"]
    },
    "Etoposide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    }
  },
  {
    "conceptId": [35805248],
    "regimenName": ["Ifosfamide and Paclitaxel"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Paclitaxel": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1378382],
      "conceptName": ["Paclitaxel"]
    },
    "Ifosfamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    }
  },
  {
    "conceptId": [35806979],
    "regimenName": ["Cyclophosphamide, Cytarabine, Mercaptopurine, Nelarabine, Pegaspargase, Vincristine"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "pegaspargase": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1326481],
      "conceptName": ["pegaspargase"]
    },
    "Cytarabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "mercaptopurine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1436650],
      "conceptName": ["mercaptopurine"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "nelarabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [19002912],
      "conceptName": ["nelarabine"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    }
  },
  {
    "conceptId": [35805048],
    "regimenName": ["CBVM, then auto HSCT"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Carmustine": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1350066],
      "conceptName": ["Carmustine"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Mitoxantrone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1309188],
      "conceptName": ["Mitoxantrone"]
    },
    "Etoposide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    }
  },
  {
    "conceptId": [35805836],
    "regimenName": ["Ifosfamide and Vinorelbine"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Ifosfamide": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    },
    "Mesna": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1354698],
      "conceptName": ["Mesna"]
    },
    "vinorelbine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1343346],
      "conceptName": ["vinorelbine"]
    }
  },
  {
    "conceptId": [35804808],
    "regimenName": ["FOLFOX chronotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "oxaliplatin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1318011],
      "conceptName": ["oxaliplatin"]
    },
    "Leucovorin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1388796],
      "conceptName": ["Leucovorin"]
    },
    "Fluorouracil": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "gemcitabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314924],
      "conceptName": ["gemcitabine"]
    },
    "cetuximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1315411],
      "conceptName": ["cetuximab"]
    },
    "docetaxel": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1315942],
      "conceptName": ["docetaxel"]
    },
    "irinotecan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1367268],
      "conceptName": ["irinotecan"]
    },
    "bevacizumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397141],
      "conceptName": ["bevacizumab"]
    },
    "panitumumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19100985],
      "conceptName": ["panitumumab"]
    }
  },
  {
    "conceptId": [35804802],
    "regimenName": ["Fluorouracil and Levamisole"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Levamisole": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1389464],
      "conceptName": ["Levamisole"]
    },
    "Fluorouracil": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "Leucovorin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1388796],
      "conceptName": ["Leucovorin"]
    }
  },
  {
    "conceptId": [35805651],
    "regimenName": ["VR-CP"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "rituximab": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "bortezomib": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1336825],
      "conceptName": ["bortezomib"]
    },
    "Prednisone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    }
  },
  {
    "conceptId": [35102024],
    "regimenName": ["CVP (Vinblastine/Prednisone)"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Vinblastine": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [19008264],
      "conceptName": ["Vinblastine"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "prednisolone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1550557],
      "conceptName": ["prednisolone"]
    }
  },
  {
    "conceptId": [35804319],
    "regimenName": ["Bevacizumab-containing therapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "bevacizumab": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1397141],
      "conceptName": ["bevacizumab"]
    },
    "Fluorouracil": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "pemetrexed": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1304919],
      "conceptName": ["pemetrexed"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "gemcitabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314924],
      "conceptName": ["gemcitabine"]
    },
    "docetaxel": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1315942],
      "conceptName": ["docetaxel"]
    },
    "letrozole": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1315946],
      "conceptName": ["letrozole"]
    },
    "oxaliplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1318011],
      "conceptName": ["oxaliplatin"]
    },
    "erlotinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1325363],
      "conceptName": ["erlotinib"]
    },
    "capecitabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1337620],
      "conceptName": ["capecitabine"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "temozolomide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1341149],
      "conceptName": ["temozolomide"]
    },
    "vinorelbine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1343346],
      "conceptName": ["vinorelbine"]
    },
    "Epirubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344354],
      "conceptName": ["Epirubicin"]
    },
    "Carboplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344905],
      "conceptName": ["Carboplatin"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Hyaluronidase / trastuzumab Injection [Herceptin Hylecta]": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1366689],
      "conceptName": ["Hyaluronidase / trastuzumab Injection [Herceptin Hylecta]"]
    },
    "irinotecan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1367268],
      "conceptName": ["irinotecan"]
    },
    "Paclitaxel": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1378382],
      "conceptName": ["Paclitaxel"]
    },
    "Topotecan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1378509],
      "conceptName": ["Topotecan"]
    },
    "Interferon Alfa-2a": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1379969],
      "conceptName": ["Interferon Alfa-2a"]
    },
    "trastuzumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1387104],
      "conceptName": ["trastuzumab"]
    },
    "Leucovorin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1388796],
      "conceptName": ["Leucovorin"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "doxorubicin liposome": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19051649],
      "conceptName": ["doxorubicin liposome"]
    },
    "Myocet": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [21017157],
      "conceptName": ["Myocet"]
    },
    "levoleucovorin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [40168303],
      "conceptName": ["levoleucovorin"]
    },
    "atezolizumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [42629079],
      "conceptName": ["atezolizumab"]
    }
  },
  {
    "conceptId": [35100617],
    "regimenName": ["MBVP"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Methotrexate": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Carmustine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1350066],
      "conceptName": ["Carmustine"]
    },
    "Prednisone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Teniposide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [19136750],
      "conceptName": ["Teniposide"]
    }
  },
  {
    "conceptId": [35805995],
    "regimenName": ["Methotrexate and Prednisone"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Methotrexate": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Prednisone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Fluorouracil": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Daunorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311799],
      "conceptName": ["Daunorubicin"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Bleomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1329241],
      "conceptName": ["Bleomycin"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Carmustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350066],
      "conceptName": ["Carmustine"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Procarbazine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1351779],
      "conceptName": ["Procarbazine"]
    },
    "Mechlorethamine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1394337],
      "conceptName": ["Mechlorethamine"]
    },
    "mercaptopurine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1436650],
      "conceptName": ["mercaptopurine"]
    },
    "Tamoxifen": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1436678],
      "conceptName": ["Tamoxifen"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "Vinblastine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008264],
      "conceptName": ["Vinblastine"]
    },
    "Vindesine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008336],
      "conceptName": ["Vindesine"]
    },
    "ASPARAGINASE": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19012585],
      "conceptName": ["ASPARAGINASE"]
    },
    "Ifosfamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    },
    "Teniposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19136750],
      "conceptName": ["Teniposide"]
    }
  },
  {
    "conceptId": [35803695],
    "regimenName": ["APO"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Prednisone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Fluorouracil": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "Melphalan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1301267],
      "conceptName": ["Melphalan"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Dacarbazine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311409],
      "conceptName": ["Dacarbazine"]
    },
    "alemtuzumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1312706],
      "conceptName": ["alemtuzumab"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Bleomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1329241],
      "conceptName": ["Bleomycin"]
    },
    "bortezomib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1336825],
      "conceptName": ["bortezomib"]
    },
    "Carboplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344905],
      "conceptName": ["Carboplatin"]
    },
    "Carmustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350066],
      "conceptName": ["Carmustine"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Procarbazine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1351779],
      "conceptName": ["Procarbazine"]
    },
    "Chlorambucil": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1390051],
      "conceptName": ["Chlorambucil"]
    },
    "Mechlorethamine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1394337],
      "conceptName": ["Mechlorethamine"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "mercaptopurine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1436650],
      "conceptName": ["mercaptopurine"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "Hyaluronidase / rituximab Injection [Rituxan Hycela]": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1593155],
      "conceptName": ["Hyaluronidase / rituximab Injection [Rituxan Hycela]"]
    },
    "Quinine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1760616],
      "conceptName": ["Quinine"]
    },
    "Vinblastine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008264],
      "conceptName": ["Vinblastine"]
    },
    "Vindesine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008336],
      "conceptName": ["Vindesine"]
    },
    "everolimus": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19011440],
      "conceptName": ["everolimus"]
    },
    "ASPARAGINASE": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19012585],
      "conceptName": ["ASPARAGINASE"]
    },
    "lenalidomide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19026972],
      "conceptName": ["lenalidomide"]
    },
    "denileukin diftitox": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19051642],
      "conceptName": ["denileukin diftitox"]
    },
    "iodine-131-tositumomab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19054997],
      "conceptName": ["iodine-131-tositumomab"]
    },
    "Ifosfamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    },
    "BCG, Live, Tice Strain": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19086176],
      "conceptName": ["BCG, Live, Tice Strain"]
    },
    "Teniposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19136750],
      "conceptName": ["Teniposide"]
    },
    "ranimustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [35197850],
      "conceptName": ["ranimustine"]
    },
    "ofatumumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [40167582],
      "conceptName": ["ofatumumab"]
    },
    "obinutuzumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [44507676],
      "conceptName": ["obinutuzumab"]
    }
  },
  {
    "conceptId": [35805336],
    "regimenName": ["Capecitabine, Cisplatin, RT"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Cisplatin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "capecitabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1337620],
      "conceptName": ["capecitabine"]
    },
    "Fluorouracil": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "cetuximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1315411],
      "conceptName": ["cetuximab"]
    },
    "Epirubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344354],
      "conceptName": ["Epirubicin"]
    },
    "trastuzumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1387104],
      "conceptName": ["trastuzumab"]
    }
  },
  {
    "conceptId": [35804388],
    "regimenName": ["Dexamethasone monotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Dexamethasone": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "inotuzumab ozogamicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [794068],
      "conceptName": ["inotuzumab ozogamicin"]
    },
    "Aspirin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1112807],
      "conceptName": ["Aspirin"]
    },
    "Melphalan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1301267],
      "conceptName": ["Melphalan"]
    },
    "imatinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1304107],
      "conceptName": ["imatinib"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Mitoxantrone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1309188],
      "conceptName": ["Mitoxantrone"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Daunorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311799],
      "conceptName": ["Daunorubicin"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "gemcitabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314924],
      "conceptName": ["gemcitabine"]
    },
    "oxaliplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1318011],
      "conceptName": ["oxaliplatin"]
    },
    "pegaspargase": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1326481],
      "conceptName": ["pegaspargase"]
    },
    "Bleomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1329241],
      "conceptName": ["Bleomycin"]
    },
    "bortezomib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1336825],
      "conceptName": ["bortezomib"]
    },
    "Vorinostat": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1337651],
      "conceptName": ["Vorinostat"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Carboplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344905],
      "conceptName": ["Carboplatin"]
    },
    "Carmustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350066],
      "conceptName": ["Carmustine"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Mesna": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1354698],
      "conceptName": ["Mesna"]
    },
    "dasatinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1358436],
      "conceptName": ["dasatinib"]
    },
    "Interferon Alfa-2a": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1379969],
      "conceptName": ["Interferon Alfa-2a"]
    },
    "Interferon Alfa-2b": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1380068],
      "conceptName": ["Interferon Alfa-2b"]
    },
    "Chlorambucil": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1390051],
      "conceptName": ["Chlorambucil"]
    },
    "fludarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1395557],
      "conceptName": ["fludarabine"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "mercaptopurine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1436650],
      "conceptName": ["mercaptopurine"]
    },
    "Thioguanine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1437379],
      "conceptName": ["Thioguanine"]
    },
    "Methylprednisolone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1506270],
      "conceptName": ["Methylprednisolone"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Clarithromycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1750500],
      "conceptName": ["Clarithromycin"]
    },
    "Quinine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1760616],
      "conceptName": ["Quinine"]
    },
    "Vindesine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008336],
      "conceptName": ["Vindesine"]
    },
    "everolimus": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19011440],
      "conceptName": ["everolimus"]
    },
    "ASPARAGINASE": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19012585],
      "conceptName": ["ASPARAGINASE"]
    },
    "bendamustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19015523],
      "conceptName": ["bendamustine"]
    },
    "lenalidomide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19026972],
      "conceptName": ["lenalidomide"]
    },
    "doxorubicin liposome": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19051649],
      "conceptName": ["doxorubicin liposome"]
    },
    "Cladribine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19054825],
      "conceptName": ["Cladribine"]
    },
    "Ifosfamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    },
    "Teniposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19136750],
      "conceptName": ["Teniposide"]
    },
    "Thalidomide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19137042],
      "conceptName": ["Thalidomide"]
    },
    "elotuzumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [35604032],
      "conceptName": ["elotuzumab"]
    },
    "daratumumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [35605744],
      "conceptName": ["daratumumab"]
    },
    "ixazomib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [35606214],
      "conceptName": ["ixazomib"]
    },
    "ofatumumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [40167582],
      "conceptName": ["ofatumumab"]
    },
    "Cytarabine liposome": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [40175460],
      "conceptName": ["Cytarabine liposome"]
    },
    "carfilzomib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [42873638],
      "conceptName": ["carfilzomib"]
    },
    "ponatinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [43013182],
      "conceptName": ["ponatinib"]
    },
    "pomalidomide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [43014237],
      "conceptName": ["pomalidomide"]
    },
    "asparaginase Erwinia chrysanthemi": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [43533115],
      "conceptName": ["asparaginase Erwinia chrysanthemi"]
    },
    "pembrolizumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [45775965],
      "conceptName": ["pembrolizumab"]
    },
    "panobinostat": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [46221435],
      "conceptName": ["panobinostat"]
    }
  },
  {
    "conceptId": [35806402],
    "regimenName": ["Carboplatin, Paclitaxel, Ipilimumab"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Carboplatin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1344905],
      "conceptName": ["Carboplatin"]
    },
    "Paclitaxel": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1378382],
      "conceptName": ["Paclitaxel"]
    },
    "ipilimumab": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [40238188],
      "conceptName": ["ipilimumab"]
    }
  },
  {
    "conceptId": [35806175],
    "regimenName": ["Cisplatin, Pemetrexed, Bevacizumab"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "bevacizumab": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1397141],
      "conceptName": ["bevacizumab"]
    },
    "Cisplatin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "pemetrexed": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1304919],
      "conceptName": ["pemetrexed"]
    }
  },
  {
    "conceptId": [35804246],
    "regimenName": ["Capecitabine and Docetaxel"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "docetaxel": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1315942],
      "conceptName": ["docetaxel"]
    },
    "capecitabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1337620],
      "conceptName": ["capecitabine"]
    },
    "gemcitabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314924],
      "conceptName": ["gemcitabine"]
    },
    "oxaliplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1318011],
      "conceptName": ["oxaliplatin"]
    },
    "Epirubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344354],
      "conceptName": ["Epirubicin"]
    }
  },
  {
    "conceptId": [35803558],
    "regimenName": ["Idarubicin, then Mitoxantrone, then Idarubicin"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Idarubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [19078097],
      "conceptName": ["Idarubicin"]
    },
    "Mitoxantrone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1309188],
      "conceptName": ["Mitoxantrone"]
    },
    "Tretinoin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [903643],
      "conceptName": ["Tretinoin"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Thioguanine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1437379],
      "conceptName": ["Thioguanine"]
    }
  },
  {
    "conceptId": [35806827],
    "regimenName": ["Flutamide, Goserelin, RT"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Goserelin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1366310],
      "conceptName": ["Goserelin"]
    },
    "Flutamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1356461],
      "conceptName": ["Flutamide"]
    }
  },
  {
    "conceptId": [35803517],
    "regimenName": ["Ivosidenib monotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "ivosidenib": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1560123],
      "conceptName": ["ivosidenib"]
    }
  },
  {
    "conceptId": [35804311],
    "regimenName": ["Capecitabine and Lapatinib"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "lapatinib": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1359548],
      "conceptName": ["lapatinib"]
    },
    "capecitabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1337620],
      "conceptName": ["capecitabine"]
    }
  },
  {
    "conceptId": [35806405],
    "regimenName": ["Carboplatin and Vinorelbine"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Carboplatin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1344905],
      "conceptName": ["Carboplatin"]
    },
    "vinorelbine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1343346],
      "conceptName": ["vinorelbine"]
    }
  },
  {
    "conceptId": [35803998],
    "regimenName": ["BeEAM"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "bendamustine": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [19015523],
      "conceptName": ["bendamustine"]
    },
    "Melphalan": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1301267],
      "conceptName": ["Melphalan"]
    },
    "Cytarabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Etoposide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    }
  },
  {
    "conceptId": [35806376],
    "regimenName": ["Isotretinoin monotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Isotretinoin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [984232],
      "conceptName": ["Isotretinoin"]
    },
    "sargramostim": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308432],
      "conceptName": ["sargramostim"]
    },
    "Aldesleukin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1309770],
      "conceptName": ["Aldesleukin"]
    },
    "Interferon Alfa-2a": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1379969],
      "conceptName": ["Interferon Alfa-2a"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "dinutuximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [46221699],
      "conceptName": ["dinutuximab"]
    }
  },
  {
    "conceptId": [35806832],
    "regimenName": ["Bicalutamide and RT"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "bicalutamide": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1344381],
      "conceptName": ["bicalutamide"]
    },
    "docetaxel": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1315942],
      "conceptName": ["docetaxel"]
    },
    "Leuprolide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1351541],
      "conceptName": ["Leuprolide"]
    },
    "Flutamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1356461],
      "conceptName": ["Flutamide"]
    },
    "Goserelin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1366310],
      "conceptName": ["Goserelin"]
    }
  },
  {
    "conceptId": [35806475],
    "regimenName": ["MA-BCD/AP"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Bleomycin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1329241],
      "conceptName": ["Bleomycin"]
    },
    "Methotrexate": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Dactinomycin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1311443],
      "conceptName": ["Dactinomycin"]
    },
    "Cisplatin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    }
  },
  {
    "conceptId": [35806112],
    "regimenName": ["Cisplatin, Lomustine, Vincristine"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Cisplatin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "Lomustine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1391846],
      "conceptName": ["Lomustine"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    }
  },
  {
    "conceptId": [35804156],
    "regimenName": ["Carboplatin and Gemcitabine"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Carboplatin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1344905],
      "conceptName": ["Carboplatin"]
    },
    "gemcitabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1314924],
      "conceptName": ["gemcitabine"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "erlotinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1325363],
      "conceptName": ["erlotinib"]
    },
    "Paclitaxel": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1378382],
      "conceptName": ["Paclitaxel"]
    },
    "bevacizumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397141],
      "conceptName": ["bevacizumab"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    }
  },
  {
    "conceptId": [35804268],
    "regimenName": ["Vinorelbine and Bevacizumab"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "bevacizumab": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1397141],
      "conceptName": ["bevacizumab"]
    },
    "vinorelbine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1343346],
      "conceptName": ["vinorelbine"]
    }
  },
  {
    "conceptId": [35804558],
    "regimenName": ["Gemcitabine, then Fluorouracil and RT, then Gemcitabine"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "gemcitabine": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1314924],
      "conceptName": ["gemcitabine"]
    },
    "Fluorouracil": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "oxaliplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1318011],
      "conceptName": ["oxaliplatin"]
    },
    "Epirubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344354],
      "conceptName": ["Epirubicin"]
    },
    "irinotecan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1367268],
      "conceptName": ["irinotecan"]
    },
    "Leucovorin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1388796],
      "conceptName": ["Leucovorin"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    }
  },
  {
    "conceptId": [35806494],
    "regimenName": ["Chlorambucil and Cisplatin"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Cisplatin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "Chlorambucil": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1390051],
      "conceptName": ["Chlorambucil"]
    }
  },
  {
    "conceptId": [35803629],
    "regimenName": ["Fludarabine, Melphalan, Alemtuzumab"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "alemtuzumab": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1312706],
      "conceptName": ["alemtuzumab"]
    },
    "Melphalan": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1301267],
      "conceptName": ["Melphalan"]
    },
    "fludarabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1395557],
      "conceptName": ["fludarabine"]
    }
  },
  {
    "conceptId": [35803739],
    "regimenName": ["Cyclosporine monotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Cyclosporine": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [19010482],
      "conceptName": ["Cyclosporine"]
    }
  },
  {
    "conceptId": [35805118],
    "regimenName": ["MINE"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Ifosfamide": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    },
    "Mesna": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1354698],
      "conceptName": ["Mesna"]
    },
    "Mitoxantrone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1309188],
      "conceptName": ["Mitoxantrone"]
    },
    "Etoposide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    }
  },
  {
    "conceptId": [35804434],
    "regimenName": ["Dabrafenib monotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "dabrafenib": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [43532299],
      "conceptName": ["dabrafenib"]
    },
    "trametinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [43532497],
      "conceptName": ["trametinib"]
    }
  },
  {
    "conceptId": [35806982],
    "regimenName": ["Methotrexate, Pegaspargase, Vincristine"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Methotrexate": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "pegaspargase": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1326481],
      "conceptName": ["pegaspargase"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    }
  },
  {
    "conceptId": [35102010],
    "regimenName": ["FEC and H (SC)"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Epirubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1344354],
      "conceptName": ["Epirubicin"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Fluorouracil": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "trastuzumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1387104],
      "conceptName": ["trastuzumab"]
    },
    "bevacizumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397141],
      "conceptName": ["bevacizumab"]
    }
  },
  {
    "conceptId": [35804337],
    "regimenName": ["CTCb, then auto HSCT"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Carboplatin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1344905],
      "conceptName": ["Carboplatin"]
    },
    "Thiotepa": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [19137385],
      "conceptName": ["Thiotepa"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    }
  },
  {
    "conceptId": [35807029],
    "regimenName": ["CISCA/VB"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Bleomycin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1329241],
      "conceptName": ["Bleomycin"]
    },
    "Cisplatin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "Vinblastine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [19008264],
      "conceptName": ["Vinblastine"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    }
  },
  {
    "conceptId": [35804001],
    "regimenName": ["Bu/TT"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Busulfan": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1333357],
      "conceptName": ["Busulfan"]
    },
    "Thiotepa": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [19137385],
      "conceptName": ["Thiotepa"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    }
  },
  {
    "conceptId": [35806383],
    "regimenName": ["Lutetium Lu 177 dotatate and Octreotide LAR"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Lutetium": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [44816340],
      "conceptName": ["Lutetium"]
    },
    "Octreotide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1522957],
      "conceptName": ["Octreotide"]
    }
  },
  {
    "conceptId": [35803456],
    "regimenName": ["DAC"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Cytarabine": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Daunorubicin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1311799],
      "conceptName": ["Daunorubicin"]
    },
    "Cladribine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [19054825],
      "conceptName": ["Cladribine"]
    }
  },
  {
    "conceptId": [35804414],
    "regimenName": ["Bu/TT, then auto HSCT"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Busulfan": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1333357],
      "conceptName": ["Busulfan"]
    },
    "Thiotepa": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [19137385],
      "conceptName": ["Thiotepa"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    }
  },
  {
    "conceptId": [35806954],
    "regimenName": ["CDE"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Etoposide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Melphalan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1301267],
      "conceptName": ["Melphalan"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Dactinomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311443],
      "conceptName": ["Dactinomycin"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Bleomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1329241],
      "conceptName": ["Bleomycin"]
    },
    "bortezomib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1336825],
      "conceptName": ["bortezomib"]
    },
    "Carboplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344905],
      "conceptName": ["Carboplatin"]
    },
    "Procarbazine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1351779],
      "conceptName": ["Procarbazine"]
    },
    "irinotecan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1367268],
      "conceptName": ["irinotecan"]
    },
    "Topotecan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1378509],
      "conceptName": ["Topotecan"]
    },
    "Mechlorethamine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1394337],
      "conceptName": ["Mechlorethamine"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "prednisolone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1550557],
      "conceptName": ["prednisolone"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Vindesine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008336],
      "conceptName": ["Vindesine"]
    },
    "Ifosfamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    },
    "Teniposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19136750],
      "conceptName": ["Teniposide"]
    },
    "Thalidomide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19137042],
      "conceptName": ["Thalidomide"]
    },
    "ranimustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [35197850],
      "conceptName": ["ranimustine"]
    }
  },
  {
    "conceptId": [35806844],
    "regimenName": ["Flutamide and Leuprolide"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Leuprolide": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1351541],
      "conceptName": ["Leuprolide"]
    },
    "Flutamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1356461],
      "conceptName": ["Flutamide"]
    }
  },
  {
    "conceptId": [35803447],
    "regimenName": ["7 plus 3i"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Idarubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [19078097],
      "conceptName": ["Idarubicin"]
    },
    "Cytarabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Tretinoin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [903643],
      "conceptName": ["Tretinoin"]
    },
    "imatinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1304107],
      "conceptName": ["imatinib"]
    },
    "Filgrastim": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1304850],
      "conceptName": ["Filgrastim"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Mitoxantrone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1309188],
      "conceptName": ["Mitoxantrone"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Vorinostat": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1337651],
      "conceptName": ["Vorinostat"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "sorafenib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1363387],
      "conceptName": ["sorafenib"]
    },
    "Lomustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1391846],
      "conceptName": ["Lomustine"]
    },
    "fludarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1395557],
      "conceptName": ["fludarabine"]
    },
    "mercaptopurine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1436650],
      "conceptName": ["mercaptopurine"]
    },
    "Thioguanine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1437379],
      "conceptName": ["Thioguanine"]
    },
    "Pravastatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551860],
      "conceptName": ["Pravastatin"]
    },
    "lenograstim": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19009705],
      "conceptName": ["lenograstim"]
    },
    "clofarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19054821],
      "conceptName": ["clofarabine"]
    },
    "Norethandrolone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19128219],
      "conceptName": ["Norethandrolone"]
    },
    "panobinostat": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [46221435],
      "conceptName": ["panobinostat"]
    }
  },
  {
    "conceptId": [35803686],
    "regimenName": ["Temozolomide and RT"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "temozolomide": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1341149],
      "conceptName": ["temozolomide"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "capecitabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1337620],
      "conceptName": ["capecitabine"]
    },
    "irinotecan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1367268],
      "conceptName": ["irinotecan"]
    },
    "Lomustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1391846],
      "conceptName": ["Lomustine"]
    },
    "bevacizumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397141],
      "conceptName": ["bevacizumab"]
    },
    "Thalidomide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19137042],
      "conceptName": ["Thalidomide"]
    },
    "dinutuximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [46221699],
      "conceptName": ["dinutuximab"]
    }
  },
  {
    "conceptId": [35805800],
    "regimenName": ["Tranexamic acid monotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Tranexamic Acid": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1303425],
      "conceptName": ["Tranexamic Acid"]
    }
  },
  {
    "conceptId": [35102004],
    "regimenName": ["FOLFOX4 (L-Leucovorin)"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "oxaliplatin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1318011],
      "conceptName": ["oxaliplatin"]
    },
    "levoleucovorin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [40168303],
      "conceptName": ["levoleucovorin"]
    },
    "Fluorouracil": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "cetuximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1315411],
      "conceptName": ["cetuximab"]
    },
    "irinotecan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1367268],
      "conceptName": ["irinotecan"]
    },
    "bevacizumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397141],
      "conceptName": ["bevacizumab"]
    }
  },
  {
    "conceptId": [35803516],
    "regimenName": ["Azacitidine and Sorafenib"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Azacitidine": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1314865],
      "conceptName": ["Azacitidine"]
    },
    "sorafenib": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1363387],
      "conceptName": ["sorafenib"]
    }
  },
  {
    "conceptId": [35805758],
    "regimenName": ["Moxetumomab pasudotox monotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "moxetumomab pasudotox": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [35200995],
      "conceptName": ["moxetumomab pasudotox"]
    }
  },
  {
    "conceptId": [35803466],
    "regimenName": ["Azacitidine and Venetoclax"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Azacitidine": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1314865],
      "conceptName": ["Azacitidine"]
    },
    "venetoclax": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [35604205],
      "conceptName": ["venetoclax"]
    }
  },
  {
    "conceptId": [35805250],
    "regimenName": ["Megestrol and Tamoxifen"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Tamoxifen": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1436678],
      "conceptName": ["Tamoxifen"]
    },
    "Megestrol": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1300978],
      "conceptName": ["Megestrol"]
    }
  },
  {
    "conceptId": [35805123],
    "regimenName": ["DICE"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Carboplatin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1344905],
      "conceptName": ["Carboplatin"]
    },
    "Ifosfamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    },
    "Dexamethasone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "Etoposide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    }
  },
  {
    "conceptId": [35805074],
    "regimenName": ["Axicabtagene ciloleucel monotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Axicabtagene ciloleucel": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [792844],
      "conceptName": ["Axicabtagene ciloleucel"]
    }
  },
  {
    "conceptId": [35806471],
    "regimenName": ["IP-BCD"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Bleomycin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1329241],
      "conceptName": ["Bleomycin"]
    },
    "Dactinomycin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1311443],
      "conceptName": ["Dactinomycin"]
    },
    "Cisplatin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "Ifosfamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    },
    "Mesna": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1354698],
      "conceptName": ["Mesna"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    }
  },
  {
    "conceptId": [35804778],
    "regimenName": ["IFL"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Leucovorin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1388796],
      "conceptName": ["Leucovorin"]
    },
    "irinotecan": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1367268],
      "conceptName": ["irinotecan"]
    },
    "Fluorouracil": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "gemcitabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314924],
      "conceptName": ["gemcitabine"]
    },
    "cetuximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1315411],
      "conceptName": ["cetuximab"]
    },
    "oxaliplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1318011],
      "conceptName": ["oxaliplatin"]
    },
    "bevacizumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397141],
      "conceptName": ["bevacizumab"]
    },
    "panitumumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19100985],
      "conceptName": ["panitumumab"]
    },
    "aflibercept": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [40244266],
      "conceptName": ["aflibercept"]
    },
    "ramucirumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [44818489],
      "conceptName": ["ramucirumab"]
    }
  },
  {
    "conceptId": [35804322],
    "regimenName": ["Enzalutamide monotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "enzalutamide": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [42900250],
      "conceptName": ["enzalutamide"]
    }
  },
  {
    "conceptId": [35806086],
    "regimenName": ["EAR and G-CSF"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "rituximab": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Cytarabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Etoposide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Melphalan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1301267],
      "conceptName": ["Melphalan"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Carmustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350066],
      "conceptName": ["Carmustine"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "Methylprednisolone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1506270],
      "conceptName": ["Methylprednisolone"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Vindesine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008336],
      "conceptName": ["Vindesine"]
    },
    "doxorubicin liposome": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19051649],
      "conceptName": ["doxorubicin liposome"]
    },
    "ibritumomab tiuxetan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19068830],
      "conceptName": ["ibritumomab tiuxetan"]
    },
    "Ifosfamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    },
    "Teniposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19136750],
      "conceptName": ["Teniposide"]
    }
  },
  {
    "conceptId": [35101813],
    "regimenName": ["Axitinib and Pembrolizumab"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "pembrolizumab": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [45775965],
      "conceptName": ["pembrolizumab"]
    },
    "axitinib": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [42709322],
      "conceptName": ["axitinib"]
    }
  },
  {
    "conceptId": [35805246],
    "regimenName": ["Cisplatin, Doxorubicin, Paclitaxel"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Paclitaxel": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1378382],
      "conceptName": ["Paclitaxel"]
    },
    "Cisplatin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    }
  },
  {
    "conceptId": [35806125],
    "regimenName": ["CVD (Vinblastine)"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Cisplatin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "Vinblastine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [19008264],
      "conceptName": ["Vinblastine"]
    },
    "Dacarbazine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1311409],
      "conceptName": ["Dacarbazine"]
    },
    "Aldesleukin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1309770],
      "conceptName": ["Aldesleukin"]
    },
    "Interferon Alfa-2b": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1380068],
      "conceptName": ["Interferon Alfa-2b"]
    }
  },
  {
    "conceptId": [35806067],
    "regimenName": ["RD"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "lenalidomide": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [19026972],
      "conceptName": ["lenalidomide"]
    },
    "Dexamethasone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "Melphalan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1301267],
      "conceptName": ["Melphalan"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "bortezomib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1336825],
      "conceptName": ["bortezomib"]
    },
    "Vorinostat": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1337651],
      "conceptName": ["Vorinostat"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Clarithromycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1750500],
      "conceptName": ["Clarithromycin"]
    },
    "bendamustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19015523],
      "conceptName": ["bendamustine"]
    },
    "elotuzumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [35604032],
      "conceptName": ["elotuzumab"]
    },
    "daratumumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [35605744],
      "conceptName": ["daratumumab"]
    },
    "ixazomib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [35606214],
      "conceptName": ["ixazomib"]
    },
    "carfilzomib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [42873638],
      "conceptName": ["carfilzomib"]
    },
    "panobinostat": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [46221435],
      "conceptName": ["panobinostat"]
    }
  },
  {
    "conceptId": [35805766],
    "regimenName": ["Cetuximab and RT"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "cetuximab": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1315411],
      "conceptName": ["cetuximab"]
    },
    "Fluorouracil": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "gemcitabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314924],
      "conceptName": ["gemcitabine"]
    },
    "docetaxel": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1315942],
      "conceptName": ["docetaxel"]
    },
    "oxaliplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1318011],
      "conceptName": ["oxaliplatin"]
    },
    "capecitabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1337620],
      "conceptName": ["capecitabine"]
    },
    "vinorelbine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1343346],
      "conceptName": ["vinorelbine"]
    },
    "Carboplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344905],
      "conceptName": ["Carboplatin"]
    },
    "irinotecan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1367268],
      "conceptName": ["irinotecan"]
    },
    "Leucovorin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1388796],
      "conceptName": ["Leucovorin"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "levoleucovorin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [40168303],
      "conceptName": ["levoleucovorin"]
    }
  },
  {
    "conceptId": [35102017],
    "regimenName": ["MCP (Prednisolone)"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Chlorambucil": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1390051],
      "conceptName": ["Chlorambucil"]
    },
    "Mitoxantrone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1309188],
      "conceptName": ["Mitoxantrone"]
    },
    "prednisolone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1550557],
      "conceptName": ["prednisolone"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    }
  },
  {
    "conceptId": [35806980],
    "regimenName": ["Doxorubicin, L-asparaginase, Mercaptopurine, Methotrexate, Vincristine, Prednisone"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Methotrexate": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "ASPARAGINASE": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [19012585],
      "conceptName": ["ASPARAGINASE"]
    },
    "mercaptopurine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1436650],
      "conceptName": ["mercaptopurine"]
    },
    "Prednisone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    }
  },
  {
    "conceptId": [35806664],
    "regimenName": ["R, then CHOP"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "rituximab": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Prednisone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "bortezomib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1336825],
      "conceptName": ["bortezomib"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "Hyaluronidase / rituximab Injection [Rituxan Hycela]": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1593155],
      "conceptName": ["Hyaluronidase / rituximab Injection [Rituxan Hycela]"]
    },
    "Vindesine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008336],
      "conceptName": ["Vindesine"]
    },
    "lenalidomide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19026972],
      "conceptName": ["lenalidomide"]
    },
    "Ifosfamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    },
    "Teniposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19136750],
      "conceptName": ["Teniposide"]
    }
  },
  {
    "conceptId": [35804293],
    "regimenName": ["Lapatinib, Letrozole, Trastuzumab"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "trastuzumab": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1387104],
      "conceptName": ["trastuzumab"]
    },
    "letrozole": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1315946],
      "conceptName": ["letrozole"]
    },
    "lapatinib": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1359548],
      "conceptName": ["lapatinib"]
    }
  },
  {
    "conceptId": [35805101],
    "regimenName": ["LD-ACOP-B"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Bleomycin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1329241],
      "conceptName": ["Bleomycin"]
    },
    "Prednisone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Dacarbazine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311409],
      "conceptName": ["Dacarbazine"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Procarbazine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1351779],
      "conceptName": ["Procarbazine"]
    },
    "Vinblastine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008264],
      "conceptName": ["Vinblastine"]
    },
    "Teniposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19136750],
      "conceptName": ["Teniposide"]
    }
  },
  {
    "conceptId": [35806483],
    "regimenName": ["Carboplatin, Olaparib, Paclitaxel"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Carboplatin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1344905],
      "conceptName": ["Carboplatin"]
    },
    "Paclitaxel": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1378382],
      "conceptName": ["Paclitaxel"]
    },
    "olaparib": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [45892579],
      "conceptName": ["olaparib"]
    }
  },
  {
    "conceptId": [35806300],
    "regimenName": ["VMP/Rd"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "lenalidomide": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [19026972],
      "conceptName": ["lenalidomide"]
    },
    "Melphalan": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1301267],
      "conceptName": ["Melphalan"]
    },
    "bortezomib": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1336825],
      "conceptName": ["bortezomib"]
    },
    "Prednisone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Dexamethasone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    }
  },
  {
    "conceptId": [35806137],
    "regimenName": ["Binimetinib and Encorafenib"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "encorafenib": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1559914],
      "conceptName": ["encorafenib"]
    },
    "Binimetinib": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1559930],
      "conceptName": ["Binimetinib"]
    }
  },
  {
    "conceptId": [35803450],
    "regimenName": ["Cytarabine, Idarubicin, Sorafenib"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Idarubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [19078097],
      "conceptName": ["Idarubicin"]
    },
    "Cytarabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "sorafenib": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1363387],
      "conceptName": ["sorafenib"]
    }
  },
  {
    "conceptId": [35805054],
    "regimenName": ["R-DexaBEAM"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Carmustine": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1350066],
      "conceptName": ["Carmustine"]
    },
    "Melphalan": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1301267],
      "conceptName": ["Melphalan"]
    },
    "rituximab": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Cytarabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Dexamethasone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "Etoposide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    }
  },
  {
    "conceptId": [35805685],
    "regimenName": ["UFTM"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Mitomycin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1389036],
      "conceptName": ["Mitomycin"]
    },
    "Fluorouracil": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "gemcitabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314924],
      "conceptName": ["gemcitabine"]
    },
    "capecitabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1337620],
      "conceptName": ["capecitabine"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Epirubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344354],
      "conceptName": ["Epirubicin"]
    },
    "Carboplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344905],
      "conceptName": ["Carboplatin"]
    },
    "irinotecan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1367268],
      "conceptName": ["irinotecan"]
    },
    "Leucovorin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1388796],
      "conceptName": ["Leucovorin"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "Vinblastine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008264],
      "conceptName": ["Vinblastine"]
    },
    "Vindesine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008336],
      "conceptName": ["Vindesine"]
    },
    "Ifosfamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    },
    "doxifluridine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [43008996],
      "conceptName": ["doxifluridine"]
    }
  },
  {
    "conceptId": [35804789],
    "regimenName": ["Trifluridine and tipiracil monotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "tipiracil / Trifluridine Oral Tablet": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [35602760],
      "conceptName": ["tipiracil / Trifluridine Oral Tablet"]
    }
  },
  {
    "conceptId": [35804079],
    "regimenName": ["Nilotinib monotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "nilotinib": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1394023],
      "conceptName": ["nilotinib"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Daunorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311799],
      "conceptName": ["Daunorubicin"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "prednisolone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1550557],
      "conceptName": ["prednisolone"]
    }
  },
  {
    "conceptId": [35806939],
    "regimenName": ["CEV and RT"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Epirubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1344354],
      "conceptName": ["Epirubicin"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "prednisolone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1550557],
      "conceptName": ["prednisolone"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    }
  },
  {
    "conceptId": [35806583],
    "regimenName": ["Fluorouracil/Fluorouracil and RT"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Fluorouracil": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "Melphalan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1301267],
      "conceptName": ["Melphalan"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Mitoxantrone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1309188],
      "conceptName": ["Mitoxantrone"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "gemcitabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314924],
      "conceptName": ["gemcitabine"]
    },
    "cetuximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1315411],
      "conceptName": ["cetuximab"]
    },
    "docetaxel": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1315942],
      "conceptName": ["docetaxel"]
    },
    "oxaliplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1318011],
      "conceptName": ["oxaliplatin"]
    },
    "capecitabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1337620],
      "conceptName": ["capecitabine"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Epirubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344354],
      "conceptName": ["Epirubicin"]
    },
    "Carboplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344905],
      "conceptName": ["Carboplatin"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "irinotecan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1367268],
      "conceptName": ["irinotecan"]
    },
    "Altretamine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1368823],
      "conceptName": ["Altretamine"]
    },
    "hydroxyurea": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1377141],
      "conceptName": ["hydroxyurea"]
    },
    "Paclitaxel": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1378382],
      "conceptName": ["Paclitaxel"]
    },
    "trastuzumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1387104],
      "conceptName": ["trastuzumab"]
    },
    "Leucovorin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1388796],
      "conceptName": ["Leucovorin"]
    },
    "Mitomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1389036],
      "conceptName": ["Mitomycin"]
    },
    "Levamisole": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1389464],
      "conceptName": ["Levamisole"]
    },
    "bevacizumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397141],
      "conceptName": ["bevacizumab"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "Tamoxifen": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1436678],
      "conceptName": ["Tamoxifen"]
    },
    "Medroxyprogesterone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1500211],
      "conceptName": ["Medroxyprogesterone"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "doxorubicin liposome": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19051649],
      "conceptName": ["doxorubicin liposome"]
    },
    "BCG, Live, Tice Strain": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19086176],
      "conceptName": ["BCG, Live, Tice Strain"]
    },
    "panitumumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19100985],
      "conceptName": ["panitumumab"]
    },
    "Streptozocin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19136210],
      "conceptName": ["Streptozocin"]
    },
    "Thiotepa": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19137385],
      "conceptName": ["Thiotepa"]
    },
    "irinotecan liposomal": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [35603068],
      "conceptName": ["irinotecan liposomal"]
    },
    "levoleucovorin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [40168303],
      "conceptName": ["levoleucovorin"]
    },
    "aflibercept": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [40244266],
      "conceptName": ["aflibercept"]
    },
    "ramucirumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [44818489],
      "conceptName": ["ramucirumab"]
    }
  },
  {
    "conceptId": [35803469],
    "regimenName": ["Clofarabine monotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "clofarabine": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [19054821],
      "conceptName": ["clofarabine"]
    },
    "Melphalan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1301267],
      "conceptName": ["Melphalan"]
    },
    "Filgrastim": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1304850],
      "conceptName": ["Filgrastim"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "decitabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19024728],
      "conceptName": ["decitabine"]
    },
    "Idarubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078097],
      "conceptName": ["Idarubicin"]
    }
  },
  {
    "conceptId": [35806962],
    "regimenName": ["EIA"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Ifosfamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    },
    "Etoposide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Dactinomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311443],
      "conceptName": ["Dactinomycin"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Bleomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1329241],
      "conceptName": ["Bleomycin"]
    },
    "irinotecan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1367268],
      "conceptName": ["irinotecan"]
    },
    "Topotecan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1378509],
      "conceptName": ["Topotecan"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Vindesine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008336],
      "conceptName": ["Vindesine"]
    },
    "Teniposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19136750],
      "conceptName": ["Teniposide"]
    }
  },
  {
    "conceptId": [35805807],
    "regimenName": ["A plus AVD"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "brentuximab vedotin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [40241969],
      "conceptName": ["brentuximab vedotin"]
    },
    "Vinblastine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [19008264],
      "conceptName": ["Vinblastine"]
    },
    "Dacarbazine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1311409],
      "conceptName": ["Dacarbazine"]
    }
  },
  {
    "conceptId": [35806292],
    "regimenName": ["Cyclophosphamide and G-CSF"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Cyclophosphamide": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "inotuzumab ozogamicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [794068],
      "conceptName": ["inotuzumab ozogamicin"]
    },
    "Fluorouracil": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "Melphalan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1301267],
      "conceptName": ["Melphalan"]
    },
    "imatinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1304107],
      "conceptName": ["imatinib"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Mitoxantrone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1309188],
      "conceptName": ["Mitoxantrone"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Dacarbazine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311409],
      "conceptName": ["Dacarbazine"]
    },
    "Dactinomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311443],
      "conceptName": ["Dactinomycin"]
    },
    "Daunorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311799],
      "conceptName": ["Daunorubicin"]
    },
    "alemtuzumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1312706],
      "conceptName": ["alemtuzumab"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "gemcitabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314924],
      "conceptName": ["gemcitabine"]
    },
    "docetaxel": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1315942],
      "conceptName": ["docetaxel"]
    },
    "pegaspargase": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1326481],
      "conceptName": ["pegaspargase"]
    },
    "Bleomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1329241],
      "conceptName": ["Bleomycin"]
    },
    "Busulfan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1333357],
      "conceptName": ["Busulfan"]
    },
    "bortezomib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1336825],
      "conceptName": ["bortezomib"]
    },
    "Vorinostat": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1337651],
      "conceptName": ["Vorinostat"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Epirubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344354],
      "conceptName": ["Epirubicin"]
    },
    "Carboplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344905],
      "conceptName": ["Carboplatin"]
    },
    "Carmustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350066],
      "conceptName": ["Carmustine"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Procarbazine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1351779],
      "conceptName": ["Procarbazine"]
    },
    "Mesna": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1354698],
      "conceptName": ["Mesna"]
    },
    "dasatinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1358436],
      "conceptName": ["dasatinib"]
    },
    "irinotecan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1367268],
      "conceptName": ["irinotecan"]
    },
    "Altretamine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1368823],
      "conceptName": ["Altretamine"]
    },
    "Paclitaxel": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1378382],
      "conceptName": ["Paclitaxel"]
    },
    "Topotecan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1378509],
      "conceptName": ["Topotecan"]
    },
    "Interferon Alfa-2b": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1380068],
      "conceptName": ["Interferon Alfa-2b"]
    },
    "Interferon gamma-1b": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1380191],
      "conceptName": ["Interferon gamma-1b"]
    },
    "trastuzumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1387104],
      "conceptName": ["trastuzumab"]
    },
    "Leucovorin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1388796],
      "conceptName": ["Leucovorin"]
    },
    "Lomustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1391846],
      "conceptName": ["Lomustine"]
    },
    "Mechlorethamine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1394337],
      "conceptName": ["Mechlorethamine"]
    },
    "fludarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1395557],
      "conceptName": ["fludarabine"]
    },
    "bevacizumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397141],
      "conceptName": ["bevacizumab"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "mercaptopurine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1436650],
      "conceptName": ["mercaptopurine"]
    },
    "Tamoxifen": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1436678],
      "conceptName": ["Tamoxifen"]
    },
    "Thioguanine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1437379],
      "conceptName": ["Thioguanine"]
    },
    "Medroxyprogesterone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1500211],
      "conceptName": ["Medroxyprogesterone"]
    },
    "Methylprednisolone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1506270],
      "conceptName": ["Methylprednisolone"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "Diethylstilbestrol": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1525866],
      "conceptName": ["Diethylstilbestrol"]
    },
    "prednisolone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1550557],
      "conceptName": ["prednisolone"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Hyaluronidase / rituximab Injection [Rituxan Hycela]": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1593155],
      "conceptName": ["Hyaluronidase / rituximab Injection [Rituxan Hycela]"]
    },
    "nelarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19002912],
      "conceptName": ["nelarabine"]
    },
    "Vinblastine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008264],
      "conceptName": ["Vinblastine"]
    },
    "Vindesine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008336],
      "conceptName": ["Vindesine"]
    },
    "everolimus": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19011440],
      "conceptName": ["everolimus"]
    },
    "ASPARAGINASE": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19012585],
      "conceptName": ["ASPARAGINASE"]
    },
    "lenalidomide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19026972],
      "conceptName": ["lenalidomide"]
    },
    "Pentostatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19031224],
      "conceptName": ["Pentostatin"]
    },
    "denileukin diftitox": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19051642],
      "conceptName": ["denileukin diftitox"]
    },
    "doxorubicin liposome": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19051649],
      "conceptName": ["doxorubicin liposome"]
    },
    "clofarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19054821],
      "conceptName": ["clofarabine"]
    },
    "Cladribine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19054825],
      "conceptName": ["Cladribine"]
    },
    "iodine-131-tositumomab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19054997],
      "conceptName": ["iodine-131-tositumomab"]
    },
    "ibritumomab tiuxetan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19068830],
      "conceptName": ["ibritumomab tiuxetan"]
    },
    "Idarubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078097],
      "conceptName": ["Idarubicin"]
    },
    "Ifosfamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    },
    "BCG, Live, Tice Strain": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19086176],
      "conceptName": ["BCG, Live, Tice Strain"]
    },
    "Teniposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19136750],
      "conceptName": ["Teniposide"]
    },
    "Thalidomide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19137042],
      "conceptName": ["Thalidomide"]
    },
    "Thiotepa": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19137385],
      "conceptName": ["Thiotepa"]
    },
    "Myocet": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [21017157],
      "conceptName": ["Myocet"]
    },
    "ranimustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [35197850],
      "conceptName": ["ranimustine"]
    },
    "ofatumumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [40167582],
      "conceptName": ["ofatumumab"]
    },
    "Cytarabine liposome": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [40175460],
      "conceptName": ["Cytarabine liposome"]
    },
    "brentuximab vedotin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [40241969],
      "conceptName": ["brentuximab vedotin"]
    },
    "carfilzomib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [42873638],
      "conceptName": ["carfilzomib"]
    },
    "vincristine liposome": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [42874135],
      "conceptName": ["vincristine liposome"]
    },
    "ponatinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [43013182],
      "conceptName": ["ponatinib"]
    },
    "pomalidomide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [43014237],
      "conceptName": ["pomalidomide"]
    },
    "obinutuzumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [44507676],
      "conceptName": ["obinutuzumab"]
    }
  },
  {
    "conceptId": [35805376],
    "regimenName": ["Hydroxyurea monotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "hydroxyurea": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1377141],
      "conceptName": ["hydroxyurea"]
    },
    "Fluorouracil": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "imatinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1304107],
      "conceptName": ["imatinib"]
    },
    "Dacarbazine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311409],
      "conceptName": ["Dacarbazine"]
    },
    "docetaxel": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1315942],
      "conceptName": ["docetaxel"]
    },
    "Carmustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350066],
      "conceptName": ["Carmustine"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    }
  },
  {
    "conceptId": [35101988],
    "regimenName": ["CHVmP"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Prednisone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Teniposide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [19136750],
      "conceptName": ["Teniposide"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Bleomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1329241],
      "conceptName": ["Bleomycin"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Interferon Alfa-2b": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1380068],
      "conceptName": ["Interferon Alfa-2b"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "Vindesine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008336],
      "conceptName": ["Vindesine"]
    },
    "Ifosfamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    }
  },
  {
    "conceptId": [35804382],
    "regimenName": ["R-CODOX-M (Doxil substituted)"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Methotrexate": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "doxorubicin liposome": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [19051649],
      "conceptName": ["doxorubicin liposome"]
    },
    "rituximab": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Ifosfamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    }
  },
  {
    "conceptId": [35806059],
    "regimenName": ["VD"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "bortezomib": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1336825],
      "conceptName": ["bortezomib"]
    },
    "Dexamethasone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "Melphalan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1301267],
      "conceptName": ["Melphalan"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Chlorambucil": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1390051],
      "conceptName": ["Chlorambucil"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "bendamustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19015523],
      "conceptName": ["bendamustine"]
    },
    "lenalidomide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19026972],
      "conceptName": ["lenalidomide"]
    },
    "doxorubicin liposome": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19051649],
      "conceptName": ["doxorubicin liposome"]
    },
    "Thalidomide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19137042],
      "conceptName": ["Thalidomide"]
    },
    "elotuzumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [35604032],
      "conceptName": ["elotuzumab"]
    },
    "daratumumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [35605744],
      "conceptName": ["daratumumab"]
    },
    "pomalidomide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [43014237],
      "conceptName": ["pomalidomide"]
    },
    "panobinostat": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [46221435],
      "conceptName": ["panobinostat"]
    }
  },
  {
    "conceptId": [35805111],
    "regimenName": ["VABE"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Bleomycin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1329241],
      "conceptName": ["Bleomycin"]
    },
    "Prednisone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Etoposide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Procarbazine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1351779],
      "conceptName": ["Procarbazine"]
    },
    "Mechlorethamine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1394337],
      "conceptName": ["Mechlorethamine"]
    },
    "Vinblastine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008264],
      "conceptName": ["Vinblastine"]
    }
  },
  {
    "conceptId": [35804632],
    "regimenName": ["Imatinib monotherapy, planned discontinuation"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "imatinib": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1304107],
      "conceptName": ["imatinib"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Mitoxantrone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1309188],
      "conceptName": ["Mitoxantrone"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Daunorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311799],
      "conceptName": ["Daunorubicin"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "hydroxyurea": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1377141],
      "conceptName": ["hydroxyurea"]
    },
    "Interferon Alfa-2a": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1379969],
      "conceptName": ["Interferon Alfa-2a"]
    },
    "Interferon Alfa-2b": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1380068],
      "conceptName": ["Interferon Alfa-2b"]
    },
    "mercaptopurine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1436650],
      "conceptName": ["mercaptopurine"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "peginterferon alfa-2a": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1714165],
      "conceptName": ["peginterferon alfa-2a"]
    },
    "ASPARAGINASE": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19012585],
      "conceptName": ["ASPARAGINASE"]
    },
    "Idarubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078097],
      "conceptName": ["Idarubicin"]
    }
  },
  {
    "conceptId": [35803525],
    "regimenName": ["Cytarabine, Idarubicin, Vorinostat"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Idarubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [19078097],
      "conceptName": ["Idarubicin"]
    },
    "Cytarabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Vorinostat": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1337651],
      "conceptName": ["Vorinostat"]
    }
  },
  {
    "conceptId": [35806286],
    "regimenName": ["MPT"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Melphalan": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1301267],
      "conceptName": ["Melphalan"]
    },
    "Thalidomide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [19137042],
      "conceptName": ["Thalidomide"]
    },
    "Prednisone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "bortezomib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1336825],
      "conceptName": ["bortezomib"]
    }
  },
  {
    "conceptId": [35805332],
    "regimenName": ["Cisplatin, Irinotecan, RT"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Cisplatin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "irinotecan": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1367268],
      "conceptName": ["irinotecan"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    }
  },
  {
    "conceptId": [35806431],
    "regimenName": ["PEV"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Cisplatin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "Vinblastine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [19008264],
      "conceptName": ["Vinblastine"]
    },
    "Etoposide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Bleomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1329241],
      "conceptName": ["Bleomycin"]
    },
    "Ifosfamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    }
  },
  {
    "conceptId": [35804780],
    "regimenName": ["IRIS and Bevacizumab"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "bevacizumab": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1397141],
      "conceptName": ["bevacizumab"]
    },
    "irinotecan": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1367268],
      "conceptName": ["irinotecan"]
    },
    "Hyaluronidase / trastuzumab Injection [Herceptin Hylecta]": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1366689],
      "conceptName": ["Hyaluronidase / trastuzumab Injection [Herceptin Hylecta]"]
    }
  },
  {
    "conceptId": [35804050],
    "regimenName": ["Mini-Hyper-CVD/MA and Inotuzumab ozogamicin"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Methotrexate": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Cytarabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "inotuzumab ozogamicin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [794068],
      "conceptName": ["inotuzumab ozogamicin"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Dexamethasone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    }
  },
  {
    "conceptId": [35805984],
    "regimenName": ["Vinblastine and Prednisone"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Prednisone": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Vinblastine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [19008264],
      "conceptName": ["Vinblastine"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Mitoxantrone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1309188],
      "conceptName": ["Mitoxantrone"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Dacarbazine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311409],
      "conceptName": ["Dacarbazine"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "gemcitabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314924],
      "conceptName": ["gemcitabine"]
    },
    "Bleomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1329241],
      "conceptName": ["Bleomycin"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Epirubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344354],
      "conceptName": ["Epirubicin"]
    },
    "Carmustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350066],
      "conceptName": ["Carmustine"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Procarbazine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1351779],
      "conceptName": ["Procarbazine"]
    },
    "Chlorambucil": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1390051],
      "conceptName": ["Chlorambucil"]
    },
    "Lomustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1391846],
      "conceptName": ["Lomustine"]
    },
    "Mechlorethamine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1394337],
      "conceptName": ["Mechlorethamine"]
    }
  },
  {
    "conceptId": [35805784],
    "regimenName": ["DEP"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "doxorubicin liposome": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [19051649],
      "conceptName": ["doxorubicin liposome"]
    },
    "Methylprednisolone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1506270],
      "conceptName": ["Methylprednisolone"]
    },
    "Etoposide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    }
  },
  {
    "conceptId": [35804385],
    "regimenName": ["COPAD/CYVE"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Cytarabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Prednisone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Etoposide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Bleomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1329241],
      "conceptName": ["Bleomycin"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "Vindesine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008336],
      "conceptName": ["Vindesine"]
    },
    "Ifosfamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    },
    "Teniposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19136750],
      "conceptName": ["Teniposide"]
    }
  },
  {
    "conceptId": [35803632],
    "regimenName": ["(90)YFC"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "ibritumomab tiuxetan": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [19068830],
      "conceptName": ["ibritumomab tiuxetan"]
    },
    "rituximab": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "fludarabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1395557],
      "conceptName": ["fludarabine"]
    }
  },
  {
    "conceptId": [35804210],
    "regimenName": ["DE"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Epirubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1344354],
      "conceptName": ["Epirubicin"]
    },
    "docetaxel": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1315942],
      "conceptName": ["docetaxel"]
    },
    "capecitabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1337620],
      "conceptName": ["capecitabine"]
    }
  },
  {
    "conceptId": [35804280],
    "regimenName": ["Abemaciclib and Anastrozole"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "abemaciclib": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [792649],
      "conceptName": ["abemaciclib"]
    },
    "anastrozole": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1348265],
      "conceptName": ["anastrozole"]
    }
  },
  {
    "conceptId": [35803593],
    "regimenName": ["LSG15"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Carboplatin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1344905],
      "conceptName": ["Carboplatin"]
    },
    "ranimustine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [35197850],
      "conceptName": ["ranimustine"]
    },
    "Vindesine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [19008336],
      "conceptName": ["Vindesine"]
    },
    "Prednisone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Etoposide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    }
  },
  {
    "conceptId": [35804615],
    "regimenName": ["OFAR"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "oxaliplatin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1318011],
      "conceptName": ["oxaliplatin"]
    },
    "rituximab": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Cytarabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "fludarabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1395557],
      "conceptName": ["fludarabine"]
    }
  },
  {
    "conceptId": [35806580],
    "regimenName": ["Lanreotide Depot/Autogel monotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "lanreotide": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1503501],
      "conceptName": ["lanreotide"]
    },
    "Interferon Alfa-2b": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1380068],
      "conceptName": ["Interferon Alfa-2b"]
    }
  },
  {
    "conceptId": [35806296],
    "regimenName": ["VAD doxil"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "doxorubicin liposome": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [19051649],
      "conceptName": ["doxorubicin liposome"]
    },
    "Dexamethasone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Thalidomide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19137042],
      "conceptName": ["Thalidomide"]
    }
  },
  {
    "conceptId": [35804343],
    "regimenName": ["MV"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Methotrexate": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Vinblastine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [19008264],
      "conceptName": ["Vinblastine"]
    },
    "Bleomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1329241],
      "conceptName": ["Bleomycin"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "mercaptopurine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1436650],
      "conceptName": ["mercaptopurine"]
    },
    "prednisolone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1550557],
      "conceptName": ["prednisolone"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    }
  },
  {
    "conceptId": [35803589],
    "regimenName": ["Mitotane and EDP"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Cisplatin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "Etoposide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Mitotane": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1309161],
      "conceptName": ["Mitotane"]
    }
  },
  {
    "conceptId": [35804009],
    "regimenName": ["LEED"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Melphalan": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1301267],
      "conceptName": ["Melphalan"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Dexamethasone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "Etoposide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "bortezomib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1336825],
      "conceptName": ["bortezomib"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "Thalidomide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19137042],
      "conceptName": ["Thalidomide"]
    }
  },
  {
    "conceptId": [35805631],
    "regimenName": ["Rituximab monotherapy, extended course"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "rituximab": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "inotuzumab ozogamicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [794068],
      "conceptName": ["inotuzumab ozogamicin"]
    },
    "Melphalan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1301267],
      "conceptName": ["Melphalan"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Mitoxantrone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1309188],
      "conceptName": ["Mitoxantrone"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Dacarbazine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311409],
      "conceptName": ["Dacarbazine"]
    },
    "Daunorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311799],
      "conceptName": ["Daunorubicin"]
    },
    "alemtuzumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1312706],
      "conceptName": ["alemtuzumab"]
    },
    "gemcitabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314924],
      "conceptName": ["gemcitabine"]
    },
    "oxaliplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1318011],
      "conceptName": ["oxaliplatin"]
    },
    "Bleomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1329241],
      "conceptName": ["Bleomycin"]
    },
    "Busulfan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1333357],
      "conceptName": ["Busulfan"]
    },
    "bortezomib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1336825],
      "conceptName": ["bortezomib"]
    },
    "Vorinostat": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1337651],
      "conceptName": ["Vorinostat"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "temozolomide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1341149],
      "conceptName": ["temozolomide"]
    },
    "vinorelbine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1343346],
      "conceptName": ["vinorelbine"]
    },
    "Epirubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344354],
      "conceptName": ["Epirubicin"]
    },
    "Carboplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344905],
      "conceptName": ["Carboplatin"]
    },
    "Carmustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350066],
      "conceptName": ["Carmustine"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Procarbazine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1351779],
      "conceptName": ["Procarbazine"]
    },
    "Mesna": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1354698],
      "conceptName": ["Mesna"]
    },
    "Paclitaxel": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1378382],
      "conceptName": ["Paclitaxel"]
    },
    "Topotecan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1378509],
      "conceptName": ["Topotecan"]
    },
    "Chlorambucil": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1390051],
      "conceptName": ["Chlorambucil"]
    },
    "Lomustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1391846],
      "conceptName": ["Lomustine"]
    },
    "fludarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1395557],
      "conceptName": ["fludarabine"]
    },
    "polatuzumab vedotin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1396729],
      "conceptName": ["polatuzumab vedotin"]
    },
    "bevacizumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397141],
      "conceptName": ["bevacizumab"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "Methylprednisolone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1506270],
      "conceptName": ["Methylprednisolone"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "prednisolone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1550557],
      "conceptName": ["prednisolone"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Hyaluronidase / rituximab Injection [Rituxan Hycela]": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1593155],
      "conceptName": ["Hyaluronidase / rituximab Injection [Rituxan Hycela]"]
    },
    "Vinblastine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008264],
      "conceptName": ["Vinblastine"]
    },
    "Vindesine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008336],
      "conceptName": ["Vindesine"]
    },
    "everolimus": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19011440],
      "conceptName": ["everolimus"]
    },
    "ASPARAGINASE": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19012585],
      "conceptName": ["ASPARAGINASE"]
    },
    "bendamustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19015523],
      "conceptName": ["bendamustine"]
    },
    "lenalidomide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19026972],
      "conceptName": ["lenalidomide"]
    },
    "Pentostatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19031224],
      "conceptName": ["Pentostatin"]
    },
    "doxorubicin liposome": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19051649],
      "conceptName": ["doxorubicin liposome"]
    },
    "Cladribine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19054825],
      "conceptName": ["Cladribine"]
    },
    "ibritumomab tiuxetan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19068830],
      "conceptName": ["ibritumomab tiuxetan"]
    },
    "Idarubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078097],
      "conceptName": ["Idarubicin"]
    },
    "Ifosfamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    },
    "temsirolimus": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19092845],
      "conceptName": ["temsirolimus"]
    },
    "Teniposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19136750],
      "conceptName": ["Teniposide"]
    },
    "Thalidomide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19137042],
      "conceptName": ["Thalidomide"]
    },
    "Thiotepa": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19137385],
      "conceptName": ["Thiotepa"]
    },
    "venetoclax": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [35604205],
      "conceptName": ["venetoclax"]
    },
    "Cytarabine liposome": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [40175460],
      "conceptName": ["Cytarabine liposome"]
    },
    "carfilzomib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [42873638],
      "conceptName": ["carfilzomib"]
    },
    "vincristine liposome": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [42874135],
      "conceptName": ["vincristine liposome"]
    },
    "Ibrutinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [44507848],
      "conceptName": ["Ibrutinib"]
    },
    "idelalisib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [45776944],
      "conceptName": ["idelalisib"]
    },
    "panobinostat": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [46221435],
      "conceptName": ["panobinostat"]
    }
  },
  {
    "conceptId": [35804299],
    "regimenName": ["FEC and H"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "trastuzumab": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1387104],
      "conceptName": ["trastuzumab"]
    },
    "Epirubicin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1344354],
      "conceptName": ["Epirubicin"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Fluorouracil": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    }
  },
  {
    "conceptId": [35803685],
    "regimenName": ["Temozolomide, then Temozolomide and RT, then Temozolomide"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "temozolomide": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1341149],
      "conceptName": ["temozolomide"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "capecitabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1337620],
      "conceptName": ["capecitabine"]
    },
    "irinotecan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1367268],
      "conceptName": ["irinotecan"]
    },
    "Lomustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1391846],
      "conceptName": ["Lomustine"]
    },
    "bevacizumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397141],
      "conceptName": ["bevacizumab"]
    },
    "Thalidomide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19137042],
      "conceptName": ["Thalidomide"]
    },
    "dinutuximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [46221699],
      "conceptName": ["dinutuximab"]
    }
  },
  {
    "conceptId": [35806379],
    "regimenName": ["Everolimus and Octreotide"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "everolimus": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [19011440],
      "conceptName": ["everolimus"]
    },
    "Octreotide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1522957],
      "conceptName": ["Octreotide"]
    }
  },
  {
    "conceptId": [35806316],
    "regimenName": ["PCD"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Cyclophosphamide": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Dexamethasone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "pomalidomide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [43014237],
      "conceptName": ["pomalidomide"]
    }
  },
  {
    "conceptId": [35804046],
    "regimenName": ["Linker regimen (consolidation)"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Methotrexate": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "ASPARAGINASE": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [19012585],
      "conceptName": ["ASPARAGINASE"]
    },
    "Cytarabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Prednisone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Daunorubicin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1311799],
      "conceptName": ["Daunorubicin"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Teniposide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [19136750],
      "conceptName": ["Teniposide"]
    }
  },
  {
    "conceptId": [35805812],
    "regimenName": ["BEACOPP-14"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Bleomycin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1329241],
      "conceptName": ["Bleomycin"]
    },
    "Prednisone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Procarbazine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1351779],
      "conceptName": ["Procarbazine"]
    },
    "Etoposide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    }
  },
  {
    "conceptId": [35807024],
    "regimenName": ["Gemcitabine, Oxaliplatin, Paclitaxel"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Paclitaxel": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1378382],
      "conceptName": ["Paclitaxel"]
    },
    "oxaliplatin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1318011],
      "conceptName": ["oxaliplatin"]
    },
    "gemcitabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1314924],
      "conceptName": ["gemcitabine"]
    }
  },
  {
    "conceptId": [35806638],
    "regimenName": ["CHOP-AL"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "alemtuzumab": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1312706],
      "conceptName": ["alemtuzumab"]
    },
    "Prednisone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    }
  },
  {
    "conceptId": [35804323],
    "regimenName": ["CVAP"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "prednisolone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1550557],
      "conceptName": ["prednisolone"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Bleomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1329241],
      "conceptName": ["Bleomycin"]
    },
    "bortezomib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1336825],
      "conceptName": ["bortezomib"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Procarbazine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1351779],
      "conceptName": ["Procarbazine"]
    },
    "ASPARAGINASE": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19012585],
      "conceptName": ["ASPARAGINASE"]
    }
  },
  {
    "conceptId": [35805859],
    "regimenName": ["BVDS"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Bleomycin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1329241],
      "conceptName": ["Bleomycin"]
    },
    "Streptozocin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [19136210],
      "conceptName": ["Streptozocin"]
    },
    "Vinblastine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [19008264],
      "conceptName": ["Vinblastine"]
    }
  },
  {
    "conceptId": [35806407],
    "regimenName": ["ABCP"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Carboplatin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1344905],
      "conceptName": ["Carboplatin"]
    },
    "Paclitaxel": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1378382],
      "conceptName": ["Paclitaxel"]
    },
    "bevacizumab": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1397141],
      "conceptName": ["bevacizumab"]
    },
    "atezolizumab": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [42629079],
      "conceptName": ["atezolizumab"]
    }
  },
  {
    "conceptId": [35804314],
    "regimenName": ["Pertuzumab and Trastuzumab"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "pertuzumab": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [42801287],
      "conceptName": ["pertuzumab"]
    },
    "trastuzumab": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1387104],
      "conceptName": ["trastuzumab"]
    },
    "docetaxel": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1315942],
      "conceptName": ["docetaxel"]
    },
    "capecitabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1337620],
      "conceptName": ["capecitabine"]
    },
    "Carboplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344905],
      "conceptName": ["Carboplatin"]
    },
    "Paclitaxel": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1378382],
      "conceptName": ["Paclitaxel"]
    }
  },
  {
    "conceptId": [35804404],
    "regimenName": ["Mercaptopurine and WBRT"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "mercaptopurine": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1436650],
      "conceptName": ["mercaptopurine"]
    },
    "Tretinoin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [903643],
      "conceptName": ["Tretinoin"]
    },
    "imatinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1304107],
      "conceptName": ["imatinib"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Daunorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311799],
      "conceptName": ["Daunorubicin"]
    },
    "pegaspargase": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1326481],
      "conceptName": ["pegaspargase"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Thioguanine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1437379],
      "conceptName": ["Thioguanine"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "prednisolone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1550557],
      "conceptName": ["prednisolone"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "nelarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19002912],
      "conceptName": ["nelarabine"]
    },
    "Vinblastine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008264],
      "conceptName": ["Vinblastine"]
    },
    "ASPARAGINASE": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19012585],
      "conceptName": ["ASPARAGINASE"]
    },
    "Idarubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078097],
      "conceptName": ["Idarubicin"]
    },
    "Norethandrolone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19128219],
      "conceptName": ["Norethandrolone"]
    }
  },
  {
    "conceptId": [35804435],
    "regimenName": ["Ipilimumab and Nivolumab"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "ipilimumab": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [40238188],
      "conceptName": ["ipilimumab"]
    },
    "nivolumab": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [45892628],
      "conceptName": ["nivolumab"]
    }
  },
  {
    "conceptId": [35806124],
    "regimenName": ["Cisplatin, Dacarbazine, Paclitaxel"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Paclitaxel": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1378382],
      "conceptName": ["Paclitaxel"]
    },
    "Cisplatin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "Dacarbazine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1311409],
      "conceptName": ["Dacarbazine"]
    }
  },
  {
    "conceptId": [35804170],
    "regimenName": ["Tagraxofusp monotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "tagraxofusp": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1356361],
      "conceptName": ["tagraxofusp"]
    }
  },
  {
    "conceptId": [35804325],
    "regimenName": ["CAMFP"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Methotrexate": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Prednisone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Fluorouracil": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    }
  },
  {
    "conceptId": [35805646],
    "regimenName": ["BVR"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "bendamustine": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [19015523],
      "conceptName": ["bendamustine"]
    },
    "rituximab": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "bortezomib": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1336825],
      "conceptName": ["bortezomib"]
    }
  },
  {
    "conceptId": [35804803],
    "regimenName": ["Fluorouracil, Folinic acid, Levamisole"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Leucovorin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1388796],
      "conceptName": ["Leucovorin"]
    },
    "Levamisole": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1389464],
      "conceptName": ["Levamisole"]
    },
    "Fluorouracil": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    }
  },
  {
    "conceptId": [35805361],
    "regimenName": ["Cisplatin, Doxorubicin liposomal, Fluorouracil"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "doxorubicin liposome": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [19051649],
      "conceptName": ["doxorubicin liposome"]
    },
    "Cisplatin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "Fluorouracil": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    }
  },
  {
    "conceptId": [35806278],
    "regimenName": ["EDAP"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Cisplatin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "Cytarabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Dexamethasone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "Etoposide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Ifosfamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    }
  },
  {
    "conceptId": [35803475],
    "regimenName": ["Gemtuzumab ozogamicin monotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Gemtuzumab ozogamicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [42799711],
      "conceptName": ["Gemtuzumab ozogamicin"]
    },
    "Tretinoin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [903643],
      "conceptName": ["Tretinoin"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Daunorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311799],
      "conceptName": ["Daunorubicin"]
    },
    "Azacitidine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314865],
      "conceptName": ["Azacitidine"]
    },
    "arsenic trioxide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1333379],
      "conceptName": ["arsenic trioxide"]
    },
    "Vorinostat": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1337651],
      "conceptName": ["Vorinostat"]
    }
  },
  {
    "conceptId": [35806841],
    "regimenName": ["Bicalutamide and Leuprolide"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Leuprolide": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1351541],
      "conceptName": ["Leuprolide"]
    },
    "bicalutamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1344381],
      "conceptName": ["bicalutamide"]
    }
  },
  {
    "conceptId": [35804797],
    "regimenName": ["FOLFIRI and Panitumumab"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "panitumumab": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [19100985],
      "conceptName": ["panitumumab"]
    },
    "Leucovorin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1388796],
      "conceptName": ["Leucovorin"]
    },
    "irinotecan": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1367268],
      "conceptName": ["irinotecan"]
    },
    "Fluorouracil": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    }
  },
  {
    "conceptId": [35804158],
    "regimenName": ["Gemcitabine and Paclitaxel"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Paclitaxel": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1378382],
      "conceptName": ["Paclitaxel"]
    },
    "gemcitabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1314924],
      "conceptName": ["gemcitabine"]
    },
    "oxaliplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1318011],
      "conceptName": ["oxaliplatin"]
    },
    "Carboplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344905],
      "conceptName": ["Carboplatin"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    }
  },
  {
    "conceptId": [35804329],
    "regimenName": ["CFP and Oophorectomy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Prednisone": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Fluorouracil": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Tamoxifen": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1436678],
      "conceptName": ["Tamoxifen"]
    }
  },
  {
    "conceptId": [35804379],
    "regimenName": ["GMALL-R"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Methotrexate": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Ifosfamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    },
    "rituximab": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Cytarabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Vindesine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [19008336],
      "conceptName": ["Vindesine"]
    },
    "Prednisone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Dexamethasone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "Etoposide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Teniposide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [19136750],
      "conceptName": ["Teniposide"]
    }
  },
  {
    "conceptId": [35804247],
    "regimenName": ["Capecitabine and Paclitaxel"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Paclitaxel": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1378382],
      "conceptName": ["Paclitaxel"]
    },
    "capecitabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1337620],
      "conceptName": ["capecitabine"]
    },
    "Carboplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344905],
      "conceptName": ["Carboplatin"]
    }
  },
  {
    "conceptId": [35804265],
    "regimenName": ["Eribulin monotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "eribulin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [40230712],
      "conceptName": ["eribulin"]
    }
  },
  {
    "conceptId": [35806957],
    "regimenName": ["CEV (Carboplatin/Etoposide)"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Carboplatin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1344905],
      "conceptName": ["Carboplatin"]
    },
    "Etoposide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Vindesine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008336],
      "conceptName": ["Vindesine"]
    },
    "ranimustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [35197850],
      "conceptName": ["ranimustine"]
    }
  },
  {
    "conceptId": [35806860],
    "regimenName": ["Ipilimumab and RT"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "ipilimumab": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [40238188],
      "conceptName": ["ipilimumab"]
    },
    "Dacarbazine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311409],
      "conceptName": ["Dacarbazine"]
    },
    "Carboplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344905],
      "conceptName": ["Carboplatin"]
    },
    "Paclitaxel": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1378382],
      "conceptName": ["Paclitaxel"]
    },
    "nivolumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [45892628],
      "conceptName": ["nivolumab"]
    }
  },
  {
    "conceptId": [35806289],
    "regimenName": ["BBD"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "bendamustine": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [19015523],
      "conceptName": ["bendamustine"]
    },
    "bortezomib": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1336825],
      "conceptName": ["bortezomib"]
    },
    "Dexamethasone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    }
  },
  {
    "conceptId": [35805886],
    "regimenName": ["Mepolizumab monotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "mepolizumab": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [35606631],
      "conceptName": ["mepolizumab"]
    }
  },
  {
    "conceptId": [35803481],
    "regimenName": ["Cytarabine and Mitoxantrone"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Cytarabine": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Mitoxantrone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1309188],
      "conceptName": ["Mitoxantrone"]
    },
    "Tretinoin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [903643],
      "conceptName": ["Tretinoin"]
    },
    "imatinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1304107],
      "conceptName": ["imatinib"]
    },
    "Filgrastim": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1304850],
      "conceptName": ["Filgrastim"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Thioguanine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1437379],
      "conceptName": ["Thioguanine"]
    },
    "Cladribine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19054825],
      "conceptName": ["Cladribine"]
    },
    "Idarubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078097],
      "conceptName": ["Idarubicin"]
    }
  },
  {
    "conceptId": [35806588],
    "regimenName": ["TFC, then allo HSCT"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Thiotepa": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [19137385],
      "conceptName": ["Thiotepa"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "fludarabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1395557],
      "conceptName": ["fludarabine"]
    }
  },
  {
    "conceptId": [35804806],
    "regimenName": ["Fluorouracil and Mitomycin"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Mitomycin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1389036],
      "conceptName": ["Mitomycin"]
    },
    "Fluorouracil": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Leucovorin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1388796],
      "conceptName": ["Leucovorin"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    }
  },
  {
    "conceptId": [35804415],
    "regimenName": ["Lomustine, Methotrexate, Procarbazine"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Methotrexate": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Lomustine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1391846],
      "conceptName": ["Lomustine"]
    },
    "Procarbazine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1351779],
      "conceptName": ["Procarbazine"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Methylprednisolone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1506270],
      "conceptName": ["Methylprednisolone"]
    }
  },
  {
    "conceptId": [35804093],
    "regimenName": ["L-Asparaginase, Vincristine, Prednisone"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "ASPARAGINASE": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [19012585],
      "conceptName": ["ASPARAGINASE"]
    },
    "Prednisone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "imatinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1304107],
      "conceptName": ["imatinib"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Daunorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311799],
      "conceptName": ["Daunorubicin"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "mercaptopurine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1436650],
      "conceptName": ["mercaptopurine"]
    },
    "Teniposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19136750],
      "conceptName": ["Teniposide"]
    }
  },
  {
    "conceptId": [35804541],
    "regimenName": ["Cisplatin and Topotecan"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Cisplatin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "Topotecan": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1378509],
      "conceptName": ["Topotecan"]
    }
  },
  {
    "conceptId": [35804336],
    "regimenName": ["CPB"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Carmustine": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1350066],
      "conceptName": ["Carmustine"]
    },
    "Cisplatin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    }
  },
  {
    "conceptId": [35804290],
    "regimenName": ["Tamoxifen and Prednisolone"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Tamoxifen": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1436678],
      "conceptName": ["Tamoxifen"]
    },
    "prednisolone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1550557],
      "conceptName": ["prednisolone"]
    }
  },
  {
    "conceptId": [35804431],
    "regimenName": ["Ifosfamide and Methotrexate"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Methotrexate": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Ifosfamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Bleomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1329241],
      "conceptName": ["Bleomycin"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Mesna": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1354698],
      "conceptName": ["Mesna"]
    },
    "Paclitaxel": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1378382],
      "conceptName": ["Paclitaxel"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Vindesine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008336],
      "conceptName": ["Vindesine"]
    },
    "ASPARAGINASE": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19012585],
      "conceptName": ["ASPARAGINASE"]
    },
    "doxorubicin liposome": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19051649],
      "conceptName": ["doxorubicin liposome"]
    },
    "Teniposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19136750],
      "conceptName": ["Teniposide"]
    },
    "Cytarabine liposome": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [40175460],
      "conceptName": ["Cytarabine liposome"]
    }
  },
  {
    "conceptId": [35804282],
    "regimenName": ["Anastrozole and Fulvestrant"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "anastrozole": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1348265],
      "conceptName": ["anastrozole"]
    },
    "fulvestrant": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1304044],
      "conceptName": ["fulvestrant"]
    }
  },
  {
    "conceptId": [35101451],
    "regimenName": ["Paclitaxel, Pertuzumab, Ado-trastuzumab emtansine"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Paclitaxel": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1378382],
      "conceptName": ["Paclitaxel"]
    },
    "pertuzumab": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [42801287],
      "conceptName": ["pertuzumab"]
    },
    "ado-trastuzumab emtansine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [43525787],
      "conceptName": ["ado-trastuzumab emtansine"]
    }
  },
  {
    "conceptId": [35806951],
    "regimenName": ["Methotrexate, RT, Cyclophosphamide"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Methotrexate": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "inotuzumab ozogamicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [794068],
      "conceptName": ["inotuzumab ozogamicin"]
    },
    "Fluorouracil": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "imatinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1304107],
      "conceptName": ["imatinib"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Mitoxantrone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1309188],
      "conceptName": ["Mitoxantrone"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Dactinomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311443],
      "conceptName": ["Dactinomycin"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Bleomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1329241],
      "conceptName": ["Bleomycin"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Epirubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344354],
      "conceptName": ["Epirubicin"]
    },
    "Carboplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344905],
      "conceptName": ["Carboplatin"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Procarbazine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1351779],
      "conceptName": ["Procarbazine"]
    },
    "dasatinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1358436],
      "conceptName": ["dasatinib"]
    },
    "Altretamine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1368823],
      "conceptName": ["Altretamine"]
    },
    "Leucovorin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1388796],
      "conceptName": ["Leucovorin"]
    },
    "Lomustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1391846],
      "conceptName": ["Lomustine"]
    },
    "Mechlorethamine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1394337],
      "conceptName": ["Mechlorethamine"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "mercaptopurine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1436650],
      "conceptName": ["mercaptopurine"]
    },
    "Tamoxifen": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1436678],
      "conceptName": ["Tamoxifen"]
    },
    "Thioguanine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1437379],
      "conceptName": ["Thioguanine"]
    },
    "Methylprednisolone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1506270],
      "conceptName": ["Methylprednisolone"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "prednisolone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1550557],
      "conceptName": ["prednisolone"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Vindesine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008336],
      "conceptName": ["Vindesine"]
    },
    "everolimus": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19011440],
      "conceptName": ["everolimus"]
    },
    "ASPARAGINASE": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19012585],
      "conceptName": ["ASPARAGINASE"]
    },
    "doxorubicin liposome": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19051649],
      "conceptName": ["doxorubicin liposome"]
    },
    "Ifosfamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    },
    "Teniposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19136750],
      "conceptName": ["Teniposide"]
    },
    "Cytarabine liposome": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [40175460],
      "conceptName": ["Cytarabine liposome"]
    },
    "ponatinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [43013182],
      "conceptName": ["ponatinib"]
    }
  },
  {
    "conceptId": [35806346],
    "regimenName": ["VMCP/VCAP"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Melphalan": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1301267],
      "conceptName": ["Melphalan"]
    },
    "Prednisone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Carmustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350066],
      "conceptName": ["Carmustine"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    }
  },
  {
    "conceptId": [35806260],
    "regimenName": ["RVD"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "lenalidomide": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [19026972],
      "conceptName": ["lenalidomide"]
    },
    "bortezomib": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1336825],
      "conceptName": ["bortezomib"]
    },
    "Dexamethasone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "Melphalan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1301267],
      "conceptName": ["Melphalan"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    }
  },
  {
    "conceptId": [35805115],
    "regimenName": ["VNCOP-B"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Bleomycin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1329241],
      "conceptName": ["Bleomycin"]
    },
    "Prednisone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Mitoxantrone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1309188],
      "conceptName": ["Mitoxantrone"]
    },
    "Etoposide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    }
  },
  {
    "conceptId": [35807028],
    "regimenName": ["Chlorambucil, Dactinomycin, Methotrexate"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Methotrexate": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Dactinomycin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1311443],
      "conceptName": ["Dactinomycin"]
    },
    "Chlorambucil": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1390051],
      "conceptName": ["Chlorambucil"]
    }
  },
  {
    "conceptId": [35806341],
    "regimenName": ["VAMP"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Methylprednisolone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1506270],
      "conceptName": ["Methylprednisolone"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "everolimus": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19011440],
      "conceptName": ["everolimus"]
    }
  },
  {
    "conceptId": [35805081],
    "regimenName": ["R-CVEP"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "rituximab": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Prednisone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Vorinostat": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1337651],
      "conceptName": ["Vorinostat"]
    },
    "Etoposide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    }
  },
  {
    "conceptId": [35806348],
    "regimenName": ["MEL200, then auto HSCT, then MEL220 and Dexamethasone, then auto HSCT"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Melphalan": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1301267],
      "conceptName": ["Melphalan"]
    },
    "Dexamethasone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "bortezomib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1336825],
      "conceptName": ["bortezomib"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Carmustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350066],
      "conceptName": ["Carmustine"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "lenalidomide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19026972],
      "conceptName": ["lenalidomide"]
    },
    "Thalidomide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19137042],
      "conceptName": ["Thalidomide"]
    }
  },
  {
    "conceptId": [35803548],
    "regimenName": ["Arsenic trioxide monotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "arsenic trioxide": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1333379],
      "conceptName": ["arsenic trioxide"]
    },
    "Tretinoin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [903643],
      "conceptName": ["Tretinoin"]
    },
    "Daunorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311799],
      "conceptName": ["Daunorubicin"]
    },
    "Chlorambucil": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1390051],
      "conceptName": ["Chlorambucil"]
    },
    "Idarubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078097],
      "conceptName": ["Idarubicin"]
    },
    "Gemtuzumab ozogamicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [42799711],
      "conceptName": ["Gemtuzumab ozogamicin"]
    }
  },
  {
    "conceptId": [35805712],
    "regimenName": ["Carmustine and RT"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Carmustine": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1350066],
      "conceptName": ["Carmustine"]
    },
    "Melphalan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1301267],
      "conceptName": ["Melphalan"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Mitoxantrone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1309188],
      "conceptName": ["Mitoxantrone"]
    },
    "Aldesleukin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1309770],
      "conceptName": ["Aldesleukin"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Dacarbazine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311409],
      "conceptName": ["Dacarbazine"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Procarbazine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1351779],
      "conceptName": ["Procarbazine"]
    },
    "hydroxyurea": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1377141],
      "conceptName": ["hydroxyurea"]
    },
    "Interferon Alfa-2b": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1380068],
      "conceptName": ["Interferon Alfa-2b"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "Methylprednisolone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1506270],
      "conceptName": ["Methylprednisolone"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Vinblastine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008264],
      "conceptName": ["Vinblastine"]
    },
    "ibritumomab tiuxetan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19068830],
      "conceptName": ["ibritumomab tiuxetan"]
    },
    "Teniposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19136750],
      "conceptName": ["Teniposide"]
    },
    "Thiotepa": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19137385],
      "conceptName": ["Thiotepa"]
    }
  },
  {
    "conceptId": [35804364],
    "regimenName": ["TAD (Tamoxifen)"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Tamoxifen": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1436678],
      "conceptName": ["Tamoxifen"]
    },
    "Danazol": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1511449],
      "conceptName": ["Danazol"]
    },
    "Aminoglutethimide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1503057],
      "conceptName": ["Aminoglutethimide"]
    }
  },
  {
    "conceptId": [35804270],
    "regimenName": ["Talazoparib monotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "talazoparib": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [35201068],
      "conceptName": ["talazoparib"]
    }
  },
  {
    "conceptId": [35804278],
    "regimenName": ["Tamoxifen and OFS"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Tamoxifen": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1436678],
      "conceptName": ["Tamoxifen"]
    },
    "Fluorouracil": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "Megestrol": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1300978],
      "conceptName": ["Megestrol"]
    },
    "Melphalan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1301267],
      "conceptName": ["Melphalan"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Dacarbazine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311409],
      "conceptName": ["Dacarbazine"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Goserelin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1366310],
      "conceptName": ["Goserelin"]
    },
    "trastuzumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1387104],
      "conceptName": ["trastuzumab"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "Medroxyprogesterone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1500211],
      "conceptName": ["Medroxyprogesterone"]
    },
    "Aminoglutethimide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1503057],
      "conceptName": ["Aminoglutethimide"]
    },
    "Danazol": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1511449],
      "conceptName": ["Danazol"]
    },
    "prednisolone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1550557],
      "conceptName": ["prednisolone"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "ribociclib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1592911],
      "conceptName": ["ribociclib"]
    },
    "everolimus": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19011440],
      "conceptName": ["everolimus"]
    },
    "ado-trastuzumab emtansine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [43525787],
      "conceptName": ["ado-trastuzumab emtansine"]
    }
  },
  {
    "conceptId": [35804006],
    "regimenName": ["CTCb"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Carboplatin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1344905],
      "conceptName": ["Carboplatin"]
    },
    "Thiotepa": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [19137385],
      "conceptName": ["Thiotepa"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    }
  },
  {
    "conceptId": [35805364],
    "regimenName": ["DCF"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Cisplatin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "docetaxel": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1315942],
      "conceptName": ["docetaxel"]
    },
    "Fluorouracil": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "Leucovorin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1388796],
      "conceptName": ["Leucovorin"]
    },
    "bevacizumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397141],
      "conceptName": ["bevacizumab"]
    }
  },
  {
    "conceptId": [35804151],
    "regimenName": ["Cisplatin, Paclitaxel, RT"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Paclitaxel": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1378382],
      "conceptName": ["Paclitaxel"]
    },
    "Cisplatin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "Fluorouracil": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Dacarbazine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311409],
      "conceptName": ["Dacarbazine"]
    },
    "gemcitabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314924],
      "conceptName": ["gemcitabine"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Epirubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344354],
      "conceptName": ["Epirubicin"]
    },
    "bevacizumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397141],
      "conceptName": ["bevacizumab"]
    },
    "Ifosfamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    }
  },
  {
    "conceptId": [35805099],
    "regimenName": ["F-MACHOP"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Methotrexate": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Cytarabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Prednisone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Fluorouracil": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    }
  },
  {
    "conceptId": [35804378],
    "regimenName": ["DA-R-EPOCH"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "rituximab": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Prednisone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Etoposide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "Vindesine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008336],
      "conceptName": ["Vindesine"]
    },
    "Ifosfamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    },
    "Teniposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19136750],
      "conceptName": ["Teniposide"]
    }
  },
  {
    "conceptId": [35804205],
    "regimenName": ["Paclitaxel monotherapy, weekly"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Paclitaxel": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1378382],
      "conceptName": ["Paclitaxel"]
    },
    "neratinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [793846],
      "conceptName": ["neratinib"]
    },
    "Fluorouracil": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Dacarbazine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311409],
      "conceptName": ["Dacarbazine"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "gemcitabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314924],
      "conceptName": ["gemcitabine"]
    },
    "oxaliplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1318011],
      "conceptName": ["oxaliplatin"]
    },
    "capecitabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1337620],
      "conceptName": ["capecitabine"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "vinorelbine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1343346],
      "conceptName": ["vinorelbine"]
    },
    "Epirubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344354],
      "conceptName": ["Epirubicin"]
    },
    "Carboplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344905],
      "conceptName": ["Carboplatin"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "lapatinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1359548],
      "conceptName": ["lapatinib"]
    },
    "Hyaluronidase / trastuzumab Injection [Herceptin Hylecta]": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1366689],
      "conceptName": ["Hyaluronidase / trastuzumab Injection [Herceptin Hylecta]"]
    },
    "Topotecan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1378509],
      "conceptName": ["Topotecan"]
    },
    "trastuzumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1387104],
      "conceptName": ["trastuzumab"]
    },
    "bevacizumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397141],
      "conceptName": ["bevacizumab"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "Ifosfamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    },
    "pazopanib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [40167554],
      "conceptName": ["pazopanib"]
    },
    "ipilimumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [40238188],
      "conceptName": ["ipilimumab"]
    },
    "atezolizumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [42629079],
      "conceptName": ["atezolizumab"]
    },
    "pertuzumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [42801287],
      "conceptName": ["pertuzumab"]
    },
    "ado-trastuzumab emtansine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [43525787],
      "conceptName": ["ado-trastuzumab emtansine"]
    },
    "Afatinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [43533090],
      "conceptName": ["Afatinib"]
    },
    "ramucirumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [44818489],
      "conceptName": ["ramucirumab"]
    },
    "pembrolizumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [45775965],
      "conceptName": ["pembrolizumab"]
    },
    "olaparib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [45892579],
      "conceptName": ["olaparib"]
    }
  },
  {
    "conceptId": [35102031],
    "regimenName": ["BEACOPP-14 (Prednisolone)"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Bleomycin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1329241],
      "conceptName": ["Bleomycin"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Procarbazine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1351779],
      "conceptName": ["Procarbazine"]
    },
    "Etoposide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "prednisolone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1550557],
      "conceptName": ["prednisolone"]
    }
  },
  {
    "conceptId": [35804144],
    "regimenName": ["Cisplatin and RT"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Cisplatin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "Fluorouracil": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "Isotretinoin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [984232],
      "conceptName": ["Isotretinoin"]
    },
    "Melphalan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1301267],
      "conceptName": ["Melphalan"]
    },
    "pemetrexed": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1304919],
      "conceptName": ["pemetrexed"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Mitotane": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1309161],
      "conceptName": ["Mitotane"]
    },
    "Aldesleukin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1309770],
      "conceptName": ["Aldesleukin"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Dacarbazine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311409],
      "conceptName": ["Dacarbazine"]
    },
    "Dactinomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311443],
      "conceptName": ["Dactinomycin"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "gemcitabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314924],
      "conceptName": ["gemcitabine"]
    },
    "cetuximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1315411],
      "conceptName": ["cetuximab"]
    },
    "docetaxel": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1315942],
      "conceptName": ["docetaxel"]
    },
    "erlotinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1325363],
      "conceptName": ["erlotinib"]
    },
    "pegaspargase": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1326481],
      "conceptName": ["pegaspargase"]
    },
    "Bleomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1329241],
      "conceptName": ["Bleomycin"]
    },
    "bortezomib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1336825],
      "conceptName": ["bortezomib"]
    },
    "capecitabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1337620],
      "conceptName": ["capecitabine"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "vinorelbine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1343346],
      "conceptName": ["vinorelbine"]
    },
    "Epirubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344354],
      "conceptName": ["Epirubicin"]
    },
    "Carboplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344905],
      "conceptName": ["Carboplatin"]
    },
    "Carmustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350066],
      "conceptName": ["Carmustine"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Mesna": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1354698],
      "conceptName": ["Mesna"]
    },
    "Hyaluronidase / trastuzumab Injection [Herceptin Hylecta]": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1366689],
      "conceptName": ["Hyaluronidase / trastuzumab Injection [Herceptin Hylecta]"]
    },
    "irinotecan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1367268],
      "conceptName": ["irinotecan"]
    },
    "Altretamine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1368823],
      "conceptName": ["Altretamine"]
    },
    "hydroxyurea": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1377141],
      "conceptName": ["hydroxyurea"]
    },
    "Paclitaxel": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1378382],
      "conceptName": ["Paclitaxel"]
    },
    "Topotecan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1378509],
      "conceptName": ["Topotecan"]
    },
    "Interferon Alfa-2a": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1379969],
      "conceptName": ["Interferon Alfa-2a"]
    },
    "Interferon Alfa-2b": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1380068],
      "conceptName": ["Interferon Alfa-2b"]
    },
    "Interferon gamma-1b": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1380191],
      "conceptName": ["Interferon gamma-1b"]
    },
    "trastuzumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1387104],
      "conceptName": ["trastuzumab"]
    },
    "Leucovorin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1388796],
      "conceptName": ["Leucovorin"]
    },
    "Mitomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1389036],
      "conceptName": ["Mitomycin"]
    },
    "Chlorambucil": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1390051],
      "conceptName": ["Chlorambucil"]
    },
    "Lomustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1391846],
      "conceptName": ["Lomustine"]
    },
    "bevacizumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397141],
      "conceptName": ["bevacizumab"]
    },
    "Tamoxifen": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1436678],
      "conceptName": ["Tamoxifen"]
    },
    "Methylprednisolone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1506270],
      "conceptName": ["Methylprednisolone"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Vinblastine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008264],
      "conceptName": ["Vinblastine"]
    },
    "Vindesine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008336],
      "conceptName": ["Vindesine"]
    },
    "raltitrexed": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19038536],
      "conceptName": ["raltitrexed"]
    },
    "doxorubicin liposome": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19051649],
      "conceptName": ["doxorubicin liposome"]
    },
    "Ifosfamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    },
    "panitumumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19100985],
      "conceptName": ["panitumumab"]
    },
    "Thalidomide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19137042],
      "conceptName": ["Thalidomide"]
    },
    "necitumumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [35606215],
      "conceptName": ["necitumumab"]
    },
    "ofatumumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [40167582],
      "conceptName": ["ofatumumab"]
    },
    "pembrolizumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [45775965],
      "conceptName": ["pembrolizumab"]
    }
  },
  {
    "conceptId": [35804044],
    "regimenName": ["Cytarabine, Idarubicin, Rituximab"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Idarubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [19078097],
      "conceptName": ["Idarubicin"]
    },
    "rituximab": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Cytarabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    }
  },
  {
    "conceptId": [35804072],
    "regimenName": ["Hyper-CVAD and Dasatinib"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Methotrexate": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Cytarabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "dasatinib": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1358436],
      "conceptName": ["dasatinib"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Dexamethasone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    }
  },
  {
    "conceptId": [35805826],
    "regimenName": ["COPP/ABVD"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Bleomycin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1329241],
      "conceptName": ["Bleomycin"]
    },
    "Prednisone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Vinblastine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [19008264],
      "conceptName": ["Vinblastine"]
    },
    "Dacarbazine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1311409],
      "conceptName": ["Dacarbazine"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Procarbazine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1351779],
      "conceptName": ["Procarbazine"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    }
  },
  {
    "conceptId": [35806339],
    "regimenName": ["VBMCP"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Carmustine": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1350066],
      "conceptName": ["Carmustine"]
    },
    "Melphalan": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1301267],
      "conceptName": ["Melphalan"]
    },
    "Prednisone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    }
  },
  {
    "conceptId": [35804767],
    "regimenName": ["CAPIRI"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "irinotecan": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1367268],
      "conceptName": ["irinotecan"]
    },
    "capecitabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1337620],
      "conceptName": ["capecitabine"]
    },
    "bevacizumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397141],
      "conceptName": ["bevacizumab"]
    }
  },
  {
    "conceptId": [35803613],
    "regimenName": ["Cyclophosphamide and TBI"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Cyclophosphamide": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "inotuzumab ozogamicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [794068],
      "conceptName": ["inotuzumab ozogamicin"]
    },
    "Fluorouracil": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "Melphalan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1301267],
      "conceptName": ["Melphalan"]
    },
    "imatinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1304107],
      "conceptName": ["imatinib"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Mitoxantrone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1309188],
      "conceptName": ["Mitoxantrone"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Dacarbazine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311409],
      "conceptName": ["Dacarbazine"]
    },
    "Dactinomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311443],
      "conceptName": ["Dactinomycin"]
    },
    "Daunorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311799],
      "conceptName": ["Daunorubicin"]
    },
    "alemtuzumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1312706],
      "conceptName": ["alemtuzumab"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "gemcitabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314924],
      "conceptName": ["gemcitabine"]
    },
    "docetaxel": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1315942],
      "conceptName": ["docetaxel"]
    },
    "pegaspargase": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1326481],
      "conceptName": ["pegaspargase"]
    },
    "Bleomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1329241],
      "conceptName": ["Bleomycin"]
    },
    "Busulfan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1333357],
      "conceptName": ["Busulfan"]
    },
    "bortezomib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1336825],
      "conceptName": ["bortezomib"]
    },
    "Vorinostat": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1337651],
      "conceptName": ["Vorinostat"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Epirubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344354],
      "conceptName": ["Epirubicin"]
    },
    "Carboplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344905],
      "conceptName": ["Carboplatin"]
    },
    "Carmustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350066],
      "conceptName": ["Carmustine"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Procarbazine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1351779],
      "conceptName": ["Procarbazine"]
    },
    "Mesna": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1354698],
      "conceptName": ["Mesna"]
    },
    "dasatinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1358436],
      "conceptName": ["dasatinib"]
    },
    "irinotecan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1367268],
      "conceptName": ["irinotecan"]
    },
    "Altretamine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1368823],
      "conceptName": ["Altretamine"]
    },
    "Paclitaxel": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1378382],
      "conceptName": ["Paclitaxel"]
    },
    "Topotecan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1378509],
      "conceptName": ["Topotecan"]
    },
    "Interferon Alfa-2b": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1380068],
      "conceptName": ["Interferon Alfa-2b"]
    },
    "Interferon gamma-1b": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1380191],
      "conceptName": ["Interferon gamma-1b"]
    },
    "trastuzumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1387104],
      "conceptName": ["trastuzumab"]
    },
    "Leucovorin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1388796],
      "conceptName": ["Leucovorin"]
    },
    "Lomustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1391846],
      "conceptName": ["Lomustine"]
    },
    "Mechlorethamine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1394337],
      "conceptName": ["Mechlorethamine"]
    },
    "fludarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1395557],
      "conceptName": ["fludarabine"]
    },
    "bevacizumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397141],
      "conceptName": ["bevacizumab"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "mercaptopurine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1436650],
      "conceptName": ["mercaptopurine"]
    },
    "Tamoxifen": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1436678],
      "conceptName": ["Tamoxifen"]
    },
    "Thioguanine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1437379],
      "conceptName": ["Thioguanine"]
    },
    "Medroxyprogesterone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1500211],
      "conceptName": ["Medroxyprogesterone"]
    },
    "Methylprednisolone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1506270],
      "conceptName": ["Methylprednisolone"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "Diethylstilbestrol": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1525866],
      "conceptName": ["Diethylstilbestrol"]
    },
    "prednisolone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1550557],
      "conceptName": ["prednisolone"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Hyaluronidase / rituximab Injection [Rituxan Hycela]": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1593155],
      "conceptName": ["Hyaluronidase / rituximab Injection [Rituxan Hycela]"]
    },
    "nelarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19002912],
      "conceptName": ["nelarabine"]
    },
    "Vinblastine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008264],
      "conceptName": ["Vinblastine"]
    },
    "Vindesine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008336],
      "conceptName": ["Vindesine"]
    },
    "everolimus": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19011440],
      "conceptName": ["everolimus"]
    },
    "ASPARAGINASE": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19012585],
      "conceptName": ["ASPARAGINASE"]
    },
    "lenalidomide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19026972],
      "conceptName": ["lenalidomide"]
    },
    "Pentostatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19031224],
      "conceptName": ["Pentostatin"]
    },
    "denileukin diftitox": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19051642],
      "conceptName": ["denileukin diftitox"]
    },
    "doxorubicin liposome": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19051649],
      "conceptName": ["doxorubicin liposome"]
    },
    "clofarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19054821],
      "conceptName": ["clofarabine"]
    },
    "Cladribine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19054825],
      "conceptName": ["Cladribine"]
    },
    "iodine-131-tositumomab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19054997],
      "conceptName": ["iodine-131-tositumomab"]
    },
    "ibritumomab tiuxetan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19068830],
      "conceptName": ["ibritumomab tiuxetan"]
    },
    "Idarubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078097],
      "conceptName": ["Idarubicin"]
    },
    "Ifosfamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    },
    "BCG, Live, Tice Strain": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19086176],
      "conceptName": ["BCG, Live, Tice Strain"]
    },
    "Teniposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19136750],
      "conceptName": ["Teniposide"]
    },
    "Thalidomide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19137042],
      "conceptName": ["Thalidomide"]
    },
    "Thiotepa": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19137385],
      "conceptName": ["Thiotepa"]
    },
    "Myocet": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [21017157],
      "conceptName": ["Myocet"]
    },
    "ranimustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [35197850],
      "conceptName": ["ranimustine"]
    },
    "ofatumumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [40167582],
      "conceptName": ["ofatumumab"]
    },
    "Cytarabine liposome": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [40175460],
      "conceptName": ["Cytarabine liposome"]
    },
    "brentuximab vedotin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [40241969],
      "conceptName": ["brentuximab vedotin"]
    },
    "carfilzomib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [42873638],
      "conceptName": ["carfilzomib"]
    },
    "vincristine liposome": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [42874135],
      "conceptName": ["vincristine liposome"]
    },
    "ponatinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [43013182],
      "conceptName": ["ponatinib"]
    },
    "pomalidomide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [43014237],
      "conceptName": ["pomalidomide"]
    },
    "obinutuzumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [44507676],
      "conceptName": ["obinutuzumab"]
    }
  },
  {
    "conceptId": [35805105],
    "regimenName": ["P/DOCE"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Prednisone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Etoposide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Bleomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1329241],
      "conceptName": ["Bleomycin"]
    },
    "Carboplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344905],
      "conceptName": ["Carboplatin"]
    },
    "Procarbazine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1351779],
      "conceptName": ["Procarbazine"]
    },
    "Mechlorethamine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1394337],
      "conceptName": ["Mechlorethamine"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "Vindesine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008336],
      "conceptName": ["Vindesine"]
    },
    "Ifosfamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    },
    "Teniposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19136750],
      "conceptName": ["Teniposide"]
    },
    "ranimustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [35197850],
      "conceptName": ["ranimustine"]
    }
  },
  {
    "conceptId": [35805107],
    "regimenName": ["PEN"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Prednisone": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Mitoxantrone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1309188],
      "conceptName": ["Mitoxantrone"]
    },
    "Etoposide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Bleomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1329241],
      "conceptName": ["Bleomycin"]
    },
    "Procarbazine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1351779],
      "conceptName": ["Procarbazine"]
    },
    "Vinblastine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008264],
      "conceptName": ["Vinblastine"]
    }
  },
  {
    "conceptId": [35805341],
    "regimenName": ["FLOT"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "oxaliplatin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1318011],
      "conceptName": ["oxaliplatin"]
    },
    "docetaxel": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1315942],
      "conceptName": ["docetaxel"]
    },
    "Leucovorin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1388796],
      "conceptName": ["Leucovorin"]
    },
    "Fluorouracil": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    }
  },
  {
    "conceptId": [35804212],
    "regimenName": ["FEC"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Epirubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1344354],
      "conceptName": ["Epirubicin"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Fluorouracil": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "trastuzumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1387104],
      "conceptName": ["trastuzumab"]
    },
    "bevacizumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397141],
      "conceptName": ["bevacizumab"]
    }
  },
  {
    "conceptId": [35806325],
    "regimenName": ["CRD"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "lenalidomide": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [19026972],
      "conceptName": ["lenalidomide"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Dexamethasone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "bortezomib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1336825],
      "conceptName": ["bortezomib"]
    }
  },
  {
    "conceptId": [35805858],
    "regimenName": ["BVCPP"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Carmustine": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1350066],
      "conceptName": ["Carmustine"]
    },
    "Prednisone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Vinblastine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [19008264],
      "conceptName": ["Vinblastine"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Procarbazine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1351779],
      "conceptName": ["Procarbazine"]
    }
  },
  {
    "conceptId": [35806581],
    "regimenName": ["Temozolomide and Thalidomide"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Thalidomide": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [19137042],
      "conceptName": ["Thalidomide"]
    },
    "temozolomide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1341149],
      "conceptName": ["temozolomide"]
    }
  },
  {
    "conceptId": [35805854],
    "regimenName": ["NOVP"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Prednisone": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Vinblastine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [19008264],
      "conceptName": ["Vinblastine"]
    },
    "Mitoxantrone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1309188],
      "conceptName": ["Mitoxantrone"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    }
  },
  {
    "conceptId": [35806909],
    "regimenName": ["VA"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Dactinomycin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1311443],
      "conceptName": ["Dactinomycin"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "irinotecan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1367268],
      "conceptName": ["irinotecan"]
    },
    "Ifosfamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    }
  },
  {
    "conceptId": [35806342],
    "regimenName": ["VBMC"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Carmustine": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1350066],
      "conceptName": ["Carmustine"]
    },
    "Melphalan": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1301267],
      "conceptName": ["Melphalan"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    }
  },
  {
    "conceptId": [35804353],
    "regimenName": ["Chlorambucil and Prednisolone"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Chlorambucil": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1390051],
      "conceptName": ["Chlorambucil"]
    },
    "prednisolone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1550557],
      "conceptName": ["prednisolone"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Mitoxantrone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1309188],
      "conceptName": ["Mitoxantrone"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Bleomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1329241],
      "conceptName": ["Bleomycin"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Procarbazine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1351779],
      "conceptName": ["Procarbazine"]
    },
    "Vinblastine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008264],
      "conceptName": ["Vinblastine"]
    }
  },
  {
    "conceptId": [35805818],
    "regimenName": ["OEPA"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Prednisone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Etoposide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Bleomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1329241],
      "conceptName": ["Bleomycin"]
    },
    "Carboplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344905],
      "conceptName": ["Carboplatin"]
    },
    "Procarbazine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1351779],
      "conceptName": ["Procarbazine"]
    },
    "Chlorambucil": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1390051],
      "conceptName": ["Chlorambucil"]
    },
    "Mechlorethamine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1394337],
      "conceptName": ["Mechlorethamine"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "Vinblastine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008264],
      "conceptName": ["Vinblastine"]
    },
    "Vindesine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008336],
      "conceptName": ["Vindesine"]
    },
    "Ifosfamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    },
    "Teniposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19136750],
      "conceptName": ["Teniposide"]
    },
    "ranimustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [35197850],
      "conceptName": ["ranimustine"]
    }
  },
  {
    "conceptId": [35101611],
    "regimenName": ["Carboplatin, nab-Paclitaxel, Atezolizumab"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Carboplatin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1344905],
      "conceptName": ["Carboplatin"]
    },
    "Paclitaxel": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1378382],
      "conceptName": ["Paclitaxel"]
    },
    "atezolizumab": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [42629079],
      "conceptName": ["atezolizumab"]
    },
    "bevacizumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397141],
      "conceptName": ["bevacizumab"]
    }
  },
  {
    "conceptId": [35805036],
    "regimenName": ["O-miniCHOP"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "ofatumumab": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [40167582],
      "conceptName": ["ofatumumab"]
    },
    "Prednisone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    }
  },
  {
    "conceptId": [35804312],
    "regimenName": ["Capecitabine and Trastuzumab"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "trastuzumab": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1387104],
      "conceptName": ["trastuzumab"]
    },
    "capecitabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1337620],
      "conceptName": ["capecitabine"]
    },
    "bevacizumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397141],
      "conceptName": ["bevacizumab"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "pertuzumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [42801287],
      "conceptName": ["pertuzumab"]
    }
  },
  {
    "conceptId": [35101482],
    "regimenName": ["CALGB 8811 early intensification"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "ASPARAGINASE": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [19012585],
      "conceptName": ["ASPARAGINASE"]
    },
    "Cytarabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "mercaptopurine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1436650],
      "conceptName": ["mercaptopurine"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Thioguanine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1437379],
      "conceptName": ["Thioguanine"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    }
  },
  {
    "conceptId": [35806093],
    "regimenName": ["BCHOP"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "bortezomib": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1336825],
      "conceptName": ["bortezomib"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "prednisolone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1550557],
      "conceptName": ["prednisolone"]
    }
  },
  {
    "conceptId": [35804356],
    "regimenName": ["DES monotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Diethylstilbestrol": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1525866],
      "conceptName": ["Diethylstilbestrol"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    }
  },
  {
    "conceptId": [35806362],
    "regimenName": ["Busulfan and Cyclophosphamide, then allo HSCT"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Busulfan": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1333357],
      "conceptName": ["Busulfan"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "fludarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1395557],
      "conceptName": ["fludarabine"]
    },
    "Thiotepa": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19137385],
      "conceptName": ["Thiotepa"]
    }
  },
  {
    "conceptId": [35804350],
    "regimenName": ["Aminoglutethimide monotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Aminoglutethimide": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1503057],
      "conceptName": ["Aminoglutethimide"]
    },
    "Tamoxifen": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1436678],
      "conceptName": ["Tamoxifen"]
    },
    "Danazol": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1511449],
      "conceptName": ["Danazol"]
    }
  },
  {
    "conceptId": [35804545],
    "regimenName": ["Fluorouracil and Folinic acid"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Leucovorin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1388796],
      "conceptName": ["Leucovorin"]
    },
    "Fluorouracil": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "gemcitabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314924],
      "conceptName": ["gemcitabine"]
    },
    "cetuximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1315411],
      "conceptName": ["cetuximab"]
    },
    "docetaxel": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1315942],
      "conceptName": ["docetaxel"]
    },
    "oxaliplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1318011],
      "conceptName": ["oxaliplatin"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "irinotecan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1367268],
      "conceptName": ["irinotecan"]
    },
    "Mitomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1389036],
      "conceptName": ["Mitomycin"]
    },
    "Levamisole": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1389464],
      "conceptName": ["Levamisole"]
    },
    "bevacizumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397141],
      "conceptName": ["bevacizumab"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "panitumumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19100985],
      "conceptName": ["panitumumab"]
    },
    "irinotecan liposomal": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [35603068],
      "conceptName": ["irinotecan liposomal"]
    },
    "aflibercept": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [40244266],
      "conceptName": ["aflibercept"]
    },
    "ramucirumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [44818489],
      "conceptName": ["ramucirumab"]
    }
  },
  {
    "conceptId": [35803522],
    "regimenName": ["7 plus 3i and Panobinostat"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Idarubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [19078097],
      "conceptName": ["Idarubicin"]
    },
    "panobinostat": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [46221435],
      "conceptName": ["panobinostat"]
    },
    "Cytarabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    }
  },
  {
    "conceptId": [35804429],
    "regimenName": ["R-MPV"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Methotrexate": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "rituximab": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Procarbazine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1351779],
      "conceptName": ["Procarbazine"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    }
  },
  {
    "conceptId": [35805838],
    "regimenName": ["O-ESHAP"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Cisplatin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "ofatumumab": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [40167582],
      "conceptName": ["ofatumumab"]
    },
    "Methylprednisolone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1506270],
      "conceptName": ["Methylprednisolone"]
    },
    "Cytarabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Etoposide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    }
  },
  {
    "conceptId": [35806468],
    "regimenName": ["MA-BCD"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Bleomycin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1329241],
      "conceptName": ["Bleomycin"]
    },
    "Methotrexate": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Dactinomycin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1311443],
      "conceptName": ["Dactinomycin"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    }
  },
  {
    "conceptId": [35805689],
    "regimenName": ["FEMTX"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Methotrexate": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Epirubicin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1344354],
      "conceptName": ["Epirubicin"]
    },
    "Fluorouracil": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    }
  },
  {
    "conceptId": [35806912],
    "regimenName": ["VIE"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Ifosfamide": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    },
    "Etoposide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Dactinomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311443],
      "conceptName": ["Dactinomycin"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "irinotecan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1367268],
      "conceptName": ["irinotecan"]
    },
    "Topotecan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1378509],
      "conceptName": ["Topotecan"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Vindesine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008336],
      "conceptName": ["Vindesine"]
    },
    "doxorubicin liposome": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19051649],
      "conceptName": ["doxorubicin liposome"]
    },
    "Teniposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19136750],
      "conceptName": ["Teniposide"]
    }
  },
  {
    "conceptId": [35806637],
    "regimenName": ["CHOP and Everolimus"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "everolimus": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [19011440],
      "conceptName": ["everolimus"]
    },
    "Prednisone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    }
  },
  {
    "conceptId": [35804148],
    "regimenName": ["MVAC, dose-dense"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Methotrexate": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Cisplatin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "Vinblastine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [19008264],
      "conceptName": ["Vinblastine"]
    }
  },
  {
    "conceptId": [35806331],
    "regimenName": ["Pomalidomide and Prednisone"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Prednisone": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "pomalidomide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [43014237],
      "conceptName": ["pomalidomide"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    }
  },
  {
    "conceptId": [35804561],
    "regimenName": ["Cisplatin, Gemcitabine, nab-Paclitaxel"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Paclitaxel": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1378382],
      "conceptName": ["Paclitaxel"]
    },
    "Cisplatin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "gemcitabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1314924],
      "conceptName": ["gemcitabine"]
    }
  },
  {
    "conceptId": [35102019],
    "regimenName": ["FULV/FULV and RT"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Leucovorin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1388796],
      "conceptName": ["Leucovorin"]
    },
    "Fluorouracil": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "gemcitabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314924],
      "conceptName": ["gemcitabine"]
    },
    "cetuximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1315411],
      "conceptName": ["cetuximab"]
    },
    "docetaxel": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1315942],
      "conceptName": ["docetaxel"]
    },
    "oxaliplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1318011],
      "conceptName": ["oxaliplatin"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "irinotecan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1367268],
      "conceptName": ["irinotecan"]
    },
    "Mitomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1389036],
      "conceptName": ["Mitomycin"]
    },
    "Levamisole": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1389464],
      "conceptName": ["Levamisole"]
    },
    "bevacizumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397141],
      "conceptName": ["bevacizumab"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "panitumumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19100985],
      "conceptName": ["panitumumab"]
    },
    "irinotecan liposomal": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [35603068],
      "conceptName": ["irinotecan liposomal"]
    },
    "aflibercept": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [40244266],
      "conceptName": ["aflibercept"]
    },
    "ramucirumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [44818489],
      "conceptName": ["ramucirumab"]
    }
  },
  {
    "conceptId": [35806587],
    "regimenName": ["Gemcitabine, Cetuximab, RT"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "cetuximab": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1315411],
      "conceptName": ["cetuximab"]
    },
    "gemcitabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1314924],
      "conceptName": ["gemcitabine"]
    }
  },
  {
    "conceptId": [35805644],
    "regimenName": ["(90)YFC, then allo HSCT"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "ibritumomab tiuxetan": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [19068830],
      "conceptName": ["ibritumomab tiuxetan"]
    },
    "rituximab": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "fludarabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1395557],
      "conceptName": ["fludarabine"]
    }
  },
  {
    "conceptId": [35102022],
    "regimenName": ["Docetaxel and Prednisolone"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "docetaxel": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1315942],
      "conceptName": ["docetaxel"]
    },
    "prednisolone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1550557],
      "conceptName": ["prednisolone"]
    }
  },
  {
    "conceptId": [35806335],
    "regimenName": ["ABCM"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Carmustine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1350066],
      "conceptName": ["Carmustine"]
    },
    "Melphalan": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1301267],
      "conceptName": ["Melphalan"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    }
  },
  {
    "conceptId": [35804308],
    "regimenName": ["TCH (Taxotere, Cyclophosphamide)"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "trastuzumab": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1387104],
      "conceptName": ["trastuzumab"]
    },
    "docetaxel": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1315942],
      "conceptName": ["docetaxel"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    }
  },
  {
    "conceptId": [35806092],
    "regimenName": ["VcR-CVAD"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "rituximab": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "bortezomib": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1336825],
      "conceptName": ["bortezomib"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Dexamethasone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    }
  },
  {
    "conceptId": [35806136],
    "regimenName": ["IL-2 monotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Aldesleukin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1309770],
      "conceptName": ["Aldesleukin"]
    },
    "Isotretinoin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [984232],
      "conceptName": ["Isotretinoin"]
    },
    "sargramostim": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308432],
      "conceptName": ["sargramostim"]
    },
    "Dacarbazine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311409],
      "conceptName": ["Dacarbazine"]
    },
    "Carmustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350066],
      "conceptName": ["Carmustine"]
    },
    "Interferon Alfa-2a": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1379969],
      "conceptName": ["Interferon Alfa-2a"]
    },
    "Interferon Alfa-2b": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1380068],
      "conceptName": ["Interferon Alfa-2b"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "Vinblastine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008264],
      "conceptName": ["Vinblastine"]
    },
    "dinutuximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [46221699],
      "conceptName": ["dinutuximab"]
    }
  },
  {
    "conceptId": [35804798],
    "regimenName": ["Irinotecan and Cetuximab"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "irinotecan": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1367268],
      "conceptName": ["irinotecan"]
    },
    "cetuximab": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1315411],
      "conceptName": ["cetuximab"]
    },
    "Fluorouracil": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "oxaliplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1318011],
      "conceptName": ["oxaliplatin"]
    },
    "Leucovorin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1388796],
      "conceptName": ["Leucovorin"]
    },
    "levoleucovorin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [40168303],
      "conceptName": ["levoleucovorin"]
    }
  },
  {
    "conceptId": [35803620],
    "regimenName": ["FC"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Cyclophosphamide": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "fludarabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1395557],
      "conceptName": ["fludarabine"]
    },
    "Mitoxantrone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1309188],
      "conceptName": ["Mitoxantrone"]
    },
    "alemtuzumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1312706],
      "conceptName": ["alemtuzumab"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Busulfan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1333357],
      "conceptName": ["Busulfan"]
    },
    "ibritumomab tiuxetan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19068830],
      "conceptName": ["ibritumomab tiuxetan"]
    },
    "Thiotepa": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19137385],
      "conceptName": ["Thiotepa"]
    },
    "ofatumumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [40167582],
      "conceptName": ["ofatumumab"]
    },
    "obinutuzumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [44507676],
      "conceptName": ["obinutuzumab"]
    }
  },
  {
    "conceptId": [35803679],
    "regimenName": ["Carmustine monotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Carmustine": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1350066],
      "conceptName": ["Carmustine"]
    },
    "Melphalan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1301267],
      "conceptName": ["Melphalan"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Mitoxantrone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1309188],
      "conceptName": ["Mitoxantrone"]
    },
    "Aldesleukin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1309770],
      "conceptName": ["Aldesleukin"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Dacarbazine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311409],
      "conceptName": ["Dacarbazine"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Procarbazine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1351779],
      "conceptName": ["Procarbazine"]
    },
    "hydroxyurea": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1377141],
      "conceptName": ["hydroxyurea"]
    },
    "Interferon Alfa-2b": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1380068],
      "conceptName": ["Interferon Alfa-2b"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "Methylprednisolone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1506270],
      "conceptName": ["Methylprednisolone"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Vinblastine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008264],
      "conceptName": ["Vinblastine"]
    },
    "ibritumomab tiuxetan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19068830],
      "conceptName": ["ibritumomab tiuxetan"]
    },
    "Teniposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19136750],
      "conceptName": ["Teniposide"]
    },
    "Thiotepa": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19137385],
      "conceptName": ["Thiotepa"]
    }
  },
  {
    "conceptId": [35804238],
    "regimenName": ["ddT (Taxotere)"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "docetaxel": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1315942],
      "conceptName": ["docetaxel"]
    },
    "Fluorouracil": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "gemcitabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314924],
      "conceptName": ["gemcitabine"]
    },
    "cetuximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1315411],
      "conceptName": ["cetuximab"]
    },
    "oxaliplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1318011],
      "conceptName": ["oxaliplatin"]
    },
    "capecitabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1337620],
      "conceptName": ["capecitabine"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Epirubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344354],
      "conceptName": ["Epirubicin"]
    },
    "bicalutamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344381],
      "conceptName": ["bicalutamide"]
    },
    "Carboplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344905],
      "conceptName": ["Carboplatin"]
    },
    "Estramustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1349025],
      "conceptName": ["Estramustine"]
    },
    "Hyaluronidase / trastuzumab Injection [Herceptin Hylecta]": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1366689],
      "conceptName": ["Hyaluronidase / trastuzumab Injection [Herceptin Hylecta]"]
    },
    "irinotecan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1367268],
      "conceptName": ["irinotecan"]
    },
    "hydroxyurea": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1377141],
      "conceptName": ["hydroxyurea"]
    },
    "trastuzumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1387104],
      "conceptName": ["trastuzumab"]
    },
    "Leucovorin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1388796],
      "conceptName": ["Leucovorin"]
    },
    "bevacizumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397141],
      "conceptName": ["bevacizumab"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "prednisolone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1550557],
      "conceptName": ["prednisolone"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "nedaplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [35198201],
      "conceptName": ["nedaplatin"]
    },
    "Vandetanib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [40238052],
      "conceptName": ["Vandetanib"]
    },
    "pertuzumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [42801287],
      "conceptName": ["pertuzumab"]
    },
    "ramucirumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [44818489],
      "conceptName": ["ramucirumab"]
    }
  },
  {
    "conceptId": [35803699],
    "regimenName": ["CHOP"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Prednisone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Fluorouracil": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "Melphalan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1301267],
      "conceptName": ["Melphalan"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Dacarbazine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311409],
      "conceptName": ["Dacarbazine"]
    },
    "alemtuzumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1312706],
      "conceptName": ["alemtuzumab"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Bleomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1329241],
      "conceptName": ["Bleomycin"]
    },
    "bortezomib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1336825],
      "conceptName": ["bortezomib"]
    },
    "Carboplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344905],
      "conceptName": ["Carboplatin"]
    },
    "Carmustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350066],
      "conceptName": ["Carmustine"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Procarbazine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1351779],
      "conceptName": ["Procarbazine"]
    },
    "Mechlorethamine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1394337],
      "conceptName": ["Mechlorethamine"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "Hyaluronidase / rituximab Injection [Rituxan Hycela]": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1593155],
      "conceptName": ["Hyaluronidase / rituximab Injection [Rituxan Hycela]"]
    },
    "Vinblastine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008264],
      "conceptName": ["Vinblastine"]
    },
    "Vindesine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008336],
      "conceptName": ["Vindesine"]
    },
    "everolimus": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19011440],
      "conceptName": ["everolimus"]
    },
    "lenalidomide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19026972],
      "conceptName": ["lenalidomide"]
    },
    "denileukin diftitox": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19051642],
      "conceptName": ["denileukin diftitox"]
    },
    "iodine-131-tositumomab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19054997],
      "conceptName": ["iodine-131-tositumomab"]
    },
    "Ifosfamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    },
    "BCG, Live, Tice Strain": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19086176],
      "conceptName": ["BCG, Live, Tice Strain"]
    },
    "Teniposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19136750],
      "conceptName": ["Teniposide"]
    },
    "ranimustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [35197850],
      "conceptName": ["ranimustine"]
    },
    "ofatumumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [40167582],
      "conceptName": ["ofatumumab"]
    },
    "obinutuzumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [44507676],
      "conceptName": ["obinutuzumab"]
    }
  },
  {
    "conceptId": [35806626],
    "regimenName": ["VBM"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Bleomycin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1329241],
      "conceptName": ["Bleomycin"]
    },
    "Methotrexate": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Mitoxantrone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1309188],
      "conceptName": ["Mitoxantrone"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "prednisolone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1550557],
      "conceptName": ["prednisolone"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    }
  },
  {
    "conceptId": [35806850],
    "regimenName": ["Apalutamide monotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "apalutamide": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [963987],
      "conceptName": ["apalutamide"]
    }
  },
  {
    "conceptId": [35100810],
    "regimenName": ["Exemestane and Tucidinostat"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "exemestane": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1398399],
      "conceptName": ["exemestane"]
    },
    "everolimus": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19011440],
      "conceptName": ["everolimus"]
    }
  },
  {
    "conceptId": [35803483],
    "regimenName": ["HDAC and G-CSF"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Cytarabine": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Filgrastim": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1304850],
      "conceptName": ["Filgrastim"]
    },
    "Mitoxantrone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1309188],
      "conceptName": ["Mitoxantrone"]
    },
    "fludarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1395557],
      "conceptName": ["fludarabine"]
    },
    "lenograstim": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19009705],
      "conceptName": ["lenograstim"]
    },
    "Daunorubicin Liposomal": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19051599],
      "conceptName": ["Daunorubicin Liposomal"]
    },
    "clofarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19054821],
      "conceptName": ["clofarabine"]
    },
    "Cladribine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19054825],
      "conceptName": ["Cladribine"]
    },
    "Idarubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078097],
      "conceptName": ["Idarubicin"]
    }
  },
  {
    "conceptId": [35803566],
    "regimenName": ["Arsenic trioxide and Idarubicin"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Idarubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [19078097],
      "conceptName": ["Idarubicin"]
    },
    "arsenic trioxide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1333379],
      "conceptName": ["arsenic trioxide"]
    },
    "Tretinoin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [903643],
      "conceptName": ["Tretinoin"]
    }
  },
  {
    "conceptId": [35804086],
    "regimenName": ["COMP"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Methotrexate": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Prednisone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Fluorouracil": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Bleomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1329241],
      "conceptName": ["Bleomycin"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Procarbazine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1351779],
      "conceptName": ["Procarbazine"]
    },
    "Mechlorethamine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1394337],
      "conceptName": ["Mechlorethamine"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "Vindesine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008336],
      "conceptName": ["Vindesine"]
    },
    "Ifosfamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    },
    "Teniposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19136750],
      "conceptName": ["Teniposide"]
    }
  },
  {
    "conceptId": [35806291],
    "regimenName": ["VMPT"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Melphalan": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1301267],
      "conceptName": ["Melphalan"]
    },
    "Thalidomide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [19137042],
      "conceptName": ["Thalidomide"]
    },
    "bortezomib": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1336825],
      "conceptName": ["bortezomib"]
    },
    "Prednisone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    }
  },
  {
    "conceptId": [35803571],
    "regimenName": ["Carboplatin and Docetaxel"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Carboplatin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1344905],
      "conceptName": ["Carboplatin"]
    },
    "docetaxel": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1315942],
      "conceptName": ["docetaxel"]
    },
    "Fluorouracil": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "trastuzumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1387104],
      "conceptName": ["trastuzumab"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "pertuzumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [42801287],
      "conceptName": ["pertuzumab"]
    }
  },
  {
    "conceptId": [35803592],
    "regimenName": ["Interferon alfa-2b and Zidovudine"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Zidovudine": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1710612],
      "conceptName": ["Zidovudine"]
    },
    "Interferon Alfa-2b": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1380068],
      "conceptName": ["Interferon Alfa-2b"]
    }
  },
  {
    "conceptId": [35803555],
    "regimenName": ["ATRA and Daunorubicin"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Tretinoin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [903643],
      "conceptName": ["Tretinoin"]
    },
    "Daunorubicin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1311799],
      "conceptName": ["Daunorubicin"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "arsenic trioxide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1333379],
      "conceptName": ["arsenic trioxide"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    }
  },
  {
    "conceptId": [35806319],
    "regimenName": ["BLD"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "bendamustine": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [19015523],
      "conceptName": ["bendamustine"]
    },
    "lenalidomide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [19026972],
      "conceptName": ["lenalidomide"]
    },
    "Dexamethasone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    }
  },
  {
    "conceptId": [35804064],
    "regimenName": ["Inotuzumab ozogamicin monotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "inotuzumab ozogamicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [794068],
      "conceptName": ["inotuzumab ozogamicin"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    }
  },
  {
    "conceptId": [35805718],
    "regimenName": ["Hydroxyurea and Imatinib"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "imatinib": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1304107],
      "conceptName": ["imatinib"]
    },
    "hydroxyurea": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1377141],
      "conceptName": ["hydroxyurea"]
    }
  },
  {
    "conceptId": [35804292],
    "regimenName": ["Lapatinib and Letrozole"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "letrozole": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1315946],
      "conceptName": ["letrozole"]
    },
    "lapatinib": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1359548],
      "conceptName": ["lapatinib"]
    },
    "trastuzumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1387104],
      "conceptName": ["trastuzumab"]
    }
  },
  {
    "conceptId": [35803547],
    "regimenName": ["ADE and ATRA"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Cytarabine": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Tretinoin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [903643],
      "conceptName": ["Tretinoin"]
    },
    "Daunorubicin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1311799],
      "conceptName": ["Daunorubicin"]
    },
    "Etoposide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    }
  },
  {
    "conceptId": [35804394],
    "regimenName": ["Osimertinib monotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "osimertinib": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [35605522],
      "conceptName": ["osimertinib"]
    }
  },
  {
    "conceptId": [35805328],
    "regimenName": ["Cisplatin, Docetaxel, RT"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Cisplatin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "docetaxel": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1315942],
      "conceptName": ["docetaxel"]
    },
    "Fluorouracil": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "Leucovorin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1388796],
      "conceptName": ["Leucovorin"]
    },
    "bevacizumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397141],
      "conceptName": ["bevacizumab"]
    }
  },
  {
    "conceptId": [35804076],
    "regimenName": ["Imatinib, Vincristine, Dexamethasone"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "imatinib": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1304107],
      "conceptName": ["imatinib"]
    },
    "Dexamethasone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    }
  },
  {
    "conceptId": [35803530],
    "regimenName": ["Daunorubicin monotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Daunorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1311799],
      "conceptName": ["Daunorubicin"]
    },
    "Tretinoin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [903643],
      "conceptName": ["Tretinoin"]
    },
    "imatinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1304107],
      "conceptName": ["imatinib"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Azacitidine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314865],
      "conceptName": ["Azacitidine"]
    },
    "pegaspargase": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1326481],
      "conceptName": ["pegaspargase"]
    },
    "arsenic trioxide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1333379],
      "conceptName": ["arsenic trioxide"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "glasdegib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1355795],
      "conceptName": ["glasdegib"]
    },
    "sorafenib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1363387],
      "conceptName": ["sorafenib"]
    },
    "nilotinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1394023],
      "conceptName": ["nilotinib"]
    },
    "mercaptopurine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1436650],
      "conceptName": ["mercaptopurine"]
    },
    "Thioguanine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1437379],
      "conceptName": ["Thioguanine"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "prednisolone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1550557],
      "conceptName": ["prednisolone"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "midostaurin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1594003],
      "conceptName": ["midostaurin"]
    },
    "ASPARAGINASE": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19012585],
      "conceptName": ["ASPARAGINASE"]
    },
    "Cladribine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19054825],
      "conceptName": ["Cladribine"]
    },
    "Teniposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19136750],
      "conceptName": ["Teniposide"]
    },
    "Gemtuzumab ozogamicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [42799711],
      "conceptName": ["Gemtuzumab ozogamicin"]
    },
    "omacetaxine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [45775576],
      "conceptName": ["omacetaxine"]
    }
  },
  {
    "conceptId": [35102002],
    "regimenName": ["AALL0232 consolidation"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "pegaspargase": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1326481],
      "conceptName": ["pegaspargase"]
    },
    "Cytarabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "mercaptopurine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1436650],
      "conceptName": ["mercaptopurine"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "nelarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19002912],
      "conceptName": ["nelarabine"]
    }
  },
  {
    "conceptId": [35803524],
    "regimenName": ["7 plus 3i and Vorinostat"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Idarubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [19078097],
      "conceptName": ["Idarubicin"]
    },
    "Cytarabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Vorinostat": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1337651],
      "conceptName": ["Vorinostat"]
    }
  },
  {
    "conceptId": [35804223],
    "regimenName": ["Paclitaxel monotherapy, q3wk"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Paclitaxel": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1378382],
      "conceptName": ["Paclitaxel"]
    },
    "neratinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [793846],
      "conceptName": ["neratinib"]
    },
    "Fluorouracil": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Dacarbazine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311409],
      "conceptName": ["Dacarbazine"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "gemcitabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314924],
      "conceptName": ["gemcitabine"]
    },
    "oxaliplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1318011],
      "conceptName": ["oxaliplatin"]
    },
    "capecitabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1337620],
      "conceptName": ["capecitabine"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "vinorelbine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1343346],
      "conceptName": ["vinorelbine"]
    },
    "Epirubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344354],
      "conceptName": ["Epirubicin"]
    },
    "Carboplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344905],
      "conceptName": ["Carboplatin"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "lapatinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1359548],
      "conceptName": ["lapatinib"]
    },
    "Hyaluronidase / trastuzumab Injection [Herceptin Hylecta]": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1366689],
      "conceptName": ["Hyaluronidase / trastuzumab Injection [Herceptin Hylecta]"]
    },
    "Topotecan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1378509],
      "conceptName": ["Topotecan"]
    },
    "trastuzumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1387104],
      "conceptName": ["trastuzumab"]
    },
    "bevacizumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397141],
      "conceptName": ["bevacizumab"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "Ifosfamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    },
    "pazopanib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [40167554],
      "conceptName": ["pazopanib"]
    },
    "ipilimumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [40238188],
      "conceptName": ["ipilimumab"]
    },
    "atezolizumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [42629079],
      "conceptName": ["atezolizumab"]
    },
    "pertuzumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [42801287],
      "conceptName": ["pertuzumab"]
    },
    "ado-trastuzumab emtansine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [43525787],
      "conceptName": ["ado-trastuzumab emtansine"]
    },
    "Afatinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [43533090],
      "conceptName": ["Afatinib"]
    },
    "ramucirumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [44818489],
      "conceptName": ["ramucirumab"]
    },
    "pembrolizumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [45775965],
      "conceptName": ["pembrolizumab"]
    },
    "olaparib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [45892579],
      "conceptName": ["olaparib"]
    }
  },
  {
    "conceptId": [35804135],
    "regimenName": ["Gemcitabine monotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "gemcitabine": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1314924],
      "conceptName": ["gemcitabine"]
    },
    "Fluorouracil": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Dacarbazine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311409],
      "conceptName": ["Dacarbazine"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "cetuximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1315411],
      "conceptName": ["cetuximab"]
    },
    "docetaxel": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1315942],
      "conceptName": ["docetaxel"]
    },
    "oxaliplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1318011],
      "conceptName": ["oxaliplatin"]
    },
    "erlotinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1325363],
      "conceptName": ["erlotinib"]
    },
    "pegaspargase": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1326481],
      "conceptName": ["pegaspargase"]
    },
    "sunitinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1336539],
      "conceptName": ["sunitinib"]
    },
    "capecitabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1337620],
      "conceptName": ["capecitabine"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "vinorelbine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1343346],
      "conceptName": ["vinorelbine"]
    },
    "Epirubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344354],
      "conceptName": ["Epirubicin"]
    },
    "Carboplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344905],
      "conceptName": ["Carboplatin"]
    },
    "Hyaluronidase / trastuzumab Injection [Herceptin Hylecta]": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1366689],
      "conceptName": ["Hyaluronidase / trastuzumab Injection [Herceptin Hylecta]"]
    },
    "irinotecan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1367268],
      "conceptName": ["irinotecan"]
    },
    "Paclitaxel": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1378382],
      "conceptName": ["Paclitaxel"]
    },
    "trastuzumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1387104],
      "conceptName": ["trastuzumab"]
    },
    "Leucovorin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1388796],
      "conceptName": ["Leucovorin"]
    },
    "Mitomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1389036],
      "conceptName": ["Mitomycin"]
    },
    "bevacizumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397141],
      "conceptName": ["bevacizumab"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "prednisolone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1550557],
      "conceptName": ["prednisolone"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Vinblastine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008264],
      "conceptName": ["Vinblastine"]
    },
    "ASPARAGINASE": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19012585],
      "conceptName": ["ASPARAGINASE"]
    },
    "bendamustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19015523],
      "conceptName": ["bendamustine"]
    },
    "doxorubicin liposome": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19051649],
      "conceptName": ["doxorubicin liposome"]
    },
    "Ifosfamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    },
    "Thalidomide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19137042],
      "conceptName": ["Thalidomide"]
    },
    "necitumumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [35606215],
      "conceptName": ["necitumumab"]
    }
  },
  {
    "conceptId": [35804417],
    "regimenName": ["Methotrexate, then Cytarabine"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Methotrexate": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Cytarabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "inotuzumab ozogamicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [794068],
      "conceptName": ["inotuzumab ozogamicin"]
    },
    "Fluorouracil": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "imatinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1304107],
      "conceptName": ["imatinib"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Daunorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311799],
      "conceptName": ["Daunorubicin"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Bleomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1329241],
      "conceptName": ["Bleomycin"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "dasatinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1358436],
      "conceptName": ["dasatinib"]
    },
    "nilotinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1394023],
      "conceptName": ["nilotinib"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "mercaptopurine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1436650],
      "conceptName": ["mercaptopurine"]
    },
    "Thioguanine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1437379],
      "conceptName": ["Thioguanine"]
    },
    "Methylprednisolone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1506270],
      "conceptName": ["Methylprednisolone"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "prednisolone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1550557],
      "conceptName": ["prednisolone"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Vindesine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008336],
      "conceptName": ["Vindesine"]
    },
    "everolimus": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19011440],
      "conceptName": ["everolimus"]
    },
    "ASPARAGINASE": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19012585],
      "conceptName": ["ASPARAGINASE"]
    },
    "doxorubicin liposome": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19051649],
      "conceptName": ["doxorubicin liposome"]
    },
    "Idarubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078097],
      "conceptName": ["Idarubicin"]
    },
    "Ifosfamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    },
    "Norethandrolone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19128219],
      "conceptName": ["Norethandrolone"]
    },
    "Teniposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19136750],
      "conceptName": ["Teniposide"]
    },
    "Thiotepa": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19137385],
      "conceptName": ["Thiotepa"]
    },
    "Cytarabine liposome": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [40175460],
      "conceptName": ["Cytarabine liposome"]
    },
    "ponatinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [43013182],
      "conceptName": ["ponatinib"]
    }
  },
  {
    "conceptId": [35804771],
    "regimenName": ["FOLFIRINOX"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "oxaliplatin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1318011],
      "conceptName": ["oxaliplatin"]
    },
    "Leucovorin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1388796],
      "conceptName": ["Leucovorin"]
    },
    "irinotecan": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1367268],
      "conceptName": ["irinotecan"]
    },
    "Fluorouracil": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "gemcitabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314924],
      "conceptName": ["gemcitabine"]
    }
  },
  {
    "conceptId": [35804032],
    "regimenName": ["Cyclophosphamide, Daunorubicin, L-Asparaginase, Vincristine, Prednisone"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "ASPARAGINASE": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [19012585],
      "conceptName": ["ASPARAGINASE"]
    },
    "Prednisone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Daunorubicin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1311799],
      "conceptName": ["Daunorubicin"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    }
  },
  {
    "conceptId": [35806436],
    "regimenName": ["GIP"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Cisplatin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "Ifosfamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    },
    "gemcitabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1314924],
      "conceptName": ["gemcitabine"]
    }
  },
  {
    "conceptId": [35807523],
    "regimenName": ["DA 3 plus 10, GO"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Cytarabine": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Gemtuzumab ozogamicin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [42799711],
      "conceptName": ["Gemtuzumab ozogamicin"]
    },
    "Daunorubicin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1311799],
      "conceptName": ["Daunorubicin"]
    }
  },
  {
    "conceptId": [35805642],
    "regimenName": ["VR"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "rituximab": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "bortezomib": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1336825],
      "conceptName": ["bortezomib"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Chlorambucil": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1390051],
      "conceptName": ["Chlorambucil"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "everolimus": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19011440],
      "conceptName": ["everolimus"]
    },
    "bendamustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19015523],
      "conceptName": ["bendamustine"]
    }
  },
  {
    "conceptId": [35803454],
    "regimenName": ["ADE (high-dose Ara-C)"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Cytarabine": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Daunorubicin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1311799],
      "conceptName": ["Daunorubicin"]
    },
    "Etoposide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Tretinoin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [903643],
      "conceptName": ["Tretinoin"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "nilotinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1394023],
      "conceptName": ["nilotinib"]
    },
    "Thioguanine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1437379],
      "conceptName": ["Thioguanine"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "prednisolone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1550557],
      "conceptName": ["prednisolone"]
    }
  },
  {
    "conceptId": [35804253],
    "regimenName": ["FEC and Bevacizumab"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "bevacizumab": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1397141],
      "conceptName": ["bevacizumab"]
    },
    "Epirubicin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1344354],
      "conceptName": ["Epirubicin"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Fluorouracil": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    }
  },
  {
    "conceptId": [35805367],
    "regimenName": ["DOF"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "oxaliplatin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1318011],
      "conceptName": ["oxaliplatin"]
    },
    "docetaxel": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1315942],
      "conceptName": ["docetaxel"]
    },
    "Fluorouracil": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "Leucovorin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1388796],
      "conceptName": ["Leucovorin"]
    }
  },
  {
    "conceptId": [35804362],
    "regimenName": ["Methotrexate and Thiotepa"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Methotrexate": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Thiotepa": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [19137385],
      "conceptName": ["Thiotepa"]
    },
    "Fluorouracil": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    }
  },
  {
    "conceptId": [35804374],
    "regimenName": ["CODOX-M"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Methotrexate": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Fluorouracil": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "imatinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1304107],
      "conceptName": ["imatinib"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Bleomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1329241],
      "conceptName": ["Bleomycin"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Procarbazine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1351779],
      "conceptName": ["Procarbazine"]
    },
    "dasatinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1358436],
      "conceptName": ["dasatinib"]
    },
    "Mechlorethamine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1394337],
      "conceptName": ["Mechlorethamine"]
    },
    "mercaptopurine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1436650],
      "conceptName": ["mercaptopurine"]
    },
    "Thioguanine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1437379],
      "conceptName": ["Thioguanine"]
    },
    "Methylprednisolone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1506270],
      "conceptName": ["Methylprednisolone"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "prednisolone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1550557],
      "conceptName": ["prednisolone"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Vindesine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008336],
      "conceptName": ["Vindesine"]
    },
    "everolimus": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19011440],
      "conceptName": ["everolimus"]
    },
    "ASPARAGINASE": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19012585],
      "conceptName": ["ASPARAGINASE"]
    },
    "Ifosfamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    },
    "Teniposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19136750],
      "conceptName": ["Teniposide"]
    },
    "ponatinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [43013182],
      "conceptName": ["ponatinib"]
    }
  },
  {
    "conceptId": [35805083],
    "regimenName": ["R-INO"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "rituximab": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "inotuzumab ozogamicin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [794068],
      "conceptName": ["inotuzumab ozogamicin"]
    }
  },
  {
    "conceptId": [35804053],
    "regimenName": ["Mercaptopurine, Methotrexate, WB-XRT"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Methotrexate": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "mercaptopurine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1436650],
      "conceptName": ["mercaptopurine"]
    },
    "Tretinoin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [903643],
      "conceptName": ["Tretinoin"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Thioguanine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1437379],
      "conceptName": ["Thioguanine"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "prednisolone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1550557],
      "conceptName": ["prednisolone"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Vinblastine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008264],
      "conceptName": ["Vinblastine"]
    },
    "ASPARAGINASE": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19012585],
      "conceptName": ["ASPARAGINASE"]
    },
    "Idarubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078097],
      "conceptName": ["Idarubicin"]
    },
    "Norethandrolone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19128219],
      "conceptName": ["Norethandrolone"]
    }
  },
  {
    "conceptId": [35806967],
    "regimenName": ["Doxorubicin and Olaratumab"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "olaratumab": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1718346],
      "conceptName": ["olaratumab"]
    }
  },
  {
    "conceptId": [35806484],
    "regimenName": ["Rucaparib monotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "rucaparib": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1718850],
      "conceptName": ["rucaparib"]
    }
  },
  {
    "conceptId": [35100884],
    "regimenName": ["Doxorubicin, 6-MP, Pegaspargase, Vincristine, Prednisolone"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "pegaspargase": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1326481],
      "conceptName": ["pegaspargase"]
    },
    "mercaptopurine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1436650],
      "conceptName": ["mercaptopurine"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "prednisolone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1550557],
      "conceptName": ["prednisolone"]
    }
  },
  {
    "conceptId": [35805845],
    "regimenName": ["ChlVPP/PABIOE"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Bleomycin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1329241],
      "conceptName": ["Bleomycin"]
    },
    "Chlorambucil": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1390051],
      "conceptName": ["Chlorambucil"]
    },
    "Vinblastine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [19008264],
      "conceptName": ["Vinblastine"]
    },
    "Procarbazine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1351779],
      "conceptName": ["Procarbazine"]
    },
    "Etoposide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "prednisolone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1550557],
      "conceptName": ["prednisolone"]
    }
  },
  {
    "conceptId": [35804822],
    "regimenName": ["Cemiplimab monotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "cemiplimab": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [35200783],
      "conceptName": ["cemiplimab"]
    }
  },
  {
    "conceptId": [35102016],
    "regimenName": ["Mitoxantrone, Asparaginase Erwinia chrysanthemi, Vincristine, Dexamethasone"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "asparaginase Erwinia chrysanthemi": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [43533115],
      "conceptName": ["asparaginase Erwinia chrysanthemi"]
    },
    "Dexamethasone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "Mitoxantrone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1309188],
      "conceptName": ["Mitoxantrone"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    }
  },
  {
    "conceptId": [35803485],
    "regimenName": ["BuFlu, then allo HSCT"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Busulfan": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1333357],
      "conceptName": ["Busulfan"]
    },
    "fludarabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1395557],
      "conceptName": ["fludarabine"]
    },
    "Melphalan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1301267],
      "conceptName": ["Melphalan"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "ibritumomab tiuxetan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19068830],
      "conceptName": ["ibritumomab tiuxetan"]
    }
  },
  {
    "conceptId": [35804236],
    "regimenName": ["ddEC"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Epirubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1344354],
      "conceptName": ["Epirubicin"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Fluorouracil": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Bleomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1329241],
      "conceptName": ["Bleomycin"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Paclitaxel": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1378382],
      "conceptName": ["Paclitaxel"]
    },
    "trastuzumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1387104],
      "conceptName": ["trastuzumab"]
    },
    "Lomustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1391846],
      "conceptName": ["Lomustine"]
    },
    "bevacizumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397141],
      "conceptName": ["bevacizumab"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "prednisolone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1550557],
      "conceptName": ["prednisolone"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Vinblastine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008264],
      "conceptName": ["Vinblastine"]
    },
    "Vindesine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008336],
      "conceptName": ["Vindesine"]
    },
    "Thiotepa": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19137385],
      "conceptName": ["Thiotepa"]
    }
  },
  {
    "conceptId": [35805069],
    "regimenName": ["Cyclophosphamide and TBI, then auto HSCT"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Cyclophosphamide": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "inotuzumab ozogamicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [794068],
      "conceptName": ["inotuzumab ozogamicin"]
    },
    "Fluorouracil": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "Melphalan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1301267],
      "conceptName": ["Melphalan"]
    },
    "imatinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1304107],
      "conceptName": ["imatinib"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Mitoxantrone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1309188],
      "conceptName": ["Mitoxantrone"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Dacarbazine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311409],
      "conceptName": ["Dacarbazine"]
    },
    "Dactinomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311443],
      "conceptName": ["Dactinomycin"]
    },
    "Daunorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311799],
      "conceptName": ["Daunorubicin"]
    },
    "alemtuzumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1312706],
      "conceptName": ["alemtuzumab"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "gemcitabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314924],
      "conceptName": ["gemcitabine"]
    },
    "docetaxel": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1315942],
      "conceptName": ["docetaxel"]
    },
    "pegaspargase": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1326481],
      "conceptName": ["pegaspargase"]
    },
    "Bleomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1329241],
      "conceptName": ["Bleomycin"]
    },
    "Busulfan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1333357],
      "conceptName": ["Busulfan"]
    },
    "bortezomib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1336825],
      "conceptName": ["bortezomib"]
    },
    "Vorinostat": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1337651],
      "conceptName": ["Vorinostat"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Epirubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344354],
      "conceptName": ["Epirubicin"]
    },
    "Carboplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344905],
      "conceptName": ["Carboplatin"]
    },
    "Carmustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350066],
      "conceptName": ["Carmustine"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Procarbazine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1351779],
      "conceptName": ["Procarbazine"]
    },
    "Mesna": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1354698],
      "conceptName": ["Mesna"]
    },
    "dasatinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1358436],
      "conceptName": ["dasatinib"]
    },
    "irinotecan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1367268],
      "conceptName": ["irinotecan"]
    },
    "Altretamine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1368823],
      "conceptName": ["Altretamine"]
    },
    "Paclitaxel": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1378382],
      "conceptName": ["Paclitaxel"]
    },
    "Topotecan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1378509],
      "conceptName": ["Topotecan"]
    },
    "Interferon Alfa-2b": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1380068],
      "conceptName": ["Interferon Alfa-2b"]
    },
    "Interferon gamma-1b": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1380191],
      "conceptName": ["Interferon gamma-1b"]
    },
    "trastuzumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1387104],
      "conceptName": ["trastuzumab"]
    },
    "Leucovorin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1388796],
      "conceptName": ["Leucovorin"]
    },
    "Lomustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1391846],
      "conceptName": ["Lomustine"]
    },
    "Mechlorethamine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1394337],
      "conceptName": ["Mechlorethamine"]
    },
    "fludarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1395557],
      "conceptName": ["fludarabine"]
    },
    "bevacizumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397141],
      "conceptName": ["bevacizumab"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "mercaptopurine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1436650],
      "conceptName": ["mercaptopurine"]
    },
    "Tamoxifen": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1436678],
      "conceptName": ["Tamoxifen"]
    },
    "Thioguanine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1437379],
      "conceptName": ["Thioguanine"]
    },
    "Medroxyprogesterone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1500211],
      "conceptName": ["Medroxyprogesterone"]
    },
    "Methylprednisolone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1506270],
      "conceptName": ["Methylprednisolone"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "Diethylstilbestrol": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1525866],
      "conceptName": ["Diethylstilbestrol"]
    },
    "prednisolone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1550557],
      "conceptName": ["prednisolone"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Hyaluronidase / rituximab Injection [Rituxan Hycela]": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1593155],
      "conceptName": ["Hyaluronidase / rituximab Injection [Rituxan Hycela]"]
    },
    "nelarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19002912],
      "conceptName": ["nelarabine"]
    },
    "Vinblastine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008264],
      "conceptName": ["Vinblastine"]
    },
    "Vindesine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008336],
      "conceptName": ["Vindesine"]
    },
    "everolimus": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19011440],
      "conceptName": ["everolimus"]
    },
    "ASPARAGINASE": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19012585],
      "conceptName": ["ASPARAGINASE"]
    },
    "lenalidomide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19026972],
      "conceptName": ["lenalidomide"]
    },
    "Pentostatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19031224],
      "conceptName": ["Pentostatin"]
    },
    "denileukin diftitox": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19051642],
      "conceptName": ["denileukin diftitox"]
    },
    "doxorubicin liposome": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19051649],
      "conceptName": ["doxorubicin liposome"]
    },
    "clofarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19054821],
      "conceptName": ["clofarabine"]
    },
    "Cladribine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19054825],
      "conceptName": ["Cladribine"]
    },
    "iodine-131-tositumomab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19054997],
      "conceptName": ["iodine-131-tositumomab"]
    },
    "ibritumomab tiuxetan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19068830],
      "conceptName": ["ibritumomab tiuxetan"]
    },
    "Idarubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078097],
      "conceptName": ["Idarubicin"]
    },
    "Ifosfamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    },
    "BCG, Live, Tice Strain": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19086176],
      "conceptName": ["BCG, Live, Tice Strain"]
    },
    "Teniposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19136750],
      "conceptName": ["Teniposide"]
    },
    "Thalidomide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19137042],
      "conceptName": ["Thalidomide"]
    },
    "Thiotepa": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19137385],
      "conceptName": ["Thiotepa"]
    },
    "Myocet": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [21017157],
      "conceptName": ["Myocet"]
    },
    "ranimustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [35197850],
      "conceptName": ["ranimustine"]
    },
    "ofatumumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [40167582],
      "conceptName": ["ofatumumab"]
    },
    "Cytarabine liposome": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [40175460],
      "conceptName": ["Cytarabine liposome"]
    },
    "brentuximab vedotin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [40241969],
      "conceptName": ["brentuximab vedotin"]
    },
    "carfilzomib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [42873638],
      "conceptName": ["carfilzomib"]
    },
    "vincristine liposome": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [42874135],
      "conceptName": ["vincristine liposome"]
    },
    "ponatinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [43013182],
      "conceptName": ["ponatinib"]
    },
    "pomalidomide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [43014237],
      "conceptName": ["pomalidomide"]
    },
    "obinutuzumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [44507676],
      "conceptName": ["obinutuzumab"]
    }
  },
  {
    "conceptId": [35804361],
    "regimenName": ["Megestrol monotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Megestrol": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1300978],
      "conceptName": ["Megestrol"]
    },
    "Tamoxifen": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1436678],
      "conceptName": ["Tamoxifen"]
    }
  },
  {
    "conceptId": [35804817],
    "regimenName": ["Romidepsin monotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "romidepsin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [40168385],
      "conceptName": ["romidepsin"]
    }
  },
  {
    "conceptId": [35806945],
    "regimenName": ["Cisplatin, Etoposide, Bevacizumab"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "bevacizumab": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1397141],
      "conceptName": ["bevacizumab"]
    },
    "Cisplatin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "Etoposide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    }
  },
  {
    "conceptId": [35806270],
    "regimenName": ["Interferon alfa and Dexamethasone"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Dexamethasone": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "Interferon Alfa-2b": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1380068],
      "conceptName": ["Interferon Alfa-2b"]
    },
    "Interferon Alfa-2a": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1379969],
      "conceptName": ["Interferon Alfa-2a"]
    }
  },
  {
    "conceptId": [35804313],
    "regimenName": ["Pertuzumab and T-DM1"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "pertuzumab": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [42801287],
      "conceptName": ["pertuzumab"]
    },
    "ado-trastuzumab emtansine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [43525787],
      "conceptName": ["ado-trastuzumab emtansine"]
    },
    "Paclitaxel": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1378382],
      "conceptName": ["Paclitaxel"]
    }
  },
  {
    "conceptId": [35806406],
    "regimenName": ["Cisplatin, Vinorelbine, Cetuximab"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Cisplatin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "cetuximab": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1315411],
      "conceptName": ["cetuximab"]
    },
    "vinorelbine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1343346],
      "conceptName": ["vinorelbine"]
    }
  },
  {
    "conceptId": [35805064],
    "regimenName": ["RICER"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Carboplatin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1344905],
      "conceptName": ["Carboplatin"]
    },
    "lenalidomide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [19026972],
      "conceptName": ["lenalidomide"]
    },
    "Ifosfamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    },
    "Mesna": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1354698],
      "conceptName": ["Mesna"]
    },
    "rituximab": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Etoposide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    }
  },
  {
    "conceptId": [35806313],
    "regimenName": ["Elo-Pd"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "elotuzumab": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [35604032],
      "conceptName": ["elotuzumab"]
    },
    "Dexamethasone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "pomalidomide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [43014237],
      "conceptName": ["pomalidomide"]
    }
  },
  {
    "conceptId": [35803596],
    "regimenName": ["Lenalidomide monotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "lenalidomide": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [19026972],
      "conceptName": ["lenalidomide"]
    },
    "Melphalan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1301267],
      "conceptName": ["Melphalan"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Azacitidine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314865],
      "conceptName": ["Azacitidine"]
    },
    "bortezomib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1336825],
      "conceptName": ["bortezomib"]
    },
    "Vorinostat": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1337651],
      "conceptName": ["Vorinostat"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Carboplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344905],
      "conceptName": ["Carboplatin"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Mesna": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1354698],
      "conceptName": ["Mesna"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Clarithromycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1750500],
      "conceptName": ["Clarithromycin"]
    },
    "bendamustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19015523],
      "conceptName": ["bendamustine"]
    },
    "Ifosfamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    },
    "elotuzumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [35604032],
      "conceptName": ["elotuzumab"]
    },
    "daratumumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [35605744],
      "conceptName": ["daratumumab"]
    },
    "ixazomib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [35606214],
      "conceptName": ["ixazomib"]
    },
    "ofatumumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [40167582],
      "conceptName": ["ofatumumab"]
    },
    "carfilzomib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [42873638],
      "conceptName": ["carfilzomib"]
    },
    "panobinostat": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [46221435],
      "conceptName": ["panobinostat"]
    }
  },
  {
    "conceptId": [35803628],
    "regimenName": ["Fludarabine and Melphalan"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Melphalan": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1301267],
      "conceptName": ["Melphalan"]
    },
    "fludarabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1395557],
      "conceptName": ["fludarabine"]
    },
    "alemtuzumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1312706],
      "conceptName": ["alemtuzumab"]
    },
    "Busulfan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1333357],
      "conceptName": ["Busulfan"]
    }
  },
  {
    "conceptId": [35804263],
    "regimenName": ["Doxorubicin non-pegylated liposomal and Bevacizumab"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "bevacizumab": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1397141],
      "conceptName": ["bevacizumab"]
    },
    "Myocet": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [21017157],
      "conceptName": ["Myocet"]
    }
  },
  {
    "conceptId": [35806485],
    "regimenName": ["Niraparib monotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "niraparib": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1593861],
      "conceptName": ["niraparib"]
    }
  },
  {
    "conceptId": [35804418],
    "regimenName": ["BEAM, then auto HSCT"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Carmustine": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1350066],
      "conceptName": ["Carmustine"]
    },
    "Melphalan": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1301267],
      "conceptName": ["Melphalan"]
    },
    "Cytarabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Etoposide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "ibritumomab tiuxetan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19068830],
      "conceptName": ["ibritumomab tiuxetan"]
    }
  },
  {
    "conceptId": [35806063],
    "regimenName": ["Daratumumab monotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "daratumumab": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [35605744],
      "conceptName": ["daratumumab"]
    },
    "Melphalan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1301267],
      "conceptName": ["Melphalan"]
    },
    "bortezomib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1336825],
      "conceptName": ["bortezomib"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "lenalidomide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19026972],
      "conceptName": ["lenalidomide"]
    },
    "Thalidomide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19137042],
      "conceptName": ["Thalidomide"]
    },
    "carfilzomib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [42873638],
      "conceptName": ["carfilzomib"]
    },
    "pomalidomide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [43014237],
      "conceptName": ["pomalidomide"]
    }
  },
  {
    "conceptId": [35806305],
    "regimenName": ["VTD-PACE"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Cisplatin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "Thalidomide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [19137042],
      "conceptName": ["Thalidomide"]
    },
    "bortezomib": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1336825],
      "conceptName": ["bortezomib"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Dexamethasone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "Etoposide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Melphalan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1301267],
      "conceptName": ["Melphalan"]
    }
  },
  {
    "conceptId": [35807047],
    "regimenName": ["Octreotide and Prednisone"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Prednisone": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Octreotide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1522957],
      "conceptName": ["Octreotide"]
    }
  },
  {
    "conceptId": [35805770],
    "regimenName": ["Cisplatin, Cetuximab, RT"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Cisplatin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "cetuximab": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1315411],
      "conceptName": ["cetuximab"]
    },
    "Fluorouracil": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "capecitabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1337620],
      "conceptName": ["capecitabine"]
    },
    "vinorelbine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1343346],
      "conceptName": ["vinorelbine"]
    }
  },
  {
    "conceptId": [35806948],
    "regimenName": ["Epirubicin and Ifosfamide"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Ifosfamide": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    },
    "Epirubicin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1344354],
      "conceptName": ["Epirubicin"]
    },
    "Mesna": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1354698],
      "conceptName": ["Mesna"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "Vindesine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008336],
      "conceptName": ["Vindesine"]
    }
  },
  {
    "conceptId": [35806288],
    "regimenName": ["Thalidomide and Prednisone"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Thalidomide": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [19137042],
      "conceptName": ["Thalidomide"]
    },
    "Prednisone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Melphalan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1301267],
      "conceptName": ["Melphalan"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "gemcitabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314924],
      "conceptName": ["gemcitabine"]
    },
    "bortezomib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1336825],
      "conceptName": ["bortezomib"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Procarbazine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1351779],
      "conceptName": ["Procarbazine"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    }
  },
  {
    "conceptId": [35805652],
    "regimenName": ["FCR, then allo HSCT"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "rituximab": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "fludarabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1395557],
      "conceptName": ["fludarabine"]
    },
    "Mitoxantrone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1309188],
      "conceptName": ["Mitoxantrone"]
    },
    "alemtuzumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1312706],
      "conceptName": ["alemtuzumab"]
    },
    "ibritumomab tiuxetan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19068830],
      "conceptName": ["ibritumomab tiuxetan"]
    }
  },
  {
    "conceptId": [35804621],
    "regimenName": ["CAP"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Prednisone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Fluorouracil": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "Melphalan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1301267],
      "conceptName": ["Melphalan"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Dacarbazine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311409],
      "conceptName": ["Dacarbazine"]
    },
    "alemtuzumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1312706],
      "conceptName": ["alemtuzumab"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Bleomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1329241],
      "conceptName": ["Bleomycin"]
    },
    "bortezomib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1336825],
      "conceptName": ["bortezomib"]
    },
    "Carboplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344905],
      "conceptName": ["Carboplatin"]
    },
    "Carmustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350066],
      "conceptName": ["Carmustine"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Procarbazine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1351779],
      "conceptName": ["Procarbazine"]
    },
    "Interferon Alfa-2b": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1380068],
      "conceptName": ["Interferon Alfa-2b"]
    },
    "Mechlorethamine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1394337],
      "conceptName": ["Mechlorethamine"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "Hyaluronidase / rituximab Injection [Rituxan Hycela]": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1593155],
      "conceptName": ["Hyaluronidase / rituximab Injection [Rituxan Hycela]"]
    },
    "Vinblastine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008264],
      "conceptName": ["Vinblastine"]
    },
    "Vindesine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008336],
      "conceptName": ["Vindesine"]
    },
    "everolimus": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19011440],
      "conceptName": ["everolimus"]
    },
    "lenalidomide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19026972],
      "conceptName": ["lenalidomide"]
    },
    "denileukin diftitox": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19051642],
      "conceptName": ["denileukin diftitox"]
    },
    "iodine-131-tositumomab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19054997],
      "conceptName": ["iodine-131-tositumomab"]
    },
    "Ifosfamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    },
    "BCG, Live, Tice Strain": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19086176],
      "conceptName": ["BCG, Live, Tice Strain"]
    },
    "Teniposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19136750],
      "conceptName": ["Teniposide"]
    },
    "ranimustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [35197850],
      "conceptName": ["ranimustine"]
    },
    "ofatumumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [40167582],
      "conceptName": ["ofatumumab"]
    },
    "brentuximab vedotin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [40241969],
      "conceptName": ["brentuximab vedotin"]
    },
    "obinutuzumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [44507676],
      "conceptName": ["obinutuzumab"]
    }
  },
  {
    "conceptId": [35804070],
    "regimenName": ["Daunorubicin, Vincristine, Prednisolone, Nilotinib"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "nilotinib": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1394023],
      "conceptName": ["nilotinib"]
    },
    "Daunorubicin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1311799],
      "conceptName": ["Daunorubicin"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "prednisolone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1550557],
      "conceptName": ["prednisolone"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    }
  },
  {
    "conceptId": [35804256],
    "regimenName": ["Paclitaxel, nanoparticle albumin-bound and Bevacizumab"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Paclitaxel": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1378382],
      "conceptName": ["Paclitaxel"]
    },
    "bevacizumab": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1397141],
      "conceptName": ["bevacizumab"]
    },
    "Carboplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344905],
      "conceptName": ["Carboplatin"]
    },
    "Topotecan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1378509],
      "conceptName": ["Topotecan"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "atezolizumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [42629079],
      "conceptName": ["atezolizumab"]
    }
  },
  {
    "conceptId": [35805714],
    "regimenName": ["Temozolomide and low-dose RT"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "temozolomide": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1341149],
      "conceptName": ["temozolomide"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "capecitabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1337620],
      "conceptName": ["capecitabine"]
    },
    "irinotecan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1367268],
      "conceptName": ["irinotecan"]
    },
    "Lomustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1391846],
      "conceptName": ["Lomustine"]
    },
    "bevacizumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397141],
      "conceptName": ["bevacizumab"]
    },
    "Thalidomide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19137042],
      "conceptName": ["Thalidomide"]
    },
    "dinutuximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [46221699],
      "conceptName": ["dinutuximab"]
    }
  },
  {
    "conceptId": [35806641],
    "regimenName": ["Bortezomib and Panobinostat"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "panobinostat": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [46221435],
      "conceptName": ["panobinostat"]
    },
    "bortezomib": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1336825],
      "conceptName": ["bortezomib"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "Thalidomide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19137042],
      "conceptName": ["Thalidomide"]
    }
  },
  {
    "conceptId": [35804089],
    "regimenName": ["Cytarabine, Daunorubicin, L-Asparaginase, Teniposide, Vincristine, Prednisone"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "ASPARAGINASE": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [19012585],
      "conceptName": ["ASPARAGINASE"]
    },
    "Cytarabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Prednisone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Daunorubicin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1311799],
      "conceptName": ["Daunorubicin"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Teniposide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [19136750],
      "conceptName": ["Teniposide"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    }
  },
  {
    "conceptId": [35805094],
    "regimenName": ["CHOP-B"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Bleomycin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1329241],
      "conceptName": ["Bleomycin"]
    },
    "Prednisone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Dacarbazine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311409],
      "conceptName": ["Dacarbazine"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Procarbazine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1351779],
      "conceptName": ["Procarbazine"]
    },
    "Vinblastine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008264],
      "conceptName": ["Vinblastine"]
    },
    "Teniposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19136750],
      "conceptName": ["Teniposide"]
    }
  },
  {
    "conceptId": [35806858],
    "regimenName": ["Docetaxel and Prednisone"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "docetaxel": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1315942],
      "conceptName": ["docetaxel"]
    },
    "Prednisone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Carboplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344905],
      "conceptName": ["Carboplatin"]
    }
  },
  {
    "conceptId": [35806894],
    "regimenName": ["Fluorouracil, Folinic acid, RT"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Leucovorin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1388796],
      "conceptName": ["Leucovorin"]
    },
    "Fluorouracil": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "gemcitabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314924],
      "conceptName": ["gemcitabine"]
    },
    "cetuximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1315411],
      "conceptName": ["cetuximab"]
    },
    "docetaxel": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1315942],
      "conceptName": ["docetaxel"]
    },
    "oxaliplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1318011],
      "conceptName": ["oxaliplatin"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "irinotecan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1367268],
      "conceptName": ["irinotecan"]
    },
    "Mitomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1389036],
      "conceptName": ["Mitomycin"]
    },
    "Levamisole": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1389464],
      "conceptName": ["Levamisole"]
    },
    "bevacizumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397141],
      "conceptName": ["bevacizumab"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "panitumumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19100985],
      "conceptName": ["panitumumab"]
    },
    "irinotecan liposomal": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [35603068],
      "conceptName": ["irinotecan liposomal"]
    },
    "aflibercept": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [40244266],
      "conceptName": ["aflibercept"]
    },
    "ramucirumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [44818489],
      "conceptName": ["ramucirumab"]
    }
  },
  {
    "conceptId": [35805348],
    "regimenName": ["Capecitabine, Paclitaxel, RT"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Paclitaxel": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1378382],
      "conceptName": ["Paclitaxel"]
    },
    "capecitabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1337620],
      "conceptName": ["capecitabine"]
    },
    "Carboplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344905],
      "conceptName": ["Carboplatin"]
    }
  },
  {
    "conceptId": [35102028],
    "regimenName": ["CHOP (Prednisolone)"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "prednisolone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1550557],
      "conceptName": ["prednisolone"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Bleomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1329241],
      "conceptName": ["Bleomycin"]
    },
    "bortezomib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1336825],
      "conceptName": ["bortezomib"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Procarbazine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1351779],
      "conceptName": ["Procarbazine"]
    },
    "ASPARAGINASE": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19012585],
      "conceptName": ["ASPARAGINASE"]
    }
  },
  {
    "conceptId": [35804287],
    "regimenName": ["Letrozole and Palbociclib"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "letrozole": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1315946],
      "conceptName": ["letrozole"]
    },
    "palbociclib": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [45892075],
      "conceptName": ["palbociclib"]
    }
  },
  {
    "conceptId": [35101493],
    "regimenName": ["Anastrozole and Palbociclib"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "anastrozole": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1348265],
      "conceptName": ["anastrozole"]
    },
    "palbociclib": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [45892075],
      "conceptName": ["palbociclib"]
    }
  },
  {
    "conceptId": [35804245],
    "regimenName": ["Capecitabine and Bevacizumab"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "bevacizumab": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1397141],
      "conceptName": ["bevacizumab"]
    },
    "capecitabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1337620],
      "conceptName": ["capecitabine"]
    },
    "oxaliplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1318011],
      "conceptName": ["oxaliplatin"]
    },
    "irinotecan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1367268],
      "conceptName": ["irinotecan"]
    },
    "trastuzumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1387104],
      "conceptName": ["trastuzumab"]
    }
  },
  {
    "conceptId": [35804756],
    "regimenName": ["FLOX"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "oxaliplatin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1318011],
      "conceptName": ["oxaliplatin"]
    },
    "Leucovorin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1388796],
      "conceptName": ["Leucovorin"]
    },
    "Fluorouracil": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "gemcitabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314924],
      "conceptName": ["gemcitabine"]
    },
    "cetuximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1315411],
      "conceptName": ["cetuximab"]
    },
    "docetaxel": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1315942],
      "conceptName": ["docetaxel"]
    },
    "irinotecan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1367268],
      "conceptName": ["irinotecan"]
    },
    "bevacizumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397141],
      "conceptName": ["bevacizumab"]
    },
    "panitumumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19100985],
      "conceptName": ["panitumumab"]
    }
  },
  {
    "conceptId": [35806429],
    "regimenName": ["Gefitinib and Pemetrexed"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "gefitinib": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1319193],
      "conceptName": ["gefitinib"]
    },
    "pemetrexed": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1304919],
      "conceptName": ["pemetrexed"]
    }
  },
  {
    "conceptId": [35804608],
    "regimenName": ["Bendamustine and Ofatumumab"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "bendamustine": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [19015523],
      "conceptName": ["bendamustine"]
    },
    "ofatumumab": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [40167582],
      "conceptName": ["ofatumumab"]
    }
  },
  {
    "conceptId": [35806073],
    "regimenName": ["Carboplatin and Vincristine"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Carboplatin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1344905],
      "conceptName": ["Carboplatin"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Bleomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1329241],
      "conceptName": ["Bleomycin"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Vindesine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008336],
      "conceptName": ["Vindesine"]
    },
    "ranimustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [35197850],
      "conceptName": ["ranimustine"]
    }
  },
  {
    "conceptId": [35806283],
    "regimenName": ["IRd"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "lenalidomide": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [19026972],
      "conceptName": ["lenalidomide"]
    },
    "ixazomib": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [35606214],
      "conceptName": ["ixazomib"]
    },
    "Dexamethasone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    }
  },
  {
    "conceptId": [35804084],
    "regimenName": ["Ponatinib monotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "ponatinib": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [43013182],
      "conceptName": ["ponatinib"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    }
  },
  {
    "conceptId": [35806088],
    "regimenName": ["RiPAD plus C"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Chlorambucil": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1390051],
      "conceptName": ["Chlorambucil"]
    },
    "rituximab": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "bortezomib": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1336825],
      "conceptName": ["bortezomib"]
    },
    "Dexamethasone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    }
  },
  {
    "conceptId": [35806434],
    "regimenName": ["CAP (Platinol)"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Cisplatin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Melphalan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1301267],
      "conceptName": ["Melphalan"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Dactinomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311443],
      "conceptName": ["Dactinomycin"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Bleomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1329241],
      "conceptName": ["Bleomycin"]
    },
    "bortezomib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1336825],
      "conceptName": ["bortezomib"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Altretamine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1368823],
      "conceptName": ["Altretamine"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Vinblastine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008264],
      "conceptName": ["Vinblastine"]
    },
    "Thalidomide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19137042],
      "conceptName": ["Thalidomide"]
    }
  },
  {
    "conceptId": [35804612],
    "regimenName": ["Ibrutinib and Rituximab"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Ibrutinib": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [44507848],
      "conceptName": ["Ibrutinib"]
    },
    "rituximab": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "bendamustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19015523],
      "conceptName": ["bendamustine"]
    }
  },
  {
    "conceptId": [35806400],
    "regimenName": ["Carboplatin and Etoposide"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Carboplatin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1344905],
      "conceptName": ["Carboplatin"]
    },
    "Etoposide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Mesna": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1354698],
      "conceptName": ["Mesna"]
    },
    "Paclitaxel": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1378382],
      "conceptName": ["Paclitaxel"]
    },
    "bevacizumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397141],
      "conceptName": ["bevacizumab"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "prednisolone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1550557],
      "conceptName": ["prednisolone"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Vindesine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008336],
      "conceptName": ["Vindesine"]
    },
    "lenalidomide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19026972],
      "conceptName": ["lenalidomide"]
    },
    "Ifosfamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    },
    "ranimustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [35197850],
      "conceptName": ["ranimustine"]
    },
    "ofatumumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [40167582],
      "conceptName": ["ofatumumab"]
    },
    "atezolizumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [42629079],
      "conceptName": ["atezolizumab"]
    }
  },
  {
    "conceptId": [35806066],
    "regimenName": ["Pd"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Dexamethasone": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "pomalidomide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [43014237],
      "conceptName": ["pomalidomide"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "bortezomib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1336825],
      "conceptName": ["bortezomib"]
    },
    "elotuzumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [35604032],
      "conceptName": ["elotuzumab"]
    },
    "daratumumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [35605744],
      "conceptName": ["daratumumab"]
    },
    "carfilzomib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [42873638],
      "conceptName": ["carfilzomib"]
    },
    "pembrolizumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [45775965],
      "conceptName": ["pembrolizumab"]
    }
  },
  {
    "conceptId": [35804242],
    "regimenName": ["VH"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "trastuzumab": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1387104],
      "conceptName": ["trastuzumab"]
    },
    "vinorelbine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1343346],
      "conceptName": ["vinorelbine"]
    }
  },
  {
    "conceptId": [35806119],
    "regimenName": ["Peginterferon alfa-2b monotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "peginterferon alfa-2b": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1797155],
      "conceptName": ["peginterferon alfa-2b"]
    }
  },
  {
    "conceptId": [35806952],
    "regimenName": ["BACO"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Bleomycin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1329241],
      "conceptName": ["Bleomycin"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Dacarbazine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311409],
      "conceptName": ["Dacarbazine"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Procarbazine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1351779],
      "conceptName": ["Procarbazine"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "prednisolone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1550557],
      "conceptName": ["prednisolone"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Vinblastine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008264],
      "conceptName": ["Vinblastine"]
    },
    "Teniposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19136750],
      "conceptName": ["Teniposide"]
    }
  },
  {
    "conceptId": [35805109],
    "regimenName": ["ProMACE-CytaBOM"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Bleomycin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1329241],
      "conceptName": ["Bleomycin"]
    },
    "Methotrexate": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Cytarabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Prednisone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Etoposide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    }
  },
  {
    "conceptId": [35806329],
    "regimenName": ["Hyper-CVAD"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Dexamethasone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Melphalan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1301267],
      "conceptName": ["Melphalan"]
    },
    "imatinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1304107],
      "conceptName": ["imatinib"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "pegaspargase": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1326481],
      "conceptName": ["pegaspargase"]
    },
    "Bleomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1329241],
      "conceptName": ["Bleomycin"]
    },
    "bortezomib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1336825],
      "conceptName": ["bortezomib"]
    },
    "Carmustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350066],
      "conceptName": ["Carmustine"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "dasatinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1358436],
      "conceptName": ["dasatinib"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "mercaptopurine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1436650],
      "conceptName": ["mercaptopurine"]
    },
    "Thioguanine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1437379],
      "conceptName": ["Thioguanine"]
    },
    "Methylprednisolone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1506270],
      "conceptName": ["Methylprednisolone"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Vindesine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008336],
      "conceptName": ["Vindesine"]
    },
    "everolimus": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19011440],
      "conceptName": ["everolimus"]
    },
    "ASPARAGINASE": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19012585],
      "conceptName": ["ASPARAGINASE"]
    },
    "Ifosfamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    },
    "Teniposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19136750],
      "conceptName": ["Teniposide"]
    },
    "ponatinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [43013182],
      "conceptName": ["ponatinib"]
    }
  },
  {
    "conceptId": [35806337],
    "regimenName": ["C-VAMP"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Methylprednisolone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1506270],
      "conceptName": ["Methylprednisolone"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "everolimus": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19011440],
      "conceptName": ["everolimus"]
    }
  },
  {
    "conceptId": [35806284],
    "regimenName": ["KRd"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "lenalidomide": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [19026972],
      "conceptName": ["lenalidomide"]
    },
    "carfilzomib": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [42873638],
      "conceptName": ["carfilzomib"]
    },
    "Dexamethasone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    }
  },
  {
    "conceptId": [35803539],
    "regimenName": ["Cytarabine monotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Cytarabine": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "inotuzumab ozogamicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [794068],
      "conceptName": ["inotuzumab ozogamicin"]
    },
    "Tretinoin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [903643],
      "conceptName": ["Tretinoin"]
    },
    "Fluorouracil": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "Melphalan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1301267],
      "conceptName": ["Melphalan"]
    },
    "imatinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1304107],
      "conceptName": ["imatinib"]
    },
    "Filgrastim": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1304850],
      "conceptName": ["Filgrastim"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Mitoxantrone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1309188],
      "conceptName": ["Mitoxantrone"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Daunorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311799],
      "conceptName": ["Daunorubicin"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Azacitidine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314865],
      "conceptName": ["Azacitidine"]
    },
    "oxaliplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1318011],
      "conceptName": ["oxaliplatin"]
    },
    "pegaspargase": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1326481],
      "conceptName": ["pegaspargase"]
    },
    "Bleomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1329241],
      "conceptName": ["Bleomycin"]
    },
    "Vorinostat": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1337651],
      "conceptName": ["Vorinostat"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Carboplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344905],
      "conceptName": ["Carboplatin"]
    },
    "Carmustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350066],
      "conceptName": ["Carmustine"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "glasdegib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1355795],
      "conceptName": ["glasdegib"]
    },
    "dasatinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1358436],
      "conceptName": ["dasatinib"]
    },
    "sorafenib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1363387],
      "conceptName": ["sorafenib"]
    },
    "Interferon Alfa-2b": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1380068],
      "conceptName": ["Interferon Alfa-2b"]
    },
    "Lomustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1391846],
      "conceptName": ["Lomustine"]
    },
    "nilotinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1394023],
      "conceptName": ["nilotinib"]
    },
    "fludarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1395557],
      "conceptName": ["fludarabine"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "mercaptopurine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1436650],
      "conceptName": ["mercaptopurine"]
    },
    "Thioguanine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1437379],
      "conceptName": ["Thioguanine"]
    },
    "Methylprednisolone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1506270],
      "conceptName": ["Methylprednisolone"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "prednisolone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1550557],
      "conceptName": ["prednisolone"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Pravastatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551860],
      "conceptName": ["Pravastatin"]
    },
    "midostaurin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1594003],
      "conceptName": ["midostaurin"]
    },
    "nelarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19002912],
      "conceptName": ["nelarabine"]
    },
    "Vindesine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008336],
      "conceptName": ["Vindesine"]
    },
    "lenograstim": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19009705],
      "conceptName": ["lenograstim"]
    },
    "everolimus": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19011440],
      "conceptName": ["everolimus"]
    },
    "ASPARAGINASE": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19012585],
      "conceptName": ["ASPARAGINASE"]
    },
    "bendamustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19015523],
      "conceptName": ["bendamustine"]
    },
    "Amsacrine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19017810],
      "conceptName": ["Amsacrine"]
    },
    "decitabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19024728],
      "conceptName": ["decitabine"]
    },
    "Daunorubicin Liposomal": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19051599],
      "conceptName": ["Daunorubicin Liposomal"]
    },
    "doxorubicin liposome": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19051649],
      "conceptName": ["doxorubicin liposome"]
    },
    "clofarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19054821],
      "conceptName": ["clofarabine"]
    },
    "Cladribine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19054825],
      "conceptName": ["Cladribine"]
    },
    "Aclarubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19057483],
      "conceptName": ["Aclarubicin"]
    },
    "ibritumomab tiuxetan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19068830],
      "conceptName": ["ibritumomab tiuxetan"]
    },
    "Idarubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078097],
      "conceptName": ["Idarubicin"]
    },
    "Ifosfamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    },
    "Norethandrolone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19128219],
      "conceptName": ["Norethandrolone"]
    },
    "Teniposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19136750],
      "conceptName": ["Teniposide"]
    },
    "Thiotepa": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19137385],
      "conceptName": ["Thiotepa"]
    },
    "venetoclax": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [35604205],
      "conceptName": ["venetoclax"]
    },
    "Fotemustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [36879099],
      "conceptName": ["Fotemustine"]
    },
    "ofatumumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [40167582],
      "conceptName": ["ofatumumab"]
    },
    "Cytarabine liposome": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [40175460],
      "conceptName": ["Cytarabine liposome"]
    },
    "Gemtuzumab ozogamicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [42799711],
      "conceptName": ["Gemtuzumab ozogamicin"]
    },
    "ponatinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [43013182],
      "conceptName": ["ponatinib"]
    },
    "omacetaxine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [45775576],
      "conceptName": ["omacetaxine"]
    },
    "panobinostat": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [46221435],
      "conceptName": ["panobinostat"]
    }
  },
  {
    "conceptId": [35804758],
    "regimenName": ["mFOLFOX6"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "oxaliplatin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1318011],
      "conceptName": ["oxaliplatin"]
    },
    "Leucovorin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1388796],
      "conceptName": ["Leucovorin"]
    },
    "Fluorouracil": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "gemcitabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314924],
      "conceptName": ["gemcitabine"]
    },
    "cetuximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1315411],
      "conceptName": ["cetuximab"]
    },
    "docetaxel": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1315942],
      "conceptName": ["docetaxel"]
    },
    "irinotecan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1367268],
      "conceptName": ["irinotecan"]
    },
    "bevacizumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397141],
      "conceptName": ["bevacizumab"]
    },
    "panitumumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19100985],
      "conceptName": ["panitumumab"]
    }
  },
  {
    "conceptId": [35804587],
    "regimenName": ["CFAR"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "alemtuzumab": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1312706],
      "conceptName": ["alemtuzumab"]
    },
    "rituximab": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "fludarabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1395557],
      "conceptName": ["fludarabine"]
    }
  },
  {
    "conceptId": [35806473],
    "regimenName": ["M-BCD"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Bleomycin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1329241],
      "conceptName": ["Bleomycin"]
    },
    "Methotrexate": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Dactinomycin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1311443],
      "conceptName": ["Dactinomycin"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    }
  },
  {
    "conceptId": [35805449],
    "regimenName": ["VAIA"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Dactinomycin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1311443],
      "conceptName": ["Dactinomycin"]
    },
    "Ifosfamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "irinotecan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1367268],
      "conceptName": ["irinotecan"]
    }
  },
  {
    "conceptId": [35806854],
    "regimenName": ["Cabazitaxel and Prednisone"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "cabazitaxel": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [40222431],
      "conceptName": ["cabazitaxel"]
    },
    "Prednisone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    }
  },
  {
    "conceptId": [35804801],
    "regimenName": ["Edrecolomab monotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Edrecolomab": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [19132294],
      "conceptName": ["Edrecolomab"]
    }
  },
  {
    "conceptId": [35804017],
    "regimenName": ["Bendamustine monotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "bendamustine": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [19015523],
      "conceptName": ["bendamustine"]
    },
    "Melphalan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1301267],
      "conceptName": ["Melphalan"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "gemcitabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314924],
      "conceptName": ["gemcitabine"]
    },
    "bortezomib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1336825],
      "conceptName": ["bortezomib"]
    },
    "vinorelbine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1343346],
      "conceptName": ["vinorelbine"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "fludarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1395557],
      "conceptName": ["fludarabine"]
    },
    "polatuzumab vedotin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1396729],
      "conceptName": ["polatuzumab vedotin"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "prednisolone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1550557],
      "conceptName": ["prednisolone"]
    },
    "lenalidomide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19026972],
      "conceptName": ["lenalidomide"]
    },
    "temsirolimus": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19092845],
      "conceptName": ["temsirolimus"]
    },
    "Thalidomide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19137042],
      "conceptName": ["Thalidomide"]
    },
    "ofatumumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [40167582],
      "conceptName": ["ofatumumab"]
    },
    "brentuximab vedotin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [40241969],
      "conceptName": ["brentuximab vedotin"]
    },
    "obinutuzumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [44507676],
      "conceptName": ["obinutuzumab"]
    },
    "Ibrutinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [44507848],
      "conceptName": ["Ibrutinib"]
    },
    "idelalisib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [45776944],
      "conceptName": ["idelalisib"]
    }
  },
  {
    "conceptId": [35806415],
    "regimenName": ["Carboplatin, Paclitaxel, Pembrolizumab"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Carboplatin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1344905],
      "conceptName": ["Carboplatin"]
    },
    "Paclitaxel": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1378382],
      "conceptName": ["Paclitaxel"]
    },
    "pembrolizumab": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [45775965],
      "conceptName": ["pembrolizumab"]
    }
  },
  {
    "conceptId": [35805122],
    "regimenName": ["CEPP(B)"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Bleomycin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1329241],
      "conceptName": ["Bleomycin"]
    },
    "Prednisone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Procarbazine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1351779],
      "conceptName": ["Procarbazine"]
    },
    "Etoposide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Mitoxantrone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1309188],
      "conceptName": ["Mitoxantrone"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Vinblastine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008264],
      "conceptName": ["Vinblastine"]
    }
  },
  {
    "conceptId": [35805080],
    "regimenName": ["Pixantrone monotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Pixantrone": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [36879010],
      "conceptName": ["Pixantrone"]
    }
  },
  {
    "conceptId": [35805639],
    "regimenName": ["R-FND"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "rituximab": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Dexamethasone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "fludarabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1395557],
      "conceptName": ["fludarabine"]
    },
    "Mitoxantrone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1309188],
      "conceptName": ["Mitoxantrone"]
    }
  },
  {
    "conceptId": [35804770],
    "regimenName": ["FOLFIRI and Bevacizumab"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "bevacizumab": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1397141],
      "conceptName": ["bevacizumab"]
    },
    "Leucovorin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1388796],
      "conceptName": ["Leucovorin"]
    },
    "irinotecan": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1367268],
      "conceptName": ["irinotecan"]
    },
    "Fluorouracil": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    }
  },
  {
    "conceptId": [35804351],
    "regimenName": ["CAMF"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Methotrexate": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Fluorouracil": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    }
  },
  {
    "conceptId": [35803515],
    "regimenName": ["Gilteritinib monotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "gilteritinib": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1355513],
      "conceptName": ["gilteritinib"]
    }
  },
  {
    "conceptId": [35803519],
    "regimenName": ["5 plus 3d"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Cytarabine": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Daunorubicin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1311799],
      "conceptName": ["Daunorubicin"]
    },
    "Tretinoin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [903643],
      "conceptName": ["Tretinoin"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Azacitidine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314865],
      "conceptName": ["Azacitidine"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "glasdegib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1355795],
      "conceptName": ["glasdegib"]
    },
    "sorafenib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1363387],
      "conceptName": ["sorafenib"]
    },
    "nilotinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1394023],
      "conceptName": ["nilotinib"]
    },
    "mercaptopurine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1436650],
      "conceptName": ["mercaptopurine"]
    },
    "Thioguanine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1437379],
      "conceptName": ["Thioguanine"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "prednisolone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1550557],
      "conceptName": ["prednisolone"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "midostaurin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1594003],
      "conceptName": ["midostaurin"]
    },
    "ASPARAGINASE": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19012585],
      "conceptName": ["ASPARAGINASE"]
    },
    "Cladribine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19054825],
      "conceptName": ["Cladribine"]
    },
    "Teniposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19136750],
      "conceptName": ["Teniposide"]
    },
    "Gemtuzumab ozogamicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [42799711],
      "conceptName": ["Gemtuzumab ozogamicin"]
    },
    "omacetaxine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [45775576],
      "conceptName": ["omacetaxine"]
    }
  },
  {
    "conceptId": [35806835],
    "regimenName": ["ADT and Apalutamide"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "apalutamide": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [963987],
      "conceptName": ["apalutamide"]
    }
  },
  {
    "conceptId": [35803671],
    "regimenName": ["Capecitabine, Mitomycin, RT"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Mitomycin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1389036],
      "conceptName": ["Mitomycin"]
    },
    "capecitabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1337620],
      "conceptName": ["capecitabine"]
    }
  },
  {
    "conceptId": [35102009],
    "regimenName": ["Fluorouracil and Levoleucovorin"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "levoleucovorin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [40168303],
      "conceptName": ["levoleucovorin"]
    },
    "Fluorouracil": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "cetuximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1315411],
      "conceptName": ["cetuximab"]
    },
    "oxaliplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1318011],
      "conceptName": ["oxaliplatin"]
    },
    "irinotecan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1367268],
      "conceptName": ["irinotecan"]
    },
    "bevacizumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397141],
      "conceptName": ["bevacizumab"]
    }
  },
  {
    "conceptId": [35806438],
    "regimenName": ["MVP (Vinblastine)"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Cisplatin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "Mitomycin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1389036],
      "conceptName": ["Mitomycin"]
    },
    "Vinblastine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [19008264],
      "conceptName": ["Vinblastine"]
    }
  },
  {
    "conceptId": [35803681],
    "regimenName": ["Lomustine, Vincristine, Prednisone"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Lomustine": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1391846],
      "conceptName": ["Lomustine"]
    },
    "Prednisone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Procarbazine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1351779],
      "conceptName": ["Procarbazine"]
    }
  },
  {
    "conceptId": [35102023],
    "regimenName": ["Cyclophosphamide, Daunorubicin, Vincristine, Prednisolone"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Cyclophosphamide": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Daunorubicin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1311799],
      "conceptName": ["Daunorubicin"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "prednisolone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1550557],
      "conceptName": ["prednisolone"]
    }
  },
  {
    "conceptId": [35804354],
    "regimenName": ["CHUT, then auto HSCT"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Thiotepa": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [19137385],
      "conceptName": ["Thiotepa"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Busulfan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1333357],
      "conceptName": ["Busulfan"]
    },
    "Epirubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344354],
      "conceptName": ["Epirubicin"]
    },
    "Carboplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344905],
      "conceptName": ["Carboplatin"]
    },
    "fludarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1395557],
      "conceptName": ["fludarabine"]
    }
  },
  {
    "conceptId": [35804239],
    "regimenName": ["iddEPC"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Paclitaxel": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1378382],
      "conceptName": ["Paclitaxel"]
    },
    "Epirubicin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1344354],
      "conceptName": ["Epirubicin"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    }
  },
  {
    "conceptId": [35804424],
    "regimenName": ["Nordic Regimen, older patients"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Methotrexate": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Ifosfamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    },
    "rituximab": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Cytarabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Vindesine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [19008336],
      "conceptName": ["Vindesine"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Dexamethasone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "Cytarabine liposome": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [40175460],
      "conceptName": ["Cytarabine liposome"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    }
  },
  {
    "conceptId": [35806397],
    "regimenName": ["Cisplatin and Vindesine"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Cisplatin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "Vindesine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [19008336],
      "conceptName": ["Vindesine"]
    },
    "Dacarbazine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311409],
      "conceptName": ["Dacarbazine"]
    },
    "Mitomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1389036],
      "conceptName": ["Mitomycin"]
    }
  },
  {
    "conceptId": [35805857],
    "regimenName": ["B-CAVe"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Bleomycin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1329241],
      "conceptName": ["Bleomycin"]
    },
    "Lomustine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1391846],
      "conceptName": ["Lomustine"]
    },
    "Vinblastine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [19008264],
      "conceptName": ["Vinblastine"]
    }
  },
  {
    "conceptId": [35805097],
    "regimenName": ["COP-Bleo"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Bleomycin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1329241],
      "conceptName": ["Bleomycin"]
    },
    "Prednisone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Mitoxantrone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1309188],
      "conceptName": ["Mitoxantrone"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Dacarbazine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311409],
      "conceptName": ["Dacarbazine"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Procarbazine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1351779],
      "conceptName": ["Procarbazine"]
    },
    "Vinblastine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008264],
      "conceptName": ["Vinblastine"]
    },
    "Teniposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19136750],
      "conceptName": ["Teniposide"]
    }
  },
  {
    "conceptId": [35804419],
    "regimenName": ["Methotrexate, then Cytarabine and Thiotepa"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Methotrexate": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Cytarabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Thiotepa": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [19137385],
      "conceptName": ["Thiotepa"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    }
  },
  {
    "conceptId": [35102015],
    "regimenName": ["MP (Prednisolone)"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Melphalan": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1301267],
      "conceptName": ["Melphalan"]
    },
    "prednisolone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1550557],
      "conceptName": ["prednisolone"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    }
  },
  {
    "conceptId": [35806099],
    "regimenName": ["Temsirolimus and Rituximab"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "rituximab": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "temsirolimus": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [19092845],
      "conceptName": ["temsirolimus"]
    },
    "bendamustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19015523],
      "conceptName": ["bendamustine"]
    }
  },
  {
    "conceptId": [35806303],
    "regimenName": ["CYKLONE"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Thalidomide": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [19137042],
      "conceptName": ["Thalidomide"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "carfilzomib": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [42873638],
      "conceptName": ["carfilzomib"]
    },
    "Dexamethasone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    }
  },
  {
    "conceptId": [35804416],
    "regimenName": ["Lomustine, Methotrexate, Procarbazine, Methylprednisolone"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Methotrexate": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Methylprednisolone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1506270],
      "conceptName": ["Methylprednisolone"]
    },
    "Lomustine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1391846],
      "conceptName": ["Lomustine"]
    },
    "Procarbazine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1351779],
      "conceptName": ["Procarbazine"]
    }
  },
  {
    "conceptId": [35804772],
    "regimenName": ["FOLFIRINOX and Bevacizumab (L-Leucovorin)"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "oxaliplatin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1318011],
      "conceptName": ["oxaliplatin"]
    },
    "bevacizumab": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1397141],
      "conceptName": ["bevacizumab"]
    },
    "irinotecan": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1367268],
      "conceptName": ["irinotecan"]
    },
    "levoleucovorin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [40168303],
      "conceptName": ["levoleucovorin"]
    },
    "Fluorouracil": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    }
  },
  {
    "conceptId": [35101990],
    "regimenName": ["Capecitabine and Fulvestrant"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "fulvestrant": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1304044],
      "conceptName": ["fulvestrant"]
    },
    "capecitabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1337620],
      "conceptName": ["capecitabine"]
    }
  },
  {
    "conceptId": [35804077],
    "regimenName": ["Cytarabine, Idarubicin, Imatinib"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Idarubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [19078097],
      "conceptName": ["Idarubicin"]
    },
    "Cytarabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "imatinib": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1304107],
      "conceptName": ["imatinib"]
    }
  },
  {
    "conceptId": [35805822],
    "regimenName": ["ChlVPP"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Chlorambucil": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1390051],
      "conceptName": ["Chlorambucil"]
    },
    "Prednisone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Vinblastine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [19008264],
      "conceptName": ["Vinblastine"]
    },
    "Procarbazine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1351779],
      "conceptName": ["Procarbazine"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    }
  },
  {
    "conceptId": [35803484],
    "regimenName": ["BuCy, then auto HSCT"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Busulfan": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1333357],
      "conceptName": ["Busulfan"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "fludarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1395557],
      "conceptName": ["fludarabine"]
    },
    "Thiotepa": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19137385],
      "conceptName": ["Thiotepa"]
    }
  },
  {
    "conceptId": [35806123],
    "regimenName": ["Cisplatin and Dacarbazine"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Cisplatin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "Dacarbazine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1311409],
      "conceptName": ["Dacarbazine"]
    },
    "Aldesleukin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1309770],
      "conceptName": ["Aldesleukin"]
    },
    "Carmustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350066],
      "conceptName": ["Carmustine"]
    },
    "Paclitaxel": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1378382],
      "conceptName": ["Paclitaxel"]
    },
    "Interferon Alfa-2b": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1380068],
      "conceptName": ["Interferon Alfa-2b"]
    },
    "Tamoxifen": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1436678],
      "conceptName": ["Tamoxifen"]
    },
    "Vinblastine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008264],
      "conceptName": ["Vinblastine"]
    },
    "Vindesine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008336],
      "conceptName": ["Vindesine"]
    }
  },
  {
    "conceptId": [35804008],
    "regimenName": ["FEAM"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Melphalan": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1301267],
      "conceptName": ["Melphalan"]
    },
    "Cytarabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Etoposide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Fotemustine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [36879099],
      "conceptName": ["Fotemustine"]
    }
  },
  {
    "conceptId": [35806375],
    "regimenName": ["GM-CSF, IL-2, Isotretinoin, Dinutuximab"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Isotretinoin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [984232],
      "conceptName": ["Isotretinoin"]
    },
    "sargramostim": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308432],
      "conceptName": ["sargramostim"]
    },
    "Aldesleukin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1309770],
      "conceptName": ["Aldesleukin"]
    },
    "dinutuximab": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [46221699],
      "conceptName": ["dinutuximab"]
    }
  },
  {
    "conceptId": [35806403],
    "regimenName": ["Carboplatin, Pemetrexed, Pembrolizumab"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Carboplatin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1344905],
      "conceptName": ["Carboplatin"]
    },
    "pemetrexed": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1304919],
      "conceptName": ["pemetrexed"]
    },
    "pembrolizumab": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [45775965],
      "conceptName": ["pembrolizumab"]
    }
  },
  {
    "conceptId": [35806051],
    "regimenName": ["CRd"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "lenalidomide": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [19026972],
      "conceptName": ["lenalidomide"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Dexamethasone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "bortezomib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1336825],
      "conceptName": ["bortezomib"]
    }
  },
  {
    "conceptId": [35807092],
    "regimenName": ["Daunorubicin liposomal monotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Daunorubicin Liposomal": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [19051599],
      "conceptName": ["Daunorubicin Liposomal"]
    },
    "Filgrastim": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1304850],
      "conceptName": ["Filgrastim"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "fludarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1395557],
      "conceptName": ["fludarabine"]
    }
  },
  {
    "conceptId": [35803549],
    "regimenName": ["Arsenic trioxide and ATRA"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "arsenic trioxide": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1333379],
      "conceptName": ["arsenic trioxide"]
    },
    "Tretinoin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [903643],
      "conceptName": ["Tretinoin"]
    },
    "Daunorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311799],
      "conceptName": ["Daunorubicin"]
    },
    "Idarubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078097],
      "conceptName": ["Idarubicin"]
    },
    "Gemtuzumab ozogamicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [42799711],
      "conceptName": ["Gemtuzumab ozogamicin"]
    }
  },
  {
    "conceptId": [35804095],
    "regimenName": ["Methotrexate monotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Methotrexate": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "inotuzumab ozogamicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [794068],
      "conceptName": ["inotuzumab ozogamicin"]
    },
    "Tretinoin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [903643],
      "conceptName": ["Tretinoin"]
    },
    "Fluorouracil": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "imatinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1304107],
      "conceptName": ["imatinib"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Mitoxantrone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1309188],
      "conceptName": ["Mitoxantrone"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Dactinomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311443],
      "conceptName": ["Dactinomycin"]
    },
    "Daunorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311799],
      "conceptName": ["Daunorubicin"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "pegaspargase": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1326481],
      "conceptName": ["pegaspargase"]
    },
    "Bleomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1329241],
      "conceptName": ["Bleomycin"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "temozolomide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1341149],
      "conceptName": ["temozolomide"]
    },
    "Epirubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344354],
      "conceptName": ["Epirubicin"]
    },
    "Carboplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344905],
      "conceptName": ["Carboplatin"]
    },
    "Carmustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350066],
      "conceptName": ["Carmustine"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Procarbazine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1351779],
      "conceptName": ["Procarbazine"]
    },
    "Mesna": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1354698],
      "conceptName": ["Mesna"]
    },
    "dasatinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1358436],
      "conceptName": ["dasatinib"]
    },
    "Altretamine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1368823],
      "conceptName": ["Altretamine"]
    },
    "Paclitaxel": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1378382],
      "conceptName": ["Paclitaxel"]
    },
    "Leucovorin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1388796],
      "conceptName": ["Leucovorin"]
    },
    "Chlorambucil": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1390051],
      "conceptName": ["Chlorambucil"]
    },
    "Lomustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1391846],
      "conceptName": ["Lomustine"]
    },
    "nilotinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1394023],
      "conceptName": ["nilotinib"]
    },
    "Mechlorethamine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1394337],
      "conceptName": ["Mechlorethamine"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "mercaptopurine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1436650],
      "conceptName": ["mercaptopurine"]
    },
    "Tamoxifen": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1436678],
      "conceptName": ["Tamoxifen"]
    },
    "Thioguanine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1437379],
      "conceptName": ["Thioguanine"]
    },
    "Methylprednisolone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1506270],
      "conceptName": ["Methylprednisolone"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "prednisolone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1550557],
      "conceptName": ["prednisolone"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Vinblastine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008264],
      "conceptName": ["Vinblastine"]
    },
    "Vindesine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008336],
      "conceptName": ["Vindesine"]
    },
    "everolimus": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19011440],
      "conceptName": ["everolimus"]
    },
    "ASPARAGINASE": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19012585],
      "conceptName": ["ASPARAGINASE"]
    },
    "doxorubicin liposome": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19051649],
      "conceptName": ["doxorubicin liposome"]
    },
    "Idarubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078097],
      "conceptName": ["Idarubicin"]
    },
    "Ifosfamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    },
    "Norethandrolone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19128219],
      "conceptName": ["Norethandrolone"]
    },
    "Teniposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19136750],
      "conceptName": ["Teniposide"]
    },
    "Thiotepa": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19137385],
      "conceptName": ["Thiotepa"]
    },
    "Cytarabine liposome": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [40175460],
      "conceptName": ["Cytarabine liposome"]
    },
    "ponatinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [43013182],
      "conceptName": ["ponatinib"]
    },
    "asparaginase Erwinia chrysanthemi": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [43533115],
      "conceptName": ["asparaginase Erwinia chrysanthemi"]
    }
  },
  {
    "conceptId": [35804781],
    "regimenName": ["IROX"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "oxaliplatin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1318011],
      "conceptName": ["oxaliplatin"]
    },
    "irinotecan": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1367268],
      "conceptName": ["irinotecan"]
    },
    "Fluorouracil": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "gemcitabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314924],
      "conceptName": ["gemcitabine"]
    },
    "cetuximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1315411],
      "conceptName": ["cetuximab"]
    },
    "Leucovorin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1388796],
      "conceptName": ["Leucovorin"]
    },
    "bevacizumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397141],
      "conceptName": ["bevacizumab"]
    },
    "levoleucovorin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [40168303],
      "conceptName": ["levoleucovorin"]
    }
  },
  {
    "conceptId": [35806077],
    "regimenName": ["R-DHAC"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Carboplatin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1344905],
      "conceptName": ["Carboplatin"]
    },
    "rituximab": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Cytarabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Dexamethasone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    }
  },
  {
    "conceptId": [35806145],
    "regimenName": ["Cisplatin, Dacarbazine, Interferon alfa-2b"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Cisplatin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "Dacarbazine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1311409],
      "conceptName": ["Dacarbazine"]
    },
    "Interferon Alfa-2b": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1380068],
      "conceptName": ["Interferon Alfa-2b"]
    },
    "Aldesleukin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1309770],
      "conceptName": ["Aldesleukin"]
    },
    "Carmustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350066],
      "conceptName": ["Carmustine"]
    },
    "Vinblastine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008264],
      "conceptName": ["Vinblastine"]
    }
  },
  {
    "conceptId": [35806492],
    "regimenName": ["Cisplatin and Cyclophosphamide"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Cisplatin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Melphalan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1301267],
      "conceptName": ["Melphalan"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Dactinomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311443],
      "conceptName": ["Dactinomycin"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Bleomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1329241],
      "conceptName": ["Bleomycin"]
    },
    "bortezomib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1336825],
      "conceptName": ["bortezomib"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Epirubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344354],
      "conceptName": ["Epirubicin"]
    },
    "Carmustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350066],
      "conceptName": ["Carmustine"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Mesna": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1354698],
      "conceptName": ["Mesna"]
    },
    "Altretamine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1368823],
      "conceptName": ["Altretamine"]
    },
    "Interferon gamma-1b": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1380191],
      "conceptName": ["Interferon gamma-1b"]
    },
    "Lomustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1391846],
      "conceptName": ["Lomustine"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Vinblastine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008264],
      "conceptName": ["Vinblastine"]
    },
    "Ifosfamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    },
    "Thalidomide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19137042],
      "conceptName": ["Thalidomide"]
    }
  },
  {
    "conceptId": [35806266],
    "regimenName": ["VBMCP/VBAD"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Carmustine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1350066],
      "conceptName": ["Carmustine"]
    },
    "Melphalan": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1301267],
      "conceptName": ["Melphalan"]
    },
    "Prednisone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Dexamethasone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    }
  },
  {
    "conceptId": [35804331],
    "regimenName": ["CMFP"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Methotrexate": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Prednisone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Fluorouracil": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Tamoxifen": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1436678],
      "conceptName": ["Tamoxifen"]
    }
  },
  {
    "conceptId": [35805058],
    "regimenName": ["R-DHAP"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Cisplatin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "rituximab": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Cytarabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Dexamethasone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Ifosfamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    }
  },
  {
    "conceptId": [35806477],
    "regimenName": ["Samarium-153 with stem cell support"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "SAMARIUM Sm153": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338558],
      "conceptName": ["SAMARIUM Sm153"]
    }
  },
  {
    "conceptId": [35806263],
    "regimenName": ["DCEP"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Cisplatin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Dexamethasone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "Etoposide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Melphalan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1301267],
      "conceptName": ["Melphalan"]
    },
    "bortezomib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1336825],
      "conceptName": ["bortezomib"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Thalidomide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19137042],
      "conceptName": ["Thalidomide"]
    }
  },
  {
    "conceptId": [35807090],
    "regimenName": ["ABV (Vincristine)"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Bleomycin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1329241],
      "conceptName": ["Bleomycin"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Dacarbazine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311409],
      "conceptName": ["Dacarbazine"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Procarbazine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1351779],
      "conceptName": ["Procarbazine"]
    },
    "Chlorambucil": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1390051],
      "conceptName": ["Chlorambucil"]
    },
    "Mechlorethamine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1394337],
      "conceptName": ["Mechlorethamine"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "prednisolone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1550557],
      "conceptName": ["prednisolone"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Vinblastine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008264],
      "conceptName": ["Vinblastine"]
    },
    "Teniposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19136750],
      "conceptName": ["Teniposide"]
    }
  },
  {
    "conceptId": [35804357],
    "regimenName": ["Estradiol monotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Estradiol": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1548195],
      "conceptName": ["Estradiol"]
    }
  },
  {
    "conceptId": [35803498],
    "regimenName": ["Clofarabine and Cytarabine"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Cytarabine": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "clofarabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [19054821],
      "conceptName": ["clofarabine"]
    },
    "Filgrastim": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1304850],
      "conceptName": ["Filgrastim"]
    },
    "decitabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19024728],
      "conceptName": ["decitabine"]
    },
    "Idarubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078097],
      "conceptName": ["Idarubicin"]
    }
  },
  {
    "conceptId": [35805079],
    "regimenName": ["Panobinostat and Rituximab"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "panobinostat": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [46221435],
      "conceptName": ["panobinostat"]
    },
    "rituximab": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    }
  },
  {
    "conceptId": [35805119],
    "regimenName": ["ESHAP"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Cisplatin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "Methylprednisolone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1506270],
      "conceptName": ["Methylprednisolone"]
    },
    "Cytarabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Etoposide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "ofatumumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [40167582],
      "conceptName": ["ofatumumab"]
    }
  },
  {
    "conceptId": [35805863],
    "regimenName": ["Sirolimus and Vorinostat"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Sirolimus": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [19034726],
      "conceptName": ["Sirolimus"]
    },
    "Vorinostat": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1337651],
      "conceptName": ["Vorinostat"]
    }
  },
  {
    "conceptId": [35806467],
    "regimenName": ["MA"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Methotrexate": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Fluorouracil": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "imatinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1304107],
      "conceptName": ["imatinib"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Dactinomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311443],
      "conceptName": ["Dactinomycin"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Bleomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1329241],
      "conceptName": ["Bleomycin"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Procarbazine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1351779],
      "conceptName": ["Procarbazine"]
    },
    "Mesna": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1354698],
      "conceptName": ["Mesna"]
    },
    "dasatinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1358436],
      "conceptName": ["dasatinib"]
    },
    "Lomustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1391846],
      "conceptName": ["Lomustine"]
    },
    "Mechlorethamine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1394337],
      "conceptName": ["Mechlorethamine"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "mercaptopurine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1436650],
      "conceptName": ["mercaptopurine"]
    },
    "Thioguanine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1437379],
      "conceptName": ["Thioguanine"]
    },
    "Methylprednisolone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1506270],
      "conceptName": ["Methylprednisolone"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "prednisolone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1550557],
      "conceptName": ["prednisolone"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Vinblastine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008264],
      "conceptName": ["Vinblastine"]
    },
    "Vindesine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008336],
      "conceptName": ["Vindesine"]
    },
    "everolimus": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19011440],
      "conceptName": ["everolimus"]
    },
    "ASPARAGINASE": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19012585],
      "conceptName": ["ASPARAGINASE"]
    },
    "Ifosfamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    },
    "Teniposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19136750],
      "conceptName": ["Teniposide"]
    },
    "ponatinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [43013182],
      "conceptName": ["ponatinib"]
    }
  },
  {
    "conceptId": [35805774],
    "regimenName": ["Carboplatin, Fluorouracil, Cetuximab"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Carboplatin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1344905],
      "conceptName": ["Carboplatin"]
    },
    "cetuximab": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1315411],
      "conceptName": ["cetuximab"]
    },
    "Fluorouracil": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    }
  },
  {
    "conceptId": [35803473],
    "regimenName": ["CPX-351 monotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Cytarabine liposome / Daunorubicin Liposomal Injection": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [794044],
      "conceptName": ["Cytarabine liposome / Daunorubicin Liposomal Injection"]
    }
  },
  {
    "conceptId": [35806172],
    "regimenName": ["Carboplatin and Pemetrexed"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Carboplatin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1344905],
      "conceptName": ["Carboplatin"]
    },
    "pemetrexed": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1304919],
      "conceptName": ["pemetrexed"]
    },
    "bevacizumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397141],
      "conceptName": ["bevacizumab"]
    },
    "pembrolizumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [45775965],
      "conceptName": ["pembrolizumab"]
    }
  },
  {
    "conceptId": [35804327],
    "regimenName": ["CEF/CMF"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Methotrexate": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Epirubicin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1344354],
      "conceptName": ["Epirubicin"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Fluorouracil": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    }
  },
  {
    "conceptId": [35102005],
    "regimenName": ["FOLFOX 7/sLV5FU2 (L-Leucovorin)"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "oxaliplatin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1318011],
      "conceptName": ["oxaliplatin"]
    },
    "levoleucovorin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [40168303],
      "conceptName": ["levoleucovorin"]
    },
    "Fluorouracil": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "cetuximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1315411],
      "conceptName": ["cetuximab"]
    },
    "irinotecan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1367268],
      "conceptName": ["irinotecan"]
    },
    "bevacizumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397141],
      "conceptName": ["bevacizumab"]
    }
  },
  {
    "conceptId": [35807023],
    "regimenName": ["VeIP"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Cisplatin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "Ifosfamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    },
    "Vinblastine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [19008264],
      "conceptName": ["Vinblastine"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    }
  },
  {
    "conceptId": [35805030],
    "regimenName": ["Ibritumomab tiuxetan monotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "ibritumomab tiuxetan": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [19068830],
      "conceptName": ["ibritumomab tiuxetan"]
    },
    "rituximab": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Melphalan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1301267],
      "conceptName": ["Melphalan"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Busulfan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1333357],
      "conceptName": ["Busulfan"]
    },
    "Carmustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350066],
      "conceptName": ["Carmustine"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "fludarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1395557],
      "conceptName": ["fludarabine"]
    }
  },
  {
    "conceptId": [35805789],
    "regimenName": ["Axitinib and TACE"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "axitinib": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [42709322],
      "conceptName": ["axitinib"]
    },
    "avelumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1593273],
      "conceptName": ["avelumab"]
    },
    "pembrolizumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [45775965],
      "conceptName": ["pembrolizumab"]
    }
  },
  {
    "conceptId": [35803458],
    "regimenName": ["HAA"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Aclarubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [19057483],
      "conceptName": ["Aclarubicin"]
    },
    "omacetaxine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [45775576],
      "conceptName": ["omacetaxine"]
    },
    "Cytarabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    }
  },
  {
    "conceptId": [35806488],
    "regimenName": ["Paclitaxel and Pazopanib"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Paclitaxel": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1378382],
      "conceptName": ["Paclitaxel"]
    },
    "pazopanib": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [40167554],
      "conceptName": ["pazopanib"]
    }
  },
  {
    "conceptId": [35805377],
    "regimenName": ["Peginterferon alfa-2a monotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "peginterferon alfa-2a": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1714165],
      "conceptName": ["peginterferon alfa-2a"]
    },
    "imatinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1304107],
      "conceptName": ["imatinib"]
    },
    "Interferon Alfa-2a": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1379969],
      "conceptName": ["Interferon Alfa-2a"]
    },
    "Interferon Alfa-2b": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1380068],
      "conceptName": ["Interferon Alfa-2b"]
    }
  },
  {
    "conceptId": [35806417],
    "regimenName": ["Necitumumab monotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "necitumumab": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [35606215],
      "conceptName": ["necitumumab"]
    },
    "gemcitabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314924],
      "conceptName": ["gemcitabine"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    }
  },
  {
    "conceptId": [35804041],
    "regimenName": ["Pediatric-like GRAALL consolidation"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Methotrexate": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "ASPARAGINASE": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [19012585],
      "conceptName": ["ASPARAGINASE"]
    },
    "Cytarabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "mercaptopurine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1436650],
      "conceptName": ["mercaptopurine"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Dexamethasone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "Etoposide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    }
  },
  {
    "conceptId": [35803443],
    "regimenName": ["Cytarabine and Idarubicin"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Idarubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [19078097],
      "conceptName": ["Idarubicin"]
    },
    "Cytarabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Tretinoin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [903643],
      "conceptName": ["Tretinoin"]
    },
    "imatinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1304107],
      "conceptName": ["imatinib"]
    },
    "Filgrastim": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1304850],
      "conceptName": ["Filgrastim"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Mitoxantrone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1309188],
      "conceptName": ["Mitoxantrone"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Vorinostat": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1337651],
      "conceptName": ["Vorinostat"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "sorafenib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1363387],
      "conceptName": ["sorafenib"]
    },
    "Lomustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1391846],
      "conceptName": ["Lomustine"]
    },
    "fludarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1395557],
      "conceptName": ["fludarabine"]
    },
    "mercaptopurine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1436650],
      "conceptName": ["mercaptopurine"]
    },
    "Thioguanine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1437379],
      "conceptName": ["Thioguanine"]
    },
    "Pravastatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551860],
      "conceptName": ["Pravastatin"]
    },
    "lenograstim": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19009705],
      "conceptName": ["lenograstim"]
    },
    "clofarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19054821],
      "conceptName": ["clofarabine"]
    },
    "Norethandrolone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19128219],
      "conceptName": ["Norethandrolone"]
    },
    "panobinostat": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [46221435],
      "conceptName": ["panobinostat"]
    }
  },
  {
    "conceptId": [35803689],
    "regimenName": ["Carboplatin and Bevacizumab"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Carboplatin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1344905],
      "conceptName": ["Carboplatin"]
    },
    "bevacizumab": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1397141],
      "conceptName": ["bevacizumab"]
    },
    "pemetrexed": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1304919],
      "conceptName": ["pemetrexed"]
    },
    "gemcitabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314924],
      "conceptName": ["gemcitabine"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Paclitaxel": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1378382],
      "conceptName": ["Paclitaxel"]
    },
    "atezolizumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [42629079],
      "conceptName": ["atezolizumab"]
    }
  },
  {
    "conceptId": [35805856],
    "regimenName": ["ABDIC"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Bleomycin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1329241],
      "conceptName": ["Bleomycin"]
    },
    "Lomustine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1391846],
      "conceptName": ["Lomustine"]
    },
    "Prednisone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Dacarbazine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1311409],
      "conceptName": ["Dacarbazine"]
    }
  },
  {
    "conceptId": [35805349],
    "regimenName": ["Carboplatin, Fluorouracil, RT"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Carboplatin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1344905],
      "conceptName": ["Carboplatin"]
    },
    "Fluorouracil": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "cetuximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1315411],
      "conceptName": ["cetuximab"]
    },
    "docetaxel": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1315942],
      "conceptName": ["docetaxel"]
    },
    "Epirubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344354],
      "conceptName": ["Epirubicin"]
    }
  },
  {
    "conceptId": [35804585],
    "regimenName": ["Bendamustine and Obinutuzumab"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "bendamustine": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [19015523],
      "conceptName": ["bendamustine"]
    },
    "obinutuzumab": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [44507676],
      "conceptName": ["obinutuzumab"]
    }
  },
  {
    "conceptId": [35804087],
    "regimenName": ["Cyclophosphamide, Doxorubicin, L-Asparaginase, Vincristine, Prednisolone"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "ASPARAGINASE": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [19012585],
      "conceptName": ["ASPARAGINASE"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "prednisolone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1550557],
      "conceptName": ["prednisolone"]
    }
  },
  {
    "conceptId": [35803479],
    "regimenName": ["Temozolomide monotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "temozolomide": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1341149],
      "conceptName": ["temozolomide"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "capecitabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1337620],
      "conceptName": ["capecitabine"]
    },
    "irinotecan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1367268],
      "conceptName": ["irinotecan"]
    },
    "Lomustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1391846],
      "conceptName": ["Lomustine"]
    },
    "bevacizumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397141],
      "conceptName": ["bevacizumab"]
    },
    "Thalidomide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19137042],
      "conceptName": ["Thalidomide"]
    },
    "dinutuximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [46221699],
      "conceptName": ["dinutuximab"]
    }
  },
  {
    "conceptId": [35804224],
    "regimenName": ["CMF"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Methotrexate": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Fluorouracil": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Epirubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344354],
      "conceptName": ["Epirubicin"]
    },
    "Altretamine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1368823],
      "conceptName": ["Altretamine"]
    },
    "Leucovorin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1388796],
      "conceptName": ["Leucovorin"]
    },
    "Tamoxifen": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1436678],
      "conceptName": ["Tamoxifen"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    }
  },
  {
    "conceptId": [35804220],
    "regimenName": ["TH (Taxotere)"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "trastuzumab": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1387104],
      "conceptName": ["trastuzumab"]
    },
    "docetaxel": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1315942],
      "conceptName": ["docetaxel"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Carboplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344905],
      "conceptName": ["Carboplatin"]
    },
    "pertuzumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [42801287],
      "conceptName": ["pertuzumab"]
    }
  },
  {
    "conceptId": [35804248],
    "regimenName": ["Capecitabine and Paclitaxel, nanoparticle albumin-bound"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Paclitaxel": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1378382],
      "conceptName": ["Paclitaxel"]
    },
    "capecitabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1337620],
      "conceptName": ["capecitabine"]
    },
    "Carboplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344905],
      "conceptName": ["Carboplatin"]
    }
  },
  {
    "conceptId": [35806307],
    "regimenName": ["Bortezomib and Doxorubicin liposomal"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "doxorubicin liposome": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [19051649],
      "conceptName": ["doxorubicin liposome"]
    },
    "bortezomib": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1336825],
      "conceptName": ["bortezomib"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    }
  },
  {
    "conceptId": [35805062],
    "regimenName": ["R-GDP"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Cisplatin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "rituximab": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "gemcitabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1314924],
      "conceptName": ["gemcitabine"]
    },
    "Dexamethasone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    }
  },
  {
    "conceptId": [35806273],
    "regimenName": ["MPR"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "lenalidomide": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [19026972],
      "conceptName": ["lenalidomide"]
    },
    "Melphalan": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1301267],
      "conceptName": ["Melphalan"]
    },
    "Prednisone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "bortezomib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1336825],
      "conceptName": ["bortezomib"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    }
  },
  {
    "conceptId": [35804281],
    "regimenName": ["Abemaciclib and Letrozole"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "abemaciclib": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [792649],
      "conceptName": ["abemaciclib"]
    },
    "letrozole": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1315946],
      "conceptName": ["letrozole"]
    }
  },
  {
    "conceptId": [35806851],
    "regimenName": ["Hydrocortisone monotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Hydrocortisone": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [975125],
      "conceptName": ["Hydrocortisone"]
    },
    "Ketoconazole": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [985708],
      "conceptName": ["Ketoconazole"]
    },
    "Dutasteride": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [989482],
      "conceptName": ["Dutasteride"]
    }
  },
  {
    "conceptId": [35806910],
    "regimenName": ["VAC"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Dactinomycin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1311443],
      "conceptName": ["Dactinomycin"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "irinotecan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1367268],
      "conceptName": ["irinotecan"]
    },
    "Ifosfamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    }
  },
  {
    "conceptId": [35803445],
    "regimenName": ["7 plus 3d and GO"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Cytarabine": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Gemtuzumab ozogamicin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [42799711],
      "conceptName": ["Gemtuzumab ozogamicin"]
    },
    "Daunorubicin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1311799],
      "conceptName": ["Daunorubicin"]
    }
  },
  {
    "conceptId": [35102020],
    "regimenName": ["eBEACOPP (Prednisolone)"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Bleomycin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1329241],
      "conceptName": ["Bleomycin"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Procarbazine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1351779],
      "conceptName": ["Procarbazine"]
    },
    "Etoposide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "prednisolone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1550557],
      "conceptName": ["prednisolone"]
    }
  },
  {
    "conceptId": [35803432],
    "regimenName": ["Rituximab monotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "rituximab": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "inotuzumab ozogamicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [794068],
      "conceptName": ["inotuzumab ozogamicin"]
    },
    "Melphalan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1301267],
      "conceptName": ["Melphalan"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Mitoxantrone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1309188],
      "conceptName": ["Mitoxantrone"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Dacarbazine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311409],
      "conceptName": ["Dacarbazine"]
    },
    "Daunorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311799],
      "conceptName": ["Daunorubicin"]
    },
    "alemtuzumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1312706],
      "conceptName": ["alemtuzumab"]
    },
    "gemcitabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314924],
      "conceptName": ["gemcitabine"]
    },
    "oxaliplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1318011],
      "conceptName": ["oxaliplatin"]
    },
    "Bleomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1329241],
      "conceptName": ["Bleomycin"]
    },
    "Busulfan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1333357],
      "conceptName": ["Busulfan"]
    },
    "bortezomib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1336825],
      "conceptName": ["bortezomib"]
    },
    "Vorinostat": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1337651],
      "conceptName": ["Vorinostat"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "temozolomide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1341149],
      "conceptName": ["temozolomide"]
    },
    "vinorelbine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1343346],
      "conceptName": ["vinorelbine"]
    },
    "Epirubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344354],
      "conceptName": ["Epirubicin"]
    },
    "Carboplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344905],
      "conceptName": ["Carboplatin"]
    },
    "Carmustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350066],
      "conceptName": ["Carmustine"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Procarbazine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1351779],
      "conceptName": ["Procarbazine"]
    },
    "Mesna": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1354698],
      "conceptName": ["Mesna"]
    },
    "Paclitaxel": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1378382],
      "conceptName": ["Paclitaxel"]
    },
    "Topotecan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1378509],
      "conceptName": ["Topotecan"]
    },
    "Chlorambucil": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1390051],
      "conceptName": ["Chlorambucil"]
    },
    "Lomustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1391846],
      "conceptName": ["Lomustine"]
    },
    "fludarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1395557],
      "conceptName": ["fludarabine"]
    },
    "polatuzumab vedotin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1396729],
      "conceptName": ["polatuzumab vedotin"]
    },
    "bevacizumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397141],
      "conceptName": ["bevacizumab"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "Methylprednisolone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1506270],
      "conceptName": ["Methylprednisolone"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "prednisolone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1550557],
      "conceptName": ["prednisolone"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Hyaluronidase / rituximab Injection [Rituxan Hycela]": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1593155],
      "conceptName": ["Hyaluronidase / rituximab Injection [Rituxan Hycela]"]
    },
    "Vinblastine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008264],
      "conceptName": ["Vinblastine"]
    },
    "Vindesine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008336],
      "conceptName": ["Vindesine"]
    },
    "everolimus": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19011440],
      "conceptName": ["everolimus"]
    },
    "ASPARAGINASE": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19012585],
      "conceptName": ["ASPARAGINASE"]
    },
    "bendamustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19015523],
      "conceptName": ["bendamustine"]
    },
    "lenalidomide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19026972],
      "conceptName": ["lenalidomide"]
    },
    "Pentostatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19031224],
      "conceptName": ["Pentostatin"]
    },
    "doxorubicin liposome": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19051649],
      "conceptName": ["doxorubicin liposome"]
    },
    "Cladribine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19054825],
      "conceptName": ["Cladribine"]
    },
    "ibritumomab tiuxetan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19068830],
      "conceptName": ["ibritumomab tiuxetan"]
    },
    "Idarubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078097],
      "conceptName": ["Idarubicin"]
    },
    "Ifosfamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    },
    "temsirolimus": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19092845],
      "conceptName": ["temsirolimus"]
    },
    "Teniposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19136750],
      "conceptName": ["Teniposide"]
    },
    "Thalidomide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19137042],
      "conceptName": ["Thalidomide"]
    },
    "Thiotepa": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19137385],
      "conceptName": ["Thiotepa"]
    },
    "venetoclax": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [35604205],
      "conceptName": ["venetoclax"]
    },
    "Cytarabine liposome": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [40175460],
      "conceptName": ["Cytarabine liposome"]
    },
    "carfilzomib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [42873638],
      "conceptName": ["carfilzomib"]
    },
    "vincristine liposome": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [42874135],
      "conceptName": ["vincristine liposome"]
    },
    "Ibrutinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [44507848],
      "conceptName": ["Ibrutinib"]
    },
    "idelalisib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [45776944],
      "conceptName": ["idelalisib"]
    },
    "panobinostat": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [46221435],
      "conceptName": ["panobinostat"]
    }
  },
  {
    "conceptId": [35804777],
    "regimenName": ["mFOLFOX6 and Bevacizumab"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "oxaliplatin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1318011],
      "conceptName": ["oxaliplatin"]
    },
    "bevacizumab": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1397141],
      "conceptName": ["bevacizumab"]
    },
    "Leucovorin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1388796],
      "conceptName": ["Leucovorin"]
    },
    "Fluorouracil": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    }
  },
  {
    "conceptId": [35806441],
    "regimenName": ["VIP"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Cisplatin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "Ifosfamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    },
    "Vinblastine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [19008264],
      "conceptName": ["Vinblastine"]
    },
    "Etoposide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    }
  },
  {
    "conceptId": [35805347],
    "regimenName": ["Capecitabine, Oxaliplatin, RT"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "oxaliplatin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1318011],
      "conceptName": ["oxaliplatin"]
    },
    "capecitabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1337620],
      "conceptName": ["capecitabine"]
    },
    "cetuximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1315411],
      "conceptName": ["cetuximab"]
    },
    "docetaxel": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1315942],
      "conceptName": ["docetaxel"]
    },
    "Epirubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344354],
      "conceptName": ["Epirubicin"]
    },
    "bevacizumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397141],
      "conceptName": ["bevacizumab"]
    },
    "panitumumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19100985],
      "conceptName": ["panitumumab"]
    }
  },
  {
    "conceptId": [35803996],
    "regimenName": ["BCNU/TT"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Carmustine": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1350066],
      "conceptName": ["Carmustine"]
    },
    "Thiotepa": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [19137385],
      "conceptName": ["Thiotepa"]
    }
  },
  {
    "conceptId": [35805804],
    "regimenName": ["AVD"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Vinblastine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [19008264],
      "conceptName": ["Vinblastine"]
    },
    "Dacarbazine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1311409],
      "conceptName": ["Dacarbazine"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Bleomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1329241],
      "conceptName": ["Bleomycin"]
    },
    "Procarbazine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1351779],
      "conceptName": ["Procarbazine"]
    },
    "Mechlorethamine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1394337],
      "conceptName": ["Mechlorethamine"]
    },
    "Methylprednisolone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1506270],
      "conceptName": ["Methylprednisolone"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "brentuximab vedotin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [40241969],
      "conceptName": ["brentuximab vedotin"]
    }
  },
  {
    "conceptId": [35805359],
    "regimenName": ["Cisplatin, Fluorouracil, Cetuximab"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Cisplatin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "cetuximab": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1315411],
      "conceptName": ["cetuximab"]
    },
    "Fluorouracil": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    }
  },
  {
    "conceptId": [35806147],
    "regimenName": ["Dacarbazine and Tamoxifen"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Tamoxifen": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1436678],
      "conceptName": ["Tamoxifen"]
    },
    "Dacarbazine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1311409],
      "conceptName": ["Dacarbazine"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    }
  },
  {
    "conceptId": [35805355],
    "regimenName": ["5-FU and Leucovorin, then 5-FU, Leucovorin, RT, then 5-FU and Leucovorin"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Leucovorin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1388796],
      "conceptName": ["Leucovorin"]
    },
    "Fluorouracil": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "gemcitabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314924],
      "conceptName": ["gemcitabine"]
    },
    "cetuximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1315411],
      "conceptName": ["cetuximab"]
    },
    "docetaxel": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1315942],
      "conceptName": ["docetaxel"]
    },
    "oxaliplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1318011],
      "conceptName": ["oxaliplatin"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "irinotecan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1367268],
      "conceptName": ["irinotecan"]
    },
    "Mitomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1389036],
      "conceptName": ["Mitomycin"]
    },
    "Levamisole": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1389464],
      "conceptName": ["Levamisole"]
    },
    "bevacizumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397141],
      "conceptName": ["bevacizumab"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "panitumumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19100985],
      "conceptName": ["panitumumab"]
    },
    "irinotecan liposomal": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [35603068],
      "conceptName": ["irinotecan liposomal"]
    },
    "aflibercept": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [40244266],
      "conceptName": ["aflibercept"]
    },
    "ramucirumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [44818489],
      "conceptName": ["ramucirumab"]
    }
  },
  {
    "conceptId": [35806419],
    "regimenName": ["Afatinib and Paclitaxel"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Paclitaxel": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1378382],
      "conceptName": ["Paclitaxel"]
    },
    "Afatinib": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [43533090],
      "conceptName": ["Afatinib"]
    }
  },
  {
    "conceptId": [35804768],
    "regimenName": ["CAPIRI-Bev"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "bevacizumab": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1397141],
      "conceptName": ["bevacizumab"]
    },
    "irinotecan": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1367268],
      "conceptName": ["irinotecan"]
    },
    "capecitabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1337620],
      "conceptName": ["capecitabine"]
    }
  },
  {
    "conceptId": [35803462],
    "regimenName": ["IC and Norethandrolone/6-MP, MTX, Norethandrolone"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Methotrexate": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Idarubicin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [19078097],
      "conceptName": ["Idarubicin"]
    },
    "Cytarabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "mercaptopurine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1436650],
      "conceptName": ["mercaptopurine"]
    },
    "Norethandrolone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [19128219],
      "conceptName": ["Norethandrolone"]
    }
  },
  {
    "conceptId": [35804235],
    "regimenName": ["ddC"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Cyclophosphamide": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "inotuzumab ozogamicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [794068],
      "conceptName": ["inotuzumab ozogamicin"]
    },
    "Fluorouracil": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "Melphalan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1301267],
      "conceptName": ["Melphalan"]
    },
    "imatinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1304107],
      "conceptName": ["imatinib"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Mitoxantrone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1309188],
      "conceptName": ["Mitoxantrone"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Dacarbazine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311409],
      "conceptName": ["Dacarbazine"]
    },
    "Dactinomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311443],
      "conceptName": ["Dactinomycin"]
    },
    "Daunorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311799],
      "conceptName": ["Daunorubicin"]
    },
    "alemtuzumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1312706],
      "conceptName": ["alemtuzumab"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "gemcitabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314924],
      "conceptName": ["gemcitabine"]
    },
    "docetaxel": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1315942],
      "conceptName": ["docetaxel"]
    },
    "pegaspargase": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1326481],
      "conceptName": ["pegaspargase"]
    },
    "Bleomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1329241],
      "conceptName": ["Bleomycin"]
    },
    "Busulfan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1333357],
      "conceptName": ["Busulfan"]
    },
    "bortezomib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1336825],
      "conceptName": ["bortezomib"]
    },
    "Vorinostat": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1337651],
      "conceptName": ["Vorinostat"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Epirubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344354],
      "conceptName": ["Epirubicin"]
    },
    "Carboplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344905],
      "conceptName": ["Carboplatin"]
    },
    "Carmustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350066],
      "conceptName": ["Carmustine"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Procarbazine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1351779],
      "conceptName": ["Procarbazine"]
    },
    "Mesna": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1354698],
      "conceptName": ["Mesna"]
    },
    "dasatinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1358436],
      "conceptName": ["dasatinib"]
    },
    "irinotecan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1367268],
      "conceptName": ["irinotecan"]
    },
    "Altretamine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1368823],
      "conceptName": ["Altretamine"]
    },
    "Paclitaxel": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1378382],
      "conceptName": ["Paclitaxel"]
    },
    "Topotecan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1378509],
      "conceptName": ["Topotecan"]
    },
    "Interferon Alfa-2b": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1380068],
      "conceptName": ["Interferon Alfa-2b"]
    },
    "Interferon gamma-1b": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1380191],
      "conceptName": ["Interferon gamma-1b"]
    },
    "trastuzumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1387104],
      "conceptName": ["trastuzumab"]
    },
    "Leucovorin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1388796],
      "conceptName": ["Leucovorin"]
    },
    "Lomustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1391846],
      "conceptName": ["Lomustine"]
    },
    "Mechlorethamine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1394337],
      "conceptName": ["Mechlorethamine"]
    },
    "fludarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1395557],
      "conceptName": ["fludarabine"]
    },
    "bevacizumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397141],
      "conceptName": ["bevacizumab"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "mercaptopurine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1436650],
      "conceptName": ["mercaptopurine"]
    },
    "Tamoxifen": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1436678],
      "conceptName": ["Tamoxifen"]
    },
    "Thioguanine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1437379],
      "conceptName": ["Thioguanine"]
    },
    "Medroxyprogesterone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1500211],
      "conceptName": ["Medroxyprogesterone"]
    },
    "Methylprednisolone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1506270],
      "conceptName": ["Methylprednisolone"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "Diethylstilbestrol": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1525866],
      "conceptName": ["Diethylstilbestrol"]
    },
    "prednisolone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1550557],
      "conceptName": ["prednisolone"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Hyaluronidase / rituximab Injection [Rituxan Hycela]": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1593155],
      "conceptName": ["Hyaluronidase / rituximab Injection [Rituxan Hycela]"]
    },
    "nelarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19002912],
      "conceptName": ["nelarabine"]
    },
    "Vinblastine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008264],
      "conceptName": ["Vinblastine"]
    },
    "Vindesine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008336],
      "conceptName": ["Vindesine"]
    },
    "everolimus": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19011440],
      "conceptName": ["everolimus"]
    },
    "ASPARAGINASE": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19012585],
      "conceptName": ["ASPARAGINASE"]
    },
    "lenalidomide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19026972],
      "conceptName": ["lenalidomide"]
    },
    "Pentostatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19031224],
      "conceptName": ["Pentostatin"]
    },
    "denileukin diftitox": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19051642],
      "conceptName": ["denileukin diftitox"]
    },
    "doxorubicin liposome": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19051649],
      "conceptName": ["doxorubicin liposome"]
    },
    "clofarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19054821],
      "conceptName": ["clofarabine"]
    },
    "Cladribine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19054825],
      "conceptName": ["Cladribine"]
    },
    "iodine-131-tositumomab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19054997],
      "conceptName": ["iodine-131-tositumomab"]
    },
    "ibritumomab tiuxetan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19068830],
      "conceptName": ["ibritumomab tiuxetan"]
    },
    "Idarubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078097],
      "conceptName": ["Idarubicin"]
    },
    "Ifosfamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    },
    "BCG, Live, Tice Strain": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19086176],
      "conceptName": ["BCG, Live, Tice Strain"]
    },
    "Teniposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19136750],
      "conceptName": ["Teniposide"]
    },
    "Thalidomide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19137042],
      "conceptName": ["Thalidomide"]
    },
    "Thiotepa": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19137385],
      "conceptName": ["Thiotepa"]
    },
    "Myocet": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [21017157],
      "conceptName": ["Myocet"]
    },
    "ranimustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [35197850],
      "conceptName": ["ranimustine"]
    },
    "ofatumumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [40167582],
      "conceptName": ["ofatumumab"]
    },
    "Cytarabine liposome": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [40175460],
      "conceptName": ["Cytarabine liposome"]
    },
    "brentuximab vedotin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [40241969],
      "conceptName": ["brentuximab vedotin"]
    },
    "carfilzomib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [42873638],
      "conceptName": ["carfilzomib"]
    },
    "vincristine liposome": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [42874135],
      "conceptName": ["vincristine liposome"]
    },
    "ponatinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [43013182],
      "conceptName": ["ponatinib"]
    },
    "pomalidomide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [43014237],
      "conceptName": ["pomalidomide"]
    },
    "obinutuzumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [44507676],
      "conceptName": ["obinutuzumab"]
    }
  },
  {
    "conceptId": [35804082],
    "regimenName": ["Bosutinib monotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "bosutinib": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [42900401],
      "conceptName": ["bosutinib"]
    }
  },
  {
    "conceptId": [35804634],
    "regimenName": ["Imatinib and Interferon"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "imatinib": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1304107],
      "conceptName": ["imatinib"]
    },
    "Interferon Alfa-2b": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1380068],
      "conceptName": ["Interferon Alfa-2b"]
    },
    "Interferon Alfa-2a": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1379969],
      "conceptName": ["Interferon Alfa-2a"]
    },
    "peginterferon alfa-2a": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1714165],
      "conceptName": ["peginterferon alfa-2a"]
    }
  },
  {
    "conceptId": [35806103],
    "regimenName": ["Doxycycline monotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxycycline": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1738521],
      "conceptName": ["Doxycycline"]
    }
  },
  {
    "conceptId": [35803506],
    "regimenName": ["FLAG-DNX"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Daunorubicin Liposomal": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [19051599],
      "conceptName": ["Daunorubicin Liposomal"]
    },
    "Cytarabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Filgrastim": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1304850],
      "conceptName": ["Filgrastim"]
    },
    "fludarabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1395557],
      "conceptName": ["fludarabine"]
    }
  },
  {
    "conceptId": [35807017],
    "regimenName": ["Accelerated BEP"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Bleomycin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1329241],
      "conceptName": ["Bleomycin"]
    },
    "Cisplatin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "Etoposide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Vinblastine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008264],
      "conceptName": ["Vinblastine"]
    }
  },
  {
    "conceptId": [35805809],
    "regimenName": ["EBVP"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Bleomycin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1329241],
      "conceptName": ["Bleomycin"]
    },
    "Epirubicin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1344354],
      "conceptName": ["Epirubicin"]
    },
    "Prednisone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Vinblastine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [19008264],
      "conceptName": ["Vinblastine"]
    }
  },
  {
    "conceptId": [35803500],
    "regimenName": ["Clofarabine and Melphalan, then allo HSCT"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Melphalan": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1301267],
      "conceptName": ["Melphalan"]
    },
    "clofarabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [19054821],
      "conceptName": ["clofarabine"]
    }
  },
  {
    "conceptId": [35804611],
    "regimenName": ["Ibrutinib and Ofatumumab"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "ofatumumab": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [40167582],
      "conceptName": ["ofatumumab"]
    },
    "Ibrutinib": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [44507848],
      "conceptName": ["Ibrutinib"]
    }
  },
  {
    "conceptId": [35803557],
    "regimenName": ["ATRA and Idarubicin"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Idarubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [19078097],
      "conceptName": ["Idarubicin"]
    },
    "Tretinoin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [903643],
      "conceptName": ["Tretinoin"]
    },
    "Mitoxantrone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1309188],
      "conceptName": ["Mitoxantrone"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "arsenic trioxide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1333379],
      "conceptName": ["arsenic trioxide"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Thioguanine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1437379],
      "conceptName": ["Thioguanine"]
    }
  },
  {
    "conceptId": [35805830],
    "regimenName": ["DexaBEAM"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Carmustine": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1350066],
      "conceptName": ["Carmustine"]
    },
    "Melphalan": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1301267],
      "conceptName": ["Melphalan"]
    },
    "Cytarabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Dexamethasone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "Etoposide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    }
  },
  {
    "conceptId": [35806856],
    "regimenName": ["Cyclophosphamide, Prednisone, Diethylstilbestrol"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Prednisone": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Diethylstilbestrol": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1525866],
      "conceptName": ["Diethylstilbestrol"]
    }
  },
  {
    "conceptId": [35806332],
    "regimenName": ["PVD"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "bortezomib": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1336825],
      "conceptName": ["bortezomib"]
    },
    "Dexamethasone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "pomalidomide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [43014237],
      "conceptName": ["pomalidomide"]
    }
  },
  {
    "conceptId": [35806418],
    "regimenName": ["Docetaxel and Nedaplatin"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "docetaxel": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1315942],
      "conceptName": ["docetaxel"]
    },
    "nedaplatin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [35198201],
      "conceptName": ["nedaplatin"]
    }
  },
  {
    "conceptId": [35101979],
    "regimenName": ["Dara-Kd"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "daratumumab": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [35605744],
      "conceptName": ["daratumumab"]
    },
    "carfilzomib": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [42873638],
      "conceptName": ["carfilzomib"]
    },
    "Dexamethasone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    }
  },
  {
    "conceptId": [35806904],
    "regimenName": ["Gemcitabine and Sunitinib"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "gemcitabine": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1314924],
      "conceptName": ["gemcitabine"]
    },
    "sunitinib": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1336539],
      "conceptName": ["sunitinib"]
    }
  },
  {
    "conceptId": [35804153],
    "regimenName": ["Paclitaxel and RT"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Paclitaxel": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1378382],
      "conceptName": ["Paclitaxel"]
    },
    "neratinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [793846],
      "conceptName": ["neratinib"]
    },
    "Fluorouracil": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Dacarbazine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311409],
      "conceptName": ["Dacarbazine"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "gemcitabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314924],
      "conceptName": ["gemcitabine"]
    },
    "oxaliplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1318011],
      "conceptName": ["oxaliplatin"]
    },
    "capecitabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1337620],
      "conceptName": ["capecitabine"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "vinorelbine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1343346],
      "conceptName": ["vinorelbine"]
    },
    "Epirubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344354],
      "conceptName": ["Epirubicin"]
    },
    "Carboplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344905],
      "conceptName": ["Carboplatin"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "lapatinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1359548],
      "conceptName": ["lapatinib"]
    },
    "Hyaluronidase / trastuzumab Injection [Herceptin Hylecta]": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1366689],
      "conceptName": ["Hyaluronidase / trastuzumab Injection [Herceptin Hylecta]"]
    },
    "Topotecan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1378509],
      "conceptName": ["Topotecan"]
    },
    "trastuzumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1387104],
      "conceptName": ["trastuzumab"]
    },
    "bevacizumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397141],
      "conceptName": ["bevacizumab"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "Ifosfamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    },
    "pazopanib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [40167554],
      "conceptName": ["pazopanib"]
    },
    "ipilimumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [40238188],
      "conceptName": ["ipilimumab"]
    },
    "atezolizumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [42629079],
      "conceptName": ["atezolizumab"]
    },
    "pertuzumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [42801287],
      "conceptName": ["pertuzumab"]
    },
    "ado-trastuzumab emtansine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [43525787],
      "conceptName": ["ado-trastuzumab emtansine"]
    },
    "Afatinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [43533090],
      "conceptName": ["Afatinib"]
    },
    "ramucirumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [44818489],
      "conceptName": ["ramucirumab"]
    },
    "pembrolizumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [45775965],
      "conceptName": ["pembrolizumab"]
    },
    "olaparib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [45892579],
      "conceptName": ["olaparib"]
    }
  },
  {
    "conceptId": [35805849],
    "regimenName": ["LOPP"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Chlorambucil": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1390051],
      "conceptName": ["Chlorambucil"]
    },
    "Prednisone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Procarbazine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1351779],
      "conceptName": ["Procarbazine"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Vinblastine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008264],
      "conceptName": ["Vinblastine"]
    }
  },
  {
    "conceptId": [35806958],
    "regimenName": ["Cyclophosphamide, Lomustine, Methotrexate"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Methotrexate": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Lomustine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1391846],
      "conceptName": ["Lomustine"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    }
  },
  {
    "conceptId": [35806836],
    "regimenName": ["ADT and Enzalutamide"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "enzalutamide": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [42900250],
      "conceptName": ["enzalutamide"]
    }
  },
  {
    "conceptId": [35804040],
    "regimenName": ["Cyclophosphamide, Daunorubicin, Vincristine, Prednisone"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Prednisone": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Daunorubicin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1311799],
      "conceptName": ["Daunorubicin"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "ASPARAGINASE": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19012585],
      "conceptName": ["ASPARAGINASE"]
    }
  },
  {
    "conceptId": [35805653],
    "regimenName": ["CHOP, then 131Iodine-Tositumomab"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "iodine-131-tositumomab": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [19054997],
      "conceptName": ["iodine-131-tositumomab"]
    },
    "Prednisone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    }
  },
  {
    "conceptId": [35101649],
    "regimenName": ["BR and Polatuzumab vedotin"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "bendamustine": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [19015523],
      "conceptName": ["bendamustine"]
    },
    "polatuzumab vedotin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1396729],
      "conceptName": ["polatuzumab vedotin"]
    },
    "rituximab": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    }
  },
  {
    "conceptId": [35805846],
    "regimenName": ["COPP (CCNU)"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Lomustine": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1391846],
      "conceptName": ["Lomustine"]
    },
    "Prednisone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Procarbazine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1351779],
      "conceptName": ["Procarbazine"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    }
  },
  {
    "conceptId": [35806364],
    "regimenName": ["Larotrectinib monotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "larotrectinib": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1355705],
      "conceptName": ["larotrectinib"]
    }
  },
  {
    "conceptId": [35804764],
    "regimenName": ["Intraperitoneal 5-FU"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Leucovorin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1388796],
      "conceptName": ["Leucovorin"]
    },
    "Fluorouracil": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "gemcitabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314924],
      "conceptName": ["gemcitabine"]
    },
    "cetuximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1315411],
      "conceptName": ["cetuximab"]
    },
    "docetaxel": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1315942],
      "conceptName": ["docetaxel"]
    },
    "oxaliplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1318011],
      "conceptName": ["oxaliplatin"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "irinotecan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1367268],
      "conceptName": ["irinotecan"]
    },
    "Mitomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1389036],
      "conceptName": ["Mitomycin"]
    },
    "Levamisole": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1389464],
      "conceptName": ["Levamisole"]
    },
    "bevacizumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397141],
      "conceptName": ["bevacizumab"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "panitumumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19100985],
      "conceptName": ["panitumumab"]
    },
    "irinotecan liposomal": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [35603068],
      "conceptName": ["irinotecan liposomal"]
    },
    "aflibercept": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [40244266],
      "conceptName": ["aflibercept"]
    },
    "ramucirumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [44818489],
      "conceptName": ["ramucirumab"]
    }
  },
  {
    "conceptId": [35803491],
    "regimenName": ["Fludarabine and TBI, then allo HSCT"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "fludarabine": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1395557],
      "conceptName": ["fludarabine"]
    },
    "Melphalan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1301267],
      "conceptName": ["Melphalan"]
    },
    "Filgrastim": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1304850],
      "conceptName": ["Filgrastim"]
    },
    "Mitoxantrone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1309188],
      "conceptName": ["Mitoxantrone"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "alemtuzumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1312706],
      "conceptName": ["alemtuzumab"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "oxaliplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1318011],
      "conceptName": ["oxaliplatin"]
    },
    "Busulfan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1333357],
      "conceptName": ["Busulfan"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "lenograstim": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19009705],
      "conceptName": ["lenograstim"]
    },
    "bendamustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19015523],
      "conceptName": ["bendamustine"]
    },
    "Daunorubicin Liposomal": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19051599],
      "conceptName": ["Daunorubicin Liposomal"]
    },
    "iodine-131-tositumomab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19054997],
      "conceptName": ["iodine-131-tositumomab"]
    },
    "ibritumomab tiuxetan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19068830],
      "conceptName": ["ibritumomab tiuxetan"]
    },
    "Idarubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078097],
      "conceptName": ["Idarubicin"]
    },
    "Thiotepa": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19137385],
      "conceptName": ["Thiotepa"]
    },
    "ofatumumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [40167582],
      "conceptName": ["ofatumumab"]
    },
    "obinutuzumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [44507676],
      "conceptName": ["obinutuzumab"]
    }
  },
  {
    "conceptId": [35805767],
    "regimenName": ["Carboplatin, Fluorouracil, Cetuximab, RT"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Carboplatin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1344905],
      "conceptName": ["Carboplatin"]
    },
    "cetuximab": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1315411],
      "conceptName": ["cetuximab"]
    },
    "Fluorouracil": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    }
  },
  {
    "conceptId": [35805032],
    "regimenName": ["R-CEOP (Etoposide)"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "rituximab": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Prednisone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Etoposide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "Vindesine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008336],
      "conceptName": ["Vindesine"]
    },
    "Ifosfamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    },
    "Teniposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19136750],
      "conceptName": ["Teniposide"]
    }
  },
  {
    "conceptId": [35803534],
    "regimenName": ["Decitabine and Valproate"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Valproate": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [745466],
      "conceptName": ["Valproate"]
    },
    "decitabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [19024728],
      "conceptName": ["decitabine"]
    }
  },
  {
    "conceptId": [35102029],
    "regimenName": ["CEOP (Prednisolone)"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Epirubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1344354],
      "conceptName": ["Epirubicin"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "prednisolone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1550557],
      "conceptName": ["prednisolone"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    }
  },
  {
    "conceptId": [35804792],
    "regimenName": ["FOLFIRI and Cetuximab"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Leucovorin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1388796],
      "conceptName": ["Leucovorin"]
    },
    "irinotecan": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1367268],
      "conceptName": ["irinotecan"]
    },
    "cetuximab": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1315411],
      "conceptName": ["cetuximab"]
    },
    "Fluorouracil": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    }
  },
  {
    "conceptId": [35805056],
    "regimenName": ["R-TBI/Cy, then auto HSCT"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "rituximab": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Mitoxantrone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1309188],
      "conceptName": ["Mitoxantrone"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Daunorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311799],
      "conceptName": ["Daunorubicin"]
    },
    "alemtuzumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1312706],
      "conceptName": ["alemtuzumab"]
    },
    "gemcitabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314924],
      "conceptName": ["gemcitabine"]
    },
    "Bleomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1329241],
      "conceptName": ["Bleomycin"]
    },
    "bortezomib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1336825],
      "conceptName": ["bortezomib"]
    },
    "Vorinostat": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1337651],
      "conceptName": ["Vorinostat"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Epirubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344354],
      "conceptName": ["Epirubicin"]
    },
    "Carmustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350066],
      "conceptName": ["Carmustine"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Procarbazine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1351779],
      "conceptName": ["Procarbazine"]
    },
    "fludarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1395557],
      "conceptName": ["fludarabine"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "Methylprednisolone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1506270],
      "conceptName": ["Methylprednisolone"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "prednisolone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1550557],
      "conceptName": ["prednisolone"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Hyaluronidase / rituximab Injection [Rituxan Hycela]": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1593155],
      "conceptName": ["Hyaluronidase / rituximab Injection [Rituxan Hycela]"]
    },
    "Vinblastine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008264],
      "conceptName": ["Vinblastine"]
    },
    "Vindesine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008336],
      "conceptName": ["Vindesine"]
    },
    "ASPARAGINASE": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19012585],
      "conceptName": ["ASPARAGINASE"]
    },
    "lenalidomide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19026972],
      "conceptName": ["lenalidomide"]
    },
    "Pentostatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19031224],
      "conceptName": ["Pentostatin"]
    },
    "doxorubicin liposome": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19051649],
      "conceptName": ["doxorubicin liposome"]
    },
    "Cladribine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19054825],
      "conceptName": ["Cladribine"]
    },
    "ibritumomab tiuxetan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19068830],
      "conceptName": ["ibritumomab tiuxetan"]
    },
    "Ifosfamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    },
    "Teniposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19136750],
      "conceptName": ["Teniposide"]
    },
    "Thalidomide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19137042],
      "conceptName": ["Thalidomide"]
    },
    "Cytarabine liposome": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [40175460],
      "conceptName": ["Cytarabine liposome"]
    },
    "vincristine liposome": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [42874135],
      "conceptName": ["vincristine liposome"]
    }
  },
  {
    "conceptId": [35806143],
    "regimenName": ["BVD"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Carmustine": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1350066],
      "conceptName": ["Carmustine"]
    },
    "Dacarbazine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1311409],
      "conceptName": ["Dacarbazine"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    }
  },
  {
    "conceptId": [35806440],
    "regimenName": ["Vindesine monotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Vindesine": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [19008336],
      "conceptName": ["Vindesine"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Dacarbazine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311409],
      "conceptName": ["Dacarbazine"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Bleomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1329241],
      "conceptName": ["Bleomycin"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Epirubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344354],
      "conceptName": ["Epirubicin"]
    },
    "Carboplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344905],
      "conceptName": ["Carboplatin"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Mitomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1389036],
      "conceptName": ["Mitomycin"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Ifosfamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    },
    "Teniposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19136750],
      "conceptName": ["Teniposide"]
    },
    "ranimustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [35197850],
      "conceptName": ["ranimustine"]
    },
    "Cytarabine liposome": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [40175460],
      "conceptName": ["Cytarabine liposome"]
    }
  },
  {
    "conceptId": [35804557],
    "regimenName": ["Capecitabine and Gemcitabine"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "gemcitabine": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1314924],
      "conceptName": ["gemcitabine"]
    },
    "capecitabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1337620],
      "conceptName": ["capecitabine"]
    },
    "docetaxel": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1315942],
      "conceptName": ["docetaxel"]
    }
  },
  {
    "conceptId": [35805352],
    "regimenName": ["Docetaxel, Fluorouracil, RT"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "docetaxel": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1315942],
      "conceptName": ["docetaxel"]
    },
    "Fluorouracil": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "oxaliplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1318011],
      "conceptName": ["oxaliplatin"]
    },
    "Carboplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344905],
      "conceptName": ["Carboplatin"]
    },
    "hydroxyurea": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1377141],
      "conceptName": ["hydroxyurea"]
    },
    "Leucovorin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1388796],
      "conceptName": ["Leucovorin"]
    },
    "bevacizumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397141],
      "conceptName": ["bevacizumab"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    }
  },
  {
    "conceptId": [35804011],
    "regimenName": ["Melphalan monotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Melphalan": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1301267],
      "conceptName": ["Melphalan"]
    },
    "Fluorouracil": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "alemtuzumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1312706],
      "conceptName": ["alemtuzumab"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Busulfan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1333357],
      "conceptName": ["Busulfan"]
    },
    "bortezomib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1336825],
      "conceptName": ["bortezomib"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Carmustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350066],
      "conceptName": ["Carmustine"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "fludarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1395557],
      "conceptName": ["fludarabine"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "Tamoxifen": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1436678],
      "conceptName": ["Tamoxifen"]
    },
    "Methylprednisolone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1506270],
      "conceptName": ["Methylprednisolone"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "prednisolone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1550557],
      "conceptName": ["prednisolone"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "bendamustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19015523],
      "conceptName": ["bendamustine"]
    },
    "lenalidomide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19026972],
      "conceptName": ["lenalidomide"]
    },
    "clofarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19054821],
      "conceptName": ["clofarabine"]
    },
    "ibritumomab tiuxetan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19068830],
      "conceptName": ["ibritumomab tiuxetan"]
    },
    "Thalidomide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19137042],
      "conceptName": ["Thalidomide"]
    },
    "daratumumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [35605744],
      "conceptName": ["daratumumab"]
    },
    "Fotemustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [36879099],
      "conceptName": ["Fotemustine"]
    },
    "carfilzomib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [42873638],
      "conceptName": ["carfilzomib"]
    }
  },
  {
    "conceptId": [35806118],
    "regimenName": ["Ipilimumab monotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "ipilimumab": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [40238188],
      "conceptName": ["ipilimumab"]
    },
    "Dacarbazine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311409],
      "conceptName": ["Dacarbazine"]
    },
    "Carboplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344905],
      "conceptName": ["Carboplatin"]
    },
    "Paclitaxel": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1378382],
      "conceptName": ["Paclitaxel"]
    },
    "nivolumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [45892628],
      "conceptName": ["nivolumab"]
    }
  },
  {
    "conceptId": [35803457],
    "regimenName": ["FLAG-Ida"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Idarubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [19078097],
      "conceptName": ["Idarubicin"]
    },
    "lenograstim": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [19009705],
      "conceptName": ["lenograstim"]
    },
    "Cytarabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Filgrastim": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1304850],
      "conceptName": ["Filgrastim"]
    },
    "fludarabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1395557],
      "conceptName": ["fludarabine"]
    }
  },
  {
    "conceptId": [35806323],
    "regimenName": ["Carfilzomib and Panobinostat"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "panobinostat": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [46221435],
      "conceptName": ["panobinostat"]
    },
    "carfilzomib": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [42873638],
      "conceptName": ["carfilzomib"]
    }
  },
  {
    "conceptId": [35806057],
    "regimenName": ["MRD"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "lenalidomide": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [19026972],
      "conceptName": ["lenalidomide"]
    },
    "Melphalan": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1301267],
      "conceptName": ["Melphalan"]
    },
    "Dexamethasone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "bortezomib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1336825],
      "conceptName": ["bortezomib"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    }
  },
  {
    "conceptId": [35806309],
    "regimenName": ["Kd"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "carfilzomib": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [42873638],
      "conceptName": ["carfilzomib"]
    },
    "Dexamethasone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "lenalidomide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19026972],
      "conceptName": ["lenalidomide"]
    },
    "Thalidomide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19137042],
      "conceptName": ["Thalidomide"]
    },
    "daratumumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [35605744],
      "conceptName": ["daratumumab"]
    },
    "pomalidomide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [43014237],
      "conceptName": ["pomalidomide"]
    }
  },
  {
    "conceptId": [35101642],
    "regimenName": ["mFOLFOX7 (L-Leucovorin)"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "oxaliplatin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1318011],
      "conceptName": ["oxaliplatin"]
    },
    "levoleucovorin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [40168303],
      "conceptName": ["levoleucovorin"]
    },
    "Fluorouracil": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "cetuximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1315411],
      "conceptName": ["cetuximab"]
    },
    "irinotecan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1367268],
      "conceptName": ["irinotecan"]
    },
    "bevacizumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397141],
      "conceptName": ["bevacizumab"]
    }
  },
  {
    "conceptId": [35101640],
    "regimenName": ["TH (Taxotere/SC)"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "docetaxel": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1315942],
      "conceptName": ["docetaxel"]
    },
    "Fluorouracil": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "gemcitabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314924],
      "conceptName": ["gemcitabine"]
    },
    "cetuximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1315411],
      "conceptName": ["cetuximab"]
    },
    "oxaliplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1318011],
      "conceptName": ["oxaliplatin"]
    },
    "capecitabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1337620],
      "conceptName": ["capecitabine"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Epirubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344354],
      "conceptName": ["Epirubicin"]
    },
    "bicalutamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344381],
      "conceptName": ["bicalutamide"]
    },
    "Carboplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344905],
      "conceptName": ["Carboplatin"]
    },
    "Estramustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1349025],
      "conceptName": ["Estramustine"]
    },
    "Hyaluronidase / trastuzumab Injection [Herceptin Hylecta]": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1366689],
      "conceptName": ["Hyaluronidase / trastuzumab Injection [Herceptin Hylecta]"]
    },
    "irinotecan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1367268],
      "conceptName": ["irinotecan"]
    },
    "hydroxyurea": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1377141],
      "conceptName": ["hydroxyurea"]
    },
    "trastuzumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1387104],
      "conceptName": ["trastuzumab"]
    },
    "Leucovorin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1388796],
      "conceptName": ["Leucovorin"]
    },
    "bevacizumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397141],
      "conceptName": ["bevacizumab"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "prednisolone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1550557],
      "conceptName": ["prednisolone"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "nedaplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [35198201],
      "conceptName": ["nedaplatin"]
    },
    "Vandetanib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [40238052],
      "conceptName": ["Vandetanib"]
    },
    "pertuzumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [42801287],
      "conceptName": ["pertuzumab"]
    },
    "ramucirumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [44818489],
      "conceptName": ["ramucirumab"]
    }
  },
  {
    "conceptId": [35804058],
    "regimenName": ["Mercaptopurine, Methotrexate, Vincristine"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Methotrexate": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "mercaptopurine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1436650],
      "conceptName": ["mercaptopurine"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Thioguanine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1437379],
      "conceptName": ["Thioguanine"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "ASPARAGINASE": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19012585],
      "conceptName": ["ASPARAGINASE"]
    }
  },
  {
    "conceptId": [35806122],
    "regimenName": ["ABC"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Carboplatin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1344905],
      "conceptName": ["Carboplatin"]
    },
    "Paclitaxel": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1378382],
      "conceptName": ["Paclitaxel"]
    },
    "bevacizumab": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1397141],
      "conceptName": ["bevacizumab"]
    },
    "atezolizumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [42629079],
      "conceptName": ["atezolizumab"]
    }
  },
  {
    "conceptId": [35804775],
    "regimenName": ["mFOLFOX7"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "oxaliplatin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1318011],
      "conceptName": ["oxaliplatin"]
    },
    "Leucovorin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1388796],
      "conceptName": ["Leucovorin"]
    },
    "Fluorouracil": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "gemcitabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314924],
      "conceptName": ["gemcitabine"]
    },
    "cetuximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1315411],
      "conceptName": ["cetuximab"]
    },
    "docetaxel": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1315942],
      "conceptName": ["docetaxel"]
    },
    "irinotecan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1367268],
      "conceptName": ["irinotecan"]
    },
    "bevacizumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397141],
      "conceptName": ["bevacizumab"]
    },
    "panitumumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19100985],
      "conceptName": ["panitumumab"]
    }
  },
  {
    "conceptId": [35803512],
    "regimenName": ["IDAC and Sorafenib"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Cytarabine": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "sorafenib": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1363387],
      "conceptName": ["sorafenib"]
    },
    "Daunorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311799],
      "conceptName": ["Daunorubicin"]
    },
    "Idarubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078097],
      "conceptName": ["Idarubicin"]
    }
  },
  {
    "conceptId": [35806837],
    "regimenName": ["ADT and Abiraterone"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "abiraterone": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [40239056],
      "conceptName": ["abiraterone"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    }
  },
  {
    "conceptId": [35803692],
    "regimenName": ["Irinotecan monotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "irinotecan": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1367268],
      "conceptName": ["irinotecan"]
    },
    "Fluorouracil": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Dactinomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311443],
      "conceptName": ["Dactinomycin"]
    },
    "gemcitabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314924],
      "conceptName": ["gemcitabine"]
    },
    "cetuximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1315411],
      "conceptName": ["cetuximab"]
    },
    "docetaxel": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1315942],
      "conceptName": ["docetaxel"]
    },
    "oxaliplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1318011],
      "conceptName": ["oxaliplatin"]
    },
    "capecitabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1337620],
      "conceptName": ["capecitabine"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "temozolomide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1341149],
      "conceptName": ["temozolomide"]
    },
    "Carboplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344905],
      "conceptName": ["Carboplatin"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Hyaluronidase / trastuzumab Injection [Herceptin Hylecta]": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1366689],
      "conceptName": ["Hyaluronidase / trastuzumab Injection [Herceptin Hylecta]"]
    },
    "Leucovorin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1388796],
      "conceptName": ["Leucovorin"]
    },
    "Mitomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1389036],
      "conceptName": ["Mitomycin"]
    },
    "bevacizumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397141],
      "conceptName": ["bevacizumab"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "Ifosfamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    },
    "panitumumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19100985],
      "conceptName": ["panitumumab"]
    },
    "levoleucovorin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [40168303],
      "conceptName": ["levoleucovorin"]
    },
    "aflibercept": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [40244266],
      "conceptName": ["aflibercept"]
    },
    "ramucirumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [44818489],
      "conceptName": ["ramucirumab"]
    },
    "dinutuximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [46221699],
      "conceptName": ["dinutuximab"]
    }
  },
  {
    "conceptId": [35806635],
    "regimenName": ["CMED"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Methotrexate": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Dexamethasone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "Etoposide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "mercaptopurine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1436650],
      "conceptName": ["mercaptopurine"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Vindesine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008336],
      "conceptName": ["Vindesine"]
    },
    "ASPARAGINASE": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19012585],
      "conceptName": ["ASPARAGINASE"]
    },
    "Ifosfamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    },
    "Teniposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19136750],
      "conceptName": ["Teniposide"]
    }
  },
  {
    "conceptId": [35805093],
    "regimenName": ["CHOP-BCG"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Prednisone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "BCG, Live, Tice Strain": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [19086176],
      "conceptName": ["BCG, Live, Tice Strain"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    }
  },
  {
    "conceptId": [35803439],
    "regimenName": ["5 plus 2d"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Cytarabine": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Daunorubicin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1311799],
      "conceptName": ["Daunorubicin"]
    },
    "Tretinoin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [903643],
      "conceptName": ["Tretinoin"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Azacitidine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314865],
      "conceptName": ["Azacitidine"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "glasdegib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1355795],
      "conceptName": ["glasdegib"]
    },
    "sorafenib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1363387],
      "conceptName": ["sorafenib"]
    },
    "nilotinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1394023],
      "conceptName": ["nilotinib"]
    },
    "mercaptopurine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1436650],
      "conceptName": ["mercaptopurine"]
    },
    "Thioguanine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1437379],
      "conceptName": ["Thioguanine"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "prednisolone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1550557],
      "conceptName": ["prednisolone"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "midostaurin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1594003],
      "conceptName": ["midostaurin"]
    },
    "ASPARAGINASE": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19012585],
      "conceptName": ["ASPARAGINASE"]
    },
    "Cladribine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19054825],
      "conceptName": ["Cladribine"]
    },
    "Teniposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19136750],
      "conceptName": ["Teniposide"]
    },
    "Gemtuzumab ozogamicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [42799711],
      "conceptName": ["Gemtuzumab ozogamicin"]
    },
    "omacetaxine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [45775576],
      "conceptName": ["omacetaxine"]
    }
  },
  {
    "conceptId": [35805982],
    "regimenName": ["Etoposide, Vinblastine, Prednisone"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Prednisone": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Vinblastine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [19008264],
      "conceptName": ["Vinblastine"]
    },
    "Etoposide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Mitoxantrone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1309188],
      "conceptName": ["Mitoxantrone"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Bleomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1329241],
      "conceptName": ["Bleomycin"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Procarbazine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1351779],
      "conceptName": ["Procarbazine"]
    },
    "Chlorambucil": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1390051],
      "conceptName": ["Chlorambucil"]
    },
    "Mechlorethamine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1394337],
      "conceptName": ["Mechlorethamine"]
    }
  },
  {
    "conceptId": [35805458],
    "regimenName": ["VAdCA/IE"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Dactinomycin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1311443],
      "conceptName": ["Dactinomycin"]
    },
    "Ifosfamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Etoposide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "irinotecan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1367268],
      "conceptName": ["irinotecan"]
    }
  },
  {
    "conceptId": [35805358],
    "regimenName": ["Carboplatin, Docetaxel, Fluorouracil"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Carboplatin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1344905],
      "conceptName": ["Carboplatin"]
    },
    "docetaxel": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1315942],
      "conceptName": ["docetaxel"]
    },
    "Fluorouracil": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    }
  },
  {
    "conceptId": [35804297],
    "regimenName": ["Fulvestrant and Palbociclib"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "palbociclib": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [45892075],
      "conceptName": ["palbociclib"]
    },
    "fulvestrant": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1304044],
      "conceptName": ["fulvestrant"]
    }
  },
  {
    "conceptId": [35804763],
    "regimenName": ["Hepatic arterial chemotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Floxuridine": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1355509],
      "conceptName": ["Floxuridine"]
    }
  },
  {
    "conceptId": [35805752],
    "regimenName": ["dmCODOX-M/IVAC - Modified Magrath"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Methotrexate": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Ifosfamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    },
    "Cytarabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Etoposide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Vindesine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008336],
      "conceptName": ["Vindesine"]
    },
    "Teniposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19136750],
      "conceptName": ["Teniposide"]
    }
  },
  {
    "conceptId": [35804377],
    "regimenName": ["CYM"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Methotrexate": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Cytarabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "inotuzumab ozogamicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [794068],
      "conceptName": ["inotuzumab ozogamicin"]
    },
    "Fluorouracil": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "imatinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1304107],
      "conceptName": ["imatinib"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Daunorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311799],
      "conceptName": ["Daunorubicin"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Bleomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1329241],
      "conceptName": ["Bleomycin"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "dasatinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1358436],
      "conceptName": ["dasatinib"]
    },
    "nilotinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1394023],
      "conceptName": ["nilotinib"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "mercaptopurine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1436650],
      "conceptName": ["mercaptopurine"]
    },
    "Thioguanine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1437379],
      "conceptName": ["Thioguanine"]
    },
    "Methylprednisolone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1506270],
      "conceptName": ["Methylprednisolone"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "prednisolone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1550557],
      "conceptName": ["prednisolone"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Vindesine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008336],
      "conceptName": ["Vindesine"]
    },
    "everolimus": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19011440],
      "conceptName": ["everolimus"]
    },
    "ASPARAGINASE": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19012585],
      "conceptName": ["ASPARAGINASE"]
    },
    "doxorubicin liposome": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19051649],
      "conceptName": ["doxorubicin liposome"]
    },
    "Idarubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078097],
      "conceptName": ["Idarubicin"]
    },
    "Ifosfamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    },
    "Norethandrolone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19128219],
      "conceptName": ["Norethandrolone"]
    },
    "Teniposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19136750],
      "conceptName": ["Teniposide"]
    },
    "Thiotepa": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19137385],
      "conceptName": ["Thiotepa"]
    },
    "Cytarabine liposome": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [40175460],
      "conceptName": ["Cytarabine liposome"]
    },
    "ponatinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [43013182],
      "conceptName": ["ponatinib"]
    }
  },
  {
    "conceptId": [35805643],
    "regimenName": ["FM"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "fludarabine": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1395557],
      "conceptName": ["fludarabine"]
    },
    "Mitoxantrone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1309188],
      "conceptName": ["Mitoxantrone"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    }
  },
  {
    "conceptId": [35805805],
    "regimenName": ["MOPP-ABV"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Bleomycin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1329241],
      "conceptName": ["Bleomycin"]
    },
    "Prednisone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Vinblastine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [19008264],
      "conceptName": ["Vinblastine"]
    },
    "Procarbazine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1351779],
      "conceptName": ["Procarbazine"]
    },
    "Mechlorethamine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1394337],
      "conceptName": ["Mechlorethamine"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Dacarbazine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311409],
      "conceptName": ["Dacarbazine"]
    }
  },
  {
    "conceptId": [35804055],
    "regimenName": ["Augmented BFM consolidation"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "ASPARAGINASE": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [19012585],
      "conceptName": ["ASPARAGINASE"]
    },
    "Cytarabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "mercaptopurine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1436650],
      "conceptName": ["mercaptopurine"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Thioguanine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1437379],
      "conceptName": ["Thioguanine"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    }
  },
  {
    "conceptId": [35804423],
    "regimenName": ["MVBP"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Methotrexate": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Carmustine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1350066],
      "conceptName": ["Carmustine"]
    },
    "Methylprednisolone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1506270],
      "conceptName": ["Methylprednisolone"]
    },
    "Etoposide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    }
  },
  {
    "conceptId": [35805821],
    "regimenName": ["Brentuximab vedotin and Dacarbazine"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "brentuximab vedotin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [40241969],
      "conceptName": ["brentuximab vedotin"]
    },
    "Dacarbazine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1311409],
      "conceptName": ["Dacarbazine"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Vinblastine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008264],
      "conceptName": ["Vinblastine"]
    }
  },
  {
    "conceptId": [35806578],
    "regimenName": ["Doxorubicin and Streptozocin"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Streptozocin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [19136210],
      "conceptName": ["Streptozocin"]
    },
    "Fluorouracil": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "Bleomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1329241],
      "conceptName": ["Bleomycin"]
    },
    "Lomustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1391846],
      "conceptName": ["Lomustine"]
    },
    "Vinblastine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008264],
      "conceptName": ["Vinblastine"]
    }
  },
  {
    "conceptId": [35807016],
    "regimenName": ["C-BOP"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Carboplatin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1344905],
      "conceptName": ["Carboplatin"]
    },
    "Bleomycin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1329241],
      "conceptName": ["Bleomycin"]
    },
    "Cisplatin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    }
  },
  {
    "conceptId": [35803572],
    "regimenName": ["Carboplatin and Paclitaxel"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Carboplatin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1344905],
      "conceptName": ["Carboplatin"]
    },
    "Paclitaxel": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1378382],
      "conceptName": ["Paclitaxel"]
    },
    "gemcitabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314924],
      "conceptName": ["gemcitabine"]
    },
    "capecitabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1337620],
      "conceptName": ["capecitabine"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "trastuzumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1387104],
      "conceptName": ["trastuzumab"]
    },
    "bevacizumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397141],
      "conceptName": ["bevacizumab"]
    },
    "ipilimumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [40238188],
      "conceptName": ["ipilimumab"]
    },
    "atezolizumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [42629079],
      "conceptName": ["atezolizumab"]
    },
    "pembrolizumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [45775965],
      "conceptName": ["pembrolizumab"]
    },
    "olaparib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [45892579],
      "conceptName": ["olaparib"]
    }
  },
  {
    "conceptId": [35805634],
    "regimenName": ["G-CHOP"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "obinutuzumab": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [44507676],
      "conceptName": ["obinutuzumab"]
    },
    "Prednisone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    }
  },
  {
    "conceptId": [35803676],
    "regimenName": ["Cisplatin and Fluorouracil"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Cisplatin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "Fluorouracil": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "gemcitabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314924],
      "conceptName": ["gemcitabine"]
    },
    "cetuximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1315411],
      "conceptName": ["cetuximab"]
    },
    "docetaxel": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1315942],
      "conceptName": ["docetaxel"]
    },
    "capecitabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1337620],
      "conceptName": ["capecitabine"]
    },
    "Epirubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344354],
      "conceptName": ["Epirubicin"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "hydroxyurea": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1377141],
      "conceptName": ["hydroxyurea"]
    },
    "Paclitaxel": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1378382],
      "conceptName": ["Paclitaxel"]
    },
    "trastuzumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1387104],
      "conceptName": ["trastuzumab"]
    },
    "Leucovorin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1388796],
      "conceptName": ["Leucovorin"]
    },
    "Mitomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1389036],
      "conceptName": ["Mitomycin"]
    },
    "bevacizumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397141],
      "conceptName": ["bevacizumab"]
    },
    "doxorubicin liposome": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19051649],
      "conceptName": ["doxorubicin liposome"]
    },
    "panitumumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19100985],
      "conceptName": ["panitumumab"]
    }
  },
  {
    "conceptId": [35803693],
    "regimenName": ["Irinotecan and Bevacizumab"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "bevacizumab": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1397141],
      "conceptName": ["bevacizumab"]
    },
    "irinotecan": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1367268],
      "conceptName": ["irinotecan"]
    },
    "Fluorouracil": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "oxaliplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1318011],
      "conceptName": ["oxaliplatin"]
    },
    "capecitabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1337620],
      "conceptName": ["capecitabine"]
    },
    "Hyaluronidase / trastuzumab Injection [Herceptin Hylecta]": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1366689],
      "conceptName": ["Hyaluronidase / trastuzumab Injection [Herceptin Hylecta]"]
    },
    "Leucovorin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1388796],
      "conceptName": ["Leucovorin"]
    },
    "levoleucovorin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [40168303],
      "conceptName": ["levoleucovorin"]
    }
  },
  {
    "conceptId": [35806428],
    "regimenName": ["Dacomitinib monotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "dacomitinib": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [35200803],
      "conceptName": ["dacomitinib"]
    }
  },
  {
    "conceptId": [35804383],
    "regimenName": ["R-CODOX-M/R-IVAC (Doxil substituted)"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Methotrexate": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "doxorubicin liposome": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [19051649],
      "conceptName": ["doxorubicin liposome"]
    },
    "Ifosfamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    },
    "rituximab": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Cytarabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Etoposide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    }
  },
  {
    "conceptId": [35806653],
    "regimenName": ["PAD/VCD"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "doxorubicin liposome": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [19051649],
      "conceptName": ["doxorubicin liposome"]
    },
    "bortezomib": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1336825],
      "conceptName": ["bortezomib"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Dexamethasone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    }
  },
  {
    "conceptId": [35806981],
    "regimenName": ["L-asparaginase monotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "ASPARAGINASE": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [19012585],
      "conceptName": ["ASPARAGINASE"]
    },
    "imatinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1304107],
      "conceptName": ["imatinib"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Daunorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311799],
      "conceptName": ["Daunorubicin"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "gemcitabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314924],
      "conceptName": ["gemcitabine"]
    },
    "oxaliplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1318011],
      "conceptName": ["oxaliplatin"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Mesna": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1354698],
      "conceptName": ["Mesna"]
    },
    "mercaptopurine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1436650],
      "conceptName": ["mercaptopurine"]
    },
    "Thioguanine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1437379],
      "conceptName": ["Thioguanine"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "prednisolone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1550557],
      "conceptName": ["prednisolone"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Ifosfamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    },
    "Teniposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19136750],
      "conceptName": ["Teniposide"]
    }
  },
  {
    "conceptId": [35806304],
    "regimenName": ["Total Therapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Cisplatin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "Melphalan": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1301267],
      "conceptName": ["Melphalan"]
    },
    "Thalidomide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [19137042],
      "conceptName": ["Thalidomide"]
    },
    "bortezomib": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1336825],
      "conceptName": ["bortezomib"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Dexamethasone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "Etoposide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    }
  },
  {
    "conceptId": [35805825],
    "regimenName": ["VEPEMB"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Bleomycin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1329241],
      "conceptName": ["Bleomycin"]
    },
    "Prednisone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Vinblastine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [19008264],
      "conceptName": ["Vinblastine"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Procarbazine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1351779],
      "conceptName": ["Procarbazine"]
    },
    "Mitoxantrone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1309188],
      "conceptName": ["Mitoxantrone"]
    },
    "Etoposide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    }
  },
  {
    "conceptId": [35803523],
    "regimenName": ["Panobinostat monotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "panobinostat": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [46221435],
      "conceptName": ["panobinostat"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "bortezomib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1336825],
      "conceptName": ["bortezomib"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "lenalidomide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19026972],
      "conceptName": ["lenalidomide"]
    },
    "Idarubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078097],
      "conceptName": ["Idarubicin"]
    },
    "Thalidomide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19137042],
      "conceptName": ["Thalidomide"]
    },
    "carfilzomib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [42873638],
      "conceptName": ["carfilzomib"]
    }
  },
  {
    "conceptId": [35804258],
    "regimenName": ["Abemaciclib monotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "abemaciclib": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [792649],
      "conceptName": ["abemaciclib"]
    },
    "fulvestrant": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1304044],
      "conceptName": ["fulvestrant"]
    },
    "letrozole": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1315946],
      "conceptName": ["letrozole"]
    },
    "anastrozole": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1348265],
      "conceptName": ["anastrozole"]
    }
  },
  {
    "conceptId": [35804316],
    "regimenName": ["Capecitabine and Neratinib"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "neratinib": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [793846],
      "conceptName": ["neratinib"]
    },
    "capecitabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1337620],
      "conceptName": ["capecitabine"]
    }
  },
  {
    "conceptId": [35805769],
    "regimenName": ["Fluorouracil, Hydroxyurea, RT"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Fluorouracil": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "hydroxyurea": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1377141],
      "conceptName": ["hydroxyurea"]
    },
    "docetaxel": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1315942],
      "conceptName": ["docetaxel"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    }
  },
  {
    "conceptId": [35806111],
    "regimenName": ["Carboplatin, Cyclophosphamide, Etoposide, Methotrexate, Vincristine"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Carboplatin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1344905],
      "conceptName": ["Carboplatin"]
    },
    "Methotrexate": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Etoposide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    }
  },
  {
    "conceptId": [35803688],
    "regimenName": ["Bevacizumab monotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "bevacizumab": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1397141],
      "conceptName": ["bevacizumab"]
    },
    "Fluorouracil": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "pemetrexed": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1304919],
      "conceptName": ["pemetrexed"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "gemcitabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314924],
      "conceptName": ["gemcitabine"]
    },
    "docetaxel": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1315942],
      "conceptName": ["docetaxel"]
    },
    "letrozole": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1315946],
      "conceptName": ["letrozole"]
    },
    "oxaliplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1318011],
      "conceptName": ["oxaliplatin"]
    },
    "erlotinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1325363],
      "conceptName": ["erlotinib"]
    },
    "capecitabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1337620],
      "conceptName": ["capecitabine"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "temozolomide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1341149],
      "conceptName": ["temozolomide"]
    },
    "vinorelbine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1343346],
      "conceptName": ["vinorelbine"]
    },
    "Epirubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344354],
      "conceptName": ["Epirubicin"]
    },
    "Carboplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344905],
      "conceptName": ["Carboplatin"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Hyaluronidase / trastuzumab Injection [Herceptin Hylecta]": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1366689],
      "conceptName": ["Hyaluronidase / trastuzumab Injection [Herceptin Hylecta]"]
    },
    "irinotecan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1367268],
      "conceptName": ["irinotecan"]
    },
    "Paclitaxel": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1378382],
      "conceptName": ["Paclitaxel"]
    },
    "Topotecan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1378509],
      "conceptName": ["Topotecan"]
    },
    "Interferon Alfa-2a": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1379969],
      "conceptName": ["Interferon Alfa-2a"]
    },
    "trastuzumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1387104],
      "conceptName": ["trastuzumab"]
    },
    "Leucovorin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1388796],
      "conceptName": ["Leucovorin"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "doxorubicin liposome": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19051649],
      "conceptName": ["doxorubicin liposome"]
    },
    "Myocet": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [21017157],
      "conceptName": ["Myocet"]
    },
    "levoleucovorin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [40168303],
      "conceptName": ["levoleucovorin"]
    },
    "atezolizumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [42629079],
      "conceptName": ["atezolizumab"]
    }
  },
  {
    "conceptId": [35803553],
    "regimenName": ["ATRA, Cytarabine, Daunorubicin"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Cytarabine": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Tretinoin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [903643],
      "conceptName": ["Tretinoin"]
    },
    "Daunorubicin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1311799],
      "conceptName": ["Daunorubicin"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    }
  },
  {
    "conceptId": [35803579],
    "regimenName": ["Erlotinib and Bevacizumab"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "bevacizumab": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1397141],
      "conceptName": ["bevacizumab"]
    },
    "erlotinib": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1325363],
      "conceptName": ["erlotinib"]
    }
  },
  {
    "conceptId": [35804231],
    "regimenName": ["CMFT"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Methotrexate": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Tamoxifen": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1436678],
      "conceptName": ["Tamoxifen"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Fluorouracil": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    }
  },
  {
    "conceptId": [35804818],
    "regimenName": ["Bleomycin and Cisplatin"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Bleomycin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1329241],
      "conceptName": ["Bleomycin"]
    },
    "Cisplatin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Dactinomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311443],
      "conceptName": ["Dactinomycin"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Carboplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344905],
      "conceptName": ["Carboplatin"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Mesna": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1354698],
      "conceptName": ["Mesna"]
    },
    "Vinblastine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008264],
      "conceptName": ["Vinblastine"]
    },
    "Ifosfamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    }
  },
  {
    "conceptId": [35803616],
    "regimenName": ["BEAM"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Carmustine": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1350066],
      "conceptName": ["Carmustine"]
    },
    "Melphalan": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1301267],
      "conceptName": ["Melphalan"]
    },
    "Cytarabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Etoposide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "ibritumomab tiuxetan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19068830],
      "conceptName": ["ibritumomab tiuxetan"]
    }
  },
  {
    "conceptId": [35806903],
    "regimenName": ["Doxorubicin and Gemcitabine"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "gemcitabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1314924],
      "conceptName": ["gemcitabine"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Vinblastine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008264],
      "conceptName": ["Vinblastine"]
    }
  },
  {
    "conceptId": [35806095],
    "regimenName": ["BeRT"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "bendamustine": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [19015523],
      "conceptName": ["bendamustine"]
    },
    "rituximab": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "temsirolimus": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [19092845],
      "conceptName": ["temsirolimus"]
    }
  },
  {
    "conceptId": [35806594],
    "regimenName": ["Capecitabine and Erlotinib"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "erlotinib": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1325363],
      "conceptName": ["erlotinib"]
    },
    "capecitabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1337620],
      "conceptName": ["capecitabine"]
    }
  },
  {
    "conceptId": [35804566],
    "regimenName": ["Gemcitabine and Mitomycin"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Mitomycin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1389036],
      "conceptName": ["Mitomycin"]
    },
    "gemcitabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1314924],
      "conceptName": ["gemcitabine"]
    }
  },
  {
    "conceptId": [35804433],
    "regimenName": ["Topotecan monotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Topotecan": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1378509],
      "conceptName": ["Topotecan"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Paclitaxel": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1378382],
      "conceptName": ["Paclitaxel"]
    },
    "bevacizumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397141],
      "conceptName": ["bevacizumab"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "Ifosfamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    }
  },
  {
    "conceptId": [35805346],
    "regimenName": ["Capecitabine, Docetaxel, Oxaliplatin, RT"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "oxaliplatin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1318011],
      "conceptName": ["oxaliplatin"]
    },
    "docetaxel": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1315942],
      "conceptName": ["docetaxel"]
    },
    "capecitabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1337620],
      "conceptName": ["capecitabine"]
    }
  },
  {
    "conceptId": [35805457],
    "regimenName": ["VAdCA"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Dactinomycin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1311443],
      "conceptName": ["Dactinomycin"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "irinotecan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1367268],
      "conceptName": ["irinotecan"]
    },
    "Ifosfamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    }
  },
  {
    "conceptId": [35804352],
    "regimenName": ["CAF and MPA"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Fluorouracil": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "Medroxyprogesterone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1500211],
      "conceptName": ["Medroxyprogesterone"]
    }
  },
  {
    "conceptId": [35804420],
    "regimenName": ["Methotrexate and Rituximab"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Methotrexate": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "rituximab": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "temozolomide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1341149],
      "conceptName": ["temozolomide"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Procarbazine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1351779],
      "conceptName": ["Procarbazine"]
    },
    "Lomustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1391846],
      "conceptName": ["Lomustine"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "prednisolone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1550557],
      "conceptName": ["prednisolone"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Vindesine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008336],
      "conceptName": ["Vindesine"]
    },
    "doxorubicin liposome": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19051649],
      "conceptName": ["doxorubicin liposome"]
    },
    "Ifosfamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    },
    "Teniposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19136750],
      "conceptName": ["Teniposide"]
    },
    "Thiotepa": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19137385],
      "conceptName": ["Thiotepa"]
    },
    "Cytarabine liposome": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [40175460],
      "conceptName": ["Cytarabine liposome"]
    }
  },
  {
    "conceptId": [35804341],
    "regimenName": ["Levamisole monotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Levamisole": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1389464],
      "conceptName": ["Levamisole"]
    },
    "Fluorouracil": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "Leucovorin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1388796],
      "conceptName": ["Leucovorin"]
    }
  },
  {
    "conceptId": [35804411],
    "regimenName": ["BCNU/TT, then auto HSCT"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Carmustine": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1350066],
      "conceptName": ["Carmustine"]
    },
    "Thiotepa": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [19137385],
      "conceptName": ["Thiotepa"]
    }
  },
  {
    "conceptId": [35805060],
    "regimenName": ["R-EPOCH"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "rituximab": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Prednisone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Etoposide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "Vindesine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008336],
      "conceptName": ["Vindesine"]
    },
    "Ifosfamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    },
    "Teniposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19136750],
      "conceptName": ["Teniposide"]
    }
  },
  {
    "conceptId": [35807022],
    "regimenName": ["Cisplatin and Epirubicin"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Cisplatin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "Epirubicin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1344354],
      "conceptName": ["Epirubicin"]
    },
    "Fluorouracil": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "gemcitabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314924],
      "conceptName": ["gemcitabine"]
    },
    "capecitabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1337620],
      "conceptName": ["capecitabine"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Mesna": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1354698],
      "conceptName": ["Mesna"]
    },
    "Paclitaxel": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1378382],
      "conceptName": ["Paclitaxel"]
    },
    "Lomustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1391846],
      "conceptName": ["Lomustine"]
    },
    "Ifosfamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    }
  },
  {
    "conceptId": [35804207],
    "regimenName": ["Docetaxel and Bevacizumab"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "bevacizumab": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1397141],
      "conceptName": ["bevacizumab"]
    },
    "docetaxel": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1315942],
      "conceptName": ["docetaxel"]
    },
    "Fluorouracil": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "Leucovorin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1388796],
      "conceptName": ["Leucovorin"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    }
  },
  {
    "conceptId": [35805047],
    "regimenName": ["CBV, then auto HSCT"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Carmustine": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1350066],
      "conceptName": ["Carmustine"]
    },
    "rituximab": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Prednisone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Etoposide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    }
  },
  {
    "conceptId": [35101467],
    "regimenName": ["nab-Paclitaxel and Trastuzumab"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Paclitaxel": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1378382],
      "conceptName": ["Paclitaxel"]
    },
    "trastuzumab": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1387104],
      "conceptName": ["trastuzumab"]
    },
    "Carboplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344905],
      "conceptName": ["Carboplatin"]
    },
    "lapatinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1359548],
      "conceptName": ["lapatinib"]
    },
    "pertuzumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [42801287],
      "conceptName": ["pertuzumab"]
    }
  },
  {
    "conceptId": [35805467],
    "regimenName": ["MESA"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Methotrexate": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "pegaspargase": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1326481],
      "conceptName": ["pegaspargase"]
    },
    "Dexamethasone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "Etoposide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    }
  },
  {
    "conceptId": [35804075],
    "regimenName": ["HAM and Imatinib"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Cytarabine": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "imatinib": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1304107],
      "conceptName": ["imatinib"]
    },
    "Mitoxantrone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1309188],
      "conceptName": ["Mitoxantrone"]
    }
  },
  {
    "conceptId": [35804576],
    "regimenName": ["FCA"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "alemtuzumab": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1312706],
      "conceptName": ["alemtuzumab"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "fludarabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1395557],
      "conceptName": ["fludarabine"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    }
  },
  {
    "conceptId": [35806133],
    "regimenName": ["Ipilimumab, then Nivolumab"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "ipilimumab": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [40238188],
      "conceptName": ["ipilimumab"]
    },
    "nivolumab": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [45892628],
      "conceptName": ["nivolumab"]
    }
  },
  {
    "conceptId": [35804769],
    "regimenName": ["Fluorouracil monotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Fluorouracil": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "Melphalan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1301267],
      "conceptName": ["Melphalan"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Mitoxantrone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1309188],
      "conceptName": ["Mitoxantrone"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "gemcitabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314924],
      "conceptName": ["gemcitabine"]
    },
    "cetuximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1315411],
      "conceptName": ["cetuximab"]
    },
    "docetaxel": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1315942],
      "conceptName": ["docetaxel"]
    },
    "oxaliplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1318011],
      "conceptName": ["oxaliplatin"]
    },
    "capecitabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1337620],
      "conceptName": ["capecitabine"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Epirubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344354],
      "conceptName": ["Epirubicin"]
    },
    "Carboplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344905],
      "conceptName": ["Carboplatin"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "irinotecan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1367268],
      "conceptName": ["irinotecan"]
    },
    "Altretamine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1368823],
      "conceptName": ["Altretamine"]
    },
    "hydroxyurea": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1377141],
      "conceptName": ["hydroxyurea"]
    },
    "Paclitaxel": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1378382],
      "conceptName": ["Paclitaxel"]
    },
    "trastuzumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1387104],
      "conceptName": ["trastuzumab"]
    },
    "Leucovorin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1388796],
      "conceptName": ["Leucovorin"]
    },
    "Mitomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1389036],
      "conceptName": ["Mitomycin"]
    },
    "Levamisole": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1389464],
      "conceptName": ["Levamisole"]
    },
    "bevacizumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397141],
      "conceptName": ["bevacizumab"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "Tamoxifen": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1436678],
      "conceptName": ["Tamoxifen"]
    },
    "Medroxyprogesterone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1500211],
      "conceptName": ["Medroxyprogesterone"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "doxorubicin liposome": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19051649],
      "conceptName": ["doxorubicin liposome"]
    },
    "BCG, Live, Tice Strain": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19086176],
      "conceptName": ["BCG, Live, Tice Strain"]
    },
    "panitumumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19100985],
      "conceptName": ["panitumumab"]
    },
    "Streptozocin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19136210],
      "conceptName": ["Streptozocin"]
    },
    "Thiotepa": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19137385],
      "conceptName": ["Thiotepa"]
    },
    "irinotecan liposomal": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [35603068],
      "conceptName": ["irinotecan liposomal"]
    },
    "levoleucovorin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [40168303],
      "conceptName": ["levoleucovorin"]
    },
    "aflibercept": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [40244266],
      "conceptName": ["aflibercept"]
    },
    "ramucirumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [44818489],
      "conceptName": ["ramucirumab"]
    }
  },
  {
    "conceptId": [35804060],
    "regimenName": ["Augmented Hyper-CVAD and Asparaginase"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "pegaspargase": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1326481],
      "conceptName": ["pegaspargase"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Dexamethasone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    }
  },
  {
    "conceptId": [35804215],
    "regimenName": ["EP"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Paclitaxel": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1378382],
      "conceptName": ["Paclitaxel"]
    },
    "Epirubicin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1344354],
      "conceptName": ["Epirubicin"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    }
  },
  {
    "conceptId": [35804264],
    "regimenName": ["Doxorubicin pegylated liposomal and Bevacizumab"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "doxorubicin liposome": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [19051649],
      "conceptName": ["doxorubicin liposome"]
    },
    "bevacizumab": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1397141],
      "conceptName": ["bevacizumab"]
    }
  },
  {
    "conceptId": [35805338],
    "regimenName": ["EOF"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "oxaliplatin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1318011],
      "conceptName": ["oxaliplatin"]
    },
    "Epirubicin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1344354],
      "conceptName": ["Epirubicin"]
    },
    "Fluorouracil": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    }
  },
  {
    "conceptId": [35803542],
    "regimenName": ["IAP"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Idarubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [19078097],
      "conceptName": ["Idarubicin"]
    },
    "Cytarabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Pravastatin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1551860],
      "conceptName": ["Pravastatin"]
    }
  },
  {
    "conceptId": [35805059],
    "regimenName": ["R-DHAP/R-VIM"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Methotrexate": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Cisplatin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "Ifosfamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    },
    "rituximab": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Cytarabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Dexamethasone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "Etoposide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    }
  },
  {
    "conceptId": [35807172],
    "regimenName": ["Dactinomycin and Vincristine"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Dactinomycin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1311443],
      "conceptName": ["Dactinomycin"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "irinotecan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1367268],
      "conceptName": ["irinotecan"]
    },
    "Ifosfamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    }
  },
  {
    "conceptId": [35805334],
    "regimenName": ["Cisplatin, Etoposide, RT"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Cisplatin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "Etoposide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Fluorouracil": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "Melphalan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1301267],
      "conceptName": ["Melphalan"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Mitotane": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1309161],
      "conceptName": ["Mitotane"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Bleomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1329241],
      "conceptName": ["Bleomycin"]
    },
    "bortezomib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1336825],
      "conceptName": ["bortezomib"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Epirubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344354],
      "conceptName": ["Epirubicin"]
    },
    "irinotecan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1367268],
      "conceptName": ["irinotecan"]
    },
    "Leucovorin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1388796],
      "conceptName": ["Leucovorin"]
    },
    "Lomustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1391846],
      "conceptName": ["Lomustine"]
    },
    "bevacizumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397141],
      "conceptName": ["bevacizumab"]
    },
    "Methylprednisolone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1506270],
      "conceptName": ["Methylprednisolone"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "Vinblastine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008264],
      "conceptName": ["Vinblastine"]
    },
    "Ifosfamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    },
    "Thalidomide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19137042],
      "conceptName": ["Thalidomide"]
    },
    "ofatumumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [40167582],
      "conceptName": ["ofatumumab"]
    }
  },
  {
    "conceptId": [35806828],
    "regimenName": ["Flutamide, Leuprolide, RT"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Leuprolide": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1351541],
      "conceptName": ["Leuprolide"]
    },
    "Flutamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1356461],
      "conceptName": ["Flutamide"]
    }
  },
  {
    "conceptId": [35805116],
    "regimenName": ["VR-CHOP"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "rituximab": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "bortezomib": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1336825],
      "conceptName": ["bortezomib"]
    },
    "Prednisone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    }
  },
  {
    "conceptId": [35806830],
    "regimenName": ["Bicalutamide and Goserelin"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Goserelin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1366310],
      "conceptName": ["Goserelin"]
    },
    "bicalutamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1344381],
      "conceptName": ["bicalutamide"]
    }
  },
  {
    "conceptId": [35806085],
    "regimenName": ["R-M-CHOP"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Methotrexate": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "rituximab": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Prednisone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "Vindesine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008336],
      "conceptName": ["Vindesine"]
    },
    "Ifosfamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    },
    "Teniposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19136750],
      "conceptName": ["Teniposide"]
    }
  },
  {
    "conceptId": [35803999],
    "regimenName": ["Bortezomib and Melphalan"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Melphalan": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1301267],
      "conceptName": ["Melphalan"]
    },
    "bortezomib": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1336825],
      "conceptName": ["bortezomib"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "lenalidomide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19026972],
      "conceptName": ["lenalidomide"]
    },
    "Thalidomide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19137042],
      "conceptName": ["Thalidomide"]
    },
    "daratumumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [35605744],
      "conceptName": ["daratumumab"]
    }
  },
  {
    "conceptId": [35804635],
    "regimenName": ["Interferon alfa monotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Interferon Alfa-2b": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1380068],
      "conceptName": ["Interferon Alfa-2b"]
    },
    "Interferon Alfa-2a": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1379969],
      "conceptName": ["Interferon Alfa-2a"]
    },
    "imatinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1304107],
      "conceptName": ["imatinib"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "peginterferon alfa-2a": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1714165],
      "conceptName": ["peginterferon alfa-2a"]
    },
    "Thalidomide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19137042],
      "conceptName": ["Thalidomide"]
    }
  },
  {
    "conceptId": [35804318],
    "regimenName": ["Carboplatin and nab-Paclitaxel"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Carboplatin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1344905],
      "conceptName": ["Carboplatin"]
    },
    "Paclitaxel": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1378382],
      "conceptName": ["Paclitaxel"]
    },
    "gemcitabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314924],
      "conceptName": ["gemcitabine"]
    },
    "capecitabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1337620],
      "conceptName": ["capecitabine"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "trastuzumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1387104],
      "conceptName": ["trastuzumab"]
    },
    "bevacizumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397141],
      "conceptName": ["bevacizumab"]
    },
    "ipilimumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [40238188],
      "conceptName": ["ipilimumab"]
    },
    "atezolizumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [42629079],
      "conceptName": ["atezolizumab"]
    },
    "pembrolizumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [45775965],
      "conceptName": ["pembrolizumab"]
    },
    "olaparib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [45892579],
      "conceptName": ["olaparib"]
    }
  },
  {
    "conceptId": [35803565],
    "regimenName": ["Mercaptopurine and Methotrexate"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Methotrexate": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "mercaptopurine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1436650],
      "conceptName": ["mercaptopurine"]
    },
    "Tretinoin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [903643],
      "conceptName": ["Tretinoin"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Thioguanine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1437379],
      "conceptName": ["Thioguanine"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "prednisolone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1550557],
      "conceptName": ["prednisolone"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Vinblastine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008264],
      "conceptName": ["Vinblastine"]
    },
    "ASPARAGINASE": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19012585],
      "conceptName": ["ASPARAGINASE"]
    },
    "Idarubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078097],
      "conceptName": ["Idarubicin"]
    },
    "Norethandrolone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19128219],
      "conceptName": ["Norethandrolone"]
    }
  },
  {
    "conceptId": [35804003],
    "regimenName": ["CBV"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Carmustine": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1350066],
      "conceptName": ["Carmustine"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Etoposide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Mitoxantrone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1309188],
      "conceptName": ["Mitoxantrone"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    }
  },
  {
    "conceptId": [35806974],
    "regimenName": ["IGEV and G-CSF"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Ifosfamide": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    },
    "vinorelbine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1343346],
      "conceptName": ["vinorelbine"]
    },
    "gemcitabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1314924],
      "conceptName": ["gemcitabine"]
    },
    "prednisolone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1550557],
      "conceptName": ["prednisolone"]
    }
  },
  {
    "conceptId": [35804154],
    "regimenName": ["PGC"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Paclitaxel": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1378382],
      "conceptName": ["Paclitaxel"]
    },
    "Cisplatin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "gemcitabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1314924],
      "conceptName": ["gemcitabine"]
    }
  },
  {
    "conceptId": [35806902],
    "regimenName": ["Bevacizumab and Interferon alfa-2a"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "bevacizumab": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1397141],
      "conceptName": ["bevacizumab"]
    },
    "Interferon Alfa-2a": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1379969],
      "conceptName": ["Interferon Alfa-2a"]
    }
  },
  {
    "conceptId": [35804600],
    "regimenName": ["R-FCM"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "rituximab": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "fludarabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1395557],
      "conceptName": ["fludarabine"]
    },
    "Mitoxantrone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1309188],
      "conceptName": ["Mitoxantrone"]
    }
  },
  {
    "conceptId": [35804294],
    "regimenName": ["Abemaciclib and Fulvestrant"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "abemaciclib": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [792649],
      "conceptName": ["abemaciclib"]
    },
    "fulvestrant": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1304044],
      "conceptName": ["fulvestrant"]
    }
  },
  {
    "conceptId": [35805065],
    "regimenName": ["R-NIMP"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Ifosfamide": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    },
    "rituximab": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "vinorelbine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1343346],
      "conceptName": ["vinorelbine"]
    },
    "Prednisone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Mitoxantrone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1309188],
      "conceptName": ["Mitoxantrone"]
    }
  },
  {
    "conceptId": [35803698],
    "regimenName": ["CHOEP-21"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Prednisone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Etoposide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Bleomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1329241],
      "conceptName": ["Bleomycin"]
    },
    "Carboplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344905],
      "conceptName": ["Carboplatin"]
    },
    "Procarbazine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1351779],
      "conceptName": ["Procarbazine"]
    },
    "Mechlorethamine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1394337],
      "conceptName": ["Mechlorethamine"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "Vindesine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008336],
      "conceptName": ["Vindesine"]
    },
    "Ifosfamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    },
    "Teniposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19136750],
      "conceptName": ["Teniposide"]
    },
    "ranimustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [35197850],
      "conceptName": ["ranimustine"]
    }
  },
  {
    "conceptId": [35805033],
    "regimenName": ["R-MegaCHOP-14"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "rituximab": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Prednisone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "bortezomib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1336825],
      "conceptName": ["bortezomib"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "Hyaluronidase / rituximab Injection [Rituxan Hycela]": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1593155],
      "conceptName": ["Hyaluronidase / rituximab Injection [Rituxan Hycela]"]
    },
    "Vindesine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008336],
      "conceptName": ["Vindesine"]
    },
    "lenalidomide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19026972],
      "conceptName": ["lenalidomide"]
    },
    "Ifosfamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    },
    "Teniposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19136750],
      "conceptName": ["Teniposide"]
    }
  },
  {
    "conceptId": [35806055],
    "regimenName": ["M-DEX"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Melphalan": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1301267],
      "conceptName": ["Melphalan"]
    },
    "Dexamethasone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "bortezomib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1336825],
      "conceptName": ["bortezomib"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Carmustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350066],
      "conceptName": ["Carmustine"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "lenalidomide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19026972],
      "conceptName": ["lenalidomide"]
    },
    "Thalidomide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19137042],
      "conceptName": ["Thalidomide"]
    }
  },
  {
    "conceptId": [35806900],
    "regimenName": ["Axitinib and Avelumab"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "avelumab": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1593273],
      "conceptName": ["avelumab"]
    },
    "axitinib": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [42709322],
      "conceptName": ["axitinib"]
    }
  },
  {
    "conceptId": [35806134],
    "regimenName": ["Nivolumab, then Ipilimumab"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "ipilimumab": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [40238188],
      "conceptName": ["ipilimumab"]
    },
    "nivolumab": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [45892628],
      "conceptName": ["nivolumab"]
    }
  },
  {
    "conceptId": [35804016],
    "regimenName": ["Z-BEAM"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Carmustine": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1350066],
      "conceptName": ["Carmustine"]
    },
    "ibritumomab tiuxetan": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [19068830],
      "conceptName": ["ibritumomab tiuxetan"]
    },
    "Melphalan": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1301267],
      "conceptName": ["Melphalan"]
    },
    "rituximab": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Cytarabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Etoposide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    }
  },
  {
    "conceptId": [35806090],
    "regimenName": ["Melphalan and TBI, then auto HSCT"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Melphalan": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1301267],
      "conceptName": ["Melphalan"]
    },
    "Fluorouracil": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "alemtuzumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1312706],
      "conceptName": ["alemtuzumab"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Busulfan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1333357],
      "conceptName": ["Busulfan"]
    },
    "bortezomib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1336825],
      "conceptName": ["bortezomib"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Carmustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350066],
      "conceptName": ["Carmustine"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "fludarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1395557],
      "conceptName": ["fludarabine"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "Tamoxifen": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1436678],
      "conceptName": ["Tamoxifen"]
    },
    "Methylprednisolone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1506270],
      "conceptName": ["Methylprednisolone"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "prednisolone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1550557],
      "conceptName": ["prednisolone"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "bendamustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19015523],
      "conceptName": ["bendamustine"]
    },
    "lenalidomide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19026972],
      "conceptName": ["lenalidomide"]
    },
    "clofarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19054821],
      "conceptName": ["clofarabine"]
    },
    "ibritumomab tiuxetan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19068830],
      "conceptName": ["ibritumomab tiuxetan"]
    },
    "Thalidomide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19137042],
      "conceptName": ["Thalidomide"]
    },
    "daratumumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [35605744],
      "conceptName": ["daratumumab"]
    },
    "Fotemustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [36879099],
      "conceptName": ["Fotemustine"]
    },
    "carfilzomib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [42873638],
      "conceptName": ["carfilzomib"]
    }
  },
  {
    "conceptId": [35804603],
    "regimenName": ["Duvelisib monotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Duvelisib": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [35200763],
      "conceptName": ["Duvelisib"]
    }
  },
  {
    "conceptId": [35804793],
    "regimenName": ["FOLFOX4 and Cetuximab"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "oxaliplatin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1318011],
      "conceptName": ["oxaliplatin"]
    },
    "Leucovorin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1388796],
      "conceptName": ["Leucovorin"]
    },
    "cetuximab": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1315411],
      "conceptName": ["cetuximab"]
    },
    "Fluorouracil": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    }
  },
  {
    "conceptId": [35806317],
    "regimenName": ["Pomalidomide monotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "pomalidomide": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [43014237],
      "conceptName": ["pomalidomide"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "bortezomib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1336825],
      "conceptName": ["bortezomib"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "elotuzumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [35604032],
      "conceptName": ["elotuzumab"]
    },
    "daratumumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [35605744],
      "conceptName": ["daratumumab"]
    },
    "carfilzomib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [42873638],
      "conceptName": ["carfilzomib"]
    },
    "pembrolizumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [45775965],
      "conceptName": ["pembrolizumab"]
    }
  },
  {
    "conceptId": [35805042],
    "regimenName": ["R-MegaCHOP"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "rituximab": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Prednisone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "bortezomib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1336825],
      "conceptName": ["bortezomib"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "Hyaluronidase / rituximab Injection [Rituxan Hycela]": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1593155],
      "conceptName": ["Hyaluronidase / rituximab Injection [Rituxan Hycela]"]
    },
    "Vindesine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008336],
      "conceptName": ["Vindesine"]
    },
    "lenalidomide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19026972],
      "conceptName": ["lenalidomide"]
    },
    "Ifosfamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    },
    "Teniposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19136750],
      "conceptName": ["Teniposide"]
    }
  },
  {
    "conceptId": [35806490],
    "regimenName": ["Trabectedin monotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "trabectedin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [35603017],
      "conceptName": ["trabectedin"]
    },
    "doxorubicin liposome": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19051649],
      "conceptName": ["doxorubicin liposome"]
    }
  },
  {
    "conceptId": [35806423],
    "regimenName": ["Brigatinib monotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "brigatinib": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1594187],
      "conceptName": ["brigatinib"]
    }
  },
  {
    "conceptId": [35805091],
    "regimenName": ["CEOP"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Epirubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1344354],
      "conceptName": ["Epirubicin"]
    },
    "Prednisone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    }
  },
  {
    "conceptId": [35804805],
    "regimenName": ["Fluorouracil and Methotrexate"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Methotrexate": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Fluorouracil": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Epirubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344354],
      "conceptName": ["Epirubicin"]
    },
    "Altretamine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1368823],
      "conceptName": ["Altretamine"]
    },
    "Leucovorin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1388796],
      "conceptName": ["Leucovorin"]
    },
    "Tamoxifen": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1436678],
      "conceptName": ["Tamoxifen"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Thiotepa": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19137385],
      "conceptName": ["Thiotepa"]
    }
  },
  {
    "conceptId": [35806487],
    "regimenName": ["Doxorubicin pegylated liposomal and Trabectedin"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "trabectedin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [35603017],
      "conceptName": ["trabectedin"]
    },
    "doxorubicin liposome": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [19051649],
      "conceptName": ["doxorubicin liposome"]
    }
  },
  {
    "conceptId": [35804100],
    "regimenName": ["Dabrafenib and Trametinib"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "dabrafenib": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [43532299],
      "conceptName": ["dabrafenib"]
    },
    "trametinib": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [43532497],
      "conceptName": ["trametinib"]
    }
  },
  {
    "conceptId": [35804430],
    "regimenName": ["Bu/TT/Cy, then auto HSCT"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Busulfan": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1333357],
      "conceptName": ["Busulfan"]
    },
    "Thiotepa": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [19137385],
      "conceptName": ["Thiotepa"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    }
  },
  {
    "conceptId": [35805861],
    "regimenName": ["CVB"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Bleomycin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1329241],
      "conceptName": ["Bleomycin"]
    },
    "Lomustine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1391846],
      "conceptName": ["Lomustine"]
    },
    "Vinblastine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [19008264],
      "conceptName": ["Vinblastine"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    }
  },
  {
    "conceptId": [35805650],
    "regimenName": ["Vorinostat and Rituximab"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "rituximab": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Vorinostat": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1337651],
      "conceptName": ["Vorinostat"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    }
  },
  {
    "conceptId": [35803533],
    "regimenName": ["D-ZAPO"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Azacitidine": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1314865],
      "conceptName": ["Azacitidine"]
    },
    "Cytarabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Prednisone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Daunorubicin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1311799],
      "conceptName": ["Daunorubicin"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    }
  },
  {
    "conceptId": [35807021],
    "regimenName": ["Carboplatin and Etoposide, then auto HSCT"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Carboplatin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1344905],
      "conceptName": ["Carboplatin"]
    },
    "Etoposide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Mesna": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1354698],
      "conceptName": ["Mesna"]
    },
    "Paclitaxel": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1378382],
      "conceptName": ["Paclitaxel"]
    },
    "bevacizumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397141],
      "conceptName": ["bevacizumab"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "prednisolone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1550557],
      "conceptName": ["prednisolone"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Vindesine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008336],
      "conceptName": ["Vindesine"]
    },
    "lenalidomide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19026972],
      "conceptName": ["lenalidomide"]
    },
    "Ifosfamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    },
    "ranimustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [35197850],
      "conceptName": ["ranimustine"]
    },
    "ofatumumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [40167582],
      "conceptName": ["ofatumumab"]
    },
    "atezolizumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [42629079],
      "conceptName": ["atezolizumab"]
    }
  },
  {
    "conceptId": [35804306],
    "regimenName": ["Neratinib monotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "neratinib": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [793846],
      "conceptName": ["neratinib"]
    },
    "capecitabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1337620],
      "conceptName": ["capecitabine"]
    },
    "Paclitaxel": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1378382],
      "conceptName": ["Paclitaxel"]
    }
  },
  {
    "conceptId": [35804062],
    "regimenName": ["Daunorubicin, L-Asparaginase, Vincristine, Prednisone"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "ASPARAGINASE": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [19012585],
      "conceptName": ["ASPARAGINASE"]
    },
    "Prednisone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Daunorubicin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1311799],
      "conceptName": ["Daunorubicin"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "imatinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1304107],
      "conceptName": ["imatinib"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Teniposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19136750],
      "conceptName": ["Teniposide"]
    }
  },
  {
    "conceptId": [35804208],
    "regimenName": ["ddAC"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Fluorouracil": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "Melphalan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1301267],
      "conceptName": ["Melphalan"]
    },
    "imatinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1304107],
      "conceptName": ["imatinib"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Dacarbazine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311409],
      "conceptName": ["Dacarbazine"]
    },
    "Dactinomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311443],
      "conceptName": ["Dactinomycin"]
    },
    "alemtuzumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1312706],
      "conceptName": ["alemtuzumab"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "docetaxel": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1315942],
      "conceptName": ["docetaxel"]
    },
    "pegaspargase": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1326481],
      "conceptName": ["pegaspargase"]
    },
    "Bleomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1329241],
      "conceptName": ["Bleomycin"]
    },
    "bortezomib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1336825],
      "conceptName": ["bortezomib"]
    },
    "Carboplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344905],
      "conceptName": ["Carboplatin"]
    },
    "Carmustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350066],
      "conceptName": ["Carmustine"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Procarbazine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1351779],
      "conceptName": ["Procarbazine"]
    },
    "dasatinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1358436],
      "conceptName": ["dasatinib"]
    },
    "irinotecan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1367268],
      "conceptName": ["irinotecan"]
    },
    "Altretamine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1368823],
      "conceptName": ["Altretamine"]
    },
    "Paclitaxel": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1378382],
      "conceptName": ["Paclitaxel"]
    },
    "Topotecan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1378509],
      "conceptName": ["Topotecan"]
    },
    "Interferon Alfa-2b": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1380068],
      "conceptName": ["Interferon Alfa-2b"]
    },
    "trastuzumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1387104],
      "conceptName": ["trastuzumab"]
    },
    "Lomustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1391846],
      "conceptName": ["Lomustine"]
    },
    "Mechlorethamine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1394337],
      "conceptName": ["Mechlorethamine"]
    },
    "bevacizumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397141],
      "conceptName": ["bevacizumab"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "mercaptopurine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1436650],
      "conceptName": ["mercaptopurine"]
    },
    "Tamoxifen": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1436678],
      "conceptName": ["Tamoxifen"]
    },
    "Thioguanine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1437379],
      "conceptName": ["Thioguanine"]
    },
    "Medroxyprogesterone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1500211],
      "conceptName": ["Medroxyprogesterone"]
    },
    "Methylprednisolone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1506270],
      "conceptName": ["Methylprednisolone"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "prednisolone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1550557],
      "conceptName": ["prednisolone"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Hyaluronidase / rituximab Injection [Rituxan Hycela]": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1593155],
      "conceptName": ["Hyaluronidase / rituximab Injection [Rituxan Hycela]"]
    },
    "Vinblastine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008264],
      "conceptName": ["Vinblastine"]
    },
    "Vindesine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008336],
      "conceptName": ["Vindesine"]
    },
    "everolimus": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19011440],
      "conceptName": ["everolimus"]
    },
    "ASPARAGINASE": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19012585],
      "conceptName": ["ASPARAGINASE"]
    },
    "lenalidomide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19026972],
      "conceptName": ["lenalidomide"]
    },
    "denileukin diftitox": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19051642],
      "conceptName": ["denileukin diftitox"]
    },
    "iodine-131-tositumomab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19054997],
      "conceptName": ["iodine-131-tositumomab"]
    },
    "Ifosfamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    },
    "BCG, Live, Tice Strain": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19086176],
      "conceptName": ["BCG, Live, Tice Strain"]
    },
    "Teniposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19136750],
      "conceptName": ["Teniposide"]
    },
    "Thalidomide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19137042],
      "conceptName": ["Thalidomide"]
    },
    "ranimustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [35197850],
      "conceptName": ["ranimustine"]
    },
    "ofatumumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [40167582],
      "conceptName": ["ofatumumab"]
    },
    "brentuximab vedotin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [40241969],
      "conceptName": ["brentuximab vedotin"]
    },
    "ponatinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [43013182],
      "conceptName": ["ponatinib"]
    },
    "obinutuzumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [44507676],
      "conceptName": ["obinutuzumab"]
    }
  },
  {
    "conceptId": [35806131],
    "regimenName": ["High-dose Interleukin-2"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Aldesleukin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1309770],
      "conceptName": ["Aldesleukin"]
    },
    "Isotretinoin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [984232],
      "conceptName": ["Isotretinoin"]
    },
    "sargramostim": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308432],
      "conceptName": ["sargramostim"]
    },
    "Dacarbazine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311409],
      "conceptName": ["Dacarbazine"]
    },
    "Carmustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350066],
      "conceptName": ["Carmustine"]
    },
    "Interferon Alfa-2a": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1379969],
      "conceptName": ["Interferon Alfa-2a"]
    },
    "Interferon Alfa-2b": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1380068],
      "conceptName": ["Interferon Alfa-2b"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "Vinblastine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008264],
      "conceptName": ["Vinblastine"]
    },
    "dinutuximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [46221699],
      "conceptName": ["dinutuximab"]
    }
  },
  {
    "conceptId": [35803460],
    "regimenName": ["AIE"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Idarubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [19078097],
      "conceptName": ["Idarubicin"]
    },
    "Cytarabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Etoposide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Tretinoin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [903643],
      "conceptName": ["Tretinoin"]
    },
    "Mitoxantrone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1309188],
      "conceptName": ["Mitoxantrone"]
    },
    "Thioguanine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1437379],
      "conceptName": ["Thioguanine"]
    }
  },
  {
    "conceptId": [35804527],
    "regimenName": ["Cisplatin and Paclitaxel"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Paclitaxel": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1378382],
      "conceptName": ["Paclitaxel"]
    },
    "Cisplatin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "Fluorouracil": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Dacarbazine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311409],
      "conceptName": ["Dacarbazine"]
    },
    "gemcitabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314924],
      "conceptName": ["gemcitabine"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Epirubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344354],
      "conceptName": ["Epirubicin"]
    },
    "bevacizumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397141],
      "conceptName": ["bevacizumab"]
    },
    "Ifosfamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    }
  },
  {
    "conceptId": [35805102],
    "regimenName": ["MACOP-B"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Bleomycin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1329241],
      "conceptName": ["Bleomycin"]
    },
    "Methotrexate": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Prednisone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    }
  },
  {
    "conceptId": [35804296],
    "regimenName": ["Everolimus and Tamoxifen"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "everolimus": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [19011440],
      "conceptName": ["everolimus"]
    },
    "Tamoxifen": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1436678],
      "conceptName": ["Tamoxifen"]
    }
  },
  {
    "conceptId": [35102026],
    "regimenName": ["CNOP (Prednisolone)"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Cyclophosphamide": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Mitoxantrone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1309188],
      "conceptName": ["Mitoxantrone"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "prednisolone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1550557],
      "conceptName": ["prednisolone"]
    },
    "Bleomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1329241],
      "conceptName": ["Bleomycin"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    }
  },
  {
    "conceptId": [35806327],
    "regimenName": ["DTPACE"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Cisplatin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "Thalidomide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [19137042],
      "conceptName": ["Thalidomide"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Dexamethasone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "Etoposide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Melphalan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1301267],
      "conceptName": ["Melphalan"]
    },
    "bortezomib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1336825],
      "conceptName": ["bortezomib"]
    }
  },
  {
    "conceptId": [35804627],
    "regimenName": ["Cytarabine and Interferon alfa-2b"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Cytarabine": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Interferon Alfa-2b": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1380068],
      "conceptName": ["Interferon Alfa-2b"]
    }
  },
  {
    "conceptId": [35805756],
    "regimenName": ["Stanford V"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Bleomycin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1329241],
      "conceptName": ["Bleomycin"]
    },
    "Prednisone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Vinblastine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [19008264],
      "conceptName": ["Vinblastine"]
    },
    "Mechlorethamine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1394337],
      "conceptName": ["Mechlorethamine"]
    },
    "Etoposide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    }
  },
  {
    "conceptId": [35806135],
    "regimenName": ["Temozolomide and Bevacizumab"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "bevacizumab": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1397141],
      "conceptName": ["bevacizumab"]
    },
    "temozolomide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1341149],
      "conceptName": ["temozolomide"]
    }
  },
  {
    "conceptId": [35805645],
    "regimenName": ["Bevacizumab and Rituximab"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "bevacizumab": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1397141],
      "conceptName": ["bevacizumab"]
    },
    "rituximab": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    }
  },
  {
    "conceptId": [35804782],
    "regimenName": ["Nordic FLOX"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "oxaliplatin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1318011],
      "conceptName": ["oxaliplatin"]
    },
    "Leucovorin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1388796],
      "conceptName": ["Leucovorin"]
    },
    "Fluorouracil": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "gemcitabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314924],
      "conceptName": ["gemcitabine"]
    },
    "cetuximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1315411],
      "conceptName": ["cetuximab"]
    },
    "docetaxel": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1315942],
      "conceptName": ["docetaxel"]
    },
    "irinotecan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1367268],
      "conceptName": ["irinotecan"]
    },
    "bevacizumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397141],
      "conceptName": ["bevacizumab"]
    },
    "panitumumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19100985],
      "conceptName": ["panitumumab"]
    }
  },
  {
    "conceptId": [35805356],
    "regimenName": ["ECF, then 5-FU and RT, then ECF"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Cisplatin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "Epirubicin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1344354],
      "conceptName": ["Epirubicin"]
    },
    "Fluorouracil": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "gemcitabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314924],
      "conceptName": ["gemcitabine"]
    }
  },
  {
    "conceptId": [35804571],
    "regimenName": ["CC"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Cyclophosphamide": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Cladribine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [19054825],
      "conceptName": ["Cladribine"]
    },
    "Mitoxantrone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1309188],
      "conceptName": ["Mitoxantrone"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    }
  },
  {
    "conceptId": [35806947],
    "regimenName": ["Cisplatin, Etoposide, Irinotecan"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Cisplatin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "irinotecan": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1367268],
      "conceptName": ["irinotecan"]
    },
    "Etoposide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    }
  },
  {
    "conceptId": [35804320],
    "regimenName": ["nab-Paclitaxel monotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Paclitaxel": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1378382],
      "conceptName": ["Paclitaxel"]
    },
    "neratinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [793846],
      "conceptName": ["neratinib"]
    },
    "Fluorouracil": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Dacarbazine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311409],
      "conceptName": ["Dacarbazine"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "gemcitabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314924],
      "conceptName": ["gemcitabine"]
    },
    "oxaliplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1318011],
      "conceptName": ["oxaliplatin"]
    },
    "capecitabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1337620],
      "conceptName": ["capecitabine"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "vinorelbine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1343346],
      "conceptName": ["vinorelbine"]
    },
    "Epirubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344354],
      "conceptName": ["Epirubicin"]
    },
    "Carboplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344905],
      "conceptName": ["Carboplatin"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "lapatinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1359548],
      "conceptName": ["lapatinib"]
    },
    "Hyaluronidase / trastuzumab Injection [Herceptin Hylecta]": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1366689],
      "conceptName": ["Hyaluronidase / trastuzumab Injection [Herceptin Hylecta]"]
    },
    "Topotecan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1378509],
      "conceptName": ["Topotecan"]
    },
    "trastuzumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1387104],
      "conceptName": ["trastuzumab"]
    },
    "bevacizumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397141],
      "conceptName": ["bevacizumab"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "Ifosfamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    },
    "pazopanib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [40167554],
      "conceptName": ["pazopanib"]
    },
    "ipilimumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [40238188],
      "conceptName": ["ipilimumab"]
    },
    "atezolizumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [42629079],
      "conceptName": ["atezolizumab"]
    },
    "pertuzumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [42801287],
      "conceptName": ["pertuzumab"]
    },
    "ado-trastuzumab emtansine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [43525787],
      "conceptName": ["ado-trastuzumab emtansine"]
    },
    "Afatinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [43533090],
      "conceptName": ["Afatinib"]
    },
    "ramucirumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [44818489],
      "conceptName": ["ramucirumab"]
    },
    "pembrolizumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [45775965],
      "conceptName": ["pembrolizumab"]
    },
    "olaparib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [45892579],
      "conceptName": ["olaparib"]
    }
  },
  {
    "conceptId": [35804773],
    "regimenName": ["FOLFOX2"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "oxaliplatin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1318011],
      "conceptName": ["oxaliplatin"]
    },
    "Leucovorin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1388796],
      "conceptName": ["Leucovorin"]
    },
    "Fluorouracil": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "gemcitabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314924],
      "conceptName": ["gemcitabine"]
    },
    "cetuximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1315411],
      "conceptName": ["cetuximab"]
    },
    "docetaxel": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1315942],
      "conceptName": ["docetaxel"]
    },
    "irinotecan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1367268],
      "conceptName": ["irinotecan"]
    },
    "bevacizumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397141],
      "conceptName": ["bevacizumab"]
    },
    "panitumumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19100985],
      "conceptName": ["panitumumab"]
    }
  },
  {
    "conceptId": [35804328],
    "regimenName": ["CFP"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Prednisone": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Fluorouracil": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Tamoxifen": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1436678],
      "conceptName": ["Tamoxifen"]
    }
  },
  {
    "conceptId": [35803552],
    "regimenName": ["ATRA monotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Tretinoin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [903643],
      "conceptName": ["Tretinoin"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Mitoxantrone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1309188],
      "conceptName": ["Mitoxantrone"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Daunorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311799],
      "conceptName": ["Daunorubicin"]
    },
    "arsenic trioxide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1333379],
      "conceptName": ["arsenic trioxide"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "mercaptopurine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1436650],
      "conceptName": ["mercaptopurine"]
    },
    "Thioguanine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1437379],
      "conceptName": ["Thioguanine"]
    },
    "Idarubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078097],
      "conceptName": ["Idarubicin"]
    },
    "Gemtuzumab ozogamicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [42799711],
      "conceptName": ["Gemtuzumab ozogamicin"]
    }
  },
  {
    "conceptId": [35804598],
    "regimenName": ["Fludarabine monotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "fludarabine": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1395557],
      "conceptName": ["fludarabine"]
    },
    "Melphalan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1301267],
      "conceptName": ["Melphalan"]
    },
    "Filgrastim": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1304850],
      "conceptName": ["Filgrastim"]
    },
    "Mitoxantrone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1309188],
      "conceptName": ["Mitoxantrone"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "alemtuzumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1312706],
      "conceptName": ["alemtuzumab"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "oxaliplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1318011],
      "conceptName": ["oxaliplatin"]
    },
    "Busulfan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1333357],
      "conceptName": ["Busulfan"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "lenograstim": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19009705],
      "conceptName": ["lenograstim"]
    },
    "bendamustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19015523],
      "conceptName": ["bendamustine"]
    },
    "Daunorubicin Liposomal": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19051599],
      "conceptName": ["Daunorubicin Liposomal"]
    },
    "iodine-131-tositumomab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19054997],
      "conceptName": ["iodine-131-tositumomab"]
    },
    "ibritumomab tiuxetan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19068830],
      "conceptName": ["ibritumomab tiuxetan"]
    },
    "Idarubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078097],
      "conceptName": ["Idarubicin"]
    },
    "Thiotepa": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19137385],
      "conceptName": ["Thiotepa"]
    },
    "ofatumumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [40167582],
      "conceptName": ["ofatumumab"]
    },
    "obinutuzumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [44507676],
      "conceptName": ["obinutuzumab"]
    }
  },
  {
    "conceptId": [35803618],
    "regimenName": ["Clofarabine and Melphalan"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Melphalan": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1301267],
      "conceptName": ["Melphalan"]
    },
    "clofarabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [19054821],
      "conceptName": ["clofarabine"]
    }
  },
  {
    "conceptId": [35804774],
    "regimenName": ["FOLFOX 7/sLV5FU2"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "oxaliplatin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1318011],
      "conceptName": ["oxaliplatin"]
    },
    "Leucovorin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1388796],
      "conceptName": ["Leucovorin"]
    },
    "Fluorouracil": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "gemcitabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314924],
      "conceptName": ["gemcitabine"]
    },
    "cetuximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1315411],
      "conceptName": ["cetuximab"]
    },
    "docetaxel": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1315942],
      "conceptName": ["docetaxel"]
    },
    "irinotecan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1367268],
      "conceptName": ["irinotecan"]
    },
    "bevacizumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397141],
      "conceptName": ["bevacizumab"]
    },
    "panitumumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19100985],
      "conceptName": ["panitumumab"]
    }
  },
  {
    "conceptId": [35805125],
    "regimenName": ["Etoposide, Ifosfamide, Methotrexate"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Methotrexate": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Ifosfamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    },
    "Etoposide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Bleomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1329241],
      "conceptName": ["Bleomycin"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Mesna": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1354698],
      "conceptName": ["Mesna"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Vindesine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008336],
      "conceptName": ["Vindesine"]
    },
    "ASPARAGINASE": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19012585],
      "conceptName": ["ASPARAGINASE"]
    },
    "doxorubicin liposome": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19051649],
      "conceptName": ["doxorubicin liposome"]
    },
    "Teniposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19136750],
      "conceptName": ["Teniposide"]
    }
  },
  {
    "conceptId": [35802849],
    "regimenName": ["mDCF"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Cisplatin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "docetaxel": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1315942],
      "conceptName": ["docetaxel"]
    },
    "Leucovorin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1388796],
      "conceptName": ["Leucovorin"]
    },
    "Fluorouracil": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "bevacizumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397141],
      "conceptName": ["bevacizumab"]
    }
  },
  {
    "conceptId": [35803471],
    "regimenName": ["Decitabine monotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "decitabine": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [19024728],
      "conceptName": ["decitabine"]
    },
    "Valproate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [745466],
      "conceptName": ["Valproate"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "clofarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19054821],
      "conceptName": ["clofarabine"]
    },
    "venetoclax": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [35604205],
      "conceptName": ["venetoclax"]
    }
  },
  {
    "conceptId": [35804340],
    "regimenName": ["FNC"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Cyclophosphamide": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Fluorouracil": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "Mitoxantrone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1309188],
      "conceptName": ["Mitoxantrone"]
    }
  },
  {
    "conceptId": [35804355],
    "regimenName": ["CMFV"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Methotrexate": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Fluorouracil": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    }
  },
  {
    "conceptId": [35804816],
    "regimenName": ["Pralatrexate monotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Pralatrexate": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [40166461],
      "conceptName": ["Pralatrexate"]
    },
    "bexarotene": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1389888],
      "conceptName": ["bexarotene"]
    }
  },
  {
    "conceptId": [35806130],
    "regimenName": ["Fotemustine monotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Fotemustine": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [36879099],
      "conceptName": ["Fotemustine"]
    },
    "Melphalan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1301267],
      "conceptName": ["Melphalan"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    }
  },
  {
    "conceptId": [35804067],
    "regimenName": ["Vincristine liposomal monotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "vincristine liposome": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [42874135],
      "conceptName": ["vincristine liposome"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "doxorubicin liposome": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19051649],
      "conceptName": ["doxorubicin liposome"]
    }
  },
  {
    "conceptId": [35806267],
    "regimenName": ["CVAD"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Dexamethasone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Melphalan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1301267],
      "conceptName": ["Melphalan"]
    },
    "imatinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1304107],
      "conceptName": ["imatinib"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "pegaspargase": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1326481],
      "conceptName": ["pegaspargase"]
    },
    "Bleomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1329241],
      "conceptName": ["Bleomycin"]
    },
    "bortezomib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1336825],
      "conceptName": ["bortezomib"]
    },
    "Carmustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350066],
      "conceptName": ["Carmustine"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "dasatinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1358436],
      "conceptName": ["dasatinib"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "mercaptopurine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1436650],
      "conceptName": ["mercaptopurine"]
    },
    "Thioguanine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1437379],
      "conceptName": ["Thioguanine"]
    },
    "Methylprednisolone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1506270],
      "conceptName": ["Methylprednisolone"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Vindesine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008336],
      "conceptName": ["Vindesine"]
    },
    "everolimus": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19011440],
      "conceptName": ["everolimus"]
    },
    "ASPARAGINASE": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19012585],
      "conceptName": ["ASPARAGINASE"]
    },
    "Ifosfamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    },
    "Teniposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19136750],
      "conceptName": ["Teniposide"]
    },
    "ponatinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [43013182],
      "conceptName": ["ponatinib"]
    }
  },
  {
    "conceptId": [35804427],
    "regimenName": ["R-MP"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Methotrexate": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "rituximab": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Procarbazine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1351779],
      "conceptName": ["Procarbazine"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Lomustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1391846],
      "conceptName": ["Lomustine"]
    }
  },
  {
    "conceptId": [35804091],
    "regimenName": ["L-Asparaginase, Vincristine, Dexamethasone"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "ASPARAGINASE": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [19012585],
      "conceptName": ["ASPARAGINASE"]
    },
    "Dexamethasone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Daunorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311799],
      "conceptName": ["Daunorubicin"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "mercaptopurine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1436650],
      "conceptName": ["mercaptopurine"]
    },
    "Thioguanine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1437379],
      "conceptName": ["Thioguanine"]
    }
  },
  {
    "conceptId": [35806142],
    "regimenName": ["BHD"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Carmustine": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1350066],
      "conceptName": ["Carmustine"]
    },
    "Dacarbazine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1311409],
      "conceptName": ["Dacarbazine"]
    },
    "hydroxyurea": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1377141],
      "conceptName": ["hydroxyurea"]
    }
  },
  {
    "conceptId": [35804157],
    "regimenName": ["CISCA"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Cisplatin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Melphalan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1301267],
      "conceptName": ["Melphalan"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Dactinomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311443],
      "conceptName": ["Dactinomycin"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Bleomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1329241],
      "conceptName": ["Bleomycin"]
    },
    "bortezomib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1336825],
      "conceptName": ["bortezomib"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Altretamine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1368823],
      "conceptName": ["Altretamine"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Vinblastine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008264],
      "conceptName": ["Vinblastine"]
    },
    "Thalidomide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19137042],
      "conceptName": ["Thalidomide"]
    }
  },
  {
    "conceptId": [35805843],
    "regimenName": ["ABVDm"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Bleomycin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1329241],
      "conceptName": ["Bleomycin"]
    },
    "Methylprednisolone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1506270],
      "conceptName": ["Methylprednisolone"]
    },
    "Vinblastine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [19008264],
      "conceptName": ["Vinblastine"]
    },
    "Dacarbazine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1311409],
      "conceptName": ["Dacarbazine"]
    }
  },
  {
    "conceptId": [35805454],
    "regimenName": ["IE"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Ifosfamide": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    },
    "Mesna": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1354698],
      "conceptName": ["Mesna"]
    },
    "Etoposide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Mitoxantrone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1309188],
      "conceptName": ["Mitoxantrone"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Carboplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344905],
      "conceptName": ["Carboplatin"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "ASPARAGINASE": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19012585],
      "conceptName": ["ASPARAGINASE"]
    },
    "lenalidomide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19026972],
      "conceptName": ["lenalidomide"]
    },
    "ofatumumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [40167582],
      "conceptName": ["ofatumumab"]
    }
  },
  {
    "conceptId": [35804761],
    "regimenName": ["FOLFIRI"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Leucovorin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1388796],
      "conceptName": ["Leucovorin"]
    },
    "irinotecan": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1367268],
      "conceptName": ["irinotecan"]
    },
    "Fluorouracil": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "gemcitabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314924],
      "conceptName": ["gemcitabine"]
    },
    "cetuximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1315411],
      "conceptName": ["cetuximab"]
    },
    "oxaliplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1318011],
      "conceptName": ["oxaliplatin"]
    },
    "bevacizumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397141],
      "conceptName": ["bevacizumab"]
    },
    "panitumumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19100985],
      "conceptName": ["panitumumab"]
    },
    "aflibercept": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [40244266],
      "conceptName": ["aflibercept"]
    },
    "ramucirumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [44818489],
      "conceptName": ["ramucirumab"]
    }
  },
  {
    "conceptId": [35804544],
    "regimenName": ["Paclitaxel, Topotecan, Bevacizumab"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Paclitaxel": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1378382],
      "conceptName": ["Paclitaxel"]
    },
    "bevacizumab": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1397141],
      "conceptName": ["bevacizumab"]
    },
    "Topotecan": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1378509],
      "conceptName": ["Topotecan"]
    }
  },
  {
    "conceptId": [35806326],
    "regimenName": ["Dara-PD"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "daratumumab": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [35605744],
      "conceptName": ["daratumumab"]
    },
    "Dexamethasone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "pomalidomide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [43014237],
      "conceptName": ["pomalidomide"]
    }
  },
  {
    "conceptId": [35804583],
    "regimenName": ["Obinutuzumab monotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "obinutuzumab": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [44507676],
      "conceptName": ["obinutuzumab"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Chlorambucil": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1390051],
      "conceptName": ["Chlorambucil"]
    },
    "fludarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1395557],
      "conceptName": ["fludarabine"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "bendamustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19015523],
      "conceptName": ["bendamustine"]
    },
    "venetoclax": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [35604205],
      "conceptName": ["venetoclax"]
    },
    "Ibrutinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [44507848],
      "conceptName": ["Ibrutinib"]
    }
  },
  {
    "conceptId": [35806949],
    "regimenName": ["VMV-VAC"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Methotrexate": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Etoposide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Bleomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1329241],
      "conceptName": ["Bleomycin"]
    },
    "Procarbazine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1351779],
      "conceptName": ["Procarbazine"]
    },
    "Mechlorethamine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1394337],
      "conceptName": ["Mechlorethamine"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "prednisolone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1550557],
      "conceptName": ["prednisolone"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Vindesine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008336],
      "conceptName": ["Vindesine"]
    },
    "Ifosfamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    },
    "Teniposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19136750],
      "conceptName": ["Teniposide"]
    }
  },
  {
    "conceptId": [35806265],
    "regimenName": ["KTd"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Thalidomide": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [19137042],
      "conceptName": ["Thalidomide"]
    },
    "carfilzomib": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [42873638],
      "conceptName": ["carfilzomib"]
    },
    "Dexamethasone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    }
  },
  {
    "conceptId": [35805045],
    "regimenName": ["R2CHOP"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "lenalidomide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [19026972],
      "conceptName": ["lenalidomide"]
    },
    "rituximab": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Prednisone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    }
  },
  {
    "conceptId": [35805657],
    "regimenName": ["CVP, then 131Iodine-Tositumomab"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "iodine-131-tositumomab": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [19054997],
      "conceptName": ["iodine-131-tositumomab"]
    },
    "Prednisone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    }
  },
  {
    "conceptId": [35805354],
    "regimenName": ["FOLFOX4 and RT"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "oxaliplatin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1318011],
      "conceptName": ["oxaliplatin"]
    },
    "Leucovorin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1388796],
      "conceptName": ["Leucovorin"]
    },
    "Fluorouracil": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "gemcitabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314924],
      "conceptName": ["gemcitabine"]
    },
    "cetuximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1315411],
      "conceptName": ["cetuximab"]
    },
    "docetaxel": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1315942],
      "conceptName": ["docetaxel"]
    },
    "irinotecan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1367268],
      "conceptName": ["irinotecan"]
    },
    "bevacizumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397141],
      "conceptName": ["bevacizumab"]
    },
    "panitumumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19100985],
      "conceptName": ["panitumumab"]
    }
  },
  {
    "conceptId": [35805366],
    "regimenName": ["Docetaxel and Irinotecan"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "docetaxel": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1315942],
      "conceptName": ["docetaxel"]
    },
    "irinotecan": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1367268],
      "conceptName": ["irinotecan"]
    }
  },
  {
    "conceptId": [35803595],
    "regimenName": ["Alemtuzumab monotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "alemtuzumab": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1312706],
      "conceptName": ["alemtuzumab"]
    },
    "Melphalan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1301267],
      "conceptName": ["Melphalan"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "fludarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1395557],
      "conceptName": ["fludarabine"]
    },
    "Methylprednisolone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1506270],
      "conceptName": ["Methylprednisolone"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    }
  },
  {
    "conceptId": [35805057],
    "regimenName": ["R-DHAOx"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "oxaliplatin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1318011],
      "conceptName": ["oxaliplatin"]
    },
    "rituximab": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Cytarabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Dexamethasone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    }
  },
  {
    "conceptId": [35804216],
    "regimenName": ["FAC"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Fluorouracil": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "bevacizumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397141],
      "conceptName": ["bevacizumab"]
    },
    "Medroxyprogesterone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1500211],
      "conceptName": ["Medroxyprogesterone"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "BCG, Live, Tice Strain": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19086176],
      "conceptName": ["BCG, Live, Tice Strain"]
    }
  },
  {
    "conceptId": [35805098],
    "regimenName": ["DICEP"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Cisplatin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Etoposide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Melphalan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1301267],
      "conceptName": ["Melphalan"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "bortezomib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1336825],
      "conceptName": ["bortezomib"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Epirubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344354],
      "conceptName": ["Epirubicin"]
    },
    "Lomustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1391846],
      "conceptName": ["Lomustine"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "Thalidomide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19137042],
      "conceptName": ["Thalidomide"]
    }
  },
  {
    "conceptId": [35804370],
    "regimenName": ["COPADM"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Methotrexate": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Prednisone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Fluorouracil": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Bleomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1329241],
      "conceptName": ["Bleomycin"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Procarbazine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1351779],
      "conceptName": ["Procarbazine"]
    },
    "Mechlorethamine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1394337],
      "conceptName": ["Mechlorethamine"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "Vindesine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008336],
      "conceptName": ["Vindesine"]
    },
    "Ifosfamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    },
    "Teniposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19136750],
      "conceptName": ["Teniposide"]
    }
  },
  {
    "conceptId": [35102032],
    "regimenName": ["AspaMetDex (Erwinaze)"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Methotrexate": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "asparaginase Erwinia chrysanthemi": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [43533115],
      "conceptName": ["asparaginase Erwinia chrysanthemi"]
    },
    "Dexamethasone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    }
  },
  {
    "conceptId": [35806859],
    "regimenName": ["Mitoxantrone and Prednisone"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Prednisone": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Mitoxantrone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1309188],
      "conceptName": ["Mitoxantrone"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Bleomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1329241],
      "conceptName": ["Bleomycin"]
    },
    "vinorelbine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1343346],
      "conceptName": ["vinorelbine"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Procarbazine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1351779],
      "conceptName": ["Procarbazine"]
    },
    "Chlorambucil": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1390051],
      "conceptName": ["Chlorambucil"]
    },
    "fludarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1395557],
      "conceptName": ["fludarabine"]
    },
    "Vinblastine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008264],
      "conceptName": ["Vinblastine"]
    },
    "Ifosfamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    }
  },
  {
    "conceptId": [35806087],
    "regimenName": ["R-MACLO/R-IVAM"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Methotrexate": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Ifosfamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    },
    "rituximab": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Cytarabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Etoposide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Vindesine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008336],
      "conceptName": ["Vindesine"]
    },
    "Teniposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19136750],
      "conceptName": ["Teniposide"]
    }
  },
  {
    "conceptId": [35805035],
    "regimenName": ["Helicobacter pylori eradication therapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Clarithromycin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1750500],
      "conceptName": ["Clarithromycin"]
    },
    "Amoxicillin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1713332],
      "conceptName": ["Amoxicillin"]
    },
    "Omeprazole": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [923645],
      "conceptName": ["Omeprazole"]
    }
  },
  {
    "conceptId": [35804582],
    "regimenName": ["Ibrutinib and Obinutuzumab"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Ibrutinib": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [44507848],
      "conceptName": ["Ibrutinib"]
    },
    "obinutuzumab": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [44507676],
      "conceptName": ["obinutuzumab"]
    }
  },
  {
    "conceptId": [35806907],
    "regimenName": ["Interferon alfa-2a and Isotretinoin"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Isotretinoin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [984232],
      "conceptName": ["Isotretinoin"]
    },
    "Interferon Alfa-2a": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1379969],
      "conceptName": ["Interferon Alfa-2a"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    }
  },
  {
    "conceptId": [35803705],
    "regimenName": ["FluBuCy, then allo HSCT"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Busulfan": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1333357],
      "conceptName": ["Busulfan"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "fludarabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1395557],
      "conceptName": ["fludarabine"]
    }
  },
  {
    "conceptId": [35805847],
    "regimenName": ["CVPP"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Lomustine": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1391846],
      "conceptName": ["Lomustine"]
    },
    "Prednisone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Vinblastine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [19008264],
      "conceptName": ["Vinblastine"]
    },
    "Procarbazine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1351779],
      "conceptName": ["Procarbazine"]
    }
  },
  {
    "conceptId": [35806866],
    "regimenName": ["Cortisone monotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Cortisone": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1507705],
      "conceptName": ["Cortisone"]
    }
  },
  {
    "conceptId": [35806089],
    "regimenName": ["R-VAD plus C"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Chlorambucil": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1390051],
      "conceptName": ["Chlorambucil"]
    },
    "rituximab": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Dexamethasone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    }
  },
  {
    "conceptId": [35804572],
    "regimenName": ["Chlorambucil and Obinutuzumab"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Chlorambucil": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1390051],
      "conceptName": ["Chlorambucil"]
    },
    "obinutuzumab": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [44507676],
      "conceptName": ["obinutuzumab"]
    }
  },
  {
    "conceptId": [35804784],
    "regimenName": ["SOX"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "oxaliplatin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1318011],
      "conceptName": ["oxaliplatin"]
    },
    "Hyaluronidase / trastuzumab Injection [Herceptin Hylecta]": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1366689],
      "conceptName": ["Hyaluronidase / trastuzumab Injection [Herceptin Hylecta]"]
    },
    "bevacizumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397141],
      "conceptName": ["bevacizumab"]
    }
  },
  {
    "conceptId": [35803527],
    "regimenName": ["Cytarabine, Daunorubicin, Vincristine"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Cytarabine": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Daunorubicin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1311799],
      "conceptName": ["Daunorubicin"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Azacitidine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314865],
      "conceptName": ["Azacitidine"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "nilotinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1394023],
      "conceptName": ["nilotinib"]
    },
    "Thioguanine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1437379],
      "conceptName": ["Thioguanine"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "prednisolone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1550557],
      "conceptName": ["prednisolone"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "ASPARAGINASE": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19012585],
      "conceptName": ["ASPARAGINASE"]
    },
    "Teniposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19136750],
      "conceptName": ["Teniposide"]
    }
  },
  {
    "conceptId": [35806268],
    "regimenName": ["TD"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Thalidomide": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [19137042],
      "conceptName": ["Thalidomide"]
    },
    "Dexamethasone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "Melphalan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1301267],
      "conceptName": ["Melphalan"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "bortezomib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1336825],
      "conceptName": ["bortezomib"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "bendamustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19015523],
      "conceptName": ["bendamustine"]
    },
    "doxorubicin liposome": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19051649],
      "conceptName": ["doxorubicin liposome"]
    },
    "daratumumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [35605744],
      "conceptName": ["daratumumab"]
    },
    "carfilzomib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [42873638],
      "conceptName": ["carfilzomib"]
    },
    "panobinostat": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [46221435],
      "conceptName": ["panobinostat"]
    }
  },
  {
    "conceptId": [35803436],
    "regimenName": ["IDAC"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Cytarabine": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "inotuzumab ozogamicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [794068],
      "conceptName": ["inotuzumab ozogamicin"]
    },
    "Tretinoin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [903643],
      "conceptName": ["Tretinoin"]
    },
    "Fluorouracil": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "Melphalan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1301267],
      "conceptName": ["Melphalan"]
    },
    "imatinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1304107],
      "conceptName": ["imatinib"]
    },
    "Filgrastim": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1304850],
      "conceptName": ["Filgrastim"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Mitoxantrone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1309188],
      "conceptName": ["Mitoxantrone"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Daunorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311799],
      "conceptName": ["Daunorubicin"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Azacitidine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314865],
      "conceptName": ["Azacitidine"]
    },
    "oxaliplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1318011],
      "conceptName": ["oxaliplatin"]
    },
    "pegaspargase": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1326481],
      "conceptName": ["pegaspargase"]
    },
    "Bleomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1329241],
      "conceptName": ["Bleomycin"]
    },
    "Vorinostat": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1337651],
      "conceptName": ["Vorinostat"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Carboplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344905],
      "conceptName": ["Carboplatin"]
    },
    "Carmustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350066],
      "conceptName": ["Carmustine"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "glasdegib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1355795],
      "conceptName": ["glasdegib"]
    },
    "dasatinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1358436],
      "conceptName": ["dasatinib"]
    },
    "sorafenib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1363387],
      "conceptName": ["sorafenib"]
    },
    "Interferon Alfa-2b": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1380068],
      "conceptName": ["Interferon Alfa-2b"]
    },
    "Lomustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1391846],
      "conceptName": ["Lomustine"]
    },
    "nilotinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1394023],
      "conceptName": ["nilotinib"]
    },
    "fludarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1395557],
      "conceptName": ["fludarabine"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "mercaptopurine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1436650],
      "conceptName": ["mercaptopurine"]
    },
    "Thioguanine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1437379],
      "conceptName": ["Thioguanine"]
    },
    "Methylprednisolone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1506270],
      "conceptName": ["Methylprednisolone"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "prednisolone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1550557],
      "conceptName": ["prednisolone"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Pravastatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551860],
      "conceptName": ["Pravastatin"]
    },
    "midostaurin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1594003],
      "conceptName": ["midostaurin"]
    },
    "nelarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19002912],
      "conceptName": ["nelarabine"]
    },
    "Vindesine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008336],
      "conceptName": ["Vindesine"]
    },
    "lenograstim": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19009705],
      "conceptName": ["lenograstim"]
    },
    "everolimus": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19011440],
      "conceptName": ["everolimus"]
    },
    "ASPARAGINASE": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19012585],
      "conceptName": ["ASPARAGINASE"]
    },
    "bendamustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19015523],
      "conceptName": ["bendamustine"]
    },
    "Amsacrine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19017810],
      "conceptName": ["Amsacrine"]
    },
    "decitabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19024728],
      "conceptName": ["decitabine"]
    },
    "Daunorubicin Liposomal": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19051599],
      "conceptName": ["Daunorubicin Liposomal"]
    },
    "doxorubicin liposome": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19051649],
      "conceptName": ["doxorubicin liposome"]
    },
    "clofarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19054821],
      "conceptName": ["clofarabine"]
    },
    "Cladribine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19054825],
      "conceptName": ["Cladribine"]
    },
    "Aclarubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19057483],
      "conceptName": ["Aclarubicin"]
    },
    "ibritumomab tiuxetan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19068830],
      "conceptName": ["ibritumomab tiuxetan"]
    },
    "Idarubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078097],
      "conceptName": ["Idarubicin"]
    },
    "Ifosfamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    },
    "Norethandrolone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19128219],
      "conceptName": ["Norethandrolone"]
    },
    "Teniposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19136750],
      "conceptName": ["Teniposide"]
    },
    "Thiotepa": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19137385],
      "conceptName": ["Thiotepa"]
    },
    "venetoclax": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [35604205],
      "conceptName": ["venetoclax"]
    },
    "Fotemustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [36879099],
      "conceptName": ["Fotemustine"]
    },
    "ofatumumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [40167582],
      "conceptName": ["ofatumumab"]
    },
    "Cytarabine liposome": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [40175460],
      "conceptName": ["Cytarabine liposome"]
    },
    "Gemtuzumab ozogamicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [42799711],
      "conceptName": ["Gemtuzumab ozogamicin"]
    },
    "ponatinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [43013182],
      "conceptName": ["ponatinib"]
    },
    "omacetaxine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [45775576],
      "conceptName": ["omacetaxine"]
    },
    "panobinostat": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [46221435],
      "conceptName": ["panobinostat"]
    }
  },
  {
    "conceptId": [35804305],
    "regimenName": ["Trastuzumab and ET"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "trastuzumab": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1387104],
      "conceptName": ["trastuzumab"]
    },
    "Tamoxifen": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1436678],
      "conceptName": ["Tamoxifen"]
    }
  },
  {
    "conceptId": [35804804],
    "regimenName": ["MOF"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Fluorouracil": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    }
  },
  {
    "conceptId": [35806627],
    "regimenName": ["BMP"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Bleomycin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1329241],
      "conceptName": ["Bleomycin"]
    },
    "Methotrexate": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Cisplatin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Dactinomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311443],
      "conceptName": ["Dactinomycin"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    }
  },
  {
    "conceptId": [35806414],
    "regimenName": ["Carboplatin, nab-Paclitaxel, Pembrolizumab"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Carboplatin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1344905],
      "conceptName": ["Carboplatin"]
    },
    "Paclitaxel": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1378382],
      "conceptName": ["Paclitaxel"]
    },
    "pembrolizumab": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [45775965],
      "conceptName": ["pembrolizumab"]
    }
  },
  {
    "conceptId": [35805850],
    "regimenName": ["LOPP/EVAP"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Chlorambucil": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1390051],
      "conceptName": ["Chlorambucil"]
    },
    "Prednisone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Vinblastine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [19008264],
      "conceptName": ["Vinblastine"]
    },
    "Procarbazine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1351779],
      "conceptName": ["Procarbazine"]
    },
    "Etoposide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    }
  },
  {
    "conceptId": [35804631],
    "regimenName": ["Imatinib monotherapy, intermittent therapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "imatinib": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1304107],
      "conceptName": ["imatinib"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Mitoxantrone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1309188],
      "conceptName": ["Mitoxantrone"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Daunorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311799],
      "conceptName": ["Daunorubicin"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "hydroxyurea": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1377141],
      "conceptName": ["hydroxyurea"]
    },
    "Interferon Alfa-2a": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1379969],
      "conceptName": ["Interferon Alfa-2a"]
    },
    "Interferon Alfa-2b": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1380068],
      "conceptName": ["Interferon Alfa-2b"]
    },
    "mercaptopurine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1436650],
      "conceptName": ["mercaptopurine"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "peginterferon alfa-2a": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1714165],
      "conceptName": ["peginterferon alfa-2a"]
    },
    "ASPARAGINASE": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19012585],
      "conceptName": ["ASPARAGINASE"]
    },
    "Idarubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078097],
      "conceptName": ["Idarubicin"]
    }
  },
  {
    "conceptId": [35101644],
    "regimenName": ["mFOLFOX6 (L-Leucovorin)"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "oxaliplatin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1318011],
      "conceptName": ["oxaliplatin"]
    },
    "levoleucovorin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [40168303],
      "conceptName": ["levoleucovorin"]
    },
    "Fluorouracil": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "cetuximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1315411],
      "conceptName": ["cetuximab"]
    },
    "irinotecan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1367268],
      "conceptName": ["irinotecan"]
    },
    "bevacizumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397141],
      "conceptName": ["bevacizumab"]
    }
  },
  {
    "conceptId": [35806890],
    "regimenName": ["Capecitabine and RT"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "capecitabine": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1337620],
      "conceptName": ["capecitabine"]
    },
    "neratinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [793846],
      "conceptName": ["neratinib"]
    },
    "Fluorouracil": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "fulvestrant": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1304044],
      "conceptName": ["fulvestrant"]
    },
    "gemcitabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314924],
      "conceptName": ["gemcitabine"]
    },
    "cetuximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1315411],
      "conceptName": ["cetuximab"]
    },
    "docetaxel": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1315942],
      "conceptName": ["docetaxel"]
    },
    "oxaliplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1318011],
      "conceptName": ["oxaliplatin"]
    },
    "erlotinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1325363],
      "conceptName": ["erlotinib"]
    },
    "temozolomide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1341149],
      "conceptName": ["temozolomide"]
    },
    "Epirubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344354],
      "conceptName": ["Epirubicin"]
    },
    "Carboplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344905],
      "conceptName": ["Carboplatin"]
    },
    "lapatinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1359548],
      "conceptName": ["lapatinib"]
    },
    "sorafenib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1363387],
      "conceptName": ["sorafenib"]
    },
    "irinotecan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1367268],
      "conceptName": ["irinotecan"]
    },
    "Paclitaxel": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1378382],
      "conceptName": ["Paclitaxel"]
    },
    "trastuzumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1387104],
      "conceptName": ["trastuzumab"]
    },
    "Mitomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1389036],
      "conceptName": ["Mitomycin"]
    },
    "bevacizumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397141],
      "conceptName": ["bevacizumab"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "ixabepilone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19025348],
      "conceptName": ["ixabepilone"]
    },
    "panitumumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19100985],
      "conceptName": ["panitumumab"]
    },
    "pertuzumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [42801287],
      "conceptName": ["pertuzumab"]
    }
  },
  {
    "conceptId": [35804049],
    "regimenName": ["Hyper-CVAD/MA"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Methotrexate": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Methylprednisolone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1506270],
      "conceptName": ["Methylprednisolone"]
    },
    "Cytarabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Dexamethasone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "everolimus": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19011440],
      "conceptName": ["everolimus"]
    }
  },
  {
    "conceptId": [35806840],
    "regimenName": ["Bicalutamide monotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "bicalutamide": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1344381],
      "conceptName": ["bicalutamide"]
    },
    "docetaxel": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1315942],
      "conceptName": ["docetaxel"]
    },
    "Leuprolide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1351541],
      "conceptName": ["Leuprolide"]
    },
    "Flutamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1356461],
      "conceptName": ["Flutamide"]
    },
    "Goserelin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1366310],
      "conceptName": ["Goserelin"]
    }
  },
  {
    "conceptId": [35101481],
    "regimenName": ["CALGB 8811 late intensification"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Thioguanine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1437379],
      "conceptName": ["Thioguanine"]
    },
    "Cytarabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Dexamethasone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "mercaptopurine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1436650],
      "conceptName": ["mercaptopurine"]
    },
    "ASPARAGINASE": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19012585],
      "conceptName": ["ASPARAGINASE"]
    }
  },
  {
    "conceptId": [35804152],
    "regimenName": ["Gemcitabine and RT"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "gemcitabine": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1314924],
      "conceptName": ["gemcitabine"]
    },
    "Fluorouracil": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Dacarbazine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311409],
      "conceptName": ["Dacarbazine"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "cetuximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1315411],
      "conceptName": ["cetuximab"]
    },
    "docetaxel": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1315942],
      "conceptName": ["docetaxel"]
    },
    "oxaliplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1318011],
      "conceptName": ["oxaliplatin"]
    },
    "erlotinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1325363],
      "conceptName": ["erlotinib"]
    },
    "pegaspargase": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1326481],
      "conceptName": ["pegaspargase"]
    },
    "sunitinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1336539],
      "conceptName": ["sunitinib"]
    },
    "capecitabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1337620],
      "conceptName": ["capecitabine"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "vinorelbine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1343346],
      "conceptName": ["vinorelbine"]
    },
    "Epirubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344354],
      "conceptName": ["Epirubicin"]
    },
    "Carboplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344905],
      "conceptName": ["Carboplatin"]
    },
    "Hyaluronidase / trastuzumab Injection [Herceptin Hylecta]": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1366689],
      "conceptName": ["Hyaluronidase / trastuzumab Injection [Herceptin Hylecta]"]
    },
    "irinotecan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1367268],
      "conceptName": ["irinotecan"]
    },
    "Paclitaxel": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1378382],
      "conceptName": ["Paclitaxel"]
    },
    "trastuzumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1387104],
      "conceptName": ["trastuzumab"]
    },
    "Leucovorin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1388796],
      "conceptName": ["Leucovorin"]
    },
    "Mitomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1389036],
      "conceptName": ["Mitomycin"]
    },
    "bevacizumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397141],
      "conceptName": ["bevacizumab"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "prednisolone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1550557],
      "conceptName": ["prednisolone"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Vinblastine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008264],
      "conceptName": ["Vinblastine"]
    },
    "ASPARAGINASE": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19012585],
      "conceptName": ["ASPARAGINASE"]
    },
    "bendamustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19015523],
      "conceptName": ["bendamustine"]
    },
    "doxorubicin liposome": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19051649],
      "conceptName": ["doxorubicin liposome"]
    },
    "Ifosfamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    },
    "Thalidomide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19137042],
      "conceptName": ["Thalidomide"]
    },
    "necitumumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [35606215],
      "conceptName": ["necitumumab"]
    }
  },
  {
    "conceptId": [35805658],
    "regimenName": ["Fludarabine, then 131Iodine-Tositumomab"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "iodine-131-tositumomab": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [19054997],
      "conceptName": ["iodine-131-tositumomab"]
    },
    "fludarabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1395557],
      "conceptName": ["fludarabine"]
    }
  },
  {
    "conceptId": [35806639],
    "regimenName": ["HyperCHidam"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Methotrexate": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Cytarabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "inotuzumab ozogamicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [794068],
      "conceptName": ["inotuzumab ozogamicin"]
    },
    "Fluorouracil": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "imatinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1304107],
      "conceptName": ["imatinib"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Bleomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1329241],
      "conceptName": ["Bleomycin"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "dasatinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1358436],
      "conceptName": ["dasatinib"]
    },
    "mercaptopurine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1436650],
      "conceptName": ["mercaptopurine"]
    },
    "Thioguanine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1437379],
      "conceptName": ["Thioguanine"]
    },
    "Methylprednisolone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1506270],
      "conceptName": ["Methylprednisolone"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Vindesine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008336],
      "conceptName": ["Vindesine"]
    },
    "everolimus": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19011440],
      "conceptName": ["everolimus"]
    },
    "ASPARAGINASE": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19012585],
      "conceptName": ["ASPARAGINASE"]
    },
    "doxorubicin liposome": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19051649],
      "conceptName": ["doxorubicin liposome"]
    },
    "Ifosfamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    },
    "Teniposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19136750],
      "conceptName": ["Teniposide"]
    },
    "Cytarabine liposome": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [40175460],
      "conceptName": ["Cytarabine liposome"]
    },
    "ponatinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [43013182],
      "conceptName": ["ponatinib"]
    }
  },
  {
    "conceptId": [35806591],
    "regimenName": ["FLEC"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Carboplatin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1344905],
      "conceptName": ["Carboplatin"]
    },
    "Epirubicin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1344354],
      "conceptName": ["Epirubicin"]
    },
    "Fluorouracil": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    }
  },
  {
    "conceptId": [35805466],
    "regimenName": ["LVP .22Sandwich.22"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "ASPARAGINASE": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [19012585],
      "conceptName": ["ASPARAGINASE"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "prednisolone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1550557],
      "conceptName": ["prednisolone"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Daunorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311799],
      "conceptName": ["Daunorubicin"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    }
  },
  {
    "conceptId": [35803673],
    "regimenName": ["Fluorouracil, Mitomycin, RT"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Mitomycin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1389036],
      "conceptName": ["Mitomycin"]
    },
    "Fluorouracil": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Leucovorin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1388796],
      "conceptName": ["Leucovorin"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    }
  },
  {
    "conceptId": [35806579],
    "regimenName": ["FAS"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Streptozocin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [19136210],
      "conceptName": ["Streptozocin"]
    },
    "Fluorouracil": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    }
  },
  {
    "conceptId": [35805691],
    "regimenName": ["Sunitinib monotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "sunitinib": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1336539],
      "conceptName": ["sunitinib"]
    },
    "gemcitabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314924],
      "conceptName": ["gemcitabine"]
    }
  },
  {
    "conceptId": [35804342],
    "regimenName": ["MF"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Methotrexate": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Fluorouracil": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Epirubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344354],
      "conceptName": ["Epirubicin"]
    },
    "Altretamine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1368823],
      "conceptName": ["Altretamine"]
    },
    "Leucovorin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1388796],
      "conceptName": ["Leucovorin"]
    },
    "Tamoxifen": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1436678],
      "conceptName": ["Tamoxifen"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Thiotepa": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19137385],
      "conceptName": ["Thiotepa"]
    }
  },
  {
    "conceptId": [35804619],
    "regimenName": ["FC, then allo HSCT"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Cyclophosphamide": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "fludarabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1395557],
      "conceptName": ["fludarabine"]
    },
    "Mitoxantrone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1309188],
      "conceptName": ["Mitoxantrone"]
    },
    "alemtuzumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1312706],
      "conceptName": ["alemtuzumab"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Busulfan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1333357],
      "conceptName": ["Busulfan"]
    },
    "ibritumomab tiuxetan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19068830],
      "conceptName": ["ibritumomab tiuxetan"]
    },
    "Thiotepa": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19137385],
      "conceptName": ["Thiotepa"]
    },
    "ofatumumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [40167582],
      "conceptName": ["ofatumumab"]
    },
    "obinutuzumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [44507676],
      "conceptName": ["obinutuzumab"]
    }
  },
  {
    "conceptId": [35804533],
    "regimenName": ["Cisplatin, Gemcitabine, RT"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Cisplatin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "gemcitabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1314924],
      "conceptName": ["gemcitabine"]
    },
    "Fluorouracil": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "erlotinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1325363],
      "conceptName": ["erlotinib"]
    },
    "pegaspargase": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1326481],
      "conceptName": ["pegaspargase"]
    },
    "Epirubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344354],
      "conceptName": ["Epirubicin"]
    },
    "Hyaluronidase / trastuzumab Injection [Herceptin Hylecta]": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1366689],
      "conceptName": ["Hyaluronidase / trastuzumab Injection [Herceptin Hylecta]"]
    },
    "Paclitaxel": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1378382],
      "conceptName": ["Paclitaxel"]
    },
    "bevacizumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397141],
      "conceptName": ["bevacizumab"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Ifosfamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    },
    "Thalidomide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19137042],
      "conceptName": ["Thalidomide"]
    },
    "necitumumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [35606215],
      "conceptName": ["necitumumab"]
    }
  },
  {
    "conceptId": [35804092],
    "regimenName": ["L-Asparaginase, Vincristine, Prednisolone"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "ASPARAGINASE": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [19012585],
      "conceptName": ["ASPARAGINASE"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "prednisolone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1550557],
      "conceptName": ["prednisolone"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Daunorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311799],
      "conceptName": ["Daunorubicin"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    }
  },
  {
    "conceptId": [35803537],
    "regimenName": ["VAMP (Amethopterin)"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Methotrexate": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "mercaptopurine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1436650],
      "conceptName": ["mercaptopurine"]
    },
    "Prednisone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "ASPARAGINASE": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19012585],
      "conceptName": ["ASPARAGINASE"]
    }
  },
  {
    "conceptId": [35804542],
    "regimenName": ["Ifosfamide monotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Ifosfamide": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    },
    "Mesna": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1354698],
      "conceptName": ["Mesna"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Mitoxantrone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1309188],
      "conceptName": ["Mitoxantrone"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Dactinomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311443],
      "conceptName": ["Dactinomycin"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Bleomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1329241],
      "conceptName": ["Bleomycin"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "vinorelbine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1343346],
      "conceptName": ["vinorelbine"]
    },
    "Epirubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344354],
      "conceptName": ["Epirubicin"]
    },
    "Carboplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344905],
      "conceptName": ["Carboplatin"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "ASPARAGINASE": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19012585],
      "conceptName": ["ASPARAGINASE"]
    },
    "lenalidomide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19026972],
      "conceptName": ["lenalidomide"]
    },
    "ofatumumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [40167582],
      "conceptName": ["ofatumumab"]
    }
  },
  {
    "conceptId": [35804056],
    "regimenName": ["Blinatumomab monotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "blinatumomab": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [45892531],
      "conceptName": ["blinatumomab"]
    }
  },
  {
    "conceptId": [35806941],
    "regimenName": ["Carboplatin, Etoposide, Atezolizumab"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Carboplatin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1344905],
      "conceptName": ["Carboplatin"]
    },
    "atezolizumab": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [42629079],
      "conceptName": ["atezolizumab"]
    },
    "Etoposide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    }
  },
  {
    "conceptId": [35806595],
    "regimenName": ["Fluorouracil, Folinic acid, nanoliposomal Irinotecan"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "irinotecan liposomal": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [35603068],
      "conceptName": ["irinotecan liposomal"]
    },
    "Leucovorin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1388796],
      "conceptName": ["Leucovorin"]
    },
    "Fluorouracil": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    }
  },
  {
    "conceptId": [35806589],
    "regimenName": ["mFOLFIRINOX, Gemcitabine, RT"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "oxaliplatin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1318011],
      "conceptName": ["oxaliplatin"]
    },
    "Leucovorin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1388796],
      "conceptName": ["Leucovorin"]
    },
    "irinotecan": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1367268],
      "conceptName": ["irinotecan"]
    },
    "gemcitabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1314924],
      "conceptName": ["gemcitabine"]
    },
    "Fluorouracil": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    }
  },
  {
    "conceptId": [35806829],
    "regimenName": ["Goserelin and RT"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Goserelin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1366310],
      "conceptName": ["Goserelin"]
    },
    "bicalutamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344381],
      "conceptName": ["bicalutamide"]
    },
    "anastrozole": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1348265],
      "conceptName": ["anastrozole"]
    },
    "Flutamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1356461],
      "conceptName": ["Flutamide"]
    },
    "Tamoxifen": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1436678],
      "conceptName": ["Tamoxifen"]
    }
  },
  {
    "conceptId": [35804823],
    "regimenName": ["Cisplatin, Interferon alfa-2a, Isotretinoin"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Cisplatin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "Isotretinoin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [984232],
      "conceptName": ["Isotretinoin"]
    },
    "Interferon Alfa-2a": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1379969],
      "conceptName": ["Interferon Alfa-2a"]
    }
  },
  {
    "conceptId": [35805247],
    "regimenName": ["Dactinomycin monotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Dactinomycin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1311443],
      "conceptName": ["Dactinomycin"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Bleomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1329241],
      "conceptName": ["Bleomycin"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Mesna": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1354698],
      "conceptName": ["Mesna"]
    },
    "irinotecan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1367268],
      "conceptName": ["irinotecan"]
    },
    "Chlorambucil": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1390051],
      "conceptName": ["Chlorambucil"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "Ifosfamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    }
  },
  {
    "conceptId": [35806596],
    "regimenName": ["FOLFOX"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "oxaliplatin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1318011],
      "conceptName": ["oxaliplatin"]
    },
    "Leucovorin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1388796],
      "conceptName": ["Leucovorin"]
    },
    "Fluorouracil": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "gemcitabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314924],
      "conceptName": ["gemcitabine"]
    },
    "cetuximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1315411],
      "conceptName": ["cetuximab"]
    },
    "docetaxel": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1315942],
      "conceptName": ["docetaxel"]
    },
    "irinotecan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1367268],
      "conceptName": ["irinotecan"]
    },
    "bevacizumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397141],
      "conceptName": ["bevacizumab"]
    },
    "panitumumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19100985],
      "conceptName": ["panitumumab"]
    }
  },
  {
    "conceptId": [35804604],
    "regimenName": ["Idelalisib and Ofatumumab"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "ofatumumab": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [40167582],
      "conceptName": ["ofatumumab"]
    },
    "idelalisib": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [45776944],
      "conceptName": ["idelalisib"]
    }
  },
  {
    "conceptId": [35806966],
    "regimenName": ["Doxorubicin, Ifosfamide, RT"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Ifosfamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Dacarbazine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311409],
      "conceptName": ["Dacarbazine"]
    },
    "Dactinomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311443],
      "conceptName": ["Dactinomycin"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Bleomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1329241],
      "conceptName": ["Bleomycin"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Mesna": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1354698],
      "conceptName": ["Mesna"]
    },
    "irinotecan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1367268],
      "conceptName": ["irinotecan"]
    },
    "Topotecan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1378509],
      "conceptName": ["Topotecan"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Vindesine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008336],
      "conceptName": ["Vindesine"]
    },
    "Teniposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19136750],
      "conceptName": ["Teniposide"]
    }
  },
  {
    "conceptId": [35803700],
    "regimenName": ["DA-EPOCH"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Prednisone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Etoposide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Bleomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1329241],
      "conceptName": ["Bleomycin"]
    },
    "Carboplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344905],
      "conceptName": ["Carboplatin"]
    },
    "Procarbazine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1351779],
      "conceptName": ["Procarbazine"]
    },
    "Mechlorethamine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1394337],
      "conceptName": ["Mechlorethamine"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "Vindesine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008336],
      "conceptName": ["Vindesine"]
    },
    "Ifosfamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    },
    "Teniposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19136750],
      "conceptName": ["Teniposide"]
    },
    "ranimustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [35197850],
      "conceptName": ["ranimustine"]
    }
  },
  {
    "conceptId": [35804036],
    "regimenName": ["Cyclophosphamide, Cytarabine, Mercaptopurine"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Cytarabine": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "mercaptopurine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1436650],
      "conceptName": ["mercaptopurine"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "imatinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1304107],
      "conceptName": ["imatinib"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "pegaspargase": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1326481],
      "conceptName": ["pegaspargase"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Thioguanine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1437379],
      "conceptName": ["Thioguanine"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "nelarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19002912],
      "conceptName": ["nelarabine"]
    },
    "ASPARAGINASE": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19012585],
      "conceptName": ["ASPARAGINASE"]
    }
  },
  {
    "conceptId": [35806401],
    "regimenName": ["Carboplatin, Paclitaxel, Bevacizumab"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Carboplatin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1344905],
      "conceptName": ["Carboplatin"]
    },
    "Paclitaxel": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1378382],
      "conceptName": ["Paclitaxel"]
    },
    "bevacizumab": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1397141],
      "conceptName": ["bevacizumab"]
    },
    "atezolizumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [42629079],
      "conceptName": ["atezolizumab"]
    }
  },
  {
    "conceptId": [35806424],
    "regimenName": ["Crizotinib monotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "crizotinib": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [40242675],
      "conceptName": ["crizotinib"]
    }
  },
  {
    "conceptId": [35803513],
    "regimenName": ["Midostaurin monotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "midostaurin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1594003],
      "conceptName": ["midostaurin"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Daunorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311799],
      "conceptName": ["Daunorubicin"]
    }
  },
  {
    "conceptId": [35805686],
    "regimenName": ["Doxifluridine and Mitomycin"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Mitomycin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1389036],
      "conceptName": ["Mitomycin"]
    },
    "doxifluridine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [43008996],
      "conceptName": ["doxifluridine"]
    }
  },
  {
    "conceptId": [35806334],
    "regimenName": ["ZRd"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "lenalidomide": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [19026972],
      "conceptName": ["lenalidomide"]
    },
    "Vorinostat": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1337651],
      "conceptName": ["Vorinostat"]
    },
    "Dexamethasone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    }
  },
  {
    "conceptId": [35806399],
    "regimenName": ["Cisplatin, Vinblastine, RT"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Cisplatin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "Vinblastine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [19008264],
      "conceptName": ["Vinblastine"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Aldesleukin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1309770],
      "conceptName": ["Aldesleukin"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Dacarbazine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311409],
      "conceptName": ["Dacarbazine"]
    },
    "Bleomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1329241],
      "conceptName": ["Bleomycin"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Interferon Alfa-2b": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1380068],
      "conceptName": ["Interferon Alfa-2b"]
    },
    "Mitomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1389036],
      "conceptName": ["Mitomycin"]
    },
    "Ifosfamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    }
  },
  {
    "conceptId": [35806105],
    "regimenName": ["Ox-P"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "oxaliplatin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1318011],
      "conceptName": ["oxaliplatin"]
    },
    "Prednisone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    }
  },
  {
    "conceptId": [35806861],
    "regimenName": ["Sipuleucel-T monotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "sipuleucel-T": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [40224095],
      "conceptName": ["sipuleucel-T"]
    }
  },
  {
    "conceptId": [35804061],
    "regimenName": ["CCE"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Cyclophosphamide": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Etoposide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "clofarabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [19054821],
      "conceptName": ["clofarabine"]
    }
  },
  {
    "conceptId": [35804574],
    "regimenName": ["Chlorambucil and Rituximab"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Chlorambucil": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1390051],
      "conceptName": ["Chlorambucil"]
    },
    "rituximab": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Mitoxantrone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1309188],
      "conceptName": ["Mitoxantrone"]
    },
    "bortezomib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1336825],
      "conceptName": ["bortezomib"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "prednisolone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1550557],
      "conceptName": ["prednisolone"]
    }
  },
  {
    "conceptId": [35806857],
    "regimenName": ["Docetaxel and Estramustine"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Estramustine": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1349025],
      "conceptName": ["Estramustine"]
    },
    "docetaxel": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1315942],
      "conceptName": ["docetaxel"]
    }
  },
  {
    "conceptId": [35806959],
    "regimenName": ["EVI"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Ifosfamide": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    },
    "Epirubicin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1344354],
      "conceptName": ["Epirubicin"]
    },
    "Vindesine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [19008336],
      "conceptName": ["Vindesine"]
    }
  },
  {
    "conceptId": [35806437],
    "regimenName": ["MACC"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Methotrexate": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Lomustine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1391846],
      "conceptName": ["Lomustine"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    }
  },
  {
    "conceptId": [35803594],
    "regimenName": ["mLSG15"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Carboplatin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1344905],
      "conceptName": ["Carboplatin"]
    },
    "ranimustine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [35197850],
      "conceptName": ["ranimustine"]
    },
    "Vindesine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [19008336],
      "conceptName": ["Vindesine"]
    },
    "Prednisone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Etoposide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    }
  },
  {
    "conceptId": [35806892],
    "regimenName": ["Capecitabine, Sorafenib, RT"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "capecitabine": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1337620],
      "conceptName": ["capecitabine"]
    },
    "sorafenib": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1363387],
      "conceptName": ["sorafenib"]
    }
  },
  {
    "conceptId": [35803441],
    "regimenName": ["HAM"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Cytarabine": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Mitoxantrone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1309188],
      "conceptName": ["Mitoxantrone"]
    },
    "Tretinoin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [903643],
      "conceptName": ["Tretinoin"]
    },
    "imatinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1304107],
      "conceptName": ["imatinib"]
    },
    "Filgrastim": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1304850],
      "conceptName": ["Filgrastim"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Thioguanine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1437379],
      "conceptName": ["Thioguanine"]
    },
    "Cladribine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19054825],
      "conceptName": ["Cladribine"]
    },
    "Idarubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078097],
      "conceptName": ["Idarubicin"]
    }
  },
  {
    "conceptId": [35804201],
    "regimenName": ["TH (Taxol)"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Paclitaxel": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1378382],
      "conceptName": ["Paclitaxel"]
    },
    "trastuzumab": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1387104],
      "conceptName": ["trastuzumab"]
    },
    "Carboplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344905],
      "conceptName": ["Carboplatin"]
    },
    "lapatinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1359548],
      "conceptName": ["lapatinib"]
    },
    "pertuzumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [42801287],
      "conceptName": ["pertuzumab"]
    }
  },
  {
    "conceptId": [35805681],
    "regimenName": ["Docetaxel and S-1"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "docetaxel": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1315942],
      "conceptName": ["docetaxel"]
    },
    "Hyaluronidase / trastuzumab Injection [Herceptin Hylecta]": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1366689],
      "conceptName": ["Hyaluronidase / trastuzumab Injection [Herceptin Hylecta]"]
    }
  },
  {
    "conceptId": [35806350],
    "regimenName": ["Melphalan, then auto HSCT, then RIC allo HSCT"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Melphalan": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1301267],
      "conceptName": ["Melphalan"]
    },
    "Busulfan": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1333357],
      "conceptName": ["Busulfan"]
    },
    "fludarabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1395557],
      "conceptName": ["fludarabine"]
    }
  },
  {
    "conceptId": [35102014],
    "regimenName": ["R-CHOP (Prednisolone)"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "rituximab": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "prednisolone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1550557],
      "conceptName": ["prednisolone"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    }
  },
  {
    "conceptId": [35805802],
    "regimenName": ["ABVD"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Bleomycin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1329241],
      "conceptName": ["Bleomycin"]
    },
    "Vinblastine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [19008264],
      "conceptName": ["Vinblastine"]
    },
    "Dacarbazine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1311409],
      "conceptName": ["Dacarbazine"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Procarbazine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1351779],
      "conceptName": ["Procarbazine"]
    },
    "Mechlorethamine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1394337],
      "conceptName": ["Mechlorethamine"]
    },
    "Methylprednisolone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1506270],
      "conceptName": ["Methylprednisolone"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    }
  },
  {
    "conceptId": [35804599],
    "regimenName": ["CVP"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Prednisone": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Fluorouracil": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "Melphalan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1301267],
      "conceptName": ["Melphalan"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Mitoxantrone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1309188],
      "conceptName": ["Mitoxantrone"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Dacarbazine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311409],
      "conceptName": ["Dacarbazine"]
    },
    "Daunorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311799],
      "conceptName": ["Daunorubicin"]
    },
    "alemtuzumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1312706],
      "conceptName": ["alemtuzumab"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Bleomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1329241],
      "conceptName": ["Bleomycin"]
    },
    "bortezomib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1336825],
      "conceptName": ["bortezomib"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Epirubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344354],
      "conceptName": ["Epirubicin"]
    },
    "Carboplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344905],
      "conceptName": ["Carboplatin"]
    },
    "Carmustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350066],
      "conceptName": ["Carmustine"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Procarbazine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1351779],
      "conceptName": ["Procarbazine"]
    },
    "Mechlorethamine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1394337],
      "conceptName": ["Mechlorethamine"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "Thioguanine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1437379],
      "conceptName": ["Thioguanine"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "Hyaluronidase / rituximab Injection [Rituxan Hycela]": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1593155],
      "conceptName": ["Hyaluronidase / rituximab Injection [Rituxan Hycela]"]
    },
    "Vinblastine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008264],
      "conceptName": ["Vinblastine"]
    },
    "Vindesine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008336],
      "conceptName": ["Vindesine"]
    },
    "everolimus": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19011440],
      "conceptName": ["everolimus"]
    },
    "ASPARAGINASE": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19012585],
      "conceptName": ["ASPARAGINASE"]
    },
    "lenalidomide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19026972],
      "conceptName": ["lenalidomide"]
    },
    "denileukin diftitox": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19051642],
      "conceptName": ["denileukin diftitox"]
    },
    "doxorubicin liposome": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19051649],
      "conceptName": ["doxorubicin liposome"]
    },
    "iodine-131-tositumomab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19054997],
      "conceptName": ["iodine-131-tositumomab"]
    },
    "Idarubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078097],
      "conceptName": ["Idarubicin"]
    },
    "Ifosfamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    },
    "BCG, Live, Tice Strain": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19086176],
      "conceptName": ["BCG, Live, Tice Strain"]
    },
    "Teniposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19136750],
      "conceptName": ["Teniposide"]
    },
    "ranimustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [35197850],
      "conceptName": ["ranimustine"]
    },
    "ofatumumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [40167582],
      "conceptName": ["ofatumumab"]
    },
    "obinutuzumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [44507676],
      "conceptName": ["obinutuzumab"]
    }
  },
  {
    "conceptId": [35805063],
    "regimenName": ["R-ICE"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Carboplatin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1344905],
      "conceptName": ["Carboplatin"]
    },
    "Ifosfamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    },
    "Mesna": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1354698],
      "conceptName": ["Mesna"]
    },
    "rituximab": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Etoposide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "lenalidomide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19026972],
      "conceptName": ["lenalidomide"]
    }
  },
  {
    "conceptId": [35803505],
    "regimenName": ["BuCy, then allo HSCT"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Busulfan": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1333357],
      "conceptName": ["Busulfan"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "fludarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1395557],
      "conceptName": ["fludarabine"]
    },
    "Thiotepa": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19137385],
      "conceptName": ["Thiotepa"]
    }
  },
  {
    "conceptId": [35805985],
    "regimenName": ["Mercaptopurine, Methotrexate, Vinblastine, Prednisolone"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Methotrexate": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "mercaptopurine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1436650],
      "conceptName": ["mercaptopurine"]
    },
    "Vinblastine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [19008264],
      "conceptName": ["Vinblastine"]
    },
    "prednisolone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1550557],
      "conceptName": ["prednisolone"]
    }
  },
  {
    "conceptId": [35805114],
    "regimenName": ["VEPA"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "prednisolone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1550557],
      "conceptName": ["prednisolone"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Bleomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1329241],
      "conceptName": ["Bleomycin"]
    },
    "bortezomib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1336825],
      "conceptName": ["bortezomib"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Procarbazine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1351779],
      "conceptName": ["Procarbazine"]
    },
    "ASPARAGINASE": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19012585],
      "conceptName": ["ASPARAGINASE"]
    }
  },
  {
    "conceptId": [35806486],
    "regimenName": ["Doxorubicin pegylated liposomal and Gemcitabine"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "doxorubicin liposome": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [19051649],
      "conceptName": ["doxorubicin liposome"]
    },
    "gemcitabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1314924],
      "conceptName": ["gemcitabine"]
    },
    "vinorelbine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1343346],
      "conceptName": ["vinorelbine"]
    }
  },
  {
    "conceptId": [35806863],
    "regimenName": ["Samarium-153 monotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "SAMARIUM Sm153": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338558],
      "conceptName": ["SAMARIUM Sm153"]
    }
  },
  {
    "conceptId": [35804081],
    "regimenName": ["Dasatinib, Vincristine, Prednisone"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Prednisone": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "dasatinib": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1358436],
      "conceptName": ["dasatinib"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    }
  },
  {
    "conceptId": [35806439],
    "regimenName": ["MVP (Vindesine)"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Cisplatin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "Mitomycin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1389036],
      "conceptName": ["Mitomycin"]
    },
    "Vindesine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [19008336],
      "conceptName": ["Vindesine"]
    }
  },
  {
    "conceptId": [35806352],
    "regimenName": ["Interferon alfa and Prednisone"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Prednisone": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Interferon Alfa-2b": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1380068],
      "conceptName": ["Interferon Alfa-2b"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Teniposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19136750],
      "conceptName": ["Teniposide"]
    }
  },
  {
    "conceptId": [35806297],
    "regimenName": ["VAD-P"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Prednisone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Dexamethasone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Melphalan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1301267],
      "conceptName": ["Melphalan"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Carmustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350066],
      "conceptName": ["Carmustine"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "Quinine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1760616],
      "conceptName": ["Quinine"]
    },
    "Vindesine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008336],
      "conceptName": ["Vindesine"]
    },
    "Ifosfamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    },
    "Teniposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19136750],
      "conceptName": ["Teniposide"]
    }
  },
  {
    "conceptId": [35804811],
    "regimenName": ["Belinostat monotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "belinostat": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [45776670],
      "conceptName": ["belinostat"]
    }
  },
  {
    "conceptId": [35804584],
    "regimenName": ["Alemtuzumab and Methylprednisolone"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Methylprednisolone": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1506270],
      "conceptName": ["Methylprednisolone"]
    },
    "alemtuzumab": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1312706],
      "conceptName": ["alemtuzumab"]
    }
  },
  {
    "conceptId": [35804276],
    "regimenName": ["Goserelin monotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Goserelin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1366310],
      "conceptName": ["Goserelin"]
    },
    "bicalutamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344381],
      "conceptName": ["bicalutamide"]
    },
    "anastrozole": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1348265],
      "conceptName": ["anastrozole"]
    },
    "Flutamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1356461],
      "conceptName": ["Flutamide"]
    },
    "Tamoxifen": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1436678],
      "conceptName": ["Tamoxifen"]
    }
  },
  {
    "conceptId": [35804581],
    "regimenName": ["Ibrutinib monotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Ibrutinib": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [44507848],
      "conceptName": ["Ibrutinib"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "bendamustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19015523],
      "conceptName": ["bendamustine"]
    },
    "venetoclax": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [35604205],
      "conceptName": ["venetoclax"]
    },
    "ofatumumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [40167582],
      "conceptName": ["ofatumumab"]
    },
    "obinutuzumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [44507676],
      "conceptName": ["obinutuzumab"]
    }
  },
  {
    "conceptId": [35805450],
    "regimenName": ["VDC/IE"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Ifosfamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Etoposide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Dactinomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311443],
      "conceptName": ["Dactinomycin"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "irinotecan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1367268],
      "conceptName": ["irinotecan"]
    },
    "Topotecan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1378509],
      "conceptName": ["Topotecan"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Vindesine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008336],
      "conceptName": ["Vindesine"]
    },
    "Teniposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19136750],
      "conceptName": ["Teniposide"]
    }
  },
  {
    "conceptId": [35805089],
    "regimenName": ["CCOP"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "doxorubicin liposome": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [19051649],
      "conceptName": ["doxorubicin liposome"]
    },
    "Prednisone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    }
  },
  {
    "conceptId": [35803452],
    "regimenName": ["7 plus 3m"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Cytarabine": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Mitoxantrone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1309188],
      "conceptName": ["Mitoxantrone"]
    },
    "Tretinoin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [903643],
      "conceptName": ["Tretinoin"]
    },
    "imatinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1304107],
      "conceptName": ["imatinib"]
    },
    "Filgrastim": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1304850],
      "conceptName": ["Filgrastim"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Thioguanine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1437379],
      "conceptName": ["Thioguanine"]
    },
    "Cladribine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19054825],
      "conceptName": ["Cladribine"]
    },
    "Idarubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078097],
      "conceptName": ["Idarubicin"]
    }
  },
  {
    "conceptId": [35805983],
    "regimenName": ["Methotrexate, Vinblastine, Prednisone"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Methotrexate": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Prednisone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Vinblastine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [19008264],
      "conceptName": ["Vinblastine"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    }
  },
  {
    "conceptId": [35807044],
    "regimenName": ["PAC"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Cisplatin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "Prednisone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    }
  },
  {
    "conceptId": [35805229],
    "regimenName": ["Erlotinib monotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "erlotinib": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1325363],
      "conceptName": ["erlotinib"]
    },
    "gemcitabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314924],
      "conceptName": ["gemcitabine"]
    },
    "capecitabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1337620],
      "conceptName": ["capecitabine"]
    },
    "Carboplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344905],
      "conceptName": ["Carboplatin"]
    },
    "bevacizumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397141],
      "conceptName": ["bevacizumab"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "cabozantinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [43012292],
      "conceptName": ["cabozantinib"]
    }
  },
  {
    "conceptId": [35805860],
    "regimenName": ["CEP"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Cisplatin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "Epirubicin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1344354],
      "conceptName": ["Epirubicin"]
    },
    "Lomustine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1391846],
      "conceptName": ["Lomustine"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Etoposide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    }
  },
  {
    "conceptId": [35806306],
    "regimenName": ["Bortezomib, Dexamethasone, Panobinostat"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "panobinostat": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [46221435],
      "conceptName": ["panobinostat"]
    },
    "bortezomib": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1336825],
      "conceptName": ["bortezomib"]
    },
    "Dexamethasone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "Thalidomide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19137042],
      "conceptName": ["Thalidomide"]
    }
  },
  {
    "conceptId": [35804807],
    "regimenName": ["Fluorouracil and Semustine"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Fluorouracil": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "Melphalan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1301267],
      "conceptName": ["Melphalan"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Mitoxantrone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1309188],
      "conceptName": ["Mitoxantrone"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "gemcitabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314924],
      "conceptName": ["gemcitabine"]
    },
    "cetuximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1315411],
      "conceptName": ["cetuximab"]
    },
    "docetaxel": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1315942],
      "conceptName": ["docetaxel"]
    },
    "oxaliplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1318011],
      "conceptName": ["oxaliplatin"]
    },
    "capecitabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1337620],
      "conceptName": ["capecitabine"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Epirubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344354],
      "conceptName": ["Epirubicin"]
    },
    "Carboplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344905],
      "conceptName": ["Carboplatin"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "irinotecan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1367268],
      "conceptName": ["irinotecan"]
    },
    "Altretamine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1368823],
      "conceptName": ["Altretamine"]
    },
    "hydroxyurea": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1377141],
      "conceptName": ["hydroxyurea"]
    },
    "Paclitaxel": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1378382],
      "conceptName": ["Paclitaxel"]
    },
    "trastuzumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1387104],
      "conceptName": ["trastuzumab"]
    },
    "Leucovorin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1388796],
      "conceptName": ["Leucovorin"]
    },
    "Mitomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1389036],
      "conceptName": ["Mitomycin"]
    },
    "Levamisole": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1389464],
      "conceptName": ["Levamisole"]
    },
    "bevacizumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397141],
      "conceptName": ["bevacizumab"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "Tamoxifen": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1436678],
      "conceptName": ["Tamoxifen"]
    },
    "Medroxyprogesterone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1500211],
      "conceptName": ["Medroxyprogesterone"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "doxorubicin liposome": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19051649],
      "conceptName": ["doxorubicin liposome"]
    },
    "BCG, Live, Tice Strain": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19086176],
      "conceptName": ["BCG, Live, Tice Strain"]
    },
    "panitumumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19100985],
      "conceptName": ["panitumumab"]
    },
    "Streptozocin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19136210],
      "conceptName": ["Streptozocin"]
    },
    "Thiotepa": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19137385],
      "conceptName": ["Thiotepa"]
    },
    "irinotecan liposomal": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [35603068],
      "conceptName": ["irinotecan liposomal"]
    },
    "levoleucovorin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [40168303],
      "conceptName": ["levoleucovorin"]
    },
    "aflibercept": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [40244266],
      "conceptName": ["aflibercept"]
    },
    "ramucirumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [44818489],
      "conceptName": ["ramucirumab"]
    }
  },
  {
    "conceptId": [35805841],
    "regimenName": ["Flu-Mel, then allo HSCT"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Melphalan": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1301267],
      "conceptName": ["Melphalan"]
    },
    "fludarabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1395557],
      "conceptName": ["fludarabine"]
    },
    "alemtuzumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1312706],
      "conceptName": ["alemtuzumab"]
    },
    "Busulfan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1333357],
      "conceptName": ["Busulfan"]
    }
  },
  {
    "conceptId": [35806911],
    "regimenName": ["VI, then VDC/IE, then VAC, then VI"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Dactinomycin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1311443],
      "conceptName": ["Dactinomycin"]
    },
    "Ifosfamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    },
    "irinotecan": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1367268],
      "conceptName": ["irinotecan"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Etoposide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    }
  },
  {
    "conceptId": [35804625],
    "regimenName": ["Uracil mustard monotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Uracil Mustard": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [19006880],
      "conceptName": ["Uracil Mustard"]
    }
  },
  {
    "conceptId": [35804071],
    "regimenName": ["Nilotinib-based consolidation"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Methotrexate": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Cytarabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "nilotinib": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1394023],
      "conceptName": ["nilotinib"]
    },
    "Daunorubicin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1311799],
      "conceptName": ["Daunorubicin"]
    },
    "Etoposide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "prednisolone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1550557],
      "conceptName": ["prednisolone"]
    }
  },
  {
    "conceptId": [35804644],
    "regimenName": ["Azacitidine and Vorinostat"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Azacitidine": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1314865],
      "conceptName": ["Azacitidine"]
    },
    "Vorinostat": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1337651],
      "conceptName": ["Vorinostat"]
    },
    "Gemtuzumab ozogamicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [42799711],
      "conceptName": ["Gemtuzumab ozogamicin"]
    }
  },
  {
    "conceptId": [35101933],
    "regimenName": ["Irinotecan and S-1"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "irinotecan": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1367268],
      "conceptName": ["irinotecan"]
    },
    "Hyaluronidase / trastuzumab Injection [Herceptin Hylecta]": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1366689],
      "conceptName": ["Hyaluronidase / trastuzumab Injection [Herceptin Hylecta]"]
    },
    "bevacizumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397141],
      "conceptName": ["bevacizumab"]
    }
  },
  {
    "conceptId": [35805719],
    "regimenName": ["Lomustine monotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Lomustine": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1391846],
      "conceptName": ["Lomustine"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Dacarbazine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311409],
      "conceptName": ["Dacarbazine"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Bleomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1329241],
      "conceptName": ["Bleomycin"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "temozolomide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1341149],
      "conceptName": ["temozolomide"]
    },
    "Epirubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344354],
      "conceptName": ["Epirubicin"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Procarbazine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1351779],
      "conceptName": ["Procarbazine"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "Methylprednisolone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1506270],
      "conceptName": ["Methylprednisolone"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Vinblastine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008264],
      "conceptName": ["Vinblastine"]
    },
    "Idarubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078097],
      "conceptName": ["Idarubicin"]
    },
    "Streptozocin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19136210],
      "conceptName": ["Streptozocin"]
    }
  },
  {
    "conceptId": [35806261],
    "regimenName": ["RVDC"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "lenalidomide": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [19026972],
      "conceptName": ["lenalidomide"]
    },
    "bortezomib": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1336825],
      "conceptName": ["bortezomib"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Dexamethasone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    }
  },
  {
    "conceptId": [35804614],
    "regimenName": ["Lenalidomide and Ofatumumab"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "lenalidomide": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [19026972],
      "conceptName": ["lenalidomide"]
    },
    "ofatumumab": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [40167582],
      "conceptName": ["ofatumumab"]
    }
  },
  {
    "conceptId": [35102007],
    "regimenName": ["FOLFIRI and Bevacizumab (L-Leucovorin)"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "bevacizumab": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1397141],
      "conceptName": ["bevacizumab"]
    },
    "irinotecan": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1367268],
      "conceptName": ["irinotecan"]
    },
    "levoleucovorin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [40168303],
      "conceptName": ["levoleucovorin"]
    },
    "Fluorouracil": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "oxaliplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1318011],
      "conceptName": ["oxaliplatin"]
    }
  },
  {
    "conceptId": [35804217],
    "regimenName": ["THP (Taxotere)"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "pertuzumab": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [42801287],
      "conceptName": ["pertuzumab"]
    },
    "trastuzumab": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1387104],
      "conceptName": ["trastuzumab"]
    },
    "docetaxel": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1315942],
      "conceptName": ["docetaxel"]
    },
    "Carboplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344905],
      "conceptName": ["Carboplatin"]
    }
  },
  {
    "conceptId": [35807030],
    "regimenName": ["Plicamycin monotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Plicamycin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [19009165],
      "conceptName": ["Plicamycin"]
    }
  },
  {
    "conceptId": [35804562],
    "regimenName": ["ECF"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Cisplatin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "Epirubicin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1344354],
      "conceptName": ["Epirubicin"]
    },
    "Fluorouracil": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "gemcitabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314924],
      "conceptName": ["gemcitabine"]
    }
  },
  {
    "conceptId": [35805640],
    "regimenName": ["O-CHOP"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "ofatumumab": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [40167582],
      "conceptName": ["ofatumumab"]
    },
    "Prednisone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    }
  },
  {
    "conceptId": [35805637],
    "regimenName": ["Interferon alfa-2a monotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Interferon Alfa-2a": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1379969],
      "conceptName": ["Interferon Alfa-2a"]
    },
    "Isotretinoin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [984232],
      "conceptName": ["Isotretinoin"]
    },
    "imatinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1304107],
      "conceptName": ["imatinib"]
    },
    "Aldesleukin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1309770],
      "conceptName": ["Aldesleukin"]
    },
    "Interferon Alfa-2b": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1380068],
      "conceptName": ["Interferon Alfa-2b"]
    },
    "bevacizumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397141],
      "conceptName": ["bevacizumab"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "peginterferon alfa-2a": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1714165],
      "conceptName": ["peginterferon alfa-2a"]
    },
    "Thalidomide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19137042],
      "conceptName": ["Thalidomide"]
    }
  },
  {
    "conceptId": [35804790],
    "regimenName": ["mFOLFOX6 and Cetuximab"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "oxaliplatin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1318011],
      "conceptName": ["oxaliplatin"]
    },
    "Leucovorin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1388796],
      "conceptName": ["Leucovorin"]
    },
    "cetuximab": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1315411],
      "conceptName": ["cetuximab"]
    },
    "Fluorouracil": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    }
  },
  {
    "conceptId": [35806905],
    "regimenName": ["Interferon alfa-2a and Interleukin-2"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Aldesleukin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1309770],
      "conceptName": ["Aldesleukin"]
    },
    "Interferon Alfa-2a": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1379969],
      "conceptName": ["Interferon Alfa-2a"]
    }
  },
  {
    "conceptId": [35806308],
    "regimenName": ["Bortezomib and Vorinostat"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "bortezomib": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1336825],
      "conceptName": ["bortezomib"]
    },
    "Vorinostat": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1337651],
      "conceptName": ["Vorinostat"]
    }
  },
  {
    "conceptId": [35806636],
    "regimenName": ["GDPT"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Cisplatin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "Thalidomide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [19137042],
      "conceptName": ["Thalidomide"]
    },
    "Prednisone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "gemcitabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1314924],
      "conceptName": ["gemcitabine"]
    }
  },
  {
    "conceptId": [35804796],
    "regimenName": ["mFOLFOXIRI and Cetuximab (L-Leucovorin)"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "oxaliplatin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1318011],
      "conceptName": ["oxaliplatin"]
    },
    "irinotecan": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1367268],
      "conceptName": ["irinotecan"]
    },
    "cetuximab": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1315411],
      "conceptName": ["cetuximab"]
    },
    "levoleucovorin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [40168303],
      "conceptName": ["levoleucovorin"]
    },
    "Fluorouracil": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    }
  },
  {
    "conceptId": [35806476],
    "regimenName": ["Cyclophosphamide and Etoposide"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Cyclophosphamide": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Etoposide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Melphalan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1301267],
      "conceptName": ["Melphalan"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Mitoxantrone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1309188],
      "conceptName": ["Mitoxantrone"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Dactinomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311443],
      "conceptName": ["Dactinomycin"]
    },
    "Daunorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311799],
      "conceptName": ["Daunorubicin"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Bleomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1329241],
      "conceptName": ["Bleomycin"]
    },
    "bortezomib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1336825],
      "conceptName": ["bortezomib"]
    },
    "Vorinostat": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1337651],
      "conceptName": ["Vorinostat"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Epirubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344354],
      "conceptName": ["Epirubicin"]
    },
    "Carboplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344905],
      "conceptName": ["Carboplatin"]
    },
    "Carmustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350066],
      "conceptName": ["Carmustine"]
    },
    "Procarbazine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1351779],
      "conceptName": ["Procarbazine"]
    },
    "irinotecan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1367268],
      "conceptName": ["irinotecan"]
    },
    "Topotecan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1378509],
      "conceptName": ["Topotecan"]
    },
    "Lomustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1391846],
      "conceptName": ["Lomustine"]
    },
    "Mechlorethamine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1394337],
      "conceptName": ["Mechlorethamine"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "mercaptopurine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1436650],
      "conceptName": ["mercaptopurine"]
    },
    "Thioguanine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1437379],
      "conceptName": ["Thioguanine"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "prednisolone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1550557],
      "conceptName": ["prednisolone"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Vinblastine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008264],
      "conceptName": ["Vinblastine"]
    },
    "Vindesine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008336],
      "conceptName": ["Vindesine"]
    },
    "ASPARAGINASE": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19012585],
      "conceptName": ["ASPARAGINASE"]
    },
    "doxorubicin liposome": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19051649],
      "conceptName": ["doxorubicin liposome"]
    },
    "clofarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19054821],
      "conceptName": ["clofarabine"]
    },
    "Ifosfamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    },
    "Teniposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19136750],
      "conceptName": ["Teniposide"]
    },
    "Thalidomide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19137042],
      "conceptName": ["Thalidomide"]
    },
    "ranimustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [35197850],
      "conceptName": ["ranimustine"]
    }
  },
  {
    "conceptId": [35805371],
    "regimenName": ["Paclitaxel and Ramucirumab"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Paclitaxel": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1378382],
      "conceptName": ["Paclitaxel"]
    },
    "ramucirumab": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [44818489],
      "conceptName": ["ramucirumab"]
    }
  },
  {
    "conceptId": [35804428],
    "regimenName": ["Procarbazine monotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Procarbazine": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1351779],
      "conceptName": ["Procarbazine"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Mitoxantrone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1309188],
      "conceptName": ["Mitoxantrone"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Dacarbazine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311409],
      "conceptName": ["Dacarbazine"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Bleomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1329241],
      "conceptName": ["Bleomycin"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Carmustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350066],
      "conceptName": ["Carmustine"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Chlorambucil": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1390051],
      "conceptName": ["Chlorambucil"]
    },
    "Lomustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1391846],
      "conceptName": ["Lomustine"]
    },
    "Mechlorethamine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1394337],
      "conceptName": ["Mechlorethamine"]
    },
    "Methylprednisolone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1506270],
      "conceptName": ["Methylprednisolone"]
    },
    "prednisolone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1550557],
      "conceptName": ["prednisolone"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Vinblastine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008264],
      "conceptName": ["Vinblastine"]
    },
    "Thalidomide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19137042],
      "conceptName": ["Thalidomide"]
    }
  },
  {
    "conceptId": [35803569],
    "regimenName": ["Busulfan and Melphalan, then auto HSCT"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Melphalan": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1301267],
      "conceptName": ["Melphalan"]
    },
    "Busulfan": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1333357],
      "conceptName": ["Busulfan"]
    },
    "fludarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1395557],
      "conceptName": ["fludarabine"]
    }
  },
  {
    "conceptId": [35803434],
    "regimenName": ["7 plus 3d (standard-dose)"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Cytarabine": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Daunorubicin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1311799],
      "conceptName": ["Daunorubicin"]
    },
    "Tretinoin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [903643],
      "conceptName": ["Tretinoin"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Azacitidine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314865],
      "conceptName": ["Azacitidine"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "glasdegib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1355795],
      "conceptName": ["glasdegib"]
    },
    "sorafenib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1363387],
      "conceptName": ["sorafenib"]
    },
    "nilotinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1394023],
      "conceptName": ["nilotinib"]
    },
    "mercaptopurine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1436650],
      "conceptName": ["mercaptopurine"]
    },
    "Thioguanine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1437379],
      "conceptName": ["Thioguanine"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "prednisolone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1550557],
      "conceptName": ["prednisolone"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "midostaurin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1594003],
      "conceptName": ["midostaurin"]
    },
    "ASPARAGINASE": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19012585],
      "conceptName": ["ASPARAGINASE"]
    },
    "Cladribine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19054825],
      "conceptName": ["Cladribine"]
    },
    "Teniposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19136750],
      "conceptName": ["Teniposide"]
    },
    "Gemtuzumab ozogamicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [42799711],
      "conceptName": ["Gemtuzumab ozogamicin"]
    },
    "omacetaxine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [45775576],
      "conceptName": ["omacetaxine"]
    }
  },
  {
    "conceptId": [35805817],
    "regimenName": ["ABVE-PC"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Bleomycin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1329241],
      "conceptName": ["Bleomycin"]
    },
    "Prednisone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Etoposide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Procarbazine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1351779],
      "conceptName": ["Procarbazine"]
    }
  },
  {
    "conceptId": [35804786],
    "regimenName": ["FOLFIRI and Ramucirumab"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Leucovorin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1388796],
      "conceptName": ["Leucovorin"]
    },
    "irinotecan": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1367268],
      "conceptName": ["irinotecan"]
    },
    "Fluorouracil": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "ramucirumab": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [44818489],
      "conceptName": ["ramucirumab"]
    }
  },
  {
    "conceptId": [35806961],
    "regimenName": ["TEC"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Carboplatin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1344905],
      "conceptName": ["Carboplatin"]
    },
    "Paclitaxel": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1378382],
      "conceptName": ["Paclitaxel"]
    },
    "Etoposide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    }
  },
  {
    "conceptId": [35804594],
    "regimenName": ["Ofatumumab monotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "ofatumumab": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [40167582],
      "conceptName": ["ofatumumab"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Carboplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344905],
      "conceptName": ["Carboplatin"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Mesna": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1354698],
      "conceptName": ["Mesna"]
    },
    "Chlorambucil": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1390051],
      "conceptName": ["Chlorambucil"]
    },
    "fludarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1395557],
      "conceptName": ["fludarabine"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "Methylprednisolone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1506270],
      "conceptName": ["Methylprednisolone"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "bendamustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19015523],
      "conceptName": ["bendamustine"]
    },
    "lenalidomide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19026972],
      "conceptName": ["lenalidomide"]
    },
    "Pentostatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19031224],
      "conceptName": ["Pentostatin"]
    },
    "Ifosfamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    },
    "Ibrutinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [44507848],
      "conceptName": ["Ibrutinib"]
    },
    "idelalisib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [45776944],
      "conceptName": ["idelalisib"]
    }
  },
  {
    "conceptId": [35805096],
    "regimenName": ["CNOP"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Prednisone": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Mitoxantrone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1309188],
      "conceptName": ["Mitoxantrone"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Bleomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1329241],
      "conceptName": ["Bleomycin"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    }
  },
  {
    "conceptId": [35804262],
    "regimenName": ["Doxorubicin non-pegylated liposomal monotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Myocet": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [21017157],
      "conceptName": ["Myocet"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "bevacizumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397141],
      "conceptName": ["bevacizumab"]
    }
  },
  {
    "conceptId": [35804413],
    "regimenName": ["MATRix"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Methotrexate": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "rituximab": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Cytarabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Thiotepa": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [19137385],
      "conceptName": ["Thiotepa"]
    }
  },
  {
    "conceptId": [35805660],
    "regimenName": ["131Iodine-Tositumomab monotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "iodine-131-tositumomab": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [19054997],
      "conceptName": ["iodine-131-tositumomab"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "fludarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1395557],
      "conceptName": ["fludarabine"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    }
  },
  {
    "conceptId": [35805077],
    "regimenName": ["GVD"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "doxorubicin liposome": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [19051649],
      "conceptName": ["doxorubicin liposome"]
    },
    "vinorelbine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1343346],
      "conceptName": ["vinorelbine"]
    },
    "gemcitabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1314924],
      "conceptName": ["gemcitabine"]
    }
  },
  {
    "conceptId": [35803463],
    "regimenName": ["MEC"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Cytarabine": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Mitoxantrone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1309188],
      "conceptName": ["Mitoxantrone"]
    },
    "Etoposide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Tretinoin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [903643],
      "conceptName": ["Tretinoin"]
    },
    "Thioguanine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1437379],
      "conceptName": ["Thioguanine"]
    },
    "Idarubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078097],
      "conceptName": ["Idarubicin"]
    }
  },
  {
    "conceptId": [35102013],
    "regimenName": ["R-CHOP (Rituximab Hycela)"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "rituximab": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Prednisone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Hyaluronidase / rituximab Injection [Rituxan Hycela]": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1593155],
      "conceptName": ["Hyaluronidase / rituximab Injection [Rituxan Hycela]"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    }
  },
  {
    "conceptId": [35806082],
    "regimenName": ["VR-CAP"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "rituximab": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "bortezomib": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1336825],
      "conceptName": ["bortezomib"]
    },
    "Prednisone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    }
  },
  {
    "conceptId": [35101452],
    "regimenName": ["Paclitaxel and Vinorelbine"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Paclitaxel": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1378382],
      "conceptName": ["Paclitaxel"]
    },
    "vinorelbine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1343346],
      "conceptName": ["vinorelbine"]
    }
  },
  {
    "conceptId": [35806946],
    "regimenName": ["Teniposide monotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Teniposide": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [19136750],
      "conceptName": ["Teniposide"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Daunorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311799],
      "conceptName": ["Daunorubicin"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Bleomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1329241],
      "conceptName": ["Bleomycin"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Carboplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344905],
      "conceptName": ["Carboplatin"]
    },
    "Carmustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350066],
      "conceptName": ["Carmustine"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Interferon Alfa-2b": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1380068],
      "conceptName": ["Interferon Alfa-2b"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Vindesine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008336],
      "conceptName": ["Vindesine"]
    },
    "ASPARAGINASE": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19012585],
      "conceptName": ["ASPARAGINASE"]
    },
    "Ifosfamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    }
  },
  {
    "conceptId": [35102030],
    "regimenName": ["Carboplatin and Cisplatin"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Carboplatin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1344905],
      "conceptName": ["Carboplatin"]
    },
    "Cisplatin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Bleomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1329241],
      "conceptName": ["Bleomycin"]
    }
  },
  {
    "conceptId": [35805028],
    "regimenName": ["R-CHOP"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "rituximab": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Prednisone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "bortezomib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1336825],
      "conceptName": ["bortezomib"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "Hyaluronidase / rituximab Injection [Rituxan Hycela]": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1593155],
      "conceptName": ["Hyaluronidase / rituximab Injection [Rituxan Hycela]"]
    },
    "Vindesine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008336],
      "conceptName": ["Vindesine"]
    },
    "lenalidomide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19026972],
      "conceptName": ["lenalidomide"]
    },
    "Ifosfamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    },
    "Teniposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19136750],
      "conceptName": ["Teniposide"]
    }
  },
  {
    "conceptId": [35805068],
    "regimenName": ["BeEAM, then auto HSCT"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "bendamustine": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [19015523],
      "conceptName": ["bendamustine"]
    },
    "Melphalan": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1301267],
      "conceptName": ["Melphalan"]
    },
    "Cytarabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Etoposide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    }
  },
  {
    "conceptId": [35805108],
    "regimenName": ["PMitCEBO"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Bleomycin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1329241],
      "conceptName": ["Bleomycin"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Mitoxantrone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1309188],
      "conceptName": ["Mitoxantrone"]
    },
    "Etoposide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "prednisolone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1550557],
      "conceptName": ["prednisolone"]
    }
  },
  {
    "conceptId": [35806821],
    "regimenName": ["ADT"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Flutamide": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1356461],
      "conceptName": ["Flutamide"]
    },
    "bicalutamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1344381],
      "conceptName": ["bicalutamide"]
    }
  },
  {
    "conceptId": [35803551],
    "regimenName": ["Arsenic trioxide, ATRA, Idarubicin"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Idarubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [19078097],
      "conceptName": ["Idarubicin"]
    },
    "arsenic trioxide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1333379],
      "conceptName": ["arsenic trioxide"]
    },
    "Tretinoin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [903643],
      "conceptName": ["Tretinoin"]
    }
  },
  {
    "conceptId": [35804391],
    "regimenName": ["Ceritinib monotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "ceritinib": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [44818466],
      "conceptName": ["ceritinib"]
    }
  },
  {
    "conceptId": [35805053],
    "regimenName": ["O-ICE"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Carboplatin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1344905],
      "conceptName": ["Carboplatin"]
    },
    "Ifosfamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    },
    "ofatumumab": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [40167582],
      "conceptName": ["ofatumumab"]
    },
    "Mesna": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1354698],
      "conceptName": ["Mesna"]
    },
    "Etoposide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    }
  },
  {
    "conceptId": [35806968],
    "regimenName": ["MAID"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Ifosfamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    },
    "Dacarbazine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1311409],
      "conceptName": ["Dacarbazine"]
    }
  },
  {
    "conceptId": [35804266],
    "regimenName": ["Gemcitabine and Bevacizumab"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "bevacizumab": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1397141],
      "conceptName": ["bevacizumab"]
    },
    "gemcitabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1314924],
      "conceptName": ["gemcitabine"]
    },
    "oxaliplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1318011],
      "conceptName": ["oxaliplatin"]
    },
    "Carboplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344905],
      "conceptName": ["Carboplatin"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    }
  },
  {
    "conceptId": [35805375],
    "regimenName": ["Aspirin and Hydroxyurea"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "hydroxyurea": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1377141],
      "conceptName": ["hydroxyurea"]
    },
    "Fluorouracil": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "imatinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1304107],
      "conceptName": ["imatinib"]
    },
    "Dacarbazine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311409],
      "conceptName": ["Dacarbazine"]
    },
    "docetaxel": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1315942],
      "conceptName": ["docetaxel"]
    },
    "Carmustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350066],
      "conceptName": ["Carmustine"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    }
  },
  {
    "conceptId": [35805071],
    "regimenName": ["Fludarabine, Busulfan, ATG, Ibritumomab tiuxetan, then allo HSCT"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "ibritumomab tiuxetan": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [19068830],
      "conceptName": ["ibritumomab tiuxetan"]
    },
    "Busulfan": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1333357],
      "conceptName": ["Busulfan"]
    },
    "rituximab": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "fludarabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1395557],
      "conceptName": ["fludarabine"]
    }
  },
  {
    "conceptId": [35803575],
    "regimenName": ["Cisplatin and Gemcitabine"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Cisplatin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "gemcitabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1314924],
      "conceptName": ["gemcitabine"]
    },
    "Fluorouracil": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "erlotinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1325363],
      "conceptName": ["erlotinib"]
    },
    "pegaspargase": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1326481],
      "conceptName": ["pegaspargase"]
    },
    "Epirubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344354],
      "conceptName": ["Epirubicin"]
    },
    "Hyaluronidase / trastuzumab Injection [Herceptin Hylecta]": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1366689],
      "conceptName": ["Hyaluronidase / trastuzumab Injection [Herceptin Hylecta]"]
    },
    "Paclitaxel": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1378382],
      "conceptName": ["Paclitaxel"]
    },
    "bevacizumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397141],
      "conceptName": ["bevacizumab"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Ifosfamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    },
    "Thalidomide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19137042],
      "conceptName": ["Thalidomide"]
    },
    "necitumumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [35606215],
      "conceptName": ["necitumumab"]
    }
  },
  {
    "conceptId": [35804309],
    "regimenName": ["ACH"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "trastuzumab": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1387104],
      "conceptName": ["trastuzumab"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    }
  },
  {
    "conceptId": [35804090],
    "regimenName": ["Doxorubicin, Methotrexate, Vincristine, Prednisone"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Methotrexate": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Prednisone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Fluorouracil": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Bleomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1329241],
      "conceptName": ["Bleomycin"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Procarbazine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1351779],
      "conceptName": ["Procarbazine"]
    },
    "Mechlorethamine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1394337],
      "conceptName": ["Mechlorethamine"]
    },
    "mercaptopurine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1436650],
      "conceptName": ["mercaptopurine"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "Vindesine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008336],
      "conceptName": ["Vindesine"]
    },
    "ASPARAGINASE": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19012585],
      "conceptName": ["ASPARAGINASE"]
    },
    "Ifosfamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    },
    "Teniposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19136750],
      "conceptName": ["Teniposide"]
    }
  },
  {
    "conceptId": [35803461],
    "regimenName": ["ICL"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Idarubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [19078097],
      "conceptName": ["Idarubicin"]
    },
    "Cytarabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Lomustine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1391846],
      "conceptName": ["Lomustine"]
    }
  },
  {
    "conceptId": [35805641],
    "regimenName": ["R-CMD"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "rituximab": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Dexamethasone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "Mitoxantrone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1309188],
      "conceptName": ["Mitoxantrone"]
    },
    "Cladribine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [19054825],
      "conceptName": ["Cladribine"]
    }
  },
  {
    "conceptId": [35101653],
    "regimenName": ["Benralizumab monotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "benralizumab": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [792993],
      "conceptName": ["benralizumab"]
    }
  },
  {
    "conceptId": [35804626],
    "regimenName": ["HDMP"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Methylprednisolone": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1506270],
      "conceptName": ["Methylprednisolone"]
    },
    "Melphalan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1301267],
      "conceptName": ["Melphalan"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Dacarbazine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311409],
      "conceptName": ["Dacarbazine"]
    },
    "alemtuzumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1312706],
      "conceptName": ["alemtuzumab"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Bleomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1329241],
      "conceptName": ["Bleomycin"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Carmustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350066],
      "conceptName": ["Carmustine"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Procarbazine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1351779],
      "conceptName": ["Procarbazine"]
    },
    "Lomustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1391846],
      "conceptName": ["Lomustine"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Vinblastine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008264],
      "conceptName": ["Vinblastine"]
    },
    "everolimus": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19011440],
      "conceptName": ["everolimus"]
    },
    "doxorubicin liposome": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19051649],
      "conceptName": ["doxorubicin liposome"]
    },
    "ofatumumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [40167582],
      "conceptName": ["ofatumumab"]
    }
  },
  {
    "conceptId": [35806972],
    "regimenName": ["Cytarabine, Ifosfamide, G-CSF"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Ifosfamide": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    },
    "Cytarabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Bleomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1329241],
      "conceptName": ["Bleomycin"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Vindesine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008336],
      "conceptName": ["Vindesine"]
    },
    "doxorubicin liposome": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19051649],
      "conceptName": ["doxorubicin liposome"]
    },
    "Teniposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19136750],
      "conceptName": ["Teniposide"]
    },
    "Cytarabine liposome": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [40175460],
      "conceptName": ["Cytarabine liposome"]
    }
  },
  {
    "conceptId": [35805635],
    "regimenName": ["Rituximab monotherapy, abbreviated course"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "rituximab": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "inotuzumab ozogamicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [794068],
      "conceptName": ["inotuzumab ozogamicin"]
    },
    "Melphalan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1301267],
      "conceptName": ["Melphalan"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Mitoxantrone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1309188],
      "conceptName": ["Mitoxantrone"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Dacarbazine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311409],
      "conceptName": ["Dacarbazine"]
    },
    "Daunorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311799],
      "conceptName": ["Daunorubicin"]
    },
    "alemtuzumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1312706],
      "conceptName": ["alemtuzumab"]
    },
    "gemcitabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314924],
      "conceptName": ["gemcitabine"]
    },
    "oxaliplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1318011],
      "conceptName": ["oxaliplatin"]
    },
    "Bleomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1329241],
      "conceptName": ["Bleomycin"]
    },
    "Busulfan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1333357],
      "conceptName": ["Busulfan"]
    },
    "bortezomib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1336825],
      "conceptName": ["bortezomib"]
    },
    "Vorinostat": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1337651],
      "conceptName": ["Vorinostat"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "temozolomide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1341149],
      "conceptName": ["temozolomide"]
    },
    "vinorelbine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1343346],
      "conceptName": ["vinorelbine"]
    },
    "Epirubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344354],
      "conceptName": ["Epirubicin"]
    },
    "Carboplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344905],
      "conceptName": ["Carboplatin"]
    },
    "Carmustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350066],
      "conceptName": ["Carmustine"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Procarbazine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1351779],
      "conceptName": ["Procarbazine"]
    },
    "Mesna": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1354698],
      "conceptName": ["Mesna"]
    },
    "Paclitaxel": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1378382],
      "conceptName": ["Paclitaxel"]
    },
    "Topotecan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1378509],
      "conceptName": ["Topotecan"]
    },
    "Chlorambucil": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1390051],
      "conceptName": ["Chlorambucil"]
    },
    "Lomustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1391846],
      "conceptName": ["Lomustine"]
    },
    "fludarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1395557],
      "conceptName": ["fludarabine"]
    },
    "polatuzumab vedotin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1396729],
      "conceptName": ["polatuzumab vedotin"]
    },
    "bevacizumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397141],
      "conceptName": ["bevacizumab"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "Methylprednisolone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1506270],
      "conceptName": ["Methylprednisolone"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "prednisolone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1550557],
      "conceptName": ["prednisolone"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Hyaluronidase / rituximab Injection [Rituxan Hycela]": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1593155],
      "conceptName": ["Hyaluronidase / rituximab Injection [Rituxan Hycela]"]
    },
    "Vinblastine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008264],
      "conceptName": ["Vinblastine"]
    },
    "Vindesine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008336],
      "conceptName": ["Vindesine"]
    },
    "everolimus": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19011440],
      "conceptName": ["everolimus"]
    },
    "ASPARAGINASE": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19012585],
      "conceptName": ["ASPARAGINASE"]
    },
    "bendamustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19015523],
      "conceptName": ["bendamustine"]
    },
    "lenalidomide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19026972],
      "conceptName": ["lenalidomide"]
    },
    "Pentostatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19031224],
      "conceptName": ["Pentostatin"]
    },
    "doxorubicin liposome": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19051649],
      "conceptName": ["doxorubicin liposome"]
    },
    "Cladribine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19054825],
      "conceptName": ["Cladribine"]
    },
    "ibritumomab tiuxetan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19068830],
      "conceptName": ["ibritumomab tiuxetan"]
    },
    "Idarubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078097],
      "conceptName": ["Idarubicin"]
    },
    "Ifosfamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    },
    "temsirolimus": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19092845],
      "conceptName": ["temsirolimus"]
    },
    "Teniposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19136750],
      "conceptName": ["Teniposide"]
    },
    "Thalidomide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19137042],
      "conceptName": ["Thalidomide"]
    },
    "Thiotepa": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19137385],
      "conceptName": ["Thiotepa"]
    },
    "venetoclax": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [35604205],
      "conceptName": ["venetoclax"]
    },
    "Cytarabine liposome": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [40175460],
      "conceptName": ["Cytarabine liposome"]
    },
    "carfilzomib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [42873638],
      "conceptName": ["carfilzomib"]
    },
    "vincristine liposome": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [42874135],
      "conceptName": ["vincristine liposome"]
    },
    "Ibrutinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [44507848],
      "conceptName": ["Ibrutinib"]
    },
    "idelalisib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [45776944],
      "conceptName": ["idelalisib"]
    },
    "panobinostat": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [46221435],
      "conceptName": ["panobinostat"]
    }
  },
  {
    "conceptId": [35805632],
    "regimenName": ["Rituximab monotherapy, very extended course"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "rituximab": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "inotuzumab ozogamicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [794068],
      "conceptName": ["inotuzumab ozogamicin"]
    },
    "Melphalan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1301267],
      "conceptName": ["Melphalan"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Mitoxantrone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1309188],
      "conceptName": ["Mitoxantrone"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Dacarbazine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311409],
      "conceptName": ["Dacarbazine"]
    },
    "Daunorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311799],
      "conceptName": ["Daunorubicin"]
    },
    "alemtuzumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1312706],
      "conceptName": ["alemtuzumab"]
    },
    "gemcitabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314924],
      "conceptName": ["gemcitabine"]
    },
    "oxaliplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1318011],
      "conceptName": ["oxaliplatin"]
    },
    "Bleomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1329241],
      "conceptName": ["Bleomycin"]
    },
    "Busulfan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1333357],
      "conceptName": ["Busulfan"]
    },
    "bortezomib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1336825],
      "conceptName": ["bortezomib"]
    },
    "Vorinostat": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1337651],
      "conceptName": ["Vorinostat"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "temozolomide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1341149],
      "conceptName": ["temozolomide"]
    },
    "vinorelbine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1343346],
      "conceptName": ["vinorelbine"]
    },
    "Epirubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344354],
      "conceptName": ["Epirubicin"]
    },
    "Carboplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344905],
      "conceptName": ["Carboplatin"]
    },
    "Carmustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350066],
      "conceptName": ["Carmustine"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Procarbazine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1351779],
      "conceptName": ["Procarbazine"]
    },
    "Mesna": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1354698],
      "conceptName": ["Mesna"]
    },
    "Paclitaxel": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1378382],
      "conceptName": ["Paclitaxel"]
    },
    "Topotecan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1378509],
      "conceptName": ["Topotecan"]
    },
    "Chlorambucil": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1390051],
      "conceptName": ["Chlorambucil"]
    },
    "Lomustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1391846],
      "conceptName": ["Lomustine"]
    },
    "fludarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1395557],
      "conceptName": ["fludarabine"]
    },
    "polatuzumab vedotin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1396729],
      "conceptName": ["polatuzumab vedotin"]
    },
    "bevacizumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397141],
      "conceptName": ["bevacizumab"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "Methylprednisolone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1506270],
      "conceptName": ["Methylprednisolone"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "prednisolone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1550557],
      "conceptName": ["prednisolone"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Hyaluronidase / rituximab Injection [Rituxan Hycela]": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1593155],
      "conceptName": ["Hyaluronidase / rituximab Injection [Rituxan Hycela]"]
    },
    "Vinblastine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008264],
      "conceptName": ["Vinblastine"]
    },
    "Vindesine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008336],
      "conceptName": ["Vindesine"]
    },
    "everolimus": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19011440],
      "conceptName": ["everolimus"]
    },
    "ASPARAGINASE": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19012585],
      "conceptName": ["ASPARAGINASE"]
    },
    "bendamustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19015523],
      "conceptName": ["bendamustine"]
    },
    "lenalidomide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19026972],
      "conceptName": ["lenalidomide"]
    },
    "Pentostatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19031224],
      "conceptName": ["Pentostatin"]
    },
    "doxorubicin liposome": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19051649],
      "conceptName": ["doxorubicin liposome"]
    },
    "Cladribine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19054825],
      "conceptName": ["Cladribine"]
    },
    "ibritumomab tiuxetan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19068830],
      "conceptName": ["ibritumomab tiuxetan"]
    },
    "Idarubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078097],
      "conceptName": ["Idarubicin"]
    },
    "Ifosfamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    },
    "temsirolimus": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19092845],
      "conceptName": ["temsirolimus"]
    },
    "Teniposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19136750],
      "conceptName": ["Teniposide"]
    },
    "Thalidomide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19137042],
      "conceptName": ["Thalidomide"]
    },
    "Thiotepa": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19137385],
      "conceptName": ["Thiotepa"]
    },
    "venetoclax": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [35604205],
      "conceptName": ["venetoclax"]
    },
    "Cytarabine liposome": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [40175460],
      "conceptName": ["Cytarabine liposome"]
    },
    "carfilzomib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [42873638],
      "conceptName": ["carfilzomib"]
    },
    "vincristine liposome": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [42874135],
      "conceptName": ["vincristine liposome"]
    },
    "Ibrutinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [44507848],
      "conceptName": ["Ibrutinib"]
    },
    "idelalisib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [45776944],
      "conceptName": ["idelalisib"]
    },
    "panobinostat": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [46221435],
      "conceptName": ["panobinostat"]
    }
  },
  {
    "conceptId": [35806368],
    "regimenName": ["Oxaliplatin and RT"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "oxaliplatin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1318011],
      "conceptName": ["oxaliplatin"]
    },
    "Fluorouracil": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "gemcitabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314924],
      "conceptName": ["gemcitabine"]
    },
    "cetuximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1315411],
      "conceptName": ["cetuximab"]
    },
    "docetaxel": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1315942],
      "conceptName": ["docetaxel"]
    },
    "capecitabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1337620],
      "conceptName": ["capecitabine"]
    },
    "Epirubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344354],
      "conceptName": ["Epirubicin"]
    },
    "Hyaluronidase / trastuzumab Injection [Herceptin Hylecta]": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1366689],
      "conceptName": ["Hyaluronidase / trastuzumab Injection [Herceptin Hylecta]"]
    },
    "irinotecan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1367268],
      "conceptName": ["irinotecan"]
    },
    "Paclitaxel": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1378382],
      "conceptName": ["Paclitaxel"]
    },
    "Leucovorin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1388796],
      "conceptName": ["Leucovorin"]
    },
    "fludarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1395557],
      "conceptName": ["fludarabine"]
    },
    "bevacizumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397141],
      "conceptName": ["bevacizumab"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "ASPARAGINASE": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19012585],
      "conceptName": ["ASPARAGINASE"]
    },
    "panitumumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19100985],
      "conceptName": ["panitumumab"]
    },
    "levoleucovorin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [40168303],
      "conceptName": ["levoleucovorin"]
    }
  },
  {
    "conceptId": [35806412],
    "regimenName": ["Cisplatin, Pemetrexed, Pembrolizumab"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Cisplatin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "pemetrexed": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1304919],
      "conceptName": ["pemetrexed"]
    },
    "pembrolizumab": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [45775965],
      "conceptName": ["pembrolizumab"]
    }
  },
  {
    "conceptId": [35806074],
    "regimenName": ["Carboplatin and Teniposide"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Carboplatin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1344905],
      "conceptName": ["Carboplatin"]
    },
    "Teniposide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [19136750],
      "conceptName": ["Teniposide"]
    }
  },
  {
    "conceptId": [35804349],
    "regimenName": ["TMF"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Methotrexate": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Thiotepa": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [19137385],
      "conceptName": ["Thiotepa"]
    },
    "Fluorouracil": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    }
  },
  {
    "conceptId": [35806274],
    "regimenName": ["RP"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "lenalidomide": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [19026972],
      "conceptName": ["lenalidomide"]
    },
    "Prednisone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Melphalan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1301267],
      "conceptName": ["Melphalan"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "bortezomib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1336825],
      "conceptName": ["bortezomib"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    }
  },
  {
    "conceptId": [35806349],
    "regimenName": ["Melphalan, then auto HSCT, then Melphalan and TBI, then auto HSCT"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Melphalan": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1301267],
      "conceptName": ["Melphalan"]
    },
    "Fluorouracil": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "alemtuzumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1312706],
      "conceptName": ["alemtuzumab"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Busulfan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1333357],
      "conceptName": ["Busulfan"]
    },
    "bortezomib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1336825],
      "conceptName": ["bortezomib"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Carmustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350066],
      "conceptName": ["Carmustine"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "fludarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1395557],
      "conceptName": ["fludarabine"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "Tamoxifen": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1436678],
      "conceptName": ["Tamoxifen"]
    },
    "Methylprednisolone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1506270],
      "conceptName": ["Methylprednisolone"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "prednisolone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1550557],
      "conceptName": ["prednisolone"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "bendamustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19015523],
      "conceptName": ["bendamustine"]
    },
    "lenalidomide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19026972],
      "conceptName": ["lenalidomide"]
    },
    "clofarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19054821],
      "conceptName": ["clofarabine"]
    },
    "ibritumomab tiuxetan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19068830],
      "conceptName": ["ibritumomab tiuxetan"]
    },
    "Thalidomide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19137042],
      "conceptName": ["Thalidomide"]
    },
    "daratumumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [35605744],
      "conceptName": ["daratumumab"]
    },
    "Fotemustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [36879099],
      "conceptName": ["Fotemustine"]
    },
    "carfilzomib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [42873638],
      "conceptName": ["carfilzomib"]
    }
  },
  {
    "conceptId": [35805447],
    "regimenName": ["VACA"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Dactinomycin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1311443],
      "conceptName": ["Dactinomycin"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "irinotecan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1367268],
      "conceptName": ["irinotecan"]
    },
    "Ifosfamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    }
  },
  {
    "conceptId": [35805468],
    "regimenName": ["SMILE"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Methotrexate": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "ASPARAGINASE": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [19012585],
      "conceptName": ["ASPARAGINASE"]
    },
    "Ifosfamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    },
    "Mesna": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1354698],
      "conceptName": ["Mesna"]
    },
    "Dexamethasone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "Etoposide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    }
  },
  {
    "conceptId": [35805055],
    "regimenName": ["R-BEAM, then auto HSCT"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Carmustine": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1350066],
      "conceptName": ["Carmustine"]
    },
    "Melphalan": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1301267],
      "conceptName": ["Melphalan"]
    },
    "rituximab": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Cytarabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Etoposide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "ibritumomab tiuxetan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19068830],
      "conceptName": ["ibritumomab tiuxetan"]
    }
  },
  {
    "conceptId": [35805753],
    "regimenName": ["EPOCH, dose-escalated"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Prednisone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Etoposide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Bleomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1329241],
      "conceptName": ["Bleomycin"]
    },
    "Carboplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344905],
      "conceptName": ["Carboplatin"]
    },
    "Procarbazine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1351779],
      "conceptName": ["Procarbazine"]
    },
    "Mechlorethamine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1394337],
      "conceptName": ["Mechlorethamine"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "Vindesine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008336],
      "conceptName": ["Vindesine"]
    },
    "Ifosfamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    },
    "Teniposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19136750],
      "conceptName": ["Teniposide"]
    },
    "ranimustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [35197850],
      "conceptName": ["ranimustine"]
    }
  },
  {
    "conceptId": [35806398],
    "regimenName": ["Carboplatin, Vinorelbine, RT"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Carboplatin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1344905],
      "conceptName": ["Carboplatin"]
    },
    "vinorelbine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1343346],
      "conceptName": ["vinorelbine"]
    }
  },
  {
    "conceptId": [35803683],
    "regimenName": ["RT, then Carmustine"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Carmustine": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1350066],
      "conceptName": ["Carmustine"]
    },
    "Melphalan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1301267],
      "conceptName": ["Melphalan"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Mitoxantrone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1309188],
      "conceptName": ["Mitoxantrone"]
    },
    "Aldesleukin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1309770],
      "conceptName": ["Aldesleukin"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Dacarbazine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311409],
      "conceptName": ["Dacarbazine"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Procarbazine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1351779],
      "conceptName": ["Procarbazine"]
    },
    "hydroxyurea": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1377141],
      "conceptName": ["hydroxyurea"]
    },
    "Interferon Alfa-2b": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1380068],
      "conceptName": ["Interferon Alfa-2b"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "Methylprednisolone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1506270],
      "conceptName": ["Methylprednisolone"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Vinblastine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008264],
      "conceptName": ["Vinblastine"]
    },
    "ibritumomab tiuxetan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19068830],
      "conceptName": ["ibritumomab tiuxetan"]
    },
    "Teniposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19136750],
      "conceptName": ["Teniposide"]
    },
    "Thiotepa": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19137385],
      "conceptName": ["Thiotepa"]
    }
  },
  {
    "conceptId": [35804277],
    "regimenName": ["Leuprolide monotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Leuprolide": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1351541],
      "conceptName": ["Leuprolide"]
    },
    "bicalutamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344381],
      "conceptName": ["bicalutamide"]
    },
    "Flutamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1356461],
      "conceptName": ["Flutamide"]
    }
  },
  {
    "conceptId": [35804057],
    "regimenName": ["Etoposide and TBI, then allo HSCT"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Etoposide": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Tretinoin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [903643],
      "conceptName": ["Tretinoin"]
    },
    "Fluorouracil": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "Melphalan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1301267],
      "conceptName": ["Melphalan"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Mitotane": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1309161],
      "conceptName": ["Mitotane"]
    },
    "Mitoxantrone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1309188],
      "conceptName": ["Mitoxantrone"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Dactinomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311443],
      "conceptName": ["Dactinomycin"]
    },
    "Daunorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311799],
      "conceptName": ["Daunorubicin"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "pegaspargase": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1326481],
      "conceptName": ["pegaspargase"]
    },
    "Bleomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1329241],
      "conceptName": ["Bleomycin"]
    },
    "bortezomib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1336825],
      "conceptName": ["bortezomib"]
    },
    "Vorinostat": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1337651],
      "conceptName": ["Vorinostat"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Epirubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344354],
      "conceptName": ["Epirubicin"]
    },
    "Carboplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344905],
      "conceptName": ["Carboplatin"]
    },
    "Carmustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350066],
      "conceptName": ["Carmustine"]
    },
    "Procarbazine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1351779],
      "conceptName": ["Procarbazine"]
    },
    "Mesna": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1354698],
      "conceptName": ["Mesna"]
    },
    "irinotecan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1367268],
      "conceptName": ["irinotecan"]
    },
    "Paclitaxel": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1378382],
      "conceptName": ["Paclitaxel"]
    },
    "Topotecan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1378509],
      "conceptName": ["Topotecan"]
    },
    "Leucovorin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1388796],
      "conceptName": ["Leucovorin"]
    },
    "Chlorambucil": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1390051],
      "conceptName": ["Chlorambucil"]
    },
    "Lomustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1391846],
      "conceptName": ["Lomustine"]
    },
    "nilotinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1394023],
      "conceptName": ["nilotinib"]
    },
    "Mechlorethamine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1394337],
      "conceptName": ["Mechlorethamine"]
    },
    "bevacizumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397141],
      "conceptName": ["bevacizumab"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "mercaptopurine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1436650],
      "conceptName": ["mercaptopurine"]
    },
    "Thioguanine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1437379],
      "conceptName": ["Thioguanine"]
    },
    "Methylprednisolone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1506270],
      "conceptName": ["Methylprednisolone"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "prednisolone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1550557],
      "conceptName": ["prednisolone"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Vinblastine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008264],
      "conceptName": ["Vinblastine"]
    },
    "Vindesine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008336],
      "conceptName": ["Vindesine"]
    },
    "ASPARAGINASE": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19012585],
      "conceptName": ["ASPARAGINASE"]
    },
    "bendamustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19015523],
      "conceptName": ["bendamustine"]
    },
    "lenalidomide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19026972],
      "conceptName": ["lenalidomide"]
    },
    "doxorubicin liposome": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19051649],
      "conceptName": ["doxorubicin liposome"]
    },
    "clofarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19054821],
      "conceptName": ["clofarabine"]
    },
    "ibritumomab tiuxetan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19068830],
      "conceptName": ["ibritumomab tiuxetan"]
    },
    "Idarubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078097],
      "conceptName": ["Idarubicin"]
    },
    "Ifosfamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    },
    "Teniposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19136750],
      "conceptName": ["Teniposide"]
    },
    "Thalidomide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19137042],
      "conceptName": ["Thalidomide"]
    },
    "ranimustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [35197850],
      "conceptName": ["ranimustine"]
    },
    "Fotemustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [36879099],
      "conceptName": ["Fotemustine"]
    },
    "ofatumumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [40167582],
      "conceptName": ["ofatumumab"]
    },
    "atezolizumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [42629079],
      "conceptName": ["atezolizumab"]
    }
  },
  {
    "conceptId": [35804295],
    "regimenName": ["Everolimus and Exemestane"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "everolimus": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [19011440],
      "conceptName": ["everolimus"]
    },
    "exemestane": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1398399],
      "conceptName": ["exemestane"]
    }
  },
  {
    "conceptId": [35805819],
    "regimenName": ["COPDAC"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Prednisone": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Dacarbazine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1311409],
      "conceptName": ["Dacarbazine"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Bleomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1329241],
      "conceptName": ["Bleomycin"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Procarbazine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1351779],
      "conceptName": ["Procarbazine"]
    },
    "Vinblastine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008264],
      "conceptName": ["Vinblastine"]
    }
  },
  {
    "conceptId": [35805061],
    "regimenName": ["R-ESHAP"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Cisplatin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "Methylprednisolone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1506270],
      "conceptName": ["Methylprednisolone"]
    },
    "rituximab": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Cytarabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Etoposide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    }
  },
  {
    "conceptId": [35803568],
    "regimenName": ["Cytarabine and G-CSF"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Cytarabine": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "inotuzumab ozogamicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [794068],
      "conceptName": ["inotuzumab ozogamicin"]
    },
    "Tretinoin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [903643],
      "conceptName": ["Tretinoin"]
    },
    "Fluorouracil": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "Melphalan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1301267],
      "conceptName": ["Melphalan"]
    },
    "imatinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1304107],
      "conceptName": ["imatinib"]
    },
    "Filgrastim": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1304850],
      "conceptName": ["Filgrastim"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Mitoxantrone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1309188],
      "conceptName": ["Mitoxantrone"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Daunorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311799],
      "conceptName": ["Daunorubicin"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Azacitidine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314865],
      "conceptName": ["Azacitidine"]
    },
    "oxaliplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1318011],
      "conceptName": ["oxaliplatin"]
    },
    "pegaspargase": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1326481],
      "conceptName": ["pegaspargase"]
    },
    "Bleomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1329241],
      "conceptName": ["Bleomycin"]
    },
    "Vorinostat": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1337651],
      "conceptName": ["Vorinostat"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Carboplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344905],
      "conceptName": ["Carboplatin"]
    },
    "Carmustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350066],
      "conceptName": ["Carmustine"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "glasdegib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1355795],
      "conceptName": ["glasdegib"]
    },
    "dasatinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1358436],
      "conceptName": ["dasatinib"]
    },
    "sorafenib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1363387],
      "conceptName": ["sorafenib"]
    },
    "Interferon Alfa-2b": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1380068],
      "conceptName": ["Interferon Alfa-2b"]
    },
    "Lomustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1391846],
      "conceptName": ["Lomustine"]
    },
    "nilotinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1394023],
      "conceptName": ["nilotinib"]
    },
    "fludarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1395557],
      "conceptName": ["fludarabine"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "mercaptopurine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1436650],
      "conceptName": ["mercaptopurine"]
    },
    "Thioguanine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1437379],
      "conceptName": ["Thioguanine"]
    },
    "Methylprednisolone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1506270],
      "conceptName": ["Methylprednisolone"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "prednisolone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1550557],
      "conceptName": ["prednisolone"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Pravastatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551860],
      "conceptName": ["Pravastatin"]
    },
    "midostaurin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1594003],
      "conceptName": ["midostaurin"]
    },
    "nelarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19002912],
      "conceptName": ["nelarabine"]
    },
    "Vindesine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008336],
      "conceptName": ["Vindesine"]
    },
    "lenograstim": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19009705],
      "conceptName": ["lenograstim"]
    },
    "everolimus": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19011440],
      "conceptName": ["everolimus"]
    },
    "ASPARAGINASE": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19012585],
      "conceptName": ["ASPARAGINASE"]
    },
    "bendamustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19015523],
      "conceptName": ["bendamustine"]
    },
    "Amsacrine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19017810],
      "conceptName": ["Amsacrine"]
    },
    "decitabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19024728],
      "conceptName": ["decitabine"]
    },
    "Daunorubicin Liposomal": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19051599],
      "conceptName": ["Daunorubicin Liposomal"]
    },
    "doxorubicin liposome": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19051649],
      "conceptName": ["doxorubicin liposome"]
    },
    "clofarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19054821],
      "conceptName": ["clofarabine"]
    },
    "Cladribine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19054825],
      "conceptName": ["Cladribine"]
    },
    "Aclarubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19057483],
      "conceptName": ["Aclarubicin"]
    },
    "ibritumomab tiuxetan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19068830],
      "conceptName": ["ibritumomab tiuxetan"]
    },
    "Idarubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078097],
      "conceptName": ["Idarubicin"]
    },
    "Ifosfamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    },
    "Norethandrolone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19128219],
      "conceptName": ["Norethandrolone"]
    },
    "Teniposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19136750],
      "conceptName": ["Teniposide"]
    },
    "Thiotepa": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19137385],
      "conceptName": ["Thiotepa"]
    },
    "venetoclax": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [35604205],
      "conceptName": ["venetoclax"]
    },
    "Fotemustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [36879099],
      "conceptName": ["Fotemustine"]
    },
    "ofatumumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [40167582],
      "conceptName": ["ofatumumab"]
    },
    "Cytarabine liposome": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [40175460],
      "conceptName": ["Cytarabine liposome"]
    },
    "Gemtuzumab ozogamicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [42799711],
      "conceptName": ["Gemtuzumab ozogamicin"]
    },
    "ponatinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [43013182],
      "conceptName": ["ponatinib"]
    },
    "omacetaxine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [45775576],
      "conceptName": ["omacetaxine"]
    },
    "panobinostat": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [46221435],
      "conceptName": ["panobinostat"]
    }
  },
  {
    "conceptId": [35805649],
    "regimenName": ["PEP-C"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Prednisone": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Procarbazine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1351779],
      "conceptName": ["Procarbazine"]
    },
    "Etoposide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Mitoxantrone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1309188],
      "conceptName": ["Mitoxantrone"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Bleomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1329241],
      "conceptName": ["Bleomycin"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Mechlorethamine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1394337],
      "conceptName": ["Mechlorethamine"]
    },
    "Vinblastine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008264],
      "conceptName": ["Vinblastine"]
    },
    "Thalidomide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19137042],
      "conceptName": ["Thalidomide"]
    }
  },
  {
    "conceptId": [35102025],
    "regimenName": ["CVP (Prednisolone)"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Cyclophosphamide": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "prednisolone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1550557],
      "conceptName": ["prednisolone"]
    },
    "Melphalan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1301267],
      "conceptName": ["Melphalan"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Mitoxantrone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1309188],
      "conceptName": ["Mitoxantrone"]
    },
    "Daunorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311799],
      "conceptName": ["Daunorubicin"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "gemcitabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314924],
      "conceptName": ["gemcitabine"]
    },
    "Bleomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1329241],
      "conceptName": ["Bleomycin"]
    },
    "bortezomib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1336825],
      "conceptName": ["bortezomib"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Epirubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344354],
      "conceptName": ["Epirubicin"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Procarbazine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1351779],
      "conceptName": ["Procarbazine"]
    },
    "ASPARAGINASE": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19012585],
      "conceptName": ["ASPARAGINASE"]
    }
  },
  {
    "conceptId": [35806964],
    "regimenName": ["Dacarbazine and Doxorubicin"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Dacarbazine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1311409],
      "conceptName": ["Dacarbazine"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Bleomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1329241],
      "conceptName": ["Bleomycin"]
    },
    "Procarbazine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1351779],
      "conceptName": ["Procarbazine"]
    },
    "Lomustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1391846],
      "conceptName": ["Lomustine"]
    },
    "Mechlorethamine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1394337],
      "conceptName": ["Mechlorethamine"]
    },
    "Methylprednisolone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1506270],
      "conceptName": ["Methylprednisolone"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Vinblastine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008264],
      "conceptName": ["Vinblastine"]
    },
    "Ifosfamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    },
    "brentuximab vedotin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [40241969],
      "conceptName": ["brentuximab vedotin"]
    }
  },
  {
    "conceptId": [35804334],
    "regimenName": ["CMFPT"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Methotrexate": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Tamoxifen": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1436678],
      "conceptName": ["Tamoxifen"]
    },
    "Prednisone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Fluorouracil": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    }
  },
  {
    "conceptId": [35803580],
    "regimenName": ["GCP"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Carboplatin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1344905],
      "conceptName": ["Carboplatin"]
    },
    "Paclitaxel": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1378382],
      "conceptName": ["Paclitaxel"]
    },
    "gemcitabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1314924],
      "conceptName": ["gemcitabine"]
    }
  },
  {
    "conceptId": [35804425],
    "regimenName": ["Nordic Regimen, younger patients"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Methotrexate": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Ifosfamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    },
    "rituximab": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Cytarabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Vindesine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [19008336],
      "conceptName": ["Vindesine"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Dexamethasone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Cytarabine liposome": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [40175460],
      "conceptName": ["Cytarabine liposome"]
    }
  },
  {
    "conceptId": [35803429],
    "regimenName": ["Cyclophosphamide and Prednisone"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Prednisone": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Fluorouracil": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "Melphalan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1301267],
      "conceptName": ["Melphalan"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Mitoxantrone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1309188],
      "conceptName": ["Mitoxantrone"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Dacarbazine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311409],
      "conceptName": ["Dacarbazine"]
    },
    "Daunorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311799],
      "conceptName": ["Daunorubicin"]
    },
    "alemtuzumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1312706],
      "conceptName": ["alemtuzumab"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Bleomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1329241],
      "conceptName": ["Bleomycin"]
    },
    "bortezomib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1336825],
      "conceptName": ["bortezomib"]
    },
    "Vorinostat": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1337651],
      "conceptName": ["Vorinostat"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Epirubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344354],
      "conceptName": ["Epirubicin"]
    },
    "Carboplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344905],
      "conceptName": ["Carboplatin"]
    },
    "Carmustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350066],
      "conceptName": ["Carmustine"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Procarbazine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1351779],
      "conceptName": ["Procarbazine"]
    },
    "Interferon Alfa-2b": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1380068],
      "conceptName": ["Interferon Alfa-2b"]
    },
    "Mechlorethamine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1394337],
      "conceptName": ["Mechlorethamine"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "Tamoxifen": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1436678],
      "conceptName": ["Tamoxifen"]
    },
    "Thioguanine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1437379],
      "conceptName": ["Thioguanine"]
    },
    "Methylprednisolone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1506270],
      "conceptName": ["Methylprednisolone"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "Diethylstilbestrol": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1525866],
      "conceptName": ["Diethylstilbestrol"]
    },
    "Hyaluronidase / rituximab Injection [Rituxan Hycela]": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1593155],
      "conceptName": ["Hyaluronidase / rituximab Injection [Rituxan Hycela]"]
    },
    "Vinblastine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008264],
      "conceptName": ["Vinblastine"]
    },
    "Vindesine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008336],
      "conceptName": ["Vindesine"]
    },
    "everolimus": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19011440],
      "conceptName": ["everolimus"]
    },
    "ASPARAGINASE": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19012585],
      "conceptName": ["ASPARAGINASE"]
    },
    "lenalidomide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19026972],
      "conceptName": ["lenalidomide"]
    },
    "denileukin diftitox": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19051642],
      "conceptName": ["denileukin diftitox"]
    },
    "doxorubicin liposome": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19051649],
      "conceptName": ["doxorubicin liposome"]
    },
    "iodine-131-tositumomab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19054997],
      "conceptName": ["iodine-131-tositumomab"]
    },
    "Idarubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078097],
      "conceptName": ["Idarubicin"]
    },
    "Ifosfamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    },
    "BCG, Live, Tice Strain": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19086176],
      "conceptName": ["BCG, Live, Tice Strain"]
    },
    "Teniposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19136750],
      "conceptName": ["Teniposide"]
    },
    "Thalidomide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19137042],
      "conceptName": ["Thalidomide"]
    },
    "ranimustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [35197850],
      "conceptName": ["ranimustine"]
    },
    "ofatumumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [40167582],
      "conceptName": ["ofatumumab"]
    },
    "brentuximab vedotin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [40241969],
      "conceptName": ["brentuximab vedotin"]
    },
    "vincristine liposome": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [42874135],
      "conceptName": ["vincristine liposome"]
    },
    "pomalidomide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [43014237],
      "conceptName": ["pomalidomide"]
    },
    "obinutuzumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [44507676],
      "conceptName": ["obinutuzumab"]
    }
  },
  {
    "conceptId": [35806310],
    "regimenName": ["Cyclophosphamide and Dexamethasone"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Cyclophosphamide": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Dexamethasone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "inotuzumab ozogamicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [794068],
      "conceptName": ["inotuzumab ozogamicin"]
    },
    "Melphalan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1301267],
      "conceptName": ["Melphalan"]
    },
    "imatinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1304107],
      "conceptName": ["imatinib"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Mitoxantrone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1309188],
      "conceptName": ["Mitoxantrone"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Daunorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311799],
      "conceptName": ["Daunorubicin"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "pegaspargase": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1326481],
      "conceptName": ["pegaspargase"]
    },
    "Bleomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1329241],
      "conceptName": ["Bleomycin"]
    },
    "bortezomib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1336825],
      "conceptName": ["bortezomib"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Carmustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350066],
      "conceptName": ["Carmustine"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "dasatinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1358436],
      "conceptName": ["dasatinib"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "mercaptopurine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1436650],
      "conceptName": ["mercaptopurine"]
    },
    "Thioguanine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1437379],
      "conceptName": ["Thioguanine"]
    },
    "Methylprednisolone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1506270],
      "conceptName": ["Methylprednisolone"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Vindesine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008336],
      "conceptName": ["Vindesine"]
    },
    "everolimus": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19011440],
      "conceptName": ["everolimus"]
    },
    "ASPARAGINASE": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19012585],
      "conceptName": ["ASPARAGINASE"]
    },
    "lenalidomide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19026972],
      "conceptName": ["lenalidomide"]
    },
    "doxorubicin liposome": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19051649],
      "conceptName": ["doxorubicin liposome"]
    },
    "Ifosfamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    },
    "Teniposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19136750],
      "conceptName": ["Teniposide"]
    },
    "Thalidomide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19137042],
      "conceptName": ["Thalidomide"]
    },
    "Cytarabine liposome": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [40175460],
      "conceptName": ["Cytarabine liposome"]
    },
    "carfilzomib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [42873638],
      "conceptName": ["carfilzomib"]
    },
    "ponatinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [43013182],
      "conceptName": ["ponatinib"]
    },
    "pomalidomide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [43014237],
      "conceptName": ["pomalidomide"]
    }
  },
  {
    "conceptId": [35805339],
    "regimenName": ["EOX"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "oxaliplatin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1318011],
      "conceptName": ["oxaliplatin"]
    },
    "Epirubicin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1344354],
      "conceptName": ["Epirubicin"]
    },
    "capecitabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1337620],
      "conceptName": ["capecitabine"]
    }
  },
  {
    "conceptId": [35803585],
    "regimenName": ["Mitotane monotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Mitotane": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1309161],
      "conceptName": ["Mitotane"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "Streptozocin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19136210],
      "conceptName": ["Streptozocin"]
    }
  },
  {
    "conceptId": [35806495],
    "regimenName": ["Cisplatin, Cyclophosphamide, Interferon gamma-1b"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Cisplatin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "Interferon gamma-1b": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1380191],
      "conceptName": ["Interferon gamma-1b"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    }
  },
  {
    "conceptId": [35803448],
    "regimenName": ["CYVE"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Cytarabine": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Etoposide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Tretinoin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [903643],
      "conceptName": ["Tretinoin"]
    },
    "Melphalan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1301267],
      "conceptName": ["Melphalan"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Mitoxantrone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1309188],
      "conceptName": ["Mitoxantrone"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Daunorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311799],
      "conceptName": ["Daunorubicin"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Bleomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1329241],
      "conceptName": ["Bleomycin"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Carmustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350066],
      "conceptName": ["Carmustine"]
    },
    "nilotinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1394023],
      "conceptName": ["nilotinib"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "mercaptopurine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1436650],
      "conceptName": ["mercaptopurine"]
    },
    "Thioguanine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1437379],
      "conceptName": ["Thioguanine"]
    },
    "Methylprednisolone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1506270],
      "conceptName": ["Methylprednisolone"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "prednisolone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1550557],
      "conceptName": ["prednisolone"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Vindesine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008336],
      "conceptName": ["Vindesine"]
    },
    "ASPARAGINASE": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19012585],
      "conceptName": ["ASPARAGINASE"]
    },
    "bendamustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19015523],
      "conceptName": ["bendamustine"]
    },
    "doxorubicin liposome": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19051649],
      "conceptName": ["doxorubicin liposome"]
    },
    "ibritumomab tiuxetan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19068830],
      "conceptName": ["ibritumomab tiuxetan"]
    },
    "Idarubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078097],
      "conceptName": ["Idarubicin"]
    },
    "Ifosfamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    },
    "Teniposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19136750],
      "conceptName": ["Teniposide"]
    },
    "Fotemustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [36879099],
      "conceptName": ["Fotemustine"]
    },
    "ofatumumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [40167582],
      "conceptName": ["ofatumumab"]
    }
  },
  {
    "conceptId": [35804814],
    "regimenName": ["Denileukin diftitox monotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "denileukin diftitox": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [19051642],
      "conceptName": ["denileukin diftitox"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    }
  },
  {
    "conceptId": [35805075],
    "regimenName": ["Everolimus monotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "everolimus": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [19011440],
      "conceptName": ["everolimus"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "bortezomib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1336825],
      "conceptName": ["bortezomib"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "exemestane": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1398399],
      "conceptName": ["exemestane"]
    },
    "Tamoxifen": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1436678],
      "conceptName": ["Tamoxifen"]
    },
    "Methylprednisolone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1506270],
      "conceptName": ["Methylprednisolone"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "Octreotide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1522957],
      "conceptName": ["Octreotide"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "lenvatinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [46221433],
      "conceptName": ["lenvatinib"]
    }
  },
  {
    "conceptId": [35803567],
    "regimenName": ["Tamibarotene monotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "tamibarotene": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [35198219],
      "conceptName": ["tamibarotene"]
    }
  },
  {
    "conceptId": [35804363],
    "regimenName": ["Mitoxantrone monotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Mitoxantrone": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1309188],
      "conceptName": ["Mitoxantrone"]
    },
    "Tretinoin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [903643],
      "conceptName": ["Tretinoin"]
    },
    "Fluorouracil": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "imatinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1304107],
      "conceptName": ["imatinib"]
    },
    "Filgrastim": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1304850],
      "conceptName": ["Filgrastim"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "pegaspargase": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1326481],
      "conceptName": ["pegaspargase"]
    },
    "Bleomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1329241],
      "conceptName": ["Bleomycin"]
    },
    "vinorelbine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1343346],
      "conceptName": ["vinorelbine"]
    },
    "Carmustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350066],
      "conceptName": ["Carmustine"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Procarbazine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1351779],
      "conceptName": ["Procarbazine"]
    },
    "Mesna": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1354698],
      "conceptName": ["Mesna"]
    },
    "Chlorambucil": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1390051],
      "conceptName": ["Chlorambucil"]
    },
    "fludarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1395557],
      "conceptName": ["fludarabine"]
    },
    "Thioguanine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1437379],
      "conceptName": ["Thioguanine"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "prednisolone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1550557],
      "conceptName": ["prednisolone"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Vinblastine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008264],
      "conceptName": ["Vinblastine"]
    },
    "Cladribine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19054825],
      "conceptName": ["Cladribine"]
    },
    "Idarubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078097],
      "conceptName": ["Idarubicin"]
    },
    "Ifosfamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    },
    "asparaginase Erwinia chrysanthemi": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [43533115],
      "conceptName": ["asparaginase Erwinia chrysanthemi"]
    }
  },
  {
    "conceptId": [35804051],
    "regimenName": ["R-Hyper-CVAD/R-MA"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Methotrexate": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "rituximab": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Cytarabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Dexamethasone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Vindesine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008336],
      "conceptName": ["Vindesine"]
    },
    "Ifosfamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    },
    "Teniposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19136750],
      "conceptName": ["Teniposide"]
    }
  },
  {
    "conceptId": [35805245],
    "regimenName": ["Carboplatin and Doxorubicin liposomal"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Carboplatin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1344905],
      "conceptName": ["Carboplatin"]
    },
    "doxorubicin liposome": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [19051649],
      "conceptName": ["doxorubicin liposome"]
    }
  },
  {
    "conceptId": [35806663],
    "regimenName": ["ACVBP, dose-adjusted"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Bleomycin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1329241],
      "conceptName": ["Bleomycin"]
    },
    "Vindesine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [19008336],
      "conceptName": ["Vindesine"]
    },
    "Prednisone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Ifosfamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    }
  },
  {
    "conceptId": [35805715],
    "regimenName": ["Temozolomide and NovoTTF-100A"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "temozolomide": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1341149],
      "conceptName": ["temozolomide"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "capecitabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1337620],
      "conceptName": ["capecitabine"]
    },
    "irinotecan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1367268],
      "conceptName": ["irinotecan"]
    },
    "Lomustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1391846],
      "conceptName": ["Lomustine"]
    },
    "bevacizumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397141],
      "conceptName": ["bevacizumab"]
    },
    "Thalidomide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19137042],
      "conceptName": ["Thalidomide"]
    },
    "dinutuximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [46221699],
      "conceptName": ["dinutuximab"]
    }
  },
  {
    "conceptId": [35804233],
    "regimenName": ["ddA"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Fluorouracil": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "Melphalan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1301267],
      "conceptName": ["Melphalan"]
    },
    "imatinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1304107],
      "conceptName": ["imatinib"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Mitotane": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1309161],
      "conceptName": ["Mitotane"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Dacarbazine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311409],
      "conceptName": ["Dacarbazine"]
    },
    "Dactinomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311443],
      "conceptName": ["Dactinomycin"]
    },
    "alemtuzumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1312706],
      "conceptName": ["alemtuzumab"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "gemcitabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314924],
      "conceptName": ["gemcitabine"]
    },
    "docetaxel": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1315942],
      "conceptName": ["docetaxel"]
    },
    "pegaspargase": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1326481],
      "conceptName": ["pegaspargase"]
    },
    "Bleomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1329241],
      "conceptName": ["Bleomycin"]
    },
    "bortezomib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1336825],
      "conceptName": ["bortezomib"]
    },
    "Epirubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344354],
      "conceptName": ["Epirubicin"]
    },
    "Carboplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344905],
      "conceptName": ["Carboplatin"]
    },
    "Carmustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350066],
      "conceptName": ["Carmustine"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Procarbazine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1351779],
      "conceptName": ["Procarbazine"]
    },
    "Mesna": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1354698],
      "conceptName": ["Mesna"]
    },
    "dasatinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1358436],
      "conceptName": ["dasatinib"]
    },
    "irinotecan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1367268],
      "conceptName": ["irinotecan"]
    },
    "Altretamine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1368823],
      "conceptName": ["Altretamine"]
    },
    "Paclitaxel": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1378382],
      "conceptName": ["Paclitaxel"]
    },
    "Topotecan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1378509],
      "conceptName": ["Topotecan"]
    },
    "Interferon Alfa-2b": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1380068],
      "conceptName": ["Interferon Alfa-2b"]
    },
    "trastuzumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1387104],
      "conceptName": ["trastuzumab"]
    },
    "Mitomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1389036],
      "conceptName": ["Mitomycin"]
    },
    "Chlorambucil": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1390051],
      "conceptName": ["Chlorambucil"]
    },
    "Lomustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1391846],
      "conceptName": ["Lomustine"]
    },
    "Mechlorethamine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1394337],
      "conceptName": ["Mechlorethamine"]
    },
    "bevacizumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397141],
      "conceptName": ["bevacizumab"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "mercaptopurine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1436650],
      "conceptName": ["mercaptopurine"]
    },
    "Tamoxifen": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1436678],
      "conceptName": ["Tamoxifen"]
    },
    "Thioguanine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1437379],
      "conceptName": ["Thioguanine"]
    },
    "Medroxyprogesterone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1500211],
      "conceptName": ["Medroxyprogesterone"]
    },
    "Methylprednisolone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1506270],
      "conceptName": ["Methylprednisolone"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "prednisolone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1550557],
      "conceptName": ["prednisolone"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Hyaluronidase / rituximab Injection [Rituxan Hycela]": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1593155],
      "conceptName": ["Hyaluronidase / rituximab Injection [Rituxan Hycela]"]
    },
    "olaratumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1718346],
      "conceptName": ["olaratumab"]
    },
    "Quinine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1760616],
      "conceptName": ["Quinine"]
    },
    "Vinblastine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008264],
      "conceptName": ["Vinblastine"]
    },
    "Vindesine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008336],
      "conceptName": ["Vindesine"]
    },
    "everolimus": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19011440],
      "conceptName": ["everolimus"]
    },
    "ASPARAGINASE": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19012585],
      "conceptName": ["ASPARAGINASE"]
    },
    "lenalidomide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19026972],
      "conceptName": ["lenalidomide"]
    },
    "denileukin diftitox": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19051642],
      "conceptName": ["denileukin diftitox"]
    },
    "iodine-131-tositumomab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19054997],
      "conceptName": ["iodine-131-tositumomab"]
    },
    "Ifosfamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    },
    "BCG, Live, Tice Strain": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19086176],
      "conceptName": ["BCG, Live, Tice Strain"]
    },
    "Strontium-89": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19132890],
      "conceptName": ["Strontium-89"]
    },
    "Streptozocin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19136210],
      "conceptName": ["Streptozocin"]
    },
    "Teniposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19136750],
      "conceptName": ["Teniposide"]
    },
    "Thalidomide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19137042],
      "conceptName": ["Thalidomide"]
    },
    "ranimustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [35197850],
      "conceptName": ["ranimustine"]
    },
    "ofatumumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [40167582],
      "conceptName": ["ofatumumab"]
    },
    "brentuximab vedotin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [40241969],
      "conceptName": ["brentuximab vedotin"]
    },
    "ponatinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [43013182],
      "conceptName": ["ponatinib"]
    },
    "obinutuzumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [44507676],
      "conceptName": ["obinutuzumab"]
    }
  },
  {
    "conceptId": [35804234],
    "regimenName": ["ddTH (Taxol)"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Paclitaxel": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1378382],
      "conceptName": ["Paclitaxel"]
    },
    "trastuzumab": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1387104],
      "conceptName": ["trastuzumab"]
    },
    "Carboplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344905],
      "conceptName": ["Carboplatin"]
    },
    "lapatinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1359548],
      "conceptName": ["lapatinib"]
    },
    "pertuzumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [42801287],
      "conceptName": ["pertuzumab"]
    }
  },
  {
    "conceptId": [35804002],
    "regimenName": ["Bu/TT/Cy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Busulfan": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1333357],
      "conceptName": ["Busulfan"]
    },
    "Thiotepa": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [19137385],
      "conceptName": ["Thiotepa"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    }
  },
  {
    "conceptId": [35805683],
    "regimenName": ["OLF"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "oxaliplatin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1318011],
      "conceptName": ["oxaliplatin"]
    },
    "Leucovorin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1388796],
      "conceptName": ["Leucovorin"]
    },
    "Fluorouracil": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "gemcitabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314924],
      "conceptName": ["gemcitabine"]
    },
    "cetuximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1315411],
      "conceptName": ["cetuximab"]
    },
    "docetaxel": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1315942],
      "conceptName": ["docetaxel"]
    },
    "irinotecan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1367268],
      "conceptName": ["irinotecan"]
    },
    "bevacizumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397141],
      "conceptName": ["bevacizumab"]
    },
    "panitumumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19100985],
      "conceptName": ["panitumumab"]
    }
  },
  {
    "conceptId": [35804575],
    "regimenName": ["CMC"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Cyclophosphamide": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Mitoxantrone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1309188],
      "conceptName": ["Mitoxantrone"]
    },
    "Cladribine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [19054825],
      "conceptName": ["Cladribine"]
    }
  },
  {
    "conceptId": [35806056],
    "regimenName": ["MP"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Melphalan": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1301267],
      "conceptName": ["Melphalan"]
    },
    "Prednisone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "bortezomib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1336825],
      "conceptName": ["bortezomib"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Carmustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350066],
      "conceptName": ["Carmustine"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "lenalidomide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19026972],
      "conceptName": ["lenalidomide"]
    },
    "Thalidomide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19137042],
      "conceptName": ["Thalidomide"]
    },
    "daratumumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [35605744],
      "conceptName": ["daratumumab"]
    },
    "carfilzomib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [42873638],
      "conceptName": ["carfilzomib"]
    }
  },
  {
    "conceptId": [35805360],
    "regimenName": ["CF and Trastuzumab"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "trastuzumab": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1387104],
      "conceptName": ["trastuzumab"]
    },
    "Cisplatin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "Fluorouracil": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    }
  },
  {
    "conceptId": [35805757],
    "regimenName": ["Cladribine and Rituximab"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "rituximab": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Cladribine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [19054825],
      "conceptName": ["Cladribine"]
    },
    "Mitoxantrone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1309188],
      "conceptName": ["Mitoxantrone"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    }
  },
  {
    "conceptId": [35804279],
    "regimenName": ["Toremifene monotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Toremifene": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1342346],
      "conceptName": ["Toremifene"]
    }
  },
  {
    "conceptId": [35805451],
    "regimenName": ["VIDE"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Ifosfamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    },
    "Etoposide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Dactinomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311443],
      "conceptName": ["Dactinomycin"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "irinotecan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1367268],
      "conceptName": ["irinotecan"]
    },
    "Topotecan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1378509],
      "conceptName": ["Topotecan"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Vindesine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008336],
      "conceptName": ["Vindesine"]
    },
    "Teniposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19136750],
      "conceptName": ["Teniposide"]
    }
  },
  {
    "conceptId": [35803502],
    "regimenName": ["Cytarabine and Thioguanine"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Thioguanine": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1437379],
      "conceptName": ["Thioguanine"]
    },
    "Cytarabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Tretinoin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [903643],
      "conceptName": ["Tretinoin"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Mitoxantrone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1309188],
      "conceptName": ["Mitoxantrone"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Daunorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311799],
      "conceptName": ["Daunorubicin"]
    },
    "pegaspargase": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1326481],
      "conceptName": ["pegaspargase"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "mercaptopurine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1436650],
      "conceptName": ["mercaptopurine"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "ASPARAGINASE": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19012585],
      "conceptName": ["ASPARAGINASE"]
    },
    "Idarubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078097],
      "conceptName": ["Idarubicin"]
    }
  },
  {
    "conceptId": [35804338],
    "regimenName": ["ECT, then auto HSCT"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Epirubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1344354],
      "conceptName": ["Epirubicin"]
    },
    "Thiotepa": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [19137385],
      "conceptName": ["Thiotepa"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    }
  },
  {
    "conceptId": [35804288],
    "regimenName": ["Letrozole and Ribociclib"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "letrozole": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1315946],
      "conceptName": ["letrozole"]
    },
    "ribociclib": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1592911],
      "conceptName": ["ribociclib"]
    }
  },
  {
    "conceptId": [35804532],
    "regimenName": ["Cisplatin, Fluorouracil, Hydroxyurea, RT"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Cisplatin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "Fluorouracil": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "hydroxyurea": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1377141],
      "conceptName": ["hydroxyurea"]
    }
  },
  {
    "conceptId": [35805768],
    "regimenName": ["Docetaxel, Fluorouracil, Hydroxyurea, RT"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "docetaxel": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1315942],
      "conceptName": ["docetaxel"]
    },
    "Fluorouracil": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "hydroxyurea": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1377141],
      "conceptName": ["hydroxyurea"]
    }
  },
  {
    "conceptId": [35804560],
    "regimenName": ["Capecitabine and Mitomycin"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Mitomycin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1389036],
      "conceptName": ["Mitomycin"]
    },
    "capecitabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1337620],
      "conceptName": ["capecitabine"]
    }
  },
  {
    "conceptId": [35806416],
    "regimenName": ["Cisplatin, Gemcitabine, Necitumumab"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Cisplatin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "necitumumab": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [35606215],
      "conceptName": ["necitumumab"]
    },
    "gemcitabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1314924],
      "conceptName": ["gemcitabine"]
    }
  },
  {
    "conceptId": [35804271],
    "regimenName": ["Anastrozole monotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "anastrozole": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1348265],
      "conceptName": ["anastrozole"]
    },
    "abemaciclib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [792649],
      "conceptName": ["abemaciclib"]
    },
    "fulvestrant": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1304044],
      "conceptName": ["fulvestrant"]
    },
    "Goserelin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1366310],
      "conceptName": ["Goserelin"]
    },
    "trastuzumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1387104],
      "conceptName": ["trastuzumab"]
    },
    "ribociclib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1592911],
      "conceptName": ["ribociclib"]
    },
    "palbociclib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [45892075],
      "conceptName": ["palbociclib"]
    }
  },
  {
    "conceptId": [35804613],
    "regimenName": ["Idelalisib monotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "idelalisib": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [45776944],
      "conceptName": ["idelalisib"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "bendamustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19015523],
      "conceptName": ["bendamustine"]
    },
    "ofatumumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [40167582],
      "conceptName": ["ofatumumab"]
    }
  },
  {
    "conceptId": [35806258],
    "regimenName": ["VMP"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Melphalan": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1301267],
      "conceptName": ["Melphalan"]
    },
    "bortezomib": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1336825],
      "conceptName": ["bortezomib"]
    },
    "Prednisone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "lenalidomide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19026972],
      "conceptName": ["lenalidomide"]
    },
    "Thalidomide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19137042],
      "conceptName": ["Thalidomide"]
    },
    "daratumumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [35605744],
      "conceptName": ["daratumumab"]
    }
  },
  {
    "conceptId": [35805120],
    "regimenName": ["VIM"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Ifosfamide": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    },
    "Mitoxantrone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1309188],
      "conceptName": ["Mitoxantrone"]
    },
    "Etoposide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Mesna": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1354698],
      "conceptName": ["Mesna"]
    }
  },
  {
    "conceptId": [35804776],
    "regimenName": ["FOLFOX4 and Bevacizumab"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "oxaliplatin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1318011],
      "conceptName": ["oxaliplatin"]
    },
    "bevacizumab": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1397141],
      "conceptName": ["bevacizumab"]
    },
    "Leucovorin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1388796],
      "conceptName": ["Leucovorin"]
    },
    "Fluorouracil": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    }
  },
  {
    "conceptId": [35804564],
    "regimenName": ["Fluorouracil, Folinic acid, Gemcitabine"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Leucovorin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1388796],
      "conceptName": ["Leucovorin"]
    },
    "gemcitabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1314924],
      "conceptName": ["gemcitabine"]
    },
    "Fluorouracil": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "oxaliplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1318011],
      "conceptName": ["oxaliplatin"]
    },
    "irinotecan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1367268],
      "conceptName": ["irinotecan"]
    }
  },
  {
    "conceptId": [35806281],
    "regimenName": ["KCd"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Cyclophosphamide": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "carfilzomib": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [42873638],
      "conceptName": ["carfilzomib"]
    },
    "Dexamethasone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "Thalidomide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19137042],
      "conceptName": ["Thalidomide"]
    }
  },
  {
    "conceptId": [35804375],
    "regimenName": ["CODOX-M/IVAC"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Methotrexate": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Ifosfamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    },
    "Cytarabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Etoposide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Vindesine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008336],
      "conceptName": ["Vindesine"]
    },
    "Teniposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19136750],
      "conceptName": ["Teniposide"]
    }
  },
  {
    "conceptId": [35805816],
    "regimenName": ["VEBEP"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Bleomycin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1329241],
      "conceptName": ["Bleomycin"]
    },
    "Epirubicin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1344354],
      "conceptName": ["Epirubicin"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Etoposide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "prednisolone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1550557],
      "conceptName": ["prednisolone"]
    }
  },
  {
    "conceptId": [35804815],
    "regimenName": ["Mogamulizumab monotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "mogamulizumab": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [35200202],
      "conceptName": ["mogamulizumab"]
    }
  },
  {
    "conceptId": [35803474],
    "regimenName": ["Decitabine and Venetoclax"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "venetoclax": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [35604205],
      "conceptName": ["venetoclax"]
    },
    "decitabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [19024728],
      "conceptName": ["decitabine"]
    }
  },
  {
    "conceptId": [35806867],
    "regimenName": ["Cyproterone acetate monotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Cyproterone": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [19010792],
      "conceptName": ["Cyproterone"]
    }
  },
  {
    "conceptId": [35805862],
    "regimenName": ["Doxorubicin and Lomustine"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Lomustine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1391846],
      "conceptName": ["Lomustine"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Dacarbazine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311409],
      "conceptName": ["Dacarbazine"]
    },
    "Bleomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1329241],
      "conceptName": ["Bleomycin"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Vinblastine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008264],
      "conceptName": ["Vinblastine"]
    },
    "Streptozocin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19136210],
      "conceptName": ["Streptozocin"]
    }
  },
  {
    "conceptId": [35805833],
    "regimenName": ["GCD-R"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Carboplatin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1344905],
      "conceptName": ["Carboplatin"]
    },
    "rituximab": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "gemcitabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1314924],
      "conceptName": ["gemcitabine"]
    },
    "Dexamethasone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    }
  },
  {
    "conceptId": [35803451],
    "regimenName": ["7 plus 3d and Glasdegib"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "glasdegib": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1355795],
      "conceptName": ["glasdegib"]
    },
    "Cytarabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Daunorubicin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1311799],
      "conceptName": ["Daunorubicin"]
    }
  },
  {
    "conceptId": [35804520],
    "regimenName": ["Bortezomib monotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "bortezomib": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1336825],
      "conceptName": ["bortezomib"]
    },
    "Melphalan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1301267],
      "conceptName": ["Melphalan"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Vorinostat": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1337651],
      "conceptName": ["Vorinostat"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Chlorambucil": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1390051],
      "conceptName": ["Chlorambucil"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "prednisolone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1550557],
      "conceptName": ["prednisolone"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "everolimus": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19011440],
      "conceptName": ["everolimus"]
    },
    "bendamustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19015523],
      "conceptName": ["bendamustine"]
    },
    "lenalidomide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19026972],
      "conceptName": ["lenalidomide"]
    },
    "doxorubicin liposome": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19051649],
      "conceptName": ["doxorubicin liposome"]
    },
    "Thalidomide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19137042],
      "conceptName": ["Thalidomide"]
    },
    "elotuzumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [35604032],
      "conceptName": ["elotuzumab"]
    },
    "daratumumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [35605744],
      "conceptName": ["daratumumab"]
    },
    "pomalidomide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [43014237],
      "conceptName": ["pomalidomide"]
    },
    "panobinostat": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [46221435],
      "conceptName": ["panobinostat"]
    }
  },
  {
    "conceptId": [35803570],
    "regimenName": ["BEP"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Bleomycin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1329241],
      "conceptName": ["Bleomycin"]
    },
    "Cisplatin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "Etoposide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Vinblastine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008264],
      "conceptName": ["Vinblastine"]
    }
  },
  {
    "conceptId": [35805823],
    "regimenName": ["ChlVPP/EVA"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Chlorambucil": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1390051],
      "conceptName": ["Chlorambucil"]
    },
    "Vinblastine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [19008264],
      "conceptName": ["Vinblastine"]
    },
    "Procarbazine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1351779],
      "conceptName": ["Procarbazine"]
    },
    "Etoposide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "prednisolone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1550557],
      "conceptName": ["prednisolone"]
    },
    "Bleomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1329241],
      "conceptName": ["Bleomycin"]
    }
  },
  {
    "conceptId": [35804204],
    "regimenName": ["TL (Taxol)"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Paclitaxel": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1378382],
      "conceptName": ["Paclitaxel"]
    },
    "lapatinib": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1359548],
      "conceptName": ["lapatinib"]
    },
    "trastuzumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1387104],
      "conceptName": ["trastuzumab"]
    }
  },
  {
    "conceptId": [35806294],
    "regimenName": ["CAD and G-CSF"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Dexamethasone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "Melphalan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1301267],
      "conceptName": ["Melphalan"]
    },
    "imatinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1304107],
      "conceptName": ["imatinib"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "pegaspargase": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1326481],
      "conceptName": ["pegaspargase"]
    },
    "Bleomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1329241],
      "conceptName": ["Bleomycin"]
    },
    "bortezomib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1336825],
      "conceptName": ["bortezomib"]
    },
    "Carmustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350066],
      "conceptName": ["Carmustine"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "dasatinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1358436],
      "conceptName": ["dasatinib"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "mercaptopurine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1436650],
      "conceptName": ["mercaptopurine"]
    },
    "Thioguanine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1437379],
      "conceptName": ["Thioguanine"]
    },
    "Methylprednisolone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1506270],
      "conceptName": ["Methylprednisolone"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Vindesine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008336],
      "conceptName": ["Vindesine"]
    },
    "everolimus": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19011440],
      "conceptName": ["everolimus"]
    },
    "ASPARAGINASE": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19012585],
      "conceptName": ["ASPARAGINASE"]
    },
    "Ifosfamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    },
    "Teniposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19136750],
      "conceptName": ["Teniposide"]
    },
    "Thalidomide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19137042],
      "conceptName": ["Thalidomide"]
    },
    "ponatinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [43013182],
      "conceptName": ["ponatinib"]
    }
  },
  {
    "conceptId": [35806381],
    "regimenName": ["Lanreotide and Interferon alfa-2b"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "lanreotide": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1503501],
      "conceptName": ["lanreotide"]
    },
    "Interferon Alfa-2b": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1380068],
      "conceptName": ["Interferon Alfa-2b"]
    }
  },
  {
    "conceptId": [35806330],
    "regimenName": ["PCP"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Prednisone": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "pomalidomide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [43014237],
      "conceptName": ["pomalidomide"]
    }
  },
  {
    "conceptId": [35804048],
    "regimenName": ["Daunorubicin, Pegaspargase, Vincristine, Prednisone"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "pegaspargase": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1326481],
      "conceptName": ["pegaspargase"]
    },
    "Prednisone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Daunorubicin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1311799],
      "conceptName": ["Daunorubicin"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    }
  },
  {
    "conceptId": [35804038],
    "regimenName": ["L-Asparaginase and Methotrexate"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Methotrexate": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "ASPARAGINASE": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [19012585],
      "conceptName": ["ASPARAGINASE"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Daunorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311799],
      "conceptName": ["Daunorubicin"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Mesna": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1354698],
      "conceptName": ["Mesna"]
    },
    "mercaptopurine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1436650],
      "conceptName": ["mercaptopurine"]
    },
    "Thioguanine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1437379],
      "conceptName": ["Thioguanine"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Ifosfamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    },
    "Teniposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19136750],
      "conceptName": ["Teniposide"]
    }
  },
  {
    "conceptId": [35806064],
    "regimenName": ["Ixazomib monotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "ixazomib": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [35606214],
      "conceptName": ["ixazomib"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "lenalidomide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19026972],
      "conceptName": ["lenalidomide"]
    }
  },
  {
    "conceptId": [35807018],
    "regimenName": ["BO"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Bleomycin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1329241],
      "conceptName": ["Bleomycin"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Mitoxantrone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1309188],
      "conceptName": ["Mitoxantrone"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Dacarbazine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311409],
      "conceptName": ["Dacarbazine"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Carboplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344905],
      "conceptName": ["Carboplatin"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Procarbazine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1351779],
      "conceptName": ["Procarbazine"]
    },
    "Chlorambucil": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1390051],
      "conceptName": ["Chlorambucil"]
    },
    "Mechlorethamine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1394337],
      "conceptName": ["Mechlorethamine"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "prednisolone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1550557],
      "conceptName": ["prednisolone"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Vinblastine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008264],
      "conceptName": ["Vinblastine"]
    },
    "Teniposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19136750],
      "conceptName": ["Teniposide"]
    }
  },
  {
    "conceptId": [35806351],
    "regimenName": ["Melphalan and Methylprednisolone, then auto HSCT"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Methylprednisolone": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1506270],
      "conceptName": ["Methylprednisolone"]
    },
    "Melphalan": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1301267],
      "conceptName": ["Melphalan"]
    }
  },
  {
    "conceptId": [35101984],
    "regimenName": ["Cyclophosphamide, Cytarabine, Pegaspargase, Thioguanine, Vincristine, Dexamethasone"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Thioguanine": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1437379],
      "conceptName": ["Thioguanine"]
    },
    "pegaspargase": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1326481],
      "conceptName": ["pegaspargase"]
    },
    "Cytarabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Dexamethasone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    }
  },
  {
    "conceptId": [35101986],
    "regimenName": ["CM"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Methotrexate": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "inotuzumab ozogamicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [794068],
      "conceptName": ["inotuzumab ozogamicin"]
    },
    "Fluorouracil": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "imatinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1304107],
      "conceptName": ["imatinib"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Mitoxantrone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1309188],
      "conceptName": ["Mitoxantrone"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Dactinomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311443],
      "conceptName": ["Dactinomycin"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Bleomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1329241],
      "conceptName": ["Bleomycin"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Epirubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344354],
      "conceptName": ["Epirubicin"]
    },
    "Carboplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344905],
      "conceptName": ["Carboplatin"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Procarbazine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1351779],
      "conceptName": ["Procarbazine"]
    },
    "dasatinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1358436],
      "conceptName": ["dasatinib"]
    },
    "Altretamine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1368823],
      "conceptName": ["Altretamine"]
    },
    "Leucovorin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1388796],
      "conceptName": ["Leucovorin"]
    },
    "Lomustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1391846],
      "conceptName": ["Lomustine"]
    },
    "Mechlorethamine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1394337],
      "conceptName": ["Mechlorethamine"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "mercaptopurine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1436650],
      "conceptName": ["mercaptopurine"]
    },
    "Tamoxifen": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1436678],
      "conceptName": ["Tamoxifen"]
    },
    "Thioguanine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1437379],
      "conceptName": ["Thioguanine"]
    },
    "Methylprednisolone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1506270],
      "conceptName": ["Methylprednisolone"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "prednisolone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1550557],
      "conceptName": ["prednisolone"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Vindesine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008336],
      "conceptName": ["Vindesine"]
    },
    "everolimus": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19011440],
      "conceptName": ["everolimus"]
    },
    "ASPARAGINASE": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19012585],
      "conceptName": ["ASPARAGINASE"]
    },
    "doxorubicin liposome": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19051649],
      "conceptName": ["doxorubicin liposome"]
    },
    "Ifosfamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    },
    "Teniposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19136750],
      "conceptName": ["Teniposide"]
    },
    "Cytarabine liposome": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [40175460],
      "conceptName": ["Cytarabine liposome"]
    },
    "ponatinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [43013182],
      "conceptName": ["ponatinib"]
    }
  },
  {
    "conceptId": [35805034],
    "regimenName": ["R-miniCEOP"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Epirubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1344354],
      "conceptName": ["Epirubicin"]
    },
    "rituximab": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Prednisone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Vinblastine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [19008264],
      "conceptName": ["Vinblastine"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    }
  },
  {
    "conceptId": [35804034],
    "regimenName": ["Imatinib and Prednisone"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Prednisone": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "imatinib": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1304107],
      "conceptName": ["imatinib"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Daunorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311799],
      "conceptName": ["Daunorubicin"]
    },
    "ASPARAGINASE": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19012585],
      "conceptName": ["ASPARAGINASE"]
    }
  },
  {
    "conceptId": [35806060],
    "regimenName": ["Bortezomib and Melphalan, then auto HSCT"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Melphalan": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1301267],
      "conceptName": ["Melphalan"]
    },
    "bortezomib": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1336825],
      "conceptName": ["bortezomib"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "lenalidomide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19026972],
      "conceptName": ["lenalidomide"]
    },
    "Thalidomide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19137042],
      "conceptName": ["Thalidomide"]
    },
    "daratumumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [35605744],
      "conceptName": ["daratumumab"]
    }
  },
  {
    "conceptId": [35804261],
    "regimenName": ["Doxorubicin and Bevacizumab"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "bevacizumab": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1397141],
      "conceptName": ["bevacizumab"]
    },
    "Fluorouracil": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    }
  },
  {
    "conceptId": [35804289],
    "regimenName": ["Ribociclib and Tamoxifen"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Tamoxifen": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1436678],
      "conceptName": ["Tamoxifen"]
    },
    "ribociclib": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1592911],
      "conceptName": ["ribociclib"]
    }
  },
  {
    "conceptId": [35805662],
    "regimenName": ["FMP"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Prednisone": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "fludarabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1395557],
      "conceptName": ["fludarabine"]
    },
    "Mitoxantrone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1309188],
      "conceptName": ["Mitoxantrone"]
    }
  },
  {
    "conceptId": [35804269],
    "regimenName": ["Olaparib monotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "olaparib": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [45892579],
      "conceptName": ["olaparib"]
    },
    "Carboplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344905],
      "conceptName": ["Carboplatin"]
    },
    "Paclitaxel": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1378382],
      "conceptName": ["Paclitaxel"]
    }
  },
  {
    "conceptId": [35804369],
    "regimenName": ["COP"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Prednisone": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Fluorouracil": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "Melphalan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1301267],
      "conceptName": ["Melphalan"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Mitoxantrone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1309188],
      "conceptName": ["Mitoxantrone"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Dacarbazine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311409],
      "conceptName": ["Dacarbazine"]
    },
    "Daunorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311799],
      "conceptName": ["Daunorubicin"]
    },
    "alemtuzumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1312706],
      "conceptName": ["alemtuzumab"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Bleomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1329241],
      "conceptName": ["Bleomycin"]
    },
    "bortezomib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1336825],
      "conceptName": ["bortezomib"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Epirubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344354],
      "conceptName": ["Epirubicin"]
    },
    "Carboplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344905],
      "conceptName": ["Carboplatin"]
    },
    "Carmustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350066],
      "conceptName": ["Carmustine"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Procarbazine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1351779],
      "conceptName": ["Procarbazine"]
    },
    "Mechlorethamine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1394337],
      "conceptName": ["Mechlorethamine"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "Thioguanine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1437379],
      "conceptName": ["Thioguanine"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "Hyaluronidase / rituximab Injection [Rituxan Hycela]": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1593155],
      "conceptName": ["Hyaluronidase / rituximab Injection [Rituxan Hycela]"]
    },
    "Vinblastine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008264],
      "conceptName": ["Vinblastine"]
    },
    "Vindesine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008336],
      "conceptName": ["Vindesine"]
    },
    "everolimus": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19011440],
      "conceptName": ["everolimus"]
    },
    "ASPARAGINASE": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19012585],
      "conceptName": ["ASPARAGINASE"]
    },
    "lenalidomide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19026972],
      "conceptName": ["lenalidomide"]
    },
    "denileukin diftitox": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19051642],
      "conceptName": ["denileukin diftitox"]
    },
    "doxorubicin liposome": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19051649],
      "conceptName": ["doxorubicin liposome"]
    },
    "iodine-131-tositumomab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19054997],
      "conceptName": ["iodine-131-tositumomab"]
    },
    "Idarubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078097],
      "conceptName": ["Idarubicin"]
    },
    "Ifosfamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    },
    "BCG, Live, Tice Strain": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19086176],
      "conceptName": ["BCG, Live, Tice Strain"]
    },
    "Teniposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19136750],
      "conceptName": ["Teniposide"]
    },
    "ranimustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [35197850],
      "conceptName": ["ranimustine"]
    },
    "ofatumumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [40167582],
      "conceptName": ["ofatumumab"]
    },
    "obinutuzumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [44507676],
      "conceptName": ["obinutuzumab"]
    }
  },
  {
    "conceptId": [35101866],
    "regimenName": ["Alpelisib and Fulvestrant"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "fulvestrant": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1304044],
      "conceptName": ["fulvestrant"]
    },
    "alpelisib": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1396423],
      "conceptName": ["alpelisib"]
    }
  },
  {
    "conceptId": [35806121],
    "regimenName": ["Talimogene laherparepvec monotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Human herpesvirus 1": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [42903942],
      "conceptName": ["Human herpesvirus 1"]
    }
  },
  {
    "conceptId": [35806139],
    "regimenName": ["Trametinib monotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "trametinib": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [43532497],
      "conceptName": ["trametinib"]
    },
    "dabrafenib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [43532299],
      "conceptName": ["dabrafenib"]
    }
  },
  {
    "conceptId": [35102011],
    "regimenName": ["R-MCP (CCNU)"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Methotrexate": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "rituximab": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Lomustine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1391846],
      "conceptName": ["Lomustine"]
    },
    "Procarbazine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1351779],
      "conceptName": ["Procarbazine"]
    }
  },
  {
    "conceptId": [35805230],
    "regimenName": ["Ado-trastuzumab emtansine monotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "ado-trastuzumab emtansine": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [43525787],
      "conceptName": ["ado-trastuzumab emtansine"]
    },
    "Paclitaxel": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1378382],
      "conceptName": ["Paclitaxel"]
    },
    "Tamoxifen": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1436678],
      "conceptName": ["Tamoxifen"]
    },
    "pertuzumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [42801287],
      "conceptName": ["pertuzumab"]
    }
  },
  {
    "conceptId": [35804066],
    "regimenName": ["Tisagenlecleucel monotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "tisagenlecleucel": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [792737],
      "conceptName": ["tisagenlecleucel"]
    }
  },
  {
    "conceptId": [35804166],
    "regimenName": ["Paclitaxel monotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Paclitaxel": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1378382],
      "conceptName": ["Paclitaxel"]
    },
    "neratinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [793846],
      "conceptName": ["neratinib"]
    },
    "Fluorouracil": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Dacarbazine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311409],
      "conceptName": ["Dacarbazine"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "gemcitabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314924],
      "conceptName": ["gemcitabine"]
    },
    "oxaliplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1318011],
      "conceptName": ["oxaliplatin"]
    },
    "capecitabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1337620],
      "conceptName": ["capecitabine"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "vinorelbine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1343346],
      "conceptName": ["vinorelbine"]
    },
    "Epirubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344354],
      "conceptName": ["Epirubicin"]
    },
    "Carboplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344905],
      "conceptName": ["Carboplatin"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "lapatinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1359548],
      "conceptName": ["lapatinib"]
    },
    "Hyaluronidase / trastuzumab Injection [Herceptin Hylecta]": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1366689],
      "conceptName": ["Hyaluronidase / trastuzumab Injection [Herceptin Hylecta]"]
    },
    "Topotecan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1378509],
      "conceptName": ["Topotecan"]
    },
    "trastuzumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1387104],
      "conceptName": ["trastuzumab"]
    },
    "bevacizumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397141],
      "conceptName": ["bevacizumab"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "Ifosfamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    },
    "pazopanib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [40167554],
      "conceptName": ["pazopanib"]
    },
    "ipilimumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [40238188],
      "conceptName": ["ipilimumab"]
    },
    "atezolizumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [42629079],
      "conceptName": ["atezolizumab"]
    },
    "pertuzumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [42801287],
      "conceptName": ["pertuzumab"]
    },
    "ado-trastuzumab emtansine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [43525787],
      "conceptName": ["ado-trastuzumab emtansine"]
    },
    "Afatinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [43533090],
      "conceptName": ["Afatinib"]
    },
    "ramucirumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [44818489],
      "conceptName": ["ramucirumab"]
    },
    "pembrolizumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [45775965],
      "conceptName": ["pembrolizumab"]
    },
    "olaparib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [45892579],
      "conceptName": ["olaparib"]
    }
  },
  {
    "conceptId": [35805853],
    "regimenName": ["MVPP"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Prednisone": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Vinblastine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [19008264],
      "conceptName": ["Vinblastine"]
    },
    "Procarbazine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1351779],
      "conceptName": ["Procarbazine"]
    },
    "Mechlorethamine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1394337],
      "conceptName": ["Mechlorethamine"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Dacarbazine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311409],
      "conceptName": ["Dacarbazine"]
    },
    "Bleomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1329241],
      "conceptName": ["Bleomycin"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    }
  },
  {
    "conceptId": [35803626],
    "regimenName": ["Fludarabine, Cyclophosphamide, ATG"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Cyclophosphamide": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "fludarabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1395557],
      "conceptName": ["fludarabine"]
    },
    "Mitoxantrone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1309188],
      "conceptName": ["Mitoxantrone"]
    },
    "alemtuzumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1312706],
      "conceptName": ["alemtuzumab"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Busulfan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1333357],
      "conceptName": ["Busulfan"]
    },
    "ibritumomab tiuxetan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19068830],
      "conceptName": ["ibritumomab tiuxetan"]
    },
    "Thiotepa": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19137385],
      "conceptName": ["Thiotepa"]
    },
    "ofatumumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [40167582],
      "conceptName": ["ofatumumab"]
    },
    "obinutuzumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [44507676],
      "conceptName": ["obinutuzumab"]
    }
  },
  {
    "conceptId": [35804097],
    "regimenName": ["Daunorubicin and Prednisone"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Prednisone": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Daunorubicin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1311799],
      "conceptName": ["Daunorubicin"]
    },
    "imatinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1304107],
      "conceptName": ["imatinib"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Azacitidine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314865],
      "conceptName": ["Azacitidine"]
    },
    "pegaspargase": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1326481],
      "conceptName": ["pegaspargase"]
    },
    "ASPARAGINASE": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19012585],
      "conceptName": ["ASPARAGINASE"]
    },
    "Teniposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19136750],
      "conceptName": ["Teniposide"]
    }
  },
  {
    "conceptId": [35805370],
    "regimenName": ["MCF"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Cisplatin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "Mitomycin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1389036],
      "conceptName": ["Mitomycin"]
    },
    "Fluorouracil": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    }
  },
  {
    "conceptId": [35804225],
    "regimenName": ["THP (Taxol)"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Paclitaxel": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1378382],
      "conceptName": ["Paclitaxel"]
    },
    "pertuzumab": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [42801287],
      "conceptName": ["pertuzumab"]
    },
    "trastuzumab": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1387104],
      "conceptName": ["trastuzumab"]
    }
  },
  {
    "conceptId": [35803455],
    "regimenName": ["CIA"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Idarubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [19078097],
      "conceptName": ["Idarubicin"]
    },
    "Cytarabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "clofarabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [19054821],
      "conceptName": ["clofarabine"]
    }
  },
  {
    "conceptId": [35804537],
    "regimenName": ["Carboplatin monotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Carboplatin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1344905],
      "conceptName": ["Carboplatin"]
    },
    "Fluorouracil": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "pemetrexed": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1304919],
      "conceptName": ["pemetrexed"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "gemcitabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314924],
      "conceptName": ["gemcitabine"]
    },
    "cetuximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1315411],
      "conceptName": ["cetuximab"]
    },
    "docetaxel": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1315942],
      "conceptName": ["docetaxel"]
    },
    "erlotinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1325363],
      "conceptName": ["erlotinib"]
    },
    "Bleomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1329241],
      "conceptName": ["Bleomycin"]
    },
    "capecitabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1337620],
      "conceptName": ["capecitabine"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "vinorelbine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1343346],
      "conceptName": ["vinorelbine"]
    },
    "Epirubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344354],
      "conceptName": ["Epirubicin"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Mesna": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1354698],
      "conceptName": ["Mesna"]
    },
    "irinotecan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1367268],
      "conceptName": ["irinotecan"]
    },
    "Paclitaxel": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1378382],
      "conceptName": ["Paclitaxel"]
    },
    "trastuzumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1387104],
      "conceptName": ["trastuzumab"]
    },
    "Mitomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1389036],
      "conceptName": ["Mitomycin"]
    },
    "bevacizumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397141],
      "conceptName": ["bevacizumab"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "prednisolone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1550557],
      "conceptName": ["prednisolone"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Vindesine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008336],
      "conceptName": ["Vindesine"]
    },
    "lenalidomide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19026972],
      "conceptName": ["lenalidomide"]
    },
    "doxorubicin liposome": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19051649],
      "conceptName": ["doxorubicin liposome"]
    },
    "Ifosfamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    },
    "Teniposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19136750],
      "conceptName": ["Teniposide"]
    },
    "Thiotepa": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19137385],
      "conceptName": ["Thiotepa"]
    },
    "ranimustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [35197850],
      "conceptName": ["ranimustine"]
    },
    "ofatumumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [40167582],
      "conceptName": ["ofatumumab"]
    },
    "ipilimumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [40238188],
      "conceptName": ["ipilimumab"]
    },
    "atezolizumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [42629079],
      "conceptName": ["atezolizumab"]
    },
    "pertuzumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [42801287],
      "conceptName": ["pertuzumab"]
    },
    "pembrolizumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [45775965],
      "conceptName": ["pembrolizumab"]
    },
    "olaparib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [45892579],
      "conceptName": ["olaparib"]
    }
  },
  {
    "conceptId": [35806969],
    "regimenName": ["Dacarbazine and Gemcitabine"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "gemcitabine": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1314924],
      "conceptName": ["gemcitabine"]
    },
    "Dacarbazine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1311409],
      "conceptName": ["Dacarbazine"]
    }
  },
  {
    "conceptId": [35806421],
    "regimenName": ["Cabozantinib and Erlotinib"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "erlotinib": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1325363],
      "conceptName": ["erlotinib"]
    },
    "cabozantinib": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [43012292],
      "conceptName": ["cabozantinib"]
    }
  },
  {
    "conceptId": [35806427],
    "regimenName": ["Cisplatin and Gemcitabine/Erlotinib"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Cisplatin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "erlotinib": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1325363],
      "conceptName": ["erlotinib"]
    },
    "gemcitabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1314924],
      "conceptName": ["gemcitabine"]
    }
  },
  {
    "conceptId": [35805855],
    "regimenName": ["SCAB"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Bleomycin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1329241],
      "conceptName": ["Bleomycin"]
    },
    "Lomustine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1391846],
      "conceptName": ["Lomustine"]
    },
    "Streptozocin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [19136210],
      "conceptName": ["Streptozocin"]
    }
  },
  {
    "conceptId": [35806275],
    "regimenName": ["Tandem melphalan, then auto HSCT"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Melphalan": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1301267],
      "conceptName": ["Melphalan"]
    },
    "Fluorouracil": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "alemtuzumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1312706],
      "conceptName": ["alemtuzumab"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Busulfan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1333357],
      "conceptName": ["Busulfan"]
    },
    "bortezomib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1336825],
      "conceptName": ["bortezomib"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Carmustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350066],
      "conceptName": ["Carmustine"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "fludarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1395557],
      "conceptName": ["fludarabine"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "Tamoxifen": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1436678],
      "conceptName": ["Tamoxifen"]
    },
    "Methylprednisolone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1506270],
      "conceptName": ["Methylprednisolone"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "prednisolone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1550557],
      "conceptName": ["prednisolone"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "bendamustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19015523],
      "conceptName": ["bendamustine"]
    },
    "lenalidomide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19026972],
      "conceptName": ["lenalidomide"]
    },
    "clofarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19054821],
      "conceptName": ["clofarabine"]
    },
    "ibritumomab tiuxetan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19068830],
      "conceptName": ["ibritumomab tiuxetan"]
    },
    "Thalidomide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19137042],
      "conceptName": ["Thalidomide"]
    },
    "daratumumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [35605744],
      "conceptName": ["daratumumab"]
    },
    "Fotemustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [36879099],
      "conceptName": ["Fotemustine"]
    },
    "carfilzomib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [42873638],
      "conceptName": ["carfilzomib"]
    }
  },
  {
    "conceptId": [35805638],
    "regimenName": ["R-FM"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "rituximab": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "fludarabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1395557],
      "conceptName": ["fludarabine"]
    },
    "Mitoxantrone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1309188],
      "conceptName": ["Mitoxantrone"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    }
  },
  {
    "conceptId": [35806410],
    "regimenName": ["Pemetrexed and Bevacizumab"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "bevacizumab": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1397141],
      "conceptName": ["bevacizumab"]
    },
    "pemetrexed": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1304919],
      "conceptName": ["pemetrexed"]
    },
    "Carboplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344905],
      "conceptName": ["Carboplatin"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    }
  },
  {
    "conceptId": [35805920],
    "regimenName": ["Fostamatinib monotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "fostamatinib": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1510328],
      "conceptName": ["fostamatinib"]
    }
  },
  {
    "conceptId": [35803622],
    "regimenName": ["Fludarabine and TBI"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "fludarabine": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1395557],
      "conceptName": ["fludarabine"]
    },
    "Melphalan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1301267],
      "conceptName": ["Melphalan"]
    },
    "Filgrastim": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1304850],
      "conceptName": ["Filgrastim"]
    },
    "Mitoxantrone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1309188],
      "conceptName": ["Mitoxantrone"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "alemtuzumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1312706],
      "conceptName": ["alemtuzumab"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "oxaliplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1318011],
      "conceptName": ["oxaliplatin"]
    },
    "Busulfan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1333357],
      "conceptName": ["Busulfan"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "lenograstim": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19009705],
      "conceptName": ["lenograstim"]
    },
    "bendamustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19015523],
      "conceptName": ["bendamustine"]
    },
    "Daunorubicin Liposomal": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19051599],
      "conceptName": ["Daunorubicin Liposomal"]
    },
    "iodine-131-tositumomab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19054997],
      "conceptName": ["iodine-131-tositumomab"]
    },
    "ibritumomab tiuxetan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19068830],
      "conceptName": ["ibritumomab tiuxetan"]
    },
    "Idarubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078097],
      "conceptName": ["Idarubicin"]
    },
    "Thiotepa": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19137385],
      "conceptName": ["Thiotepa"]
    },
    "ofatumumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [40167582],
      "conceptName": ["ofatumumab"]
    },
    "obinutuzumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [44507676],
      "conceptName": ["obinutuzumab"]
    }
  },
  {
    "conceptId": [35804324],
    "regimenName": ["ACT"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Tamoxifen": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1436678],
      "conceptName": ["Tamoxifen"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    }
  },
  {
    "conceptId": [35805647],
    "regimenName": ["Copanlisib monotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "copanlisib": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [792499],
      "conceptName": ["copanlisib"]
    }
  },
  {
    "conceptId": [35806132],
    "regimenName": ["Low-dose Interleukin-2"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Aldesleukin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1309770],
      "conceptName": ["Aldesleukin"]
    },
    "Isotretinoin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [984232],
      "conceptName": ["Isotretinoin"]
    },
    "sargramostim": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308432],
      "conceptName": ["sargramostim"]
    },
    "Dacarbazine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311409],
      "conceptName": ["Dacarbazine"]
    },
    "Carmustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350066],
      "conceptName": ["Carmustine"]
    },
    "Interferon Alfa-2a": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1379969],
      "conceptName": ["Interferon Alfa-2a"]
    },
    "Interferon Alfa-2b": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1380068],
      "conceptName": ["Interferon Alfa-2b"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "Vinblastine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008264],
      "conceptName": ["Vinblastine"]
    },
    "dinutuximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [46221699],
      "conceptName": ["dinutuximab"]
    }
  },
  {
    "conceptId": [35804592],
    "regimenName": ["O-FC"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "ofatumumab": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [40167582],
      "conceptName": ["ofatumumab"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "fludarabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1395557],
      "conceptName": ["fludarabine"]
    }
  },
  {
    "conceptId": [35806259],
    "regimenName": ["VTD"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Thalidomide": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [19137042],
      "conceptName": ["Thalidomide"]
    },
    "bortezomib": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1336825],
      "conceptName": ["bortezomib"]
    },
    "Dexamethasone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "Melphalan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1301267],
      "conceptName": ["Melphalan"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "daratumumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [35605744],
      "conceptName": ["daratumumab"]
    },
    "panobinostat": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [46221435],
      "conceptName": ["panobinostat"]
    }
  },
  {
    "conceptId": [35805633],
    "regimenName": ["G-CVP"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "obinutuzumab": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [44507676],
      "conceptName": ["obinutuzumab"]
    },
    "Prednisone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    }
  },
  {
    "conceptId": [35805648],
    "regimenName": ["Lenalidomide, Dexamethasone, Rituximab"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "lenalidomide": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [19026972],
      "conceptName": ["lenalidomide"]
    },
    "rituximab": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Dexamethasone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    }
  },
  {
    "conceptId": [35804371],
    "regimenName": ["R-COPADM"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Methotrexate": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "rituximab": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "prednisolone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1550557],
      "conceptName": ["prednisolone"]
    }
  },
  {
    "conceptId": [35803531],
    "regimenName": ["DAT"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Thioguanine": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1437379],
      "conceptName": ["Thioguanine"]
    },
    "Cytarabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Daunorubicin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1311799],
      "conceptName": ["Daunorubicin"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    }
  },
  {
    "conceptId": [35805711],
    "regimenName": ["Bevacizumab and RT"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "bevacizumab": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1397141],
      "conceptName": ["bevacizumab"]
    },
    "Fluorouracil": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "pemetrexed": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1304919],
      "conceptName": ["pemetrexed"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "gemcitabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314924],
      "conceptName": ["gemcitabine"]
    },
    "docetaxel": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1315942],
      "conceptName": ["docetaxel"]
    },
    "letrozole": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1315946],
      "conceptName": ["letrozole"]
    },
    "oxaliplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1318011],
      "conceptName": ["oxaliplatin"]
    },
    "erlotinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1325363],
      "conceptName": ["erlotinib"]
    },
    "capecitabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1337620],
      "conceptName": ["capecitabine"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "temozolomide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1341149],
      "conceptName": ["temozolomide"]
    },
    "vinorelbine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1343346],
      "conceptName": ["vinorelbine"]
    },
    "Epirubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344354],
      "conceptName": ["Epirubicin"]
    },
    "Carboplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344905],
      "conceptName": ["Carboplatin"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Hyaluronidase / trastuzumab Injection [Herceptin Hylecta]": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1366689],
      "conceptName": ["Hyaluronidase / trastuzumab Injection [Herceptin Hylecta]"]
    },
    "irinotecan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1367268],
      "conceptName": ["irinotecan"]
    },
    "Paclitaxel": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1378382],
      "conceptName": ["Paclitaxel"]
    },
    "Topotecan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1378509],
      "conceptName": ["Topotecan"]
    },
    "Interferon Alfa-2a": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1379969],
      "conceptName": ["Interferon Alfa-2a"]
    },
    "trastuzumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1387104],
      "conceptName": ["trastuzumab"]
    },
    "Leucovorin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1388796],
      "conceptName": ["Leucovorin"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "doxorubicin liposome": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19051649],
      "conceptName": ["doxorubicin liposome"]
    },
    "Myocet": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [21017157],
      "conceptName": ["Myocet"]
    },
    "levoleucovorin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [40168303],
      "conceptName": ["levoleucovorin"]
    },
    "atezolizumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [42629079],
      "conceptName": ["atezolizumab"]
    }
  },
  {
    "conceptId": [35102012],
    "regimenName": ["R-CHOP-14 (Prednisolone)"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "rituximab": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "prednisolone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1550557],
      "conceptName": ["prednisolone"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    }
  },
  {
    "conceptId": [35804301],
    "regimenName": ["T-DM1 monotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "ado-trastuzumab emtansine": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [43525787],
      "conceptName": ["ado-trastuzumab emtansine"]
    },
    "Paclitaxel": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1378382],
      "conceptName": ["Paclitaxel"]
    },
    "Tamoxifen": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1436678],
      "conceptName": ["Tamoxifen"]
    },
    "pertuzumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [42801287],
      "conceptName": ["pertuzumab"]
    }
  },
  {
    "conceptId": [35803476],
    "regimenName": ["Glasdegib and LoDAC"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "glasdegib": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1355795],
      "conceptName": ["glasdegib"]
    },
    "Cytarabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Daunorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311799],
      "conceptName": ["Daunorubicin"]
    }
  },
  {
    "conceptId": [35803564],
    "regimenName": ["ATRA, Mercaptopurine, Methotrexate"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Methotrexate": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "mercaptopurine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1436650],
      "conceptName": ["mercaptopurine"]
    },
    "Tretinoin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [903643],
      "conceptName": ["Tretinoin"]
    }
  },
  {
    "conceptId": [35804243],
    "regimenName": ["Lapatinib and Trastuzumab"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "trastuzumab": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1387104],
      "conceptName": ["trastuzumab"]
    },
    "lapatinib": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1359548],
      "conceptName": ["lapatinib"]
    },
    "letrozole": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1315946],
      "conceptName": ["letrozole"]
    },
    "Paclitaxel": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1378382],
      "conceptName": ["Paclitaxel"]
    }
  },
  {
    "conceptId": [35806898],
    "regimenName": ["Fluorouracil, then Fluorouracil and RT, then Fluorouracil"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Fluorouracil": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "Melphalan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1301267],
      "conceptName": ["Melphalan"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Mitoxantrone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1309188],
      "conceptName": ["Mitoxantrone"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "gemcitabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314924],
      "conceptName": ["gemcitabine"]
    },
    "cetuximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1315411],
      "conceptName": ["cetuximab"]
    },
    "docetaxel": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1315942],
      "conceptName": ["docetaxel"]
    },
    "oxaliplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1318011],
      "conceptName": ["oxaliplatin"]
    },
    "capecitabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1337620],
      "conceptName": ["capecitabine"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Epirubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344354],
      "conceptName": ["Epirubicin"]
    },
    "Carboplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344905],
      "conceptName": ["Carboplatin"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "irinotecan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1367268],
      "conceptName": ["irinotecan"]
    },
    "Altretamine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1368823],
      "conceptName": ["Altretamine"]
    },
    "hydroxyurea": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1377141],
      "conceptName": ["hydroxyurea"]
    },
    "Paclitaxel": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1378382],
      "conceptName": ["Paclitaxel"]
    },
    "trastuzumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1387104],
      "conceptName": ["trastuzumab"]
    },
    "Leucovorin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1388796],
      "conceptName": ["Leucovorin"]
    },
    "Mitomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1389036],
      "conceptName": ["Mitomycin"]
    },
    "Levamisole": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1389464],
      "conceptName": ["Levamisole"]
    },
    "bevacizumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397141],
      "conceptName": ["bevacizumab"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "Tamoxifen": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1436678],
      "conceptName": ["Tamoxifen"]
    },
    "Medroxyprogesterone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1500211],
      "conceptName": ["Medroxyprogesterone"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "doxorubicin liposome": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19051649],
      "conceptName": ["doxorubicin liposome"]
    },
    "BCG, Live, Tice Strain": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19086176],
      "conceptName": ["BCG, Live, Tice Strain"]
    },
    "panitumumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19100985],
      "conceptName": ["panitumumab"]
    },
    "Streptozocin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19136210],
      "conceptName": ["Streptozocin"]
    },
    "Thiotepa": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19137385],
      "conceptName": ["Thiotepa"]
    },
    "irinotecan liposomal": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [35603068],
      "conceptName": ["irinotecan liposomal"]
    },
    "levoleucovorin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [40168303],
      "conceptName": ["levoleucovorin"]
    },
    "aflibercept": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [40244266],
      "conceptName": ["aflibercept"]
    },
    "ramucirumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [44818489],
      "conceptName": ["ramucirumab"]
    }
  },
  {
    "conceptId": [35804539],
    "regimenName": ["Cisplatin and Mitomycin"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Mitomycin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1389036],
      "conceptName": ["Mitomycin"]
    },
    "Cisplatin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "Fluorouracil": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "Vinblastine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008264],
      "conceptName": ["Vinblastine"]
    },
    "Vindesine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008336],
      "conceptName": ["Vindesine"]
    },
    "Ifosfamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    }
  },
  {
    "conceptId": [35804052],
    "regimenName": ["CALGB 8811 regimen"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Thioguanine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1437379],
      "conceptName": ["Thioguanine"]
    },
    "Methotrexate": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "ASPARAGINASE": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [19012585],
      "conceptName": ["ASPARAGINASE"]
    },
    "Cytarabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "mercaptopurine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1436650],
      "conceptName": ["mercaptopurine"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Dexamethasone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    }
  },
  {
    "conceptId": [35806302],
    "regimenName": ["BiRD"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "lenalidomide": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [19026972],
      "conceptName": ["lenalidomide"]
    },
    "Clarithromycin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1750500],
      "conceptName": ["Clarithromycin"]
    },
    "Dexamethasone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    }
  },
  {
    "conceptId": [35806586],
    "regimenName": ["Docetaxel, Gemcitabine, RT"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "docetaxel": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1315942],
      "conceptName": ["docetaxel"]
    },
    "gemcitabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1314924],
      "conceptName": ["gemcitabine"]
    },
    "capecitabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1337620],
      "conceptName": ["capecitabine"]
    }
  },
  {
    "conceptId": [35805776],
    "regimenName": ["Cisplatin, Fluorouracil, Panitumumab"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Cisplatin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "panitumumab": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [19100985],
      "conceptName": ["panitumumab"]
    },
    "Fluorouracil": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    }
  },
  {
    "conceptId": [35803703],
    "regimenName": ["DHAP"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Cisplatin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "Cytarabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Dexamethasone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Ifosfamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    },
    "ofatumumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [40167582],
      "conceptName": ["ofatumumab"]
    }
  },
  {
    "conceptId": [35805078],
    "regimenName": ["Oxaliplatin monotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "oxaliplatin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1318011],
      "conceptName": ["oxaliplatin"]
    },
    "Fluorouracil": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "gemcitabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314924],
      "conceptName": ["gemcitabine"]
    },
    "cetuximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1315411],
      "conceptName": ["cetuximab"]
    },
    "docetaxel": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1315942],
      "conceptName": ["docetaxel"]
    },
    "capecitabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1337620],
      "conceptName": ["capecitabine"]
    },
    "Epirubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344354],
      "conceptName": ["Epirubicin"]
    },
    "Hyaluronidase / trastuzumab Injection [Herceptin Hylecta]": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1366689],
      "conceptName": ["Hyaluronidase / trastuzumab Injection [Herceptin Hylecta]"]
    },
    "irinotecan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1367268],
      "conceptName": ["irinotecan"]
    },
    "Paclitaxel": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1378382],
      "conceptName": ["Paclitaxel"]
    },
    "Leucovorin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1388796],
      "conceptName": ["Leucovorin"]
    },
    "fludarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1395557],
      "conceptName": ["fludarabine"]
    },
    "bevacizumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397141],
      "conceptName": ["bevacizumab"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "ASPARAGINASE": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19012585],
      "conceptName": ["ASPARAGINASE"]
    },
    "panitumumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19100985],
      "conceptName": ["panitumumab"]
    },
    "levoleucovorin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [40168303],
      "conceptName": ["levoleucovorin"]
    }
  },
  {
    "conceptId": [35804538],
    "regimenName": ["Cisplatin and Ifosfamide"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Cisplatin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "Ifosfamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Dactinomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311443],
      "conceptName": ["Dactinomycin"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "gemcitabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314924],
      "conceptName": ["gemcitabine"]
    },
    "Bleomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1329241],
      "conceptName": ["Bleomycin"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Epirubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344354],
      "conceptName": ["Epirubicin"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Mesna": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1354698],
      "conceptName": ["Mesna"]
    },
    "Paclitaxel": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1378382],
      "conceptName": ["Paclitaxel"]
    },
    "Mitomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1389036],
      "conceptName": ["Mitomycin"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "Vinblastine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008264],
      "conceptName": ["Vinblastine"]
    }
  },
  {
    "conceptId": [35804033],
    "regimenName": ["DOLP"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "ASPARAGINASE": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [19012585],
      "conceptName": ["ASPARAGINASE"]
    },
    "Prednisone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Daunorubicin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1311799],
      "conceptName": ["Daunorubicin"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "imatinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1304107],
      "conceptName": ["imatinib"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Teniposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19136750],
      "conceptName": ["Teniposide"]
    }
  },
  {
    "conceptId": [35803477],
    "regimenName": ["LoDAC"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Cytarabine": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "inotuzumab ozogamicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [794068],
      "conceptName": ["inotuzumab ozogamicin"]
    },
    "Tretinoin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [903643],
      "conceptName": ["Tretinoin"]
    },
    "Fluorouracil": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "Melphalan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1301267],
      "conceptName": ["Melphalan"]
    },
    "imatinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1304107],
      "conceptName": ["imatinib"]
    },
    "Filgrastim": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1304850],
      "conceptName": ["Filgrastim"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Mitoxantrone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1309188],
      "conceptName": ["Mitoxantrone"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Daunorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311799],
      "conceptName": ["Daunorubicin"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Azacitidine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314865],
      "conceptName": ["Azacitidine"]
    },
    "oxaliplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1318011],
      "conceptName": ["oxaliplatin"]
    },
    "pegaspargase": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1326481],
      "conceptName": ["pegaspargase"]
    },
    "Bleomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1329241],
      "conceptName": ["Bleomycin"]
    },
    "Vorinostat": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1337651],
      "conceptName": ["Vorinostat"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Carboplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344905],
      "conceptName": ["Carboplatin"]
    },
    "Carmustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350066],
      "conceptName": ["Carmustine"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "glasdegib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1355795],
      "conceptName": ["glasdegib"]
    },
    "dasatinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1358436],
      "conceptName": ["dasatinib"]
    },
    "sorafenib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1363387],
      "conceptName": ["sorafenib"]
    },
    "Interferon Alfa-2b": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1380068],
      "conceptName": ["Interferon Alfa-2b"]
    },
    "Lomustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1391846],
      "conceptName": ["Lomustine"]
    },
    "nilotinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1394023],
      "conceptName": ["nilotinib"]
    },
    "fludarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1395557],
      "conceptName": ["fludarabine"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "mercaptopurine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1436650],
      "conceptName": ["mercaptopurine"]
    },
    "Thioguanine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1437379],
      "conceptName": ["Thioguanine"]
    },
    "Methylprednisolone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1506270],
      "conceptName": ["Methylprednisolone"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "prednisolone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1550557],
      "conceptName": ["prednisolone"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Pravastatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551860],
      "conceptName": ["Pravastatin"]
    },
    "midostaurin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1594003],
      "conceptName": ["midostaurin"]
    },
    "nelarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19002912],
      "conceptName": ["nelarabine"]
    },
    "Vindesine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008336],
      "conceptName": ["Vindesine"]
    },
    "lenograstim": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19009705],
      "conceptName": ["lenograstim"]
    },
    "everolimus": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19011440],
      "conceptName": ["everolimus"]
    },
    "ASPARAGINASE": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19012585],
      "conceptName": ["ASPARAGINASE"]
    },
    "bendamustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19015523],
      "conceptName": ["bendamustine"]
    },
    "Amsacrine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19017810],
      "conceptName": ["Amsacrine"]
    },
    "decitabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19024728],
      "conceptName": ["decitabine"]
    },
    "Daunorubicin Liposomal": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19051599],
      "conceptName": ["Daunorubicin Liposomal"]
    },
    "doxorubicin liposome": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19051649],
      "conceptName": ["doxorubicin liposome"]
    },
    "clofarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19054821],
      "conceptName": ["clofarabine"]
    },
    "Cladribine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19054825],
      "conceptName": ["Cladribine"]
    },
    "Aclarubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19057483],
      "conceptName": ["Aclarubicin"]
    },
    "ibritumomab tiuxetan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19068830],
      "conceptName": ["ibritumomab tiuxetan"]
    },
    "Idarubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078097],
      "conceptName": ["Idarubicin"]
    },
    "Ifosfamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    },
    "Norethandrolone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19128219],
      "conceptName": ["Norethandrolone"]
    },
    "Teniposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19136750],
      "conceptName": ["Teniposide"]
    },
    "Thiotepa": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19137385],
      "conceptName": ["Thiotepa"]
    },
    "venetoclax": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [35604205],
      "conceptName": ["venetoclax"]
    },
    "Fotemustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [36879099],
      "conceptName": ["Fotemustine"]
    },
    "ofatumumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [40167582],
      "conceptName": ["ofatumumab"]
    },
    "Cytarabine liposome": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [40175460],
      "conceptName": ["Cytarabine liposome"]
    },
    "Gemtuzumab ozogamicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [42799711],
      "conceptName": ["Gemtuzumab ozogamicin"]
    },
    "ponatinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [43013182],
      "conceptName": ["ponatinib"]
    },
    "omacetaxine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [45775576],
      "conceptName": ["omacetaxine"]
    },
    "panobinostat": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [46221435],
      "conceptName": ["panobinostat"]
    }
  },
  {
    "conceptId": [35805848],
    "regimenName": ["Doxorubicin and Vinblastine"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Vinblastine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [19008264],
      "conceptName": ["Vinblastine"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Dacarbazine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311409],
      "conceptName": ["Dacarbazine"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "gemcitabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314924],
      "conceptName": ["gemcitabine"]
    },
    "Bleomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1329241],
      "conceptName": ["Bleomycin"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Procarbazine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1351779],
      "conceptName": ["Procarbazine"]
    },
    "Chlorambucil": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1390051],
      "conceptName": ["Chlorambucil"]
    },
    "Lomustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1391846],
      "conceptName": ["Lomustine"]
    },
    "Mechlorethamine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1394337],
      "conceptName": ["Mechlorethamine"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "Methylprednisolone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1506270],
      "conceptName": ["Methylprednisolone"]
    },
    "prednisolone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1550557],
      "conceptName": ["prednisolone"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Streptozocin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19136210],
      "conceptName": ["Streptozocin"]
    },
    "brentuximab vedotin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [40241969],
      "conceptName": ["brentuximab vedotin"]
    }
  },
  {
    "conceptId": [35102008],
    "regimenName": ["FOLFIRI (L-Leucovorin)"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "irinotecan": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1367268],
      "conceptName": ["irinotecan"]
    },
    "levoleucovorin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [40168303],
      "conceptName": ["levoleucovorin"]
    },
    "Fluorouracil": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "cetuximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1315411],
      "conceptName": ["cetuximab"]
    },
    "oxaliplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1318011],
      "conceptName": ["oxaliplatin"]
    },
    "bevacizumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397141],
      "conceptName": ["bevacizumab"]
    }
  },
  {
    "conceptId": [35804765],
    "regimenName": ["Intraperitoneal hyperthermic mitomycin"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Mitomycin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1389036],
      "conceptName": ["Mitomycin"]
    },
    "Fluorouracil": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "gemcitabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314924],
      "conceptName": ["gemcitabine"]
    },
    "capecitabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1337620],
      "conceptName": ["capecitabine"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Epirubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344354],
      "conceptName": ["Epirubicin"]
    },
    "Carboplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344905],
      "conceptName": ["Carboplatin"]
    },
    "irinotecan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1367268],
      "conceptName": ["irinotecan"]
    },
    "Leucovorin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1388796],
      "conceptName": ["Leucovorin"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "Vinblastine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008264],
      "conceptName": ["Vinblastine"]
    },
    "Vindesine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008336],
      "conceptName": ["Vindesine"]
    },
    "Ifosfamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    },
    "doxifluridine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [43008996],
      "conceptName": ["doxifluridine"]
    }
  },
  {
    "conceptId": [35803704],
    "regimenName": ["GDP"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Cisplatin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "gemcitabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1314924],
      "conceptName": ["gemcitabine"]
    },
    "Dexamethasone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "pegaspargase": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1326481],
      "conceptName": ["pegaspargase"]
    }
  },
  {
    "conceptId": [35805126],
    "regimenName": ["ICE"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Carboplatin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1344905],
      "conceptName": ["Carboplatin"]
    },
    "Ifosfamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    },
    "Mesna": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1354698],
      "conceptName": ["Mesna"]
    },
    "Etoposide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "lenalidomide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19026972],
      "conceptName": ["lenalidomide"]
    },
    "ofatumumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [40167582],
      "conceptName": ["ofatumumab"]
    }
  },
  {
    "conceptId": [35806338],
    "regimenName": ["DEX-IFN"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Dexamethasone": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "Interferon Alfa-2b": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1380068],
      "conceptName": ["Interferon Alfa-2b"]
    },
    "Interferon Alfa-2a": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1379969],
      "conceptName": ["Interferon Alfa-2a"]
    }
  },
  {
    "conceptId": [35803543],
    "regimenName": ["SHAI"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Idarubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [19078097],
      "conceptName": ["Idarubicin"]
    },
    "Cytarabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Tretinoin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [903643],
      "conceptName": ["Tretinoin"]
    },
    "imatinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1304107],
      "conceptName": ["imatinib"]
    },
    "Filgrastim": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1304850],
      "conceptName": ["Filgrastim"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Mitoxantrone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1309188],
      "conceptName": ["Mitoxantrone"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Vorinostat": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1337651],
      "conceptName": ["Vorinostat"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "sorafenib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1363387],
      "conceptName": ["sorafenib"]
    },
    "Lomustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1391846],
      "conceptName": ["Lomustine"]
    },
    "fludarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1395557],
      "conceptName": ["fludarabine"]
    },
    "mercaptopurine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1436650],
      "conceptName": ["mercaptopurine"]
    },
    "Thioguanine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1437379],
      "conceptName": ["Thioguanine"]
    },
    "Pravastatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551860],
      "conceptName": ["Pravastatin"]
    },
    "lenograstim": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19009705],
      "conceptName": ["lenograstim"]
    },
    "clofarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19054821],
      "conceptName": ["clofarabine"]
    },
    "Norethandrolone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19128219],
      "conceptName": ["Norethandrolone"]
    },
    "panobinostat": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [46221435],
      "conceptName": ["panobinostat"]
    }
  },
  {
    "conceptId": [35806472],
    "regimenName": ["MAPI"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Methotrexate": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Cisplatin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "Ifosfamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    },
    "Mesna": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1354698],
      "conceptName": ["Mesna"]
    }
  },
  {
    "conceptId": [35805448],
    "regimenName": ["VACA/IE"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Dactinomycin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1311443],
      "conceptName": ["Dactinomycin"]
    },
    "Ifosfamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Etoposide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "irinotecan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1367268],
      "conceptName": ["irinotecan"]
    }
  },
  {
    "conceptId": [35804522],
    "regimenName": ["TCP"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Thalidomide": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [19137042],
      "conceptName": ["Thalidomide"]
    },
    "Prednisone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Procarbazine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1351779],
      "conceptName": ["Procarbazine"]
    }
  },
  {
    "conceptId": [35804381],
    "regimenName": ["R-CODOX-M/R-IVAC"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Methotrexate": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Ifosfamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    },
    "rituximab": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Cytarabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Etoposide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Vindesine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008336],
      "conceptName": ["Vindesine"]
    },
    "Teniposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19136750],
      "conceptName": ["Teniposide"]
    }
  },
  {
    "conceptId": [35803610],
    "regimenName": ["BuCyTBI"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Busulfan": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1333357],
      "conceptName": ["Busulfan"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "fludarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1395557],
      "conceptName": ["fludarabine"]
    },
    "Thiotepa": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19137385],
      "conceptName": ["Thiotepa"]
    }
  },
  {
    "conceptId": [35806282],
    "regimenName": ["Dara-VMP"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "daratumumab": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [35605744],
      "conceptName": ["daratumumab"]
    },
    "Melphalan": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1301267],
      "conceptName": ["Melphalan"]
    },
    "bortezomib": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1336825],
      "conceptName": ["bortezomib"]
    },
    "Prednisone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    }
  },
  {
    "conceptId": [35803687],
    "regimenName": ["Temozolomide and RT, then Temozolomide"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "temozolomide": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1341149],
      "conceptName": ["temozolomide"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "capecitabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1337620],
      "conceptName": ["capecitabine"]
    },
    "irinotecan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1367268],
      "conceptName": ["irinotecan"]
    },
    "Lomustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1391846],
      "conceptName": ["Lomustine"]
    },
    "bevacizumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397141],
      "conceptName": ["bevacizumab"]
    },
    "Thalidomide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19137042],
      "conceptName": ["Thalidomide"]
    },
    "dinutuximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [46221699],
      "conceptName": ["dinutuximab"]
    }
  },
  {
    "conceptId": [35803554],
    "regimenName": ["Arsenic trioxide, then ATRA and Daunorubicin"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "arsenic trioxide": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1333379],
      "conceptName": ["arsenic trioxide"]
    },
    "Tretinoin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [903643],
      "conceptName": ["Tretinoin"]
    },
    "Daunorubicin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1311799],
      "conceptName": ["Daunorubicin"]
    }
  },
  {
    "conceptId": [35804595],
    "regimenName": ["PCR"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Pentostatin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [19031224],
      "conceptName": ["Pentostatin"]
    },
    "rituximab": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    }
  },
  {
    "conceptId": [35804432],
    "regimenName": ["Temsirolimus monotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "temsirolimus": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [19092845],
      "conceptName": ["temsirolimus"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "bendamustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19015523],
      "conceptName": ["bendamustine"]
    }
  },
  {
    "conceptId": [35804617],
    "regimenName": ["Venetoclax monotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "venetoclax": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [35604205],
      "conceptName": ["venetoclax"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Azacitidine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314865],
      "conceptName": ["Azacitidine"]
    },
    "decitabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19024728],
      "conceptName": ["decitabine"]
    },
    "obinutuzumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [44507676],
      "conceptName": ["obinutuzumab"]
    },
    "Ibrutinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [44507848],
      "conceptName": ["Ibrutinib"]
    }
  },
  {
    "conceptId": [35805363],
    "regimenName": ["CX and Trastuzumab"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "trastuzumab": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1387104],
      "conceptName": ["trastuzumab"]
    },
    "Cisplatin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "capecitabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1337620],
      "conceptName": ["capecitabine"]
    }
  },
  {
    "conceptId": [35806386],
    "regimenName": ["Octreotide and Interferon alfa"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Octreotide": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1522957],
      "conceptName": ["Octreotide"]
    },
    "Interferon Alfa-2b": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1380068],
      "conceptName": ["Interferon Alfa-2b"]
    }
  },
  {
    "conceptId": [35804406],
    "regimenName": ["R-CHOEP-14"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "rituximab": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Prednisone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Etoposide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "Vindesine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008336],
      "conceptName": ["Vindesine"]
    },
    "Ifosfamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    },
    "Teniposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19136750],
      "conceptName": ["Teniposide"]
    }
  },
  {
    "conceptId": [35806264],
    "regimenName": ["VAD"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Dexamethasone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Melphalan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1301267],
      "conceptName": ["Melphalan"]
    },
    "imatinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1304107],
      "conceptName": ["imatinib"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "pegaspargase": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1326481],
      "conceptName": ["pegaspargase"]
    },
    "Bleomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1329241],
      "conceptName": ["Bleomycin"]
    },
    "bortezomib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1336825],
      "conceptName": ["bortezomib"]
    },
    "Carmustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350066],
      "conceptName": ["Carmustine"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "dasatinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1358436],
      "conceptName": ["dasatinib"]
    },
    "Chlorambucil": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1390051],
      "conceptName": ["Chlorambucil"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "mercaptopurine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1436650],
      "conceptName": ["mercaptopurine"]
    },
    "Thioguanine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1437379],
      "conceptName": ["Thioguanine"]
    },
    "Methylprednisolone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1506270],
      "conceptName": ["Methylprednisolone"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Quinine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1760616],
      "conceptName": ["Quinine"]
    },
    "Vindesine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008336],
      "conceptName": ["Vindesine"]
    },
    "everolimus": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19011440],
      "conceptName": ["everolimus"]
    },
    "ASPARAGINASE": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19012585],
      "conceptName": ["ASPARAGINASE"]
    },
    "Ifosfamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    },
    "Teniposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19136750],
      "conceptName": ["Teniposide"]
    },
    "ponatinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [43013182],
      "conceptName": ["ponatinib"]
    }
  },
  {
    "conceptId": [35806298],
    "regimenName": ["VAD-P/Q"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Quinine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1760616],
      "conceptName": ["Quinine"]
    },
    "Prednisone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Dexamethasone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    }
  },
  {
    "conceptId": [35806897],
    "regimenName": ["Capecitabine/Capecitabine and RT"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "capecitabine": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1337620],
      "conceptName": ["capecitabine"]
    },
    "neratinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [793846],
      "conceptName": ["neratinib"]
    },
    "Fluorouracil": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "fulvestrant": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1304044],
      "conceptName": ["fulvestrant"]
    },
    "gemcitabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314924],
      "conceptName": ["gemcitabine"]
    },
    "cetuximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1315411],
      "conceptName": ["cetuximab"]
    },
    "docetaxel": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1315942],
      "conceptName": ["docetaxel"]
    },
    "oxaliplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1318011],
      "conceptName": ["oxaliplatin"]
    },
    "erlotinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1325363],
      "conceptName": ["erlotinib"]
    },
    "temozolomide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1341149],
      "conceptName": ["temozolomide"]
    },
    "Epirubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344354],
      "conceptName": ["Epirubicin"]
    },
    "Carboplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344905],
      "conceptName": ["Carboplatin"]
    },
    "lapatinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1359548],
      "conceptName": ["lapatinib"]
    },
    "sorafenib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1363387],
      "conceptName": ["sorafenib"]
    },
    "irinotecan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1367268],
      "conceptName": ["irinotecan"]
    },
    "Paclitaxel": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1378382],
      "conceptName": ["Paclitaxel"]
    },
    "trastuzumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1387104],
      "conceptName": ["trastuzumab"]
    },
    "Mitomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1389036],
      "conceptName": ["Mitomycin"]
    },
    "bevacizumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397141],
      "conceptName": ["bevacizumab"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "ixabepilone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19025348],
      "conceptName": ["ixabepilone"]
    },
    "panitumumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19100985],
      "conceptName": ["panitumumab"]
    },
    "pertuzumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [42801287],
      "conceptName": ["pertuzumab"]
    }
  },
  {
    "conceptId": [35804059],
    "regimenName": ["Methotrexate and Vincristine"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Methotrexate": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "inotuzumab ozogamicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [794068],
      "conceptName": ["inotuzumab ozogamicin"]
    },
    "Fluorouracil": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "imatinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1304107],
      "conceptName": ["imatinib"]
    },
    "Mitoxantrone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1309188],
      "conceptName": ["Mitoxantrone"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Daunorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311799],
      "conceptName": ["Daunorubicin"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "pegaspargase": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1326481],
      "conceptName": ["pegaspargase"]
    },
    "Bleomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1329241],
      "conceptName": ["Bleomycin"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Carboplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344905],
      "conceptName": ["Carboplatin"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Procarbazine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1351779],
      "conceptName": ["Procarbazine"]
    },
    "dasatinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1358436],
      "conceptName": ["dasatinib"]
    },
    "nilotinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1394023],
      "conceptName": ["nilotinib"]
    },
    "Mechlorethamine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1394337],
      "conceptName": ["Mechlorethamine"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "mercaptopurine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1436650],
      "conceptName": ["mercaptopurine"]
    },
    "Thioguanine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1437379],
      "conceptName": ["Thioguanine"]
    },
    "Methylprednisolone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1506270],
      "conceptName": ["Methylprednisolone"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "prednisolone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1550557],
      "conceptName": ["prednisolone"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Vindesine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008336],
      "conceptName": ["Vindesine"]
    },
    "everolimus": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19011440],
      "conceptName": ["everolimus"]
    },
    "ASPARAGINASE": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19012585],
      "conceptName": ["ASPARAGINASE"]
    },
    "doxorubicin liposome": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19051649],
      "conceptName": ["doxorubicin liposome"]
    },
    "Ifosfamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    },
    "Teniposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19136750],
      "conceptName": ["Teniposide"]
    },
    "Cytarabine liposome": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [40175460],
      "conceptName": ["Cytarabine liposome"]
    },
    "ponatinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [43013182],
      "conceptName": ["ponatinib"]
    }
  },
  {
    "conceptId": [35806293],
    "regimenName": ["TAD (Thalidomide)"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Thalidomide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [19137042],
      "conceptName": ["Thalidomide"]
    },
    "Dexamethasone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "Melphalan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1301267],
      "conceptName": ["Melphalan"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "bortezomib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1336825],
      "conceptName": ["bortezomib"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    }
  },
  {
    "conceptId": [35804596],
    "regimenName": ["RCC"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "rituximab": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Cladribine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [19054825],
      "conceptName": ["Cladribine"]
    }
  },
  {
    "conceptId": [35805038],
    "regimenName": ["R-CDOP"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "doxorubicin liposome": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [19051649],
      "conceptName": ["doxorubicin liposome"]
    },
    "rituximab": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Prednisone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    }
  },
  {
    "conceptId": [35806435],
    "regimenName": ["Ifosfamide and Gemcitabine"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Ifosfamide": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    },
    "gemcitabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1314924],
      "conceptName": ["gemcitabine"]
    },
    "vinorelbine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1343346],
      "conceptName": ["vinorelbine"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "prednisolone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1550557],
      "conceptName": ["prednisolone"]
    }
  },
  {
    "conceptId": [35804219],
    "regimenName": ["TAC (Taxotere)"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "docetaxel": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1315942],
      "conceptName": ["docetaxel"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    }
  },
  {
    "conceptId": [35101507],
    "regimenName": ["AC-T"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Paclitaxel": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1378382],
      "conceptName": ["Paclitaxel"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    }
  },
  {
    "conceptId": [35806409],
    "regimenName": ["Carboplatin, Pemetrexed, Bevacizumab"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Carboplatin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1344905],
      "conceptName": ["Carboplatin"]
    },
    "bevacizumab": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1397141],
      "conceptName": ["bevacizumab"]
    },
    "pemetrexed": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1304919],
      "conceptName": ["pemetrexed"]
    }
  },
  {
    "conceptId": [35804624],
    "regimenName": ["FR"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "rituximab": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "fludarabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1395557],
      "conceptName": ["fludarabine"]
    },
    "Mitoxantrone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1309188],
      "conceptName": ["Mitoxantrone"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "alemtuzumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1312706],
      "conceptName": ["alemtuzumab"]
    },
    "oxaliplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1318011],
      "conceptName": ["oxaliplatin"]
    },
    "Busulfan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1333357],
      "conceptName": ["Busulfan"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "bendamustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19015523],
      "conceptName": ["bendamustine"]
    },
    "ibritumomab tiuxetan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19068830],
      "conceptName": ["ibritumomab tiuxetan"]
    }
  },
  {
    "conceptId": [35805051],
    "regimenName": ["Z-BEAM, then auto HSCT"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Carmustine": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1350066],
      "conceptName": ["Carmustine"]
    },
    "ibritumomab tiuxetan": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [19068830],
      "conceptName": ["ibritumomab tiuxetan"]
    },
    "Melphalan": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1301267],
      "conceptName": ["Melphalan"]
    },
    "rituximab": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Cytarabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Etoposide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    }
  },
  {
    "conceptId": [35804360],
    "regimenName": ["Medroxyprogesterone monotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Medroxyprogesterone": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1500211],
      "conceptName": ["Medroxyprogesterone"]
    },
    "Fluorouracil": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Tamoxifen": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1436678],
      "conceptName": ["Tamoxifen"]
    }
  },
  {
    "conceptId": [35803490],
    "regimenName": ["Etoposide and Mitoxantrone"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Mitoxantrone": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1309188],
      "conceptName": ["Mitoxantrone"]
    },
    "Etoposide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Tretinoin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [903643],
      "conceptName": ["Tretinoin"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Bleomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1329241],
      "conceptName": ["Bleomycin"]
    },
    "Carmustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350066],
      "conceptName": ["Carmustine"]
    },
    "Procarbazine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1351779],
      "conceptName": ["Procarbazine"]
    },
    "Mesna": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1354698],
      "conceptName": ["Mesna"]
    },
    "Thioguanine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1437379],
      "conceptName": ["Thioguanine"]
    },
    "prednisolone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1550557],
      "conceptName": ["prednisolone"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Vinblastine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008264],
      "conceptName": ["Vinblastine"]
    },
    "Idarubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078097],
      "conceptName": ["Idarubicin"]
    },
    "Ifosfamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    }
  },
  {
    "conceptId": [35806640],
    "regimenName": ["DD-CHOP"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Prednisone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "denileukin diftitox": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [19051642],
      "conceptName": ["denileukin diftitox"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    }
  },
  {
    "conceptId": [35804820],
    "regimenName": ["Sonidegib monotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "sonidegib": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [46275491],
      "conceptName": ["sonidegib"]
    }
  },
  {
    "conceptId": [35804559],
    "regimenName": ["GemOx"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "oxaliplatin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1318011],
      "conceptName": ["oxaliplatin"]
    },
    "gemcitabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1314924],
      "conceptName": ["gemcitabine"]
    },
    "Fluorouracil": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "irinotecan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1367268],
      "conceptName": ["irinotecan"]
    },
    "Paclitaxel": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1378382],
      "conceptName": ["Paclitaxel"]
    },
    "Leucovorin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1388796],
      "conceptName": ["Leucovorin"]
    },
    "bevacizumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397141],
      "conceptName": ["bevacizumab"]
    },
    "ASPARAGINASE": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19012585],
      "conceptName": ["ASPARAGINASE"]
    }
  },
  {
    "conceptId": [35805828],
    "regimenName": ["Brentuximab vedotin and Nivolumab"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "brentuximab vedotin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [40241969],
      "conceptName": ["brentuximab vedotin"]
    },
    "nivolumab": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [45892628],
      "conceptName": ["nivolumab"]
    }
  },
  {
    "conceptId": [35805799],
    "regimenName": ["Tamoxifen acid monotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Tamoxifen": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1436678],
      "conceptName": ["Tamoxifen"]
    },
    "Fluorouracil": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "Megestrol": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1300978],
      "conceptName": ["Megestrol"]
    },
    "Melphalan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1301267],
      "conceptName": ["Melphalan"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Dacarbazine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311409],
      "conceptName": ["Dacarbazine"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Goserelin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1366310],
      "conceptName": ["Goserelin"]
    },
    "trastuzumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1387104],
      "conceptName": ["trastuzumab"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "Medroxyprogesterone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1500211],
      "conceptName": ["Medroxyprogesterone"]
    },
    "Aminoglutethimide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1503057],
      "conceptName": ["Aminoglutethimide"]
    },
    "Danazol": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1511449],
      "conceptName": ["Danazol"]
    },
    "prednisolone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1550557],
      "conceptName": ["prednisolone"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "ribociclib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1592911],
      "conceptName": ["ribociclib"]
    },
    "everolimus": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19011440],
      "conceptName": ["everolimus"]
    },
    "ado-trastuzumab emtansine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [43525787],
      "conceptName": ["ado-trastuzumab emtansine"]
    }
  },
  {
    "conceptId": [35804010],
    "regimenName": ["Melphalan and TBI"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Melphalan": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1301267],
      "conceptName": ["Melphalan"]
    },
    "Fluorouracil": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "alemtuzumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1312706],
      "conceptName": ["alemtuzumab"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Busulfan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1333357],
      "conceptName": ["Busulfan"]
    },
    "bortezomib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1336825],
      "conceptName": ["bortezomib"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Carmustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350066],
      "conceptName": ["Carmustine"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "fludarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1395557],
      "conceptName": ["fludarabine"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "Tamoxifen": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1436678],
      "conceptName": ["Tamoxifen"]
    },
    "Methylprednisolone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1506270],
      "conceptName": ["Methylprednisolone"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "prednisolone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1550557],
      "conceptName": ["prednisolone"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "bendamustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19015523],
      "conceptName": ["bendamustine"]
    },
    "lenalidomide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19026972],
      "conceptName": ["lenalidomide"]
    },
    "clofarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19054821],
      "conceptName": ["clofarabine"]
    },
    "ibritumomab tiuxetan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19068830],
      "conceptName": ["ibritumomab tiuxetan"]
    },
    "Thalidomide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19137042],
      "conceptName": ["Thalidomide"]
    },
    "daratumumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [35605744],
      "conceptName": ["daratumumab"]
    },
    "Fotemustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [36879099],
      "conceptName": ["Fotemustine"]
    },
    "carfilzomib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [42873638],
      "conceptName": ["carfilzomib"]
    }
  },
  {
    "conceptId": [35803587],
    "regimenName": ["Mitotane and Streptozocin"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Streptozocin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [19136210],
      "conceptName": ["Streptozocin"]
    },
    "Mitotane": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1309161],
      "conceptName": ["Mitotane"]
    }
  },
  {
    "conceptId": [35805688],
    "regimenName": ["FAMTX"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Methotrexate": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Fluorouracil": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    }
  },
  {
    "conceptId": [35805043],
    "regimenName": ["R-IFE"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Ifosfamide": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    },
    "rituximab": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Etoposide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Carboplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344905],
      "conceptName": ["Carboplatin"]
    },
    "Mesna": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1354698],
      "conceptName": ["Mesna"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Vindesine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008336],
      "conceptName": ["Vindesine"]
    },
    "lenalidomide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19026972],
      "conceptName": ["lenalidomide"]
    },
    "doxorubicin liposome": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19051649],
      "conceptName": ["doxorubicin liposome"]
    },
    "Teniposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19136750],
      "conceptName": ["Teniposide"]
    }
  },
  {
    "conceptId": [35804094],
    "regimenName": ["Mercaptopurine and Prednisone"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "mercaptopurine": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1436650],
      "conceptName": ["mercaptopurine"]
    },
    "Prednisone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "ASPARAGINASE": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19012585],
      "conceptName": ["ASPARAGINASE"]
    }
  },
  {
    "conceptId": [35805808],
    "regimenName": ["BEACOPP"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Bleomycin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1329241],
      "conceptName": ["Bleomycin"]
    },
    "Prednisone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Procarbazine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1351779],
      "conceptName": ["Procarbazine"]
    },
    "Etoposide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    }
  },
  {
    "conceptId": [35805813],
    "regimenName": ["ABVD, DD-DI"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Bleomycin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1329241],
      "conceptName": ["Bleomycin"]
    },
    "Vinblastine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [19008264],
      "conceptName": ["Vinblastine"]
    },
    "Dacarbazine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1311409],
      "conceptName": ["Dacarbazine"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Procarbazine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1351779],
      "conceptName": ["Procarbazine"]
    },
    "Mechlorethamine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1394337],
      "conceptName": ["Mechlorethamine"]
    },
    "Methylprednisolone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1506270],
      "conceptName": ["Methylprednisolone"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    }
  },
  {
    "conceptId": [35805455],
    "regimenName": ["Irinotecan and Temozolomide"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "irinotecan": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1367268],
      "conceptName": ["irinotecan"]
    },
    "temozolomide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1341149],
      "conceptName": ["temozolomide"]
    },
    "dinutuximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [46221699],
      "conceptName": ["dinutuximab"]
    }
  },
  {
    "conceptId": [35802851],
    "regimenName": ["KMP"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Melphalan": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1301267],
      "conceptName": ["Melphalan"]
    },
    "Prednisone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "carfilzomib": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [42873638],
      "conceptName": ["carfilzomib"]
    }
  },
  {
    "conceptId": [35806144],
    "regimenName": ["CDB"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Carmustine": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1350066],
      "conceptName": ["Carmustine"]
    },
    "Cisplatin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "Dacarbazine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1311409],
      "conceptName": ["Dacarbazine"]
    },
    "Aldesleukin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1309770],
      "conceptName": ["Aldesleukin"]
    },
    "Interferon Alfa-2b": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1380068],
      "conceptName": ["Interferon Alfa-2b"]
    }
  },
  {
    "conceptId": [35804570],
    "regimenName": ["BR"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "bendamustine": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [19015523],
      "conceptName": ["bendamustine"]
    },
    "rituximab": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "bortezomib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1336825],
      "conceptName": ["bortezomib"]
    },
    "fludarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1395557],
      "conceptName": ["fludarabine"]
    },
    "polatuzumab vedotin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1396729],
      "conceptName": ["polatuzumab vedotin"]
    },
    "lenalidomide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19026972],
      "conceptName": ["lenalidomide"]
    },
    "temsirolimus": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19092845],
      "conceptName": ["temsirolimus"]
    },
    "Ibrutinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [44507848],
      "conceptName": ["Ibrutinib"]
    },
    "idelalisib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [45776944],
      "conceptName": ["idelalisib"]
    }
  },
  {
    "conceptId": [35807524],
    "regimenName": ["DA 3 plus 10"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Cytarabine": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Daunorubicin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1311799],
      "conceptName": ["Daunorubicin"]
    },
    "Tretinoin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [903643],
      "conceptName": ["Tretinoin"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Azacitidine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314865],
      "conceptName": ["Azacitidine"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "glasdegib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1355795],
      "conceptName": ["glasdegib"]
    },
    "sorafenib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1363387],
      "conceptName": ["sorafenib"]
    },
    "nilotinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1394023],
      "conceptName": ["nilotinib"]
    },
    "mercaptopurine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1436650],
      "conceptName": ["mercaptopurine"]
    },
    "Thioguanine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1437379],
      "conceptName": ["Thioguanine"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "prednisolone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1550557],
      "conceptName": ["prednisolone"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "midostaurin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1594003],
      "conceptName": ["midostaurin"]
    },
    "ASPARAGINASE": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19012585],
      "conceptName": ["ASPARAGINASE"]
    },
    "Cladribine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19054825],
      "conceptName": ["Cladribine"]
    },
    "Teniposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19136750],
      "conceptName": ["Teniposide"]
    },
    "Gemtuzumab ozogamicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [42799711],
      "conceptName": ["Gemtuzumab ozogamicin"]
    },
    "omacetaxine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [45775576],
      "conceptName": ["omacetaxine"]
    }
  },
  {
    "conceptId": [35807170],
    "regimenName": ["Thioguanine monotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Thioguanine": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1437379],
      "conceptName": ["Thioguanine"]
    },
    "Tretinoin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [903643],
      "conceptName": ["Tretinoin"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Mitoxantrone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1309188],
      "conceptName": ["Mitoxantrone"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Daunorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311799],
      "conceptName": ["Daunorubicin"]
    },
    "pegaspargase": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1326481],
      "conceptName": ["pegaspargase"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "mercaptopurine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1436650],
      "conceptName": ["mercaptopurine"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "ASPARAGINASE": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19012585],
      "conceptName": ["ASPARAGINASE"]
    },
    "Idarubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078097],
      "conceptName": ["Idarubicin"]
    }
  },
  {
    "conceptId": [35805981],
    "regimenName": ["Etoposide and Prednisone"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Prednisone": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Etoposide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Mitoxantrone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1309188],
      "conceptName": ["Mitoxantrone"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Bleomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1329241],
      "conceptName": ["Bleomycin"]
    },
    "Vorinostat": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1337651],
      "conceptName": ["Vorinostat"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Carboplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344905],
      "conceptName": ["Carboplatin"]
    },
    "Carmustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350066],
      "conceptName": ["Carmustine"]
    },
    "Procarbazine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1351779],
      "conceptName": ["Procarbazine"]
    },
    "Chlorambucil": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1390051],
      "conceptName": ["Chlorambucil"]
    },
    "Mechlorethamine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1394337],
      "conceptName": ["Mechlorethamine"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "Vinblastine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008264],
      "conceptName": ["Vinblastine"]
    },
    "Vindesine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008336],
      "conceptName": ["Vindesine"]
    },
    "Ifosfamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    },
    "Teniposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19136750],
      "conceptName": ["Teniposide"]
    },
    "Thalidomide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19137042],
      "conceptName": ["Thalidomide"]
    },
    "ranimustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [35197850],
      "conceptName": ["ranimustine"]
    }
  },
  {
    "conceptId": [35803501],
    "regimenName": ["FLAG"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "lenograstim": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [19009705],
      "conceptName": ["lenograstim"]
    },
    "Cytarabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Filgrastim": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1304850],
      "conceptName": ["Filgrastim"]
    },
    "fludarabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1395557],
      "conceptName": ["fludarabine"]
    },
    "Idarubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078097],
      "conceptName": ["Idarubicin"]
    }
  },
  {
    "conceptId": [35806378],
    "regimenName": ["Irinotecan, Temozolomide, Dinutuximab"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "irinotecan": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1367268],
      "conceptName": ["irinotecan"]
    },
    "temozolomide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1341149],
      "conceptName": ["temozolomide"]
    },
    "dinutuximab": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [46221699],
      "conceptName": ["dinutuximab"]
    }
  },
  {
    "conceptId": [35101949],
    "regimenName": ["Gemcitabine and Trastuzumab"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "trastuzumab": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1387104],
      "conceptName": ["trastuzumab"]
    },
    "gemcitabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1314924],
      "conceptName": ["gemcitabine"]
    }
  },
  {
    "conceptId": [35804232],
    "regimenName": ["TC (Taxotere)"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "docetaxel": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1315942],
      "conceptName": ["docetaxel"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "trastuzumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1387104],
      "conceptName": ["trastuzumab"]
    }
  },
  {
    "conceptId": [35806141],
    "regimenName": ["BCG and Dacarbazine"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Dacarbazine": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1311409],
      "conceptName": ["Dacarbazine"]
    },
    "BCG, Live, Tice Strain": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [19086176],
      "conceptName": ["BCG, Live, Tice Strain"]
    }
  },
  {
    "conceptId": [35807046],
    "regimenName": ["ADOC"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Cisplatin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    }
  },
  {
    "conceptId": [35803672],
    "regimenName": ["Cisplatin, Fluorouracil, RT"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Cisplatin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "Fluorouracil": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "gemcitabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314924],
      "conceptName": ["gemcitabine"]
    },
    "cetuximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1315411],
      "conceptName": ["cetuximab"]
    },
    "docetaxel": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1315942],
      "conceptName": ["docetaxel"]
    },
    "capecitabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1337620],
      "conceptName": ["capecitabine"]
    },
    "Epirubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344354],
      "conceptName": ["Epirubicin"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "hydroxyurea": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1377141],
      "conceptName": ["hydroxyurea"]
    },
    "Paclitaxel": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1378382],
      "conceptName": ["Paclitaxel"]
    },
    "trastuzumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1387104],
      "conceptName": ["trastuzumab"]
    },
    "Leucovorin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1388796],
      "conceptName": ["Leucovorin"]
    },
    "Mitomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1389036],
      "conceptName": ["Mitomycin"]
    },
    "bevacizumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397141],
      "conceptName": ["bevacizumab"]
    },
    "doxorubicin liposome": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19051649],
      "conceptName": ["doxorubicin liposome"]
    },
    "panitumumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19100985],
      "conceptName": ["panitumumab"]
    }
  },
  {
    "conceptId": [35805037],
    "regimenName": ["R-BL"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "bendamustine": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [19015523],
      "conceptName": ["bendamustine"]
    },
    "lenalidomide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [19026972],
      "conceptName": ["lenalidomide"]
    },
    "rituximab": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    }
  },
  {
    "conceptId": [35805777],
    "regimenName": ["Bleomycin, Methotrexate, Vinblastine/RT"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Bleomycin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1329241],
      "conceptName": ["Bleomycin"]
    },
    "Methotrexate": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Vinblastine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [19008264],
      "conceptName": ["Vinblastine"]
    }
  },
  {
    "conceptId": [35804054],
    "regimenName": ["International ALL Trial"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Thioguanine": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1437379],
      "conceptName": ["Thioguanine"]
    },
    "Cytarabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Daunorubicin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1311799],
      "conceptName": ["Daunorubicin"]
    },
    "Dexamethasone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "Etoposide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    }
  },
  {
    "conceptId": [35804241],
    "regimenName": ["Vinorelbine monotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "vinorelbine": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1343346],
      "conceptName": ["vinorelbine"]
    },
    "Mitoxantrone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1309188],
      "conceptName": ["Mitoxantrone"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "gemcitabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314924],
      "conceptName": ["gemcitabine"]
    },
    "cetuximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1315411],
      "conceptName": ["cetuximab"]
    },
    "Epirubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344354],
      "conceptName": ["Epirubicin"]
    },
    "Carboplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344905],
      "conceptName": ["Carboplatin"]
    },
    "Mesna": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1354698],
      "conceptName": ["Mesna"]
    },
    "Paclitaxel": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1378382],
      "conceptName": ["Paclitaxel"]
    },
    "trastuzumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1387104],
      "conceptName": ["trastuzumab"]
    },
    "bevacizumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397141],
      "conceptName": ["bevacizumab"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "prednisolone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1550557],
      "conceptName": ["prednisolone"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "bendamustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19015523],
      "conceptName": ["bendamustine"]
    },
    "doxorubicin liposome": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19051649],
      "conceptName": ["doxorubicin liposome"]
    },
    "Ifosfamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    }
  },
  {
    "conceptId": [35804199],
    "regimenName": ["AC"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Fluorouracil": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "Melphalan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1301267],
      "conceptName": ["Melphalan"]
    },
    "imatinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1304107],
      "conceptName": ["imatinib"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Dacarbazine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311409],
      "conceptName": ["Dacarbazine"]
    },
    "Dactinomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311443],
      "conceptName": ["Dactinomycin"]
    },
    "alemtuzumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1312706],
      "conceptName": ["alemtuzumab"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "docetaxel": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1315942],
      "conceptName": ["docetaxel"]
    },
    "pegaspargase": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1326481],
      "conceptName": ["pegaspargase"]
    },
    "Bleomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1329241],
      "conceptName": ["Bleomycin"]
    },
    "bortezomib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1336825],
      "conceptName": ["bortezomib"]
    },
    "Carboplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344905],
      "conceptName": ["Carboplatin"]
    },
    "Carmustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350066],
      "conceptName": ["Carmustine"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Procarbazine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1351779],
      "conceptName": ["Procarbazine"]
    },
    "dasatinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1358436],
      "conceptName": ["dasatinib"]
    },
    "irinotecan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1367268],
      "conceptName": ["irinotecan"]
    },
    "Altretamine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1368823],
      "conceptName": ["Altretamine"]
    },
    "Paclitaxel": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1378382],
      "conceptName": ["Paclitaxel"]
    },
    "Topotecan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1378509],
      "conceptName": ["Topotecan"]
    },
    "Interferon Alfa-2b": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1380068],
      "conceptName": ["Interferon Alfa-2b"]
    },
    "trastuzumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1387104],
      "conceptName": ["trastuzumab"]
    },
    "Lomustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1391846],
      "conceptName": ["Lomustine"]
    },
    "Mechlorethamine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1394337],
      "conceptName": ["Mechlorethamine"]
    },
    "bevacizumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397141],
      "conceptName": ["bevacizumab"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "mercaptopurine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1436650],
      "conceptName": ["mercaptopurine"]
    },
    "Tamoxifen": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1436678],
      "conceptName": ["Tamoxifen"]
    },
    "Thioguanine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1437379],
      "conceptName": ["Thioguanine"]
    },
    "Medroxyprogesterone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1500211],
      "conceptName": ["Medroxyprogesterone"]
    },
    "Methylprednisolone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1506270],
      "conceptName": ["Methylprednisolone"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "prednisolone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1550557],
      "conceptName": ["prednisolone"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Hyaluronidase / rituximab Injection [Rituxan Hycela]": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1593155],
      "conceptName": ["Hyaluronidase / rituximab Injection [Rituxan Hycela]"]
    },
    "Vinblastine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008264],
      "conceptName": ["Vinblastine"]
    },
    "Vindesine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008336],
      "conceptName": ["Vindesine"]
    },
    "everolimus": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19011440],
      "conceptName": ["everolimus"]
    },
    "ASPARAGINASE": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19012585],
      "conceptName": ["ASPARAGINASE"]
    },
    "lenalidomide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19026972],
      "conceptName": ["lenalidomide"]
    },
    "denileukin diftitox": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19051642],
      "conceptName": ["denileukin diftitox"]
    },
    "iodine-131-tositumomab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19054997],
      "conceptName": ["iodine-131-tositumomab"]
    },
    "Ifosfamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    },
    "BCG, Live, Tice Strain": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19086176],
      "conceptName": ["BCG, Live, Tice Strain"]
    },
    "Teniposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19136750],
      "conceptName": ["Teniposide"]
    },
    "Thalidomide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19137042],
      "conceptName": ["Thalidomide"]
    },
    "ranimustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [35197850],
      "conceptName": ["ranimustine"]
    },
    "ofatumumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [40167582],
      "conceptName": ["ofatumumab"]
    },
    "brentuximab vedotin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [40241969],
      "conceptName": ["brentuximab vedotin"]
    },
    "ponatinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [43013182],
      "conceptName": ["ponatinib"]
    },
    "obinutuzumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [44507676],
      "conceptName": ["obinutuzumab"]
    }
  },
  {
    "conceptId": [35804136],
    "regimenName": ["Mitomycin monotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Mitomycin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1389036],
      "conceptName": ["Mitomycin"]
    },
    "Fluorouracil": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "gemcitabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314924],
      "conceptName": ["gemcitabine"]
    },
    "capecitabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1337620],
      "conceptName": ["capecitabine"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Epirubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344354],
      "conceptName": ["Epirubicin"]
    },
    "Carboplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344905],
      "conceptName": ["Carboplatin"]
    },
    "irinotecan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1367268],
      "conceptName": ["irinotecan"]
    },
    "Leucovorin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1388796],
      "conceptName": ["Leucovorin"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "Vinblastine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008264],
      "conceptName": ["Vinblastine"]
    },
    "Vindesine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008336],
      "conceptName": ["Vindesine"]
    },
    "Ifosfamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    },
    "doxifluridine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [43008996],
      "conceptName": ["doxifluridine"]
    }
  },
  {
    "conceptId": [35803431],
    "regimenName": ["Prednisolone monotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "prednisolone": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1550557],
      "conceptName": ["prednisolone"]
    },
    "Melphalan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1301267],
      "conceptName": ["Melphalan"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Mitoxantrone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1309188],
      "conceptName": ["Mitoxantrone"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Daunorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311799],
      "conceptName": ["Daunorubicin"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "gemcitabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314924],
      "conceptName": ["gemcitabine"]
    },
    "docetaxel": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1315942],
      "conceptName": ["docetaxel"]
    },
    "pegaspargase": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1326481],
      "conceptName": ["pegaspargase"]
    },
    "Bleomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1329241],
      "conceptName": ["Bleomycin"]
    },
    "bortezomib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1336825],
      "conceptName": ["bortezomib"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "vinorelbine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1343346],
      "conceptName": ["vinorelbine"]
    },
    "Epirubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344354],
      "conceptName": ["Epirubicin"]
    },
    "Carboplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344905],
      "conceptName": ["Carboplatin"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Procarbazine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1351779],
      "conceptName": ["Procarbazine"]
    },
    "Chlorambucil": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1390051],
      "conceptName": ["Chlorambucil"]
    },
    "nilotinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1394023],
      "conceptName": ["nilotinib"]
    },
    "mercaptopurine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1436650],
      "conceptName": ["mercaptopurine"]
    },
    "Tamoxifen": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1436678],
      "conceptName": ["Tamoxifen"]
    },
    "Vinblastine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008264],
      "conceptName": ["Vinblastine"]
    },
    "ASPARAGINASE": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19012585],
      "conceptName": ["ASPARAGINASE"]
    },
    "bendamustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19015523],
      "conceptName": ["bendamustine"]
    },
    "Ifosfamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    },
    "Thalidomide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19137042],
      "conceptName": ["Thalidomide"]
    }
  },
  {
    "conceptId": [35803563],
    "regimenName": ["Cytarabine and Idarubicin, then Etoposide and Mitoxantrone, then Cytarabine, Idarubicin, Thioguanine, with ATRA"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Thioguanine": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1437379],
      "conceptName": ["Thioguanine"]
    },
    "Idarubicin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [19078097],
      "conceptName": ["Idarubicin"]
    },
    "Cytarabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Tretinoin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [903643],
      "conceptName": ["Tretinoin"]
    },
    "Mitoxantrone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1309188],
      "conceptName": ["Mitoxantrone"]
    },
    "Etoposide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    }
  },
  {
    "conceptId": [35804639],
    "regimenName": ["Interferon alfa-2b and DLI"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Interferon Alfa-2b": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1380068],
      "conceptName": ["Interferon Alfa-2b"]
    },
    "imatinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1304107],
      "conceptName": ["imatinib"]
    },
    "Aldesleukin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1309770],
      "conceptName": ["Aldesleukin"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Dacarbazine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311409],
      "conceptName": ["Dacarbazine"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Carmustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350066],
      "conceptName": ["Carmustine"]
    },
    "Interferon Alfa-2a": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1379969],
      "conceptName": ["Interferon Alfa-2a"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "lanreotide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1503501],
      "conceptName": ["lanreotide"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "Octreotide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1522957],
      "conceptName": ["Octreotide"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Zidovudine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1710612],
      "conceptName": ["Zidovudine"]
    },
    "peginterferon alfa-2a": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1714165],
      "conceptName": ["peginterferon alfa-2a"]
    },
    "Vinblastine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008264],
      "conceptName": ["Vinblastine"]
    },
    "Teniposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19136750],
      "conceptName": ["Teniposide"]
    },
    "Thalidomide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19137042],
      "conceptName": ["Thalidomide"]
    }
  },
  {
    "conceptId": [35804783],
    "regimenName": ["OXAFAFU"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "oxaliplatin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1318011],
      "conceptName": ["oxaliplatin"]
    },
    "Leucovorin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1388796],
      "conceptName": ["Leucovorin"]
    },
    "Fluorouracil": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "gemcitabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314924],
      "conceptName": ["gemcitabine"]
    },
    "cetuximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1315411],
      "conceptName": ["cetuximab"]
    },
    "docetaxel": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1315942],
      "conceptName": ["docetaxel"]
    },
    "irinotecan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1367268],
      "conceptName": ["irinotecan"]
    },
    "bevacizumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397141],
      "conceptName": ["bevacizumab"]
    },
    "panitumumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19100985],
      "conceptName": ["panitumumab"]
    }
  },
  {
    "conceptId": [35806314],
    "regimenName": ["Elo-Rd"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "lenalidomide": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [19026972],
      "conceptName": ["lenalidomide"]
    },
    "elotuzumab": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [35604032],
      "conceptName": ["elotuzumab"]
    },
    "Dexamethasone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    }
  },
  {
    "conceptId": [35804035],
    "regimenName": ["Vincristine and Prednisone"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Prednisone": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Fluorouracil": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "Melphalan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1301267],
      "conceptName": ["Melphalan"]
    },
    "imatinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1304107],
      "conceptName": ["imatinib"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Mitoxantrone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1309188],
      "conceptName": ["Mitoxantrone"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Dacarbazine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311409],
      "conceptName": ["Dacarbazine"]
    },
    "Daunorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311799],
      "conceptName": ["Daunorubicin"]
    },
    "alemtuzumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1312706],
      "conceptName": ["alemtuzumab"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Azacitidine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314865],
      "conceptName": ["Azacitidine"]
    },
    "pegaspargase": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1326481],
      "conceptName": ["pegaspargase"]
    },
    "Bleomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1329241],
      "conceptName": ["Bleomycin"]
    },
    "bortezomib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1336825],
      "conceptName": ["bortezomib"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Epirubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344354],
      "conceptName": ["Epirubicin"]
    },
    "Carboplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344905],
      "conceptName": ["Carboplatin"]
    },
    "Carmustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350066],
      "conceptName": ["Carmustine"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Procarbazine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1351779],
      "conceptName": ["Procarbazine"]
    },
    "dasatinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1358436],
      "conceptName": ["dasatinib"]
    },
    "Chlorambucil": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1390051],
      "conceptName": ["Chlorambucil"]
    },
    "Lomustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1391846],
      "conceptName": ["Lomustine"]
    },
    "Mechlorethamine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1394337],
      "conceptName": ["Mechlorethamine"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "mercaptopurine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1436650],
      "conceptName": ["mercaptopurine"]
    },
    "Thioguanine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1437379],
      "conceptName": ["Thioguanine"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "Hyaluronidase / rituximab Injection [Rituxan Hycela]": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1593155],
      "conceptName": ["Hyaluronidase / rituximab Injection [Rituxan Hycela]"]
    },
    "Quinine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1760616],
      "conceptName": ["Quinine"]
    },
    "Vinblastine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008264],
      "conceptName": ["Vinblastine"]
    },
    "Vindesine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008336],
      "conceptName": ["Vindesine"]
    },
    "everolimus": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19011440],
      "conceptName": ["everolimus"]
    },
    "ASPARAGINASE": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19012585],
      "conceptName": ["ASPARAGINASE"]
    },
    "lenalidomide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19026972],
      "conceptName": ["lenalidomide"]
    },
    "denileukin diftitox": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19051642],
      "conceptName": ["denileukin diftitox"]
    },
    "doxorubicin liposome": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19051649],
      "conceptName": ["doxorubicin liposome"]
    },
    "iodine-131-tositumomab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19054997],
      "conceptName": ["iodine-131-tositumomab"]
    },
    "Idarubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078097],
      "conceptName": ["Idarubicin"]
    },
    "Ifosfamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    },
    "BCG, Live, Tice Strain": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19086176],
      "conceptName": ["BCG, Live, Tice Strain"]
    },
    "Teniposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19136750],
      "conceptName": ["Teniposide"]
    },
    "ranimustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [35197850],
      "conceptName": ["ranimustine"]
    },
    "ofatumumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [40167582],
      "conceptName": ["ofatumumab"]
    },
    "obinutuzumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [44507676],
      "conceptName": ["obinutuzumab"]
    }
  },
  {
    "conceptId": [35804222],
    "regimenName": ["Trastuzumab monotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "trastuzumab": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1387104],
      "conceptName": ["trastuzumab"]
    },
    "Fluorouracil": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "gemcitabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314924],
      "conceptName": ["gemcitabine"]
    },
    "docetaxel": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1315942],
      "conceptName": ["docetaxel"]
    },
    "letrozole": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1315946],
      "conceptName": ["letrozole"]
    },
    "capecitabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1337620],
      "conceptName": ["capecitabine"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "vinorelbine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1343346],
      "conceptName": ["vinorelbine"]
    },
    "Epirubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344354],
      "conceptName": ["Epirubicin"]
    },
    "Carboplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344905],
      "conceptName": ["Carboplatin"]
    },
    "anastrozole": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1348265],
      "conceptName": ["anastrozole"]
    },
    "lapatinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1359548],
      "conceptName": ["lapatinib"]
    },
    "Paclitaxel": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1378382],
      "conceptName": ["Paclitaxel"]
    },
    "bevacizumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397141],
      "conceptName": ["bevacizumab"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "Tamoxifen": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1436678],
      "conceptName": ["Tamoxifen"]
    },
    "pertuzumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [42801287],
      "conceptName": ["pertuzumab"]
    }
  },
  {
    "conceptId": [35806426],
    "regimenName": ["Carboplatin and Gemcitabine/Erlotinib"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Carboplatin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1344905],
      "conceptName": ["Carboplatin"]
    },
    "erlotinib": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1325363],
      "conceptName": ["erlotinib"]
    },
    "gemcitabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1314924],
      "conceptName": ["gemcitabine"]
    }
  },
  {
    "conceptId": [35804530],
    "regimenName": ["Carboplatin and RT"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Carboplatin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1344905],
      "conceptName": ["Carboplatin"]
    },
    "Fluorouracil": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "pemetrexed": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1304919],
      "conceptName": ["pemetrexed"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "gemcitabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314924],
      "conceptName": ["gemcitabine"]
    },
    "cetuximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1315411],
      "conceptName": ["cetuximab"]
    },
    "docetaxel": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1315942],
      "conceptName": ["docetaxel"]
    },
    "erlotinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1325363],
      "conceptName": ["erlotinib"]
    },
    "Bleomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1329241],
      "conceptName": ["Bleomycin"]
    },
    "capecitabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1337620],
      "conceptName": ["capecitabine"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "vinorelbine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1343346],
      "conceptName": ["vinorelbine"]
    },
    "Epirubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344354],
      "conceptName": ["Epirubicin"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Mesna": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1354698],
      "conceptName": ["Mesna"]
    },
    "irinotecan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1367268],
      "conceptName": ["irinotecan"]
    },
    "Paclitaxel": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1378382],
      "conceptName": ["Paclitaxel"]
    },
    "trastuzumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1387104],
      "conceptName": ["trastuzumab"]
    },
    "Mitomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1389036],
      "conceptName": ["Mitomycin"]
    },
    "bevacizumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397141],
      "conceptName": ["bevacizumab"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "prednisolone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1550557],
      "conceptName": ["prednisolone"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Vindesine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008336],
      "conceptName": ["Vindesine"]
    },
    "lenalidomide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19026972],
      "conceptName": ["lenalidomide"]
    },
    "doxorubicin liposome": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19051649],
      "conceptName": ["doxorubicin liposome"]
    },
    "Ifosfamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    },
    "Teniposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19136750],
      "conceptName": ["Teniposide"]
    },
    "Thiotepa": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19137385],
      "conceptName": ["Thiotepa"]
    },
    "ranimustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [35197850],
      "conceptName": ["ranimustine"]
    },
    "ofatumumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [40167582],
      "conceptName": ["ofatumumab"]
    },
    "ipilimumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [40238188],
      "conceptName": ["ipilimumab"]
    },
    "atezolizumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [42629079],
      "conceptName": ["atezolizumab"]
    },
    "pertuzumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [42801287],
      "conceptName": ["pertuzumab"]
    },
    "pembrolizumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [45775965],
      "conceptName": ["pembrolizumab"]
    },
    "olaparib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [45892579],
      "conceptName": ["olaparib"]
    }
  },
  {
    "conceptId": [35806355],
    "regimenName": ["Pomalidomide, Dexamethasone, Pembrolizumab"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Dexamethasone": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "pembrolizumab": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [45775965],
      "conceptName": ["pembrolizumab"]
    },
    "pomalidomide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [43014237],
      "conceptName": ["pomalidomide"]
    }
  },
  {
    "conceptId": [35803690],
    "regimenName": ["Cyclophosphamide monotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Cyclophosphamide": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "inotuzumab ozogamicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [794068],
      "conceptName": ["inotuzumab ozogamicin"]
    },
    "Fluorouracil": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "Melphalan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1301267],
      "conceptName": ["Melphalan"]
    },
    "imatinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1304107],
      "conceptName": ["imatinib"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Mitoxantrone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1309188],
      "conceptName": ["Mitoxantrone"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Dacarbazine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311409],
      "conceptName": ["Dacarbazine"]
    },
    "Dactinomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311443],
      "conceptName": ["Dactinomycin"]
    },
    "Daunorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311799],
      "conceptName": ["Daunorubicin"]
    },
    "alemtuzumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1312706],
      "conceptName": ["alemtuzumab"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "gemcitabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314924],
      "conceptName": ["gemcitabine"]
    },
    "docetaxel": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1315942],
      "conceptName": ["docetaxel"]
    },
    "pegaspargase": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1326481],
      "conceptName": ["pegaspargase"]
    },
    "Bleomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1329241],
      "conceptName": ["Bleomycin"]
    },
    "Busulfan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1333357],
      "conceptName": ["Busulfan"]
    },
    "bortezomib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1336825],
      "conceptName": ["bortezomib"]
    },
    "Vorinostat": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1337651],
      "conceptName": ["Vorinostat"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Epirubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344354],
      "conceptName": ["Epirubicin"]
    },
    "Carboplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344905],
      "conceptName": ["Carboplatin"]
    },
    "Carmustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350066],
      "conceptName": ["Carmustine"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Procarbazine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1351779],
      "conceptName": ["Procarbazine"]
    },
    "Mesna": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1354698],
      "conceptName": ["Mesna"]
    },
    "dasatinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1358436],
      "conceptName": ["dasatinib"]
    },
    "irinotecan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1367268],
      "conceptName": ["irinotecan"]
    },
    "Altretamine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1368823],
      "conceptName": ["Altretamine"]
    },
    "Paclitaxel": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1378382],
      "conceptName": ["Paclitaxel"]
    },
    "Topotecan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1378509],
      "conceptName": ["Topotecan"]
    },
    "Interferon Alfa-2b": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1380068],
      "conceptName": ["Interferon Alfa-2b"]
    },
    "Interferon gamma-1b": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1380191],
      "conceptName": ["Interferon gamma-1b"]
    },
    "trastuzumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1387104],
      "conceptName": ["trastuzumab"]
    },
    "Leucovorin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1388796],
      "conceptName": ["Leucovorin"]
    },
    "Lomustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1391846],
      "conceptName": ["Lomustine"]
    },
    "Mechlorethamine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1394337],
      "conceptName": ["Mechlorethamine"]
    },
    "fludarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1395557],
      "conceptName": ["fludarabine"]
    },
    "bevacizumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397141],
      "conceptName": ["bevacizumab"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "mercaptopurine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1436650],
      "conceptName": ["mercaptopurine"]
    },
    "Tamoxifen": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1436678],
      "conceptName": ["Tamoxifen"]
    },
    "Thioguanine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1437379],
      "conceptName": ["Thioguanine"]
    },
    "Medroxyprogesterone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1500211],
      "conceptName": ["Medroxyprogesterone"]
    },
    "Methylprednisolone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1506270],
      "conceptName": ["Methylprednisolone"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "Diethylstilbestrol": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1525866],
      "conceptName": ["Diethylstilbestrol"]
    },
    "prednisolone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1550557],
      "conceptName": ["prednisolone"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Hyaluronidase / rituximab Injection [Rituxan Hycela]": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1593155],
      "conceptName": ["Hyaluronidase / rituximab Injection [Rituxan Hycela]"]
    },
    "nelarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19002912],
      "conceptName": ["nelarabine"]
    },
    "Vinblastine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008264],
      "conceptName": ["Vinblastine"]
    },
    "Vindesine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008336],
      "conceptName": ["Vindesine"]
    },
    "everolimus": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19011440],
      "conceptName": ["everolimus"]
    },
    "ASPARAGINASE": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19012585],
      "conceptName": ["ASPARAGINASE"]
    },
    "lenalidomide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19026972],
      "conceptName": ["lenalidomide"]
    },
    "Pentostatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19031224],
      "conceptName": ["Pentostatin"]
    },
    "denileukin diftitox": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19051642],
      "conceptName": ["denileukin diftitox"]
    },
    "doxorubicin liposome": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19051649],
      "conceptName": ["doxorubicin liposome"]
    },
    "clofarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19054821],
      "conceptName": ["clofarabine"]
    },
    "Cladribine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19054825],
      "conceptName": ["Cladribine"]
    },
    "iodine-131-tositumomab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19054997],
      "conceptName": ["iodine-131-tositumomab"]
    },
    "ibritumomab tiuxetan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19068830],
      "conceptName": ["ibritumomab tiuxetan"]
    },
    "Idarubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078097],
      "conceptName": ["Idarubicin"]
    },
    "Ifosfamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    },
    "BCG, Live, Tice Strain": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19086176],
      "conceptName": ["BCG, Live, Tice Strain"]
    },
    "Teniposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19136750],
      "conceptName": ["Teniposide"]
    },
    "Thalidomide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19137042],
      "conceptName": ["Thalidomide"]
    },
    "Thiotepa": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19137385],
      "conceptName": ["Thiotepa"]
    },
    "Myocet": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [21017157],
      "conceptName": ["Myocet"]
    },
    "ranimustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [35197850],
      "conceptName": ["ranimustine"]
    },
    "ofatumumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [40167582],
      "conceptName": ["ofatumumab"]
    },
    "Cytarabine liposome": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [40175460],
      "conceptName": ["Cytarabine liposome"]
    },
    "brentuximab vedotin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [40241969],
      "conceptName": ["brentuximab vedotin"]
    },
    "carfilzomib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [42873638],
      "conceptName": ["carfilzomib"]
    },
    "vincristine liposome": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [42874135],
      "conceptName": ["vincristine liposome"]
    },
    "ponatinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [43013182],
      "conceptName": ["ponatinib"]
    },
    "pomalidomide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [43014237],
      "conceptName": ["pomalidomide"]
    },
    "obinutuzumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [44507676],
      "conceptName": ["obinutuzumab"]
    }
  },
  {
    "conceptId": [35803544],
    "regimenName": ["Vosaroxin and Cytarabine"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Cytarabine": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "inotuzumab ozogamicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [794068],
      "conceptName": ["inotuzumab ozogamicin"]
    },
    "Tretinoin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [903643],
      "conceptName": ["Tretinoin"]
    },
    "Fluorouracil": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "Melphalan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1301267],
      "conceptName": ["Melphalan"]
    },
    "imatinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1304107],
      "conceptName": ["imatinib"]
    },
    "Filgrastim": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1304850],
      "conceptName": ["Filgrastim"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Mitoxantrone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1309188],
      "conceptName": ["Mitoxantrone"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Daunorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311799],
      "conceptName": ["Daunorubicin"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Azacitidine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314865],
      "conceptName": ["Azacitidine"]
    },
    "oxaliplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1318011],
      "conceptName": ["oxaliplatin"]
    },
    "pegaspargase": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1326481],
      "conceptName": ["pegaspargase"]
    },
    "Bleomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1329241],
      "conceptName": ["Bleomycin"]
    },
    "Vorinostat": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1337651],
      "conceptName": ["Vorinostat"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Carboplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344905],
      "conceptName": ["Carboplatin"]
    },
    "Carmustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350066],
      "conceptName": ["Carmustine"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "glasdegib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1355795],
      "conceptName": ["glasdegib"]
    },
    "dasatinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1358436],
      "conceptName": ["dasatinib"]
    },
    "sorafenib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1363387],
      "conceptName": ["sorafenib"]
    },
    "Interferon Alfa-2b": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1380068],
      "conceptName": ["Interferon Alfa-2b"]
    },
    "Lomustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1391846],
      "conceptName": ["Lomustine"]
    },
    "nilotinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1394023],
      "conceptName": ["nilotinib"]
    },
    "fludarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1395557],
      "conceptName": ["fludarabine"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "mercaptopurine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1436650],
      "conceptName": ["mercaptopurine"]
    },
    "Thioguanine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1437379],
      "conceptName": ["Thioguanine"]
    },
    "Methylprednisolone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1506270],
      "conceptName": ["Methylprednisolone"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "prednisolone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1550557],
      "conceptName": ["prednisolone"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Pravastatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551860],
      "conceptName": ["Pravastatin"]
    },
    "midostaurin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1594003],
      "conceptName": ["midostaurin"]
    },
    "nelarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19002912],
      "conceptName": ["nelarabine"]
    },
    "Vindesine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008336],
      "conceptName": ["Vindesine"]
    },
    "lenograstim": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19009705],
      "conceptName": ["lenograstim"]
    },
    "everolimus": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19011440],
      "conceptName": ["everolimus"]
    },
    "ASPARAGINASE": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19012585],
      "conceptName": ["ASPARAGINASE"]
    },
    "bendamustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19015523],
      "conceptName": ["bendamustine"]
    },
    "Amsacrine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19017810],
      "conceptName": ["Amsacrine"]
    },
    "decitabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19024728],
      "conceptName": ["decitabine"]
    },
    "Daunorubicin Liposomal": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19051599],
      "conceptName": ["Daunorubicin Liposomal"]
    },
    "doxorubicin liposome": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19051649],
      "conceptName": ["doxorubicin liposome"]
    },
    "clofarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19054821],
      "conceptName": ["clofarabine"]
    },
    "Cladribine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19054825],
      "conceptName": ["Cladribine"]
    },
    "Aclarubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19057483],
      "conceptName": ["Aclarubicin"]
    },
    "ibritumomab tiuxetan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19068830],
      "conceptName": ["ibritumomab tiuxetan"]
    },
    "Idarubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078097],
      "conceptName": ["Idarubicin"]
    },
    "Ifosfamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    },
    "Norethandrolone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19128219],
      "conceptName": ["Norethandrolone"]
    },
    "Teniposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19136750],
      "conceptName": ["Teniposide"]
    },
    "Thiotepa": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19137385],
      "conceptName": ["Thiotepa"]
    },
    "venetoclax": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [35604205],
      "conceptName": ["venetoclax"]
    },
    "Fotemustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [36879099],
      "conceptName": ["Fotemustine"]
    },
    "ofatumumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [40167582],
      "conceptName": ["ofatumumab"]
    },
    "Cytarabine liposome": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [40175460],
      "conceptName": ["Cytarabine liposome"]
    },
    "Gemtuzumab ozogamicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [42799711],
      "conceptName": ["Gemtuzumab ozogamicin"]
    },
    "ponatinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [43013182],
      "conceptName": ["ponatinib"]
    },
    "omacetaxine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [45775576],
      "conceptName": ["omacetaxine"]
    },
    "panobinostat": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [46221435],
      "conceptName": ["panobinostat"]
    }
  },
  {
    "conceptId": [35806852],
    "regimenName": ["Ketoconazole and Hydrocortisone"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Hydrocortisone": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [975125],
      "conceptName": ["Hydrocortisone"]
    },
    "Ketoconazole": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [985708],
      "conceptName": ["Ketoconazole"]
    },
    "Dutasteride": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [989482],
      "conceptName": ["Dutasteride"]
    }
  },
  {
    "conceptId": [35806433],
    "regimenName": ["CAMP"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Methotrexate": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Procarbazine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1351779],
      "conceptName": ["Procarbazine"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Mechlorethamine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1394337],
      "conceptName": ["Mechlorethamine"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    }
  },
  {
    "conceptId": [35806942],
    "regimenName": ["Carboplatin, Etoposide, Bevacizumab"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Carboplatin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1344905],
      "conceptName": ["Carboplatin"]
    },
    "bevacizumab": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1397141],
      "conceptName": ["bevacizumab"]
    },
    "Etoposide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    }
  },
  {
    "conceptId": [35805027],
    "regimenName": ["ACVBP-R"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Bleomycin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1329241],
      "conceptName": ["Bleomycin"]
    },
    "rituximab": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Vindesine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [19008336],
      "conceptName": ["Vindesine"]
    },
    "Prednisone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    }
  },
  {
    "conceptId": [35805090],
    "regimenName": ["CEEP"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Epirubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1344354],
      "conceptName": ["Epirubicin"]
    },
    "Vindesine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [19008336],
      "conceptName": ["Vindesine"]
    },
    "Prednisone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    }
  },
  {
    "conceptId": [35806965],
    "regimenName": ["Doxorubicin and Ifosfamide"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Ifosfamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Dacarbazine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311409],
      "conceptName": ["Dacarbazine"]
    },
    "Dactinomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311443],
      "conceptName": ["Dactinomycin"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Bleomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1329241],
      "conceptName": ["Bleomycin"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Mesna": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1354698],
      "conceptName": ["Mesna"]
    },
    "irinotecan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1367268],
      "conceptName": ["irinotecan"]
    },
    "Topotecan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1378509],
      "conceptName": ["Topotecan"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Vindesine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008336],
      "conceptName": ["Vindesine"]
    },
    "Teniposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19136750],
      "conceptName": ["Teniposide"]
    }
  },
  {
    "conceptId": [35804812],
    "regimenName": ["Bexarotene monotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "bexarotene": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1389888],
      "conceptName": ["bexarotene"]
    },
    "Pralatrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [40166461],
      "conceptName": ["Pralatrexate"]
    }
  },
  {
    "conceptId": [35803529],
    "regimenName": ["Cytarabine, Doxorubicin, Vincristine, Prednisolone"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Cytarabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "prednisolone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1550557],
      "conceptName": ["prednisolone"]
    }
  },
  {
    "conceptId": [35805837],
    "regimenName": ["Mini-BEAM"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Carmustine": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1350066],
      "conceptName": ["Carmustine"]
    },
    "Melphalan": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1301267],
      "conceptName": ["Melphalan"]
    },
    "Cytarabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Etoposide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "ibritumomab tiuxetan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19068830],
      "conceptName": ["ibritumomab tiuxetan"]
    }
  },
  {
    "conceptId": [35806408],
    "regimenName": ["Atezolizumab and Bevacizumab"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "bevacizumab": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1397141],
      "conceptName": ["bevacizumab"]
    },
    "atezolizumab": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [42629079],
      "conceptName": ["atezolizumab"]
    },
    "Carboplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344905],
      "conceptName": ["Carboplatin"]
    },
    "Paclitaxel": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1378382],
      "conceptName": ["Paclitaxel"]
    }
  },
  {
    "conceptId": [35101262],
    "regimenName": ["SOX and Bevacizumab"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "oxaliplatin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1318011],
      "conceptName": ["oxaliplatin"]
    },
    "bevacizumab": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1397141],
      "conceptName": ["bevacizumab"]
    },
    "Hyaluronidase / trastuzumab Injection [Herceptin Hylecta]": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1366689],
      "conceptName": ["Hyaluronidase / trastuzumab Injection [Herceptin Hylecta]"]
    }
  },
  {
    "conceptId": [35805343],
    "regimenName": ["Capecitabine, Carboplatin, Paclitaxel, RT"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Carboplatin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1344905],
      "conceptName": ["Carboplatin"]
    },
    "Paclitaxel": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1378382],
      "conceptName": ["Paclitaxel"]
    },
    "capecitabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1337620],
      "conceptName": ["capecitabine"]
    }
  },
  {
    "conceptId": [35804606],
    "regimenName": ["Acalabrutinib monotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "acalabrutinib": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [792764],
      "conceptName": ["acalabrutinib"]
    }
  },
  {
    "conceptId": [35804178],
    "regimenName": ["Denosumab monotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "denosumab": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [40222444],
      "conceptName": ["denosumab"]
    }
  },
  {
    "conceptId": [35806173],
    "regimenName": ["Cisplatin and Pemetrexed"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Cisplatin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "pemetrexed": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1304919],
      "conceptName": ["pemetrexed"]
    },
    "bevacizumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397141],
      "conceptName": ["bevacizumab"]
    },
    "pembrolizumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [45775965],
      "conceptName": ["pembrolizumab"]
    }
  },
  {
    "conceptId": [35805831],
    "regimenName": ["DHAP - time intensified"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Cisplatin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "Cytarabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Dexamethasone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Ifosfamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    },
    "ofatumumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [40167582],
      "conceptName": ["ofatumumab"]
    }
  },
  {
    "conceptId": [35804628],
    "regimenName": ["Hydroxyurea and Interferon alfa"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "hydroxyurea": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1377141],
      "conceptName": ["hydroxyurea"]
    },
    "Fluorouracil": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "imatinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1304107],
      "conceptName": ["imatinib"]
    },
    "Dacarbazine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311409],
      "conceptName": ["Dacarbazine"]
    },
    "docetaxel": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1315942],
      "conceptName": ["docetaxel"]
    },
    "Carmustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350066],
      "conceptName": ["Carmustine"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    }
  },
  {
    "conceptId": [35804085],
    "regimenName": ["Aminopterin monotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Aminopterin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [44506771],
      "conceptName": ["Aminopterin"]
    }
  },
  {
    "conceptId": [35804607],
    "regimenName": ["Alemtuzumab and Rituximab"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "alemtuzumab": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1312706],
      "conceptName": ["alemtuzumab"]
    },
    "rituximab": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "fludarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1395557],
      "conceptName": ["fludarabine"]
    }
  },
  {
    "conceptId": [35804043],
    "regimenName": ["Cyclophosphamide, Daunorubicin, L-Asparaginase, Vincristine, Prednisone, Rituximab"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "ASPARAGINASE": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [19012585],
      "conceptName": ["ASPARAGINASE"]
    },
    "rituximab": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Prednisone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Daunorubicin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1311799],
      "conceptName": ["Daunorubicin"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    }
  },
  {
    "conceptId": [35803684],
    "regimenName": ["RT, then Temozolomide"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "temozolomide": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1341149],
      "conceptName": ["temozolomide"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "capecitabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1337620],
      "conceptName": ["capecitabine"]
    },
    "irinotecan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1367268],
      "conceptName": ["irinotecan"]
    },
    "Lomustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1391846],
      "conceptName": ["Lomustine"]
    },
    "bevacizumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397141],
      "conceptName": ["bevacizumab"]
    },
    "Thalidomide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19137042],
      "conceptName": ["Thalidomide"]
    },
    "dinutuximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [46221699],
      "conceptName": ["dinutuximab"]
    }
  },
  {
    "conceptId": [35806084],
    "regimenName": ["TAM6, then auto HSCT"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Melphalan": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1301267],
      "conceptName": ["Melphalan"]
    },
    "Cytarabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Carmustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350066],
      "conceptName": ["Carmustine"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "bendamustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19015523],
      "conceptName": ["bendamustine"]
    },
    "ibritumomab tiuxetan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19068830],
      "conceptName": ["ibritumomab tiuxetan"]
    },
    "Fotemustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [36879099],
      "conceptName": ["Fotemustine"]
    }
  },
  {
    "conceptId": [35805636],
    "regimenName": ["R-CHVP plus I"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "rituximab": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Etoposide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "prednisolone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1550557],
      "conceptName": ["prednisolone"]
    }
  },
  {
    "conceptId": [35806269],
    "regimenName": ["PAD"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "bortezomib": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1336825],
      "conceptName": ["bortezomib"]
    },
    "Dexamethasone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "Melphalan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1301267],
      "conceptName": ["Melphalan"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Chlorambucil": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1390051],
      "conceptName": ["Chlorambucil"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "Thalidomide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19137042],
      "conceptName": ["Thalidomide"]
    }
  },
  {
    "conceptId": [35806295],
    "regimenName": ["TVAD doxil"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "doxorubicin liposome": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [19051649],
      "conceptName": ["doxorubicin liposome"]
    },
    "Thalidomide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [19137042],
      "conceptName": ["Thalidomide"]
    },
    "Dexamethasone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    }
  },
  {
    "conceptId": [35804412],
    "regimenName": ["Cytarabine, Methotrexate, Rituximab"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Methotrexate": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "rituximab": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Cytarabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Vindesine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008336],
      "conceptName": ["Vindesine"]
    },
    "doxorubicin liposome": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19051649],
      "conceptName": ["doxorubicin liposome"]
    },
    "Ifosfamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    },
    "Teniposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19136750],
      "conceptName": ["Teniposide"]
    },
    "Thiotepa": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19137385],
      "conceptName": ["Thiotepa"]
    },
    "Cytarabine liposome": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [40175460],
      "conceptName": ["Cytarabine liposome"]
    }
  },
  {
    "conceptId": [35807168],
    "regimenName": ["DRC"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "rituximab": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Dexamethasone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "bortezomib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1336825],
      "conceptName": ["bortezomib"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Vindesine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008336],
      "conceptName": ["Vindesine"]
    },
    "Ifosfamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    },
    "Teniposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19136750],
      "conceptName": ["Teniposide"]
    },
    "Cytarabine liposome": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [40175460],
      "conceptName": ["Cytarabine liposome"]
    }
  },
  {
    "conceptId": [35806482],
    "regimenName": ["Carboplatin, Gemcitabine, Bevacizumab"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Carboplatin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1344905],
      "conceptName": ["Carboplatin"]
    },
    "bevacizumab": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1397141],
      "conceptName": ["bevacizumab"]
    },
    "gemcitabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1314924],
      "conceptName": ["gemcitabine"]
    }
  },
  {
    "conceptId": [35804638],
    "regimenName": ["Busulfan monotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Busulfan": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1333357],
      "conceptName": ["Busulfan"]
    },
    "Melphalan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1301267],
      "conceptName": ["Melphalan"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "fludarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1395557],
      "conceptName": ["fludarabine"]
    },
    "ibritumomab tiuxetan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19068830],
      "conceptName": ["ibritumomab tiuxetan"]
    },
    "Thiotepa": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19137385],
      "conceptName": ["Thiotepa"]
    }
  },
  {
    "conceptId": [35805690],
    "regimenName": ["Pazopanib monotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "pazopanib": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [40167554],
      "conceptName": ["pazopanib"]
    },
    "Paclitaxel": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1378382],
      "conceptName": ["Paclitaxel"]
    }
  },
  {
    "conceptId": [35807027],
    "regimenName": ["Bleomycin and Vinblastine"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Bleomycin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1329241],
      "conceptName": ["Bleomycin"]
    },
    "Vinblastine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [19008264],
      "conceptName": ["Vinblastine"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Mitoxantrone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1309188],
      "conceptName": ["Mitoxantrone"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Dacarbazine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311409],
      "conceptName": ["Dacarbazine"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Epirubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344354],
      "conceptName": ["Epirubicin"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Procarbazine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1351779],
      "conceptName": ["Procarbazine"]
    },
    "Chlorambucil": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1390051],
      "conceptName": ["Chlorambucil"]
    },
    "Lomustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1391846],
      "conceptName": ["Lomustine"]
    },
    "Mechlorethamine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1394337],
      "conceptName": ["Mechlorethamine"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "Methylprednisolone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1506270],
      "conceptName": ["Methylprednisolone"]
    },
    "prednisolone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1550557],
      "conceptName": ["prednisolone"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Streptozocin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19136210],
      "conceptName": ["Streptozocin"]
    }
  },
  {
    "conceptId": [35805795],
    "regimenName": ["Lenvatinib monotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "lenvatinib": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [46221433],
      "conceptName": ["lenvatinib"]
    },
    "everolimus": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19011440],
      "conceptName": ["everolimus"]
    }
  },
  {
    "conceptId": [35805362],
    "regimenName": ["CX-C"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Cisplatin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "cetuximab": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1315411],
      "conceptName": ["cetuximab"]
    },
    "capecitabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1337620],
      "conceptName": ["capecitabine"]
    }
  },
  {
    "conceptId": [35806848],
    "regimenName": ["Abiraterone and Prednisone"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Prednisone": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "abiraterone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [40239056],
      "conceptName": ["abiraterone"]
    }
  },
  {
    "conceptId": [35803478],
    "regimenName": ["LoDAC and Venetoclax"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "venetoclax": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [35604205],
      "conceptName": ["venetoclax"]
    },
    "Cytarabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    }
  },
  {
    "conceptId": [35804609],
    "regimenName": ["FluCam"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "alemtuzumab": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1312706],
      "conceptName": ["alemtuzumab"]
    },
    "fludarabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1395557],
      "conceptName": ["fludarabine"]
    },
    "Melphalan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1301267],
      "conceptName": ["Melphalan"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    }
  },
  {
    "conceptId": [35807043],
    "regimenName": ["Vincristine monotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Vincristine": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "inotuzumab ozogamicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [794068],
      "conceptName": ["inotuzumab ozogamicin"]
    },
    "Fluorouracil": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "Melphalan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1301267],
      "conceptName": ["Melphalan"]
    },
    "imatinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1304107],
      "conceptName": ["imatinib"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Mitoxantrone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1309188],
      "conceptName": ["Mitoxantrone"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Dacarbazine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311409],
      "conceptName": ["Dacarbazine"]
    },
    "Dactinomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311443],
      "conceptName": ["Dactinomycin"]
    },
    "Daunorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311799],
      "conceptName": ["Daunorubicin"]
    },
    "alemtuzumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1312706],
      "conceptName": ["alemtuzumab"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Azacitidine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314865],
      "conceptName": ["Azacitidine"]
    },
    "gemcitabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314924],
      "conceptName": ["gemcitabine"]
    },
    "pegaspargase": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1326481],
      "conceptName": ["pegaspargase"]
    },
    "Bleomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1329241],
      "conceptName": ["Bleomycin"]
    },
    "bortezomib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1336825],
      "conceptName": ["bortezomib"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Epirubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344354],
      "conceptName": ["Epirubicin"]
    },
    "Carboplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344905],
      "conceptName": ["Carboplatin"]
    },
    "Carmustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350066],
      "conceptName": ["Carmustine"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Procarbazine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1351779],
      "conceptName": ["Procarbazine"]
    },
    "dasatinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1358436],
      "conceptName": ["dasatinib"]
    },
    "irinotecan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1367268],
      "conceptName": ["irinotecan"]
    },
    "Topotecan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1378509],
      "conceptName": ["Topotecan"]
    },
    "Chlorambucil": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1390051],
      "conceptName": ["Chlorambucil"]
    },
    "Lomustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1391846],
      "conceptName": ["Lomustine"]
    },
    "nilotinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1394023],
      "conceptName": ["nilotinib"]
    },
    "Mechlorethamine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1394337],
      "conceptName": ["Mechlorethamine"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "mercaptopurine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1436650],
      "conceptName": ["mercaptopurine"]
    },
    "Thioguanine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1437379],
      "conceptName": ["Thioguanine"]
    },
    "Methylprednisolone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1506270],
      "conceptName": ["Methylprednisolone"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "prednisolone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1550557],
      "conceptName": ["prednisolone"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Hyaluronidase / rituximab Injection [Rituxan Hycela]": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1593155],
      "conceptName": ["Hyaluronidase / rituximab Injection [Rituxan Hycela]"]
    },
    "Quinine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1760616],
      "conceptName": ["Quinine"]
    },
    "nelarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19002912],
      "conceptName": ["nelarabine"]
    },
    "Vinblastine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008264],
      "conceptName": ["Vinblastine"]
    },
    "Vindesine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008336],
      "conceptName": ["Vindesine"]
    },
    "everolimus": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19011440],
      "conceptName": ["everolimus"]
    },
    "ASPARAGINASE": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19012585],
      "conceptName": ["ASPARAGINASE"]
    },
    "lenalidomide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19026972],
      "conceptName": ["lenalidomide"]
    },
    "denileukin diftitox": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19051642],
      "conceptName": ["denileukin diftitox"]
    },
    "doxorubicin liposome": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19051649],
      "conceptName": ["doxorubicin liposome"]
    },
    "iodine-131-tositumomab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19054997],
      "conceptName": ["iodine-131-tositumomab"]
    },
    "Idarubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078097],
      "conceptName": ["Idarubicin"]
    },
    "Ifosfamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    },
    "BCG, Live, Tice Strain": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19086176],
      "conceptName": ["BCG, Live, Tice Strain"]
    },
    "Teniposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19136750],
      "conceptName": ["Teniposide"]
    },
    "Thalidomide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19137042],
      "conceptName": ["Thalidomide"]
    },
    "ranimustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [35197850],
      "conceptName": ["ranimustine"]
    },
    "ofatumumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [40167582],
      "conceptName": ["ofatumumab"]
    },
    "Cytarabine liposome": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [40175460],
      "conceptName": ["Cytarabine liposome"]
    },
    "ponatinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [43013182],
      "conceptName": ["ponatinib"]
    },
    "asparaginase Erwinia chrysanthemi": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [43533115],
      "conceptName": ["asparaginase Erwinia chrysanthemi"]
    },
    "obinutuzumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [44507676],
      "conceptName": ["obinutuzumab"]
    }
  },
  {
    "conceptId": [35805092],
    "regimenName": ["CHOP Modified"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Prednisone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Fluorouracil": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "Melphalan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1301267],
      "conceptName": ["Melphalan"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Dacarbazine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311409],
      "conceptName": ["Dacarbazine"]
    },
    "alemtuzumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1312706],
      "conceptName": ["alemtuzumab"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Bleomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1329241],
      "conceptName": ["Bleomycin"]
    },
    "bortezomib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1336825],
      "conceptName": ["bortezomib"]
    },
    "Carboplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344905],
      "conceptName": ["Carboplatin"]
    },
    "Carmustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350066],
      "conceptName": ["Carmustine"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Procarbazine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1351779],
      "conceptName": ["Procarbazine"]
    },
    "Mechlorethamine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1394337],
      "conceptName": ["Mechlorethamine"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "Hyaluronidase / rituximab Injection [Rituxan Hycela]": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1593155],
      "conceptName": ["Hyaluronidase / rituximab Injection [Rituxan Hycela]"]
    },
    "Vinblastine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008264],
      "conceptName": ["Vinblastine"]
    },
    "Vindesine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008336],
      "conceptName": ["Vindesine"]
    },
    "everolimus": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19011440],
      "conceptName": ["everolimus"]
    },
    "lenalidomide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19026972],
      "conceptName": ["lenalidomide"]
    },
    "denileukin diftitox": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19051642],
      "conceptName": ["denileukin diftitox"]
    },
    "iodine-131-tositumomab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19054997],
      "conceptName": ["iodine-131-tositumomab"]
    },
    "Ifosfamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    },
    "BCG, Live, Tice Strain": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19086176],
      "conceptName": ["BCG, Live, Tice Strain"]
    },
    "Teniposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19136750],
      "conceptName": ["Teniposide"]
    },
    "ranimustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [35197850],
      "conceptName": ["ranimustine"]
    },
    "ofatumumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [40167582],
      "conceptName": ["ofatumumab"]
    },
    "obinutuzumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [44507676],
      "conceptName": ["obinutuzumab"]
    }
  },
  {
    "conceptId": [35807025],
    "regimenName": ["Oxaliplatin and Bevacizumab"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "oxaliplatin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1318011],
      "conceptName": ["oxaliplatin"]
    },
    "bevacizumab": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1397141],
      "conceptName": ["bevacizumab"]
    },
    "Fluorouracil": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "gemcitabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314924],
      "conceptName": ["gemcitabine"]
    },
    "capecitabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1337620],
      "conceptName": ["capecitabine"]
    },
    "Hyaluronidase / trastuzumab Injection [Herceptin Hylecta]": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1366689],
      "conceptName": ["Hyaluronidase / trastuzumab Injection [Herceptin Hylecta]"]
    },
    "irinotecan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1367268],
      "conceptName": ["irinotecan"]
    },
    "Leucovorin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1388796],
      "conceptName": ["Leucovorin"]
    },
    "levoleucovorin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [40168303],
      "conceptName": ["levoleucovorin"]
    }
  },
  {
    "conceptId": [35806094],
    "regimenName": ["Arsenic trioxide and Chlorambucil"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "arsenic trioxide": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1333379],
      "conceptName": ["arsenic trioxide"]
    },
    "Chlorambucil": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1390051],
      "conceptName": ["Chlorambucil"]
    }
  },
  {
    "conceptId": [35806098],
    "regimenName": ["RT-PEPC"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "rituximab": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Thalidomide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [19137042],
      "conceptName": ["Thalidomide"]
    },
    "Prednisone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Procarbazine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1351779],
      "conceptName": ["Procarbazine"]
    },
    "Etoposide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    }
  },
  {
    "conceptId": [35804759],
    "regimenName": ["Tegafur, Uracil, Folinic acid"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Leucovorin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1388796],
      "conceptName": ["Leucovorin"]
    },
    "Fluorouracil": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "gemcitabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314924],
      "conceptName": ["gemcitabine"]
    },
    "cetuximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1315411],
      "conceptName": ["cetuximab"]
    },
    "docetaxel": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1315942],
      "conceptName": ["docetaxel"]
    },
    "oxaliplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1318011],
      "conceptName": ["oxaliplatin"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "irinotecan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1367268],
      "conceptName": ["irinotecan"]
    },
    "Mitomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1389036],
      "conceptName": ["Mitomycin"]
    },
    "Levamisole": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1389464],
      "conceptName": ["Levamisole"]
    },
    "bevacizumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397141],
      "conceptName": ["bevacizumab"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "panitumumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19100985],
      "conceptName": ["panitumumab"]
    },
    "irinotecan liposomal": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [35603068],
      "conceptName": ["irinotecan liposomal"]
    },
    "aflibercept": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [40244266],
      "conceptName": ["aflibercept"]
    },
    "ramucirumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [44818489],
      "conceptName": ["ramucirumab"]
    }
  },
  {
    "conceptId": [35805806],
    "regimenName": ["VAMP (Methotrexate)"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Methotrexate": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Prednisone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Vinblastine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [19008264],
      "conceptName": ["Vinblastine"]
    }
  },
  {
    "conceptId": [35805456],
    "regimenName": ["TC, then IE, VDoxoC, VEC"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Ifosfamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    },
    "Topotecan": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1378509],
      "conceptName": ["Topotecan"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Etoposide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    }
  },
  {
    "conceptId": [35806336],
    "regimenName": ["mCOP/MP"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Melphalan": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1301267],
      "conceptName": ["Melphalan"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "prednisolone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1550557],
      "conceptName": ["prednisolone"]
    }
  },
  {
    "conceptId": [35804622],
    "regimenName": ["Chlorambucil monotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Chlorambucil": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1390051],
      "conceptName": ["Chlorambucil"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Mitoxantrone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1309188],
      "conceptName": ["Mitoxantrone"]
    },
    "Dactinomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311443],
      "conceptName": ["Dactinomycin"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Bleomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1329241],
      "conceptName": ["Bleomycin"]
    },
    "arsenic trioxide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1333379],
      "conceptName": ["arsenic trioxide"]
    },
    "bortezomib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1336825],
      "conceptName": ["bortezomib"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Procarbazine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1351779],
      "conceptName": ["Procarbazine"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "prednisolone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1550557],
      "conceptName": ["prednisolone"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Vinblastine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008264],
      "conceptName": ["Vinblastine"]
    },
    "ofatumumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [40167582],
      "conceptName": ["ofatumumab"]
    },
    "obinutuzumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [44507676],
      "conceptName": ["obinutuzumab"]
    }
  },
  {
    "conceptId": [35807526],
    "regimenName": ["FOLFIRINOX/modified FOLFIRINOX plus /- Chemoradiation"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "oxaliplatin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1318011],
      "conceptName": ["oxaliplatin"]
    },
    "Leucovorin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1388796],
      "conceptName": ["Leucovorin"]
    },
    "irinotecan": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1367268],
      "conceptName": ["irinotecan"]
    },
    "Fluorouracil": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "gemcitabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314924],
      "conceptName": ["gemcitabine"]
    }
  },
  {
    "conceptId": [35804330],
    "regimenName": ["CMFL"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Methotrexate": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Leucovorin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1388796],
      "conceptName": ["Leucovorin"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Fluorouracil": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    }
  },
  {
    "conceptId": [35803697],
    "regimenName": ["CHOEP-14"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Prednisone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Etoposide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Bleomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1329241],
      "conceptName": ["Bleomycin"]
    },
    "Carboplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344905],
      "conceptName": ["Carboplatin"]
    },
    "Procarbazine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1351779],
      "conceptName": ["Procarbazine"]
    },
    "Mechlorethamine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1394337],
      "conceptName": ["Mechlorethamine"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "Vindesine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008336],
      "conceptName": ["Vindesine"]
    },
    "Ifosfamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    },
    "Teniposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19136750],
      "conceptName": ["Teniposide"]
    },
    "ranimustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [35197850],
      "conceptName": ["ranimustine"]
    }
  },
  {
    "conceptId": [35806593],
    "regimenName": ["PEFG"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Cisplatin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "Epirubicin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1344354],
      "conceptName": ["Epirubicin"]
    },
    "gemcitabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1314924],
      "conceptName": ["gemcitabine"]
    },
    "Fluorouracil": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    }
  },
  {
    "conceptId": [35806058],
    "regimenName": ["Melphalan, then auto HSCT"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Melphalan": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1301267],
      "conceptName": ["Melphalan"]
    },
    "Fluorouracil": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "alemtuzumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1312706],
      "conceptName": ["alemtuzumab"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Busulfan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1333357],
      "conceptName": ["Busulfan"]
    },
    "bortezomib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1336825],
      "conceptName": ["bortezomib"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Carmustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350066],
      "conceptName": ["Carmustine"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "fludarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1395557],
      "conceptName": ["fludarabine"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "Tamoxifen": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1436678],
      "conceptName": ["Tamoxifen"]
    },
    "Methylprednisolone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1506270],
      "conceptName": ["Methylprednisolone"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "prednisolone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1550557],
      "conceptName": ["prednisolone"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "bendamustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19015523],
      "conceptName": ["bendamustine"]
    },
    "lenalidomide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19026972],
      "conceptName": ["lenalidomide"]
    },
    "clofarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19054821],
      "conceptName": ["clofarabine"]
    },
    "ibritumomab tiuxetan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19068830],
      "conceptName": ["ibritumomab tiuxetan"]
    },
    "Thalidomide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19137042],
      "conceptName": ["Thalidomide"]
    },
    "daratumumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [35605744],
      "conceptName": ["daratumumab"]
    },
    "Fotemustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [36879099],
      "conceptName": ["Fotemustine"]
    },
    "carfilzomib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [42873638],
      "conceptName": ["carfilzomib"]
    }
  },
  {
    "conceptId": [35804567],
    "regimenName": ["Gemcitabine and nab-Paclitaxel"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Paclitaxel": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1378382],
      "conceptName": ["Paclitaxel"]
    },
    "gemcitabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1314924],
      "conceptName": ["gemcitabine"]
    },
    "oxaliplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1318011],
      "conceptName": ["oxaliplatin"]
    },
    "Carboplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344905],
      "conceptName": ["Carboplatin"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    }
  },
  {
    "conceptId": [35805790],
    "regimenName": ["TACE"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Carboplatin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1344905],
      "conceptName": ["Carboplatin"]
    },
    "Doxorubicin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Mitomycin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1389036],
      "conceptName": ["Mitomycin"]
    },
    "Epirubicin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1344354],
      "conceptName": ["Epirubicin"]
    }
  },
  {
    "conceptId": [35803625],
    "regimenName": ["Fludarabine, Busulfan, ATG, Ibritumomab tiuxetan"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "ibritumomab tiuxetan": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [19068830],
      "conceptName": ["ibritumomab tiuxetan"]
    },
    "Busulfan": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1333357],
      "conceptName": ["Busulfan"]
    },
    "rituximab": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "fludarabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1395557],
      "conceptName": ["fludarabine"]
    }
  },
  {
    "conceptId": [35803526],
    "regimenName": ["7 plus 5i"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Idarubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [19078097],
      "conceptName": ["Idarubicin"]
    },
    "Cytarabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Tretinoin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [903643],
      "conceptName": ["Tretinoin"]
    },
    "imatinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1304107],
      "conceptName": ["imatinib"]
    },
    "Filgrastim": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1304850],
      "conceptName": ["Filgrastim"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Mitoxantrone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1309188],
      "conceptName": ["Mitoxantrone"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Vorinostat": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1337651],
      "conceptName": ["Vorinostat"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "sorafenib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1363387],
      "conceptName": ["sorafenib"]
    },
    "Lomustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1391846],
      "conceptName": ["Lomustine"]
    },
    "fludarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1395557],
      "conceptName": ["fludarabine"]
    },
    "mercaptopurine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1436650],
      "conceptName": ["mercaptopurine"]
    },
    "Thioguanine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1437379],
      "conceptName": ["Thioguanine"]
    },
    "Pravastatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551860],
      "conceptName": ["Pravastatin"]
    },
    "lenograstim": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19009705],
      "conceptName": ["lenograstim"]
    },
    "clofarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19054821],
      "conceptName": ["clofarabine"]
    },
    "Norethandrolone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19128219],
      "conceptName": ["Norethandrolone"]
    },
    "panobinostat": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [46221435],
      "conceptName": ["panobinostat"]
    }
  },
  {
    "conceptId": [35803510],
    "regimenName": ["HiDAC and Midostaurin"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Cytarabine": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "midostaurin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1594003],
      "conceptName": ["midostaurin"]
    },
    "Daunorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311799],
      "conceptName": ["Daunorubicin"]
    }
  },
  {
    "conceptId": [35804372],
    "regimenName": ["BASIC"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Methotrexate": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "rituximab": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Prednisone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "Vindesine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008336],
      "conceptName": ["Vindesine"]
    },
    "Ifosfamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    },
    "Teniposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19136750],
      "conceptName": ["Teniposide"]
    }
  },
  {
    "conceptId": [35805337],
    "regimenName": ["ECX"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Cisplatin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "Epirubicin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1344354],
      "conceptName": ["Epirubicin"]
    },
    "capecitabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1337620],
      "conceptName": ["capecitabine"]
    }
  },
  {
    "conceptId": [35806493],
    "regimenName": ["CHAD"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Cisplatin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Altretamine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1368823],
      "conceptName": ["Altretamine"]
    }
  },
  {
    "conceptId": [35804140],
    "regimenName": ["Thiotepa monotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Thiotepa": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [19137385],
      "conceptName": ["Thiotepa"]
    },
    "Fluorouracil": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Busulfan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1333357],
      "conceptName": ["Busulfan"]
    },
    "Epirubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344354],
      "conceptName": ["Epirubicin"]
    },
    "Carboplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344905],
      "conceptName": ["Carboplatin"]
    },
    "Carmustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350066],
      "conceptName": ["Carmustine"]
    },
    "fludarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1395557],
      "conceptName": ["fludarabine"]
    }
  },
  {
    "conceptId": [35806290],
    "regimenName": ["VTP"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Thalidomide": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [19137042],
      "conceptName": ["Thalidomide"]
    },
    "bortezomib": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1336825],
      "conceptName": ["bortezomib"]
    },
    "Prednisone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Melphalan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1301267],
      "conceptName": ["Melphalan"]
    }
  },
  {
    "conceptId": [35807169],
    "regimenName": ["Thalidomide and Rituximab"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "rituximab": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Thalidomide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [19137042],
      "conceptName": ["Thalidomide"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Procarbazine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1351779],
      "conceptName": ["Procarbazine"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    }
  },
  {
    "conceptId": [35805076],
    "regimenName": ["Everolimus and Rituximab"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "everolimus": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [19011440],
      "conceptName": ["everolimus"]
    },
    "rituximab": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "bortezomib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1336825],
      "conceptName": ["bortezomib"]
    }
  },
  {
    "conceptId": [35804163],
    "regimenName": ["Docetaxel and Ramucirumab"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "docetaxel": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1315942],
      "conceptName": ["docetaxel"]
    },
    "ramucirumab": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [44818489],
      "conceptName": ["ramucirumab"]
    }
  },
  {
    "conceptId": [35803682],
    "regimenName": ["PCV"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Lomustine": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1391846],
      "conceptName": ["Lomustine"]
    },
    "Procarbazine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1351779],
      "conceptName": ["Procarbazine"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    }
  },
  {
    "conceptId": [35805052],
    "regimenName": ["O-DHAP"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Cisplatin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "ofatumumab": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [40167582],
      "conceptName": ["ofatumumab"]
    },
    "Cytarabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Dexamethasone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    }
  },
  {
    "conceptId": [35806083],
    "regimenName": ["maxi-R-CHOP/R-HiDAC"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "rituximab": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Cytarabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Prednisone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "Vindesine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008336],
      "conceptName": ["Vindesine"]
    },
    "Ifosfamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    },
    "Teniposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19136750],
      "conceptName": ["Teniposide"]
    }
  },
  {
    "conceptId": [35806978],
    "regimenName": ["Cyclophosphamide, Cytarabine, Mercaptopurine, Pegaspargase, Vincristine"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "pegaspargase": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1326481],
      "conceptName": ["pegaspargase"]
    },
    "Cytarabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "mercaptopurine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1436650],
      "conceptName": ["mercaptopurine"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "nelarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19002912],
      "conceptName": ["nelarabine"]
    }
  },
  {
    "conceptId": [35805829],
    "regimenName": ["BVB"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "bendamustine": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [19015523],
      "conceptName": ["bendamustine"]
    },
    "brentuximab vedotin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [40241969],
      "conceptName": ["brentuximab vedotin"]
    }
  },
  {
    "conceptId": [35806096],
    "regimenName": ["BDR"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "rituximab": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "bortezomib": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1336825],
      "conceptName": ["bortezomib"]
    },
    "Dexamethasone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Chlorambucil": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1390051],
      "conceptName": ["Chlorambucil"]
    }
  },
  {
    "conceptId": [35806491],
    "regimenName": ["Treosulfan monotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "treosulfan": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [19042545],
      "conceptName": ["treosulfan"]
    }
  },
  {
    "conceptId": [35805796],
    "regimenName": ["TACE, then 5-FU"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Fluorouracil": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "Melphalan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1301267],
      "conceptName": ["Melphalan"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Mitomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1389036],
      "conceptName": ["Mitomycin"]
    },
    "bevacizumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397141],
      "conceptName": ["bevacizumab"]
    },
    "Medroxyprogesterone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1500211],
      "conceptName": ["Medroxyprogesterone"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "BCG, Live, Tice Strain": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19086176],
      "conceptName": ["BCG, Live, Tice Strain"]
    },
    "Streptozocin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19136210],
      "conceptName": ["Streptozocin"]
    }
  },
  {
    "conceptId": [35806380],
    "regimenName": ["Fluorouracil and Streptozocin"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Streptozocin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [19136210],
      "conceptName": ["Streptozocin"]
    },
    "Fluorouracil": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    }
  },
  {
    "conceptId": [35805452],
    "regimenName": ["VAI"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Dactinomycin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1311443],
      "conceptName": ["Dactinomycin"]
    },
    "Ifosfamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "irinotecan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1367268],
      "conceptName": ["irinotecan"]
    }
  },
  {
    "conceptId": [35101978],
    "regimenName": ["ddAC-T"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Paclitaxel": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1378382],
      "conceptName": ["Paclitaxel"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    }
  },
  {
    "conceptId": [35804134],
    "regimenName": ["Doxorubicin monotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Fluorouracil": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "Melphalan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1301267],
      "conceptName": ["Melphalan"]
    },
    "imatinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1304107],
      "conceptName": ["imatinib"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Mitotane": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1309161],
      "conceptName": ["Mitotane"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Dacarbazine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311409],
      "conceptName": ["Dacarbazine"]
    },
    "Dactinomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311443],
      "conceptName": ["Dactinomycin"]
    },
    "alemtuzumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1312706],
      "conceptName": ["alemtuzumab"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "gemcitabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314924],
      "conceptName": ["gemcitabine"]
    },
    "docetaxel": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1315942],
      "conceptName": ["docetaxel"]
    },
    "pegaspargase": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1326481],
      "conceptName": ["pegaspargase"]
    },
    "Bleomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1329241],
      "conceptName": ["Bleomycin"]
    },
    "bortezomib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1336825],
      "conceptName": ["bortezomib"]
    },
    "Epirubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344354],
      "conceptName": ["Epirubicin"]
    },
    "Carboplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344905],
      "conceptName": ["Carboplatin"]
    },
    "Carmustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350066],
      "conceptName": ["Carmustine"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Procarbazine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1351779],
      "conceptName": ["Procarbazine"]
    },
    "Mesna": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1354698],
      "conceptName": ["Mesna"]
    },
    "dasatinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1358436],
      "conceptName": ["dasatinib"]
    },
    "irinotecan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1367268],
      "conceptName": ["irinotecan"]
    },
    "Altretamine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1368823],
      "conceptName": ["Altretamine"]
    },
    "Paclitaxel": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1378382],
      "conceptName": ["Paclitaxel"]
    },
    "Topotecan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1378509],
      "conceptName": ["Topotecan"]
    },
    "Interferon Alfa-2b": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1380068],
      "conceptName": ["Interferon Alfa-2b"]
    },
    "trastuzumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1387104],
      "conceptName": ["trastuzumab"]
    },
    "Mitomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1389036],
      "conceptName": ["Mitomycin"]
    },
    "Chlorambucil": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1390051],
      "conceptName": ["Chlorambucil"]
    },
    "Lomustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1391846],
      "conceptName": ["Lomustine"]
    },
    "Mechlorethamine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1394337],
      "conceptName": ["Mechlorethamine"]
    },
    "bevacizumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397141],
      "conceptName": ["bevacizumab"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "mercaptopurine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1436650],
      "conceptName": ["mercaptopurine"]
    },
    "Tamoxifen": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1436678],
      "conceptName": ["Tamoxifen"]
    },
    "Thioguanine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1437379],
      "conceptName": ["Thioguanine"]
    },
    "Medroxyprogesterone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1500211],
      "conceptName": ["Medroxyprogesterone"]
    },
    "Methylprednisolone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1506270],
      "conceptName": ["Methylprednisolone"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "prednisolone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1550557],
      "conceptName": ["prednisolone"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Hyaluronidase / rituximab Injection [Rituxan Hycela]": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1593155],
      "conceptName": ["Hyaluronidase / rituximab Injection [Rituxan Hycela]"]
    },
    "olaratumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1718346],
      "conceptName": ["olaratumab"]
    },
    "Quinine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1760616],
      "conceptName": ["Quinine"]
    },
    "Vinblastine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008264],
      "conceptName": ["Vinblastine"]
    },
    "Vindesine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008336],
      "conceptName": ["Vindesine"]
    },
    "everolimus": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19011440],
      "conceptName": ["everolimus"]
    },
    "ASPARAGINASE": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19012585],
      "conceptName": ["ASPARAGINASE"]
    },
    "lenalidomide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19026972],
      "conceptName": ["lenalidomide"]
    },
    "denileukin diftitox": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19051642],
      "conceptName": ["denileukin diftitox"]
    },
    "iodine-131-tositumomab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19054997],
      "conceptName": ["iodine-131-tositumomab"]
    },
    "Ifosfamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    },
    "BCG, Live, Tice Strain": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19086176],
      "conceptName": ["BCG, Live, Tice Strain"]
    },
    "Strontium-89": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19132890],
      "conceptName": ["Strontium-89"]
    },
    "Streptozocin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19136210],
      "conceptName": ["Streptozocin"]
    },
    "Teniposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19136750],
      "conceptName": ["Teniposide"]
    },
    "Thalidomide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19137042],
      "conceptName": ["Thalidomide"]
    },
    "ranimustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [35197850],
      "conceptName": ["ranimustine"]
    },
    "ofatumumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [40167582],
      "conceptName": ["ofatumumab"]
    },
    "brentuximab vedotin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [40241969],
      "conceptName": ["brentuximab vedotin"]
    },
    "ponatinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [43013182],
      "conceptName": ["ponatinib"]
    },
    "obinutuzumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [44507676],
      "conceptName": ["obinutuzumab"]
    }
  },
  {
    "conceptId": [35804819],
    "regimenName": ["Cisplatin and Doxorubicin"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Cisplatin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "Melphalan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1301267],
      "conceptName": ["Melphalan"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Mitotane": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1309161],
      "conceptName": ["Mitotane"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Dactinomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311443],
      "conceptName": ["Dactinomycin"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Bleomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1329241],
      "conceptName": ["Bleomycin"]
    },
    "bortezomib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1336825],
      "conceptName": ["bortezomib"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Mesna": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1354698],
      "conceptName": ["Mesna"]
    },
    "Altretamine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1368823],
      "conceptName": ["Altretamine"]
    },
    "Paclitaxel": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1378382],
      "conceptName": ["Paclitaxel"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Vinblastine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008264],
      "conceptName": ["Vinblastine"]
    },
    "Ifosfamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    },
    "Thalidomide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19137042],
      "conceptName": ["Thalidomide"]
    }
  },
  {
    "conceptId": [35803521],
    "regimenName": ["7 plus 3d (low-dose)"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Cytarabine": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Daunorubicin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1311799],
      "conceptName": ["Daunorubicin"]
    },
    "Tretinoin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [903643],
      "conceptName": ["Tretinoin"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Azacitidine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314865],
      "conceptName": ["Azacitidine"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "glasdegib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1355795],
      "conceptName": ["glasdegib"]
    },
    "sorafenib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1363387],
      "conceptName": ["sorafenib"]
    },
    "nilotinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1394023],
      "conceptName": ["nilotinib"]
    },
    "mercaptopurine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1436650],
      "conceptName": ["mercaptopurine"]
    },
    "Thioguanine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1437379],
      "conceptName": ["Thioguanine"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "prednisolone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1550557],
      "conceptName": ["prednisolone"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "midostaurin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1594003],
      "conceptName": ["midostaurin"]
    },
    "ASPARAGINASE": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19012585],
      "conceptName": ["ASPARAGINASE"]
    },
    "Cladribine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19054825],
      "conceptName": ["Cladribine"]
    },
    "Teniposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19136750],
      "conceptName": ["Teniposide"]
    },
    "Gemtuzumab ozogamicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [42799711],
      "conceptName": ["Gemtuzumab ozogamicin"]
    },
    "omacetaxine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [45775576],
      "conceptName": ["omacetaxine"]
    }
  },
  {
    "conceptId": [35804244],
    "regimenName": ["AT (Taxotere)"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "docetaxel": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1315942],
      "conceptName": ["docetaxel"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    }
  },
  {
    "conceptId": [35803435],
    "regimenName": ["HiDAC"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Cytarabine": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "inotuzumab ozogamicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [794068],
      "conceptName": ["inotuzumab ozogamicin"]
    },
    "Tretinoin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [903643],
      "conceptName": ["Tretinoin"]
    },
    "Fluorouracil": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "Melphalan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1301267],
      "conceptName": ["Melphalan"]
    },
    "imatinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1304107],
      "conceptName": ["imatinib"]
    },
    "Filgrastim": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1304850],
      "conceptName": ["Filgrastim"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Mitoxantrone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1309188],
      "conceptName": ["Mitoxantrone"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Daunorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311799],
      "conceptName": ["Daunorubicin"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Azacitidine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314865],
      "conceptName": ["Azacitidine"]
    },
    "oxaliplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1318011],
      "conceptName": ["oxaliplatin"]
    },
    "pegaspargase": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1326481],
      "conceptName": ["pegaspargase"]
    },
    "Bleomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1329241],
      "conceptName": ["Bleomycin"]
    },
    "Vorinostat": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1337651],
      "conceptName": ["Vorinostat"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Carboplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344905],
      "conceptName": ["Carboplatin"]
    },
    "Carmustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350066],
      "conceptName": ["Carmustine"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "glasdegib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1355795],
      "conceptName": ["glasdegib"]
    },
    "dasatinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1358436],
      "conceptName": ["dasatinib"]
    },
    "sorafenib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1363387],
      "conceptName": ["sorafenib"]
    },
    "Interferon Alfa-2b": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1380068],
      "conceptName": ["Interferon Alfa-2b"]
    },
    "Lomustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1391846],
      "conceptName": ["Lomustine"]
    },
    "nilotinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1394023],
      "conceptName": ["nilotinib"]
    },
    "fludarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1395557],
      "conceptName": ["fludarabine"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "mercaptopurine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1436650],
      "conceptName": ["mercaptopurine"]
    },
    "Thioguanine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1437379],
      "conceptName": ["Thioguanine"]
    },
    "Methylprednisolone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1506270],
      "conceptName": ["Methylprednisolone"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "prednisolone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1550557],
      "conceptName": ["prednisolone"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Pravastatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551860],
      "conceptName": ["Pravastatin"]
    },
    "midostaurin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1594003],
      "conceptName": ["midostaurin"]
    },
    "nelarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19002912],
      "conceptName": ["nelarabine"]
    },
    "Vindesine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008336],
      "conceptName": ["Vindesine"]
    },
    "lenograstim": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19009705],
      "conceptName": ["lenograstim"]
    },
    "everolimus": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19011440],
      "conceptName": ["everolimus"]
    },
    "ASPARAGINASE": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19012585],
      "conceptName": ["ASPARAGINASE"]
    },
    "bendamustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19015523],
      "conceptName": ["bendamustine"]
    },
    "Amsacrine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19017810],
      "conceptName": ["Amsacrine"]
    },
    "decitabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19024728],
      "conceptName": ["decitabine"]
    },
    "Daunorubicin Liposomal": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19051599],
      "conceptName": ["Daunorubicin Liposomal"]
    },
    "doxorubicin liposome": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19051649],
      "conceptName": ["doxorubicin liposome"]
    },
    "clofarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19054821],
      "conceptName": ["clofarabine"]
    },
    "Cladribine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19054825],
      "conceptName": ["Cladribine"]
    },
    "Aclarubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19057483],
      "conceptName": ["Aclarubicin"]
    },
    "ibritumomab tiuxetan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19068830],
      "conceptName": ["ibritumomab tiuxetan"]
    },
    "Idarubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078097],
      "conceptName": ["Idarubicin"]
    },
    "Ifosfamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    },
    "Norethandrolone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19128219],
      "conceptName": ["Norethandrolone"]
    },
    "Teniposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19136750],
      "conceptName": ["Teniposide"]
    },
    "Thiotepa": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19137385],
      "conceptName": ["Thiotepa"]
    },
    "venetoclax": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [35604205],
      "conceptName": ["venetoclax"]
    },
    "Fotemustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [36879099],
      "conceptName": ["Fotemustine"]
    },
    "ofatumumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [40167582],
      "conceptName": ["ofatumumab"]
    },
    "Cytarabine liposome": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [40175460],
      "conceptName": ["Cytarabine liposome"]
    },
    "Gemtuzumab ozogamicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [42799711],
      "conceptName": ["Gemtuzumab ozogamicin"]
    },
    "ponatinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [43013182],
      "conceptName": ["ponatinib"]
    },
    "omacetaxine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [45775576],
      "conceptName": ["omacetaxine"]
    },
    "panobinostat": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [46221435],
      "conceptName": ["panobinostat"]
    }
  },
  {
    "conceptId": [35804346],
    "regimenName": ["PF"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Melphalan": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1301267],
      "conceptName": ["Melphalan"]
    },
    "Fluorouracil": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Tamoxifen": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1436678],
      "conceptName": ["Tamoxifen"]
    }
  },
  {
    "conceptId": [35803511],
    "regimenName": ["7 plus 3d and Sorafenib"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Cytarabine": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Daunorubicin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1311799],
      "conceptName": ["Daunorubicin"]
    },
    "sorafenib": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1363387],
      "conceptName": ["sorafenib"]
    }
  },
  {
    "conceptId": [35806146],
    "regimenName": ["Cisplatin, Dacarbazine, Tamoxifen"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Cisplatin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "Tamoxifen": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1436678],
      "conceptName": ["Tamoxifen"]
    },
    "Dacarbazine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1311409],
      "conceptName": ["Dacarbazine"]
    }
  },
  {
    "conceptId": [35805106],
    "regimenName": ["PACEBOM"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Bleomycin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1329241],
      "conceptName": ["Bleomycin"]
    },
    "Methotrexate": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Etoposide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "prednisolone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1550557],
      "conceptName": ["prednisolone"]
    }
  },
  {
    "conceptId": [35805797],
    "regimenName": ["Cabozantinib monotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "cabozantinib": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [43012292],
      "conceptName": ["cabozantinib"]
    },
    "erlotinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1325363],
      "conceptName": ["erlotinib"]
    }
  },
  {
    "conceptId": [35806956],
    "regimenName": ["CEV (Cyclophosphamide/Epirubicin)"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Epirubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1344354],
      "conceptName": ["Epirubicin"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "prednisolone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1550557],
      "conceptName": ["prednisolone"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    }
  },
  {
    "conceptId": [35806382],
    "regimenName": ["Lanreotide monotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "lanreotide": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1503501],
      "conceptName": ["lanreotide"]
    },
    "Interferon Alfa-2b": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1380068],
      "conceptName": ["Interferon Alfa-2b"]
    }
  },
  {
    "conceptId": [35804286],
    "regimenName": ["Letrozole and Bevacizumab"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "bevacizumab": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1397141],
      "conceptName": ["bevacizumab"]
    },
    "letrozole": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1315946],
      "conceptName": ["letrozole"]
    }
  },
  {
    "conceptId": [35805088],
    "regimenName": ["CAP-BOP"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Bleomycin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1329241],
      "conceptName": ["Bleomycin"]
    },
    "Prednisone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Procarbazine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1351779],
      "conceptName": ["Procarbazine"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Dacarbazine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311409],
      "conceptName": ["Dacarbazine"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Vinblastine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008264],
      "conceptName": ["Vinblastine"]
    }
  },
  {
    "conceptId": [35804335],
    "regimenName": ["CMFVP"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Methotrexate": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Prednisone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Fluorouracil": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    }
  },
  {
    "conceptId": [35806277],
    "regimenName": ["PAD doxil"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "doxorubicin liposome": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [19051649],
      "conceptName": ["doxorubicin liposome"]
    },
    "bortezomib": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1336825],
      "conceptName": ["bortezomib"]
    },
    "Dexamethasone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    }
  },
  {
    "conceptId": [35806328],
    "regimenName": ["FRD"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "panobinostat": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [46221435],
      "conceptName": ["panobinostat"]
    },
    "lenalidomide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [19026972],
      "conceptName": ["lenalidomide"]
    },
    "Dexamethasone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    }
  },
  {
    "conceptId": [35804421],
    "regimenName": ["MPV"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Methotrexate": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Procarbazine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1351779],
      "conceptName": ["Procarbazine"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Mechlorethamine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1394337],
      "conceptName": ["Mechlorethamine"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    }
  },
  {
    "conceptId": [35806432],
    "regimenName": ["MVP and RT"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Mitomycin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1389036],
      "conceptName": ["Mitomycin"]
    },
    "Cisplatin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "Vindesine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [19008336],
      "conceptName": ["Vindesine"]
    }
  },
  {
    "conceptId": [35805778],
    "regimenName": ["CABO"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Bleomycin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1329241],
      "conceptName": ["Bleomycin"]
    },
    "Methotrexate": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Cisplatin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    }
  },
  {
    "conceptId": [35804791],
    "regimenName": ["CapeOx and Panitumumab"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "oxaliplatin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1318011],
      "conceptName": ["oxaliplatin"]
    },
    "panitumumab": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [19100985],
      "conceptName": ["panitumumab"]
    },
    "capecitabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1337620],
      "conceptName": ["capecitabine"]
    }
  },
  {
    "conceptId": [35806839],
    "regimenName": ["ADT, Docetaxel, Estramustine"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Estramustine": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1349025],
      "conceptName": ["Estramustine"]
    },
    "docetaxel": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1315942],
      "conceptName": ["docetaxel"]
    }
  },
  {
    "conceptId": [35805049],
    "regimenName": ["ACE"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Etoposide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Melphalan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1301267],
      "conceptName": ["Melphalan"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Dactinomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311443],
      "conceptName": ["Dactinomycin"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Bleomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1329241],
      "conceptName": ["Bleomycin"]
    },
    "bortezomib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1336825],
      "conceptName": ["bortezomib"]
    },
    "Carboplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344905],
      "conceptName": ["Carboplatin"]
    },
    "Procarbazine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1351779],
      "conceptName": ["Procarbazine"]
    },
    "irinotecan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1367268],
      "conceptName": ["irinotecan"]
    },
    "Topotecan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1378509],
      "conceptName": ["Topotecan"]
    },
    "Mechlorethamine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1394337],
      "conceptName": ["Mechlorethamine"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "prednisolone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1550557],
      "conceptName": ["prednisolone"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Vindesine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008336],
      "conceptName": ["Vindesine"]
    },
    "Ifosfamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    },
    "Teniposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19136750],
      "conceptName": ["Teniposide"]
    },
    "Thalidomide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19137042],
      "conceptName": ["Thalidomide"]
    },
    "ranimustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [35197850],
      "conceptName": ["ranimustine"]
    }
  },
  {
    "conceptId": [35804254],
    "regimenName": ["MC"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Myocet": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [21017157],
      "conceptName": ["Myocet"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    }
  },
  {
    "conceptId": [35805754],
    "regimenName": ["R-EPOCH, dose-escalated"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "rituximab": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Prednisone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Etoposide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "Vindesine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008336],
      "conceptName": ["Vindesine"]
    },
    "Ifosfamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    },
    "Teniposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19136750],
      "conceptName": ["Teniposide"]
    }
  },
  {
    "conceptId": [35805469],
    "regimenName": ["AspaMetDex"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Methotrexate": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "ASPARAGINASE": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [19012585],
      "conceptName": ["ASPARAGINASE"]
    },
    "Dexamethasone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Mesna": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1354698],
      "conceptName": ["Mesna"]
    },
    "mercaptopurine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1436650],
      "conceptName": ["mercaptopurine"]
    },
    "Thioguanine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1437379],
      "conceptName": ["Thioguanine"]
    },
    "Ifosfamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    }
  },
  {
    "conceptId": [35804088],
    "regimenName": ["Cytarabine, Daunorubicin, L-Asparaginase, Vincristine, Dexamethasone"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "ASPARAGINASE": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [19012585],
      "conceptName": ["ASPARAGINASE"]
    },
    "Cytarabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Daunorubicin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1311799],
      "conceptName": ["Daunorubicin"]
    },
    "Dexamethasone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    }
  },
  {
    "conceptId": [35804164],
    "regimenName": ["Durvalumab monotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "durvalumab": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1594034],
      "conceptName": ["durvalumab"]
    }
  },
  {
    "conceptId": [35804813],
    "regimenName": ["Bexarotene and Pralatrexate"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Pralatrexate": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [40166461],
      "conceptName": ["Pralatrexate"]
    },
    "bexarotene": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1389888],
      "conceptName": ["bexarotene"]
    }
  },
  {
    "conceptId": [35805684],
    "regimenName": ["Paclitaxel and S-1"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Paclitaxel": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1378382],
      "conceptName": ["Paclitaxel"]
    },
    "Hyaluronidase / trastuzumab Injection [Herceptin Hylecta]": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1366689],
      "conceptName": ["Hyaluronidase / trastuzumab Injection [Herceptin Hylecta]"]
    }
  },
  {
    "conceptId": [35805331],
    "regimenName": ["Fluorouracil, Paclitaxel, RT"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Paclitaxel": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1378382],
      "conceptName": ["Paclitaxel"]
    },
    "Fluorouracil": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    }
  },
  {
    "conceptId": [35805086],
    "regimenName": ["ACOMLA"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Methotrexate": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Cytarabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Fluorouracil": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "imatinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1304107],
      "conceptName": ["imatinib"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Bleomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1329241],
      "conceptName": ["Bleomycin"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "dasatinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1358436],
      "conceptName": ["dasatinib"]
    },
    "mercaptopurine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1436650],
      "conceptName": ["mercaptopurine"]
    },
    "Thioguanine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1437379],
      "conceptName": ["Thioguanine"]
    },
    "Methylprednisolone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1506270],
      "conceptName": ["Methylprednisolone"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Vindesine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008336],
      "conceptName": ["Vindesine"]
    },
    "everolimus": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19011440],
      "conceptName": ["everolimus"]
    },
    "ASPARAGINASE": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19012585],
      "conceptName": ["ASPARAGINASE"]
    },
    "Ifosfamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    },
    "Teniposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19136750],
      "conceptName": ["Teniposide"]
    },
    "ponatinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [43013182],
      "conceptName": ["ponatinib"]
    }
  },
  {
    "conceptId": [35805852],
    "regimenName": ["MOPP/ABVD"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Bleomycin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1329241],
      "conceptName": ["Bleomycin"]
    },
    "Prednisone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Vinblastine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [19008264],
      "conceptName": ["Vinblastine"]
    },
    "Dacarbazine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1311409],
      "conceptName": ["Dacarbazine"]
    },
    "Procarbazine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1351779],
      "conceptName": ["Procarbazine"]
    },
    "Mechlorethamine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1394337],
      "conceptName": ["Mechlorethamine"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    }
  },
  {
    "conceptId": [35804211],
    "regimenName": ["EC"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Epirubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1344354],
      "conceptName": ["Epirubicin"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Fluorouracil": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Bleomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1329241],
      "conceptName": ["Bleomycin"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Paclitaxel": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1378382],
      "conceptName": ["Paclitaxel"]
    },
    "trastuzumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1387104],
      "conceptName": ["trastuzumab"]
    },
    "Lomustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1391846],
      "conceptName": ["Lomustine"]
    },
    "bevacizumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397141],
      "conceptName": ["bevacizumab"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "prednisolone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1550557],
      "conceptName": ["prednisolone"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Vinblastine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008264],
      "conceptName": ["Vinblastine"]
    },
    "Vindesine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008336],
      "conceptName": ["Vindesine"]
    },
    "Thiotepa": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19137385],
      "conceptName": ["Thiotepa"]
    }
  },
  {
    "conceptId": [35803465],
    "regimenName": ["Azacitidine monotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Azacitidine": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1314865],
      "conceptName": ["Azacitidine"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Daunorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311799],
      "conceptName": ["Daunorubicin"]
    },
    "Vorinostat": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1337651],
      "conceptName": ["Vorinostat"]
    },
    "sorafenib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1363387],
      "conceptName": ["sorafenib"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "lenalidomide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19026972],
      "conceptName": ["lenalidomide"]
    },
    "venetoclax": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [35604205],
      "conceptName": ["venetoclax"]
    },
    "Gemtuzumab ozogamicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [42799711],
      "conceptName": ["Gemtuzumab ozogamicin"]
    }
  },
  {
    "conceptId": [35806960],
    "regimenName": ["PCDE"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Cisplatin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "Epirubicin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1344354],
      "conceptName": ["Epirubicin"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Etoposide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Lomustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1391846],
      "conceptName": ["Lomustine"]
    }
  },
  {
    "conceptId": [35807019],
    "regimenName": ["M-TIP"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Paclitaxel": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1378382],
      "conceptName": ["Paclitaxel"]
    },
    "Methotrexate": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Cisplatin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "Ifosfamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    }
  },
  {
    "conceptId": [35804221],
    "regimenName": ["Tamoxifen monotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Tamoxifen": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1436678],
      "conceptName": ["Tamoxifen"]
    },
    "Fluorouracil": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "Megestrol": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1300978],
      "conceptName": ["Megestrol"]
    },
    "Melphalan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1301267],
      "conceptName": ["Melphalan"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Dacarbazine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311409],
      "conceptName": ["Dacarbazine"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Goserelin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1366310],
      "conceptName": ["Goserelin"]
    },
    "trastuzumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1387104],
      "conceptName": ["trastuzumab"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "Medroxyprogesterone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1500211],
      "conceptName": ["Medroxyprogesterone"]
    },
    "Aminoglutethimide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1503057],
      "conceptName": ["Aminoglutethimide"]
    },
    "Danazol": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1511449],
      "conceptName": ["Danazol"]
    },
    "prednisolone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1550557],
      "conceptName": ["prednisolone"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "ribociclib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1592911],
      "conceptName": ["ribociclib"]
    },
    "everolimus": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19011440],
      "conceptName": ["everolimus"]
    },
    "ado-trastuzumab emtansine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [43525787],
      "conceptName": ["ado-trastuzumab emtansine"]
    }
  },
  {
    "conceptId": [35806126],
    "regimenName": ["CVD (Vindesine)"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Cisplatin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "Vindesine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [19008336],
      "conceptName": ["Vindesine"]
    },
    "Dacarbazine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1311409],
      "conceptName": ["Dacarbazine"]
    }
  },
  {
    "conceptId": [35804298],
    "regimenName": ["ECH"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "trastuzumab": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1387104],
      "conceptName": ["trastuzumab"]
    },
    "Epirubicin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1344354],
      "conceptName": ["Epirubicin"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Fluorouracil": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    }
  },
  {
    "conceptId": [35804643],
    "regimenName": ["Azacitidine and Lenalidomide"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Azacitidine": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1314865],
      "conceptName": ["Azacitidine"]
    },
    "lenalidomide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [19026972],
      "conceptName": ["lenalidomide"]
    }
  },
  {
    "conceptId": [35804285],
    "regimenName": ["Fulvestrant and Ribociclib"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "ribociclib": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1592911],
      "conceptName": ["ribociclib"]
    },
    "fulvestrant": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1304044],
      "conceptName": ["fulvestrant"]
    }
  },
  {
    "conceptId": [35805084],
    "regimenName": ["TTR"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Paclitaxel": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1378382],
      "conceptName": ["Paclitaxel"]
    },
    "rituximab": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Topotecan": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1378509],
      "conceptName": ["Topotecan"]
    }
  },
  {
    "conceptId": [35803540],
    "regimenName": ["Vorinostat monotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Vorinostat": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1337651],
      "conceptName": ["Vorinostat"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Azacitidine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314865],
      "conceptName": ["Azacitidine"]
    },
    "bortezomib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1336825],
      "conceptName": ["bortezomib"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "lenalidomide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19026972],
      "conceptName": ["lenalidomide"]
    },
    "Sirolimus": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19034726],
      "conceptName": ["Sirolimus"]
    },
    "Idarubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078097],
      "conceptName": ["Idarubicin"]
    },
    "Gemtuzumab ozogamicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [42799711],
      "conceptName": ["Gemtuzumab ozogamicin"]
    }
  },
  {
    "conceptId": [35804209],
    "regimenName": ["Paclitaxel monotherapy, dose-dense (q2wk)"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Paclitaxel": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1378382],
      "conceptName": ["Paclitaxel"]
    },
    "neratinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [793846],
      "conceptName": ["neratinib"]
    },
    "Fluorouracil": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Dacarbazine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311409],
      "conceptName": ["Dacarbazine"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "gemcitabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314924],
      "conceptName": ["gemcitabine"]
    },
    "oxaliplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1318011],
      "conceptName": ["oxaliplatin"]
    },
    "capecitabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1337620],
      "conceptName": ["capecitabine"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "vinorelbine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1343346],
      "conceptName": ["vinorelbine"]
    },
    "Epirubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344354],
      "conceptName": ["Epirubicin"]
    },
    "Carboplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344905],
      "conceptName": ["Carboplatin"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "lapatinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1359548],
      "conceptName": ["lapatinib"]
    },
    "Hyaluronidase / trastuzumab Injection [Herceptin Hylecta]": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1366689],
      "conceptName": ["Hyaluronidase / trastuzumab Injection [Herceptin Hylecta]"]
    },
    "Topotecan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1378509],
      "conceptName": ["Topotecan"]
    },
    "trastuzumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1387104],
      "conceptName": ["trastuzumab"]
    },
    "bevacizumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397141],
      "conceptName": ["bevacizumab"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "Ifosfamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    },
    "pazopanib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [40167554],
      "conceptName": ["pazopanib"]
    },
    "ipilimumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [40238188],
      "conceptName": ["ipilimumab"]
    },
    "atezolizumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [42629079],
      "conceptName": ["atezolizumab"]
    },
    "pertuzumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [42801287],
      "conceptName": ["pertuzumab"]
    },
    "ado-trastuzumab emtansine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [43525787],
      "conceptName": ["ado-trastuzumab emtansine"]
    },
    "Afatinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [43533090],
      "conceptName": ["Afatinib"]
    },
    "ramucirumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [44818489],
      "conceptName": ["ramucirumab"]
    },
    "pembrolizumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [45775965],
      "conceptName": ["pembrolizumab"]
    },
    "olaparib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [45892579],
      "conceptName": ["olaparib"]
    }
  },
  {
    "conceptId": [35803518],
    "regimenName": ["Enasidenib monotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "enasidenib": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [793797],
      "conceptName": ["enasidenib"]
    }
  },
  {
    "conceptId": [35805755],
    "regimenName": ["SC-EPOCH-RR"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "rituximab": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Prednisone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Etoposide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "Vindesine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008336],
      "conceptName": ["Vindesine"]
    },
    "Ifosfamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    },
    "Teniposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19136750],
      "conceptName": ["Teniposide"]
    }
  },
  {
    "conceptId": [35805031],
    "regimenName": ["R-CHOP-14"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "rituximab": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Prednisone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "bortezomib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1336825],
      "conceptName": ["bortezomib"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "Hyaluronidase / rituximab Injection [Rituxan Hycela]": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1593155],
      "conceptName": ["Hyaluronidase / rituximab Injection [Rituxan Hycela]"]
    },
    "Vindesine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008336],
      "conceptName": ["Vindesine"]
    },
    "lenalidomide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19026972],
      "conceptName": ["lenalidomide"]
    },
    "Ifosfamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    },
    "Teniposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19136750],
      "conceptName": ["Teniposide"]
    }
  },
  {
    "conceptId": [35806466],
    "regimenName": ["Cisplatin, Epirubicin, Ifosfamide"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Cisplatin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "Ifosfamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    },
    "Epirubicin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1344354],
      "conceptName": ["Epirubicin"]
    },
    "Mesna": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1354698],
      "conceptName": ["Mesna"]
    }
  },
  {
    "conceptId": [35804794],
    "regimenName": ["FOLFOX4 and Panitumumab"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "oxaliplatin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1318011],
      "conceptName": ["oxaliplatin"]
    },
    "panitumumab": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [19100985],
      "conceptName": ["panitumumab"]
    },
    "Leucovorin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1388796],
      "conceptName": ["Leucovorin"]
    },
    "Fluorouracil": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    }
  },
  {
    "conceptId": [35805072],
    "regimenName": ["LEED, then auto HSCT"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Melphalan": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1301267],
      "conceptName": ["Melphalan"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Dexamethasone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "Etoposide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "bortezomib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1336825],
      "conceptName": ["bortezomib"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "Thalidomide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19137042],
      "conceptName": ["Thalidomide"]
    }
  },
  {
    "conceptId": [35805117],
    "regimenName": ["EPIC regimen"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Carboplatin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1344905],
      "conceptName": ["Carboplatin"]
    },
    "Ifosfamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    },
    "Etoposide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "prednisolone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1550557],
      "conceptName": ["prednisolone"]
    }
  },
  {
    "conceptId": [35804358],
    "regimenName": ["Fluoxymesterone monotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Fluoxymesterone": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1555887],
      "conceptName": ["Fluoxymesterone"]
    }
  },
  {
    "conceptId": [35804821],
    "regimenName": ["Vismodegib monotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "vismodegib": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [42709321],
      "conceptName": ["vismodegib"]
    }
  },
  {
    "conceptId": [35804251],
    "regimenName": ["Epirubicin and Vinorelbine"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Epirubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1344354],
      "conceptName": ["Epirubicin"]
    },
    "vinorelbine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1343346],
      "conceptName": ["vinorelbine"]
    }
  },
  {
    "conceptId": [35804534],
    "regimenName": ["Fluorouracil and RT"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Fluorouracil": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "Melphalan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1301267],
      "conceptName": ["Melphalan"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Mitoxantrone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1309188],
      "conceptName": ["Mitoxantrone"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "gemcitabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314924],
      "conceptName": ["gemcitabine"]
    },
    "cetuximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1315411],
      "conceptName": ["cetuximab"]
    },
    "docetaxel": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1315942],
      "conceptName": ["docetaxel"]
    },
    "oxaliplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1318011],
      "conceptName": ["oxaliplatin"]
    },
    "capecitabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1337620],
      "conceptName": ["capecitabine"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Epirubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344354],
      "conceptName": ["Epirubicin"]
    },
    "Carboplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344905],
      "conceptName": ["Carboplatin"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "irinotecan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1367268],
      "conceptName": ["irinotecan"]
    },
    "Altretamine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1368823],
      "conceptName": ["Altretamine"]
    },
    "hydroxyurea": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1377141],
      "conceptName": ["hydroxyurea"]
    },
    "Paclitaxel": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1378382],
      "conceptName": ["Paclitaxel"]
    },
    "trastuzumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1387104],
      "conceptName": ["trastuzumab"]
    },
    "Leucovorin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1388796],
      "conceptName": ["Leucovorin"]
    },
    "Mitomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1389036],
      "conceptName": ["Mitomycin"]
    },
    "Levamisole": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1389464],
      "conceptName": ["Levamisole"]
    },
    "bevacizumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397141],
      "conceptName": ["bevacizumab"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "Tamoxifen": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1436678],
      "conceptName": ["Tamoxifen"]
    },
    "Medroxyprogesterone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1500211],
      "conceptName": ["Medroxyprogesterone"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "doxorubicin liposome": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19051649],
      "conceptName": ["doxorubicin liposome"]
    },
    "BCG, Live, Tice Strain": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19086176],
      "conceptName": ["BCG, Live, Tice Strain"]
    },
    "panitumumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19100985],
      "conceptName": ["panitumumab"]
    },
    "Streptozocin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19136210],
      "conceptName": ["Streptozocin"]
    },
    "Thiotepa": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19137385],
      "conceptName": ["Thiotepa"]
    },
    "irinotecan liposomal": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [35603068],
      "conceptName": ["irinotecan liposomal"]
    },
    "levoleucovorin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [40168303],
      "conceptName": ["levoleucovorin"]
    },
    "aflibercept": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [40244266],
      "conceptName": ["aflibercept"]
    },
    "ramucirumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [44818489],
      "conceptName": ["ramucirumab"]
    }
  },
  {
    "conceptId": [35806312],
    "regimenName": ["Dara-Vd"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "daratumumab": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [35605744],
      "conceptName": ["daratumumab"]
    },
    "bortezomib": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1336825],
      "conceptName": ["bortezomib"]
    },
    "Dexamethasone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "Thalidomide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19137042],
      "conceptName": ["Thalidomide"]
    }
  },
  {
    "conceptId": [35805814],
    "regimenName": ["C-MOPP/ABV"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Bleomycin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1329241],
      "conceptName": ["Bleomycin"]
    },
    "Prednisone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Vinblastine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [19008264],
      "conceptName": ["Vinblastine"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Procarbazine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1351779],
      "conceptName": ["Procarbazine"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Dacarbazine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311409],
      "conceptName": ["Dacarbazine"]
    }
  },
  {
    "conceptId": [35805121],
    "regimenName": ["VIPD"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Cisplatin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "Ifosfamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    },
    "Dexamethasone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "Etoposide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    }
  },
  {
    "conceptId": [35804373],
    "regimenName": ["CALGB 10-002 regimen"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Methotrexate": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Ifosfamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    },
    "rituximab": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Cytarabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Dexamethasone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "Etoposide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Vindesine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008336],
      "conceptName": ["Vindesine"]
    },
    "Teniposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19136750],
      "conceptName": ["Teniposide"]
    }
  },
  {
    "conceptId": [35806384],
    "regimenName": ["Octreotide monotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Octreotide": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1522957],
      "conceptName": ["Octreotide"]
    },
    "Interferon Alfa-2b": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1380068],
      "conceptName": ["Interferon Alfa-2b"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "everolimus": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19011440],
      "conceptName": ["everolimus"]
    },
    "Lutetium": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [44816340],
      "conceptName": ["Lutetium"]
    }
  },
  {
    "conceptId": [35806413],
    "regimenName": ["Gefitinib monotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "gefitinib": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1319193],
      "conceptName": ["gefitinib"]
    },
    "pemetrexed": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1304919],
      "conceptName": ["pemetrexed"]
    }
  },
  {
    "conceptId": [35804376],
    "regimenName": ["COPAD"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Prednisone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Fluorouracil": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "Melphalan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1301267],
      "conceptName": ["Melphalan"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Dacarbazine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311409],
      "conceptName": ["Dacarbazine"]
    },
    "alemtuzumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1312706],
      "conceptName": ["alemtuzumab"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Bleomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1329241],
      "conceptName": ["Bleomycin"]
    },
    "bortezomib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1336825],
      "conceptName": ["bortezomib"]
    },
    "Carboplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344905],
      "conceptName": ["Carboplatin"]
    },
    "Carmustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350066],
      "conceptName": ["Carmustine"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Procarbazine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1351779],
      "conceptName": ["Procarbazine"]
    },
    "Mechlorethamine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1394337],
      "conceptName": ["Mechlorethamine"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "Hyaluronidase / rituximab Injection [Rituxan Hycela]": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1593155],
      "conceptName": ["Hyaluronidase / rituximab Injection [Rituxan Hycela]"]
    },
    "Vinblastine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008264],
      "conceptName": ["Vinblastine"]
    },
    "Vindesine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008336],
      "conceptName": ["Vindesine"]
    },
    "everolimus": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19011440],
      "conceptName": ["everolimus"]
    },
    "lenalidomide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19026972],
      "conceptName": ["lenalidomide"]
    },
    "denileukin diftitox": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19051642],
      "conceptName": ["denileukin diftitox"]
    },
    "iodine-131-tositumomab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19054997],
      "conceptName": ["iodine-131-tositumomab"]
    },
    "Ifosfamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    },
    "BCG, Live, Tice Strain": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19086176],
      "conceptName": ["BCG, Live, Tice Strain"]
    },
    "Teniposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19136750],
      "conceptName": ["Teniposide"]
    },
    "ranimustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [35197850],
      "conceptName": ["ranimustine"]
    },
    "ofatumumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [40167582],
      "conceptName": ["ofatumumab"]
    },
    "obinutuzumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [44507676],
      "conceptName": ["obinutuzumab"]
    }
  },
  {
    "conceptId": [35804426],
    "regimenName": ["R-MCP"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Chlorambucil": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1390051],
      "conceptName": ["Chlorambucil"]
    },
    "rituximab": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Mitoxantrone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1309188],
      "conceptName": ["Mitoxantrone"]
    },
    "prednisolone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1550557],
      "conceptName": ["prednisolone"]
    }
  },
  {
    "conceptId": [35804273],
    "regimenName": ["Letrozole monotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "letrozole": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1315946],
      "conceptName": ["letrozole"]
    },
    "abemaciclib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [792649],
      "conceptName": ["abemaciclib"]
    },
    "lapatinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1359548],
      "conceptName": ["lapatinib"]
    },
    "trastuzumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1387104],
      "conceptName": ["trastuzumab"]
    },
    "bevacizumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397141],
      "conceptName": ["bevacizumab"]
    },
    "ribociclib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1592911],
      "conceptName": ["ribociclib"]
    },
    "palbociclib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [45892075],
      "conceptName": ["palbociclib"]
    }
  },
  {
    "conceptId": [35806396],
    "regimenName": ["Cisplatin and Vinblastine"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Cisplatin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "Vinblastine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [19008264],
      "conceptName": ["Vinblastine"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Aldesleukin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1309770],
      "conceptName": ["Aldesleukin"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Dacarbazine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311409],
      "conceptName": ["Dacarbazine"]
    },
    "Bleomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1329241],
      "conceptName": ["Bleomycin"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Interferon Alfa-2b": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1380068],
      "conceptName": ["Interferon Alfa-2b"]
    },
    "Mitomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1389036],
      "conceptName": ["Mitomycin"]
    },
    "Ifosfamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    }
  },
  {
    "conceptId": [35806079],
    "regimenName": ["DexaBEAM and G-CSF"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Carmustine": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1350066],
      "conceptName": ["Carmustine"]
    },
    "Melphalan": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1301267],
      "conceptName": ["Melphalan"]
    },
    "Cytarabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Dexamethasone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "Etoposide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    }
  },
  {
    "conceptId": [35806347],
    "regimenName": ["Melphalan, then auto HSCT, then Melphalan and Busulfan, then auto HSCT"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Melphalan": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1301267],
      "conceptName": ["Melphalan"]
    },
    "Busulfan": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1333357],
      "conceptName": ["Busulfan"]
    },
    "fludarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1395557],
      "conceptName": ["fludarabine"]
    }
  },
  {
    "conceptId": [35804633],
    "regimenName": ["Imatinib and LoDAC"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Cytarabine": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "imatinib": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1304107],
      "conceptName": ["imatinib"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Mitoxantrone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1309188],
      "conceptName": ["Mitoxantrone"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "mercaptopurine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1436650],
      "conceptName": ["mercaptopurine"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "Idarubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078097],
      "conceptName": ["Idarubicin"]
    }
  },
  {
    "conceptId": [35803442],
    "regimenName": ["Cytarabine and Daunorubicin"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Cytarabine": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Daunorubicin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1311799],
      "conceptName": ["Daunorubicin"]
    },
    "Tretinoin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [903643],
      "conceptName": ["Tretinoin"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Azacitidine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314865],
      "conceptName": ["Azacitidine"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "glasdegib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1355795],
      "conceptName": ["glasdegib"]
    },
    "sorafenib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1363387],
      "conceptName": ["sorafenib"]
    },
    "nilotinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1394023],
      "conceptName": ["nilotinib"]
    },
    "mercaptopurine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1436650],
      "conceptName": ["mercaptopurine"]
    },
    "Thioguanine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1437379],
      "conceptName": ["Thioguanine"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "prednisolone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1550557],
      "conceptName": ["prednisolone"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "midostaurin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1594003],
      "conceptName": ["midostaurin"]
    },
    "ASPARAGINASE": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19012585],
      "conceptName": ["ASPARAGINASE"]
    },
    "Cladribine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19054825],
      "conceptName": ["Cladribine"]
    },
    "Teniposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19136750],
      "conceptName": ["Teniposide"]
    },
    "Gemtuzumab ozogamicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [42799711],
      "conceptName": ["Gemtuzumab ozogamicin"]
    },
    "omacetaxine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [45775576],
      "conceptName": ["omacetaxine"]
    }
  },
  {
    "conceptId": [35806053],
    "regimenName": ["Rd"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "lenalidomide": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [19026972],
      "conceptName": ["lenalidomide"]
    },
    "Dexamethasone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "Melphalan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1301267],
      "conceptName": ["Melphalan"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "bortezomib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1336825],
      "conceptName": ["bortezomib"]
    },
    "Vorinostat": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1337651],
      "conceptName": ["Vorinostat"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Clarithromycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1750500],
      "conceptName": ["Clarithromycin"]
    },
    "bendamustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19015523],
      "conceptName": ["bendamustine"]
    },
    "elotuzumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [35604032],
      "conceptName": ["elotuzumab"]
    },
    "daratumumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [35605744],
      "conceptName": ["daratumumab"]
    },
    "ixazomib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [35606214],
      "conceptName": ["ixazomib"]
    },
    "carfilzomib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [42873638],
      "conceptName": ["carfilzomib"]
    },
    "panobinostat": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [46221435],
      "conceptName": ["panobinostat"]
    }
  },
  {
    "conceptId": [35807167],
    "regimenName": ["CaRD"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "rituximab": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "carfilzomib": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [42873638],
      "conceptName": ["carfilzomib"]
    },
    "Dexamethasone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    }
  },
  {
    "conceptId": [35806176],
    "regimenName": ["Gemcitabine and Vinorelbine"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "vinorelbine": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1343346],
      "conceptName": ["vinorelbine"]
    },
    "gemcitabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1314924],
      "conceptName": ["gemcitabine"]
    },
    "prednisolone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1550557],
      "conceptName": ["prednisolone"]
    },
    "bendamustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19015523],
      "conceptName": ["bendamustine"]
    },
    "doxorubicin liposome": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19051649],
      "conceptName": ["doxorubicin liposome"]
    },
    "Ifosfamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    }
  },
  {
    "conceptId": [35805463],
    "regimenName": ["DEP and RT"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Cisplatin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "Dexamethasone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "Etoposide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Melphalan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1301267],
      "conceptName": ["Melphalan"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "bortezomib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1336825],
      "conceptName": ["bortezomib"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Ifosfamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    },
    "Thalidomide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19137042],
      "conceptName": ["Thalidomide"]
    }
  },
  {
    "conceptId": [35806356],
    "regimenName": ["VAD and Cyclosporine"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Dexamethasone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Melphalan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1301267],
      "conceptName": ["Melphalan"]
    },
    "imatinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1304107],
      "conceptName": ["imatinib"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "pegaspargase": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1326481],
      "conceptName": ["pegaspargase"]
    },
    "Bleomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1329241],
      "conceptName": ["Bleomycin"]
    },
    "bortezomib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1336825],
      "conceptName": ["bortezomib"]
    },
    "Carmustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350066],
      "conceptName": ["Carmustine"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "dasatinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1358436],
      "conceptName": ["dasatinib"]
    },
    "Chlorambucil": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1390051],
      "conceptName": ["Chlorambucil"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "mercaptopurine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1436650],
      "conceptName": ["mercaptopurine"]
    },
    "Thioguanine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1437379],
      "conceptName": ["Thioguanine"]
    },
    "Methylprednisolone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1506270],
      "conceptName": ["Methylprednisolone"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Quinine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1760616],
      "conceptName": ["Quinine"]
    },
    "Vindesine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008336],
      "conceptName": ["Vindesine"]
    },
    "everolimus": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19011440],
      "conceptName": ["everolimus"]
    },
    "ASPARAGINASE": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19012585],
      "conceptName": ["ASPARAGINASE"]
    },
    "Ifosfamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    },
    "Teniposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19136750],
      "conceptName": ["Teniposide"]
    },
    "ponatinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [43013182],
      "conceptName": ["ponatinib"]
    }
  },
  {
    "conceptId": [35806324],
    "regimenName": ["KPD"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "carfilzomib": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [42873638],
      "conceptName": ["carfilzomib"]
    },
    "Dexamethasone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "pomalidomide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [43014237],
      "conceptName": ["pomalidomide"]
    }
  },
  {
    "conceptId": [35803997],
    "regimenName": ["BEAC"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Carmustine": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1350066],
      "conceptName": ["Carmustine"]
    },
    "Cytarabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Etoposide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    }
  },
  {
    "conceptId": [35804563],
    "regimenName": ["FELV"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Leucovorin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1388796],
      "conceptName": ["Leucovorin"]
    },
    "Fluorouracil": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "Etoposide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    }
  },
  {
    "conceptId": [35804800],
    "regimenName": ["Panitumumab monotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "panitumumab": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [19100985],
      "conceptName": ["panitumumab"]
    },
    "Fluorouracil": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "oxaliplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1318011],
      "conceptName": ["oxaliplatin"]
    },
    "capecitabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1337620],
      "conceptName": ["capecitabine"]
    },
    "irinotecan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1367268],
      "conceptName": ["irinotecan"]
    },
    "Leucovorin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1388796],
      "conceptName": ["Leucovorin"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    }
  },
  {
    "conceptId": [35804390],
    "regimenName": ["Alectinib monotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "alectinib": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [35604657],
      "conceptName": ["alectinib"]
    }
  },
  {
    "conceptId": [35805803],
    "regimenName": ["eBEACOPP"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Bleomycin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1329241],
      "conceptName": ["Bleomycin"]
    },
    "Prednisone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Procarbazine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1351779],
      "conceptName": ["Procarbazine"]
    },
    "Etoposide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    }
  },
  {
    "conceptId": [35804000],
    "regimenName": ["Busulfan and Melphalan"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Melphalan": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1301267],
      "conceptName": ["Melphalan"]
    },
    "Busulfan": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1333357],
      "conceptName": ["Busulfan"]
    },
    "fludarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1395557],
      "conceptName": ["fludarabine"]
    }
  },
  {
    "conceptId": [35804636],
    "regimenName": ["Radotinib monotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "radotinib": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [43009098],
      "conceptName": ["radotinib"]
    }
  },
  {
    "conceptId": [35803446],
    "regimenName": ["Cytarabine, Daunorubicin, Gemtuzumab ozogamicin"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Cytarabine": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Gemtuzumab ozogamicin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [42799711],
      "conceptName": ["Gemtuzumab ozogamicin"]
    },
    "Daunorubicin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1311799],
      "conceptName": ["Daunorubicin"]
    }
  },
  {
    "conceptId": [35803535],
    "regimenName": ["Mercaptopurine monotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "mercaptopurine": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1436650],
      "conceptName": ["mercaptopurine"]
    },
    "Tretinoin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [903643],
      "conceptName": ["Tretinoin"]
    },
    "imatinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1304107],
      "conceptName": ["imatinib"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Daunorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311799],
      "conceptName": ["Daunorubicin"]
    },
    "pegaspargase": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1326481],
      "conceptName": ["pegaspargase"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Thioguanine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1437379],
      "conceptName": ["Thioguanine"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "prednisolone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1550557],
      "conceptName": ["prednisolone"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "nelarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19002912],
      "conceptName": ["nelarabine"]
    },
    "Vinblastine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008264],
      "conceptName": ["Vinblastine"]
    },
    "ASPARAGINASE": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19012585],
      "conceptName": ["ASPARAGINASE"]
    },
    "Idarubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078097],
      "conceptName": ["Idarubicin"]
    },
    "Norethandrolone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19128219],
      "conceptName": ["Norethandrolone"]
    }
  },
  {
    "conceptId": [35805815],
    "regimenName": ["MOPP"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Prednisone": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Procarbazine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1351779],
      "conceptName": ["Procarbazine"]
    },
    "Mechlorethamine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1394337],
      "conceptName": ["Mechlorethamine"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Dacarbazine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311409],
      "conceptName": ["Dacarbazine"]
    },
    "Bleomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1329241],
      "conceptName": ["Bleomycin"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Vinblastine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008264],
      "conceptName": ["Vinblastine"]
    }
  },
  {
    "conceptId": [35806344],
    "regimenName": ["VMCP"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Melphalan": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1301267],
      "conceptName": ["Melphalan"]
    },
    "Prednisone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Carmustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350066],
      "conceptName": ["Carmustine"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    }
  },
  {
    "conceptId": [35805810],
    "regimenName": ["RABVD"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Bleomycin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1329241],
      "conceptName": ["Bleomycin"]
    },
    "rituximab": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Vinblastine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [19008264],
      "conceptName": ["Vinblastine"]
    },
    "Dacarbazine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1311409],
      "conceptName": ["Dacarbazine"]
    }
  },
  {
    "conceptId": [35806625],
    "regimenName": ["TIP"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Paclitaxel": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1378382],
      "conceptName": ["Paclitaxel"]
    },
    "Cisplatin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "Ifosfamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    }
  },
  {
    "conceptId": [35804252],
    "regimenName": ["FAC and Bevacizumab"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "bevacizumab": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1397141],
      "conceptName": ["bevacizumab"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Fluorouracil": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    }
  },
  {
    "conceptId": [35803508],
    "regimenName": ["Ruxolitinib monotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "ruxolitinib": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [40244464],
      "conceptName": ["ruxolitinib"]
    }
  },
  {
    "conceptId": [35806128],
    "regimenName": ["Dacarbazine and Interferon alfa"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Dacarbazine": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1311409],
      "conceptName": ["Dacarbazine"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Aldesleukin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1309770],
      "conceptName": ["Aldesleukin"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "gemcitabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314924],
      "conceptName": ["gemcitabine"]
    },
    "Bleomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1329241],
      "conceptName": ["Bleomycin"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Carmustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350066],
      "conceptName": ["Carmustine"]
    },
    "Procarbazine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1351779],
      "conceptName": ["Procarbazine"]
    },
    "hydroxyurea": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1377141],
      "conceptName": ["hydroxyurea"]
    },
    "Paclitaxel": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1378382],
      "conceptName": ["Paclitaxel"]
    },
    "Interferon Alfa-2b": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1380068],
      "conceptName": ["Interferon Alfa-2b"]
    },
    "Lomustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1391846],
      "conceptName": ["Lomustine"]
    },
    "Mechlorethamine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1394337],
      "conceptName": ["Mechlorethamine"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "Tamoxifen": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1436678],
      "conceptName": ["Tamoxifen"]
    },
    "Methylprednisolone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1506270],
      "conceptName": ["Methylprednisolone"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Vinblastine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008264],
      "conceptName": ["Vinblastine"]
    },
    "Vindesine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008336],
      "conceptName": ["Vindesine"]
    },
    "Ifosfamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    },
    "BCG, Live, Tice Strain": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19086176],
      "conceptName": ["BCG, Live, Tice Strain"]
    },
    "ipilimumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [40238188],
      "conceptName": ["ipilimumab"]
    },
    "brentuximab vedotin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [40241969],
      "conceptName": ["brentuximab vedotin"]
    }
  },
  {
    "conceptId": [35804339],
    "regimenName": ["FAC and BCG"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Fluorouracil": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "BCG, Live, Tice Strain": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [19086176],
      "conceptName": ["BCG, Live, Tice Strain"]
    }
  },
  {
    "conceptId": [35805842],
    "regimenName": ["Fludarabine, Melphalan, Alemtuzumab, then allo HSCT"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "alemtuzumab": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1312706],
      "conceptName": ["alemtuzumab"]
    },
    "Melphalan": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1301267],
      "conceptName": ["Melphalan"]
    },
    "fludarabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1395557],
      "conceptName": ["fludarabine"]
    }
  },
  {
    "conceptId": [35804345],
    "regimenName": ["PAF"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Melphalan": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1301267],
      "conceptName": ["Melphalan"]
    },
    "Fluorouracil": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    }
  },
  {
    "conceptId": [35806321],
    "regimenName": ["Bortezomib, Thalidomide, Dexamethasone, Panobinostat"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "panobinostat": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [46221435],
      "conceptName": ["panobinostat"]
    },
    "Thalidomide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [19137042],
      "conceptName": ["Thalidomide"]
    },
    "bortezomib": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1336825],
      "conceptName": ["bortezomib"]
    },
    "Dexamethasone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    }
  },
  {
    "conceptId": [35803546],
    "regimenName": ["Cladribine monotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Cladribine": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [19054825],
      "conceptName": ["Cladribine"]
    },
    "Filgrastim": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1304850],
      "conceptName": ["Filgrastim"]
    },
    "Mitoxantrone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1309188],
      "conceptName": ["Mitoxantrone"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Daunorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311799],
      "conceptName": ["Daunorubicin"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    }
  },
  {
    "conceptId": [35803574],
    "regimenName": ["Cisplatin and Docetaxel"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Cisplatin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "docetaxel": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1315942],
      "conceptName": ["docetaxel"]
    },
    "Fluorouracil": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "Leucovorin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1388796],
      "conceptName": ["Leucovorin"]
    },
    "bevacizumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397141],
      "conceptName": ["bevacizumab"]
    }
  },
  {
    "conceptId": [35805104],
    "regimenName": ["m-BNCOD"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Bleomycin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1329241],
      "conceptName": ["Bleomycin"]
    },
    "Methotrexate": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Dexamethasone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "Mitoxantrone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1309188],
      "conceptName": ["Mitoxantrone"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    }
  },
  {
    "conceptId": [35805372],
    "regimenName": ["Ramucirumab monotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "ramucirumab": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [44818489],
      "conceptName": ["ramucirumab"]
    },
    "Fluorouracil": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "docetaxel": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1315942],
      "conceptName": ["docetaxel"]
    },
    "irinotecan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1367268],
      "conceptName": ["irinotecan"]
    },
    "Paclitaxel": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1378382],
      "conceptName": ["Paclitaxel"]
    },
    "Leucovorin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1388796],
      "conceptName": ["Leucovorin"]
    }
  },
  {
    "conceptId": [35804063],
    "regimenName": ["Hyper-CVAD/MA and Everolimus"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Methotrexate": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "everolimus": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [19011440],
      "conceptName": ["everolimus"]
    },
    "Methylprednisolone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1506270],
      "conceptName": ["Methylprednisolone"]
    },
    "Cytarabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Dexamethasone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    }
  },
  {
    "conceptId": [35804291],
    "regimenName": ["Anastrozole and Trastuzumab"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "trastuzumab": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1387104],
      "conceptName": ["trastuzumab"]
    },
    "anastrozole": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1348265],
      "conceptName": ["anastrozole"]
    }
  },
  {
    "conceptId": [35805335],
    "regimenName": ["CX"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Cisplatin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "capecitabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1337620],
      "conceptName": ["capecitabine"]
    },
    "Fluorouracil": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "cetuximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1315411],
      "conceptName": ["cetuximab"]
    },
    "Epirubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344354],
      "conceptName": ["Epirubicin"]
    },
    "trastuzumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1387104],
      "conceptName": ["trastuzumab"]
    }
  },
  {
    "conceptId": [35803545],
    "regimenName": ["Azacitidine, Vorinostat, Gemtuzumab ozogamicin"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Azacitidine": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1314865],
      "conceptName": ["Azacitidine"]
    },
    "Gemtuzumab ozogamicin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [42799711],
      "conceptName": ["Gemtuzumab ozogamicin"]
    },
    "Vorinostat": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1337651],
      "conceptName": ["Vorinostat"]
    }
  },
  {
    "conceptId": [35803487],
    "regimenName": ["Sorafenib monotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "sorafenib": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1363387],
      "conceptName": ["sorafenib"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Daunorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311799],
      "conceptName": ["Daunorubicin"]
    },
    "Azacitidine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314865],
      "conceptName": ["Azacitidine"]
    },
    "capecitabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1337620],
      "conceptName": ["capecitabine"]
    },
    "Idarubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078097],
      "conceptName": ["Idarubicin"]
    }
  },
  {
    "conceptId": [35806843],
    "regimenName": ["Flutamide monotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Flutamide": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1356461],
      "conceptName": ["Flutamide"]
    },
    "bicalutamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344381],
      "conceptName": ["bicalutamide"]
    },
    "Leuprolide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1351541],
      "conceptName": ["Leuprolide"]
    },
    "Goserelin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1366310],
      "conceptName": ["Goserelin"]
    }
  },
  {
    "conceptId": [35101612],
    "regimenName": ["Carboplatin, Etoposide, RT"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Carboplatin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1344905],
      "conceptName": ["Carboplatin"]
    },
    "Etoposide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Mesna": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1354698],
      "conceptName": ["Mesna"]
    },
    "Paclitaxel": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1378382],
      "conceptName": ["Paclitaxel"]
    },
    "bevacizumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397141],
      "conceptName": ["bevacizumab"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "prednisolone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1550557],
      "conceptName": ["prednisolone"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Vindesine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008336],
      "conceptName": ["Vindesine"]
    },
    "lenalidomide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19026972],
      "conceptName": ["lenalidomide"]
    },
    "Ifosfamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    },
    "ranimustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [35197850],
      "conceptName": ["ranimustine"]
    },
    "ofatumumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [40167582],
      "conceptName": ["ofatumumab"]
    },
    "atezolizumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [42629079],
      "conceptName": ["atezolizumab"]
    }
  },
  {
    "conceptId": [35806174],
    "regimenName": ["Cisplatin and Raltitrexed"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Cisplatin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "raltitrexed": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [19038536],
      "conceptName": ["raltitrexed"]
    }
  },
  {
    "conceptId": [35804047],
    "regimenName": ["Daunorubicin, Pegaspargase, Vincristine, Dexamethasone"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "pegaspargase": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1326481],
      "conceptName": ["pegaspargase"]
    },
    "Daunorubicin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1311799],
      "conceptName": ["Daunorubicin"]
    },
    "Dexamethasone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    }
  },
  {
    "conceptId": [35806117],
    "regimenName": ["Interferon alfa-2b monotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Interferon Alfa-2b": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1380068],
      "conceptName": ["Interferon Alfa-2b"]
    },
    "imatinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1304107],
      "conceptName": ["imatinib"]
    },
    "Aldesleukin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1309770],
      "conceptName": ["Aldesleukin"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Dacarbazine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311409],
      "conceptName": ["Dacarbazine"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Carmustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350066],
      "conceptName": ["Carmustine"]
    },
    "Interferon Alfa-2a": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1379969],
      "conceptName": ["Interferon Alfa-2a"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "lanreotide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1503501],
      "conceptName": ["lanreotide"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "Octreotide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1522957],
      "conceptName": ["Octreotide"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Zidovudine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1710612],
      "conceptName": ["Zidovudine"]
    },
    "peginterferon alfa-2a": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1714165],
      "conceptName": ["peginterferon alfa-2a"]
    },
    "Vinblastine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008264],
      "conceptName": ["Vinblastine"]
    },
    "Teniposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19136750],
      "conceptName": ["Teniposide"]
    },
    "Thalidomide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19137042],
      "conceptName": ["Thalidomide"]
    }
  },
  {
    "conceptId": [35101312],
    "regimenName": ["Isotretinoin and Dinutuximab"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Isotretinoin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [984232],
      "conceptName": ["Isotretinoin"]
    },
    "dinutuximab": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [46221699],
      "conceptName": ["dinutuximab"]
    },
    "sargramostim": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308432],
      "conceptName": ["sargramostim"]
    },
    "Aldesleukin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1309770],
      "conceptName": ["Aldesleukin"]
    }
  },
  {
    "conceptId": [35806322],
    "regimenName": ["BTD"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "bendamustine": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [19015523],
      "conceptName": ["bendamustine"]
    },
    "Thalidomide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [19137042],
      "conceptName": ["Thalidomide"]
    },
    "Dexamethasone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    }
  },
  {
    "conceptId": [35805067],
    "regimenName": ["BEAM, then allo HSCT"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Carmustine": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1350066],
      "conceptName": ["Carmustine"]
    },
    "Melphalan": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1301267],
      "conceptName": ["Melphalan"]
    },
    "Cytarabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Etoposide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "ibritumomab tiuxetan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19068830],
      "conceptName": ["ibritumomab tiuxetan"]
    }
  },
  {
    "conceptId": [35805687],
    "regimenName": ["FAM"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Mitomycin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1389036],
      "conceptName": ["Mitomycin"]
    },
    "Fluorouracil": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    }
  },
  {
    "conceptId": [35806646],
    "regimenName": ["Cyclophosphamide, Dacarbazine, Vincristine"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Dacarbazine": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1311409],
      "conceptName": ["Dacarbazine"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Bleomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1329241],
      "conceptName": ["Bleomycin"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Procarbazine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1351779],
      "conceptName": ["Procarbazine"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Vinblastine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008264],
      "conceptName": ["Vinblastine"]
    }
  },
  {
    "conceptId": [35804535],
    "regimenName": ["Hydroxyurea and RT"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "hydroxyurea": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1377141],
      "conceptName": ["hydroxyurea"]
    },
    "Fluorouracil": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "imatinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1304107],
      "conceptName": ["imatinib"]
    },
    "Dacarbazine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311409],
      "conceptName": ["Dacarbazine"]
    },
    "docetaxel": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1315942],
      "conceptName": ["docetaxel"]
    },
    "Carmustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350066],
      "conceptName": ["Carmustine"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    }
  },
  {
    "conceptId": [35803560],
    "regimenName": ["Idarubicin, then Mitoxantrone, then Idarubicin, with ATRA"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Idarubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [19078097],
      "conceptName": ["Idarubicin"]
    },
    "Tretinoin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [903643],
      "conceptName": ["Tretinoin"]
    },
    "Mitoxantrone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1309188],
      "conceptName": ["Mitoxantrone"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Thioguanine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1437379],
      "conceptName": ["Thioguanine"]
    }
  },
  {
    "conceptId": [35803493],
    "regimenName": ["Fludarabine, Busulfan, ATG, then allo HSCT"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Busulfan": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1333357],
      "conceptName": ["Busulfan"]
    },
    "fludarabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1395557],
      "conceptName": ["fludarabine"]
    },
    "Melphalan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1301267],
      "conceptName": ["Melphalan"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "ibritumomab tiuxetan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19068830],
      "conceptName": ["ibritumomab tiuxetan"]
    }
  },
  {
    "conceptId": [35805446],
    "regimenName": ["EVAIA"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Dactinomycin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1311443],
      "conceptName": ["Dactinomycin"]
    },
    "Ifosfamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    },
    "Etoposide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "irinotecan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1367268],
      "conceptName": ["irinotecan"]
    }
  },
  {
    "conceptId": [35803619],
    "regimenName": ["Cyclophosphamide, Fludarabine, Thiotepa"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Thiotepa": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [19137385],
      "conceptName": ["Thiotepa"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "fludarabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1395557],
      "conceptName": ["fludarabine"]
    }
  },
  {
    "conceptId": [35806943],
    "regimenName": ["Carboplatin and Irinotecan"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Carboplatin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1344905],
      "conceptName": ["Carboplatin"]
    },
    "irinotecan": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1367268],
      "conceptName": ["irinotecan"]
    }
  },
  {
    "conceptId": [35806311],
    "regimenName": ["Dara-Rd"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "lenalidomide": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [19026972],
      "conceptName": ["lenalidomide"]
    },
    "daratumumab": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [35605744],
      "conceptName": ["daratumumab"]
    },
    "Dexamethasone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    }
  },
  {
    "conceptId": [35806343],
    "regimenName": ["VCP"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Prednisone": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Fluorouracil": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "Melphalan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1301267],
      "conceptName": ["Melphalan"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Mitoxantrone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1309188],
      "conceptName": ["Mitoxantrone"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Dacarbazine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311409],
      "conceptName": ["Dacarbazine"]
    },
    "Daunorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311799],
      "conceptName": ["Daunorubicin"]
    },
    "alemtuzumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1312706],
      "conceptName": ["alemtuzumab"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Bleomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1329241],
      "conceptName": ["Bleomycin"]
    },
    "bortezomib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1336825],
      "conceptName": ["bortezomib"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Epirubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344354],
      "conceptName": ["Epirubicin"]
    },
    "Carboplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344905],
      "conceptName": ["Carboplatin"]
    },
    "Carmustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350066],
      "conceptName": ["Carmustine"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Procarbazine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1351779],
      "conceptName": ["Procarbazine"]
    },
    "Mechlorethamine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1394337],
      "conceptName": ["Mechlorethamine"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "Thioguanine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1437379],
      "conceptName": ["Thioguanine"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "Hyaluronidase / rituximab Injection [Rituxan Hycela]": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1593155],
      "conceptName": ["Hyaluronidase / rituximab Injection [Rituxan Hycela]"]
    },
    "Vinblastine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008264],
      "conceptName": ["Vinblastine"]
    },
    "Vindesine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008336],
      "conceptName": ["Vindesine"]
    },
    "everolimus": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19011440],
      "conceptName": ["everolimus"]
    },
    "ASPARAGINASE": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19012585],
      "conceptName": ["ASPARAGINASE"]
    },
    "lenalidomide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19026972],
      "conceptName": ["lenalidomide"]
    },
    "denileukin diftitox": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19051642],
      "conceptName": ["denileukin diftitox"]
    },
    "doxorubicin liposome": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19051649],
      "conceptName": ["doxorubicin liposome"]
    },
    "iodine-131-tositumomab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19054997],
      "conceptName": ["iodine-131-tositumomab"]
    },
    "Idarubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078097],
      "conceptName": ["Idarubicin"]
    },
    "Ifosfamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    },
    "BCG, Live, Tice Strain": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19086176],
      "conceptName": ["BCG, Live, Tice Strain"]
    },
    "Teniposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19136750],
      "conceptName": ["Teniposide"]
    },
    "ranimustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [35197850],
      "conceptName": ["ranimustine"]
    },
    "ofatumumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [40167582],
      "conceptName": ["ofatumumab"]
    },
    "obinutuzumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [44507676],
      "conceptName": ["obinutuzumab"]
    }
  },
  {
    "conceptId": [35804591],
    "regimenName": ["Lenalidomide and Rituximab"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "lenalidomide": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [19026972],
      "conceptName": ["lenalidomide"]
    },
    "rituximab": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Carboplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344905],
      "conceptName": ["Carboplatin"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Mesna": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1354698],
      "conceptName": ["Mesna"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "bendamustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19015523],
      "conceptName": ["bendamustine"]
    },
    "Ifosfamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    }
  },
  {
    "conceptId": [35806584],
    "regimenName": ["mFOLFIRINOX"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "oxaliplatin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1318011],
      "conceptName": ["oxaliplatin"]
    },
    "Leucovorin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1388796],
      "conceptName": ["Leucovorin"]
    },
    "irinotecan": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1367268],
      "conceptName": ["irinotecan"]
    },
    "Fluorouracil": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "gemcitabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314924],
      "conceptName": ["gemcitabine"]
    }
  },
  {
    "conceptId": [35803472],
    "regimenName": ["Clofarabine and LoDAC/Decitabine"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Cytarabine": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "decitabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [19024728],
      "conceptName": ["decitabine"]
    },
    "clofarabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [19054821],
      "conceptName": ["clofarabine"]
    }
  },
  {
    "conceptId": [35804590],
    "regimenName": ["Idelalisib and Rituximab"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "rituximab": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "idelalisib": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [45776944],
      "conceptName": ["idelalisib"]
    },
    "bendamustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19015523],
      "conceptName": ["bendamustine"]
    }
  },
  {
    "conceptId": [35803556],
    "regimenName": ["ATRA, Cytarabine, Idarubicin"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Idarubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [19078097],
      "conceptName": ["Idarubicin"]
    },
    "Cytarabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Tretinoin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [903643],
      "conceptName": ["Tretinoin"]
    },
    "Mitoxantrone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1309188],
      "conceptName": ["Mitoxantrone"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Thioguanine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1437379],
      "conceptName": ["Thioguanine"]
    }
  },
  {
    "conceptId": [35806577],
    "regimenName": ["Capecitabine and Temozolomide"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "temozolomide": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1341149],
      "conceptName": ["temozolomide"]
    },
    "capecitabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1337620],
      "conceptName": ["capecitabine"]
    }
  },
  {
    "conceptId": [35805113],
    "regimenName": ["VCAP"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Vindesine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [19008336],
      "conceptName": ["Vindesine"]
    },
    "Prednisone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Bleomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1329241],
      "conceptName": ["Bleomycin"]
    },
    "Carboplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344905],
      "conceptName": ["Carboplatin"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "Ifosfamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    },
    "Teniposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19136750],
      "conceptName": ["Teniposide"]
    },
    "ranimustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [35197850],
      "conceptName": ["ranimustine"]
    }
  },
  {
    "conceptId": [35805087],
    "regimenName": ["BCOP"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Carmustine": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1350066],
      "conceptName": ["Carmustine"]
    },
    "Prednisone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Melphalan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1301267],
      "conceptName": ["Melphalan"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Procarbazine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1351779],
      "conceptName": ["Procarbazine"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    }
  },
  {
    "conceptId": [35803440],
    "regimenName": ["CLAG"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Cytarabine": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Filgrastim": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1304850],
      "conceptName": ["Filgrastim"]
    },
    "Cladribine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [19054825],
      "conceptName": ["Cladribine"]
    },
    "Mitoxantrone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1309188],
      "conceptName": ["Mitoxantrone"]
    }
  },
  {
    "conceptId": [35804602],
    "regimenName": ["BR and Idelalisib"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "bendamustine": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [19015523],
      "conceptName": ["bendamustine"]
    },
    "rituximab": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "idelalisib": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [45776944],
      "conceptName": ["idelalisib"]
    }
  },
  {
    "conceptId": [35804069],
    "regimenName": ["Dasatinib and Prednisone"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Prednisone": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "dasatinib": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1358436],
      "conceptName": ["dasatinib"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    }
  },
  {
    "conceptId": [35806480],
    "regimenName": ["Altretamine monotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Altretamine": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1368823],
      "conceptName": ["Altretamine"]
    },
    "Fluorouracil": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    }
  },
  {
    "conceptId": [35101351],
    "regimenName": ["Imatinib, Vincristine, Prednisone"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Prednisone": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "imatinib": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1304107],
      "conceptName": ["imatinib"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Daunorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311799],
      "conceptName": ["Daunorubicin"]
    },
    "ASPARAGINASE": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19012585],
      "conceptName": ["ASPARAGINASE"]
    }
  },
  {
    "conceptId": [35803459],
    "regimenName": ["HAD"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "omacetaxine": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [45775576],
      "conceptName": ["omacetaxine"]
    },
    "Cytarabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Daunorubicin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1311799],
      "conceptName": ["Daunorubicin"]
    }
  },
  {
    "conceptId": [35806823],
    "regimenName": ["Flutamide and Goserelin"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Goserelin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1366310],
      "conceptName": ["Goserelin"]
    },
    "Flutamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1356461],
      "conceptName": ["Flutamide"]
    }
  },
  {
    "conceptId": [35807026],
    "regimenName": ["BVP"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Bleomycin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1329241],
      "conceptName": ["Bleomycin"]
    },
    "Cisplatin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "Vinblastine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [19008264],
      "conceptName": ["Vinblastine"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    }
  },
  {
    "conceptId": [35803536],
    "regimenName": ["PATCO"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Thioguanine": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1437379],
      "conceptName": ["Thioguanine"]
    },
    "Cytarabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Prednisone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    }
  },
  {
    "conceptId": [35804257],
    "regimenName": ["S-1 monotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Hyaluronidase / trastuzumab Injection [Herceptin Hylecta]": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1366689],
      "conceptName": ["Hyaluronidase / trastuzumab Injection [Herceptin Hylecta]"]
    },
    "gemcitabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314924],
      "conceptName": ["gemcitabine"]
    },
    "docetaxel": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1315942],
      "conceptName": ["docetaxel"]
    },
    "oxaliplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1318011],
      "conceptName": ["oxaliplatin"]
    },
    "irinotecan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1367268],
      "conceptName": ["irinotecan"]
    },
    "Paclitaxel": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1378382],
      "conceptName": ["Paclitaxel"]
    },
    "bevacizumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397141],
      "conceptName": ["bevacizumab"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    }
  },
  {
    "conceptId": [35804080],
    "regimenName": ["Dasatinib monotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "dasatinib": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1358436],
      "conceptName": ["dasatinib"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    }
  },
  {
    "conceptId": [35805811],
    "regimenName": ["IGEV"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Ifosfamide": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    },
    "vinorelbine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1343346],
      "conceptName": ["vinorelbine"]
    },
    "gemcitabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1314924],
      "conceptName": ["gemcitabine"]
    },
    "prednisolone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1550557],
      "conceptName": ["prednisolone"]
    }
  },
  {
    "conceptId": [35805851],
    "regimenName": ["Mechlorethamine monotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Mechlorethamine": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1394337],
      "conceptName": ["Mechlorethamine"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Dacarbazine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311409],
      "conceptName": ["Dacarbazine"]
    },
    "Bleomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1329241],
      "conceptName": ["Bleomycin"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Procarbazine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1351779],
      "conceptName": ["Procarbazine"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Vinblastine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008264],
      "conceptName": ["Vinblastine"]
    }
  },
  {
    "conceptId": [35102027],
    "regimenName": ["CHOP Modified (Prednisolone)"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "prednisolone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1550557],
      "conceptName": ["prednisolone"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Bleomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1329241],
      "conceptName": ["Bleomycin"]
    },
    "bortezomib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1336825],
      "conceptName": ["bortezomib"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Procarbazine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1351779],
      "conceptName": ["Procarbazine"]
    },
    "ASPARAGINASE": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19012585],
      "conceptName": ["ASPARAGINASE"]
    }
  },
  {
    "conceptId": [35803678],
    "regimenName": ["Pembrolizumab monotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "pembrolizumab": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [45775965],
      "conceptName": ["pembrolizumab"]
    },
    "pemetrexed": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1304919],
      "conceptName": ["pemetrexed"]
    },
    "Carboplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344905],
      "conceptName": ["Carboplatin"]
    },
    "Paclitaxel": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1378382],
      "conceptName": ["Paclitaxel"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "axitinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [42709322],
      "conceptName": ["axitinib"]
    },
    "pomalidomide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [43014237],
      "conceptName": ["pomalidomide"]
    }
  },
  {
    "conceptId": [35805824],
    "regimenName": ["PVAG"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Prednisone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Vinblastine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [19008264],
      "conceptName": ["Vinblastine"]
    },
    "gemcitabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1314924],
      "conceptName": ["gemcitabine"]
    }
  },
  {
    "conceptId": [35806864],
    "regimenName": ["Aspirin and Dexamethasone"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Aspirin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1112807],
      "conceptName": ["Aspirin"]
    },
    "Dexamethasone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    }
  },
  {
    "conceptId": [35805243],
    "regimenName": ["CIM"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Cisplatin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "Ifosfamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    },
    "Mesna": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1354698],
      "conceptName": ["Mesna"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Dactinomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311443],
      "conceptName": ["Dactinomycin"]
    },
    "Bleomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1329241],
      "conceptName": ["Bleomycin"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Epirubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344354],
      "conceptName": ["Epirubicin"]
    }
  },
  {
    "conceptId": [35100084],
    "regimenName": ["Venetoclax and Obinutuzumab"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "venetoclax": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [35604205],
      "conceptName": ["venetoclax"]
    },
    "obinutuzumab": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [44507676],
      "conceptName": ["obinutuzumab"]
    }
  },
  {
    "conceptId": [35806973],
    "regimenName": ["CYVE and G-CSF"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Cytarabine": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Etoposide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Tretinoin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [903643],
      "conceptName": ["Tretinoin"]
    },
    "Melphalan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1301267],
      "conceptName": ["Melphalan"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Mitoxantrone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1309188],
      "conceptName": ["Mitoxantrone"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Daunorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311799],
      "conceptName": ["Daunorubicin"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Bleomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1329241],
      "conceptName": ["Bleomycin"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Carmustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350066],
      "conceptName": ["Carmustine"]
    },
    "nilotinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1394023],
      "conceptName": ["nilotinib"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "mercaptopurine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1436650],
      "conceptName": ["mercaptopurine"]
    },
    "Thioguanine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1437379],
      "conceptName": ["Thioguanine"]
    },
    "Methylprednisolone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1506270],
      "conceptName": ["Methylprednisolone"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "prednisolone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1550557],
      "conceptName": ["prednisolone"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Vindesine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008336],
      "conceptName": ["Vindesine"]
    },
    "ASPARAGINASE": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19012585],
      "conceptName": ["ASPARAGINASE"]
    },
    "bendamustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19015523],
      "conceptName": ["bendamustine"]
    },
    "doxorubicin liposome": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19051649],
      "conceptName": ["doxorubicin liposome"]
    },
    "ibritumomab tiuxetan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19068830],
      "conceptName": ["ibritumomab tiuxetan"]
    },
    "Idarubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078097],
      "conceptName": ["Idarubicin"]
    },
    "Ifosfamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    },
    "Teniposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19136750],
      "conceptName": ["Teniposide"]
    },
    "Fotemustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [36879099],
      "conceptName": ["Fotemustine"]
    },
    "ofatumumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [40167582],
      "conceptName": ["ofatumumab"]
    }
  },
  {
    "conceptId": [35806585],
    "regimenName": ["Gemcitabine/Fluorouracil and RT"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "gemcitabine": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1314924],
      "conceptName": ["gemcitabine"]
    },
    "Fluorouracil": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "oxaliplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1318011],
      "conceptName": ["oxaliplatin"]
    },
    "Epirubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344354],
      "conceptName": ["Epirubicin"]
    },
    "irinotecan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1367268],
      "conceptName": ["irinotecan"]
    },
    "Leucovorin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1388796],
      "conceptName": ["Leucovorin"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    }
  },
  {
    "conceptId": [35804366],
    "regimenName": ["VAP"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "prednisolone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1550557],
      "conceptName": ["prednisolone"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "pegaspargase": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1326481],
      "conceptName": ["pegaspargase"]
    },
    "Bleomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1329241],
      "conceptName": ["Bleomycin"]
    },
    "bortezomib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1336825],
      "conceptName": ["bortezomib"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Procarbazine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1351779],
      "conceptName": ["Procarbazine"]
    },
    "Chlorambucil": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1390051],
      "conceptName": ["Chlorambucil"]
    },
    "mercaptopurine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1436650],
      "conceptName": ["mercaptopurine"]
    },
    "Vinblastine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008264],
      "conceptName": ["Vinblastine"]
    },
    "ASPARAGINASE": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19012585],
      "conceptName": ["ASPARAGINASE"]
    }
  },
  {
    "conceptId": [35805771],
    "regimenName": ["Docetaxel, Cetuximab, RT"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "docetaxel": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1315942],
      "conceptName": ["docetaxel"]
    },
    "cetuximab": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1315411],
      "conceptName": ["cetuximab"]
    }
  },
  {
    "conceptId": [35805919],
    "regimenName": ["Danazol monotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Danazol": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1511449],
      "conceptName": ["Danazol"]
    },
    "Tamoxifen": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1436678],
      "conceptName": ["Tamoxifen"]
    },
    "Aminoglutethimide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1503057],
      "conceptName": ["Aminoglutethimide"]
    }
  },
  {
    "conceptId": [35803576],
    "regimenName": ["Cisplatin and Irinotecan"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Cisplatin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "irinotecan": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1367268],
      "conceptName": ["irinotecan"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    }
  },
  {
    "conceptId": [35805827],
    "regimenName": ["BeGEV"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "bendamustine": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [19015523],
      "conceptName": ["bendamustine"]
    },
    "vinorelbine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1343346],
      "conceptName": ["vinorelbine"]
    },
    "gemcitabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1314924],
      "conceptName": ["gemcitabine"]
    },
    "prednisolone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1550557],
      "conceptName": ["prednisolone"]
    }
  },
  {
    "conceptId": [35804272],
    "regimenName": ["Anastrozole and Goserelin"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "anastrozole": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1348265],
      "conceptName": ["anastrozole"]
    },
    "Goserelin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1366310],
      "conceptName": ["Goserelin"]
    }
  },
  {
    "conceptId": [35804616],
    "regimenName": ["R-BAC"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "bendamustine": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [19015523],
      "conceptName": ["bendamustine"]
    },
    "rituximab": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Cytarabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    }
  },
  {
    "conceptId": [35805345],
    "regimenName": ["Capecitabine, Docetaxel, RT"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "docetaxel": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1315942],
      "conceptName": ["docetaxel"]
    },
    "capecitabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1337620],
      "conceptName": ["capecitabine"]
    },
    "gemcitabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314924],
      "conceptName": ["gemcitabine"]
    },
    "oxaliplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1318011],
      "conceptName": ["oxaliplatin"]
    },
    "Epirubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344354],
      "conceptName": ["Epirubicin"]
    }
  },
  {
    "conceptId": [35803541],
    "regimenName": ["POMP"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Methotrexate": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "mercaptopurine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1436650],
      "conceptName": ["mercaptopurine"]
    },
    "Prednisone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "ASPARAGINASE": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19012585],
      "conceptName": ["ASPARAGINASE"]
    }
  },
  {
    "conceptId": [35803430],
    "regimenName": ["Prednisone monotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Prednisone": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Fluorouracil": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "Melphalan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1301267],
      "conceptName": ["Melphalan"]
    },
    "imatinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1304107],
      "conceptName": ["imatinib"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Mitoxantrone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1309188],
      "conceptName": ["Mitoxantrone"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Dacarbazine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311409],
      "conceptName": ["Dacarbazine"]
    },
    "Daunorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311799],
      "conceptName": ["Daunorubicin"]
    },
    "alemtuzumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1312706],
      "conceptName": ["alemtuzumab"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Azacitidine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314865],
      "conceptName": ["Azacitidine"]
    },
    "gemcitabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314924],
      "conceptName": ["gemcitabine"]
    },
    "docetaxel": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1315942],
      "conceptName": ["docetaxel"]
    },
    "oxaliplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1318011],
      "conceptName": ["oxaliplatin"]
    },
    "pegaspargase": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1326481],
      "conceptName": ["pegaspargase"]
    },
    "Bleomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1329241],
      "conceptName": ["Bleomycin"]
    },
    "bortezomib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1336825],
      "conceptName": ["bortezomib"]
    },
    "Vorinostat": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1337651],
      "conceptName": ["Vorinostat"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "vinorelbine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1343346],
      "conceptName": ["vinorelbine"]
    },
    "Epirubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344354],
      "conceptName": ["Epirubicin"]
    },
    "Carboplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344905],
      "conceptName": ["Carboplatin"]
    },
    "Carmustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350066],
      "conceptName": ["Carmustine"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Procarbazine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1351779],
      "conceptName": ["Procarbazine"]
    },
    "dasatinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1358436],
      "conceptName": ["dasatinib"]
    },
    "Interferon Alfa-2b": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1380068],
      "conceptName": ["Interferon Alfa-2b"]
    },
    "Chlorambucil": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1390051],
      "conceptName": ["Chlorambucil"]
    },
    "Lomustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1391846],
      "conceptName": ["Lomustine"]
    },
    "Mechlorethamine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1394337],
      "conceptName": ["Mechlorethamine"]
    },
    "fludarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1395557],
      "conceptName": ["fludarabine"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "mercaptopurine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1436650],
      "conceptName": ["mercaptopurine"]
    },
    "Tamoxifen": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1436678],
      "conceptName": ["Tamoxifen"]
    },
    "Thioguanine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1437379],
      "conceptName": ["Thioguanine"]
    },
    "Methylprednisolone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1506270],
      "conceptName": ["Methylprednisolone"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "Octreotide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1522957],
      "conceptName": ["Octreotide"]
    },
    "Diethylstilbestrol": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1525866],
      "conceptName": ["Diethylstilbestrol"]
    },
    "Hyaluronidase / rituximab Injection [Rituxan Hycela]": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1593155],
      "conceptName": ["Hyaluronidase / rituximab Injection [Rituxan Hycela]"]
    },
    "Quinine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1760616],
      "conceptName": ["Quinine"]
    },
    "Vinblastine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008264],
      "conceptName": ["Vinblastine"]
    },
    "Vindesine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008336],
      "conceptName": ["Vindesine"]
    },
    "everolimus": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19011440],
      "conceptName": ["everolimus"]
    },
    "ASPARAGINASE": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19012585],
      "conceptName": ["ASPARAGINASE"]
    },
    "lenalidomide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19026972],
      "conceptName": ["lenalidomide"]
    },
    "denileukin diftitox": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19051642],
      "conceptName": ["denileukin diftitox"]
    },
    "doxorubicin liposome": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19051649],
      "conceptName": ["doxorubicin liposome"]
    },
    "iodine-131-tositumomab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19054997],
      "conceptName": ["iodine-131-tositumomab"]
    },
    "Idarubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078097],
      "conceptName": ["Idarubicin"]
    },
    "Ifosfamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    },
    "BCG, Live, Tice Strain": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19086176],
      "conceptName": ["BCG, Live, Tice Strain"]
    },
    "Teniposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19136750],
      "conceptName": ["Teniposide"]
    },
    "Thalidomide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19137042],
      "conceptName": ["Thalidomide"]
    },
    "ranimustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [35197850],
      "conceptName": ["ranimustine"]
    },
    "daratumumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [35605744],
      "conceptName": ["daratumumab"]
    },
    "ofatumumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [40167582],
      "conceptName": ["ofatumumab"]
    },
    "cabazitaxel": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [40222431],
      "conceptName": ["cabazitaxel"]
    },
    "abiraterone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [40239056],
      "conceptName": ["abiraterone"]
    },
    "brentuximab vedotin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [40241969],
      "conceptName": ["brentuximab vedotin"]
    },
    "carfilzomib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [42873638],
      "conceptName": ["carfilzomib"]
    },
    "vincristine liposome": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [42874135],
      "conceptName": ["vincristine liposome"]
    },
    "pomalidomide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [43014237],
      "conceptName": ["pomalidomide"]
    },
    "obinutuzumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [44507676],
      "conceptName": ["obinutuzumab"]
    }
  },
  {
    "conceptId": [35805751],
    "regimenName": ["dmCODOX-M - Modified Magrath"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Methotrexate": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Fluorouracil": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "imatinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1304107],
      "conceptName": ["imatinib"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Bleomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1329241],
      "conceptName": ["Bleomycin"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Procarbazine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1351779],
      "conceptName": ["Procarbazine"]
    },
    "dasatinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1358436],
      "conceptName": ["dasatinib"]
    },
    "Mechlorethamine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1394337],
      "conceptName": ["Mechlorethamine"]
    },
    "mercaptopurine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1436650],
      "conceptName": ["mercaptopurine"]
    },
    "Thioguanine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1437379],
      "conceptName": ["Thioguanine"]
    },
    "Methylprednisolone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1506270],
      "conceptName": ["Methylprednisolone"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "prednisolone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1550557],
      "conceptName": ["prednisolone"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Vindesine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008336],
      "conceptName": ["Vindesine"]
    },
    "everolimus": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19011440],
      "conceptName": ["everolimus"]
    },
    "ASPARAGINASE": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19012585],
      "conceptName": ["ASPARAGINASE"]
    },
    "Ifosfamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    },
    "Teniposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19136750],
      "conceptName": ["Teniposide"]
    },
    "ponatinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [43013182],
      "conceptName": ["ponatinib"]
    }
  },
  {
    "conceptId": [35804284],
    "regimenName": ["Fulvestrant monotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "fulvestrant": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1304044],
      "conceptName": ["fulvestrant"]
    },
    "abemaciclib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [792649],
      "conceptName": ["abemaciclib"]
    },
    "capecitabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1337620],
      "conceptName": ["capecitabine"]
    },
    "anastrozole": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1348265],
      "conceptName": ["anastrozole"]
    },
    "alpelisib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1396423],
      "conceptName": ["alpelisib"]
    },
    "ribociclib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1592911],
      "conceptName": ["ribociclib"]
    },
    "palbociclib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [45892075],
      "conceptName": ["palbociclib"]
    }
  },
  {
    "conceptId": [35804779],
    "regimenName": ["IFL and Bevacizumab"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "bevacizumab": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1397141],
      "conceptName": ["bevacizumab"]
    },
    "Leucovorin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1388796],
      "conceptName": ["Leucovorin"]
    },
    "irinotecan": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1367268],
      "conceptName": ["irinotecan"]
    },
    "Fluorouracil": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    }
  },
  {
    "conceptId": [35806285],
    "regimenName": ["CPR"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "lenalidomide": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [19026972],
      "conceptName": ["lenalidomide"]
    },
    "Prednisone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    }
  },
  {
    "conceptId": [35803611],
    "regimenName": ["Busulfan and Cyclophosphamide"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Busulfan": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1333357],
      "conceptName": ["Busulfan"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "fludarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1395557],
      "conceptName": ["fludarabine"]
    },
    "Thiotepa": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19137385],
      "conceptName": ["Thiotepa"]
    }
  },
  {
    "conceptId": [35806425],
    "regimenName": ["Lorlatinib monotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Lorlatinib": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [35201733],
      "conceptName": ["Lorlatinib"]
    }
  },
  {
    "conceptId": [35804267],
    "regimenName": ["Ixabepilone monotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "ixabepilone": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [19025348],
      "conceptName": ["ixabepilone"]
    },
    "capecitabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1337620],
      "conceptName": ["capecitabine"]
    }
  },
  {
    "conceptId": [35804593],
    "regimenName": ["PCO"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "ofatumumab": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [40167582],
      "conceptName": ["ofatumumab"]
    },
    "Pentostatin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [19031224],
      "conceptName": ["Pentostatin"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    }
  },
  {
    "conceptId": [35803453],
    "regimenName": ["ADE (standard-dose Ara-C)"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Cytarabine": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Daunorubicin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1311799],
      "conceptName": ["Daunorubicin"]
    },
    "Etoposide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Tretinoin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [903643],
      "conceptName": ["Tretinoin"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "nilotinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1394023],
      "conceptName": ["nilotinib"]
    },
    "Thioguanine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1437379],
      "conceptName": ["Thioguanine"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "prednisolone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1550557],
      "conceptName": ["prednisolone"]
    }
  },
  {
    "conceptId": [35804543],
    "regimenName": ["Paclitaxel and Topotecan"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Paclitaxel": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1378382],
      "conceptName": ["Paclitaxel"]
    },
    "Topotecan": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1378509],
      "conceptName": ["Topotecan"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "bevacizumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397141],
      "conceptName": ["bevacizumab"]
    }
  },
  {
    "conceptId": [35804138],
    "regimenName": ["Atezolizumab monotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "atezolizumab": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [42629079],
      "conceptName": ["atezolizumab"]
    },
    "Carboplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344905],
      "conceptName": ["Carboplatin"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Paclitaxel": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1378382],
      "conceptName": ["Paclitaxel"]
    },
    "bevacizumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397141],
      "conceptName": ["bevacizumab"]
    }
  },
  {
    "conceptId": [35806279],
    "regimenName": ["VP"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "bortezomib": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1336825],
      "conceptName": ["bortezomib"]
    },
    "Prednisone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Melphalan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1301267],
      "conceptName": ["Melphalan"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "lenalidomide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19026972],
      "conceptName": ["lenalidomide"]
    },
    "Thalidomide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19137042],
      "conceptName": ["Thalidomide"]
    },
    "daratumumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [35605744],
      "conceptName": ["daratumumab"]
    }
  },
  {
    "conceptId": [35806842],
    "regimenName": ["Degarelix monotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "degarelix": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [19058410],
      "conceptName": ["degarelix"]
    }
  },
  {
    "conceptId": [35100304],
    "regimenName": ["Selinexor and Dexamethasone"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Dexamethasone": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "inotuzumab ozogamicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [794068],
      "conceptName": ["inotuzumab ozogamicin"]
    },
    "Aspirin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1112807],
      "conceptName": ["Aspirin"]
    },
    "Melphalan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1301267],
      "conceptName": ["Melphalan"]
    },
    "imatinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1304107],
      "conceptName": ["imatinib"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Mitoxantrone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1309188],
      "conceptName": ["Mitoxantrone"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Daunorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311799],
      "conceptName": ["Daunorubicin"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "gemcitabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314924],
      "conceptName": ["gemcitabine"]
    },
    "oxaliplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1318011],
      "conceptName": ["oxaliplatin"]
    },
    "pegaspargase": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1326481],
      "conceptName": ["pegaspargase"]
    },
    "Bleomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1329241],
      "conceptName": ["Bleomycin"]
    },
    "bortezomib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1336825],
      "conceptName": ["bortezomib"]
    },
    "Vorinostat": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1337651],
      "conceptName": ["Vorinostat"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Carboplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344905],
      "conceptName": ["Carboplatin"]
    },
    "Carmustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350066],
      "conceptName": ["Carmustine"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Mesna": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1354698],
      "conceptName": ["Mesna"]
    },
    "dasatinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1358436],
      "conceptName": ["dasatinib"]
    },
    "Interferon Alfa-2a": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1379969],
      "conceptName": ["Interferon Alfa-2a"]
    },
    "Interferon Alfa-2b": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1380068],
      "conceptName": ["Interferon Alfa-2b"]
    },
    "Chlorambucil": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1390051],
      "conceptName": ["Chlorambucil"]
    },
    "fludarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1395557],
      "conceptName": ["fludarabine"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "mercaptopurine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1436650],
      "conceptName": ["mercaptopurine"]
    },
    "Thioguanine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1437379],
      "conceptName": ["Thioguanine"]
    },
    "Methylprednisolone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1506270],
      "conceptName": ["Methylprednisolone"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Clarithromycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1750500],
      "conceptName": ["Clarithromycin"]
    },
    "Quinine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1760616],
      "conceptName": ["Quinine"]
    },
    "Vindesine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008336],
      "conceptName": ["Vindesine"]
    },
    "everolimus": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19011440],
      "conceptName": ["everolimus"]
    },
    "ASPARAGINASE": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19012585],
      "conceptName": ["ASPARAGINASE"]
    },
    "bendamustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19015523],
      "conceptName": ["bendamustine"]
    },
    "lenalidomide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19026972],
      "conceptName": ["lenalidomide"]
    },
    "doxorubicin liposome": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19051649],
      "conceptName": ["doxorubicin liposome"]
    },
    "Cladribine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19054825],
      "conceptName": ["Cladribine"]
    },
    "Ifosfamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    },
    "Teniposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19136750],
      "conceptName": ["Teniposide"]
    },
    "Thalidomide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19137042],
      "conceptName": ["Thalidomide"]
    },
    "elotuzumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [35604032],
      "conceptName": ["elotuzumab"]
    },
    "daratumumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [35605744],
      "conceptName": ["daratumumab"]
    },
    "ixazomib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [35606214],
      "conceptName": ["ixazomib"]
    },
    "ofatumumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [40167582],
      "conceptName": ["ofatumumab"]
    },
    "Cytarabine liposome": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [40175460],
      "conceptName": ["Cytarabine liposome"]
    },
    "carfilzomib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [42873638],
      "conceptName": ["carfilzomib"]
    },
    "ponatinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [43013182],
      "conceptName": ["ponatinib"]
    },
    "pomalidomide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [43014237],
      "conceptName": ["pomalidomide"]
    },
    "asparaginase Erwinia chrysanthemi": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [43533115],
      "conceptName": ["asparaginase Erwinia chrysanthemi"]
    },
    "pembrolizumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [45775965],
      "conceptName": ["pembrolizumab"]
    },
    "panobinostat": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [46221435],
      "conceptName": ["panobinostat"]
    }
  },
  {
    "conceptId": [35806422],
    "regimenName": ["Docetaxel and Vandetanib"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "docetaxel": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1315942],
      "conceptName": ["docetaxel"]
    },
    "Vandetanib": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [40238052],
      "conceptName": ["Vandetanib"]
    }
  },
  {
    "conceptId": [35803577],
    "regimenName": ["Docetaxel and Gemcitabine"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "docetaxel": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1315942],
      "conceptName": ["docetaxel"]
    },
    "gemcitabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1314924],
      "conceptName": ["gemcitabine"]
    },
    "capecitabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1337620],
      "conceptName": ["capecitabine"]
    }
  },
  {
    "conceptId": [35805844],
    "regimenName": ["BCVPP"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Carmustine": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1350066],
      "conceptName": ["Carmustine"]
    },
    "Prednisone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Procarbazine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1351779],
      "conceptName": ["Procarbazine"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    }
  },
  {
    "conceptId": [35806496],
    "regimenName": ["Hexa-CAF"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Methotrexate": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Fluorouracil": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "Altretamine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1368823],
      "conceptName": ["Altretamine"]
    }
  },
  {
    "conceptId": [35806280],
    "regimenName": ["Carfilzomib monotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "carfilzomib": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [42873638],
      "conceptName": ["carfilzomib"]
    },
    "Melphalan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1301267],
      "conceptName": ["Melphalan"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "lenalidomide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19026972],
      "conceptName": ["lenalidomide"]
    },
    "Thalidomide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19137042],
      "conceptName": ["Thalidomide"]
    },
    "daratumumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [35605744],
      "conceptName": ["daratumumab"]
    },
    "pomalidomide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [43014237],
      "conceptName": ["pomalidomide"]
    },
    "panobinostat": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [46221435],
      "conceptName": ["panobinostat"]
    }
  },
  {
    "conceptId": [35806138],
    "regimenName": ["Cobimetinib and Vemurafenib"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Cobimetinib": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [35605804],
      "conceptName": ["Cobimetinib"]
    },
    "Vemurafenib": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [40241937],
      "conceptName": ["Vemurafenib"]
    }
  },
  {
    "conceptId": [35804101],
    "regimenName": ["Vemurafenib monotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Vemurafenib": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [40241937],
      "conceptName": ["Vemurafenib"]
    },
    "Cobimetinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [35605804],
      "conceptName": ["Cobimetinib"]
    }
  },
  {
    "conceptId": [35804348],
    "regimenName": ["PT"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Tamoxifen": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1436678],
      "conceptName": ["Tamoxifen"]
    },
    "Prednisone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Fluorouracil": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    }
  },
  {
    "conceptId": [35804605],
    "regimenName": ["Venetoclax and Rituximab"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "venetoclax": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [35604205],
      "conceptName": ["venetoclax"]
    },
    "rituximab": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    }
  },
  {
    "conceptId": [35803677],
    "regimenName": ["Nivolumab monotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "nivolumab": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [45892628],
      "conceptName": ["nivolumab"]
    },
    "ipilimumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [40238188],
      "conceptName": ["ipilimumab"]
    },
    "brentuximab vedotin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [40241969],
      "conceptName": ["brentuximab vedotin"]
    }
  },
  {
    "conceptId": [35804206],
    "regimenName": ["AC and Bevacizumab"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "bevacizumab": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1397141],
      "conceptName": ["bevacizumab"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Fluorouracil": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    }
  },
  {
    "conceptId": [35803591],
    "regimenName": ["CHOP-14"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Prednisone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Fluorouracil": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "Melphalan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1301267],
      "conceptName": ["Melphalan"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Dacarbazine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311409],
      "conceptName": ["Dacarbazine"]
    },
    "alemtuzumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1312706],
      "conceptName": ["alemtuzumab"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Bleomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1329241],
      "conceptName": ["Bleomycin"]
    },
    "bortezomib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1336825],
      "conceptName": ["bortezomib"]
    },
    "Carboplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344905],
      "conceptName": ["Carboplatin"]
    },
    "Carmustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350066],
      "conceptName": ["Carmustine"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Procarbazine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1351779],
      "conceptName": ["Procarbazine"]
    },
    "Mechlorethamine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1394337],
      "conceptName": ["Mechlorethamine"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "Hyaluronidase / rituximab Injection [Rituxan Hycela]": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1593155],
      "conceptName": ["Hyaluronidase / rituximab Injection [Rituxan Hycela]"]
    },
    "Vinblastine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008264],
      "conceptName": ["Vinblastine"]
    },
    "Vindesine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008336],
      "conceptName": ["Vindesine"]
    },
    "everolimus": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19011440],
      "conceptName": ["everolimus"]
    },
    "lenalidomide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19026972],
      "conceptName": ["lenalidomide"]
    },
    "denileukin diftitox": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19051642],
      "conceptName": ["denileukin diftitox"]
    },
    "iodine-131-tositumomab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19054997],
      "conceptName": ["iodine-131-tositumomab"]
    },
    "Ifosfamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    },
    "BCG, Live, Tice Strain": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19086176],
      "conceptName": ["BCG, Live, Tice Strain"]
    },
    "Teniposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19136750],
      "conceptName": ["Teniposide"]
    },
    "ranimustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [35197850],
      "conceptName": ["ranimustine"]
    },
    "ofatumumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [40167582],
      "conceptName": ["ofatumumab"]
    },
    "obinutuzumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [44507676],
      "conceptName": ["obinutuzumab"]
    }
  },
  {
    "conceptId": [35804200],
    "regimenName": ["Neratinib and Paclitaxel"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Paclitaxel": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1378382],
      "conceptName": ["Paclitaxel"]
    },
    "neratinib": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [793846],
      "conceptName": ["neratinib"]
    }
  },
  {
    "conceptId": [35803503],
    "regimenName": ["F-SHAI"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Idarubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [19078097],
      "conceptName": ["Idarubicin"]
    },
    "Cytarabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "fludarabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1395557],
      "conceptName": ["fludarabine"]
    },
    "Filgrastim": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1304850],
      "conceptName": ["Filgrastim"]
    },
    "lenograstim": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19009705],
      "conceptName": ["lenograstim"]
    }
  },
  {
    "conceptId": [35805085],
    "regimenName": ["ABP"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Bleomycin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1329241],
      "conceptName": ["Bleomycin"]
    },
    "Prednisone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Dacarbazine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311409],
      "conceptName": ["Dacarbazine"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Procarbazine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1351779],
      "conceptName": ["Procarbazine"]
    },
    "Lomustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1391846],
      "conceptName": ["Lomustine"]
    },
    "Mechlorethamine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1394337],
      "conceptName": ["Mechlorethamine"]
    },
    "Vinblastine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008264],
      "conceptName": ["Vinblastine"]
    },
    "Vindesine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008336],
      "conceptName": ["Vindesine"]
    },
    "Ifosfamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    },
    "Teniposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19136750],
      "conceptName": ["Teniposide"]
    }
  },
  {
    "conceptId": [35805775],
    "regimenName": ["Cisplatin and Cetuximab"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Cisplatin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "cetuximab": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1315411],
      "conceptName": ["cetuximab"]
    },
    "Fluorouracil": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "capecitabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1337620],
      "conceptName": ["capecitabine"]
    },
    "vinorelbine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1343346],
      "conceptName": ["vinorelbine"]
    }
  },
  {
    "conceptId": [35803486],
    "regimenName": ["CLARA"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Cytarabine": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Filgrastim": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1304850],
      "conceptName": ["Filgrastim"]
    },
    "clofarabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [19054821],
      "conceptName": ["clofarabine"]
    }
  },
  {
    "conceptId": [35805656],
    "regimenName": ["COPA"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Prednisone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Fluorouracil": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "Melphalan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1301267],
      "conceptName": ["Melphalan"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Dacarbazine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311409],
      "conceptName": ["Dacarbazine"]
    },
    "alemtuzumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1312706],
      "conceptName": ["alemtuzumab"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Bleomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1329241],
      "conceptName": ["Bleomycin"]
    },
    "bortezomib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1336825],
      "conceptName": ["bortezomib"]
    },
    "Carboplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344905],
      "conceptName": ["Carboplatin"]
    },
    "Carmustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350066],
      "conceptName": ["Carmustine"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Procarbazine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1351779],
      "conceptName": ["Procarbazine"]
    },
    "Mechlorethamine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1394337],
      "conceptName": ["Mechlorethamine"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "Hyaluronidase / rituximab Injection [Rituxan Hycela]": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1593155],
      "conceptName": ["Hyaluronidase / rituximab Injection [Rituxan Hycela]"]
    },
    "Vinblastine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008264],
      "conceptName": ["Vinblastine"]
    },
    "Vindesine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008336],
      "conceptName": ["Vindesine"]
    },
    "everolimus": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19011440],
      "conceptName": ["everolimus"]
    },
    "lenalidomide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19026972],
      "conceptName": ["lenalidomide"]
    },
    "denileukin diftitox": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19051642],
      "conceptName": ["denileukin diftitox"]
    },
    "iodine-131-tositumomab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19054997],
      "conceptName": ["iodine-131-tositumomab"]
    },
    "Ifosfamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    },
    "BCG, Live, Tice Strain": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19086176],
      "conceptName": ["BCG, Live, Tice Strain"]
    },
    "Teniposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19136750],
      "conceptName": ["Teniposide"]
    },
    "ranimustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [35197850],
      "conceptName": ["ranimustine"]
    },
    "ofatumumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [40167582],
      "conceptName": ["ofatumumab"]
    },
    "obinutuzumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [44507676],
      "conceptName": ["obinutuzumab"]
    }
  },
  {
    "conceptId": [35804250],
    "regimenName": ["EC and Bevacizumab"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "bevacizumab": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1397141],
      "conceptName": ["bevacizumab"]
    },
    "Epirubicin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1344354],
      "conceptName": ["Epirubicin"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Fluorouracil": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    }
  },
  {
    "conceptId": [35804588],
    "regimenName": ["G-FC"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "obinutuzumab": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [44507676],
      "conceptName": ["obinutuzumab"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "fludarabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1395557],
      "conceptName": ["fludarabine"]
    }
  },
  {
    "conceptId": [35804237],
    "regimenName": ["ddFEC"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Epirubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1344354],
      "conceptName": ["Epirubicin"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Fluorouracil": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "trastuzumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1387104],
      "conceptName": ["trastuzumab"]
    },
    "bevacizumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397141],
      "conceptName": ["bevacizumab"]
    }
  },
  {
    "conceptId": [35804146],
    "regimenName": ["MVAC"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Methotrexate": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Cisplatin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "Vinblastine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [19008264],
      "conceptName": ["Vinblastine"]
    }
  },
  {
    "conceptId": [35805839],
    "regimenName": ["Vinblastine monotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Vinblastine": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [19008264],
      "conceptName": ["Vinblastine"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Mitoxantrone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1309188],
      "conceptName": ["Mitoxantrone"]
    },
    "Aldesleukin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1309770],
      "conceptName": ["Aldesleukin"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Dacarbazine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311409],
      "conceptName": ["Dacarbazine"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "gemcitabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314924],
      "conceptName": ["gemcitabine"]
    },
    "Bleomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1329241],
      "conceptName": ["Bleomycin"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Epirubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344354],
      "conceptName": ["Epirubicin"]
    },
    "Carmustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350066],
      "conceptName": ["Carmustine"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Procarbazine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1351779],
      "conceptName": ["Procarbazine"]
    },
    "Interferon Alfa-2b": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1380068],
      "conceptName": ["Interferon Alfa-2b"]
    },
    "Mitomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1389036],
      "conceptName": ["Mitomycin"]
    },
    "Chlorambucil": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1390051],
      "conceptName": ["Chlorambucil"]
    },
    "Lomustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1391846],
      "conceptName": ["Lomustine"]
    },
    "Mechlorethamine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1394337],
      "conceptName": ["Mechlorethamine"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "mercaptopurine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1436650],
      "conceptName": ["mercaptopurine"]
    },
    "Methylprednisolone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1506270],
      "conceptName": ["Methylprednisolone"]
    },
    "prednisolone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1550557],
      "conceptName": ["prednisolone"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Ifosfamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    },
    "Streptozocin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19136210],
      "conceptName": ["Streptozocin"]
    },
    "brentuximab vedotin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [40241969],
      "conceptName": ["brentuximab vedotin"]
    }
  },
  {
    "conceptId": [35805654],
    "regimenName": ["CHVP"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Prednisone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Teniposide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [19136750],
      "conceptName": ["Teniposide"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Bleomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1329241],
      "conceptName": ["Bleomycin"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Interferon Alfa-2b": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1380068],
      "conceptName": ["Interferon Alfa-2b"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "Vindesine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008336],
      "conceptName": ["Vindesine"]
    },
    "Ifosfamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    }
  },
  {
    "conceptId": [35806853],
    "regimenName": ["Ketoconazole, Hydrocortisone, Dutasteride"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Hydrocortisone": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [975125],
      "conceptName": ["Hydrocortisone"]
    },
    "Ketoconazole": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [985708],
      "conceptName": ["Ketoconazole"]
    },
    "Dutasteride": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [989482],
      "conceptName": ["Dutasteride"]
    }
  },
  {
    "conceptId": [35807050],
    "regimenName": ["Vandetanib monotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Vandetanib": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [40238052],
      "conceptName": ["Vandetanib"]
    },
    "docetaxel": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1315942],
      "conceptName": ["docetaxel"]
    }
  },
  {
    "conceptId": [35803573],
    "regimenName": ["Cisplatin monotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Cisplatin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "Fluorouracil": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "Isotretinoin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [984232],
      "conceptName": ["Isotretinoin"]
    },
    "Melphalan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1301267],
      "conceptName": ["Melphalan"]
    },
    "pemetrexed": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1304919],
      "conceptName": ["pemetrexed"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Mitotane": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1309161],
      "conceptName": ["Mitotane"]
    },
    "Aldesleukin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1309770],
      "conceptName": ["Aldesleukin"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Dacarbazine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311409],
      "conceptName": ["Dacarbazine"]
    },
    "Dactinomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311443],
      "conceptName": ["Dactinomycin"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "gemcitabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314924],
      "conceptName": ["gemcitabine"]
    },
    "cetuximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1315411],
      "conceptName": ["cetuximab"]
    },
    "docetaxel": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1315942],
      "conceptName": ["docetaxel"]
    },
    "erlotinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1325363],
      "conceptName": ["erlotinib"]
    },
    "pegaspargase": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1326481],
      "conceptName": ["pegaspargase"]
    },
    "Bleomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1329241],
      "conceptName": ["Bleomycin"]
    },
    "bortezomib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1336825],
      "conceptName": ["bortezomib"]
    },
    "capecitabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1337620],
      "conceptName": ["capecitabine"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "vinorelbine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1343346],
      "conceptName": ["vinorelbine"]
    },
    "Epirubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344354],
      "conceptName": ["Epirubicin"]
    },
    "Carboplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344905],
      "conceptName": ["Carboplatin"]
    },
    "Carmustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350066],
      "conceptName": ["Carmustine"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Mesna": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1354698],
      "conceptName": ["Mesna"]
    },
    "Hyaluronidase / trastuzumab Injection [Herceptin Hylecta]": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1366689],
      "conceptName": ["Hyaluronidase / trastuzumab Injection [Herceptin Hylecta]"]
    },
    "irinotecan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1367268],
      "conceptName": ["irinotecan"]
    },
    "Altretamine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1368823],
      "conceptName": ["Altretamine"]
    },
    "hydroxyurea": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1377141],
      "conceptName": ["hydroxyurea"]
    },
    "Paclitaxel": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1378382],
      "conceptName": ["Paclitaxel"]
    },
    "Topotecan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1378509],
      "conceptName": ["Topotecan"]
    },
    "Interferon Alfa-2a": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1379969],
      "conceptName": ["Interferon Alfa-2a"]
    },
    "Interferon Alfa-2b": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1380068],
      "conceptName": ["Interferon Alfa-2b"]
    },
    "Interferon gamma-1b": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1380191],
      "conceptName": ["Interferon gamma-1b"]
    },
    "trastuzumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1387104],
      "conceptName": ["trastuzumab"]
    },
    "Leucovorin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1388796],
      "conceptName": ["Leucovorin"]
    },
    "Mitomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1389036],
      "conceptName": ["Mitomycin"]
    },
    "Chlorambucil": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1390051],
      "conceptName": ["Chlorambucil"]
    },
    "Lomustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1391846],
      "conceptName": ["Lomustine"]
    },
    "bevacizumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397141],
      "conceptName": ["bevacizumab"]
    },
    "Tamoxifen": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1436678],
      "conceptName": ["Tamoxifen"]
    },
    "Methylprednisolone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1506270],
      "conceptName": ["Methylprednisolone"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Vinblastine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008264],
      "conceptName": ["Vinblastine"]
    },
    "Vindesine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008336],
      "conceptName": ["Vindesine"]
    },
    "raltitrexed": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19038536],
      "conceptName": ["raltitrexed"]
    },
    "doxorubicin liposome": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19051649],
      "conceptName": ["doxorubicin liposome"]
    },
    "Ifosfamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    },
    "panitumumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19100985],
      "conceptName": ["panitumumab"]
    },
    "Thalidomide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19137042],
      "conceptName": ["Thalidomide"]
    },
    "necitumumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [35606215],
      "conceptName": ["necitumumab"]
    },
    "ofatumumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [40167582],
      "conceptName": ["ofatumumab"]
    },
    "pembrolizumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [45775965],
      "conceptName": ["pembrolizumab"]
    }
  },
  {
    "conceptId": [35804623],
    "regimenName": ["Chlorambucil and Prednisone"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Chlorambucil": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1390051],
      "conceptName": ["Chlorambucil"]
    },
    "Prednisone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Mitoxantrone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1309188],
      "conceptName": ["Mitoxantrone"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Procarbazine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1351779],
      "conceptName": ["Procarbazine"]
    },
    "Vinblastine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008264],
      "conceptName": ["Vinblastine"]
    }
  },
  {
    "conceptId": [35804213],
    "regimenName": ["DI EC"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Epirubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1344354],
      "conceptName": ["Epirubicin"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Fluorouracil": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Bleomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1329241],
      "conceptName": ["Bleomycin"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Paclitaxel": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1378382],
      "conceptName": ["Paclitaxel"]
    },
    "trastuzumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1387104],
      "conceptName": ["trastuzumab"]
    },
    "Lomustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1391846],
      "conceptName": ["Lomustine"]
    },
    "bevacizumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397141],
      "conceptName": ["bevacizumab"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "prednisolone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1550557],
      "conceptName": ["prednisolone"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Vinblastine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008264],
      "conceptName": ["Vinblastine"]
    },
    "Vindesine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008336],
      "conceptName": ["Vindesine"]
    },
    "Thiotepa": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19137385],
      "conceptName": ["Thiotepa"]
    }
  },
  {
    "conceptId": [35804315],
    "regimenName": ["TPC"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Carboplatin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1344905],
      "conceptName": ["Carboplatin"]
    },
    "Paclitaxel": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1378382],
      "conceptName": ["Paclitaxel"]
    },
    "trastuzumab": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1387104],
      "conceptName": ["trastuzumab"]
    }
  },
  {
    "conceptId": [35803470],
    "regimenName": ["Clofarabine and LoDAC"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Cytarabine": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "clofarabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [19054821],
      "conceptName": ["clofarabine"]
    },
    "Filgrastim": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1304850],
      "conceptName": ["Filgrastim"]
    },
    "decitabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19024728],
      "conceptName": ["decitabine"]
    },
    "Idarubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078097],
      "conceptName": ["Idarubicin"]
    }
  },
  {
    "conceptId": [35806340],
    "regimenName": ["DCEP and G-CSF"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Cisplatin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Dexamethasone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "Etoposide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Melphalan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1301267],
      "conceptName": ["Melphalan"]
    },
    "bortezomib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1336825],
      "conceptName": ["bortezomib"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Thalidomide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19137042],
      "conceptName": ["Thalidomide"]
    }
  },
  {
    "conceptId": [35806062],
    "regimenName": ["VMD"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Melphalan": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1301267],
      "conceptName": ["Melphalan"]
    },
    "bortezomib": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1336825],
      "conceptName": ["bortezomib"]
    },
    "Dexamethasone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "lenalidomide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19026972],
      "conceptName": ["lenalidomide"]
    },
    "Thalidomide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19137042],
      "conceptName": ["Thalidomide"]
    }
  },
  {
    "conceptId": [35803696],
    "regimenName": ["BV-CHP"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "brentuximab vedotin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [40241969],
      "conceptName": ["brentuximab vedotin"]
    },
    "Prednisone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    }
  },
  {
    "conceptId": [35805368],
    "regimenName": ["Irinotecan liposomal monotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "irinotecan liposomal": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [35603068],
      "conceptName": ["irinotecan liposomal"]
    },
    "Fluorouracil": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "Leucovorin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1388796],
      "conceptName": ["Leucovorin"]
    }
  },
  {
    "conceptId": [35805039],
    "regimenName": ["R-CEOP90 (Epirubicin)"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Epirubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1344354],
      "conceptName": ["Epirubicin"]
    },
    "rituximab": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "prednisolone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1550557],
      "conceptName": ["prednisolone"]
    }
  },
  {
    "conceptId": [35806354],
    "regimenName": ["Carmustine and Doxorubicin"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Carmustine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1350066],
      "conceptName": ["Carmustine"]
    },
    "Melphalan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1301267],
      "conceptName": ["Melphalan"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    }
  },
  {
    "conceptId": [35806838],
    "regimenName": ["ADT and Docetaxel"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "docetaxel": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1315942],
      "conceptName": ["docetaxel"]
    },
    "bicalutamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1344381],
      "conceptName": ["bicalutamide"]
    }
  },
  {
    "conceptId": [35806404],
    "regimenName": ["Pemetrexed and Pembrolizumab"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "pemetrexed": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1304919],
      "conceptName": ["pemetrexed"]
    },
    "pembrolizumab": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [45775965],
      "conceptName": ["pembrolizumab"]
    },
    "Carboplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344905],
      "conceptName": ["Carboplatin"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    }
  },
  {
    "conceptId": [35804098],
    "regimenName": ["Pentostatin monotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Pentostatin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [19031224],
      "conceptName": ["Pentostatin"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "ofatumumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [40167582],
      "conceptName": ["ofatumumab"]
    }
  },
  {
    "conceptId": [35805661],
    "regimenName": ["MCP"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Chlorambucil": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1390051],
      "conceptName": ["Chlorambucil"]
    },
    "Prednisone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Mitoxantrone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1309188],
      "conceptName": ["Mitoxantrone"]
    }
  },
  {
    "conceptId": [35804045],
    "regimenName": ["Cyclophosphamide, Idarubicin, Vincristine, Prednisone"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Idarubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [19078097],
      "conceptName": ["Idarubicin"]
    },
    "Prednisone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    }
  },
  {
    "conceptId": [35803691],
    "regimenName": ["Etoposide monotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Etoposide": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Tretinoin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [903643],
      "conceptName": ["Tretinoin"]
    },
    "Fluorouracil": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "Melphalan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1301267],
      "conceptName": ["Melphalan"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Mitotane": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1309161],
      "conceptName": ["Mitotane"]
    },
    "Mitoxantrone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1309188],
      "conceptName": ["Mitoxantrone"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Dactinomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311443],
      "conceptName": ["Dactinomycin"]
    },
    "Daunorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311799],
      "conceptName": ["Daunorubicin"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "pegaspargase": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1326481],
      "conceptName": ["pegaspargase"]
    },
    "Bleomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1329241],
      "conceptName": ["Bleomycin"]
    },
    "bortezomib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1336825],
      "conceptName": ["bortezomib"]
    },
    "Vorinostat": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1337651],
      "conceptName": ["Vorinostat"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Epirubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344354],
      "conceptName": ["Epirubicin"]
    },
    "Carboplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344905],
      "conceptName": ["Carboplatin"]
    },
    "Carmustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350066],
      "conceptName": ["Carmustine"]
    },
    "Procarbazine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1351779],
      "conceptName": ["Procarbazine"]
    },
    "Mesna": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1354698],
      "conceptName": ["Mesna"]
    },
    "irinotecan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1367268],
      "conceptName": ["irinotecan"]
    },
    "Paclitaxel": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1378382],
      "conceptName": ["Paclitaxel"]
    },
    "Topotecan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1378509],
      "conceptName": ["Topotecan"]
    },
    "Leucovorin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1388796],
      "conceptName": ["Leucovorin"]
    },
    "Chlorambucil": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1390051],
      "conceptName": ["Chlorambucil"]
    },
    "Lomustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1391846],
      "conceptName": ["Lomustine"]
    },
    "nilotinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1394023],
      "conceptName": ["nilotinib"]
    },
    "Mechlorethamine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1394337],
      "conceptName": ["Mechlorethamine"]
    },
    "bevacizumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397141],
      "conceptName": ["bevacizumab"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "mercaptopurine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1436650],
      "conceptName": ["mercaptopurine"]
    },
    "Thioguanine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1437379],
      "conceptName": ["Thioguanine"]
    },
    "Methylprednisolone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1506270],
      "conceptName": ["Methylprednisolone"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "prednisolone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1550557],
      "conceptName": ["prednisolone"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Vinblastine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008264],
      "conceptName": ["Vinblastine"]
    },
    "Vindesine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008336],
      "conceptName": ["Vindesine"]
    },
    "ASPARAGINASE": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19012585],
      "conceptName": ["ASPARAGINASE"]
    },
    "bendamustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19015523],
      "conceptName": ["bendamustine"]
    },
    "lenalidomide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19026972],
      "conceptName": ["lenalidomide"]
    },
    "doxorubicin liposome": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19051649],
      "conceptName": ["doxorubicin liposome"]
    },
    "clofarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19054821],
      "conceptName": ["clofarabine"]
    },
    "ibritumomab tiuxetan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19068830],
      "conceptName": ["ibritumomab tiuxetan"]
    },
    "Idarubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078097],
      "conceptName": ["Idarubicin"]
    },
    "Ifosfamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    },
    "Teniposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19136750],
      "conceptName": ["Teniposide"]
    },
    "Thalidomide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19137042],
      "conceptName": ["Thalidomide"]
    },
    "ranimustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [35197850],
      "conceptName": ["ranimustine"]
    },
    "Fotemustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [36879099],
      "conceptName": ["Fotemustine"]
    },
    "ofatumumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [40167582],
      "conceptName": ["ofatumumab"]
    },
    "atezolizumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [42629079],
      "conceptName": ["atezolizumab"]
    }
  },
  {
    "conceptId": [35805682],
    "regimenName": ["Fluorouracil, Folinic acid, Mitomycin"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Mitomycin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1389036],
      "conceptName": ["Mitomycin"]
    },
    "Leucovorin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1388796],
      "conceptName": ["Leucovorin"]
    },
    "Fluorouracil": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    }
  },
  {
    "conceptId": [35804580],
    "regimenName": ["Fludarabine and Alemtuzumab"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "alemtuzumab": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1312706],
      "conceptName": ["alemtuzumab"]
    },
    "fludarabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1395557],
      "conceptName": ["fludarabine"]
    },
    "Melphalan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1301267],
      "conceptName": ["Melphalan"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    }
  },
  {
    "conceptId": [35805070],
    "regimenName": ["FEAM, then auto HSCT"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Melphalan": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1301267],
      "conceptName": ["Melphalan"]
    },
    "Cytarabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Etoposide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Fotemustine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [36879099],
      "conceptName": ["Fotemustine"]
    }
  },
  {
    "conceptId": [35804637],
    "regimenName": ["BuCyTBI, then allo HSCT"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Busulfan": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1333357],
      "conceptName": ["Busulfan"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "fludarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1395557],
      "conceptName": ["fludarabine"]
    },
    "Thiotepa": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19137385],
      "conceptName": ["Thiotepa"]
    }
  },
  {
    "conceptId": [35803532],
    "regimenName": ["DCTER"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Thioguanine": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1437379],
      "conceptName": ["Thioguanine"]
    },
    "Cytarabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Daunorubicin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1311799],
      "conceptName": ["Daunorubicin"]
    },
    "Dexamethasone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "Etoposide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    }
  },
  {
    "conceptId": [35803467],
    "regimenName": ["Azacitidine and Gemtuzumab ozogamicin"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Azacitidine": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1314865],
      "conceptName": ["Azacitidine"]
    },
    "Gemtuzumab ozogamicin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [42799711],
      "conceptName": ["Gemtuzumab ozogamicin"]
    },
    "Vorinostat": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1337651],
      "conceptName": ["Vorinostat"]
    }
  },
  {
    "conceptId": [35100653],
    "regimenName": ["Lomustine, Temozolomide, RT"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Lomustine": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1391846],
      "conceptName": ["Lomustine"]
    },
    "temozolomide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1341149],
      "conceptName": ["temozolomide"]
    }
  },
  {
    "conceptId": [35804274],
    "regimenName": ["Exemestane monotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "exemestane": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1398399],
      "conceptName": ["exemestane"]
    },
    "everolimus": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19011440],
      "conceptName": ["everolimus"]
    }
  },
  {
    "conceptId": [35806489],
    "regimenName": ["Topotecan and Bevacizumab"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "bevacizumab": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1397141],
      "conceptName": ["bevacizumab"]
    },
    "Topotecan": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1378509],
      "conceptName": ["Topotecan"]
    },
    "Paclitaxel": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1378382],
      "conceptName": ["Paclitaxel"]
    }
  },
  {
    "conceptId": [35805835],
    "regimenName": ["GVP"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "vinorelbine": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1343346],
      "conceptName": ["vinorelbine"]
    },
    "gemcitabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1314924],
      "conceptName": ["gemcitabine"]
    },
    "prednisolone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1550557],
      "conceptName": ["prednisolone"]
    },
    "bendamustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19015523],
      "conceptName": ["bendamustine"]
    },
    "Ifosfamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    }
  },
  {
    "conceptId": [35805340],
    "regimenName": ["FLEP"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Cisplatin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "Leucovorin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1388796],
      "conceptName": ["Leucovorin"]
    },
    "Fluorouracil": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "Etoposide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    }
  },
  {
    "conceptId": [35806065],
    "regimenName": ["Ixazomib and Dexamethasone"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "ixazomib": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [35606214],
      "conceptName": ["ixazomib"]
    },
    "Dexamethasone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "lenalidomide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19026972],
      "conceptName": ["lenalidomide"]
    }
  },
  {
    "conceptId": [35803509],
    "regimenName": ["7 plus 3d and Midostaurin"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Cytarabine": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Daunorubicin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1311799],
      "conceptName": ["Daunorubicin"]
    },
    "midostaurin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1594003],
      "conceptName": ["midostaurin"]
    }
  },
  {
    "conceptId": [35803449],
    "regimenName": ["7 plus 3i and Sorafenib"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Idarubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [19078097],
      "conceptName": ["Idarubicin"]
    },
    "Cytarabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "sorafenib": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1363387],
      "conceptName": ["sorafenib"]
    }
  },
  {
    "conceptId": [35805095],
    "regimenName": ["C-MOPP"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Prednisone": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Procarbazine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1351779],
      "conceptName": ["Procarbazine"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Dacarbazine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311409],
      "conceptName": ["Dacarbazine"]
    },
    "Bleomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1329241],
      "conceptName": ["Bleomycin"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Carmustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350066],
      "conceptName": ["Carmustine"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Mechlorethamine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1394337],
      "conceptName": ["Mechlorethamine"]
    },
    "Vinblastine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008264],
      "conceptName": ["Vinblastine"]
    }
  },
  {
    "conceptId": [35804283],
    "regimenName": ["Anastrozole and Ribociclib"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "anastrozole": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1348265],
      "conceptName": ["anastrozole"]
    },
    "ribociclib": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1592911],
      "conceptName": ["ribociclib"]
    }
  },
  {
    "conceptId": [35805110],
    "regimenName": ["ProMACE-MOPP"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Methotrexate": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Prednisone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Procarbazine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1351779],
      "conceptName": ["Procarbazine"]
    },
    "Mechlorethamine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1394337],
      "conceptName": ["Mechlorethamine"]
    },
    "Etoposide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    }
  },
  {
    "conceptId": [35804310],
    "regimenName": ["Capecitabine, Bevacizumab, Trastuzumab"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "trastuzumab": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1387104],
      "conceptName": ["trastuzumab"]
    },
    "bevacizumab": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1397141],
      "conceptName": ["bevacizumab"]
    },
    "capecitabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1337620],
      "conceptName": ["capecitabine"]
    }
  },
  {
    "conceptId": [35803614],
    "regimenName": ["Etoposide and TBI"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Etoposide": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Tretinoin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [903643],
      "conceptName": ["Tretinoin"]
    },
    "Fluorouracil": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "Melphalan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1301267],
      "conceptName": ["Melphalan"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Mitotane": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1309161],
      "conceptName": ["Mitotane"]
    },
    "Mitoxantrone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1309188],
      "conceptName": ["Mitoxantrone"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Dactinomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311443],
      "conceptName": ["Dactinomycin"]
    },
    "Daunorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311799],
      "conceptName": ["Daunorubicin"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "pegaspargase": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1326481],
      "conceptName": ["pegaspargase"]
    },
    "Bleomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1329241],
      "conceptName": ["Bleomycin"]
    },
    "bortezomib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1336825],
      "conceptName": ["bortezomib"]
    },
    "Vorinostat": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1337651],
      "conceptName": ["Vorinostat"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Epirubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344354],
      "conceptName": ["Epirubicin"]
    },
    "Carboplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344905],
      "conceptName": ["Carboplatin"]
    },
    "Carmustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350066],
      "conceptName": ["Carmustine"]
    },
    "Procarbazine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1351779],
      "conceptName": ["Procarbazine"]
    },
    "Mesna": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1354698],
      "conceptName": ["Mesna"]
    },
    "irinotecan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1367268],
      "conceptName": ["irinotecan"]
    },
    "Paclitaxel": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1378382],
      "conceptName": ["Paclitaxel"]
    },
    "Topotecan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1378509],
      "conceptName": ["Topotecan"]
    },
    "Leucovorin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1388796],
      "conceptName": ["Leucovorin"]
    },
    "Chlorambucil": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1390051],
      "conceptName": ["Chlorambucil"]
    },
    "Lomustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1391846],
      "conceptName": ["Lomustine"]
    },
    "nilotinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1394023],
      "conceptName": ["nilotinib"]
    },
    "Mechlorethamine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1394337],
      "conceptName": ["Mechlorethamine"]
    },
    "bevacizumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397141],
      "conceptName": ["bevacizumab"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "mercaptopurine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1436650],
      "conceptName": ["mercaptopurine"]
    },
    "Thioguanine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1437379],
      "conceptName": ["Thioguanine"]
    },
    "Methylprednisolone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1506270],
      "conceptName": ["Methylprednisolone"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "prednisolone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1550557],
      "conceptName": ["prednisolone"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Vinblastine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008264],
      "conceptName": ["Vinblastine"]
    },
    "Vindesine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008336],
      "conceptName": ["Vindesine"]
    },
    "ASPARAGINASE": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19012585],
      "conceptName": ["ASPARAGINASE"]
    },
    "bendamustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19015523],
      "conceptName": ["bendamustine"]
    },
    "lenalidomide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19026972],
      "conceptName": ["lenalidomide"]
    },
    "doxorubicin liposome": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19051649],
      "conceptName": ["doxorubicin liposome"]
    },
    "clofarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19054821],
      "conceptName": ["clofarabine"]
    },
    "ibritumomab tiuxetan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19068830],
      "conceptName": ["ibritumomab tiuxetan"]
    },
    "Idarubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078097],
      "conceptName": ["Idarubicin"]
    },
    "Ifosfamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    },
    "Teniposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19136750],
      "conceptName": ["Teniposide"]
    },
    "Thalidomide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19137042],
      "conceptName": ["Thalidomide"]
    },
    "ranimustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [35197850],
      "conceptName": ["ranimustine"]
    },
    "Fotemustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [36879099],
      "conceptName": ["Fotemustine"]
    },
    "ofatumumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [40167582],
      "conceptName": ["ofatumumab"]
    },
    "atezolizumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [42629079],
      "conceptName": ["atezolizumab"]
    }
  },
  {
    "conceptId": [35806287],
    "regimenName": ["Thalidomide and Prednisolone"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Thalidomide": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [19137042],
      "conceptName": ["Thalidomide"]
    },
    "prednisolone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1550557],
      "conceptName": ["prednisolone"]
    }
  },
  {
    "conceptId": [35805793],
    "regimenName": ["TACE"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Fluorouracil": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "Melphalan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1301267],
      "conceptName": ["Melphalan"]
    },
    "imatinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1304107],
      "conceptName": ["imatinib"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Mitotane": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1309161],
      "conceptName": ["Mitotane"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Dacarbazine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311409],
      "conceptName": ["Dacarbazine"]
    },
    "Dactinomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311443],
      "conceptName": ["Dactinomycin"]
    },
    "alemtuzumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1312706],
      "conceptName": ["alemtuzumab"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "gemcitabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314924],
      "conceptName": ["gemcitabine"]
    },
    "docetaxel": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1315942],
      "conceptName": ["docetaxel"]
    },
    "pegaspargase": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1326481],
      "conceptName": ["pegaspargase"]
    },
    "Bleomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1329241],
      "conceptName": ["Bleomycin"]
    },
    "bortezomib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1336825],
      "conceptName": ["bortezomib"]
    },
    "Epirubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344354],
      "conceptName": ["Epirubicin"]
    },
    "Carboplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344905],
      "conceptName": ["Carboplatin"]
    },
    "Carmustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350066],
      "conceptName": ["Carmustine"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Procarbazine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1351779],
      "conceptName": ["Procarbazine"]
    },
    "Mesna": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1354698],
      "conceptName": ["Mesna"]
    },
    "dasatinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1358436],
      "conceptName": ["dasatinib"]
    },
    "irinotecan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1367268],
      "conceptName": ["irinotecan"]
    },
    "Altretamine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1368823],
      "conceptName": ["Altretamine"]
    },
    "Paclitaxel": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1378382],
      "conceptName": ["Paclitaxel"]
    },
    "Topotecan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1378509],
      "conceptName": ["Topotecan"]
    },
    "Interferon Alfa-2b": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1380068],
      "conceptName": ["Interferon Alfa-2b"]
    },
    "trastuzumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1387104],
      "conceptName": ["trastuzumab"]
    },
    "Mitomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1389036],
      "conceptName": ["Mitomycin"]
    },
    "Chlorambucil": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1390051],
      "conceptName": ["Chlorambucil"]
    },
    "Lomustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1391846],
      "conceptName": ["Lomustine"]
    },
    "Mechlorethamine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1394337],
      "conceptName": ["Mechlorethamine"]
    },
    "bevacizumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397141],
      "conceptName": ["bevacizumab"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "mercaptopurine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1436650],
      "conceptName": ["mercaptopurine"]
    },
    "Tamoxifen": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1436678],
      "conceptName": ["Tamoxifen"]
    },
    "Thioguanine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1437379],
      "conceptName": ["Thioguanine"]
    },
    "Medroxyprogesterone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1500211],
      "conceptName": ["Medroxyprogesterone"]
    },
    "Methylprednisolone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1506270],
      "conceptName": ["Methylprednisolone"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "prednisolone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1550557],
      "conceptName": ["prednisolone"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Hyaluronidase / rituximab Injection [Rituxan Hycela]": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1593155],
      "conceptName": ["Hyaluronidase / rituximab Injection [Rituxan Hycela]"]
    },
    "olaratumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1718346],
      "conceptName": ["olaratumab"]
    },
    "Quinine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1760616],
      "conceptName": ["Quinine"]
    },
    "Vinblastine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008264],
      "conceptName": ["Vinblastine"]
    },
    "Vindesine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008336],
      "conceptName": ["Vindesine"]
    },
    "everolimus": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19011440],
      "conceptName": ["everolimus"]
    },
    "ASPARAGINASE": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19012585],
      "conceptName": ["ASPARAGINASE"]
    },
    "lenalidomide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19026972],
      "conceptName": ["lenalidomide"]
    },
    "denileukin diftitox": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19051642],
      "conceptName": ["denileukin diftitox"]
    },
    "iodine-131-tositumomab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19054997],
      "conceptName": ["iodine-131-tositumomab"]
    },
    "Ifosfamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    },
    "BCG, Live, Tice Strain": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19086176],
      "conceptName": ["BCG, Live, Tice Strain"]
    },
    "Strontium-89": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19132890],
      "conceptName": ["Strontium-89"]
    },
    "Streptozocin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19136210],
      "conceptName": ["Streptozocin"]
    },
    "Teniposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19136750],
      "conceptName": ["Teniposide"]
    },
    "Thalidomide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19137042],
      "conceptName": ["Thalidomide"]
    },
    "ranimustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [35197850],
      "conceptName": ["ranimustine"]
    },
    "ofatumumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [40167582],
      "conceptName": ["ofatumumab"]
    },
    "brentuximab vedotin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [40241969],
      "conceptName": ["brentuximab vedotin"]
    },
    "ponatinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [43013182],
      "conceptName": ["ponatinib"]
    },
    "obinutuzumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [44507676],
      "conceptName": ["obinutuzumab"]
    }
  },
  {
    "conceptId": [35804255],
    "regimenName": ["Paclitaxel and Bevacizumab"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Paclitaxel": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1378382],
      "conceptName": ["Paclitaxel"]
    },
    "bevacizumab": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1397141],
      "conceptName": ["bevacizumab"]
    },
    "Carboplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344905],
      "conceptName": ["Carboplatin"]
    },
    "Topotecan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1378509],
      "conceptName": ["Topotecan"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "atezolizumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [42629079],
      "conceptName": ["atezolizumab"]
    }
  },
  {
    "conceptId": [35803520],
    "regimenName": ["5 plus 3i"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Idarubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [19078097],
      "conceptName": ["Idarubicin"]
    },
    "Cytarabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Tretinoin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [903643],
      "conceptName": ["Tretinoin"]
    },
    "imatinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1304107],
      "conceptName": ["imatinib"]
    },
    "Filgrastim": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1304850],
      "conceptName": ["Filgrastim"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Mitoxantrone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1309188],
      "conceptName": ["Mitoxantrone"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Vorinostat": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1337651],
      "conceptName": ["Vorinostat"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "sorafenib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1363387],
      "conceptName": ["sorafenib"]
    },
    "Lomustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1391846],
      "conceptName": ["Lomustine"]
    },
    "fludarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1395557],
      "conceptName": ["fludarabine"]
    },
    "mercaptopurine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1436650],
      "conceptName": ["mercaptopurine"]
    },
    "Thioguanine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1437379],
      "conceptName": ["Thioguanine"]
    },
    "Pravastatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551860],
      "conceptName": ["Pravastatin"]
    },
    "lenograstim": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19009705],
      "conceptName": ["lenograstim"]
    },
    "clofarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19054821],
      "conceptName": ["clofarabine"]
    },
    "Norethandrolone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19128219],
      "conceptName": ["Norethandrolone"]
    },
    "panobinostat": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [46221435],
      "conceptName": ["panobinostat"]
    }
  },
  {
    "conceptId": [35806940],
    "regimenName": ["Belotecan and Cisplatin"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Cisplatin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "Fluorouracil": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "Isotretinoin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [984232],
      "conceptName": ["Isotretinoin"]
    },
    "Melphalan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1301267],
      "conceptName": ["Melphalan"]
    },
    "pemetrexed": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1304919],
      "conceptName": ["pemetrexed"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Mitotane": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1309161],
      "conceptName": ["Mitotane"]
    },
    "Aldesleukin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1309770],
      "conceptName": ["Aldesleukin"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Dacarbazine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311409],
      "conceptName": ["Dacarbazine"]
    },
    "Dactinomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311443],
      "conceptName": ["Dactinomycin"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "gemcitabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314924],
      "conceptName": ["gemcitabine"]
    },
    "cetuximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1315411],
      "conceptName": ["cetuximab"]
    },
    "docetaxel": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1315942],
      "conceptName": ["docetaxel"]
    },
    "erlotinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1325363],
      "conceptName": ["erlotinib"]
    },
    "pegaspargase": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1326481],
      "conceptName": ["pegaspargase"]
    },
    "Bleomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1329241],
      "conceptName": ["Bleomycin"]
    },
    "bortezomib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1336825],
      "conceptName": ["bortezomib"]
    },
    "capecitabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1337620],
      "conceptName": ["capecitabine"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "vinorelbine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1343346],
      "conceptName": ["vinorelbine"]
    },
    "Epirubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344354],
      "conceptName": ["Epirubicin"]
    },
    "Carboplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344905],
      "conceptName": ["Carboplatin"]
    },
    "Carmustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350066],
      "conceptName": ["Carmustine"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Mesna": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1354698],
      "conceptName": ["Mesna"]
    },
    "Hyaluronidase / trastuzumab Injection [Herceptin Hylecta]": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1366689],
      "conceptName": ["Hyaluronidase / trastuzumab Injection [Herceptin Hylecta]"]
    },
    "irinotecan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1367268],
      "conceptName": ["irinotecan"]
    },
    "Altretamine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1368823],
      "conceptName": ["Altretamine"]
    },
    "hydroxyurea": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1377141],
      "conceptName": ["hydroxyurea"]
    },
    "Paclitaxel": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1378382],
      "conceptName": ["Paclitaxel"]
    },
    "Topotecan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1378509],
      "conceptName": ["Topotecan"]
    },
    "Interferon Alfa-2a": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1379969],
      "conceptName": ["Interferon Alfa-2a"]
    },
    "Interferon Alfa-2b": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1380068],
      "conceptName": ["Interferon Alfa-2b"]
    },
    "Interferon gamma-1b": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1380191],
      "conceptName": ["Interferon gamma-1b"]
    },
    "trastuzumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1387104],
      "conceptName": ["trastuzumab"]
    },
    "Leucovorin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1388796],
      "conceptName": ["Leucovorin"]
    },
    "Mitomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1389036],
      "conceptName": ["Mitomycin"]
    },
    "Chlorambucil": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1390051],
      "conceptName": ["Chlorambucil"]
    },
    "Lomustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1391846],
      "conceptName": ["Lomustine"]
    },
    "bevacizumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397141],
      "conceptName": ["bevacizumab"]
    },
    "Tamoxifen": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1436678],
      "conceptName": ["Tamoxifen"]
    },
    "Methylprednisolone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1506270],
      "conceptName": ["Methylprednisolone"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Vinblastine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008264],
      "conceptName": ["Vinblastine"]
    },
    "Vindesine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008336],
      "conceptName": ["Vindesine"]
    },
    "raltitrexed": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19038536],
      "conceptName": ["raltitrexed"]
    },
    "doxorubicin liposome": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19051649],
      "conceptName": ["doxorubicin liposome"]
    },
    "Ifosfamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    },
    "panitumumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19100985],
      "conceptName": ["panitumumab"]
    },
    "Thalidomide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19137042],
      "conceptName": ["Thalidomide"]
    },
    "necitumumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [35606215],
      "conceptName": ["necitumumab"]
    },
    "ofatumumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [40167582],
      "conceptName": ["ofatumumab"]
    },
    "pembrolizumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [45775965],
      "conceptName": ["pembrolizumab"]
    }
  },
  {
    "conceptId": [35806430],
    "regimenName": ["MIC"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Mitomycin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1389036],
      "conceptName": ["Mitomycin"]
    },
    "Cisplatin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "Ifosfamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    }
  },
  {
    "conceptId": [35804755],
    "regimenName": ["CapeOx"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "oxaliplatin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1318011],
      "conceptName": ["oxaliplatin"]
    },
    "capecitabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1337620],
      "conceptName": ["capecitabine"]
    },
    "cetuximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1315411],
      "conceptName": ["cetuximab"]
    },
    "docetaxel": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1315942],
      "conceptName": ["docetaxel"]
    },
    "Epirubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344354],
      "conceptName": ["Epirubicin"]
    },
    "bevacizumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397141],
      "conceptName": ["bevacizumab"]
    },
    "panitumumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19100985],
      "conceptName": ["panitumumab"]
    }
  },
  {
    "conceptId": [35102006],
    "regimenName": ["FOLFIRI and Cetuximab (L-Leucovorin)"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "irinotecan": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1367268],
      "conceptName": ["irinotecan"]
    },
    "cetuximab": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1315411],
      "conceptName": ["cetuximab"]
    },
    "levoleucovorin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [40168303],
      "conceptName": ["levoleucovorin"]
    },
    "Fluorouracil": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "oxaliplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1318011],
      "conceptName": ["oxaliplatin"]
    }
  },
  {
    "conceptId": [35804240],
    "regimenName": ["Goserelin and Tamoxifen"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Tamoxifen": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1436678],
      "conceptName": ["Tamoxifen"]
    },
    "Goserelin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1366310],
      "conceptName": ["Goserelin"]
    }
  },
  {
    "conceptId": [35804787],
    "regimenName": ["FOLFIRI and Ziv-aflibercept"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "aflibercept": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [40244266],
      "conceptName": ["aflibercept"]
    },
    "Leucovorin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1388796],
      "conceptName": ["Leucovorin"]
    },
    "irinotecan": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1367268],
      "conceptName": ["irinotecan"]
    },
    "Fluorouracil": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    }
  },
  {
    "conceptId": [35806104],
    "regimenName": ["Clarithromycin monotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Clarithromycin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1750500],
      "conceptName": ["Clarithromycin"]
    },
    "Omeprazole": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [923645],
      "conceptName": ["Omeprazole"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "Amoxicillin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1713332],
      "conceptName": ["Amoxicillin"]
    },
    "lenalidomide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19026972],
      "conceptName": ["lenalidomide"]
    }
  },
  {
    "conceptId": [35804300],
    "regimenName": ["TCHP (Taxotere)"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Carboplatin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1344905],
      "conceptName": ["Carboplatin"]
    },
    "pertuzumab": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [42801287],
      "conceptName": ["pertuzumab"]
    },
    "trastuzumab": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1387104],
      "conceptName": ["trastuzumab"]
    },
    "docetaxel": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1315942],
      "conceptName": ["docetaxel"]
    }
  },
  {
    "conceptId": [35803581],
    "regimenName": ["Gemcitabine and Irinotecan"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "irinotecan": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1367268],
      "conceptName": ["irinotecan"]
    },
    "gemcitabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1314924],
      "conceptName": ["gemcitabine"]
    },
    "Fluorouracil": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "oxaliplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1318011],
      "conceptName": ["oxaliplatin"]
    },
    "Leucovorin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1388796],
      "conceptName": ["Leucovorin"]
    }
  },
  {
    "conceptId": [35804078],
    "regimenName": ["Imatinib-based consolidation"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Cytarabine": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "mercaptopurine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1436650],
      "conceptName": ["mercaptopurine"]
    },
    "imatinib": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1304107],
      "conceptName": ["imatinib"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    }
  },
  {
    "conceptId": [35806377],
    "regimenName": ["Cyclophosphamide and Vincristine"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Cyclophosphamide": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "inotuzumab ozogamicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [794068],
      "conceptName": ["inotuzumab ozogamicin"]
    },
    "Fluorouracil": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "Melphalan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1301267],
      "conceptName": ["Melphalan"]
    },
    "imatinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1304107],
      "conceptName": ["imatinib"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Mitoxantrone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1309188],
      "conceptName": ["Mitoxantrone"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Dacarbazine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311409],
      "conceptName": ["Dacarbazine"]
    },
    "Dactinomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311443],
      "conceptName": ["Dactinomycin"]
    },
    "Daunorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311799],
      "conceptName": ["Daunorubicin"]
    },
    "alemtuzumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1312706],
      "conceptName": ["alemtuzumab"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "gemcitabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314924],
      "conceptName": ["gemcitabine"]
    },
    "pegaspargase": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1326481],
      "conceptName": ["pegaspargase"]
    },
    "Bleomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1329241],
      "conceptName": ["Bleomycin"]
    },
    "bortezomib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1336825],
      "conceptName": ["bortezomib"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Epirubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344354],
      "conceptName": ["Epirubicin"]
    },
    "Carboplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344905],
      "conceptName": ["Carboplatin"]
    },
    "Carmustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350066],
      "conceptName": ["Carmustine"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Procarbazine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1351779],
      "conceptName": ["Procarbazine"]
    },
    "dasatinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1358436],
      "conceptName": ["dasatinib"]
    },
    "irinotecan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1367268],
      "conceptName": ["irinotecan"]
    },
    "Topotecan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1378509],
      "conceptName": ["Topotecan"]
    },
    "Mechlorethamine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1394337],
      "conceptName": ["Mechlorethamine"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "mercaptopurine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1436650],
      "conceptName": ["mercaptopurine"]
    },
    "Thioguanine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1437379],
      "conceptName": ["Thioguanine"]
    },
    "Methylprednisolone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1506270],
      "conceptName": ["Methylprednisolone"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "prednisolone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1550557],
      "conceptName": ["prednisolone"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Hyaluronidase / rituximab Injection [Rituxan Hycela]": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1593155],
      "conceptName": ["Hyaluronidase / rituximab Injection [Rituxan Hycela]"]
    },
    "nelarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19002912],
      "conceptName": ["nelarabine"]
    },
    "Vinblastine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008264],
      "conceptName": ["Vinblastine"]
    },
    "Vindesine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008336],
      "conceptName": ["Vindesine"]
    },
    "everolimus": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19011440],
      "conceptName": ["everolimus"]
    },
    "ASPARAGINASE": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19012585],
      "conceptName": ["ASPARAGINASE"]
    },
    "lenalidomide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19026972],
      "conceptName": ["lenalidomide"]
    },
    "denileukin diftitox": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19051642],
      "conceptName": ["denileukin diftitox"]
    },
    "doxorubicin liposome": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19051649],
      "conceptName": ["doxorubicin liposome"]
    },
    "iodine-131-tositumomab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19054997],
      "conceptName": ["iodine-131-tositumomab"]
    },
    "Idarubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078097],
      "conceptName": ["Idarubicin"]
    },
    "Ifosfamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    },
    "BCG, Live, Tice Strain": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19086176],
      "conceptName": ["BCG, Live, Tice Strain"]
    },
    "Teniposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19136750],
      "conceptName": ["Teniposide"]
    },
    "ranimustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [35197850],
      "conceptName": ["ranimustine"]
    },
    "ofatumumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [40167582],
      "conceptName": ["ofatumumab"]
    },
    "Cytarabine liposome": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [40175460],
      "conceptName": ["Cytarabine liposome"]
    },
    "ponatinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [43013182],
      "conceptName": ["ponatinib"]
    },
    "obinutuzumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [44507676],
      "conceptName": ["obinutuzumab"]
    }
  },
  {
    "conceptId": [35805329],
    "regimenName": ["Cisplatin and Etoposide"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Cisplatin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "Etoposide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Fluorouracil": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "Melphalan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1301267],
      "conceptName": ["Melphalan"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Mitotane": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1309161],
      "conceptName": ["Mitotane"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Bleomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1329241],
      "conceptName": ["Bleomycin"]
    },
    "bortezomib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1336825],
      "conceptName": ["bortezomib"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Epirubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344354],
      "conceptName": ["Epirubicin"]
    },
    "irinotecan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1367268],
      "conceptName": ["irinotecan"]
    },
    "Leucovorin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1388796],
      "conceptName": ["Leucovorin"]
    },
    "Lomustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1391846],
      "conceptName": ["Lomustine"]
    },
    "bevacizumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397141],
      "conceptName": ["bevacizumab"]
    },
    "Methylprednisolone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1506270],
      "conceptName": ["Methylprednisolone"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "Vinblastine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008264],
      "conceptName": ["Vinblastine"]
    },
    "Ifosfamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    },
    "Thalidomide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19137042],
      "conceptName": ["Thalidomide"]
    },
    "ofatumumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [40167582],
      "conceptName": ["ofatumumab"]
    }
  },
  {
    "conceptId": [35805834],
    "regimenName": ["Gemcitabine and Rituximab"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "rituximab": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "gemcitabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1314924],
      "conceptName": ["gemcitabine"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "oxaliplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1318011],
      "conceptName": ["oxaliplatin"]
    },
    "Carboplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344905],
      "conceptName": ["Carboplatin"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "prednisolone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1550557],
      "conceptName": ["prednisolone"]
    }
  },
  {
    "conceptId": [35804073],
    "regimenName": ["Hyper-CVAD and Imatinib"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Methotrexate": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Cytarabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "imatinib": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1304107],
      "conceptName": ["imatinib"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Dexamethasone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    }
  },
  {
    "conceptId": [35806097],
    "regimenName": ["Ibrutinib and Venetoclax"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "venetoclax": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [35604205],
      "conceptName": ["venetoclax"]
    },
    "Ibrutinib": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [44507848],
      "conceptName": ["Ibrutinib"]
    }
  },
  {
    "conceptId": [35806944],
    "regimenName": ["CAV"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Fluorouracil": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "Melphalan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1301267],
      "conceptName": ["Melphalan"]
    },
    "imatinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1304107],
      "conceptName": ["imatinib"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Dacarbazine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311409],
      "conceptName": ["Dacarbazine"]
    },
    "Dactinomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311443],
      "conceptName": ["Dactinomycin"]
    },
    "alemtuzumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1312706],
      "conceptName": ["alemtuzumab"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "pegaspargase": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1326481],
      "conceptName": ["pegaspargase"]
    },
    "Bleomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1329241],
      "conceptName": ["Bleomycin"]
    },
    "bortezomib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1336825],
      "conceptName": ["bortezomib"]
    },
    "Carboplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344905],
      "conceptName": ["Carboplatin"]
    },
    "Carmustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350066],
      "conceptName": ["Carmustine"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Procarbazine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1351779],
      "conceptName": ["Procarbazine"]
    },
    "dasatinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1358436],
      "conceptName": ["dasatinib"]
    },
    "irinotecan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1367268],
      "conceptName": ["irinotecan"]
    },
    "Topotecan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1378509],
      "conceptName": ["Topotecan"]
    },
    "Mechlorethamine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1394337],
      "conceptName": ["Mechlorethamine"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "mercaptopurine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1436650],
      "conceptName": ["mercaptopurine"]
    },
    "Thioguanine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1437379],
      "conceptName": ["Thioguanine"]
    },
    "Methylprednisolone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1506270],
      "conceptName": ["Methylprednisolone"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "prednisolone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1550557],
      "conceptName": ["prednisolone"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Hyaluronidase / rituximab Injection [Rituxan Hycela]": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1593155],
      "conceptName": ["Hyaluronidase / rituximab Injection [Rituxan Hycela]"]
    },
    "Vinblastine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008264],
      "conceptName": ["Vinblastine"]
    },
    "Vindesine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008336],
      "conceptName": ["Vindesine"]
    },
    "everolimus": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19011440],
      "conceptName": ["everolimus"]
    },
    "ASPARAGINASE": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19012585],
      "conceptName": ["ASPARAGINASE"]
    },
    "lenalidomide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19026972],
      "conceptName": ["lenalidomide"]
    },
    "denileukin diftitox": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19051642],
      "conceptName": ["denileukin diftitox"]
    },
    "iodine-131-tositumomab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19054997],
      "conceptName": ["iodine-131-tositumomab"]
    },
    "Ifosfamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    },
    "BCG, Live, Tice Strain": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19086176],
      "conceptName": ["BCG, Live, Tice Strain"]
    },
    "Teniposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19136750],
      "conceptName": ["Teniposide"]
    },
    "ranimustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [35197850],
      "conceptName": ["ranimustine"]
    },
    "ofatumumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [40167582],
      "conceptName": ["ofatumumab"]
    },
    "ponatinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [43013182],
      "conceptName": ["ponatinib"]
    },
    "obinutuzumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [44507676],
      "conceptName": ["obinutuzumab"]
    }
  },
  {
    "conceptId": [35803612],
    "regimenName": ["Busulfan and Fludarabine"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Busulfan": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1333357],
      "conceptName": ["Busulfan"]
    },
    "fludarabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1395557],
      "conceptName": ["fludarabine"]
    },
    "Melphalan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1301267],
      "conceptName": ["Melphalan"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "ibritumomab tiuxetan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19068830],
      "conceptName": ["ibritumomab tiuxetan"]
    }
  },
  {
    "conceptId": [35804422],
    "regimenName": ["MT-R"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Methotrexate": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "rituximab": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "temozolomide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1341149],
      "conceptName": ["temozolomide"]
    }
  },
  {
    "conceptId": [35806080],
    "regimenName": ["R-CHOP/R-DHAP"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Cisplatin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "rituximab": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Cytarabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Prednisone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Dexamethasone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    }
  },
  {
    "conceptId": [35806474],
    "regimenName": ["M-EI"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Methotrexate": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Ifosfamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    },
    "Mesna": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1354698],
      "conceptName": ["Mesna"]
    },
    "Etoposide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "ASPARAGINASE": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19012585],
      "conceptName": ["ASPARAGINASE"]
    }
  },
  {
    "conceptId": [35804392],
    "regimenName": ["Afatinib monotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Afatinib": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [43533090],
      "conceptName": ["Afatinib"]
    },
    "Paclitaxel": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1378382],
      "conceptName": ["Paclitaxel"]
    }
  },
  {
    "conceptId": [35805350],
    "regimenName": ["Carboplatin, Paclitaxel, RT"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Carboplatin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1344905],
      "conceptName": ["Carboplatin"]
    },
    "Paclitaxel": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1378382],
      "conceptName": ["Paclitaxel"]
    },
    "gemcitabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314924],
      "conceptName": ["gemcitabine"]
    },
    "capecitabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1337620],
      "conceptName": ["capecitabine"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "trastuzumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1387104],
      "conceptName": ["trastuzumab"]
    },
    "bevacizumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397141],
      "conceptName": ["bevacizumab"]
    },
    "ipilimumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [40238188],
      "conceptName": ["ipilimumab"]
    },
    "atezolizumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [42629079],
      "conceptName": ["atezolizumab"]
    },
    "pembrolizumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [45775965],
      "conceptName": ["pembrolizumab"]
    },
    "olaparib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [45892579],
      "conceptName": ["olaparib"]
    }
  },
  {
    "conceptId": [35101473],
    "regimenName": ["Mercaptopurine, Methotrexate, Vincristine, Dexamethasone"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Methotrexate": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "mercaptopurine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1436650],
      "conceptName": ["mercaptopurine"]
    },
    "Dexamethasone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Thioguanine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1437379],
      "conceptName": ["Thioguanine"]
    },
    "ASPARAGINASE": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19012585],
      "conceptName": ["ASPARAGINASE"]
    }
  },
  {
    "conceptId": [35803494],
    "regimenName": ["CLAG-M"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Cytarabine": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Filgrastim": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1304850],
      "conceptName": ["Filgrastim"]
    },
    "Mitoxantrone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1309188],
      "conceptName": ["Mitoxantrone"]
    },
    "Cladribine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [19054825],
      "conceptName": ["Cladribine"]
    }
  },
  {
    "conceptId": [35806318],
    "regimenName": ["Bortezomib and Cyclophosphamide"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "bortezomib": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1336825],
      "conceptName": ["bortezomib"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Melphalan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1301267],
      "conceptName": ["Melphalan"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "prednisolone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1550557],
      "conceptName": ["prednisolone"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "lenalidomide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19026972],
      "conceptName": ["lenalidomide"]
    },
    "doxorubicin liposome": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19051649],
      "conceptName": ["doxorubicin liposome"]
    },
    "Thalidomide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19137042],
      "conceptName": ["Thalidomide"]
    }
  },
  {
    "conceptId": [35806953],
    "regimenName": ["CAV/PE"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Cisplatin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Etoposide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    }
  },
  {
    "conceptId": [35803615],
    "regimenName": ["Fludarabine, Busulfan, Cyclophosphamide"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Busulfan": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1333357],
      "conceptName": ["Busulfan"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "fludarabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1395557],
      "conceptName": ["fludarabine"]
    }
  },
  {
    "conceptId": [35805655],
    "regimenName": ["CHVP-I"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Prednisone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Interferon Alfa-2b": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1380068],
      "conceptName": ["Interferon Alfa-2b"]
    },
    "Teniposide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [19136750],
      "conceptName": ["Teniposide"]
    }
  },
  {
    "conceptId": [35806470],
    "regimenName": ["MAPIE"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Methotrexate": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Cisplatin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "Ifosfamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    },
    "Etoposide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    }
  },
  {
    "conceptId": [35805112],
    "regimenName": ["VACOP-B"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Bleomycin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1329241],
      "conceptName": ["Bleomycin"]
    },
    "Prednisone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Etoposide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Procarbazine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1351779],
      "conceptName": ["Procarbazine"]
    }
  },
  {
    "conceptId": [35806906],
    "regimenName": ["Everolimus and Lenvatinib"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "everolimus": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [19011440],
      "conceptName": ["everolimus"]
    },
    "lenvatinib": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [46221433],
      "conceptName": ["lenvatinib"]
    }
  },
  {
    "conceptId": [35806272],
    "regimenName": ["VT"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Thalidomide": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [19137042],
      "conceptName": ["Thalidomide"]
    },
    "bortezomib": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1336825],
      "conceptName": ["bortezomib"]
    },
    "Melphalan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1301267],
      "conceptName": ["Melphalan"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "daratumumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [35605744],
      "conceptName": ["daratumumab"]
    },
    "panobinostat": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [46221435],
      "conceptName": ["panobinostat"]
    }
  },
  {
    "conceptId": [35806115],
    "regimenName": ["CVD, IL-2, IFN alfa-2b - sequential biochemotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Cisplatin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "Vinblastine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [19008264],
      "conceptName": ["Vinblastine"]
    },
    "Dacarbazine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1311409],
      "conceptName": ["Dacarbazine"]
    },
    "Aldesleukin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1309770],
      "conceptName": ["Aldesleukin"]
    },
    "Interferon Alfa-2b": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1380068],
      "conceptName": ["Interferon Alfa-2b"]
    }
  },
  {
    "conceptId": [35805679],
    "regimenName": ["FP, then Capecitabine and RT, then FP"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Cisplatin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "Fluorouracil": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "capecitabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1337620],
      "conceptName": ["capecitabine"]
    }
  },
  {
    "conceptId": [35805840],
    "regimenName": ["CBV-Mx, then auto HSCT"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Carmustine": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1350066],
      "conceptName": ["Carmustine"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Mitoxantrone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1309188],
      "conceptName": ["Mitoxantrone"]
    },
    "Etoposide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    }
  },
  {
    "conceptId": [35803538],
    "regimenName": ["Amsacrine and Cytarabine"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Amsacrine": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [19017810],
      "conceptName": ["Amsacrine"]
    },
    "Cytarabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    }
  },
  {
    "conceptId": [35806901],
    "regimenName": ["Axitinib monotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "axitinib": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [42709322],
      "conceptName": ["axitinib"]
    },
    "avelumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1593273],
      "conceptName": ["avelumab"]
    },
    "pembrolizumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [45775965],
      "conceptName": ["pembrolizumab"]
    }
  },
  {
    "conceptId": [35805365],
    "regimenName": ["mDCF and Bevacizumab"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "bevacizumab": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1397141],
      "conceptName": ["bevacizumab"]
    },
    "Cisplatin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "docetaxel": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1315942],
      "conceptName": ["docetaxel"]
    },
    "Leucovorin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1388796],
      "conceptName": ["Leucovorin"]
    },
    "Fluorouracil": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    }
  },
  {
    "conceptId": [35804007],
    "regimenName": ["Cyclophosphamide, Etoposide, TBI"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Cyclophosphamide": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Etoposide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Melphalan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1301267],
      "conceptName": ["Melphalan"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Mitoxantrone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1309188],
      "conceptName": ["Mitoxantrone"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Dactinomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311443],
      "conceptName": ["Dactinomycin"]
    },
    "Daunorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311799],
      "conceptName": ["Daunorubicin"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Bleomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1329241],
      "conceptName": ["Bleomycin"]
    },
    "bortezomib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1336825],
      "conceptName": ["bortezomib"]
    },
    "Vorinostat": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1337651],
      "conceptName": ["Vorinostat"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Epirubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344354],
      "conceptName": ["Epirubicin"]
    },
    "Carboplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344905],
      "conceptName": ["Carboplatin"]
    },
    "Carmustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350066],
      "conceptName": ["Carmustine"]
    },
    "Procarbazine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1351779],
      "conceptName": ["Procarbazine"]
    },
    "irinotecan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1367268],
      "conceptName": ["irinotecan"]
    },
    "Topotecan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1378509],
      "conceptName": ["Topotecan"]
    },
    "Lomustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1391846],
      "conceptName": ["Lomustine"]
    },
    "Mechlorethamine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1394337],
      "conceptName": ["Mechlorethamine"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "mercaptopurine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1436650],
      "conceptName": ["mercaptopurine"]
    },
    "Thioguanine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1437379],
      "conceptName": ["Thioguanine"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "prednisolone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1550557],
      "conceptName": ["prednisolone"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Vinblastine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008264],
      "conceptName": ["Vinblastine"]
    },
    "Vindesine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008336],
      "conceptName": ["Vindesine"]
    },
    "ASPARAGINASE": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19012585],
      "conceptName": ["ASPARAGINASE"]
    },
    "doxorubicin liposome": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19051649],
      "conceptName": ["doxorubicin liposome"]
    },
    "clofarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19054821],
      "conceptName": ["clofarabine"]
    },
    "Ifosfamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    },
    "Teniposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19136750],
      "conceptName": ["Teniposide"]
    },
    "Thalidomide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19137042],
      "conceptName": ["Thalidomide"]
    },
    "ranimustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [35197850],
      "conceptName": ["ranimustine"]
    }
  },
  {
    "conceptId": [35803488],
    "regimenName": ["Cyclophosphamide and TBI, then allo HSCT"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Cyclophosphamide": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "inotuzumab ozogamicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [794068],
      "conceptName": ["inotuzumab ozogamicin"]
    },
    "Fluorouracil": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "Melphalan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1301267],
      "conceptName": ["Melphalan"]
    },
    "imatinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1304107],
      "conceptName": ["imatinib"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Mitoxantrone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1309188],
      "conceptName": ["Mitoxantrone"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Dacarbazine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311409],
      "conceptName": ["Dacarbazine"]
    },
    "Dactinomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311443],
      "conceptName": ["Dactinomycin"]
    },
    "Daunorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311799],
      "conceptName": ["Daunorubicin"]
    },
    "alemtuzumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1312706],
      "conceptName": ["alemtuzumab"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "gemcitabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314924],
      "conceptName": ["gemcitabine"]
    },
    "docetaxel": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1315942],
      "conceptName": ["docetaxel"]
    },
    "pegaspargase": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1326481],
      "conceptName": ["pegaspargase"]
    },
    "Bleomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1329241],
      "conceptName": ["Bleomycin"]
    },
    "Busulfan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1333357],
      "conceptName": ["Busulfan"]
    },
    "bortezomib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1336825],
      "conceptName": ["bortezomib"]
    },
    "Vorinostat": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1337651],
      "conceptName": ["Vorinostat"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Epirubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344354],
      "conceptName": ["Epirubicin"]
    },
    "Carboplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344905],
      "conceptName": ["Carboplatin"]
    },
    "Carmustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350066],
      "conceptName": ["Carmustine"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Procarbazine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1351779],
      "conceptName": ["Procarbazine"]
    },
    "Mesna": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1354698],
      "conceptName": ["Mesna"]
    },
    "dasatinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1358436],
      "conceptName": ["dasatinib"]
    },
    "irinotecan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1367268],
      "conceptName": ["irinotecan"]
    },
    "Altretamine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1368823],
      "conceptName": ["Altretamine"]
    },
    "Paclitaxel": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1378382],
      "conceptName": ["Paclitaxel"]
    },
    "Topotecan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1378509],
      "conceptName": ["Topotecan"]
    },
    "Interferon Alfa-2b": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1380068],
      "conceptName": ["Interferon Alfa-2b"]
    },
    "Interferon gamma-1b": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1380191],
      "conceptName": ["Interferon gamma-1b"]
    },
    "trastuzumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1387104],
      "conceptName": ["trastuzumab"]
    },
    "Leucovorin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1388796],
      "conceptName": ["Leucovorin"]
    },
    "Lomustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1391846],
      "conceptName": ["Lomustine"]
    },
    "Mechlorethamine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1394337],
      "conceptName": ["Mechlorethamine"]
    },
    "fludarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1395557],
      "conceptName": ["fludarabine"]
    },
    "bevacizumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397141],
      "conceptName": ["bevacizumab"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "mercaptopurine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1436650],
      "conceptName": ["mercaptopurine"]
    },
    "Tamoxifen": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1436678],
      "conceptName": ["Tamoxifen"]
    },
    "Thioguanine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1437379],
      "conceptName": ["Thioguanine"]
    },
    "Medroxyprogesterone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1500211],
      "conceptName": ["Medroxyprogesterone"]
    },
    "Methylprednisolone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1506270],
      "conceptName": ["Methylprednisolone"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "Diethylstilbestrol": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1525866],
      "conceptName": ["Diethylstilbestrol"]
    },
    "prednisolone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1550557],
      "conceptName": ["prednisolone"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Hyaluronidase / rituximab Injection [Rituxan Hycela]": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1593155],
      "conceptName": ["Hyaluronidase / rituximab Injection [Rituxan Hycela]"]
    },
    "nelarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19002912],
      "conceptName": ["nelarabine"]
    },
    "Vinblastine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008264],
      "conceptName": ["Vinblastine"]
    },
    "Vindesine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008336],
      "conceptName": ["Vindesine"]
    },
    "everolimus": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19011440],
      "conceptName": ["everolimus"]
    },
    "ASPARAGINASE": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19012585],
      "conceptName": ["ASPARAGINASE"]
    },
    "lenalidomide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19026972],
      "conceptName": ["lenalidomide"]
    },
    "Pentostatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19031224],
      "conceptName": ["Pentostatin"]
    },
    "denileukin diftitox": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19051642],
      "conceptName": ["denileukin diftitox"]
    },
    "doxorubicin liposome": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19051649],
      "conceptName": ["doxorubicin liposome"]
    },
    "clofarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19054821],
      "conceptName": ["clofarabine"]
    },
    "Cladribine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19054825],
      "conceptName": ["Cladribine"]
    },
    "iodine-131-tositumomab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19054997],
      "conceptName": ["iodine-131-tositumomab"]
    },
    "ibritumomab tiuxetan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19068830],
      "conceptName": ["ibritumomab tiuxetan"]
    },
    "Idarubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078097],
      "conceptName": ["Idarubicin"]
    },
    "Ifosfamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    },
    "BCG, Live, Tice Strain": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19086176],
      "conceptName": ["BCG, Live, Tice Strain"]
    },
    "Teniposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19136750],
      "conceptName": ["Teniposide"]
    },
    "Thalidomide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19137042],
      "conceptName": ["Thalidomide"]
    },
    "Thiotepa": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19137385],
      "conceptName": ["Thiotepa"]
    },
    "Myocet": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [21017157],
      "conceptName": ["Myocet"]
    },
    "ranimustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [35197850],
      "conceptName": ["ranimustine"]
    },
    "ofatumumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [40167582],
      "conceptName": ["ofatumumab"]
    },
    "Cytarabine liposome": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [40175460],
      "conceptName": ["Cytarabine liposome"]
    },
    "brentuximab vedotin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [40241969],
      "conceptName": ["brentuximab vedotin"]
    },
    "carfilzomib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [42873638],
      "conceptName": ["carfilzomib"]
    },
    "vincristine liposome": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [42874135],
      "conceptName": ["vincristine liposome"]
    },
    "ponatinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [43013182],
      "conceptName": ["ponatinib"]
    },
    "pomalidomide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [43014237],
      "conceptName": ["pomalidomide"]
    },
    "obinutuzumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [44507676],
      "conceptName": ["obinutuzumab"]
    }
  },
  {
    "conceptId": [35805124],
    "regimenName": ["EPOCH"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Prednisone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Etoposide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Bleomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1329241],
      "conceptName": ["Bleomycin"]
    },
    "Carboplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344905],
      "conceptName": ["Carboplatin"]
    },
    "Procarbazine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1351779],
      "conceptName": ["Procarbazine"]
    },
    "Mechlorethamine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1394337],
      "conceptName": ["Mechlorethamine"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "Vindesine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008336],
      "conceptName": ["Vindesine"]
    },
    "Ifosfamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    },
    "Teniposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19136750],
      "conceptName": ["Teniposide"]
    },
    "ranimustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [35197850],
      "conceptName": ["ranimustine"]
    }
  },
  {
    "conceptId": [35805050],
    "regimenName": ["ACVBP"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Bleomycin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1329241],
      "conceptName": ["Bleomycin"]
    },
    "Methotrexate": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Ifosfamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    },
    "Cytarabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Vindesine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [19008336],
      "conceptName": ["Vindesine"]
    },
    "Prednisone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Etoposide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    }
  },
  {
    "conceptId": [35804610],
    "regimenName": ["Fludarabine and Prednisone"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Prednisone": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "fludarabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1395557],
      "conceptName": ["fludarabine"]
    },
    "Mitoxantrone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1309188],
      "conceptName": ["Mitoxantrone"]
    }
  },
  {
    "conceptId": [35806315],
    "regimenName": ["Elo-Vd"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "elotuzumab": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [35604032],
      "conceptName": ["elotuzumab"]
    },
    "bortezomib": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1336825],
      "conceptName": ["bortezomib"]
    },
    "Dexamethasone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    }
  },
  {
    "conceptId": [35806469],
    "regimenName": ["MAP"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Methotrexate": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Cisplatin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Dactinomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311443],
      "conceptName": ["Dactinomycin"]
    },
    "Bleomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1329241],
      "conceptName": ["Bleomycin"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Mesna": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1354698],
      "conceptName": ["Mesna"]
    },
    "Vinblastine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008264],
      "conceptName": ["Vinblastine"]
    },
    "Ifosfamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    }
  },
  {
    "conceptId": [35806895],
    "regimenName": ["mFOLFOX6 and RT"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "oxaliplatin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1318011],
      "conceptName": ["oxaliplatin"]
    },
    "Leucovorin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1388796],
      "conceptName": ["Leucovorin"]
    },
    "Fluorouracil": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "gemcitabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314924],
      "conceptName": ["gemcitabine"]
    },
    "cetuximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1315411],
      "conceptName": ["cetuximab"]
    },
    "docetaxel": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1315942],
      "conceptName": ["docetaxel"]
    },
    "irinotecan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1367268],
      "conceptName": ["irinotecan"]
    },
    "bevacizumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397141],
      "conceptName": ["bevacizumab"]
    },
    "panitumumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19100985],
      "conceptName": ["panitumumab"]
    }
  },
  {
    "conceptId": [35806101],
    "regimenName": ["BFR, then allo HSCT"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "bendamustine": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [19015523],
      "conceptName": ["bendamustine"]
    },
    "rituximab": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "fludarabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1395557],
      "conceptName": ["fludarabine"]
    }
  },
  {
    "conceptId": [35804573],
    "regimenName": ["Chlorambucil and Ofatumumab"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Chlorambucil": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1390051],
      "conceptName": ["Chlorambucil"]
    },
    "ofatumumab": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [40167582],
      "conceptName": ["ofatumumab"]
    }
  },
  {
    "conceptId": [35805100],
    "regimenName": ["HOP"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Prednisone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Fluorouracil": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "Melphalan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1301267],
      "conceptName": ["Melphalan"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Dacarbazine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311409],
      "conceptName": ["Dacarbazine"]
    },
    "alemtuzumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1312706],
      "conceptName": ["alemtuzumab"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Bleomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1329241],
      "conceptName": ["Bleomycin"]
    },
    "bortezomib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1336825],
      "conceptName": ["bortezomib"]
    },
    "Carboplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344905],
      "conceptName": ["Carboplatin"]
    },
    "Carmustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350066],
      "conceptName": ["Carmustine"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Procarbazine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1351779],
      "conceptName": ["Procarbazine"]
    },
    "Chlorambucil": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1390051],
      "conceptName": ["Chlorambucil"]
    },
    "Mechlorethamine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1394337],
      "conceptName": ["Mechlorethamine"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "mercaptopurine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1436650],
      "conceptName": ["mercaptopurine"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "Hyaluronidase / rituximab Injection [Rituxan Hycela]": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1593155],
      "conceptName": ["Hyaluronidase / rituximab Injection [Rituxan Hycela]"]
    },
    "Quinine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1760616],
      "conceptName": ["Quinine"]
    },
    "Vinblastine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008264],
      "conceptName": ["Vinblastine"]
    },
    "Vindesine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008336],
      "conceptName": ["Vindesine"]
    },
    "everolimus": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19011440],
      "conceptName": ["everolimus"]
    },
    "ASPARAGINASE": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19012585],
      "conceptName": ["ASPARAGINASE"]
    },
    "lenalidomide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19026972],
      "conceptName": ["lenalidomide"]
    },
    "denileukin diftitox": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19051642],
      "conceptName": ["denileukin diftitox"]
    },
    "iodine-131-tositumomab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19054997],
      "conceptName": ["iodine-131-tositumomab"]
    },
    "Ifosfamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    },
    "BCG, Live, Tice Strain": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19086176],
      "conceptName": ["BCG, Live, Tice Strain"]
    },
    "Teniposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19136750],
      "conceptName": ["Teniposide"]
    },
    "ranimustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [35197850],
      "conceptName": ["ranimustine"]
    },
    "ofatumumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [40167582],
      "conceptName": ["ofatumumab"]
    },
    "obinutuzumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [44507676],
      "conceptName": ["obinutuzumab"]
    }
  },
  {
    "conceptId": [35804568],
    "regimenName": ["GEMOX-B"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "oxaliplatin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1318011],
      "conceptName": ["oxaliplatin"]
    },
    "bevacizumab": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1397141],
      "conceptName": ["bevacizumab"]
    },
    "gemcitabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1314924],
      "conceptName": ["gemcitabine"]
    }
  },
  {
    "conceptId": [35101987],
    "regimenName": ["CHVmP-VB"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Bleomycin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1329241],
      "conceptName": ["Bleomycin"]
    },
    "Prednisone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Teniposide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [19136750],
      "conceptName": ["Teniposide"]
    }
  },
  {
    "conceptId": [35803582],
    "regimenName": ["PCE"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Carboplatin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1344905],
      "conceptName": ["Carboplatin"]
    },
    "Paclitaxel": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1378382],
      "conceptName": ["Paclitaxel"]
    },
    "Etoposide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    }
  },
  {
    "conceptId": [35804380],
    "regimenName": ["R-CODOX-M"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Methotrexate": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "rituximab": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "prednisolone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1550557],
      "conceptName": ["prednisolone"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Vindesine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008336],
      "conceptName": ["Vindesine"]
    },
    "Ifosfamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    },
    "Teniposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19136750],
      "conceptName": ["Teniposide"]
    }
  },
  {
    "conceptId": [35804757],
    "regimenName": ["FOLFOX4"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "oxaliplatin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1318011],
      "conceptName": ["oxaliplatin"]
    },
    "Leucovorin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1388796],
      "conceptName": ["Leucovorin"]
    },
    "Fluorouracil": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "gemcitabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314924],
      "conceptName": ["gemcitabine"]
    },
    "cetuximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1315411],
      "conceptName": ["cetuximab"]
    },
    "docetaxel": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1315942],
      "conceptName": ["docetaxel"]
    },
    "irinotecan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1367268],
      "conceptName": ["irinotecan"]
    },
    "bevacizumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397141],
      "conceptName": ["bevacizumab"]
    },
    "panitumumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19100985],
      "conceptName": ["panitumumab"]
    }
  },
  {
    "conceptId": [35804159],
    "regimenName": ["Avelumab monotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "avelumab": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1593273],
      "conceptName": ["avelumab"]
    },
    "axitinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [42709322],
      "conceptName": ["axitinib"]
    }
  },
  {
    "conceptId": [35804540],
    "regimenName": ["Cisplatin, Paclitaxel, Bevacizumab"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Paclitaxel": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1378382],
      "conceptName": ["Paclitaxel"]
    },
    "bevacizumab": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1397141],
      "conceptName": ["bevacizumab"]
    },
    "Cisplatin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    }
  },
  {
    "conceptId": [35804249],
    "regimenName": ["Doxorubicin pegylated liposomal monotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "doxorubicin liposome": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [19051649],
      "conceptName": ["doxorubicin liposome"]
    },
    "Fluorouracil": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "gemcitabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314924],
      "conceptName": ["gemcitabine"]
    },
    "bortezomib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1336825],
      "conceptName": ["bortezomib"]
    },
    "vinorelbine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1343346],
      "conceptName": ["vinorelbine"]
    },
    "Carboplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344905],
      "conceptName": ["Carboplatin"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "bevacizumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397141],
      "conceptName": ["bevacizumab"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "Methylprednisolone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1506270],
      "conceptName": ["Methylprednisolone"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Ifosfamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    },
    "Thalidomide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19137042],
      "conceptName": ["Thalidomide"]
    },
    "trabectedin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [35603017],
      "conceptName": ["trabectedin"]
    },
    "vincristine liposome": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [42874135],
      "conceptName": ["vincristine liposome"]
    }
  },
  {
    "conceptId": [35806363],
    "regimenName": ["DDGP"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Cisplatin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "pegaspargase": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1326481],
      "conceptName": ["pegaspargase"]
    },
    "gemcitabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1314924],
      "conceptName": ["gemcitabine"]
    },
    "Dexamethasone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    }
  },
  {
    "conceptId": [35804096],
    "regimenName": ["Bacillus Calmette-Guerin (BCG) monotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "BCG, Live, Tice Strain": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [19086176],
      "conceptName": ["BCG, Live, Tice Strain"]
    },
    "Fluorouracil": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Dacarbazine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311409],
      "conceptName": ["Dacarbazine"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    }
  },
  {
    "conceptId": [35805791],
    "regimenName": ["DEB-TACE"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Fluorouracil": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "Melphalan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1301267],
      "conceptName": ["Melphalan"]
    },
    "imatinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1304107],
      "conceptName": ["imatinib"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Mitotane": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1309161],
      "conceptName": ["Mitotane"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Dacarbazine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311409],
      "conceptName": ["Dacarbazine"]
    },
    "Dactinomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311443],
      "conceptName": ["Dactinomycin"]
    },
    "alemtuzumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1312706],
      "conceptName": ["alemtuzumab"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "gemcitabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314924],
      "conceptName": ["gemcitabine"]
    },
    "docetaxel": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1315942],
      "conceptName": ["docetaxel"]
    },
    "pegaspargase": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1326481],
      "conceptName": ["pegaspargase"]
    },
    "Bleomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1329241],
      "conceptName": ["Bleomycin"]
    },
    "bortezomib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1336825],
      "conceptName": ["bortezomib"]
    },
    "Epirubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344354],
      "conceptName": ["Epirubicin"]
    },
    "Carboplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344905],
      "conceptName": ["Carboplatin"]
    },
    "Carmustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350066],
      "conceptName": ["Carmustine"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Procarbazine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1351779],
      "conceptName": ["Procarbazine"]
    },
    "Mesna": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1354698],
      "conceptName": ["Mesna"]
    },
    "dasatinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1358436],
      "conceptName": ["dasatinib"]
    },
    "irinotecan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1367268],
      "conceptName": ["irinotecan"]
    },
    "Altretamine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1368823],
      "conceptName": ["Altretamine"]
    },
    "Paclitaxel": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1378382],
      "conceptName": ["Paclitaxel"]
    },
    "Topotecan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1378509],
      "conceptName": ["Topotecan"]
    },
    "Interferon Alfa-2b": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1380068],
      "conceptName": ["Interferon Alfa-2b"]
    },
    "trastuzumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1387104],
      "conceptName": ["trastuzumab"]
    },
    "Mitomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1389036],
      "conceptName": ["Mitomycin"]
    },
    "Chlorambucil": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1390051],
      "conceptName": ["Chlorambucil"]
    },
    "Lomustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1391846],
      "conceptName": ["Lomustine"]
    },
    "Mechlorethamine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1394337],
      "conceptName": ["Mechlorethamine"]
    },
    "bevacizumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397141],
      "conceptName": ["bevacizumab"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "mercaptopurine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1436650],
      "conceptName": ["mercaptopurine"]
    },
    "Tamoxifen": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1436678],
      "conceptName": ["Tamoxifen"]
    },
    "Thioguanine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1437379],
      "conceptName": ["Thioguanine"]
    },
    "Medroxyprogesterone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1500211],
      "conceptName": ["Medroxyprogesterone"]
    },
    "Methylprednisolone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1506270],
      "conceptName": ["Methylprednisolone"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "prednisolone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1550557],
      "conceptName": ["prednisolone"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Hyaluronidase / rituximab Injection [Rituxan Hycela]": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1593155],
      "conceptName": ["Hyaluronidase / rituximab Injection [Rituxan Hycela]"]
    },
    "olaratumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1718346],
      "conceptName": ["olaratumab"]
    },
    "Quinine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1760616],
      "conceptName": ["Quinine"]
    },
    "Vinblastine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008264],
      "conceptName": ["Vinblastine"]
    },
    "Vindesine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008336],
      "conceptName": ["Vindesine"]
    },
    "everolimus": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19011440],
      "conceptName": ["everolimus"]
    },
    "ASPARAGINASE": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19012585],
      "conceptName": ["ASPARAGINASE"]
    },
    "lenalidomide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19026972],
      "conceptName": ["lenalidomide"]
    },
    "denileukin diftitox": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19051642],
      "conceptName": ["denileukin diftitox"]
    },
    "iodine-131-tositumomab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19054997],
      "conceptName": ["iodine-131-tositumomab"]
    },
    "Ifosfamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    },
    "BCG, Live, Tice Strain": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19086176],
      "conceptName": ["BCG, Live, Tice Strain"]
    },
    "Strontium-89": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19132890],
      "conceptName": ["Strontium-89"]
    },
    "Streptozocin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19136210],
      "conceptName": ["Streptozocin"]
    },
    "Teniposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19136750],
      "conceptName": ["Teniposide"]
    },
    "Thalidomide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19137042],
      "conceptName": ["Thalidomide"]
    },
    "ranimustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [35197850],
      "conceptName": ["ranimustine"]
    },
    "ofatumumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [40167582],
      "conceptName": ["ofatumumab"]
    },
    "brentuximab vedotin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [40241969],
      "conceptName": ["brentuximab vedotin"]
    },
    "ponatinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [43013182],
      "conceptName": ["ponatinib"]
    },
    "obinutuzumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [44507676],
      "conceptName": ["obinutuzumab"]
    }
  },
  {
    "conceptId": [35806855],
    "regimenName": ["Carboplatin, Docetaxel, Prednisone"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Carboplatin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1344905],
      "conceptName": ["Carboplatin"]
    },
    "docetaxel": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1315942],
      "conceptName": ["docetaxel"]
    },
    "Prednisone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    }
  },
  {
    "conceptId": [35805832],
    "regimenName": ["GCD"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Carboplatin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1344905],
      "conceptName": ["Carboplatin"]
    },
    "gemcitabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1314924],
      "conceptName": ["gemcitabine"]
    },
    "Dexamethasone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    }
  },
  {
    "conceptId": [35803444],
    "regimenName": ["7 plus 3d (high-dose)"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Cytarabine": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Daunorubicin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1311799],
      "conceptName": ["Daunorubicin"]
    },
    "Tretinoin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [903643],
      "conceptName": ["Tretinoin"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Azacitidine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314865],
      "conceptName": ["Azacitidine"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "glasdegib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1355795],
      "conceptName": ["glasdegib"]
    },
    "sorafenib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1363387],
      "conceptName": ["sorafenib"]
    },
    "nilotinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1394023],
      "conceptName": ["nilotinib"]
    },
    "mercaptopurine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1436650],
      "conceptName": ["mercaptopurine"]
    },
    "Thioguanine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1437379],
      "conceptName": ["Thioguanine"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "prednisolone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1550557],
      "conceptName": ["prednisolone"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "midostaurin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1594003],
      "conceptName": ["midostaurin"]
    },
    "ASPARAGINASE": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19012585],
      "conceptName": ["ASPARAGINASE"]
    },
    "Cladribine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19054825],
      "conceptName": ["Cladribine"]
    },
    "Teniposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19136750],
      "conceptName": ["Teniposide"]
    },
    "Gemtuzumab ozogamicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [42799711],
      "conceptName": ["Gemtuzumab ozogamicin"]
    },
    "omacetaxine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [45775576],
      "conceptName": ["omacetaxine"]
    }
  },
  {
    "conceptId": [35804302],
    "regimenName": ["T-DM1 and ET"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Tamoxifen": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1436678],
      "conceptName": ["Tamoxifen"]
    },
    "ado-trastuzumab emtansine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [43525787],
      "conceptName": ["ado-trastuzumab emtansine"]
    }
  },
  {
    "conceptId": [35804226],
    "regimenName": ["AT (Taxol)"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Paclitaxel": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1378382],
      "conceptName": ["Paclitaxel"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    }
  },
  {
    "conceptId": [35804565],
    "regimenName": ["Gemcitabine, Cisplatin, S-1"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Cisplatin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "gemcitabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1314924],
      "conceptName": ["gemcitabine"]
    },
    "Hyaluronidase / trastuzumab Injection [Herceptin Hylecta]": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1366689],
      "conceptName": ["Hyaluronidase / trastuzumab Injection [Herceptin Hylecta]"]
    }
  },
  {
    "conceptId": [35804630],
    "regimenName": ["Imatinib monotherapy, high dose"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "imatinib": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1304107],
      "conceptName": ["imatinib"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Mitoxantrone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1309188],
      "conceptName": ["Mitoxantrone"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Daunorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311799],
      "conceptName": ["Daunorubicin"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "hydroxyurea": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1377141],
      "conceptName": ["hydroxyurea"]
    },
    "Interferon Alfa-2a": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1379969],
      "conceptName": ["Interferon Alfa-2a"]
    },
    "Interferon Alfa-2b": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1380068],
      "conceptName": ["Interferon Alfa-2b"]
    },
    "mercaptopurine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1436650],
      "conceptName": ["mercaptopurine"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "peginterferon alfa-2a": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1714165],
      "conceptName": ["peginterferon alfa-2a"]
    },
    "ASPARAGINASE": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19012585],
      "conceptName": ["ASPARAGINASE"]
    },
    "Idarubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078097],
      "conceptName": ["Idarubicin"]
    }
  },
  {
    "conceptId": [35804317],
    "regimenName": ["Capecitabine, Pertuzumab, Trastuzumab"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "pertuzumab": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [42801287],
      "conceptName": ["pertuzumab"]
    },
    "trastuzumab": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1387104],
      "conceptName": ["trastuzumab"]
    },
    "capecitabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1337620],
      "conceptName": ["capecitabine"]
    }
  },
  {
    "conceptId": [35806822],
    "regimenName": ["ADT and RT"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Flutamide": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1356461],
      "conceptName": ["Flutamide"]
    },
    "bicalutamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1344381],
      "conceptName": ["bicalutamide"]
    }
  },
  {
    "conceptId": [35804162],
    "regimenName": ["Docetaxel monotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "docetaxel": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1315942],
      "conceptName": ["docetaxel"]
    },
    "Fluorouracil": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "gemcitabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314924],
      "conceptName": ["gemcitabine"]
    },
    "cetuximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1315411],
      "conceptName": ["cetuximab"]
    },
    "oxaliplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1318011],
      "conceptName": ["oxaliplatin"]
    },
    "capecitabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1337620],
      "conceptName": ["capecitabine"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Epirubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344354],
      "conceptName": ["Epirubicin"]
    },
    "bicalutamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344381],
      "conceptName": ["bicalutamide"]
    },
    "Carboplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344905],
      "conceptName": ["Carboplatin"]
    },
    "Estramustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1349025],
      "conceptName": ["Estramustine"]
    },
    "Hyaluronidase / trastuzumab Injection [Herceptin Hylecta]": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1366689],
      "conceptName": ["Hyaluronidase / trastuzumab Injection [Herceptin Hylecta]"]
    },
    "irinotecan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1367268],
      "conceptName": ["irinotecan"]
    },
    "hydroxyurea": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1377141],
      "conceptName": ["hydroxyurea"]
    },
    "trastuzumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1387104],
      "conceptName": ["trastuzumab"]
    },
    "Leucovorin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1388796],
      "conceptName": ["Leucovorin"]
    },
    "bevacizumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397141],
      "conceptName": ["bevacizumab"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "prednisolone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1550557],
      "conceptName": ["prednisolone"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "nedaplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [35198201],
      "conceptName": ["nedaplatin"]
    },
    "Vandetanib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [40238052],
      "conceptName": ["Vandetanib"]
    },
    "pertuzumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [42801287],
      "conceptName": ["pertuzumab"]
    },
    "ramucirumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [44818489],
      "conceptName": ["ramucirumab"]
    }
  },
  {
    "conceptId": [35804766],
    "regimenName": ["CapeOx and Bevacizumab"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "oxaliplatin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1318011],
      "conceptName": ["oxaliplatin"]
    },
    "bevacizumab": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1397141],
      "conceptName": ["bevacizumab"]
    },
    "capecitabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1337620],
      "conceptName": ["capecitabine"]
    }
  },
  {
    "conceptId": [35803437],
    "regimenName": ["7 plus 3d (intermediate-dose)"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Cytarabine": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Daunorubicin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1311799],
      "conceptName": ["Daunorubicin"]
    },
    "Tretinoin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [903643],
      "conceptName": ["Tretinoin"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Azacitidine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314865],
      "conceptName": ["Azacitidine"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "glasdegib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1355795],
      "conceptName": ["glasdegib"]
    },
    "sorafenib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1363387],
      "conceptName": ["sorafenib"]
    },
    "nilotinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1394023],
      "conceptName": ["nilotinib"]
    },
    "mercaptopurine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1436650],
      "conceptName": ["mercaptopurine"]
    },
    "Thioguanine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1437379],
      "conceptName": ["Thioguanine"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "prednisolone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1550557],
      "conceptName": ["prednisolone"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "midostaurin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1594003],
      "conceptName": ["midostaurin"]
    },
    "ASPARAGINASE": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19012585],
      "conceptName": ["ASPARAGINASE"]
    },
    "Cladribine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19054825],
      "conceptName": ["Cladribine"]
    },
    "Teniposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19136750],
      "conceptName": ["Teniposide"]
    },
    "Gemtuzumab ozogamicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [42799711],
      "conceptName": ["Gemtuzumab ozogamicin"]
    },
    "omacetaxine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [45775576],
      "conceptName": ["omacetaxine"]
    }
  },
  {
    "conceptId": [35804218],
    "regimenName": ["PET"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Paclitaxel": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1378382],
      "conceptName": ["Paclitaxel"]
    },
    "Cisplatin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "Epirubicin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1344354],
      "conceptName": ["Epirubicin"]
    }
  },
  {
    "conceptId": [35804037],
    "regimenName": ["Daunorubicin, L-Asparaginase, Vincristine, Prednisone, Imatinib"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "ASPARAGINASE": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [19012585],
      "conceptName": ["ASPARAGINASE"]
    },
    "Prednisone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "imatinib": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1304107],
      "conceptName": ["imatinib"]
    },
    "Daunorubicin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1311799],
      "conceptName": ["Daunorubicin"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    }
  },
  {
    "conceptId": [35804640],
    "regimenName": ["Omacetaxine monotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "omacetaxine": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [45775576],
      "conceptName": ["omacetaxine"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Daunorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311799],
      "conceptName": ["Daunorubicin"]
    },
    "Aclarubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19057483],
      "conceptName": ["Aclarubicin"]
    }
  },
  {
    "conceptId": [35805630],
    "regimenName": ["R-CVP"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "rituximab": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Prednisone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Daunorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311799],
      "conceptName": ["Daunorubicin"]
    },
    "bortezomib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1336825],
      "conceptName": ["bortezomib"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "Hyaluronidase / rituximab Injection [Rituxan Hycela]": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1593155],
      "conceptName": ["Hyaluronidase / rituximab Injection [Rituxan Hycela]"]
    },
    "Vindesine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008336],
      "conceptName": ["Vindesine"]
    },
    "ASPARAGINASE": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19012585],
      "conceptName": ["ASPARAGINASE"]
    },
    "lenalidomide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19026972],
      "conceptName": ["lenalidomide"]
    },
    "doxorubicin liposome": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19051649],
      "conceptName": ["doxorubicin liposome"]
    },
    "Ifosfamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    },
    "Teniposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19136750],
      "conceptName": ["Teniposide"]
    }
  },
  {
    "conceptId": [35804165],
    "regimenName": ["Erdafitinib monotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "erdafitinib": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1511250],
      "conceptName": ["erdafitinib"]
    }
  },
  {
    "conceptId": [35804083],
    "regimenName": ["Imatinib monotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "imatinib": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1304107],
      "conceptName": ["imatinib"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Mitoxantrone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1309188],
      "conceptName": ["Mitoxantrone"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Daunorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311799],
      "conceptName": ["Daunorubicin"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "hydroxyurea": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1377141],
      "conceptName": ["hydroxyurea"]
    },
    "Interferon Alfa-2a": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1379969],
      "conceptName": ["Interferon Alfa-2a"]
    },
    "Interferon Alfa-2b": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1380068],
      "conceptName": ["Interferon Alfa-2b"]
    },
    "mercaptopurine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1436650],
      "conceptName": ["mercaptopurine"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "peginterferon alfa-2a": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1714165],
      "conceptName": ["peginterferon alfa-2a"]
    },
    "ASPARAGINASE": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19012585],
      "conceptName": ["ASPARAGINASE"]
    },
    "Idarubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078097],
      "conceptName": ["Idarubicin"]
    }
  },
  {
    "conceptId": [35807171],
    "regimenName": ["RVR"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "everolimus": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [19011440],
      "conceptName": ["everolimus"]
    },
    "rituximab": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "bortezomib": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1336825],
      "conceptName": ["bortezomib"]
    }
  },
  {
    "conceptId": [35805333],
    "regimenName": ["CLF"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Cisplatin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "Leucovorin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1388796],
      "conceptName": ["Leucovorin"]
    },
    "Fluorouracil": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "docetaxel": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1315942],
      "conceptName": ["docetaxel"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "bevacizumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397141],
      "conceptName": ["bevacizumab"]
    }
  },
  {
    "conceptId": [35804347],
    "regimenName": ["PFT"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Tamoxifen": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1436678],
      "conceptName": ["Tamoxifen"]
    },
    "Melphalan": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1301267],
      "conceptName": ["Melphalan"]
    },
    "Fluorouracil": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    }
  },
  {
    "conceptId": [35102021],
    "regimenName": ["DOLP (Prednisolone)"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "ASPARAGINASE": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [19012585],
      "conceptName": ["ASPARAGINASE"]
    },
    "Daunorubicin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1311799],
      "conceptName": ["Daunorubicin"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "prednisolone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1550557],
      "conceptName": ["prednisolone"]
    }
  },
  {
    "conceptId": [35803627],
    "regimenName": ["Fludarabine, Cyclophosphamide, TBI for dUCB or haploidentical transplant"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Cyclophosphamide": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "fludarabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1395557],
      "conceptName": ["fludarabine"]
    },
    "Mitoxantrone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1309188],
      "conceptName": ["Mitoxantrone"]
    },
    "alemtuzumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1312706],
      "conceptName": ["alemtuzumab"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Busulfan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1333357],
      "conceptName": ["Busulfan"]
    },
    "ibritumomab tiuxetan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19068830],
      "conceptName": ["ibritumomab tiuxetan"]
    },
    "Thiotepa": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19137385],
      "conceptName": ["Thiotepa"]
    },
    "ofatumumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [40167582],
      "conceptName": ["ofatumumab"]
    },
    "obinutuzumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [44507676],
      "conceptName": ["obinutuzumab"]
    }
  },
  {
    "conceptId": [35806140],
    "regimenName": ["Binimetinib monotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Binimetinib": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1559930],
      "conceptName": ["Binimetinib"]
    },
    "encorafenib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1559914],
      "conceptName": ["encorafenib"]
    }
  },
  {
    "conceptId": [35804228],
    "regimenName": ["Epirubicin monotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Epirubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1344354],
      "conceptName": ["Epirubicin"]
    },
    "Fluorouracil": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "gemcitabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314924],
      "conceptName": ["gemcitabine"]
    },
    "docetaxel": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1315942],
      "conceptName": ["docetaxel"]
    },
    "oxaliplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1318011],
      "conceptName": ["oxaliplatin"]
    },
    "Bleomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1329241],
      "conceptName": ["Bleomycin"]
    },
    "capecitabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1337620],
      "conceptName": ["capecitabine"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "vinorelbine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1343346],
      "conceptName": ["vinorelbine"]
    },
    "Carboplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344905],
      "conceptName": ["Carboplatin"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Mesna": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1354698],
      "conceptName": ["Mesna"]
    },
    "Paclitaxel": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1378382],
      "conceptName": ["Paclitaxel"]
    },
    "trastuzumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1387104],
      "conceptName": ["trastuzumab"]
    },
    "Mitomycin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1389036],
      "conceptName": ["Mitomycin"]
    },
    "Lomustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1391846],
      "conceptName": ["Lomustine"]
    },
    "bevacizumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397141],
      "conceptName": ["bevacizumab"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "prednisolone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1550557],
      "conceptName": ["prednisolone"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Vinblastine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008264],
      "conceptName": ["Vinblastine"]
    },
    "Vindesine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008336],
      "conceptName": ["Vindesine"]
    },
    "Ifosfamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    },
    "Thiotepa": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19137385],
      "conceptName": ["Thiotepa"]
    }
  },
  {
    "conceptId": [35804601],
    "regimenName": ["BR and Ibrutinib"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "bendamustine": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [19015523],
      "conceptName": ["bendamustine"]
    },
    "Ibrutinib": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [44507848],
      "conceptName": ["Ibrutinib"]
    },
    "rituximab": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    }
  },
  {
    "conceptId": [35804074],
    "regimenName": ["Hyper-CVAD and Ponatinib"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Methotrexate": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Cytarabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "ponatinib": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [43013182],
      "conceptName": ["ponatinib"]
    },
    "Dexamethasone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    }
  },
  {
    "conceptId": [35805773],
    "regimenName": ["Carboplatin and Fluorouracil"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Carboplatin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1344905],
      "conceptName": ["Carboplatin"]
    },
    "Fluorouracil": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "cetuximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1315411],
      "conceptName": ["cetuximab"]
    },
    "docetaxel": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1315942],
      "conceptName": ["docetaxel"]
    },
    "Epirubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344354],
      "conceptName": ["Epirubicin"]
    }
  },
  {
    "conceptId": [35805465],
    "regimenName": ["GELOX/RT"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "oxaliplatin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1318011],
      "conceptName": ["oxaliplatin"]
    },
    "ASPARAGINASE": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [19012585],
      "conceptName": ["ASPARAGINASE"]
    },
    "gemcitabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1314924],
      "conceptName": ["gemcitabine"]
    }
  },
  {
    "conceptId": [35804005],
    "regimenName": ["CHUT"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Thiotepa": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [19137385],
      "conceptName": ["Thiotepa"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Busulfan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1333357],
      "conceptName": ["Busulfan"]
    },
    "Epirubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344354],
      "conceptName": ["Epirubicin"]
    },
    "Carboplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344905],
      "conceptName": ["Carboplatin"]
    },
    "fludarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1395557],
      "conceptName": ["fludarabine"]
    }
  },
  {
    "conceptId": [35806113],
    "regimenName": ["Cyclophosphamide and Vincristine/Cisplatin and Etoposide"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Cisplatin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Etoposide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Vincristine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    }
  },
  {
    "conceptId": [35806950],
    "regimenName": ["CC/DE and RT"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Doxorubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Cisplatin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Etoposide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Melphalan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1301267],
      "conceptName": ["Melphalan"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "bortezomib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1336825],
      "conceptName": ["bortezomib"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "Thalidomide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19137042],
      "conceptName": ["Thalidomide"]
    }
  },
  {
    "conceptId": [35803562],
    "regimenName": ["Cytarabine and Idarubicin, then Mitoxantrone, then Cytarabine and Idarubicin, with ATRA"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Idarubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [19078097],
      "conceptName": ["Idarubicin"]
    },
    "Cytarabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Tretinoin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [903643],
      "conceptName": ["Tretinoin"]
    },
    "Mitoxantrone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1309188],
      "conceptName": ["Mitoxantrone"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Thioguanine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1437379],
      "conceptName": ["Thioguanine"]
    }
  },
  {
    "conceptId": [35804167],
    "regimenName": ["Paclitaxel, nanoparticle albumin-bound monotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Paclitaxel": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1378382],
      "conceptName": ["Paclitaxel"]
    },
    "neratinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [793846],
      "conceptName": ["neratinib"]
    },
    "Fluorouracil": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Dacarbazine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311409],
      "conceptName": ["Dacarbazine"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "gemcitabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314924],
      "conceptName": ["gemcitabine"]
    },
    "oxaliplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1318011],
      "conceptName": ["oxaliplatin"]
    },
    "capecitabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1337620],
      "conceptName": ["capecitabine"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "vinorelbine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1343346],
      "conceptName": ["vinorelbine"]
    },
    "Epirubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344354],
      "conceptName": ["Epirubicin"]
    },
    "Carboplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344905],
      "conceptName": ["Carboplatin"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "lapatinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1359548],
      "conceptName": ["lapatinib"]
    },
    "Hyaluronidase / trastuzumab Injection [Herceptin Hylecta]": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1366689],
      "conceptName": ["Hyaluronidase / trastuzumab Injection [Herceptin Hylecta]"]
    },
    "Topotecan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1378509],
      "conceptName": ["Topotecan"]
    },
    "trastuzumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1387104],
      "conceptName": ["trastuzumab"]
    },
    "bevacizumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397141],
      "conceptName": ["bevacizumab"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "Ifosfamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    },
    "pazopanib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [40167554],
      "conceptName": ["pazopanib"]
    },
    "ipilimumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [40238188],
      "conceptName": ["ipilimumab"]
    },
    "atezolizumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [42629079],
      "conceptName": ["atezolizumab"]
    },
    "pertuzumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [42801287],
      "conceptName": ["pertuzumab"]
    },
    "ado-trastuzumab emtansine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [43525787],
      "conceptName": ["ado-trastuzumab emtansine"]
    },
    "Afatinib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [43533090],
      "conceptName": ["Afatinib"]
    },
    "ramucirumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [44818489],
      "conceptName": ["ramucirumab"]
    },
    "pembrolizumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [45775965],
      "conceptName": ["pembrolizumab"]
    },
    "olaparib": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [45892579],
      "conceptName": ["olaparib"]
    }
  },
  {
    "conceptId": [35805659],
    "regimenName": ["FND"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Dexamethasone": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "fludarabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1395557],
      "conceptName": ["fludarabine"]
    },
    "Mitoxantrone": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1309188],
      "conceptName": ["Mitoxantrone"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    }
  },
  {
    "conceptId": [35806129],
    "regimenName": ["Dacarbazine and Ipilimumab"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "ipilimumab": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [40238188],
      "conceptName": ["ipilimumab"]
    },
    "Dacarbazine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1311409],
      "conceptName": ["Dacarbazine"]
    }
  },
  {
    "conceptId": [35806497],
    "regimenName": ["Altretamine and Cisplatin"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Cisplatin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "Altretamine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1368823],
      "conceptName": ["Altretamine"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    }
  },
  {
    "conceptId": [35803550],
    "regimenName": ["Arsenic trioxide, ATRA, Gemtuzumab ozogamicin"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "arsenic trioxide": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1333379],
      "conceptName": ["arsenic trioxide"]
    },
    "Gemtuzumab ozogamicin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [42799711],
      "conceptName": ["Gemtuzumab ozogamicin"]
    },
    "Tretinoin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [903643],
      "conceptName": ["Tretinoin"]
    }
  },
  {
    "conceptId": [35804214],
    "regimenName": ["EDC"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Epirubicin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1344354],
      "conceptName": ["Epirubicin"]
    },
    "docetaxel": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1315942],
      "conceptName": ["docetaxel"]
    },
    "capecitabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1337620],
      "conceptName": ["capecitabine"]
    }
  },
  {
    "conceptId": [35804359],
    "regimenName": ["Formestane monotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "formestane": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [19020079],
      "conceptName": ["formestane"]
    }
  },
  {
    "conceptId": [35807020],
    "regimenName": ["PVeBV"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Bleomycin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1329241],
      "conceptName": ["Bleomycin"]
    },
    "Cisplatin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "Vinblastine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [19008264],
      "conceptName": ["Vinblastine"]
    },
    "Etoposide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    }
  },
  {
    "conceptId": [35805066],
    "regimenName": ["BEAC, then auto HSCT"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Carmustine": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1350066],
      "conceptName": ["Carmustine"]
    },
    "Cytarabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Cyclophosphamide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Etoposide": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    }
  },
  {
    "conceptId": [35803702],
    "regimenName": ["Brentuximab vedotin monotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "brentuximab vedotin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [40241969],
      "conceptName": ["brentuximab vedotin"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Dacarbazine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311409],
      "conceptName": ["Dacarbazine"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Vinblastine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008264],
      "conceptName": ["Vinblastine"]
    },
    "bendamustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19015523],
      "conceptName": ["bendamustine"]
    },
    "nivolumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [45892628],
      "conceptName": ["nivolumab"]
    }
  },
  {
    "conceptId": [35805082],
    "regimenName": ["R-GemOx"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "oxaliplatin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1318011],
      "conceptName": ["oxaliplatin"]
    },
    "rituximab": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "gemcitabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1314924],
      "conceptName": ["gemcitabine"]
    }
  },
  {
    "conceptId": [35804569],
    "regimenName": ["Regorafenib monotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "regorafenib": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [42903460],
      "conceptName": ["regorafenib"]
    }
  },
  {
    "conceptId": [35805353],
    "regimenName": ["Fluorouracil, Oxaliplatin, RT"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "oxaliplatin": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1318011],
      "conceptName": ["oxaliplatin"]
    },
    "Fluorouracil": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [955632],
      "conceptName": ["Fluorouracil"]
    },
    "gemcitabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314924],
      "conceptName": ["gemcitabine"]
    },
    "cetuximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1315411],
      "conceptName": ["cetuximab"]
    },
    "docetaxel": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1315942],
      "conceptName": ["docetaxel"]
    },
    "Epirubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344354],
      "conceptName": ["Epirubicin"]
    },
    "irinotecan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1367268],
      "conceptName": ["irinotecan"]
    },
    "Leucovorin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1388796],
      "conceptName": ["Leucovorin"]
    },
    "bevacizumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397141],
      "conceptName": ["bevacizumab"]
    },
    "panitumumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19100985],
      "conceptName": ["panitumumab"]
    },
    "levoleucovorin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [40168303],
      "conceptName": ["levoleucovorin"]
    }
  },
  {
    "conceptId": [35806078],
    "regimenName": ["R-HiDAC"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "rituximab": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Cytarabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Melphalan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1301267],
      "conceptName": ["Melphalan"]
    },
    "Methotrexate": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "oxaliplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1318011],
      "conceptName": ["oxaliplatin"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    },
    "Carboplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1344905],
      "conceptName": ["Carboplatin"]
    },
    "Carmustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350066],
      "conceptName": ["Carmustine"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "fludarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1395557],
      "conceptName": ["fludarabine"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "Methylprednisolone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1506270],
      "conceptName": ["Methylprednisolone"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    },
    "Vindesine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19008336],
      "conceptName": ["Vindesine"]
    },
    "bendamustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19015523],
      "conceptName": ["bendamustine"]
    },
    "doxorubicin liposome": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19051649],
      "conceptName": ["doxorubicin liposome"]
    },
    "ibritumomab tiuxetan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19068830],
      "conceptName": ["ibritumomab tiuxetan"]
    },
    "Idarubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078097],
      "conceptName": ["Idarubicin"]
    },
    "Ifosfamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19078187],
      "conceptName": ["Ifosfamide"]
    },
    "Teniposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19136750],
      "conceptName": ["Teniposide"]
    },
    "Thiotepa": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19137385],
      "conceptName": ["Thiotepa"]
    },
    "Cytarabine liposome": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [40175460],
      "conceptName": ["Cytarabine liposome"]
    }
  },
  {
    "conceptId": [35806983],
    "regimenName": ["Nelarabine monotherapy"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "nelarabine": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [19002912],
      "conceptName": ["nelarabine"]
    },
    "Vincristine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1308290],
      "conceptName": ["Vincristine"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "pegaspargase": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1326481],
      "conceptName": ["pegaspargase"]
    },
    "mercaptopurine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1436650],
      "conceptName": ["mercaptopurine"]
    }
  },
  {
    "conceptId": [35804143],
    "regimenName": ["MCV"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Methotrexate": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1305058],
      "conceptName": ["Methotrexate"]
    },
    "Cisplatin": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "Vinblastine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [19008264],
      "conceptName": ["Vinblastine"]
    },
    "Doxorubicin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1338512],
      "conceptName": ["Doxorubicin"]
    }
  },
  {
    "conceptId": [35804620],
    "regimenName": ["Fludarabine, Cyclophosphamide, ATG, then allo HSCT"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Cyclophosphamide": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "fludarabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1395557],
      "conceptName": ["fludarabine"]
    },
    "Mitoxantrone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1309188],
      "conceptName": ["Mitoxantrone"]
    },
    "alemtuzumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1312706],
      "conceptName": ["alemtuzumab"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Busulfan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1333357],
      "conceptName": ["Busulfan"]
    },
    "ibritumomab tiuxetan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19068830],
      "conceptName": ["ibritumomab tiuxetan"]
    },
    "Thiotepa": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19137385],
      "conceptName": ["Thiotepa"]
    },
    "ofatumumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [40167582],
      "conceptName": ["ofatumumab"]
    },
    "obinutuzumab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [44507676],
      "conceptName": ["obinutuzumab"]
    }
  },
  {
    "conceptId": [35804014],
    "regimenName": ["TAM6"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Melphalan": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1301267],
      "conceptName": ["Melphalan"]
    },
    "Cytarabine": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "rituximab": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Carmustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350066],
      "conceptName": ["Carmustine"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Dexamethasone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1518254],
      "conceptName": ["Dexamethasone"]
    },
    "bendamustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19015523],
      "conceptName": ["bendamustine"]
    },
    "ibritumomab tiuxetan": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [19068830],
      "conceptName": ["ibritumomab tiuxetan"]
    },
    "Fotemustine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [36879099],
      "conceptName": ["Fotemustine"]
    }
  },
  {
    "conceptId": [35804589],
    "regimenName": ["HDMP-R"],
    "validStartDate": ["2020-01-10"],
    "validEndDate": ["2099-12-31"],
    "invalidReason": [""],
    "includeDescendant": [true],
    "gapDateBetweenCycle": [40],
    "gapDateBefore": [30],
    "gapDateAfter": [20],
    "combinationCriteria": [7],
    "outofCohortPeriod": [false],
    "origin": ["Ajou University"],
    "Methylprednisolone": {
      "role": ["primary"],
      "table": ["drug_exposure"],
      "conceptId": [1506270],
      "conceptName": ["Methylprednisolone"]
    },
    "rituximab": {
      "role": ["secondary"],
      "table": ["drug_exposure"],
      "conceptId": [1314273],
      "conceptName": ["rituximab"]
    },
    "Cyclophosphamide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1310317],
      "conceptName": ["Cyclophosphamide"]
    },
    "Cytarabine": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1311078],
      "conceptName": ["Cytarabine"]
    },
    "Etoposide": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1350504],
      "conceptName": ["Etoposide"]
    },
    "Cisplatin": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1397599],
      "conceptName": ["Cisplatin"]
    },
    "Prednisone": {
      "role": ["excluded"],
      "table": ["drug_exposure"],
      "conceptId": [1551099],
      "conceptName": ["Prednisone"]
    }
  }
]
